,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
0,,578269,[],CHEMBL698856,Inhibition of Interleukin-1 receptor-associated kinase-4,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1,,,CHEMBL1145138,J. Med. Chem.,2003.0,,CHEMBL142425,,CHEMBL142425,,False,http://www.openphacts.org/units/Nanomolar,277081,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1,,1663207,[],CHEMBL863888,Inhibitory activity against IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,,,CHEMBL1148543,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL197603,,CHEMBL197603,,False,http://www.openphacts.org/units/Nanomolar,415316,>,1,True,>,,IC50,nM,,25000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,25.0
2,,1723345,[],CHEMBL861307,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,CCOc1nc(NC(C)=O)cc(N)c1C#N,,,CHEMBL1148638,J. Med. Chem.,2006.0,,CHEMBL208637,,CHEMBL208637,,False,http://www.openphacts.org/units/Nanomolar,492955,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,9900.0
3,,1723614,[],CHEMBL861307,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl,,,CHEMBL1148638,J. Med. Chem.,2006.0,,CHEMBL210928,,CHEMBL210928,,False,http://www.openphacts.org/units/Nanomolar,493010,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,9900.0
4,,1723615,[],CHEMBL861307,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1,,,CHEMBL1148638,J. Med. Chem.,2006.0,,CHEMBL210032,,CHEMBL210032,,False,http://www.openphacts.org/units/Nanomolar,493002,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,9900.0
5,,1723616,[],CHEMBL861307,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1,,,CHEMBL1148638,J. Med. Chem.,2006.0,,CHEMBL378627,,CHEMBL378627,,False,http://www.openphacts.org/units/Nanomolar,492990,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,9900.0
6,,1723617,[],CHEMBL861307,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N,,,CHEMBL1148638,J. Med. Chem.,2006.0,,CHEMBL210963,,CHEMBL210963,,False,http://www.openphacts.org/units/Nanomolar,492973,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,9900.0
7,,1723618,[],CHEMBL861307,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,,,CHEMBL1148638,J. Med. Chem.,2006.0,,CHEMBL210618,,CHEMBL210618,,False,http://www.openphacts.org/units/Nanomolar,492969,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,9900.0
8,,1724376,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.12', 'le': '0.35', 'lle': '2.68', 'sei': '5.35'}",CHEMBL210658,,CHEMBL210658,5.40,False,http://www.openphacts.org/units/Nanomolar,477133,=,1,True,=,,IC50,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.0
9,,1724377,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=[N+]([O-])c1cccc(CNc2nc3ccccc3[nH]2)c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL209668,,CHEMBL209668,,False,http://qudt.org/vocab/unit#Percent,477134,=,1,True,=,,Inhibition,%,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,8.0
10,,1724378,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1cccc([N+](=O)[O-])c1)Nc1nc2ccccc2[nH]1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210748,,CHEMBL210748,,False,http://qudt.org/vocab/unit#Percent,477135,=,1,True,=,,Inhibition,%,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,15.0
11,,1724379,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=[N+]([O-])c1cccc(S(=O)(=O)Nc2nc3ccccc3[nH]2)c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL208762,,CHEMBL208762,,False,http://qudt.org/vocab/unit#Percent,477136,=,1,True,=,,Inhibition,%,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,45.0
12,,1724380,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(C(=O)Nc2nc3ccccc3[nH]2)c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.56', 'le': '0.33', 'lle': '2.18', 'sei': '5.97'}",CHEMBL426133,,CHEMBL426133,4.87,False,http://www.openphacts.org/units/Nanomolar,477137,=,1,True,=,,IC50,nM,,13600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,13.6
13,,1724381,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2[nH]1)c1ccccc1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210730,,CHEMBL210730,,False,http://qudt.org/vocab/unit#Percent,477138,=,1,True,=,,Inhibition,%,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,11.0
14,,1724382,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2[nH]1)c1ccc(F)c([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.28', 'le': '0.32', 'lle': '2.33', 'sei': '5.14'}",CHEMBL209118,,CHEMBL209118,5.19,False,http://www.openphacts.org/units/Nanomolar,477139,=,1,True,=,,IC50,nM,,6500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,6.5
15,,1724383,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)Nc2nc3ccccc3[nH]2)cc1[N+](=O)[O-],,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.61', 'le': '0.31', 'lle': '1.89', 'sei': '4.88'}",CHEMBL209715,,CHEMBL209715,4.92,False,http://www.openphacts.org/units/Nanomolar,477140,=,1,True,=,,IC50,nM,,12000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,12.0
16,,1724384,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.84', 'le': '0.31', 'lle': '1.70', 'sei': '6.33'}",CHEMBL209716,,CHEMBL209716,5.70,False,http://www.openphacts.org/units/Nanomolar,477141,=,1,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.0
17,,1724385,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCn1c(NC(=O)c2cccc(Cl)c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.80', 'le': '0.27', 'lle': '-0.22', 'sei': '9.64'}",CHEMBL377654,,CHEMBL377654,4.52,False,http://www.openphacts.org/units/Nanomolar,477142,=,1,True,=,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
18,,1724386,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCn1c(NC(=O)c2ccc(Cl)c(Cl)c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.25', 'le': '0.31', 'lle': '0.12', 'sei': '11.77'}",CHEMBL209075,,CHEMBL209075,5.52,False,http://www.openphacts.org/units/Nanomolar,477143,=,1,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3.0
19,,1724387,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CCCCn1c(NC(=O)c2ccc([N+](=O)[O-])cc2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL425952,,CHEMBL425952,,False,http://qudt.org/vocab/unit#Percent,477144,=,1,True,=,,Inhibition,%,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,8.0
20,,1724388,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCn1c(NC(=O)c2ccc(OC)cc2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.04', 'le': '0.30', 'lle': '1.09', 'sei': '9.24'}",CHEMBL380097,,CHEMBL380097,5.19,False,http://www.openphacts.org/units/Nanomolar,477145,=,1,True,=,,IC50,nM,,6500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,6.5
21,,1724389,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1nc2ccc[nH]c-2n1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210375,,CHEMBL210375,,False,http://qudt.org/vocab/unit#Percent,477146,=,1,True,=,,Inhibition,%,,39.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,39.0
22,,1724390,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2cc[nH]cc-2n1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.97', 'le': '0.29', 'lle': '2.45', 'sei': '3.97'}",CHEMBL380009,,CHEMBL380009,4.52,False,http://www.openphacts.org/units/Nanomolar,477147,=,1,True,=,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
23,,1724391,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2s1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210875,,CHEMBL210875,,False,http://qudt.org/vocab/unit#Percent,477148,=,1,True,=,,Inhibition,%,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,11.0
24,,1724392,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2cc(Cl)ccc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.49', 'le': '0.32', 'lle': '1.84', 'sei': '5.17'}",CHEMBL210682,,CHEMBL210682,5.22,False,http://www.openphacts.org/units/Nanomolar,477149,=,1,True,=,,IC50,nM,,6000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,6.0
25,,1724393,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.81', 'le': '0.33', 'lle': '2.49', 'sei': '5.30'}",CHEMBL208116,,CHEMBL208116,5.35,False,http://www.openphacts.org/units/Nanomolar,477150,=,1,True,=,,IC50,nM,,4500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.5
26,,1724394,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '20.58', 'le': '0.38', 'lle': '3.07', 'sei': '6.04'}",CHEMBL377259,,CHEMBL377259,6.10,False,http://www.openphacts.org/units/Nanomolar,477151,=,1,True,=,,IC50,nM,,800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.8
27,,1724395,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.65', 'le': '0.35', 'lle': '3.09', 'sei': '5.29'}",CHEMBL206991,,CHEMBL206991,5.82,False,http://www.openphacts.org/units/Nanomolar,477152,=,1,True,=,,IC50,nM,,1500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.5
28,,1724396,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.52', 'le': '0.25', 'lle': '2.09', 'sei': '3.62'}",CHEMBL208561,,CHEMBL208561,4.60,False,http://www.openphacts.org/units/Nanomolar,477153,=,1,True,=,,IC50,nM,,25000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,25.0
29,,1724397,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCCS(=O)(=O)c1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.90', 'le': '0.27', 'lle': '2.49', 'sei': '4.00'}",CHEMBL209820,,CHEMBL209820,5.40,False,http://www.openphacts.org/units/Nanomolar,477154,=,1,True,=,,IC50,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.0
30,,1724398,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1nc2cc([N+](=O)[O-])ccc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210751,,CHEMBL210751,,False,http://qudt.org/vocab/unit#Percent,477155,=,1,True,=,,Inhibition,%,,29.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,29.0
31,,1724399,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1nc2c([N+](=O)[O-])cccc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL377640,,CHEMBL377640,,False,http://qudt.org/vocab/unit#Percent,477156,=,1,True,=,,Inhibition,%,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,25.0
32,,1724400,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)c(F)cc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.21', 'le': '0.27', 'lle': '1.52', 'sei': '4.48'}",CHEMBL208667,,CHEMBL208667,4.52,False,http://www.openphacts.org/units/Nanomolar,477157,=,1,True,=,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
33,,1724401,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1nc2cc(Cl)c(Cl)cc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210260,,CHEMBL210260,,False,http://qudt.org/vocab/unit#Percent,477158,=,1,True,=,,Inhibition,%,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,10.0
34,,1724402,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1nc2c(F)c(F)ccc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210311,,CHEMBL210311,,False,http://qudt.org/vocab/unit#Percent,477159,=,1,True,=,,Inhibition,%,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,24.0
35,,1724403,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2nc(NC(=O)c3cccc([N+](=O)[O-])c3)[nH]c2cc1C,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.43', 'le': '0.30', 'lle': '1.76', 'sei': '5.05'}",CHEMBL210821,,CHEMBL210821,5.10,False,http://www.openphacts.org/units/Nanomolar,477160,=,1,True,=,,IC50,nM,,8000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,8.0
36,,1724404,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.37', 'le': '0.34', 'lle': '2.48', 'sei': '6.33'}",CHEMBL210822,,CHEMBL210822,5.70,False,http://www.openphacts.org/units/Nanomolar,477161,=,1,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.0
37,,1724405,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)n1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.50', 'le': '0.34', 'lle': '2.22', 'sei': '6.66'}",CHEMBL209202,,CHEMBL209202,6.00,False,http://www.openphacts.org/units/Nanomolar,477162,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.0
38,,1724406,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,C=CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '18.62', 'le': '0.34', 'lle': '2.62', 'sei': '6.66'}",CHEMBL210774,,CHEMBL210774,6.00,False,http://www.openphacts.org/units/Nanomolar,477163,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.0
39,,1724407,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '13.33', 'le': '0.25', 'lle': '0.31', 'sei': '5.22'}",CHEMBL207226,,CHEMBL207226,4.70,False,http://www.openphacts.org/units/Nanomolar,477164,=,1,True,=,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
40,,1724408,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CCC1CCC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.64', 'le': '0.29', 'lle': '1.31', 'sei': '6.33'}",CHEMBL208166,,CHEMBL208166,5.70,False,http://www.openphacts.org/units/Nanomolar,477165,=,1,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.0
41,,1724409,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.63', 'le': '0.33', 'lle': '3.16', 'sei': '6.04'}",CHEMBL210354,,CHEMBL210354,6.00,False,http://www.openphacts.org/units/Nanomolar,477166,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.0
42,,1724410,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.08', 'le': '0.30', 'lle': '2.47', 'sei': '5.74'}",CHEMBL210366,,CHEMBL210366,5.70,False,http://www.openphacts.org/units/Nanomolar,477167,=,1,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.0
43,,1724411,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)Cn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.37', 'le': '0.32', 'lle': '3.64', 'sei': '5.50'}",CHEMBL210194,,CHEMBL210194,6.40,False,http://www.openphacts.org/units/Nanomolar,477168,=,1,True,=,,IC50,nM,,400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.4
44,,1724412,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.69', 'le': '0.29', 'lle': '2.85', 'sei': '5.16'}",CHEMBL208709,,CHEMBL208709,6.00,False,http://www.openphacts.org/units/Nanomolar,477169,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.0
45,,1724413,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1C1CCOC1=O)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.09', 'le': '0.32', 'lle': '3.58', 'sei': '5.38'}",CHEMBL207464,,CHEMBL207464,6.26,False,http://www.openphacts.org/units/Nanomolar,477170,=,1,True,=,,IC50,nM,,550.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.55
46,,1724414,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CC1CCCO1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '17.20', 'le': '0.32', 'lle': '2.92', 'sei': '6.35'}",CHEMBL210983,,CHEMBL210983,6.30,False,http://www.openphacts.org/units/Nanomolar,477171,=,1,True,=,,IC50,nM,,500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.5
47,,1724415,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CCO)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '19.61', 'le': '0.36', 'lle': '4.21', 'sei': '5.80'}",CHEMBL379985,,CHEMBL379985,6.40,False,http://www.openphacts.org/units/Nanomolar,477172,=,1,True,=,,IC50,nM,,400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.4
48,,1724416,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '20.05', 'le': '0.37', 'lle': '4.24', 'sei': '6.19'}",CHEMBL210887,,CHEMBL210887,6.82,False,http://www.openphacts.org/units/Nanomolar,477173,=,1,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.15
49,,1724417,[],CHEMBL870863,Inhibition of IRAK4 at 30 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)Cn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL209817,,CHEMBL209817,,False,http://qudt.org/vocab/unit#Percent,477174,=,1,True,=,,Inhibition,%,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,38.0
50,,1724418,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '15.23', 'le': '0.28', 'lle': '2.73', 'sei': '4.24'}",CHEMBL377125,,CHEMBL377125,5.40,False,http://www.openphacts.org/units/Nanomolar,477175,=,1,True,=,,IC50,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.0
51,,1724419,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.69', 'le': '0.27', 'lle': '2.25', 'sei': '5.79'}",CHEMBL377801,,CHEMBL377801,5.40,False,http://www.openphacts.org/units/Nanomolar,477176,=,1,True,=,,IC50,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.0
52,,1724420,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '14.48', 'le': '0.27', 'lle': '1.98', 'sei': '5.92'}",CHEMBL378693,,CHEMBL378693,5.52,False,http://www.openphacts.org/units/Nanomolar,477177,=,1,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3.0
53,,1724421,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,"{'bei': '16.94', 'le': '0.32', 'lle': '4.17', 'sei': '6.53'}",CHEMBL379787,,CHEMBL379787,6.70,False,http://www.openphacts.org/units/Nanomolar,477178,=,1,True,=,,IC50,nM,,200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.2
54,,1724422,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,C=CCN(C(=O)c1cccc([N+](=O)[O-])c1)c1nc2ccccc2n1CC=C,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL210714,,CHEMBL210714,,False,http://www.openphacts.org/units/Nanomolar,477179,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
55,,1724423,[],CHEMBL870864,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C(=O)c1cccc([N+](=O)[O-])c1)c1nc2ccccc2n1C1CCOC1=O,,,CHEMBL1147720,Bioorg. Med. Chem. Lett.,2006.0,,CHEMBL208743,,CHEMBL208743,,False,http://www.openphacts.org/units/Nanomolar,477180,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
56,,1744444,[],CHEMBL866115,Inhibition of Irak4,B,,,BAO_0000192,BAO_0000357,single protein format,CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl,,,CHEMBL1138045,J. Med. Chem.,2006.0,,CHEMBL377383,,CHEMBL377383,,False,http://www.openphacts.org/units/Nanomolar,501943,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,9.9
57,,1824559,[],CHEMBL914324,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2,,,CHEMBL1142994,J. Med. Chem.,2007.0,,CHEMBL223367,,CHEMBL223367,,False,http://www.openphacts.org/units/Nanomolar,628447,>,1,True,>,,Ki,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,10.0
58,,1824602,[],CHEMBL914324,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2,,,CHEMBL1142994,J. Med. Chem.,2007.0,,CHEMBL223460,,CHEMBL223460,,False,http://www.openphacts.org/units/Nanomolar,628438,>,1,True,>,,Ki,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,10.0
59,,1824731,[],CHEMBL914324,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2,,,CHEMBL1142994,J. Med. Chem.,2007.0,,CHEMBL373598,,CHEMBL373598,,False,http://www.openphacts.org/units/Nanomolar,628405,>,1,True,>,,Ki,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,10.0
60,,2050276,[],CHEMBL925573,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1,,,CHEMBL1140541,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL400754,,CHEMBL400754,,False,http://qudt.org/vocab/unit#Percent,680458,=,1,True,=,,Inhibition,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.0
61,,2051629,[],CHEMBL941767,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2,,,CHEMBL1140564,Bioorg. Med. Chem. Lett.,2007.0,,CHEMBL248757,,CHEMBL248757,,False,http://www.openphacts.org/units/Nanomolar,680853,>,1,True,>,,Ki,nM,,9921.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,9.921
62,,2081799,[],CHEMBL928822,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1,,,CHEMBL1141535,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL404115,,CHEMBL404115,,False,http://qudt.org/vocab/unit#Percent,690111,<=,1,True,<=,,Inhibition,%,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,20.0
63,,2147286,[],CHEMBL921876,Activity of human IRAK4 kinase at 1 uM,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,,,CHEMBL1147076,Proc. Natl. Acad. Sci. U.S.A.,2007.0,,CHEMBL259084,MLN-8054,CHEMBL259084,,False,http://qudt.org/vocab/unit#Percent,709269,=,1,False,=,,Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,97.0
64,,2170950,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.58', 'le': '0.36', 'lle': '1.44', 'sei': '10.12'}",CHEMBL258853,,CHEMBL258853,5.55,False,http://www.openphacts.org/units/Nanomolar,697354,=,1,True,=,,IC50,nM,,2800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.8
65,,2170952,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N2CCOCC2)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.29', 'le': '0.38', 'lle': '5.13', 'sei': '8.33'}",CHEMBL256713,,CHEMBL256713,7.70,False,http://www.openphacts.org/units/Nanomolar,697379,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.02
66,,2170953,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N2CCN(C)CC2)ccc1NC(=O)c1cccc(-c2cnn(C)c2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.69', 'le': '0.29', 'lle': '3.89', 'sei': '8.44'}",CHEMBL256717,,CHEMBL256717,6.38,False,http://www.openphacts.org/units/Nanomolar,697378,=,1,True,=,,IC50,nM,,420.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.42
67,,2170954,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2cccc(C(=O)Nc3ccccc3Cl)n2)cn1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '19.66', 'le': '0.38', 'lle': '2.76', 'sei': '10.28'}",CHEMBL256917,,CHEMBL256917,6.15,False,http://www.openphacts.org/units/Nanomolar,697377,=,1,True,=,,IC50,nM,,710.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.71
68,,2170955,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1cccc(-c2cn[nH]c2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.69', 'le': '0.40', 'lle': '2.80', 'sei': '8.75'}",CHEMBL256719,,CHEMBL256719,6.18,False,http://www.openphacts.org/units/Nanomolar,697376,=,1,True,=,,IC50,nM,,660.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.66
69,,2170956,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1cccc(-c2ccn[nH]2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '19.40', 'le': '0.38', 'lle': '2.42', 'sei': '8.20'}",CHEMBL257366,,CHEMBL257366,5.80,False,http://www.openphacts.org/units/Nanomolar,697375,=,1,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.6
70,,2170957,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2cccc(C(=O)Nc3ccccc3Cl)n2)cn1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL256345,,CHEMBL256345,,False,http://www.openphacts.org/units/Nanomolar,697374,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
71,,2170958,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1cccc(-c2cncnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL402104,,CHEMBL402104,,False,http://www.openphacts.org/units/Nanomolar,697373,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
72,,2170959,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1cccc(-c2cncs2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL428598,,CHEMBL428598,,False,http://www.openphacts.org/units/Nanomolar,697372,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
73,,2170960,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1cccc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.65', 'le': '0.34', 'lle': '1.42', 'sei': '9.96'}",CHEMBL257125,,CHEMBL257125,5.47,False,http://www.openphacts.org/units/Nanomolar,697371,=,1,True,=,,IC50,nM,,3400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3.4
74,,2170961,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N2CCN(C)CC2)ccc1NC(=O)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.76', 'le': '0.30', 'lle': '3.24', 'sei': '9.15'}",CHEMBL257127,,CHEMBL257127,6.46,False,http://www.openphacts.org/units/Nanomolar,697370,=,1,True,=,,IC50,nM,,350.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.35
75,,2170962,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N2CCOCC2)ccc1NC(=O)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.14', 'le': '0.33', 'lle': '3.50', 'sei': '8.87'}",CHEMBL403662,,CHEMBL403662,6.80,False,http://www.openphacts.org/units/Nanomolar,697369,=,1,True,=,,IC50,nM,,160.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.16
76,,2170963,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(NC(=O)c2csc(-c3cccnc3)n2)c(OC)c1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.34', 'le': '0.34', 'lle': '2.45', 'sei': '8.07'}",CHEMBL404514,,CHEMBL404514,5.92,False,http://www.openphacts.org/units/Nanomolar,697368,=,1,True,=,,IC50,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.2
77,,2170964,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1NC(=O)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL254545,,CHEMBL254545,,False,http://www.openphacts.org/units/Nanomolar,697367,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
78,,2170965,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1c(Cl)cccc1Cl)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL255503,,CHEMBL255503,,False,http://www.openphacts.org/units/Nanomolar,697366,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
79,,2170966,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(N2CCOCC2)cc1)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.15', 'le': '0.29', 'lle': '2.26', 'sei': '8.24'}",CHEMBL414028,,CHEMBL414028,5.55,False,http://www.openphacts.org/units/Nanomolar,697365,=,1,True,=,,IC50,nM,,2800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.8
80,,2170967,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(NC(=O)c3csc(-c4cccnc4)n3)cc2)CC1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.22', 'le': '0.31', 'lle': '2.94', 'sei': '10.03'}",CHEMBL254546,,CHEMBL254546,6.16,False,http://www.openphacts.org/units/Nanomolar,697364,=,1,True,=,,IC50,nM,,700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.7
81,,2170968,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(N2CCCCC2)cc1)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.42', 'le': '0.30', 'lle': '1.17', 'sei': '9.67'}",CHEMBL407821,,CHEMBL407821,5.62,False,http://www.openphacts.org/units/Nanomolar,697363,=,1,True,=,,IC50,nM,,2400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.4
82,,2170970,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(NC(=O)c2csc(-c3cccnc3)n2)cc1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.44', 'le': '0.34', 'lle': '1.96', 'sei': '8.47'}",CHEMBL265923,,CHEMBL265923,5.43,False,http://www.openphacts.org/units/Nanomolar,697362,=,1,True,=,,IC50,nM,,3700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3.7
83,,2170971,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(NC(=O)c2csc(-c3cccnc3)n2)c1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.22', 'le': '0.31', 'lle': '1.58', 'sei': '7.88'}",CHEMBL408077,,CHEMBL408077,5.05,False,http://www.openphacts.org/units/Nanomolar,697361,=,1,True,=,,IC50,nM,,8900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,8.9
84,,2170972,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(NC(=O)c2csc(-c3cccnc3)n2)c1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '18.01', 'le': '0.35', 'lle': '1.55', 'sei': '9.69'}",CHEMBL259375,,CHEMBL259375,5.32,False,http://www.openphacts.org/units/Nanomolar,697360,=,1,True,=,,IC50,nM,,4800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.8
85,,2170973,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1OC(F)F)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.27', 'le': '0.34', 'lle': '1.94', 'sei': '9.36'}",CHEMBL408383,,CHEMBL408383,6.00,False,http://www.openphacts.org/units/Nanomolar,697359,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.0
86,,2170974,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1NC(=O)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '19.58', 'le': '0.38', 'lle': '2.63', 'sei': '9.51'}",CHEMBL259797,,CHEMBL259797,6.10,False,http://www.openphacts.org/units/Nanomolar,697358,=,1,True,=,,IC50,nM,,800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.8
87,,2170975,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccccc1NC(=O)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL260007,,CHEMBL260007,,False,http://www.openphacts.org/units/Nanomolar,697357,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
88,,2170976,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1NC(=O)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.39', 'le': '0.33', 'lle': '1.37', 'sei': '9.36'}",CHEMBL259213,,CHEMBL259213,5.14,False,http://www.openphacts.org/units/Nanomolar,697356,=,1,True,=,,IC50,nM,,7300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,7.3
89,,2170977,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1)c1csc(-c2cccnc2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '18.28', 'le': '0.35', 'lle': '1.68', 'sei': '9.37'}",CHEMBL260339,,CHEMBL260339,5.14,False,http://www.openphacts.org/units/Nanomolar,697355,=,1,True,=,,IC50,nM,,7200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,7.2
90,,2171002,[],CHEMBL936449,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1csc(-c2ccc[n+]([O-])c2)n1,,,CHEMBL1143094,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.56', 'le': '0.32', 'lle': '1.81', 'sei': '7.49'}",CHEMBL255235,,CHEMBL255235,5.16,False,http://www.openphacts.org/units/Nanomolar,697380,=,1,True,=,,IC50,nM,,6900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,6.9
91,,2172515,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccn2c(-c3ccnc(NC4CCNCC4)n3)cnc2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.64', 'le': '0.41', 'lle': '4.71', 'sei': '9.93'}",CHEMBL255098,,CHEMBL255098,6.67,False,http://www.openphacts.org/units/Nanomolar,710491,=,1,True,=,,IC50,nM,,216.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,216.0
92,,2172516,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2ncc(-c3cccc(N[C@@H]4CCCNC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.06', 'le': '0.40', 'lle': '4.59', 'sei': '9.00'}",CHEMBL403210,,CHEMBL403210,7.02,False,http://www.openphacts.org/units/Nanomolar,710534,=,1,True,=,,IC50,nM,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,95.0
93,,2172517,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2ncc(-c3cccc(NC4CNC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '27.61', 'le': '0.51', 'lle': '6.36', 'sei': '12.85'}",CHEMBL403433,,CHEMBL403433,8.15,False,http://www.openphacts.org/units/Nanomolar,710533,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
94,,2172518,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2ncc(-c3cccc(NC4CCCNC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.54', 'le': '0.48', 'lle': '4.84', 'sei': '14.83'}",CHEMBL256961,,CHEMBL256961,8.05,False,http://www.openphacts.org/units/Nanomolar,710532,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
95,,2172519,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2ncc(-c3cccc(NC4CCNC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '28.68', 'le': '0.56', 'lle': '6.18', 'sei': '16.59'}",CHEMBL401633,,CHEMBL401633,9.00,False,http://www.openphacts.org/units/Nanomolar,710531,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
96,,2172520,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2ncc(-c3cccc(NC4CNC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '27.43', 'le': '0.53', 'lle': '5.79', 'sei': '15.16'}",CHEMBL256963,,CHEMBL256963,8.22,False,http://www.openphacts.org/units/Nanomolar,710530,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
97,,2172521,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2cnc3ccccn23)nc(N2CCCNCC2)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.52', 'le': '0.39', 'lle': '4.11', 'sei': '13.89'}",CHEMBL403490,,CHEMBL403490,6.31,False,http://www.openphacts.org/units/Nanomolar,710529,=,1,True,=,,IC50,nM,,487.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,487.0
98,,2172522,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCN(c2cccc(-c3cnc4ccccn34)n2)C1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.38', 'le': '0.39', 'lle': '3.95', 'sei': '10.55'}",CHEMBL404142,,CHEMBL404142,6.27,False,http://www.openphacts.org/units/Nanomolar,710528,=,1,True,=,,IC50,nM,,535.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,535.0
99,,2172523,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(c2cccc(-c3cnc4ccccn34)n2)CC1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '19.52', 'le': '0.36', 'lle': '3.41', 'sei': '9.63'}",CHEMBL402079,,CHEMBL402079,5.73,False,http://www.openphacts.org/units/Nanomolar,710527,=,1,True,=,,IC50,nM,,1880.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1880.0
100,,2172524,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2cnc3ccccn23)nc(N2C[C@H]3C[C@@H]2CN3)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '23.68', 'le': '0.43', 'lle': '4.95', 'sei': '15.18'}",CHEMBL402080,,CHEMBL402080,6.90,False,http://www.openphacts.org/units/Nanomolar,710526,=,1,True,=,,IC50,nM,,126.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,126.0
101,,2172525,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(N[C@H]2CCCNC2)nc(-c2cnc3ccccn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.32', 'le': '0.48', 'lle': '5.16', 'sei': '14.23'}",CHEMBL256504,,CHEMBL256504,7.72,False,http://www.openphacts.org/units/Nanomolar,710525,=,1,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
102,,2172526,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNC2)nc(-c2cnc3ccccn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.42', 'le': '0.41', 'lle': '4.09', 'sei': '11.55'}",CHEMBL402344,,CHEMBL402344,6.26,False,http://www.openphacts.org/units/Nanomolar,710524,=,1,True,=,,IC50,nM,,545.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,545.0
103,,2172527,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CNC2)nc(-c2cnc3ccccn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '27.92', 'le': '0.51', 'lle': '5.63', 'sei': '13.66'}",CHEMBL437208,,CHEMBL437208,7.41,False,http://www.openphacts.org/units/Nanomolar,710523,=,1,True,=,,IC50,nM,,39.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,39.0
104,,2172528,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NCC2CCCN2)nc(-c2cnc3ccccn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.17', 'le': '0.40', 'lle': '3.94', 'sei': '11.99'}",CHEMBL403395,,CHEMBL403395,6.50,False,http://www.openphacts.org/units/Nanomolar,710522,=,1,True,=,,IC50,nM,,313.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,313.0
105,,2172529,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NCC2CCNCC2)nc(-c2cnc3ccccn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.95', 'le': '0.33', 'lle': '2.71', 'sei': '10.17'}",CHEMBL255439,,CHEMBL255439,5.52,False,http://www.openphacts.org/units/Nanomolar,710521,=,1,True,=,,IC50,nM,,3030.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3030.0
106,,2172530,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2C[C@@H]3CC[C@H](C2)N3)nc(-c2cnc3ccccn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.81', 'le': '0.38', 'lle': '3.56', 'sei': '12.25'}",CHEMBL402295,,CHEMBL402295,6.65,False,http://www.openphacts.org/units/Nanomolar,710520,=,1,True,=,,IC50,nM,,225.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,225.0
107,,2172531,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN1[C@H]2CC[C@@H]1CC(Nc1cccc(-c3cnc4ccccn34)n1)C2,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '18.11', 'le': '0.33', 'lle': '2.61', 'sei': '13.28'}",CHEMBL255253,,CHEMBL255253,6.04,False,http://www.openphacts.org/units/Nanomolar,710519,=,1,True,=,,IC50,nM,,914.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,914.0
108,,2172532,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCNc1cccc(-c2cnc3ccccn23)n1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.02', 'le': '0.40', 'lle': '3.73', 'sei': '8.63'}",CHEMBL256513,,CHEMBL256513,5.89,False,http://www.openphacts.org/units/Nanomolar,710518,=,1,True,=,,IC50,nM,,1300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1300.0
109,,2172533,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCNc1cccc(-c2cnc3ccccn23)n1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '17.24', 'le': '0.32', 'lle': '2.33', 'sei': '11.20'}",CHEMBL258025,,CHEMBL258025,5.09,False,http://www.openphacts.org/units/Nanomolar,710517,=,1,True,=,,IC50,nM,,8100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8100.0
110,,2172534,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cnc(CNc2cccc(-c3cnc4ccccn34)n2)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.71', 'le': '0.37', 'lle': '3.56', 'sei': '10.50'}",CHEMBL258024,,CHEMBL258024,6.30,False,http://www.openphacts.org/units/Nanomolar,710516,=,1,True,=,,IC50,nM,,497.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,497.0
111,,2172535,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nccc1Nc1cccc(-c2cnc3ccccn23)n1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.48', 'le': '0.37', 'lle': '3.08', 'sei': '9.90'}",CHEMBL258233,,CHEMBL258233,5.95,False,http://www.openphacts.org/units/Nanomolar,710515,=,1,True,=,,IC50,nM,,1134.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1134.0
112,,2172536,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccccc1Nc1cccc(-c2cnc3ccccn23)n1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.44', 'le': '0.36', 'lle': '2.35', 'sei': '9.64'}",CHEMBL404471,,CHEMBL404471,6.36,False,http://www.openphacts.org/units/Nanomolar,710513,=,1,True,=,,IC50,nM,,433.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,433.0
113,,2172537,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2cccc(-c3cnc4ccccn34)n2)cc1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.73', 'le': '0.37', 'lle': '1.80', 'sei': '14.06'}",CHEMBL256734,,CHEMBL256734,5.94,False,http://www.openphacts.org/units/Nanomolar,710512,=,1,True,=,,IC50,nM,,1156.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1156.0
114,,2172538,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)c1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.06', 'le': '0.37', 'lle': '5.05', 'sei': '9.80'}",CHEMBL256733,,CHEMBL256733,7.31,False,http://www.openphacts.org/units/Nanomolar,710511,=,1,True,=,,IC50,nM,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,49.0
115,,2172539,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1)N1CCOCC1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '16.19', 'le': '0.30', 'lle': '4.55', 'sei': '7.85'}",CHEMBL256735,,CHEMBL256735,6.58,False,http://www.openphacts.org/units/Nanomolar,710510,=,1,True,=,,IC50,nM,,263.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,263.0
116,,2172540,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.68', 'le': '0.45', 'lle': '6.64', 'sei': '8.53'}",CHEMBL403358,,CHEMBL403358,8.30,False,http://www.openphacts.org/units/Nanomolar,710509,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
117,,2172541,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-c2cnc3ccc(-c4ccc[nH]4)cn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.09', 'le': '0.36', 'lle': '3.64', 'sei': '10.28'}",CHEMBL255445,,CHEMBL255445,7.20,False,http://www.openphacts.org/units/Nanomolar,710508,=,1,True,=,,IC50,nM,,63.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,63.0
118,,2172542,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-c2cnc3ccc(-c4cc[nH]n4)cn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.20', 'le': '0.44', 'lle': '5.75', 'sei': '10.49'}",CHEMBL255867,,CHEMBL255867,8.70,False,http://www.openphacts.org/units/Nanomolar,710507,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
119,,2172543,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc3ncc(-c4cccc(NC5CCNCC5)n4)n3c2)cn1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.84', 'le': '0.40', 'lle': '5.19', 'sei': '11.32'}",CHEMBL255446,,CHEMBL255446,8.15,False,http://www.openphacts.org/units/Nanomolar,710506,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
120,,2172544,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2ccc3ncc(-c4cccc(NC5CCNCC5)n4)n3c2)cn1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.22', 'le': '0.37', 'lle': '4.47', 'sei': '10.60'}",CHEMBL402361,,CHEMBL402361,8.10,False,http://www.openphacts.org/units/Nanomolar,710505,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
121,,2172545,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.38', 'le': '0.48', 'lle': '5.97', 'sei': '10.76'}",CHEMBL255873,,CHEMBL255873,8.40,False,http://www.openphacts.org/units/Nanomolar,710504,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
122,,2172546,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '25.42', 'le': '0.47', 'lle': '5.65', 'sei': '12.95'}",CHEMBL402629,,CHEMBL402629,8.22,False,http://www.openphacts.org/units/Nanomolar,710503,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
123,,2172547,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '27.45', 'le': '0.53', 'lle': '5.79', 'sei': '16.59'}",CHEMBL256570,,CHEMBL256570,9.00,False,http://www.openphacts.org/units/Nanomolar,710502,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
124,,2172548,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(c1)ncn2-c1cccc(NC2CCNCC2)n1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '19.40', 'le': '0.35', 'lle': '3.07', 'sei': '10.89'}",CHEMBL404472,,CHEMBL404472,5.96,False,http://www.openphacts.org/units/Nanomolar,710501,=,1,True,=,,IC50,nM,,1085.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1085.0
125,,2172549,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2ncn(-c3cccc(NC4CCNCC4)n3)c2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.02', 'le': '0.48', 'lle': '5.11', 'sei': '14.61'}",CHEMBL404473,,CHEMBL404473,8.00,False,http://www.openphacts.org/units/Nanomolar,710500,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
126,,2172550,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cc2ncn(-c3cccc(NC4CCNCC4)n3)c2cc1Cl,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '18.72', 'le': '0.39', 'lle': '2.89', 'sei': '12.38'}",CHEMBL256942,,CHEMBL256942,6.78,False,http://www.openphacts.org/units/Nanomolar,710499,=,1,True,=,,IC50,nM,,166.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,166.0
127,,2172551,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2c(c1)ncn2-c1cccc(NC2CCNCC2)n1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.20', 'le': '0.41', 'lle': '3.71', 'sei': '12.69'}",CHEMBL403442,,CHEMBL403442,6.95,False,http://www.openphacts.org/units/Nanomolar,710498,=,1,True,=,,IC50,nM,,112.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,112.0
128,,2172552,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc2ncn(-c3cccc(NC4CCNCC4)n3)c2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '26.00', 'le': '0.51', 'lle': '5.28', 'sei': '15.56'}",CHEMBL436653,,CHEMBL436653,8.52,False,http://www.openphacts.org/units/Nanomolar,710497,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
129,,2172553,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncn(-c3cccc(NC4CCNCC4)n3)c2cc1OC,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '19.08', 'le': '0.35', 'lle': '4.14', 'sei': '9.21'}",CHEMBL402612,,CHEMBL402612,6.74,False,http://www.openphacts.org/units/Nanomolar,710496,=,1,True,=,,IC50,nM,,181.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,181.0
130,,2172554,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)ncn2-c1cccc(NC2CCNCC2)n1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.66', 'le': '0.38', 'lle': '4.09', 'sei': '10.44'}",CHEMBL255935,,CHEMBL255935,6.68,False,http://www.openphacts.org/units/Nanomolar,710495,=,1,True,=,,IC50,nM,,208.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,208.0
131,,2172555,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2ncn(-c3cccc(NC4CCNCC4)n3)c2c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.19', 'le': '0.45', 'lle': '5.23', 'sei': '12.22'}",CHEMBL402174,,CHEMBL402174,7.82,False,http://www.openphacts.org/units/Nanomolar,710494,=,1,True,=,,IC50,nM,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.0
132,,2172556,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-n2cnc3ccccc32)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.39', 'le': '0.44', 'lle': '4.57', 'sei': '13.06'}",CHEMBL255272,,CHEMBL255272,7.16,False,http://www.openphacts.org/units/Nanomolar,710493,=,1,True,=,,IC50,nM,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,70.0
133,,2172557,[],CHEMBL921622,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-c2cnc3ccccn23)c1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '25.41', 'le': '0.46', 'lle': '4.90', 'sei': '13.74'}",CHEMBL258004,,CHEMBL258004,7.46,False,http://www.openphacts.org/units/Nanomolar,710492,=,1,True,=,,IC50,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,35.0
134,,2172558,[],CHEMBL921623,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1ccc(Nc2cccc(-c3cnc4ccccn34)n2)cc1,,,CHEMBL1145577,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL258026,,CHEMBL258026,,False,http://qudt.org/vocab/unit#Percent,710514,=,1,True,=,,Inhibition,%,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,12.0
135,,2182814,[],CHEMBL941440,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12,,,CHEMBL1156476,J. Biol. Chem.,2007.0,,CHEMBL179242,,CHEMBL179242,,False,http://qudt.org/vocab/unit#Percent,791691,=,1,True,=,,Inhibition,%,,-5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-5.0
136,,2248241,[],CHEMBL1012695,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1,,,CHEMBL1139352,J. Med. Chem.,2009.0,,CHEMBL183906,,CHEMBL183906,,False,http://qudt.org/vocab/unit#Percent,776827,=,1,True,=,,Inhibition,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.0
137,,2248242,[],CHEMBL1012695,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1,,,CHEMBL1139352,J. Med. Chem.,2009.0,,CHEMBL84558,,CHEMBL84558,,False,http://qudt.org/vocab/unit#Percent,776960,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
138,,2348629,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccn2c(-c3ccnc(NC4CCNCC4)n3)cnc2c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '22.64', 'le': '0.41', 'lle': '4.71', 'sei': '9.93'}",CHEMBL255098,,CHEMBL255098,6.67,True,http://www.openphacts.org/units/Nanomolar,794944,=,1,True,=,,IC50,nM,,216.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,216.0
139,,2348632,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)CN1CCC(Nc2nccc(-c3cnc4ccccn34)n2)CC1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '15.11', 'le': '0.28', 'lle': '4.11', 'sei': '6.32'}",CHEMBL485323,,CHEMBL485323,5.52,False,http://www.openphacts.org/units/Nanomolar,794945,=,1,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3.0
140,,2348634,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1nccc(-c2cnc3ccccn23)n1)C1CCNCC1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.72', 'le': '0.40', 'lle': '4.72', 'sei': '11.48'}",CHEMBL485324,,CHEMBL485324,6.70,False,http://www.openphacts.org/units/Nanomolar,794946,=,1,True,=,,IC50,nM,,200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,200.0
141,,2348637,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccn2c(-c3ccnc(OC4CCNCC4)n3)cnc2c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.06', 'le': '0.37', 'lle': '4.00', 'sei': '9.21'}",CHEMBL482709,,CHEMBL482709,5.92,False,http://www.openphacts.org/units/Nanomolar,795026,=,1,True,=,,IC50,nM,,1189.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1189.0
142,,2348642,[],CHEMBL956502,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,c1ccn2c(-c3ccnc(NC4CCNCC4)c3)cnc2c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL482511,,CHEMBL482511,,False,http://qudt.org/vocab/unit#Percent,795028,=,1,True,=,,Inhibition,%,,31.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,31.0
143,,2348645,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1nccc(-c2cnc3ccccn23)n1)C1CCCCC1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '20.81', 'le': '0.38', 'lle': '2.84', 'sei': '13.81'}",CHEMBL482708,,CHEMBL482708,6.40,False,http://www.openphacts.org/units/Nanomolar,795029,=,1,True,=,,IC50,nM,,400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,400.0
144,,2348647,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-n2cnc3ccccc32)c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '24.39', 'le': '0.44', 'lle': '4.57', 'sei': '13.06'}",CHEMBL255272,,CHEMBL255272,7.16,True,http://www.openphacts.org/units/Nanomolar,795030,=,1,True,=,,IC50,nM,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,70.0
145,,2348650,[],CHEMBL956502,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-n2ccc3ccccc32)c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,,CHEMBL483315,,CHEMBL483315,,False,http://qudt.org/vocab/unit#Percent,795031,=,1,True,=,,Inhibition,%,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,30.0
146,,2348653,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-c2n[nH]c3ccccc23)c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '21.61', 'le': '0.39', 'lle': '3.55', 'sei': '9.66'}",CHEMBL500069,,CHEMBL500069,6.34,False,http://www.openphacts.org/units/Nanomolar,795115,=,1,True,=,,IC50,nM,,456.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,456.0
147,,2348656,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-c2cncc3ccccc23)c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '18.77', 'le': '0.34', 'lle': '2.25', 'sei': '11.46'}",CHEMBL482522,,CHEMBL482522,5.71,False,http://www.openphacts.org/units/Nanomolar,795116,=,1,True,=,,IC50,nM,,1934.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1934.0
148,,2348659,[],CHEMBL956501,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)nc(-c2cnc3ccccn23)c1,,,CHEMBL1150395,Bioorg. Med. Chem. Lett.,2008.0,"{'bei': '25.41', 'le': '0.46', 'lle': '4.90', 'sei': '13.74'}",CHEMBL258004,,CHEMBL258004,7.46,True,http://www.openphacts.org/units/Nanomolar,795027,=,1,True,=,,IC50,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,35.0
149,,2357003,[],CHEMBL964657,Inhibition of IRAK4 at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1,,,CHEMBL1150317,J. Med. Chem.,2008.0,,CHEMBL525893,,CHEMBL525893,,False,http://qudt.org/vocab/unit#Percent,766945,>,1,True,>,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
150,,2511589,[],CHEMBL973443,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1138507,J. Med. Chem.,2009.0,"{'bei': '16.01', 'le': '0.29', 'lle': '3.12', 'sei': '10.75'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.47,False,http://www.openphacts.org/units/Nanomolar,735412,=,1,True,=,,IC50,nM,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.034
151,,2639181,[],CHEMBL970459,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1,,,CHEMBL1136908,Bioorg. Med. Chem. Lett.,2009.0,"{'bei': '14.94', 'le': '0.29', 'lle': '2.11', 'sei': '7.48'}",CHEMBL494221,,CHEMBL494221,5.64,False,http://www.openphacts.org/units/Nanomolar,756670,=,1,True,=,,Ki,nM,,2300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,2300.0
152,,2639182,[],CHEMBL970459,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1,,,CHEMBL1136908,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL493169,,CHEMBL493169,,False,http://www.openphacts.org/units/Nanomolar,756435,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,4000.0
153,,2721631,[],CHEMBL1057459,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F,,,CHEMBL1154027,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL551079,,CHEMBL551079,,False,http://qudt.org/vocab/unit#Percent,830551,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
154,,2926264,[],CHEMBL1056937,Inhibition of IRAK4 assessed as remaining enzyme activity at 3 uM relative to DMSO,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12,,,CHEMBL1154183,J. Med. Chem.,2009.0,,CHEMBL574236,,CHEMBL574236,,False,http://qudt.org/vocab/unit#Percent,850263,=,1,False,=,,Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,93.0
155,,2928450,[],CHEMBL1049948,Inhibition of IRAK4 assessed as remaining enzyme activity at 1 uM relative to DMSO,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12,,,CHEMBL1154183,J. Med. Chem.,2009.0,,CHEMBL566515,,CHEMBL566515,,False,http://qudt.org/vocab/unit#Percent,850094,=,1,False,=,,Activity,%,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,82.0
156,,2938412,[],CHEMBL1038679,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1,,,CHEMBL1154622,J. Med. Chem.,2009.0,,CHEMBL583042,,CHEMBL583042,,False,http://www.openphacts.org/units/Nanomolar,853617,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
157,Not Active,2938612,[],CHEMBL1040625,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1,,,CHEMBL1154675,J. Med. Chem.,2009.0,,CHEMBL565286,,CHEMBL565286,,False,,852232,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
158,,2943262,[],CHEMBL1060312,Inhibition of IRAK4 by HTRF assay,B,,,BAO_0000192,BAO_0000357,single protein format,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1sc1ccc(-c3ccc(O)cc3)cc12,,,CHEMBL1154637,J. Med. Chem.,2009.0,,CHEMBL583187,,CHEMBL583187,,False,http://www.openphacts.org/units/Nanomolar,849004,>,1,True,>,,Ki,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,microM,UO_0000065,,1.0
159,,2943263,[],CHEMBL1060312,Inhibition of IRAK4 by HTRF assay,B,,,BAO_0000192,BAO_0000357,single protein format,O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12,,,CHEMBL1154637,J. Med. Chem.,2009.0,,CHEMBL583144,,CHEMBL583144,,False,http://www.openphacts.org/units/Nanomolar,849065,>,1,True,>,,Ki,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,microM,UO_0000065,,1.0
160,,2985702,[],CHEMBL1037172,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1O,,,CHEMBL1156143,J. Med. Chem.,2009.0,,CHEMBL9941,,CHEMBL9941,,False,http://qudt.org/vocab/unit#Percent,861058,=,1,True,=,,Inhibition,%,,41.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,41.0
161,,2992214,[],CHEMBL1044517,Inhibition of human IRAK4 at 20 uM by FRET assay,B,,,BAO_0000201,BAO_0000357,single protein format,C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1,,,CHEMBL1156108,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL576620,,CHEMBL576620,,False,http://qudt.org/vocab/unit#Percent,863113,=,1,True,=,,Inhibition,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,1.0
162,,3052636,[],CHEMBL1041123,Residual activity of IRAK4 at 1 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL604483,,CHEMBL604483,,False,http://qudt.org/vocab/unit#Percent,873100,=,1,False,=,,Residual activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,97.0
163,,3053945,[],CHEMBL1046837,Residual activity of IRAK4 at 10 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL604483,,CHEMBL604483,,False,http://qudt.org/vocab/unit#Percent,873100,=,1,False,=,,Residual activity,%,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,34.0
164,,3054197,[],CHEMBL1040665,Residual activity of IRAK4 at 0.1 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL595143,,CHEMBL595143,,False,http://qudt.org/vocab/unit#Percent,872953,=,1,False,=,,Residual activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,100.0
165,,3055484,[],CHEMBL1041123,Residual activity of IRAK4 at 1 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL595143,,CHEMBL595143,,False,http://qudt.org/vocab/unit#Percent,872953,=,1,False,=,,Residual activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,91.0
166,,3056789,[],CHEMBL1046837,Residual activity of IRAK4 at 10 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL595143,,CHEMBL595143,,False,http://qudt.org/vocab/unit#Percent,872953,=,1,False,=,,Residual activity,%,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,36.0
167,,3057041,[],CHEMBL1040665,Residual activity of IRAK4 at 0.1 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL595373,,CHEMBL595373,,False,http://qudt.org/vocab/unit#Percent,872954,=,1,False,=,,Residual activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,96.0
168,,3058361,[],CHEMBL1041123,Residual activity of IRAK4 at 1 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL595373,,CHEMBL595373,,False,http://qudt.org/vocab/unit#Percent,872954,=,1,False,=,,Residual activity,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,90.0
169,,3058613,[],CHEMBL1046837,Residual activity of IRAK4 at 10 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL595373,,CHEMBL595373,,False,http://qudt.org/vocab/unit#Percent,872954,=,1,False,=,,Residual activity,%,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,26.0
170,,3072959,[],CHEMBL1040665,Residual activity of IRAK4 at 0.1 uM by microplate scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,,,CHEMBL1152560,Bioorg. Med. Chem.,2009.0,,CHEMBL604483,,CHEMBL604483,,False,http://qudt.org/vocab/unit#Percent,873100,=,1,False,=,,Residual activity,%,,101.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual activity,%,UO_0000187,,101.0
171,,3084440,[],CHEMBL1073303,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,,,CHEMBL1153138,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL590109,,CHEMBL590109,,False,http://www.openphacts.org/units/Nanomolar,871256,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
172,,3200305,[],CHEMBL1102105,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc(C2=NNC(=O)/C2=N\Nc2cccc(OC)c2)cc1,,,CHEMBL1154953,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.00', 'le': '0.35', 'lle': '4.15', 'sei': '7.31'}",CHEMBL1080902,,CHEMBL1080902,6.16,False,http://www.openphacts.org/units/Nanomolar,892716,=,1,True,=,,Ki,nM,,690.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,690.0
173,,3200331,[],CHEMBL1102105,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc(C2=NNC(=O)/C2=N\Nc2cccnc2)cc1,,,CHEMBL1154953,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.72', 'le': '0.36', 'lle': '4.43', 'sei': '6.62'}",CHEMBL1076721,,CHEMBL1076721,5.82,False,http://www.openphacts.org/units/Nanomolar,892718,=,1,True,=,,Ki,nM,,1500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1500.0
174,,3200357,[],CHEMBL1102105,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccccc1,,,CHEMBL1154953,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '20.18', 'le': '0.37', 'lle': '4.57', 'sei': '6.77'}",CHEMBL1086736,,CHEMBL1086736,5.96,False,http://www.openphacts.org/units/Nanomolar,892950,=,1,True,=,,Ki,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1100.0
175,,3213937,[],CHEMBL1114893,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O,,,CHEMBL1154316,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL1077739,,CHEMBL1198514,,False,http://qudt.org/vocab/unit#Percent,897686,=,1,True,=,,Inhibition,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.0
176,,3224847,[],CHEMBL1100365,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1,,,CHEMBL1154277,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL1081678,,CHEMBL1081678,,False,http://qudt.org/vocab/unit#Percent,897055,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
177,,3225097,[],CHEMBL1100365,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1,,,CHEMBL1154277,Bioorg. Med. Chem. Lett.,2009.0,,CHEMBL1078665,,CHEMBL1078665,,False,http://qudt.org/vocab/unit#Percent,897300,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
178,,3260074,[],CHEMBL1104317,Inhibition of IRAK4 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1,,,CHEMBL1156950,J. Med. Chem.,2010.0,,CHEMBL1089524,,CHEMBL1089524,,False,http://qudt.org/vocab/unit#Percent,901865,=,1,False,=,,Activity,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,70.0
179,,3261399,[],CHEMBL1104317,Inhibition of IRAK4 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,,,CHEMBL1156950,J. Med. Chem.,2010.0,,CHEMBL1088901,,CHEMBL1088901,,False,http://qudt.org/vocab/unit#Percent,901866,=,1,False,=,,Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,81.0
180,Not Active,3271988,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL576349,IC261,CHEMBL576349,,False,,912298,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
181,Not Active,3271989,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,COc1ccccc1/C=C1/C(=O)Nc2ccccc21,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL444673,,CHEMBL444673,,False,,912299,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
182,Not Active,3271990,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1088391,,CHEMBL1088391,,False,,912300,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
183,Not Active,3271991,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-],,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1088392,,CHEMBL1088392,,False,,912301,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
184,Not Active,3271992,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1088529,,CHEMBL1088529,,False,,912302,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
185,Not Active,3271993,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1086669,,CHEMBL1086669,,False,,912383,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
186,Not Active,3271994,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1086670,,CHEMBL1086670,,False,,912384,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
187,Not Active,3271995,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1086795,,CHEMBL1086795,,False,,912385,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
188,Not Active,3271996,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1086796,,CHEMBL1086796,,False,,912386,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
189,Not Active,3271997,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL383871,,CHEMBL383871,,False,,912387,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
190,,3271998,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1086939,,CHEMBL1086939,,False,http://qudt.org/vocab/unit#Percent,912388,<,1,True,<,,Inhibition,%,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,20.0
191,Not Active,3271999,[],CHEMBL1108301,Inhibition of IRAK4 at 5 uM,B,,,BAO_0000376,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,,,CHEMBL1157898,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL535,SUNITINIB,CHEMBL535,,False,,912462,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
192,,3358616,[],CHEMBL1174670,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1,,,CHEMBL1177794,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1171523,,CHEMBL1171523,,False,http://qudt.org/vocab/unit#Percent,921401,=,1,True,=,,Inhibition,%,,72.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,72.0
193,,3359058,[],CHEMBL1174670,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1,,,CHEMBL1177794,Bioorg. Med. Chem. Lett.,2010.0,,CHEMBL1170139,,CHEMBL1170139,,False,http://qudt.org/vocab/unit#Percent,921546,=,1,True,=,,Inhibition,%,,64.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,64.0
194,,3443420,[],CHEMBL1244453,Inhibition of IRAK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21,,,CHEMBL1240340,Nat. Chem. Biol.,2008.0,,CHEMBL1241578,,CHEMBL1241578,,False,http://qudt.org/vocab/unit#Percent,952381,=,1,True,=,,Inhibition,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,0.0
195,,3443637,[],CHEMBL1244453,Inhibition of IRAK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,,,CHEMBL1240340,Nat. Chem. Biol.,2008.0,,CHEMBL1081312,,CHEMBL1081312,,False,http://qudt.org/vocab/unit#Percent,952382,=,1,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.0
196,,3444792,[],CHEMBL1244453,Inhibition of IRAK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21,,,CHEMBL1240340,Nat. Chem. Biol.,2008.0,,CHEMBL1233882,,CHEMBL1233882,,False,http://qudt.org/vocab/unit#Percent,952383,=,1,True,=,,Inhibition,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,0.0
197,,3445416,[],CHEMBL1244453,Inhibition of IRAK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC,,,CHEMBL1240340,Nat. Chem. Biol.,2008.0,,CHEMBL1233881,,CHEMBL1233881,,False,http://qudt.org/vocab/unit#Percent,952519,=,1,True,=,,Inhibition,%,,-3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-3.0
198,,3445633,[],CHEMBL1244453,Inhibition of IRAK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,,,CHEMBL1240340,Nat. Chem. Biol.,2008.0,,CHEMBL1241674,,CHEMBL1241674,,False,http://qudt.org/vocab/unit#Percent,952520,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
199,,3445839,[],CHEMBL1244453,Inhibition of IRAK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21,,,CHEMBL1240340,Nat. Chem. Biol.,2008.0,,CHEMBL1230790,,CHEMBL1230790,,False,http://qudt.org/vocab/unit#Percent,951710,=,1,True,=,,Inhibition,%,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,38.0
200,,3446029,[],CHEMBL1244453,Inhibition of IRAK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,,,CHEMBL1240340,Nat. Chem. Biol.,2008.0,,CHEMBL1234815,,CHEMBL1234815,,False,http://qudt.org/vocab/unit#Percent,952659,=,1,True,=,,Inhibition,%,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,9.0
201,,3446246,[],CHEMBL1244586,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,,,CHEMBL1240341,Leukemia,2009.0,"{'bei': '11.77', 'le': '0.24', 'lle': '1.05', 'sei': '7.53'}",CHEMBL288441,BOSUTINIB,CHEMBL288441,6.24,False,http://www.openphacts.org/units/Nanomolar,952798,=,1,True,=,,IC50,nM,,574.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,574.0
202,,3446272,[],CHEMBL1244595,Inhibition of IRAK4 at 10 mM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,,,CHEMBL1240341,Leukemia,2009.0,,CHEMBL1421,DASATINIB,CHEMBL1421,,False,http://qudt.org/vocab/unit#Percent,952799,=,1,True,=,,Inhibition,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,84.0
203,,3463254,[],CHEMBL1252442,Inhibition of IRAK4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,,CHEMBL379300,A-443654,CHEMBL379300,,False,http://qudt.org/vocab/unit#Percent,956180,=,1,True,=,,Inhibition,%,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,53.0
204,,3463798,[],CHEMBL1252442,Inhibition of IRAK4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,,CHEMBL1254209,,CHEMBL1254209,,False,http://qudt.org/vocab/unit#Percent,956402,=,1,True,=,,Inhibition,%,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,9.0
205,,3464017,[],CHEMBL1252442,Inhibition of IRAK4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,,,CHEMBL1250448,Nat. Chem. Biol.,2009.0,,CHEMBL577784,BX-795,CHEMBL577784,,False,http://qudt.org/vocab/unit#Percent,956403,=,1,True,=,,Inhibition,%,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,49.0
206,,3521126,[],CHEMBL1272500,Inhibition of IRK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO,,,CHEMBL1268847,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '18.98', 'le': '0.37', 'lle': '4.88', 'sei': '7.55'}",CHEMBL1232515,,CHEMBL1232515,8.10,False,http://www.openphacts.org/units/Nanomolar,966600,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
207,,3521246,[],CHEMBL1272500,Inhibition of IRK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1,,,CHEMBL1268847,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '13.10', 'le': '0.25', 'lle': '1.94', 'sei': '5.97'}",CHEMBL1270399,,CHEMBL1270399,5.75,False,http://www.openphacts.org/units/Nanomolar,965994,=,1,True,=,,IC50,nM,,1800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1800.0
208,,5121140,[],CHEMBL1646171,Inhibition of human IRAK4 at 10 uM after 60 mins by TR-FRET assay,B,,,BAO_0000201,BAO_0000357,single protein format,S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1,,,CHEMBL1641539,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1644616,,CHEMBL1644616,,False,http://qudt.org/vocab/unit#Percent,1320437,=,1,True,=,,Inhibition,%,,114.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,114.0
209,,5133668,[],CHEMBL1648744,Inhibition of IRAK4 assessed as residual activity at 10 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,,,CHEMBL1641579,Bioorg. Med. Chem.,2011.0,,CHEMBL1641990,,CHEMBL1641990,,False,http://qudt.org/vocab/unit#Percent,1317232,=,1,False,=,,Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,93.0
210,,5133763,[],CHEMBL1648744,Inhibition of IRAK4 assessed as residual activity at 10 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,,,CHEMBL1641579,Bioorg. Med. Chem.,2011.0,,CHEMBL1641989,,CHEMBL1641989,,False,http://qudt.org/vocab/unit#Percent,1317231,=,1,False,=,,Activity,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,98.0
211,,5133908,[],CHEMBL1648744,Inhibition of IRAK4 assessed as residual activity at 10 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1,,,CHEMBL1641579,Bioorg. Med. Chem.,2011.0,,CHEMBL1641992,,CHEMBL1641992,,False,http://qudt.org/vocab/unit#Percent,1317234,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
212,,5143820,[],CHEMBL1656203,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl,,,CHEMBL1649074,J. Med. Chem.,2011.0,"{'bei': '18.98', 'le': '0.37', 'lle': '4.88', 'sei': '7.55'}",CHEMBL1650533,,CHEMBL1232515,8.10,False,http://www.openphacts.org/units/Nanomolar,1323214,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
213,,5143826,[],CHEMBL1656203,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl,,,CHEMBL1649074,J. Med. Chem.,2011.0,"{'bei': '14.41', 'le': '0.28', 'lle': '2.53', 'sei': '6.89'}",CHEMBL1650545,,CHEMBL1739675,6.00,False,http://www.openphacts.org/units/Nanomolar,1323226,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
214,,5143832,[],CHEMBL1656203,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1,,,CHEMBL1649074,J. Med. Chem.,2011.0,"{'bei': '14.87', 'le': '0.29', 'lle': '2.72', 'sei': '7.12'}",CHEMBL1650551,,CHEMBL1739675,6.19,False,http://www.openphacts.org/units/Nanomolar,1323232,=,1,True,=,,IC50,nM,,640.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,640.0
215,,5191481,[],CHEMBL1664097,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC,,,CHEMBL1649416,J. Med. Chem.,2011.0,,CHEMBL1236782,,CHEMBL1236782,,False,http://qudt.org/vocab/unit#Percent,1322571,=,1,True,=,,Inhibition,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,70.0
216,,5191482,[],CHEMBL1664097,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12,,,CHEMBL1649416,J. Med. Chem.,2011.0,,CHEMBL1650131,,CHEMBL1650131,,False,http://qudt.org/vocab/unit#Percent,1322574,=,1,True,=,,Inhibition,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,91.0
217,,5243719,[],CHEMBL1685682,Inhibition of IRAK4 at 0.1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684543,,CHEMBL1684543,,False,http://qudt.org/vocab/unit#Percent,1335920,=,1,True,=,,Inhibition,%,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,25.0
218,,5243827,[],CHEMBL1685931,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684543,,CHEMBL1684543,,False,http://qudt.org/vocab/unit#Percent,1335920,=,1,True,=,,Inhibition,%,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,3.0
219,,5243940,[],CHEMBL1685682,Inhibition of IRAK4 at 0.1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684654,,CHEMBL1684654,,False,http://qudt.org/vocab/unit#Percent,1336053,=,1,True,=,,Inhibition,%,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,6.0
220,,5244048,[],CHEMBL1685931,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684654,,CHEMBL1684654,,False,http://qudt.org/vocab/unit#Percent,1336053,=,1,True,=,,Inhibition,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,0.0
221,,5244921,[],CHEMBL1685682,Inhibition of IRAK4 at 0.1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684662,,CHEMBL1684662,,False,http://qudt.org/vocab/unit#Percent,1336062,=,1,True,=,,Inhibition,%,,57.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,57.0
222,,5245029,[],CHEMBL1685931,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684662,,CHEMBL1684662,,False,http://qudt.org/vocab/unit#Percent,1336062,=,1,True,=,,Inhibition,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.0
223,,5245180,[],CHEMBL1685682,Inhibition of IRAK4 at 0.1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684525,,CHEMBL1684525,,False,http://qudt.org/vocab/unit#Percent,1335902,=,1,True,=,,Inhibition,%,,101.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,101.0
224,,5246010,[],CHEMBL1685931,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1,,,CHEMBL1681705,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1684525,,CHEMBL1684525,,False,http://qudt.org/vocab/unit#Percent,1335902,=,1,True,=,,Inhibition,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,86.0
225,,6167650,[],CHEMBL1769191,Inhibition of IRAK4,B,,,BAO_0000192,BAO_0000357,single protein format,CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1,,,CHEMBL1765075,J. Med. Chem.,2011.0,,CHEMBL1765781,,CHEMBL1765781,,False,http://www.openphacts.org/units/Nanomolar,1416487,>,1,True,>,,Ki,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,1.0
226,,6267507,[],CHEMBL1799026,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F,,,CHEMBL1795280,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1797211,,CHEMBL1797211,,False,http://qudt.org/vocab/unit#Percent,1437577,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
227,,6267508,[],CHEMBL1799026,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1,,,CHEMBL1795280,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1797224,,CHEMBL1797224,,False,http://qudt.org/vocab/unit#Percent,1437590,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
228,,6268165,[],CHEMBL1805337,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1,,,CHEMBL1799927,Bioorg. Med. Chem. Lett.,2010.0,"{'bei': '19.73', 'le': '0.40', 'lle': '3.43', 'sei': '8.09'}",CHEMBL1270795,,CHEMBL1270795,6.78,False,http://www.openphacts.org/units/Nanomolar,1440209,=,1,True,=,,IC50,nM,,167.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,167.0
229,,6352222,[],CHEMBL1825829,Inhibition of IRAK4 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP,B,,,BAO_0001103,BAO_0000357,single protein format,Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1,,,CHEMBL1821675,Eur. J. Med. Chem.,2011.0,,CHEMBL215205,,CHEMBL215205,,False,http://qudt.org/vocab/unit#Percent,1454804,=,1,False,=,,Activity,%,,58.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,58.0
230,,6373525,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccccc1Nc1nc(N)n(-c2ccccn2)n1,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '22.59', 'le': '0.41', 'lle': '4.38', 'sei': '7.02'}",CHEMBL1835741,,CHEMBL1835741,6.38,False,http://www.openphacts.org/units/Nanomolar,1462004,=,1,True,=,,Ki,nM,,420.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,420.0
231,,6373530,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,Nc1nc(Nc2ccccc2Cl)nn1-c1ccccn1,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '20.65', 'le': '0.40', 'lle': '3.28', 'sei': '7.25'}",CHEMBL1835742,,CHEMBL1835742,5.92,False,http://www.openphacts.org/units/Nanomolar,1462005,=,1,True,=,,Ki,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1200.0
232,,6373535,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc(N2CCOCC2)cc1Nc1nc(N)n(-c2ccccn2)n1,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '18.50', 'le': '0.34', 'lle': '4.97', 'sei': '6.58'}",CHEMBL1833992,,CHEMBL1833992,6.80,False,http://www.openphacts.org/units/Nanomolar,1462006,=,1,True,=,,Ki,nM,,160.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,160.0
233,,6373540,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,Nc1nc(Nc2cc(N3CCOCC3)ccc2F)nn1-c1ccccn1,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '17.89', 'le': '0.33', 'lle': '4.40', 'sei': '6.75'}",CHEMBL1835743,,CHEMBL1835743,6.36,False,http://www.openphacts.org/units/Nanomolar,1462007,=,1,True,=,,Ki,nM,,440.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,440.0
234,,6373545,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,N#Cc1ccc(-n2nc(Nc3ccccc3Cl)nc2N)nc1,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '23.88', 'le': '0.46', 'lle': '4.93', 'sei': '7.06'}",CHEMBL1835744,,CHEMBL1835744,7.44,False,http://www.openphacts.org/units/Nanomolar,1462008,=,1,True,=,,Ki,nM,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,36.0
235,,6373550,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc(N2CCOCC2)ccc1Nc1nc(N)n(-c2ccc(C#N)cn2)n1,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '16.48', 'le': '0.30', 'lle': '4.77', 'sei': '5.09'}",CHEMBL1835745,,CHEMBL1835745,6.47,False,http://www.openphacts.org/units/Nanomolar,1462009,=,1,True,=,,Ki,nM,,340.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,340.0
236,,6373555,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccccc1Nc1nc(N)n(-c2cc(NCCN(C)C)ncn2)n1,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '19.24', 'le': '0.36', 'lle': '5.74', 'sei': '5.97'}",CHEMBL1835746,,CHEMBL1835746,7.11,False,http://www.openphacts.org/units/Nanomolar,1462010,=,1,True,=,,Ki,nM,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,78.0
237,,6374726,[],CHEMBL1840412,Inhibition of IRAK4 by spectrophotometry,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc(Nc2nc(N)n(-c3ccccn3)n2)cc1OC,,,CHEMBL1833953,J. Med. Chem.,2011.0,"{'bei': '23.59', 'le': '0.44', 'lle': '5.36', 'sei': '7.36'}",CHEMBL1835740,,CHEMBL1835740,7.37,False,http://www.openphacts.org/units/Nanomolar,1462003,=,1,True,=,,Ki,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,43.0
238,,6385843,[],CHEMBL1838362,Inhibition of human IRAK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1,,,CHEMBL1833925,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1834114,,CHEMBL1834114,,False,http://qudt.org/vocab/unit#Percent,1460091,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
239,,6385844,[],CHEMBL1838362,Inhibition of human IRAK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1,,,CHEMBL1833925,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1834318,,CHEMBL1834318,,False,http://qudt.org/vocab/unit#Percent,1460321,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
240,,6385845,[],CHEMBL1838362,Inhibition of human IRAK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23,,,CHEMBL1833925,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1834323,,CHEMBL1834323,,False,http://qudt.org/vocab/unit#Percent,1460326,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
241,,6385846,[],CHEMBL1838362,Inhibition of human IRAK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23,,,CHEMBL1833925,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1834324,,CHEMBL1834324,,False,http://qudt.org/vocab/unit#Percent,1460327,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
242,,6385847,[],CHEMBL1838362,Inhibition of human IRAK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2,,,CHEMBL1833925,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1834330,,CHEMBL1834330,,False,http://qudt.org/vocab/unit#Percent,1460333,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
243,,6386334,[],CHEMBL1839907,Inhibition of recombinant IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O,,,CHEMBL1833940,J. Med. Chem.,2011.0,,CHEMBL1834657,INFIGRATINIB PHOSPHATE,CHEMBL1852688,,False,http://www.openphacts.org/units/Nanomolar,1460724,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
244,,7567515,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL105442,CI-1040,CHEMBL105442,,False,http://www.openphacts.org/units/Nanomolar,1539357,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
245,,7567986,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL180022,NERATINIB,CHEMBL180022,,False,http://www.openphacts.org/units/Nanomolar,1539371,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
246,,7568454,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL386051,,CHEMBL386051,,False,http://www.openphacts.org/units/Nanomolar,1539385,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
247,,7568886,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '16.01', 'le': '0.30', 'lle': '5.40', 'sei': '6.64'}",CHEMBL1721885,SU-014813,CHEMBL1721885,7.09,False,http://www.openphacts.org/units/Nanomolar,1539399,=,1,True,=,,Kd,nM,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,82.0
248,,7569029,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL491473,CEDIRANIB,CHEMBL491473,,False,http://www.openphacts.org/units/Nanomolar,1539344,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
249,,7569489,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL221959,TOFACITINIB,CHEMBL221959,,False,http://www.openphacts.org/units/Nanomolar,1539358,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
250,,7569961,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL941,IMATINIB,CHEMBL941,,False,http://www.openphacts.org/units/Nanomolar,1539372,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
251,,7570424,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '8.73', 'le': '0.18', 'lle': '-0.51', 'sei': '5.46'}",CHEMBL450786,PHA-665752,CHEMBL450786,5.60,False,http://www.openphacts.org/units/Nanomolar,1539386,=,1,True,=,,Kd,nM,,2500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,2500.0
252,,7570851,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '18.02', 'le': '0.34', 'lle': '3.85', 'sei': '9.30'}",CHEMBL535,SUNITINIB,CHEMBL535,7.18,False,http://www.openphacts.org/units/Nanomolar,1539400,=,1,True,=,,Kd,nM,,66.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,66.0
253,,7571005,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1614701,SELUMETINIB,CHEMBL1614701,,False,http://www.openphacts.org/units/Nanomolar,1539345,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
254,,7571462,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '12.09', 'le': '0.25', 'lle': '0.40', 'sei': '6.98'}",CHEMBL601719,CRIZOTINIB,CHEMBL601719,5.44,False,http://www.openphacts.org/units/Nanomolar,1539359,=,1,True,=,,Kd,nM,,3600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,3600.0
255,,7571938,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1789941,RUXOLITINIB,CHEMBL1789941,,False,http://www.openphacts.org/units/Nanomolar,1539373,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
256,,7572401,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL573339,PI-103,CHEMBL573339,,False,http://www.openphacts.org/units/Nanomolar,1539387,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
257,,7572817,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '11.58', 'le': '0.23', 'lle': '2.09', 'sei': '6.91'}",CHEMBL509032,TAE-684,CHEMBL509032,7.11,False,http://www.openphacts.org/units/Nanomolar,1539401,=,1,True,=,,Kd,nM,,77.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,77.0
258,,7572986,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '10.88', 'le': '0.20', 'lle': '2.12', 'sei': '5.52'}",CHEMBL513909,BI-2536,CHEMBL513909,5.68,False,http://www.openphacts.org/units/Nanomolar,1539346,=,1,True,=,,Kd,nM,,2100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,2100.0
259,,7573443,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1421,DASATINIB,CHEMBL1421,,False,http://www.openphacts.org/units/Nanomolar,1539360,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
260,,7573919,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '13.17', 'le': '0.24', 'lle': '2.31', 'sei': '5.77'}",CHEMBL1908395,,CHEMBL1908842,6.07,False,http://www.openphacts.org/units/Nanomolar,1539374,=,1,True,=,,Kd,nM,,860.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,860.0
261,,7574964,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '11.29', 'le': '0.21', 'lle': '2.47', 'sei': '6.47'}",CHEMBL502835,NINTEDANIB,CHEMBL502835,6.09,False,http://www.openphacts.org/units/Nanomolar,1539347,=,1,True,=,,Kd,nM,,810.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,810.0
262,,7575425,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL553,ERLOTINIB,CHEMBL553,,False,http://www.openphacts.org/units/Nanomolar,1539361,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
263,,7575896,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1908396,,CHEMBL1908396,,False,http://www.openphacts.org/units/Nanomolar,1539375,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
264,,7575919,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL608533,MIDOSTAURIN,CHEMBL608533,,False,http://www.openphacts.org/units/Nanomolar,1539388,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
265,,7576327,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL230011,TG100-115,CHEMBL230011,,False,http://www.openphacts.org/units/Nanomolar,1539402,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
266,,7576938,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1173655,AFATINIB,CHEMBL1173655,,False,http://www.openphacts.org/units/Nanomolar,1539348,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
267,,7577397,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1230609,FORETINIB,CHEMBL1230609,,False,http://www.openphacts.org/units/Nanomolar,1539362,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
268,,7577903,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1230020,PLX-4720,CHEMBL1230020,,False,http://www.openphacts.org/units/Nanomolar,1539389,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
269,,7578308,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '11.28', 'le': '0.22', 'lle': '1.10', 'sei': '5.46'}",CHEMBL1287853,FEDRATINIB,CHEMBL1287853,5.92,False,http://www.openphacts.org/units/Nanomolar,1539403,=,1,True,=,,Kd,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,1200.0
270,,7578946,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '15.63', 'le': '0.28', 'lle': '1.72', 'sei': '7.29'}",CHEMBL379218,,CHEMBL379218,5.60,False,http://www.openphacts.org/units/Nanomolar,1539335,=,1,True,=,,Kd,nM,,2500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,2500.0
271,,7579320,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL103667,DORAMAPIMOD,CHEMBL103667,,False,http://www.openphacts.org/units/Nanomolar,1539349,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
272,,7579802,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '18.55', 'le': '0.34', 'lle': '3.39', 'sei': '10.11'}",CHEMBL1908397,KW-2449,CHEMBL1908397,6.17,False,http://www.openphacts.org/units/Nanomolar,1539376,=,1,True,=,,Kd,nM,,680.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,680.0
273,,7580271,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '17.40', 'le': '0.32', 'lle': '2.53', 'sei': '5.08'}",CHEMBL1241674,,CHEMBL1241674,5.37,False,http://www.openphacts.org/units/Nanomolar,1539390,=,1,True,=,,Kd,nM,,4300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,4300.0
274,,7580674,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '14.99', 'le': '0.32', 'lle': '2.12', 'sei': '11.97'}",CHEMBL24828,VANDETANIB,CHEMBL24828,7.12,False,http://www.openphacts.org/units/Nanomolar,1539404,=,1,True,=,,Kd,nM,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,75.0
275,,7581304,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1908391,MASITINIB,CHEMBL1908391,,False,http://www.openphacts.org/units/Nanomolar,1539336,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
276,,7581692,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '14.49', 'le': '0.28', 'lle': '2.52', 'sei': '6.19'}",CHEMBL428690,ALVOCIDIB,CHEMBL428690,5.82,False,http://www.openphacts.org/units/Nanomolar,1539363,=,1,True,=,,Kd,nM,,1500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,1500.0
277,,7582163,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL554,LAPATINIB,CHEMBL554,,False,http://www.openphacts.org/units/Nanomolar,1539377,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
278,,7582627,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL101253,VATALANIB,CHEMBL101253,,False,http://www.openphacts.org/units/Nanomolar,1539391,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
279,,7583027,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '11.69', 'le': '0.22', 'lle': '1.93', 'sei': '5.32'}",CHEMBL572878,TOZASERTIB,CHEMBL572878,5.43,False,http://www.openphacts.org/units/Nanomolar,1539405,=,1,True,=,,Kd,nM,,3700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,3700.0
280,,7583605,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL249697,BMS-345541,CHEMBL249697,,False,http://www.openphacts.org/units/Nanomolar,1539350,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
281,,7584050,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL525191,,CHEMBL525191,,False,http://www.openphacts.org/units/Nanomolar,1539364,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
282,,7584521,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL300138,ENZASTAURIN,CHEMBL300138,,False,http://www.openphacts.org/units/Nanomolar,1539378,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
283,,7584983,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '14.57', 'le': '0.28', 'lle': '3.22', 'sei': '5.32'}",CHEMBL475251,R-406,CHEMBL475251,6.85,False,http://www.openphacts.org/units/Nanomolar,1539392,=,1,True,=,,Kd,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,140.0
284,,7585387,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL119385,NEFLAMAPIMOD,CHEMBL119385,,False,http://www.openphacts.org/units/Nanomolar,1539406,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
285,,7585538,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL223360,LINIFANIB,CHEMBL223360,,False,http://www.openphacts.org/units/Nanomolar,1539337,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
286,,7585946,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL296468,BMS-387032,CHEMBL296468,,False,http://www.openphacts.org/units/Nanomolar,1539351,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
287,,7586392,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL521851,PICTILISIB,CHEMBL521851,,False,http://www.openphacts.org/units/Nanomolar,1539365,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
288,,7586863,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL91829,RUBOXISTAURIN,CHEMBL91829,,False,http://www.openphacts.org/units/Nanomolar,1539379,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
289,,7587317,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL384304,RG-547,CHEMBL384304,,False,http://www.openphacts.org/units/Nanomolar,1539393,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
290,,7587499,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL576982,QUIZARTINIB,CHEMBL576982,,False,http://www.openphacts.org/units/Nanomolar,1539338,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
291,,7587918,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL377300,BRIVANIB,CHEMBL377300,,False,http://www.openphacts.org/units/Nanomolar,1539352,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
292,,7588371,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '14.02', 'le': '0.28', 'lle': '1.99', 'sei': '9.12'}",CHEMBL939,GEFITINIB,CHEMBL939,6.27,False,http://www.openphacts.org/units/Nanomolar,1539366,=,1,True,=,,Kd,nM,,540.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,540.0
293,,7588842,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL608154,,CHEMBL608154,,False,http://www.openphacts.org/units/Nanomolar,1539380,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
294,,7589293,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL10,SB-203580,CHEMBL10,,False,http://www.openphacts.org/units/Nanomolar,1539394,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
295,,7589464,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1289926,AXITINIB,CHEMBL1289926,,False,http://www.openphacts.org/units/Nanomolar,1539339,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
296,,7589888,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '19.95', 'le': '0.36', 'lle': '5.30', 'sei': '9.89'}",CHEMBL603469,LESTAURTINIB,CHEMBL603469,8.77,False,http://www.openphacts.org/units/Nanomolar,1539353,=,1,True,=,,Kd,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,1.7
297,,7590355,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL464552,,CHEMBL464552,,False,http://www.openphacts.org/units/Nanomolar,1539367,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
298,,7590829,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL124660,TANDUTINIB,CHEMBL124660,,False,http://www.openphacts.org/units/Nanomolar,1539381,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
299,,7591437,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL572881,MOTESANIB,CHEMBL572881,,False,http://www.openphacts.org/units/Nanomolar,1539340,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
300,,7591859,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '17.55', 'le': '0.32', 'lle': '4.35', 'sei': '7.32'}",CHEMBL522892,DOVITINIB,CHEMBL522892,6.89,False,http://www.openphacts.org/units/Nanomolar,1539354,=,1,True,=,,Kd,nM,,130.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,130.0
301,,7592331,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1908394,GSK-461364,CHEMBL1908394,,False,http://www.openphacts.org/units/Nanomolar,1539368,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
302,,7592815,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1236107,SGX-523,CHEMBL1236107,,False,http://www.openphacts.org/units/Nanomolar,1539395,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
303,,7593404,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL574738,AST-487,CHEMBL574738,,False,http://www.openphacts.org/units/Nanomolar,1539341,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
304,,7593839,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL558752,RAF-265,CHEMBL558752,,False,http://www.openphacts.org/units/Nanomolar,1539355,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
305,,7594342,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL259084,MLN-8054,CHEMBL259084,,False,http://www.openphacts.org/units/Nanomolar,1539382,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
306,,7594794,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '12.15', 'le': '0.24', 'lle': '1.25', 'sei': '7.77'}",CHEMBL288441,BOSUTINIB,CHEMBL288441,6.44,False,http://www.openphacts.org/units/Nanomolar,1539396,=,1,True,=,,Kd,nM,,360.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,360.0
307,,7595372,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL445813,AT-7519,CHEMBL445813,,False,http://www.openphacts.org/units/Nanomolar,1539342,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
308,,7595816,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '12.18', 'le': '0.24', 'lle': '1.53', 'sei': '6.68'}",CHEMBL31965,CANERTINIB,CHEMBL31965,5.92,False,http://www.openphacts.org/units/Nanomolar,1539356,=,1,True,=,,Kd,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,1200.0
309,,7595848,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL494089,GSK-690693,CHEMBL494089,,False,http://www.openphacts.org/units/Nanomolar,1539369,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
310,,7596319,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL255863,NILOTINIB,CHEMBL255863,,False,http://www.openphacts.org/units/Nanomolar,1539383,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
311,,7596766,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL1336,SORAFENIB,CHEMBL1336,,False,http://www.openphacts.org/units/Nanomolar,1539397,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
312,,7597344,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL215152,AZD-1152-HQPA,CHEMBL215152,,False,http://www.openphacts.org/units/Nanomolar,1539343,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
313,,7597828,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL261849,GW632580X,CHEMBL261849,,False,http://www.openphacts.org/units/Nanomolar,1539370,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
314,,7598298,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,,CHEMBL477772,PAZOPANIB,CHEMBL477772,,False,http://www.openphacts.org/units/Nanomolar,1539384,>,1,True,>,,Kd,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,10000.0
315,,7598740,[],CHEMBL1908795,Binding constant for IRAK4 kinase domain,B,,,BAO_0000034,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1908390,Nat. Biotechnol.,2011.0,"{'bei': '18.80', 'le': '0.34', 'lle': '4.42', 'sei': '12.63'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.77,False,http://www.openphacts.org/units/Nanomolar,1539398,=,1,True,=,,Kd,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,1.7
316,,7922646,[],CHEMBL1919002,Inhibition of human recombinant IRAK4 at 0.5 uM by radiometric filter-binding assay,B,,,BAO_0000201,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1915438,,CHEMBL1915438,,False,http://qudt.org/vocab/unit#Percent,1557626,=,1,True,=,,Inhibition,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,88.0
317,,7931098,[],CHEMBL1919273,Inhibition of IRAK4 relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12,,,CHEMBL1914368,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1916891,,CHEMBL1916891,,False,http://qudt.org/vocab/unit#Percent,1559392,=,1,True,=,,Inhibition,%,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,10.0
318,,7959805,[],CHEMBL1932877,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O,,,CHEMBL1926590,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1929238,,CHEMBL1929238,,False,http://www.openphacts.org/units/Nanomolar,1566418,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
319,,7959806,[],CHEMBL1932877,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,,,CHEMBL1926590,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL103667,DORAMAPIMOD,CHEMBL103667,,False,http://www.openphacts.org/units/Nanomolar,1566420,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
320,,7969735,[],CHEMBL1931235,Inhibition of IRAK4 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay,B,,,BAO_0001103,BAO_0000357,single protein format,Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2,,,CHEMBL1926576,Eur. J. Med. Chem.,2012.0,,CHEMBL1927262,,CHEMBL1927262,,False,http://qudt.org/vocab/unit#Percent,1563965,=,1,False,=,,Activity,%,,55.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,55.0
321,,7970433,[],CHEMBL1930184,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O,,,CHEMBL1926538,Eur. J. Med. Chem.,2012.0,,CHEMBL1929247,,CHEMBL1929247,,False,http://qudt.org/vocab/unit#Percent,1566431,=,1,True,=,,Inhibition,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.0
322,,7992194,[],CHEMBL1935884,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O,,,CHEMBL1932974,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1934353,,CHEMBL1934353,,False,http://qudt.org/vocab/unit#Percent,1568370,=,1,True,=,,Inhibition,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,86.0
323,Active,7996804,[],CHEMBL1941725,Inhibition of IRAK4 at 10 uM by colorimetric analysis,B,,,BAO_0000376,BAO_0000357,single protein format,Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1,,,CHEMBL1938312,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1938953,,CHEMBL1938953,,False,,1570722,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
324,Active,7996805,[],CHEMBL1941725,Inhibition of IRAK4 at 10 uM by colorimetric analysis,B,,,BAO_0000376,BAO_0000357,single protein format,Clc1cccc(-n2cc(-c3ccncc3)nn2)c1,,,CHEMBL1938312,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1938954,,CHEMBL1938954,,False,,1570723,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
325,Active,7996806,[],CHEMBL1941725,Inhibition of IRAK4 at 10 uM by colorimetric analysis,B,,,BAO_0000376,BAO_0000357,single protein format,Clc1ccc(-n2nncc2-c2ccncc2)cc1,,,CHEMBL1938312,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL62965,,CHEMBL62965,,False,,1570733,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
326,Active,7996807,[],CHEMBL1941725,Inhibition of IRAK4 at 10 uM by colorimetric analysis,B,,,BAO_0000376,BAO_0000357,single protein format,Clc1cccc(-n2nncc2-c2ccncc2)c1,,,CHEMBL1938312,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL303351,,CHEMBL303351,,False,,1570734,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
327,,8004444,[],CHEMBL1943607,Inhibition of human IRAK4 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM,B,,,BAO_0000201,BAO_0000219,cell-based format,C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23,,,CHEMBL1938230,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1940980,,CHEMBL1940980,,False,http://qudt.org/vocab/unit#Percent,1573291,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
328,,8004445,[],CHEMBL1943607,Inhibition of human IRAK4 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM,B,,,BAO_0000201,BAO_0000219,cell-based format,C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23,,,CHEMBL1938230,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1940981,,CHEMBL1940981,,False,http://qudt.org/vocab/unit#Percent,1573292,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
329,,8004446,[],CHEMBL1943607,Inhibition of human IRAK4 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM,B,,,BAO_0000201,BAO_0000219,cell-based format,C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23,,,CHEMBL1938230,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1940987,,CHEMBL1940987,,False,http://qudt.org/vocab/unit#Percent,1573298,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
330,,8004447,[],CHEMBL1943607,Inhibition of human IRAK4 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM,B,,,BAO_0000201,BAO_0000219,cell-based format,C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23,,,CHEMBL1938230,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL1940990,,CHEMBL1940990,,False,http://qudt.org/vocab/unit#Percent,1573301,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
331,,8009708,[],CHEMBL1941382,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12,,,CHEMBL1938231,J. Med. Chem.,2011.0,,CHEMBL1938642,,CHEMBL1938642,,False,http://qudt.org/vocab/unit#Percent,1570314,>,1,True,>,,Inhibition,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,90.0
332,,8013106,[],CHEMBL1948125,Inhibition of IRAK4 using ATP as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O,,,CHEMBL1944596,J. Med. Chem.,2012.0,,CHEMBL1945559,,CHEMBL1945559,,False,http://www.openphacts.org/units/Nanomolar,1574680,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
333,,8018795,[],CHEMBL1948937,Inhibition of IRAK4 assessed as activity remaining at 10 uM,B,,,BAO_0001103,BAO_0000357,single protein format,O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1,,,CHEMBL1944561,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1945953,,CHEMBL1945953,,False,http://qudt.org/vocab/unit#Percent,1575128,=,1,False,=,,Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,97.0
334,,8018796,[],CHEMBL1948937,Inhibition of IRAK4 assessed as activity remaining at 10 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1,,,CHEMBL1944561,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1945950,,CHEMBL1945950,,False,http://qudt.org/vocab/unit#Percent,1575125,=,1,False,=,,Activity,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,87.0
335,,8018797,[],CHEMBL1948937,Inhibition of IRAK4 assessed as activity remaining at 10 uM,B,,,BAO_0001103,BAO_0000357,single protein format,O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1,,,CHEMBL1944561,Bioorg. Med. Chem. Lett.,2011.0,,CHEMBL1946262,,CHEMBL1946262,,False,http://qudt.org/vocab/unit#Percent,1575517,=,1,False,=,,Activity,%,,112.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,112.0
336,,8061215,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1nccc2c1nc(-c1nonc1N)n2CC,,,CHEMBL1961873,,,,CHEMBL365072,,CHEMBL365072,,False,http://qudt.org/vocab/unit#Percent,1583356,=,16,True,=,,Inhibition,%,,-1.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.82
337,,8061392,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O,,,CHEMBL1961873,,,,CHEMBL1789962,GW643971X,CHEMBL1789962,,False,http://qudt.org/vocab/unit#Percent,1583532,=,16,True,=,,Inhibition,%,,1.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.48
338,,8061616,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O,,,CHEMBL1961873,,,,CHEMBL1789962,GW643971X,CHEMBL1789962,,False,http://qudt.org/vocab/unit#Percent,1583532,=,16,True,=,,Inhibition,%,,-1.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.52
339,,8061723,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1,,,CHEMBL1961873,,,,CHEMBL318892,,CHEMBL318892,,False,http://qudt.org/vocab/unit#Percent,1583290,=,16,True,=,,Inhibition,%,,1.95,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.95
340,,8062138,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21,,,CHEMBL1961873,,,,CHEMBL1516890,GW441756X,CHEMBL1516890,,False,http://qudt.org/vocab/unit#Percent,1583471,=,16,True,=,,Inhibition,%,,6.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,6.41
341,,8062254,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1,,,CHEMBL1961873,,,,CHEMBL30432,GW282974X,CHEMBL30432,,False,http://qudt.org/vocab/unit#Percent,1583440,=,16,True,=,,Inhibition,%,,1.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.57
342,,8062478,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(-c2nonc2N)nc2cnccc21,,,CHEMBL1961873,,,,CHEMBL188048,,CHEMBL188048,,False,http://qudt.org/vocab/unit#Percent,1583343,=,16,True,=,,Inhibition,%,,3.47,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.47
343,,8062640,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1,,,CHEMBL1961873,,,,CHEMBL261129,,CHEMBL261129,,False,http://qudt.org/vocab/unit#Percent,1583337,=,16,True,=,,Inhibition,%,,2.24,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.24
344,,8062962,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2ccncc21,,,CHEMBL1961873,,,,CHEMBL185710,,CHEMBL185710,,False,http://qudt.org/vocab/unit#Percent,1583347,=,16,True,=,,Inhibition,%,,0.65,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.65
345,,8063094,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL1909412,,CHEMBL200320,,False,http://qudt.org/vocab/unit#Percent,1583323,=,16,True,=,,Inhibition,%,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.0
346,,8063485,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL188794,GW829115X,CHEMBL188794,,False,http://qudt.org/vocab/unit#Percent,1583627,=,16,True,=,,Inhibition,%,,2.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.17
347,,8063593,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1,,,CHEMBL1961873,,,,CHEMBL318892,,CHEMBL318892,,False,http://qudt.org/vocab/unit#Percent,1583290,=,16,True,=,,Inhibition,%,,1.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.28
348,,8063817,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL1909378,,CHEMBL440084,,False,http://qudt.org/vocab/unit#Percent,1583321,=,16,True,=,,Inhibition,%,,2.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.26
349,,8063999,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21,,,CHEMBL1961873,,,,CHEMBL1516890,GW441756X,CHEMBL1516890,,False,http://qudt.org/vocab/unit#Percent,1583471,=,16,True,=,,Inhibition,%,,5.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.04
350,,8064338,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(-c2nonc2N)nc2cnccc21,,,CHEMBL1961873,,,,CHEMBL188048,,CHEMBL188048,,False,http://qudt.org/vocab/unit#Percent,1583343,=,16,True,=,,Inhibition,%,,1.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.21
351,,8064548,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,,,CHEMBL1961873,,,,CHEMBL466412,GSK-238063A,CHEMBL466412,,False,http://qudt.org/vocab/unit#Percent,1583395,=,16,True,=,,Inhibition,%,,2.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.83
352,,8064686,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL1909412,,CHEMBL200320,,False,http://qudt.org/vocab/unit#Percent,1583323,=,16,True,=,,Inhibition,%,,0.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.37
353,,8064910,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl,,,CHEMBL1961873,,,,CHEMBL1794060,GW575533A,CHEMBL360561,,False,http://qudt.org/vocab/unit#Percent,1583499,=,16,True,=,,Inhibition,%,,2.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.27
354,,8065076,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL188794,GW829115X,CHEMBL188794,,False,http://qudt.org/vocab/unit#Percent,1583627,=,16,True,=,,Inhibition,%,,0.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.42
355,,8065416,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL1909378,,CHEMBL440084,,False,http://qudt.org/vocab/unit#Percent,1583321,=,16,True,=,,Inhibition,%,,1.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.06
356,,8065591,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1,,,CHEMBL1961873,,,,CHEMBL362155,GW827102X,CHEMBL362155,,False,http://qudt.org/vocab/unit#Percent,1583620,=,16,True,=,,Inhibition,%,,6.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,6.37
357,,8065930,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21,,,CHEMBL1961873,,,,CHEMBL220465,GSK-248233A,CHEMBL220465,,False,http://qudt.org/vocab/unit#Percent,1583397,=,16,True,=,,Inhibition,%,,0.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.85
358,,8066140,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,,,CHEMBL1961873,,,,CHEMBL466412,GSK-238063A,CHEMBL466412,,False,http://qudt.org/vocab/unit#Percent,1583395,=,16,True,=,,Inhibition,%,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.5
359,,8066500,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl,,,CHEMBL1961873,,,,CHEMBL1794060,GW575533A,CHEMBL360561,,False,http://qudt.org/vocab/unit#Percent,1583499,=,16,True,=,,Inhibition,%,,2.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.28
360,,8066666,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1,,,CHEMBL1961873,,,,CHEMBL408732,,CHEMBL408732,,False,http://qudt.org/vocab/unit#Percent,1583335,=,16,True,=,,Inhibition,%,,2.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.75
361,,8067014,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909370,GW694234A,CHEMBL243908,,False,http://qudt.org/vocab/unit#Percent,1583553,=,16,True,=,,Inhibition,%,,1.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.75
362,,8067189,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1,,,CHEMBL1961873,,,,CHEMBL362155,GW827102X,CHEMBL362155,,False,http://qudt.org/vocab/unit#Percent,1583620,=,16,True,=,,Inhibition,%,,0.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.32
363,,8067534,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21,,,CHEMBL1961873,,,,CHEMBL220465,GSK-248233A,CHEMBL220465,,False,http://qudt.org/vocab/unit#Percent,1583397,=,16,True,=,,Inhibition,%,,0.95,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.95
364,,8067744,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1nccc2c1nc(-c1nonc1N)n2CC,,,CHEMBL1961873,,,,CHEMBL365072,,CHEMBL365072,,False,http://qudt.org/vocab/unit#Percent,1583356,=,16,True,=,,Inhibition,%,,2.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.27
365,,8068103,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1,,,CHEMBL1961873,,,,CHEMBL359999,GW801372X,CHEMBL359999,,False,http://qudt.org/vocab/unit#Percent,1583597,=,16,True,=,,Inhibition,%,,5.71,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.71
366,,8068267,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1,,,CHEMBL1961873,,,,CHEMBL408732,,CHEMBL408732,,False,http://qudt.org/vocab/unit#Percent,1583335,=,16,True,=,,Inhibition,%,,0.45,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.45
367,,8068491,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,,,CHEMBL1961873,,,,CHEMBL1794061,GW627834A,CHEMBL192413,,False,http://qudt.org/vocab/unit#Percent,1583524,=,16,True,=,,Inhibition,%,,2.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.82
368,,8068616,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909370,GW694234A,CHEMBL243908,,False,http://qudt.org/vocab/unit#Percent,1583553,=,16,True,=,,Inhibition,%,,1.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.23
369,,8068790,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909367,GW680908A,CHEMBL244099,,False,http://qudt.org/vocab/unit#Percent,1583542,=,16,True,=,,Inhibition,%,,2.19,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.19
370,,8069014,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909367,GW680908A,CHEMBL244099,,False,http://qudt.org/vocab/unit#Percent,1583542,=,16,True,=,,Inhibition,%,,1.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.11
371,,8069139,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1,,,CHEMBL1961873,,,,CHEMBL485745,GW434756X,CHEMBL485745,,False,http://qudt.org/vocab/unit#Percent,1583467,=,16,True,=,,Inhibition,%,,2.69,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.69
372,,8069434,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1,,,CHEMBL1961873,,,,CHEMBL359999,GW801372X,CHEMBL359999,,False,http://qudt.org/vocab/unit#Percent,1583597,=,16,True,=,,Inhibition,%,,18.59,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,18.59
373,,8069819,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,,,CHEMBL1961873,,,,CHEMBL1794061,GW627834A,CHEMBL192413,,False,http://qudt.org/vocab/unit#Percent,1583524,=,16,True,=,,Inhibition,%,,0.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.78
374,,8069945,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL397570,,CHEMBL397570,,False,http://qudt.org/vocab/unit#Percent,1583310,=,16,True,=,,Inhibition,%,,1.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.78
375,,8070341,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1,,,CHEMBL1961873,,,,CHEMBL399410,,CHEMBL399410,,False,http://qudt.org/vocab/unit#Percent,1583322,=,16,True,=,,Inhibition,%,,3.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.57
376,,8070466,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1,,,CHEMBL1961873,,,,CHEMBL485745,GW434756X,CHEMBL485745,,False,http://qudt.org/vocab/unit#Percent,1583467,=,16,True,=,,Inhibition,%,,0.14,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.14
377,,8070690,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,,,CHEMBL1961873,,,,CHEMBL206544,GW682841X,CHEMBL206544,,False,http://qudt.org/vocab/unit#Percent,1583544,=,16,True,=,,Inhibition,%,,1.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.27
378,,8070764,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1,,,CHEMBL1961873,,,,CHEMBL468963,GW779439X,CHEMBL468963,,False,http://qudt.org/vocab/unit#Percent,1583576,=,16,True,=,,Inhibition,%,,10.68,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,10.68
379,,8070988,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1,,,CHEMBL1961873,,,,CHEMBL468963,GW779439X,CHEMBL468963,,False,http://qudt.org/vocab/unit#Percent,1583576,=,16,True,=,,Inhibition,%,,32.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,32.39
380,,8071145,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL1909397,GW279320X,CHEMBL1909397,,False,http://qudt.org/vocab/unit#Percent,1583436,=,16,True,=,,Inhibition,%,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.1
381,,8071271,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL397570,,CHEMBL397570,,False,http://qudt.org/vocab/unit#Percent,1583310,=,16,True,=,,Inhibition,%,,0.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.51
382,,8071495,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,,,CHEMBL1961873,,,,CHEMBL185238,GW786460X,CHEMBL185238,,False,http://qudt.org/vocab/unit#Percent,1583589,=,16,True,=,,Inhibition,%,,1.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.85
383,,8071668,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1,,,CHEMBL1961873,,,,CHEMBL399410,,CHEMBL399410,,False,http://qudt.org/vocab/unit#Percent,1583322,=,16,True,=,,Inhibition,%,,1.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.12
384,,8072017,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,,,CHEMBL1961873,,,,CHEMBL206544,GW682841X,CHEMBL206544,,False,http://qudt.org/vocab/unit#Percent,1583544,=,16,True,=,,Inhibition,%,,0.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.36
385,,8072331,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909366,GW659386A,CHEMBL244289,,False,http://qudt.org/vocab/unit#Percent,1583536,=,16,True,=,,Inhibition,%,,3.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.51
386,,8072488,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL1909397,GW279320X,CHEMBL1909397,,False,http://qudt.org/vocab/unit#Percent,1583436,=,16,True,=,,Inhibition,%,,1.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.43
387,,8072837,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,,,CHEMBL1961873,,,,CHEMBL185238,GW786460X,CHEMBL185238,,False,http://qudt.org/vocab/unit#Percent,1583589,=,16,True,=,,Inhibition,%,,0.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.21
388,,8073004,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL408564,,CHEMBL408564,,False,http://qudt.org/vocab/unit#Percent,1583349,=,16,True,=,,Inhibition,%,,5.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.57
389,,8073353,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl,,,CHEMBL1961873,,,,CHEMBL1909369,GW693917A,CHEMBL244482,,False,http://qudt.org/vocab/unit#Percent,1583552,=,16,True,=,,Inhibition,%,,1.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.94
390,,8073696,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL271843,GW275944X,CHEMBL271843,,False,http://qudt.org/vocab/unit#Percent,1583433,=,16,True,=,,Inhibition,%,,2.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.09
391,,8073929,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909366,GW659386A,CHEMBL244289,,False,http://qudt.org/vocab/unit#Percent,1583536,=,16,True,=,,Inhibition,%,,-0.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.12
392,,8074081,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909371,GW694590A,CHEMBL243891,,False,http://qudt.org/vocab/unit#Percent,1583554,=,16,True,=,,Inhibition,%,,2.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.38
393,,8074305,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909371,GW694590A,CHEMBL243891,,False,http://qudt.org/vocab/unit#Percent,1583554,=,16,True,=,,Inhibition,%,,0.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.86
394,,8074435,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL482326,GSK-1030062A,CHEMBL482326,,False,http://qudt.org/vocab/unit#Percent,1583373,=,16,True,=,,Inhibition,%,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.2
395,,8074592,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL408564,,CHEMBL408564,,False,http://qudt.org/vocab/unit#Percent,1583349,=,16,True,=,,Inhibition,%,,1.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.08
396,,8074816,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1785002,,CHEMBL1785002,,False,http://qudt.org/vocab/unit#Percent,1583303,=,16,True,=,,Inhibition,%,,3.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.72
397,,8074943,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl,,,CHEMBL1961873,,,,CHEMBL1909369,GW693917A,CHEMBL244482,,False,http://qudt.org/vocab/unit#Percent,1583552,=,16,True,=,,Inhibition,%,,0.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.25
398,,8075278,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL271843,GW275944X,CHEMBL271843,,False,http://qudt.org/vocab/unit#Percent,1583433,=,16,True,=,,Inhibition,%,,-0.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.03
399,,8075515,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21,,,CHEMBL1961873,,,,CHEMBL1096290,GSK-1000163A,CHEMBL1096290,,False,http://qudt.org/vocab/unit#Percent,1583367,=,16,True,=,,Inhibition,%,,3.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.31
400,,8075880,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1,,,CHEMBL1961873,,,,CHEMBL156987,,CHEMBL156987,,False,http://qudt.org/vocab/unit#Percent,1583318,=,16,True,=,,Inhibition,%,,3.69,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.69
401,,8076022,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL482326,GSK-1030062A,CHEMBL482326,,False,http://qudt.org/vocab/unit#Percent,1583373,=,16,True,=,,Inhibition,%,,-0.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.25
402,,8076394,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1785002,,CHEMBL1785002,,False,http://qudt.org/vocab/unit#Percent,1583303,=,16,True,=,,Inhibition,%,,1.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.16
403,,8076528,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL458438,GSK-1511931A,CHEMBL458438,,False,http://qudt.org/vocab/unit#Percent,1583378,=,16,True,=,,Inhibition,%,,5.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.39
404,,8076854,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1,,,CHEMBL1961873,,,,CHEMBL14112,SB-210313,CHEMBL14112,,False,http://qudt.org/vocab/unit#Percent,1583282,=,16,True,=,,Inhibition,%,,3.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.04
405,,8077101,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21,,,CHEMBL1961873,,,,CHEMBL1096290,GSK-1000163A,CHEMBL1096290,,False,http://qudt.org/vocab/unit#Percent,1583367,=,16,True,=,,Inhibition,%,,-0.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.93
406,,8077453,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1,,,CHEMBL1961873,,,,CHEMBL156987,,CHEMBL156987,,False,http://qudt.org/vocab/unit#Percent,1583318,=,16,True,=,,Inhibition,%,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.5
407,,8077604,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1,,,CHEMBL1961873,,,,CHEMBL522709,GSK-317315A,CHEMBL522709,,False,http://qudt.org/vocab/unit#Percent,1583405,=,16,True,=,,Inhibition,%,,1.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.48
408,,8077828,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1,,,CHEMBL1961873,,,,CHEMBL522709,GSK-317315A,CHEMBL522709,,False,http://qudt.org/vocab/unit#Percent,1583405,=,16,True,=,,Inhibition,%,,0.87,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.87
409,,8077971,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL473629,GSK-204925A,CHEMBL473629,,False,http://qudt.org/vocab/unit#Percent,1583386,=,16,True,=,,Inhibition,%,,2.95,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.95
410,,8078110,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL458438,GSK-1511931A,CHEMBL458438,,False,http://qudt.org/vocab/unit#Percent,1583378,=,16,True,=,,Inhibition,%,,-0.29,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.29
411,,8078334,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL103115,GW831091X,CHEMBL103115,,False,http://qudt.org/vocab/unit#Percent,1583268,=,16,True,=,,Inhibition,%,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.6
412,,8078436,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1,,,CHEMBL1961873,,,,CHEMBL14112,SB-210313,CHEMBL14112,,False,http://qudt.org/vocab/unit#Percent,1583282,=,16,True,=,,Inhibition,%,,-0.71,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.71
413,,8078686,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909349,GSK-1007102B,CHEMBL1099276,,False,http://qudt.org/vocab/unit#Percent,1583368,=,16,True,=,,Inhibition,%,,2.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.57
414,,8078910,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909349,GSK-1007102B,CHEMBL1099276,,False,http://qudt.org/vocab/unit#Percent,1583368,=,16,True,=,,Inhibition,%,,-0.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.97
415,,8079026,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1,,,CHEMBL1961873,,,,CHEMBL270164,GW607117X,CHEMBL270164,,False,http://qudt.org/vocab/unit#Percent,1583513,=,16,True,=,,Inhibition,%,,4.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.13
416,,8079408,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl,,,CHEMBL1961873,,,,CHEMBL1794067,GSK-978744A,CHEMBL1794067,,False,http://qudt.org/vocab/unit#Percent,1583429,=,16,True,=,,Inhibition,%,,1.29,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.29
417,,8079550,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL473629,GSK-204925A,CHEMBL473629,,False,http://qudt.org/vocab/unit#Percent,1583386,=,16,True,=,,Inhibition,%,,0.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.72
418,,8079913,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL103115,GW831091X,CHEMBL103115,,False,http://qudt.org/vocab/unit#Percent,1583268,=,16,True,=,,Inhibition,%,,-1.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.08
419,,8080018,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21,,,CHEMBL1961873,,,,CHEMBL1794071,,CHEMBL1851806,,False,http://qudt.org/vocab/unit#Percent,1583326,=,16,True,=,,Inhibition,%,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.0
420,,8080242,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21,,,CHEMBL1961873,,,,CHEMBL1794071,,CHEMBL1851806,,False,http://qudt.org/vocab/unit#Percent,1583326,=,16,True,=,,Inhibition,%,,-0.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.27
421,,8080494,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL269883,GW416981X,CHEMBL269883,,False,http://qudt.org/vocab/unit#Percent,1583463,=,16,True,=,,Inhibition,%,,2.68,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.68
422,,8080609,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1,,,CHEMBL1961873,,,,CHEMBL270164,GW607117X,CHEMBL270164,,False,http://qudt.org/vocab/unit#Percent,1583513,=,16,True,=,,Inhibition,%,,0.84,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.84
423,,8080997,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl,,,CHEMBL1961873,,,,CHEMBL1794067,GSK-978744A,CHEMBL1794067,,False,http://qudt.org/vocab/unit#Percent,1583429,=,16,True,=,,Inhibition,%,,-0.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.05
424,,8081132,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL1909391,GW576924A,CHEMBL215716,,False,http://qudt.org/vocab/unit#Percent,1583503,=,16,True,=,,Inhibition,%,,3.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.06
425,,8081356,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL1909391,GW576924A,CHEMBL215716,,False,http://qudt.org/vocab/unit#Percent,1583503,=,16,True,=,,Inhibition,%,,1.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.06
426,,8081500,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1,,,CHEMBL1961873,,,,CHEMBL476259,GSK-1326255A,CHEMBL476259,,False,http://qudt.org/vocab/unit#Percent,1583376,=,16,True,=,,Inhibition,%,,3.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.12
427,,8081827,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL160333,,CHEMBL160333,,False,http://qudt.org/vocab/unit#Percent,1583319,=,16,True,=,,Inhibition,%,,2.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.97
428,,8082079,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL269883,GW416981X,CHEMBL269883,,False,http://qudt.org/vocab/unit#Percent,1583463,=,16,True,=,,Inhibition,%,,0.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.81
429,,8082192,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909411,,CHEMBL15202,,False,http://qudt.org/vocab/unit#Percent,1583364,=,16,True,=,,Inhibition,%,,3.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.13
430,,8082416,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909411,,CHEMBL15202,,False,http://qudt.org/vocab/unit#Percent,1583364,=,16,True,=,,Inhibition,%,,0.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.86
431,,8082589,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1909407,,CHEMBL274064,,False,http://qudt.org/vocab/unit#Percent,1583285,=,16,True,=,,Inhibition,%,,3.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.05
432,,8082936,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL517507,GW782912X,CHEMBL517507,,False,http://qudt.org/vocab/unit#Percent,1583582,=,16,True,=,,Inhibition,%,,3.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.77
433,,8083092,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1,,,CHEMBL1961873,,,,CHEMBL476259,GSK-1326255A,CHEMBL476259,,False,http://qudt.org/vocab/unit#Percent,1583376,=,16,True,=,,Inhibition,%,,3.69,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.69
434,,8083415,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL160333,,CHEMBL160333,,False,http://qudt.org/vocab/unit#Percent,1583319,=,16,True,=,,Inhibition,%,,0.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.96
435,,8083669,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nonc1-c1nc2cnccc2n1C1CCCCC1,,,CHEMBL1961873,,,,CHEMBL189231,,CHEMBL189231,,False,http://qudt.org/vocab/unit#Percent,1583340,=,16,True,=,,Inhibition,%,,2.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.08
436,,8084003,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1,,,CHEMBL1961873,,,,CHEMBL95207,,CHEMBL95207,,False,http://qudt.org/vocab/unit#Percent,1583286,=,16,True,=,,Inhibition,%,,3.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.88
437,,8084188,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1909407,,CHEMBL274064,,False,http://qudt.org/vocab/unit#Percent,1583285,=,16,True,=,,Inhibition,%,,-1.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.58
438,,8084530,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL517507,GW782912X,CHEMBL517507,,False,http://qudt.org/vocab/unit#Percent,1583582,=,16,True,=,,Inhibition,%,,1.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.51
439,,8084691,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL272026,GW290597X,CHEMBL272026,,False,http://qudt.org/vocab/unit#Percent,1583443,=,16,True,=,,Inhibition,%,,3.89,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.89
440,,8084915,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL272026,GW290597X,CHEMBL272026,,False,http://qudt.org/vocab/unit#Percent,1583443,=,16,True,=,,Inhibition,%,,1.67,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.67
441,,8085013,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,,,CHEMBL1961873,,,,CHEMBL103080,,CHEMBL103080,,False,http://qudt.org/vocab/unit#Percent,1583351,=,16,True,=,,Inhibition,%,,4.95,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.95
442,,8085269,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nonc1-c1nc2cnccc2n1C1CCCCC1,,,CHEMBL1961873,,,,CHEMBL189231,,CHEMBL189231,,False,http://qudt.org/vocab/unit#Percent,1583340,=,16,True,=,,Inhibition,%,,-1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.3
443,,8085601,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1,,,CHEMBL1961873,,,,CHEMBL95207,,CHEMBL95207,,False,http://qudt.org/vocab/unit#Percent,1583286,=,16,True,=,,Inhibition,%,,0.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.94
444,,8085790,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1,,,CHEMBL1961873,,,,CHEMBL409892,GW305178X,CHEMBL409892,,False,http://qudt.org/vocab/unit#Percent,1583453,=,16,True,=,,Inhibition,%,,2.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.94
445,,8086014,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1,,,CHEMBL1961873,,,,CHEMBL409892,GW305178X,CHEMBL409892,,False,http://qudt.org/vocab/unit#Percent,1583453,=,16,True,=,,Inhibition,%,,2.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.77
446,,8086129,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1,,,CHEMBL1961873,,,,CHEMBL30432,GW282974X,CHEMBL30432,,False,http://qudt.org/vocab/unit#Percent,1583440,=,16,True,=,,Inhibition,%,,3.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.11
447,,8086515,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1,,,CHEMBL1961873,,,,CHEMBL261129,,CHEMBL261129,,False,http://qudt.org/vocab/unit#Percent,1583337,=,16,True,=,,Inhibition,%,,3.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.04
448,,8086614,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,,,CHEMBL1961873,,,,CHEMBL103080,,CHEMBL103080,,False,http://qudt.org/vocab/unit#Percent,1583351,=,16,True,=,,Inhibition,%,,0.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.25
449,,8086838,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2ccncc21,,,CHEMBL1961873,,,,CHEMBL185710,,CHEMBL185710,,False,http://qudt.org/vocab/unit#Percent,1583347,=,16,True,=,,Inhibition,%,,2.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.09
450,,8087049,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL263796,GW445014X,CHEMBL263796,,False,http://qudt.org/vocab/unit#Percent,1583475,=,16,True,=,,Inhibition,%,,1.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.25
451,,8087207,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,,,CHEMBL1961873,,,,CHEMBL318728,GW549390X,CHEMBL318728,,False,http://qudt.org/vocab/unit#Percent,1583485,=,16,True,=,,Inhibition,%,,2.65,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.65
452,,8087545,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909358,GW654652C,CHEMBL475932,,False,http://qudt.org/vocab/unit#Percent,1583535,=,16,True,=,,Inhibition,%,,1.99,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.99
453,,8087683,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL475761,GW784684X,CHEMBL475761,,False,http://qudt.org/vocab/unit#Percent,1583584,=,16,True,=,,Inhibition,%,,0.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.28
454,,8087907,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL475761,GW784684X,CHEMBL475761,,False,http://qudt.org/vocab/unit#Percent,1583584,=,16,True,=,,Inhibition,%,,0.56,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.56
455,,8088049,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl,,,CHEMBL1961873,,,,CHEMBL1909376,,CHEMBL493066,,False,http://qudt.org/vocab/unit#Percent,1583358,=,16,True,=,,Inhibition,%,,2.74,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.74
456,,8088421,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1,,,CHEMBL1961873,,,,CHEMBL230597,GSK-586581A,CHEMBL230597,,False,http://qudt.org/vocab/unit#Percent,1583415,=,16,True,=,,Inhibition,%,,0.55,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.55
457,,8088549,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21,,,CHEMBL1961873,,,,CHEMBL506153,GW876790X,CHEMBL506153,,False,http://qudt.org/vocab/unit#Percent,1583281,=,16,True,=,,Inhibition,%,,3.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.05
458,,8088866,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2ccccc21,,,CHEMBL1961873,,,,CHEMBL365286,GW549034X,CHEMBL365286,,False,http://qudt.org/vocab/unit#Percent,1583484,=,16,True,=,,Inhibition,%,,-0.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.13
459,,8089218,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1,,,CHEMBL1961873,,,,CHEMBL517171,GSK-1713088A,CHEMBL517171,,False,http://qudt.org/vocab/unit#Percent,1583379,=,16,True,=,,Inhibition,%,,-2.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.83
460,,8089366,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,,,CHEMBL1961873,,,,CHEMBL207410,GW772405X,CHEMBL207410,,False,http://qudt.org/vocab/unit#Percent,1583573,=,16,True,=,,Inhibition,%,,0.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.26
461,,8089710,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL476351,GW775608X,CHEMBL476351,,False,http://qudt.org/vocab/unit#Percent,1583574,=,16,True,=,,Inhibition,%,,0.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.94
462,,8089890,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,,,CHEMBL1961873,,,,CHEMBL1909402,GW568326X,CHEMBL1909402,,False,http://qudt.org/vocab/unit#Percent,1583490,=,16,True,=,,Inhibition,%,,0.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.57
463,,8090114,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,,,CHEMBL1961873,,,,CHEMBL1909402,GW568326X,CHEMBL1909402,,False,http://qudt.org/vocab/unit#Percent,1583490,=,16,True,=,,Inhibition,%,,0.46,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.46
464,,8090279,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2,,,CHEMBL1961873,,,,CHEMBL505915,GSK-1751853A,CHEMBL505915,,False,http://qudt.org/vocab/unit#Percent,1583380,=,16,True,=,,Inhibition,%,,-0.19,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.19
465,,8090446,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1,,,CHEMBL1961873,,,,CHEMBL524057,GW683768X,CHEMBL524057,,False,http://qudt.org/vocab/unit#Percent,1583548,=,16,True,=,,Inhibition,%,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.5
466,,8090670,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12,,,CHEMBL1961873,,,,CHEMBL486124,GW874091X,CHEMBL486124,,False,http://qudt.org/vocab/unit#Percent,1583280,=,16,True,=,,Inhibition,%,,1.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.72
467,,8090809,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1,,,CHEMBL1961873,,,,CHEMBL183993,GW811761X,CHEMBL183993,,False,http://qudt.org/vocab/unit#Percent,1583610,=,16,True,=,,Inhibition,%,,1.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.01
468,,8091014,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL186213,GW827105X,CHEMBL186213,,False,http://qudt.org/vocab/unit#Percent,1583621,=,16,True,=,,Inhibition,%,,1.92,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.92
469,,8091375,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL263796,GW445014X,CHEMBL263796,,False,http://qudt.org/vocab/unit#Percent,1583475,=,16,True,=,,Inhibition,%,,2.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.37
470,,8091530,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1,,,CHEMBL1961873,,,,CHEMBL517666,GW796921X,CHEMBL517666,,False,http://qudt.org/vocab/unit#Percent,1583595,=,16,True,=,,Inhibition,%,,1.62,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.62
471,,8091754,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1,,,CHEMBL1961873,,,,CHEMBL517666,GW796921X,CHEMBL517666,,False,http://qudt.org/vocab/unit#Percent,1583595,=,16,True,=,,Inhibition,%,,2.19,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.19
472,,8091870,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1794062,GW577921A,CHEMBL194027,,False,http://qudt.org/vocab/unit#Percent,1583504,=,16,True,=,,Inhibition,%,,2.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.31
473,,8092231,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275798,,CHEMBL275798,,False,http://qudt.org/vocab/unit#Percent,1583291,=,16,True,=,,Inhibition,%,,0.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.54
474,,8092382,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl,,,CHEMBL1961873,,,,CHEMBL1909376,,CHEMBL493066,,False,http://qudt.org/vocab/unit#Percent,1583358,=,16,True,=,,Inhibition,%,,3.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.54
475,,8092754,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1,,,CHEMBL1961873,,,,CHEMBL230597,GSK-586581A,CHEMBL230597,,False,http://qudt.org/vocab/unit#Percent,1583415,=,16,True,=,,Inhibition,%,,1.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.37
476,,8092883,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL521806,GSK-237700A,CHEMBL521806,,False,http://qudt.org/vocab/unit#Percent,1583393,=,16,True,=,,Inhibition,%,,1.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.23
477,,8093107,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL521806,GSK-237700A,CHEMBL521806,,False,http://qudt.org/vocab/unit#Percent,1583393,=,16,True,=,,Inhibition,%,,2.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.08
478,,8093195,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2ccccc21,,,CHEMBL1961873,,,,CHEMBL365286,GW549034X,CHEMBL365286,,False,http://qudt.org/vocab/unit#Percent,1583484,=,16,True,=,,Inhibition,%,,1.55,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.55
479,,8093419,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,,,CHEMBL1961873,,,,CHEMBL1909403,GW569293E,CHEMBL1952232,,False,http://qudt.org/vocab/unit#Percent,1583492,=,16,True,=,,Inhibition,%,,-1.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.58
480,,8093559,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1,,,CHEMBL1961873,,,,CHEMBL517171,GSK-1713088A,CHEMBL517171,,False,http://qudt.org/vocab/unit#Percent,1583379,=,16,True,=,,Inhibition,%,,2.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.25
481,,8093698,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL270544,GW396574X,CHEMBL270544,,False,http://qudt.org/vocab/unit#Percent,1583456,=,16,True,=,,Inhibition,%,,-0.76,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.76
482,,8093922,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL270544,GW396574X,CHEMBL270544,,False,http://qudt.org/vocab/unit#Percent,1583456,=,16,True,=,,Inhibition,%,,0.79,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.79
483,,8094042,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1,,,CHEMBL1961873,,,,CHEMBL179453,GW622055X,CHEMBL179453,,False,http://qudt.org/vocab/unit#Percent,1583522,=,16,True,=,,Inhibition,%,,-1.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.05
484,,8094446,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909353,GW458344A,CHEMBL373576,,False,http://qudt.org/vocab/unit#Percent,1583479,=,16,True,=,,Inhibition,%,,-0.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.17
485,,8094621,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2,,,CHEMBL1961873,,,,CHEMBL505915,GSK-1751853A,CHEMBL505915,,False,http://qudt.org/vocab/unit#Percent,1583380,=,16,True,=,,Inhibition,%,,-0.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.43
486,,8095001,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12,,,CHEMBL1961873,,,,CHEMBL486124,GW874091X,CHEMBL486124,,False,http://qudt.org/vocab/unit#Percent,1583280,=,16,True,=,,Inhibition,%,,1.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.58
487,,8095141,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1,,,CHEMBL1961873,,,,CHEMBL188381,GW806742X,CHEMBL188381,,False,http://qudt.org/vocab/unit#Percent,1583601,=,16,True,=,,Inhibition,%,,1.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.26
488,,8095344,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909385,GW458787A,CHEMBL213342,,False,http://qudt.org/vocab/unit#Percent,1583480,=,16,True,=,,Inhibition,%,,1.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.54
489,,8095568,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909385,GW458787A,CHEMBL213342,,False,http://qudt.org/vocab/unit#Percent,1583480,=,16,True,=,,Inhibition,%,,1.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.78
490,,8095709,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1,,,CHEMBL1961873,,,,CHEMBL513897,GSK-994854A,CHEMBL513897,,False,http://qudt.org/vocab/unit#Percent,1583431,=,16,True,=,,Inhibition,%,,2.14,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.14
491,,8096081,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl,,,CHEMBL1961873,,,,CHEMBL1909380,GW282449A,CHEMBL416031,,False,http://qudt.org/vocab/unit#Percent,1583438,=,16,True,=,,Inhibition,%,,0.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.58
492,,8096198,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1794062,GW577921A,CHEMBL194027,,False,http://qudt.org/vocab/unit#Percent,1583504,=,16,True,=,,Inhibition,%,,2.99,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.99
493,,8096422,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275666,,CHEMBL275666,,False,http://qudt.org/vocab/unit#Percent,1583300,=,16,True,=,,Inhibition,%,,1.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.97
494,,8096561,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275798,,CHEMBL275798,,False,http://qudt.org/vocab/unit#Percent,1583291,=,16,True,=,,Inhibition,%,,0.35,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.35
495,,8096717,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1,,,CHEMBL1961873,,,,CHEMBL475599,GSK-300014A,CHEMBL475599,,False,http://qudt.org/vocab/unit#Percent,1583402,=,16,True,=,,Inhibition,%,,2.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.58
496,,8096941,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1,,,CHEMBL1961873,,,,CHEMBL475599,GSK-300014A,CHEMBL475599,,False,http://qudt.org/vocab/unit#Percent,1583402,=,16,True,=,,Inhibition,%,,3.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.31
497,,8097088,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL506414,GW684626B,CHEMBL506414,,False,http://qudt.org/vocab/unit#Percent,1583549,=,16,True,=,,Inhibition,%,,0.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.39
498,,8097399,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1,,,CHEMBL1961873,,,,CHEMBL493326,GSK-317314A,CHEMBL493326,,False,http://qudt.org/vocab/unit#Percent,1583404,=,16,True,=,,Inhibition,%,,1.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.82
499,,8097619,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1,,,CHEMBL1961873,,,,CHEMBL1909403,GW569293E,CHEMBL1952232,,False,http://qudt.org/vocab/unit#Percent,1583492,=,16,True,=,,Inhibition,%,,1.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.48
500,,8097769,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21,,,CHEMBL1961873,,,,CHEMBL1096626,GSK-938890A,CHEMBL1096626,,False,http://qudt.org/vocab/unit#Percent,1583424,=,16,True,=,,Inhibition,%,,-2.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.13
501,,8098126,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909373,GW701427A,CHEMBL244097,,False,http://qudt.org/vocab/unit#Percent,1583558,=,16,True,=,,Inhibition,%,,1.45,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.45
502,,8098246,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1,,,CHEMBL1961873,,,,CHEMBL179453,GW622055X,CHEMBL179453,,False,http://qudt.org/vocab/unit#Percent,1583522,=,16,True,=,,Inhibition,%,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.5
503,,8098470,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1,,,CHEMBL1961873,,,,CHEMBL516248,GW804482X,CHEMBL516248,,False,http://qudt.org/vocab/unit#Percent,1583598,=,16,True,=,,Inhibition,%,,-1.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.12
504,,8098650,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909353,GW458344A,CHEMBL373576,,False,http://qudt.org/vocab/unit#Percent,1583479,=,16,True,=,,Inhibition,%,,-0.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.12
505,,8098835,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL458865,GSK-1220512A,CHEMBL458865,,False,http://qudt.org/vocab/unit#Percent,1583375,=,16,True,=,,Inhibition,%,,0.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.7
506,,8099203,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909386,GW566221A,CHEMBL377437,,False,http://qudt.org/vocab/unit#Percent,1583488,=,16,True,=,,Inhibition,%,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.8
507,,8099345,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1,,,CHEMBL1961873,,,,CHEMBL188381,GW806742X,CHEMBL188381,,False,http://qudt.org/vocab/unit#Percent,1583601,=,16,True,=,,Inhibition,%,,2.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.86
508,,8099569,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL471789,GSK-1030059A,CHEMBL471789,,False,http://qudt.org/vocab/unit#Percent,1583371,=,16,True,=,,Inhibition,%,,0.98,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.98
509,,8099763,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1,,,CHEMBL1961873,,,,CHEMBL1885746,GW561436X,CHEMBL1885746,,False,http://qudt.org/vocab/unit#Percent,1583487,=,16,True,=,,Inhibition,%,,0.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.03
510,,8099910,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1,,,CHEMBL1961873,,,,CHEMBL513897,GSK-994854A,CHEMBL513897,,False,http://qudt.org/vocab/unit#Percent,1583431,=,16,True,=,,Inhibition,%,,5.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.18
511,,8100134,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL303687,GW829877X,CHEMBL303687,,False,http://qudt.org/vocab/unit#Percent,1583629,=,16,True,=,,Inhibition,%,,2.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.16
512,,8100280,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl,,,CHEMBL1961873,,,,CHEMBL1909380,GW282449A,CHEMBL416031,,False,http://qudt.org/vocab/unit#Percent,1583438,=,16,True,=,,Inhibition,%,,1.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.32
513,,8100620,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275666,,CHEMBL275666,,False,http://qudt.org/vocab/unit#Percent,1583300,=,16,True,=,,Inhibition,%,,2.24,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.24
514,,8100760,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL1909393,GW583373A,CHEMBL212965,,False,http://qudt.org/vocab/unit#Percent,1583509,=,16,True,=,,Inhibition,%,,0.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.32
515,,8101144,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2ccncc2)cc1C(N)=O,,,CHEMBL1961873,,,,CHEMBL231013,GSK-605714A,CHEMBL231013,,False,http://qudt.org/vocab/unit#Percent,1583416,=,16,True,=,,Inhibition,%,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.8
516,,8101286,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL506414,GW684626B,CHEMBL506414,,False,http://qudt.org/vocab/unit#Percent,1583549,=,16,True,=,,Inhibition,%,,1.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.34
517,,8101510,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL443563,GW627512B,CHEMBL443563,,False,http://qudt.org/vocab/unit#Percent,1583523,=,16,True,=,,Inhibition,%,,-0.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.52
518,,8101695,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1,,,CHEMBL1961873,,,,CHEMBL493326,GSK-317314A,CHEMBL493326,,False,http://qudt.org/vocab/unit#Percent,1583404,=,16,True,=,,Inhibition,%,,1.46,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.46
519,,8101948,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1,,,CHEMBL1961873,,,,CHEMBL206010,GW814408X,CHEMBL206010,,False,http://qudt.org/vocab/unit#Percent,1583612,=,16,True,=,,Inhibition,%,,-2.59,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.59
520,,8102103,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21,,,CHEMBL1961873,,,,CHEMBL1096626,GSK-938890A,CHEMBL1096626,,False,http://qudt.org/vocab/unit#Percent,1583424,=,16,True,=,,Inhibition,%,,0.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.37
521,,8102327,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL251549,GW782612X,CHEMBL251549,,False,http://qudt.org/vocab/unit#Percent,1583580,=,16,True,=,,Inhibition,%,,-3.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.26
522,,8102458,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909373,GW701427A,CHEMBL244097,,False,http://qudt.org/vocab/unit#Percent,1583558,=,16,True,=,,Inhibition,%,,0.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.26
523,,8102802,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1,,,CHEMBL1961873,,,,CHEMBL516248,GW804482X,CHEMBL516248,,False,http://qudt.org/vocab/unit#Percent,1583598,=,16,True,=,,Inhibition,%,,-1.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.16
524,,8102980,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1,,,CHEMBL1961873,,,,CHEMBL215993,GW284372X,CHEMBL215993,,False,http://qudt.org/vocab/unit#Percent,1583441,=,16,True,=,,Inhibition,%,,0.92,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.92
525,,8103176,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL458865,GSK-1220512A,CHEMBL458865,,False,http://qudt.org/vocab/unit#Percent,1583375,=,16,True,=,,Inhibition,%,,1.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.94
526,,8103400,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21,,,CHEMBL1961873,,,,CHEMBL1096634,GSK-943949A,CHEMBL1096634,,False,http://qudt.org/vocab/unit#Percent,1583425,=,16,True,=,,Inhibition,%,,1.14,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.14
527,,8103538,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909386,GW566221A,CHEMBL377437,,False,http://qudt.org/vocab/unit#Percent,1583488,=,16,True,=,,Inhibition,%,,2.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.23
528,,8103912,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL471789,GSK-1030059A,CHEMBL471789,,False,http://qudt.org/vocab/unit#Percent,1583371,=,16,True,=,,Inhibition,%,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.4
529,,8104097,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1,,,CHEMBL1961873,,,,CHEMBL1885746,GW561436X,CHEMBL1885746,,False,http://qudt.org/vocab/unit#Percent,1583487,=,16,True,=,,Inhibition,%,,-0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.5
530,,8104469,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL303687,GW829877X,CHEMBL303687,,False,http://qudt.org/vocab/unit#Percent,1583629,=,16,True,=,,Inhibition,%,,4.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.05
531,,8104615,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL269827,GW276655X,CHEMBL269827,,False,http://qudt.org/vocab/unit#Percent,1583434,=,16,True,=,,Inhibition,%,,0.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.31
532,,8104953,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL13972,,CHEMBL13972,,False,http://qudt.org/vocab/unit#Percent,1583295,=,16,True,=,,Inhibition,%,,2.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.17
533,,8105093,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL1909393,GW583373A,CHEMBL212965,,False,http://qudt.org/vocab/unit#Percent,1583509,=,16,True,=,,Inhibition,%,,0.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.82
534,,8105317,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275168,,CHEMBL275168,,False,http://qudt.org/vocab/unit#Percent,1583306,=,16,True,=,,Inhibition,%,,0.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.34
535,,8105483,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2ccncc2)cc1C(N)=O,,,CHEMBL1961873,,,,CHEMBL231013,GSK-605714A,CHEMBL231013,,False,http://qudt.org/vocab/unit#Percent,1583416,=,16,True,=,,Inhibition,%,,2.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.34
536,,8105845,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL443563,GW627512B,CHEMBL443563,,False,http://qudt.org/vocab/unit#Percent,1583523,=,16,True,=,,Inhibition,%,,0.55,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.55
537,,8105901,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL479079,GW612286X,CHEMBL479079,,False,http://qudt.org/vocab/unit#Percent,1583514,=,16,True,=,,Inhibition,%,,6.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,6.36
538,,8106125,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,,,CHEMBL1961873,,,,CHEMBL205798,GW703087X,CHEMBL205798,,False,http://qudt.org/vocab/unit#Percent,1583559,=,16,True,=,,Inhibition,%,,-1.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.12
539,,8106290,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1,,,CHEMBL1961873,,,,CHEMBL206010,GW814408X,CHEMBL206010,,False,http://qudt.org/vocab/unit#Percent,1583612,=,16,True,=,,Inhibition,%,,5.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.06
540,,8106670,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL251549,GW782612X,CHEMBL251549,,False,http://qudt.org/vocab/unit#Percent,1583580,=,16,True,=,,Inhibition,%,,3.19,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.19
541,,8106799,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1,,,CHEMBL1961873,,,,CHEMBL275473,GW572401X,CHEMBL275473,,False,http://qudt.org/vocab/unit#Percent,1583495,=,16,True,=,,Inhibition,%,,0.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.75
542,,8107144,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1,,,CHEMBL1961873,,,,CHEMBL505187,GSK-718429A,CHEMBL505187,,False,http://qudt.org/vocab/unit#Percent,1583423,=,16,True,=,,Inhibition,%,,-0.99,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.99
543,,8107316,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1,,,CHEMBL1961873,,,,CHEMBL215993,GW284372X,CHEMBL215993,,False,http://qudt.org/vocab/unit#Percent,1583441,=,16,True,=,,Inhibition,%,,1.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.06
544,,8107540,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br,,,CHEMBL1961873,,,,CHEMBL480371,GW853609X,CHEMBL480371,,False,http://qudt.org/vocab/unit#Percent,1583276,=,16,True,=,,Inhibition,%,,0.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.4
545,,8107741,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21,,,CHEMBL1961873,,,,CHEMBL1096634,GSK-943949A,CHEMBL1096634,,False,http://qudt.org/vocab/unit#Percent,1583425,=,16,True,=,,Inhibition,%,,1.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.37
546,,8107876,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,,,CHEMBL1961873,,,,CHEMBL1909382,GW759710A,CHEMBL400388,,False,http://qudt.org/vocab/unit#Percent,1583566,=,16,True,=,,Inhibition,%,,0.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.1
547,,8108258,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL518968,GSK-1030061A,CHEMBL518968,,False,http://qudt.org/vocab/unit#Percent,1583372,=,16,True,=,,Inhibition,%,,2.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.12
548,,8108433,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909364,GW589961A,CHEMBL396283,,False,http://qudt.org/vocab/unit#Percent,1583511,=,16,True,=,,Inhibition,%,,-0.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.12
549,,8108804,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,,,CHEMBL1961873,,,,CHEMBL1794069,GSK-571989A,CHEMBL1794069,,False,http://qudt.org/vocab/unit#Percent,1583413,=,16,True,=,,Inhibition,%,,2.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.66
550,,8108946,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL269827,GW276655X,CHEMBL269827,,False,http://qudt.org/vocab/unit#Percent,1583434,=,16,True,=,,Inhibition,%,,1.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.08
551,,8109170,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,,,CHEMBL1961873,,,,CHEMBL212250,GW615311X,CHEMBL212250,,False,http://qudt.org/vocab/unit#Percent,1583515,=,16,True,=,,Inhibition,%,,0.22,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.22
552,,8109284,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL13972,,CHEMBL13972,,False,http://qudt.org/vocab/unit#Percent,1583295,=,16,True,=,,Inhibition,%,,2.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.43
553,,8109638,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275168,,CHEMBL275168,,False,http://qudt.org/vocab/unit#Percent,1583306,=,16,True,=,,Inhibition,%,,0.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.58
554,,8109809,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,,,CHEMBL1961873,,,,CHEMBL1794070,GSK-579289A,CHEMBL1794070,,False,http://qudt.org/vocab/unit#Percent,1583414,=,16,True,=,,Inhibition,%,,1.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.54
555,,8110165,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1,,,CHEMBL1961873,,,,CHEMBL176553,GW631581B,CHEMBL176553,,False,http://qudt.org/vocab/unit#Percent,1583525,=,16,True,=,,Inhibition,%,,2.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.03
556,,8110444,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,,,CHEMBL1961873,,,,CHEMBL205798,GW703087X,CHEMBL205798,,False,http://qudt.org/vocab/unit#Percent,1583559,=,16,True,=,,Inhibition,%,,1.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.86
557,,8110610,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O,,,CHEMBL1961873,,,,CHEMBL1909405,GW618013A,CHEMBL1896047,,False,http://qudt.org/vocab/unit#Percent,1583517,=,16,True,=,,Inhibition,%,,-2.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.77
558,,8110992,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794064,GSK-561866B,CHEMBL494280,,False,http://qudt.org/vocab/unit#Percent,1583412,=,16,True,=,,Inhibition,%,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.9
559,,8111115,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1,,,CHEMBL1961873,,,,CHEMBL275473,GW572401X,CHEMBL275473,,False,http://qudt.org/vocab/unit#Percent,1583495,=,16,True,=,,Inhibition,%,,0.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.8
560,,8111339,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,,,CHEMBL1961873,,,,CHEMBL243907,GW673715X,CHEMBL243907,,False,http://qudt.org/vocab/unit#Percent,1583538,=,16,True,=,,Inhibition,%,,0.53,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.53
561,,8111466,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1,,,CHEMBL1961873,,,,CHEMBL505187,GSK-718429A,CHEMBL505187,,False,http://qudt.org/vocab/unit#Percent,1583423,=,16,True,=,,Inhibition,%,,-0.44,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.44
562,,8111856,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br,,,CHEMBL1961873,,,,CHEMBL480371,GW853609X,CHEMBL480371,,False,http://qudt.org/vocab/unit#Percent,1583276,=,16,True,=,,Inhibition,%,,1.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.13
563,,8112061,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,,,CHEMBL1961873,,,,CHEMBL192417,GW632046X,CHEMBL192417,,False,http://qudt.org/vocab/unit#Percent,1583526,=,16,True,=,,Inhibition,%,,1.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.25
564,,8112198,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1,,,CHEMBL1961873,,,,CHEMBL1909382,GW759710A,CHEMBL400388,,False,http://qudt.org/vocab/unit#Percent,1583566,=,16,True,=,,Inhibition,%,,2.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.52
565,,8112422,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL442363,GW809885X,CHEMBL442363,,False,http://qudt.org/vocab/unit#Percent,1583605,=,16,True,=,,Inhibition,%,,-0.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.08
566,,8112590,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL518968,GSK-1030061A,CHEMBL518968,,False,http://qudt.org/vocab/unit#Percent,1583372,=,16,True,=,,Inhibition,%,,1.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.97
567,,8112762,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl,,,CHEMBL1961873,,,,CHEMBL1909364,GW589961A,CHEMBL396283,,False,http://qudt.org/vocab/unit#Percent,1583511,=,16,True,=,,Inhibition,%,,0.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.32
568,,8112986,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909388,GW568377A,CHEMBL213822,,False,http://qudt.org/vocab/unit#Percent,1583491,=,16,True,=,,Inhibition,%,,0.62,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.62
569,,8113138,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,,,CHEMBL1961873,,,,CHEMBL1794069,GSK-571989A,CHEMBL1794069,,False,http://qudt.org/vocab/unit#Percent,1583413,=,16,True,=,,Inhibition,%,,6.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,6.25
570,,8113498,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,,,CHEMBL1961873,,,,CHEMBL212250,GW615311X,CHEMBL212250,,False,http://qudt.org/vocab/unit#Percent,1583515,=,16,True,=,,Inhibition,%,,0.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.93
571,,8113622,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909400,,CHEMBL14212,,False,http://qudt.org/vocab/unit#Percent,1583307,=,16,True,=,,Inhibition,%,,0.99,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.99
572,,8113962,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1785003,,CHEMBL1785003,,False,http://qudt.org/vocab/unit#Percent,1583304,=,16,True,=,,Inhibition,%,,-0.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.81
573,,8114138,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl,,,CHEMBL1961873,,,,CHEMBL1794070,GSK-579289A,CHEMBL1794070,,False,http://qudt.org/vocab/unit#Percent,1583414,=,16,True,=,,Inhibition,%,,3.69,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.69
574,,8114362,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909387,GW567808A,CHEMBL214419,,False,http://qudt.org/vocab/unit#Percent,1583489,=,16,True,=,,Inhibition,%,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.1
575,,8114494,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1,,,CHEMBL1961873,,,,CHEMBL176553,GW631581B,CHEMBL176553,,False,http://qudt.org/vocab/unit#Percent,1583525,=,16,True,=,,Inhibition,%,,2.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.83
576,,8114770,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477978,GW782907X,CHEMBL477978,,False,http://qudt.org/vocab/unit#Percent,1583581,=,16,True,=,,Inhibition,%,,-1.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.27
577,,8114936,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O,,,CHEMBL1961873,,,,CHEMBL1909405,GW618013A,CHEMBL1896047,,False,http://qudt.org/vocab/unit#Percent,1583517,=,16,True,=,,Inhibition,%,,1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.66
578,,8115160,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,,,CHEMBL1961873,,,,CHEMBL588025,GW770249A,CHEMBL247228,,False,http://qudt.org/vocab/unit#Percent,1583570,=,16,True,=,,Inhibition,%,,-1.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.81
579,,8115325,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794064,GSK-561866B,CHEMBL494280,,False,http://qudt.org/vocab/unit#Percent,1583412,=,16,True,=,,Inhibition,%,,-2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.0
580,,8115669,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1,,,CHEMBL1961873,,,,CHEMBL243907,GW673715X,CHEMBL243907,,False,http://qudt.org/vocab/unit#Percent,1583538,=,16,True,=,,Inhibition,%,,1.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.04
581,,8115802,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909375,GSK-614526A,CHEMBL1963560,,False,http://qudt.org/vocab/unit#Percent,1583417,=,16,True,=,,Inhibition,%,,0.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.18
582,,8116185,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL410072,GW301784X,CHEMBL410072,,False,http://qudt.org/vocab/unit#Percent,1583449,=,16,True,=,,Inhibition,%,,-1.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.23
583,,8116388,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1,,,CHEMBL1961873,,,,CHEMBL192417,GW632046X,CHEMBL192417,,False,http://qudt.org/vocab/unit#Percent,1583526,=,16,True,=,,Inhibition,%,,1.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.27
584,,8116746,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL442363,GW809885X,CHEMBL442363,,False,http://qudt.org/vocab/unit#Percent,1583605,=,16,True,=,,Inhibition,%,,0.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.93
585,,8116918,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12,,,CHEMBL1961873,,,,CHEMBL241517,GW856804X,CHEMBL241517,,False,http://qudt.org/vocab/unit#Percent,1583277,=,16,True,=,,Inhibition,%,,1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.66
586,,8117313,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909388,GW568377A,CHEMBL213822,,False,http://qudt.org/vocab/unit#Percent,1583491,=,16,True,=,,Inhibition,%,,1.15,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.15
587,,8117471,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl,,,CHEMBL1961873,,,,CHEMBL1909350,GSK-949675A,CHEMBL1098943,,False,http://qudt.org/vocab/unit#Percent,1583426,=,16,True,=,,Inhibition,%,,2.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.16
588,,8117825,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL529066,GW574783B,CHEMBL380247,,False,http://qudt.org/vocab/unit#Percent,1583498,=,16,True,=,,Inhibition,%,,0.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.4
589,,8117963,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909400,,CHEMBL14212,,False,http://qudt.org/vocab/unit#Percent,1583307,=,16,True,=,,Inhibition,%,,1.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.42
590,,8118187,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL1785004,,CHEMBL1785004,,False,http://qudt.org/vocab/unit#Percent,1583301,=,16,True,=,,Inhibition,%,,1.33,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.33
591,,8118303,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1785003,,CHEMBL1785003,,False,http://qudt.org/vocab/unit#Percent,1583304,=,16,True,=,,Inhibition,%,,-0.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.77
592,,8118699,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909387,GW567808A,CHEMBL214419,,False,http://qudt.org/vocab/unit#Percent,1583489,=,16,True,=,,Inhibition,%,,3.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.11
593,,8118835,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL514938,GSK-969786A,CHEMBL514938,,False,http://qudt.org/vocab/unit#Percent,1583428,=,16,True,=,,Inhibition,%,,0.84,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.84
594,,8119106,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477978,GW782907X,CHEMBL477978,,False,http://qudt.org/vocab/unit#Percent,1583581,=,16,True,=,,Inhibition,%,,1.67,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.67
595,,8119489,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,,,CHEMBL1961873,,,,CHEMBL588025,GW770249A,CHEMBL247228,,False,http://qudt.org/vocab/unit#Percent,1583570,=,16,True,=,,Inhibition,%,,1.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.77
596,,8119656,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,,,CHEMBL1961873,,,,CHEMBL205765,GW794726X,CHEMBL205765,,False,http://qudt.org/vocab/unit#Percent,1583591,=,16,True,=,,Inhibition,%,,-0.61,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.61
597,,8119999,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl,,,CHEMBL1961873,,,,CHEMBL1909355,GW461104A,CHEMBL516375,,False,http://qudt.org/vocab/unit#Percent,1583482,=,16,True,=,,Inhibition,%,,0.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.41
598,,8120138,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909375,GSK-614526A,CHEMBL1963560,,False,http://qudt.org/vocab/unit#Percent,1583417,=,16,True,=,,Inhibition,%,,0.53,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.53
599,,8120362,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1,,,CHEMBL1961873,,,,CHEMBL188247,GW832467X,CHEMBL188247,,False,http://qudt.org/vocab/unit#Percent,1583269,=,16,True,=,,Inhibition,%,,-0.63,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.63
600,,8120522,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL410072,GW301784X,CHEMBL410072,,False,http://qudt.org/vocab/unit#Percent,1583449,=,16,True,=,,Inhibition,%,,-0.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.85
601,,8120723,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794066,GSK-619487A,CHEMBL522857,,False,http://qudt.org/vocab/unit#Percent,1583418,=,16,True,=,,Inhibition,%,,2.02,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.02
602,,8120947,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794066,GSK-619487A,CHEMBL522857,,False,http://qudt.org/vocab/unit#Percent,1583418,=,16,True,=,,Inhibition,%,,1.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.93
603,,8121075,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL271594,GW300653X,CHEMBL271594,,False,http://qudt.org/vocab/unit#Percent,1583446,=,16,True,=,,Inhibition,%,,0.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.36
604,,8121247,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12,,,CHEMBL1961873,,,,CHEMBL241517,GW856804X,CHEMBL241517,,False,http://qudt.org/vocab/unit#Percent,1583277,=,16,True,=,,Inhibition,%,,2.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.08
605,,8121471,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL1909409,GSK-238583A,CHEMBL455434,,False,http://qudt.org/vocab/unit#Percent,1583396,=,16,True,=,,Inhibition,%,,-0.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.04
606,,8121638,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1,,,CHEMBL1961873,,,,CHEMBL1909399,GW352430A,CHEMBL1794054,,False,http://qudt.org/vocab/unit#Percent,1583455,=,16,True,=,,Inhibition,%,,-0.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.38
607,,8121801,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl,,,CHEMBL1961873,,,,CHEMBL1909350,GSK-949675A,CHEMBL1098943,,False,http://qudt.org/vocab/unit#Percent,1583426,=,16,True,=,,Inhibition,%,,3.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.06
608,,8122025,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br,,,CHEMBL1961873,,,,CHEMBL518953,GSK-1023156A,CHEMBL518953,,False,http://qudt.org/vocab/unit#Percent,1583369,=,16,True,=,,Inhibition,%,,1.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.39
609,,8122146,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL529066,GW574783B,CHEMBL380247,,False,http://qudt.org/vocab/unit#Percent,1583498,=,16,True,=,,Inhibition,%,,0.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.86
610,,8122508,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL1785004,,CHEMBL1785004,,False,http://qudt.org/vocab/unit#Percent,1583301,=,16,True,=,,Inhibition,%,,1.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.17
611,,8122628,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL268885,GSK-711701A,CHEMBL268885,,False,http://qudt.org/vocab/unit#Percent,1583422,=,16,True,=,,Inhibition,%,,1.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.96
612,,8122852,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL268885,GSK-711701A,CHEMBL268885,,False,http://qudt.org/vocab/unit#Percent,1583422,=,16,True,=,,Inhibition,%,,1.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.85
613,,8123019,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL14014,,CHEMBL14014,,False,http://qudt.org/vocab/unit#Percent,1583298,=,16,True,=,,Inhibition,%,,2.63,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.63
614,,8123161,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL514938,GSK-969786A,CHEMBL514938,,False,http://qudt.org/vocab/unit#Percent,1583428,=,16,True,=,,Inhibition,%,,1.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.26
615,,8123385,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL514499,GW843682X,CHEMBL514499,,False,http://qudt.org/vocab/unit#Percent,1583272,=,16,True,=,,Inhibition,%,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.2
616,,8123439,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL511765,GSK-2213727A,CHEMBL511765,,False,http://qudt.org/vocab/unit#Percent,1583390,=,16,True,=,,Inhibition,%,,-2.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.25
617,,8123663,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL511765,GSK-2213727A,CHEMBL511765,,False,http://qudt.org/vocab/unit#Percent,1583390,=,16,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.0
618,,8123813,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O,,,CHEMBL1961873,,,,CHEMBL1789961,GW513184X,CHEMBL1789961,,False,http://qudt.org/vocab/unit#Percent,1583483,=,16,True,=,,Inhibition,%,,-2.02,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.02
619,,8123980,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,,,CHEMBL1961873,,,,CHEMBL205765,GW794726X,CHEMBL205765,,False,http://qudt.org/vocab/unit#Percent,1583591,=,16,True,=,,Inhibition,%,,-0.89,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.89
620,,8124204,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL204934,GW813360X,CHEMBL204934,,False,http://qudt.org/vocab/unit#Percent,1583611,=,16,True,=,,Inhibition,%,,-2.35,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.35
621,,8124323,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl,,,CHEMBL1961873,,,,CHEMBL1909355,GW461104A,CHEMBL516375,,False,http://qudt.org/vocab/unit#Percent,1583482,=,16,True,=,,Inhibition,%,,1.35,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.35
622,,8124686,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1,,,CHEMBL1961873,,,,CHEMBL188247,GW832467X,CHEMBL188247,,False,http://qudt.org/vocab/unit#Percent,1583269,=,16,True,=,,Inhibition,%,,-0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.5
623,,8124851,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL1909408,GSK-200398A,CHEMBL507821,,False,http://qudt.org/vocab/unit#Percent,1583385,=,16,True,=,,Inhibition,%,,-1.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.41
624,,8125276,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL428877,,CHEMBL428877,,False,http://qudt.org/vocab/unit#Percent,1583294,=,16,True,=,,Inhibition,%,,2.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.21
625,,8125406,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL271594,GW300653X,CHEMBL271594,,False,http://qudt.org/vocab/unit#Percent,1583446,=,16,True,=,,Inhibition,%,,0.49,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.49
626,,8125798,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL1909409,GSK-238583A,CHEMBL455434,,False,http://qudt.org/vocab/unit#Percent,1583396,=,16,True,=,,Inhibition,%,,-0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.2
627,,8125962,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1,,,CHEMBL1961873,,,,CHEMBL1909399,GW352430A,CHEMBL1794054,,False,http://qudt.org/vocab/unit#Percent,1583455,=,16,True,=,,Inhibition,%,,0.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.01
628,,8126350,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br,,,CHEMBL1961873,,,,CHEMBL518953,GSK-1023156A,CHEMBL518953,,False,http://qudt.org/vocab/unit#Percent,1583369,=,16,True,=,,Inhibition,%,,2.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.57
629,,8126465,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,,,CHEMBL1961873,,,,CHEMBL247228,GW770249X,CHEMBL247228,,False,http://qudt.org/vocab/unit#Percent,1583571,=,16,True,=,,Inhibition,%,,-1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.2
630,,8126825,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1,,,CHEMBL1961873,,,,CHEMBL271595,GW297361X,CHEMBL271595,,False,http://qudt.org/vocab/unit#Percent,1583445,=,16,True,=,,Inhibition,%,,1.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.82
631,,8127171,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL13868,,CHEMBL13868,,False,http://qudt.org/vocab/unit#Percent,1583296,=,16,True,=,,Inhibition,%,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.5
632,,8127338,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL14014,,CHEMBL14014,,False,http://qudt.org/vocab/unit#Percent,1583298,=,16,True,=,,Inhibition,%,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.7
633,,8127704,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL514499,GW843682X,CHEMBL514499,,False,http://qudt.org/vocab/unit#Percent,1583272,=,16,True,=,,Inhibition,%,,1.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.85
634,,8127992,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL519881,GW861893X,CHEMBL519881,,False,http://qudt.org/vocab/unit#Percent,1583278,=,16,True,=,,Inhibition,%,,-1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.6
635,,8128144,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O,,,CHEMBL1961873,,,,CHEMBL1789961,GW513184X,CHEMBL1789961,,False,http://qudt.org/vocab/unit#Percent,1583483,=,16,True,=,,Inhibition,%,,3.98,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.98
636,,8128535,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL204934,GW813360X,CHEMBL204934,,False,http://qudt.org/vocab/unit#Percent,1583611,=,16,True,=,,Inhibition,%,,0.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.01
637,,8128654,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL187081,PYRAZOLOPYRIDAZINE 1,CHEMBL187081,,False,http://qudt.org/vocab/unit#Percent,1583608,=,16,True,=,,Inhibition,%,,0.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.48
638,,8128878,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL187081,PYRAZOLOPYRIDAZINE 1,CHEMBL187081,,False,http://qudt.org/vocab/unit#Percent,1583608,=,16,True,=,,Inhibition,%,,11.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,11.08
639,,8129015,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL352222,,CHEMBL352222,,False,http://qudt.org/vocab/unit#Percent,1583311,=,16,True,=,,Inhibition,%,,0.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.93
640,,8129186,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL1909408,GSK-200398A,CHEMBL507821,,False,http://qudt.org/vocab/unit#Percent,1583385,=,16,True,=,,Inhibition,%,,-0.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.48
641,,8129410,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl,,,CHEMBL1961873,,,,CHEMBL1794072,,CHEMBL1852436,,False,http://qudt.org/vocab/unit#Percent,1583332,=,16,True,=,,Inhibition,%,,-0.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.42
642,,8129599,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL428877,,CHEMBL428877,,False,http://qudt.org/vocab/unit#Percent,1583294,=,16,True,=,,Inhibition,%,,2.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.52
643,,8129738,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909343,,CHEMBL35785,,False,http://qudt.org/vocab/unit#Percent,1583330,=,16,True,=,,Inhibition,%,,-0.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.42
644,,8129962,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1909343,,CHEMBL35785,,False,http://qudt.org/vocab/unit#Percent,1583330,=,16,True,=,,Inhibition,%,,-0.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.13
645,,8130123,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1,,,CHEMBL1961873,,,,CHEMBL446024,GW683003X,CHEMBL446024,,False,http://qudt.org/vocab/unit#Percent,1583545,=,16,True,=,,Inhibition,%,,0.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.77
646,,8130295,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909345,,CHEMBL39300,,False,http://qudt.org/vocab/unit#Percent,1583333,=,16,True,=,,Inhibition,%,,0.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.27
647,,8130679,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,,,CHEMBL1961873,,,,CHEMBL1882194,GW780056X,CHEMBL1882194,,False,http://qudt.org/vocab/unit#Percent,1583577,=,16,True,=,,Inhibition,%,,1.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.17
648,,8130795,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,,,CHEMBL1961873,,,,CHEMBL247228,GW770249X,CHEMBL247228,,False,http://qudt.org/vocab/unit#Percent,1583571,=,16,True,=,,Inhibition,%,,-0.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.37
649,,8131019,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL418348,,CHEMBL418348,,False,http://qudt.org/vocab/unit#Percent,1583302,=,16,True,=,,Inhibition,%,,1.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.58
650,,8131158,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1,,,CHEMBL1961873,,,,CHEMBL271595,GW297361X,CHEMBL271595,,False,http://qudt.org/vocab/unit#Percent,1583445,=,16,True,=,,Inhibition,%,,2.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.58
651,,8131502,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL13868,,CHEMBL13868,,False,http://qudt.org/vocab/unit#Percent,1583296,=,16,True,=,,Inhibition,%,,1.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.78
652,,8131669,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL179465,GW621970X,CHEMBL179465,,False,http://qudt.org/vocab/unit#Percent,1583521,=,16,True,=,,Inhibition,%,,2.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.36
653,,8132034,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,,,CHEMBL1961873,,,,CHEMBL273564,GW795493X,CHEMBL273564,,False,http://qudt.org/vocab/unit#Percent,1583593,=,16,True,=,,Inhibition,%,,2.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.03
654,,8132320,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL519881,GW861893X,CHEMBL519881,,False,http://qudt.org/vocab/unit#Percent,1583278,=,16,True,=,,Inhibition,%,,0.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.83
655,,8132467,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1,,,CHEMBL1961873,,,,CHEMBL220244,GW427984X,CHEMBL220244,,False,http://qudt.org/vocab/unit#Percent,1583464,=,16,True,=,,Inhibition,%,,-1.62,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.62
656,,8132691,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1,,,CHEMBL1961873,,,,CHEMBL220244,GW427984X,CHEMBL220244,,False,http://qudt.org/vocab/unit#Percent,1583464,=,16,True,=,,Inhibition,%,,2.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.21
657,,8132859,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL218970,GW445017X,CHEMBL218970,,False,http://qudt.org/vocab/unit#Percent,1583477,=,16,True,=,,Inhibition,%,,-1.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.64
658,,8133204,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1,,,CHEMBL1961873,,,,CHEMBL513330,GW781673X,CHEMBL513330,,False,http://qudt.org/vocab/unit#Percent,1583579,=,16,True,=,,Inhibition,%,,-1.73,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.73
659,,8133342,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL352222,,CHEMBL352222,,False,http://qudt.org/vocab/unit#Percent,1583311,=,16,True,=,,Inhibition,%,,0.63,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.63
660,,8133738,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl,,,CHEMBL1961873,,,,CHEMBL1794072,,CHEMBL1852436,,False,http://qudt.org/vocab/unit#Percent,1583332,=,16,True,=,,Inhibition,%,,0.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.12
661,,8133918,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909360,GW830263A,CHEMBL187494,,False,http://qudt.org/vocab/unit#Percent,1583631,=,16,True,=,,Inhibition,%,,0.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.32
662,,8134290,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2cc3c(N)ncnc3o2)cc1,,,CHEMBL1961873,,,,CHEMBL373073,GW642138X,CHEMBL373073,,False,http://qudt.org/vocab/unit#Percent,1583531,=,16,True,=,,Inhibition,%,,-0.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.28
663,,8134450,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1,,,CHEMBL1961873,,,,CHEMBL446024,GW683003X,CHEMBL446024,,False,http://qudt.org/vocab/unit#Percent,1583545,=,16,True,=,,Inhibition,%,,1.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.21
664,,8134634,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909345,,CHEMBL39300,,False,http://qudt.org/vocab/unit#Percent,1583333,=,16,True,=,,Inhibition,%,,0.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.13
665,,8134858,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1,,,CHEMBL1961873,,,,CHEMBL1794058,GW278681X,CHEMBL1794058,,False,http://qudt.org/vocab/unit#Percent,1583435,=,16,True,=,,Inhibition,%,,-0.49,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.49
666,,8135018,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,,,CHEMBL1961873,,,,CHEMBL1882194,GW780056X,CHEMBL1882194,,False,http://qudt.org/vocab/unit#Percent,1583577,=,16,True,=,,Inhibition,%,,3.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.85
667,,8135357,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL418348,,CHEMBL418348,,False,http://qudt.org/vocab/unit#Percent,1583302,=,16,True,=,,Inhibition,%,,2.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.09
668,,8135498,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL417804,,CHEMBL417804,,False,http://qudt.org/vocab/unit#Percent,1583299,=,16,True,=,,Inhibition,%,,2.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.05
669,,8135722,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL417804,,CHEMBL417804,,False,http://qudt.org/vocab/unit#Percent,1583299,=,16,True,=,,Inhibition,%,,2.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.51
670,,8135843,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL269450,,CHEMBL269450,,False,http://qudt.org/vocab/unit#Percent,1583292,=,16,True,=,,Inhibition,%,,1.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.36
671,,8136011,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL179465,GW621970X,CHEMBL179465,,False,http://qudt.org/vocab/unit#Percent,1583521,=,16,True,=,,Inhibition,%,,5.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.42
672,,8136235,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1,,,CHEMBL1961873,,,,CHEMBL305477,GW829874X,CHEMBL305477,,False,http://qudt.org/vocab/unit#Percent,1583628,=,16,True,=,,Inhibition,%,,1.63,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.63
673,,8136379,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12,,,CHEMBL1961873,,,,CHEMBL273564,GW795493X,CHEMBL273564,,False,http://qudt.org/vocab/unit#Percent,1583593,=,16,True,=,,Inhibition,%,,2.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.34
674,,8136669,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL467581,GSK-2219385A,CHEMBL467581,,False,http://qudt.org/vocab/unit#Percent,1583391,=,16,True,=,,Inhibition,%,,-1.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.54
675,,8137028,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL374453,GSK-299115A,CHEMBL374453,,False,http://qudt.org/vocab/unit#Percent,1583401,=,16,True,=,,Inhibition,%,,-3.53,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.53
676,,8137191,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL218970,GW445017X,CHEMBL218970,,False,http://qudt.org/vocab/unit#Percent,1583477,=,16,True,=,,Inhibition,%,,0.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.01
677,,8137535,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1,,,CHEMBL1961873,,,,CHEMBL513330,GW781673X,CHEMBL513330,,False,http://qudt.org/vocab/unit#Percent,1583579,=,16,True,=,,Inhibition,%,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.1
678,,8137683,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,,,CHEMBL1961873,,,,CHEMBL2062289,,CHEMBL38425,,False,http://qudt.org/vocab/unit#Percent,1583334,=,16,True,=,,Inhibition,%,,0.45,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.45
679,,8137907,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,,,CHEMBL1961873,,,,CHEMBL2062289,,CHEMBL38425,,False,http://qudt.org/vocab/unit#Percent,1583334,=,16,True,=,,Inhibition,%,,1.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.11
680,,8138073,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL234838,GW572738X,CHEMBL234838,,False,http://qudt.org/vocab/unit#Percent,1583496,=,16,True,=,,Inhibition,%,,-1.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.41
681,,8138252,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909360,GW830263A,CHEMBL187494,,False,http://qudt.org/vocab/unit#Percent,1583631,=,16,True,=,,Inhibition,%,,0.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.52
682,,8138624,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2cc3c(N)ncnc3o2)cc1,,,CHEMBL1961873,,,,CHEMBL373073,GW642138X,CHEMBL373073,,False,http://qudt.org/vocab/unit#Percent,1583531,=,16,True,=,,Inhibition,%,,0.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.08
683,,8138782,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477583,GW743024X,CHEMBL477583,,False,http://qudt.org/vocab/unit#Percent,1583565,=,16,True,=,,Inhibition,%,,1.67,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.67
684,,8139006,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477583,GW743024X,CHEMBL477583,,False,http://qudt.org/vocab/unit#Percent,1583565,=,16,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.0
685,,8139191,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1,,,CHEMBL1961873,,,,CHEMBL1794058,GW278681X,CHEMBL1794058,,False,http://qudt.org/vocab/unit#Percent,1583435,=,16,True,=,,Inhibition,%,,-0.15,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.15
686,,8139350,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909354,GW459057A,CHEMBL374680,,False,http://qudt.org/vocab/unit#Percent,1583481,=,16,True,=,,Inhibition,%,,1.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.97
687,,8139688,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909389,GW574782A,CHEMBL387207,,False,http://qudt.org/vocab/unit#Percent,1583497,=,16,True,=,,Inhibition,%,,0.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.72
688,,8140053,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL1909390,GW576609A,CHEMBL212954,,False,http://qudt.org/vocab/unit#Percent,1583502,=,16,True,=,,Inhibition,%,,1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.66
689,,8140176,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL269450,,CHEMBL269450,,False,http://qudt.org/vocab/unit#Percent,1583292,=,16,True,=,,Inhibition,%,,1.99,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.99
690,,8140559,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1,,,CHEMBL1961873,,,,CHEMBL305477,GW829874X,CHEMBL305477,,False,http://qudt.org/vocab/unit#Percent,1583628,=,16,True,=,,Inhibition,%,,2.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.48
691,,8140702,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL273611,,CHEMBL273611,,False,http://qudt.org/vocab/unit#Percent,1583297,=,16,True,=,,Inhibition,%,,2.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.54
692,,8140926,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL273611,,CHEMBL273611,,False,http://qudt.org/vocab/unit#Percent,1583297,=,16,True,=,,Inhibition,%,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.7
693,,8141004,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL467581,GSK-2219385A,CHEMBL467581,,False,http://qudt.org/vocab/unit#Percent,1583391,=,16,True,=,,Inhibition,%,,1.55,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.55
694,,8141358,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL374453,GSK-299115A,CHEMBL374453,,False,http://qudt.org/vocab/unit#Percent,1583401,=,16,True,=,,Inhibition,%,,0.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.93
695,,8141518,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL67241,GW794607X,CHEMBL67241,,False,http://qudt.org/vocab/unit#Percent,1583590,=,16,True,=,,Inhibition,%,,2.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.03
696,,8141742,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL67241,GW794607X,CHEMBL67241,,False,http://qudt.org/vocab/unit#Percent,1583590,=,16,True,=,,Inhibition,%,,0.71,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.71
697,,8141861,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1,,,CHEMBL1961873,,,,CHEMBL218859,GW445012X,CHEMBL218859,,False,http://qudt.org/vocab/unit#Percent,1583474,=,16,True,=,,Inhibition,%,,-1.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.78
698,,8142246,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL188257,GW827106X,CHEMBL188257,,False,http://qudt.org/vocab/unit#Percent,1583622,=,16,True,=,,Inhibition,%,,-0.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.42
699,,8142414,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL234838,GW572738X,CHEMBL234838,,False,http://qudt.org/vocab/unit#Percent,1583496,=,16,True,=,,Inhibition,%,,-0.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.41
700,,8142590,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl,,,CHEMBL1961873,,,,CHEMBL1909356,GW569530A,CHEMBL505970,,False,http://qudt.org/vocab/unit#Percent,1583493,=,16,True,=,,Inhibition,%,,0.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.78
701,,8142814,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl,,,CHEMBL1961873,,,,CHEMBL1909356,GW569530A,CHEMBL505970,,False,http://qudt.org/vocab/unit#Percent,1583493,=,16,True,=,,Inhibition,%,,1.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.16
702,,8142963,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477979,GW785974X,CHEMBL477979,,False,http://qudt.org/vocab/unit#Percent,1583588,=,16,True,=,,Inhibition,%,,-1.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.36
703,,8143342,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,,,CHEMBL1961873,,,,CHEMBL205966,GW659893X,CHEMBL205966,,False,http://qudt.org/vocab/unit#Percent,1583537,=,16,True,=,,Inhibition,%,,0.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.78
704,,8143529,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1,,,CHEMBL1961873,,,,CHEMBL1880739,GW305074X,CHEMBL1880739,,False,http://qudt.org/vocab/unit#Percent,1583452,=,16,True,=,,Inhibition,%,,1.47,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.47
705,,8143688,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909354,GW459057A,CHEMBL374680,,False,http://qudt.org/vocab/unit#Percent,1583481,=,16,True,=,,Inhibition,%,,2.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.42
706,,8143912,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1,,,CHEMBL1961873,,,,CHEMBL434729,GW829906X,CHEMBL434729,,False,http://qudt.org/vocab/unit#Percent,1583630,=,16,True,=,,Inhibition,%,,2.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.03
707,,8144026,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909389,GW574782A,CHEMBL387207,,False,http://qudt.org/vocab/unit#Percent,1583497,=,16,True,=,,Inhibition,%,,1.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.09
708,,8144389,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL1909390,GW576609A,CHEMBL212954,,False,http://qudt.org/vocab/unit#Percent,1583502,=,16,True,=,,Inhibition,%,,1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.66
709,,8144519,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+],,,CHEMBL1961873,,,,CHEMBL1909401,,CHEMBL14233,,False,http://qudt.org/vocab/unit#Percent,1583308,=,16,True,=,,Inhibition,%,,2.29,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.29
710,,8144743,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+],,,CHEMBL1961873,,,,CHEMBL1909401,,CHEMBL14233,,False,http://qudt.org/vocab/unit#Percent,1583308,=,16,True,=,,Inhibition,%,,2.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.96
711,,8144896,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N,,,CHEMBL1961873,,,,CHEMBL230592,GSK-635416A,CHEMBL230592,,False,http://qudt.org/vocab/unit#Percent,1583421,=,16,True,=,,Inhibition,%,,0.68,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.68
712,,8145257,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,,,CHEMBL1961873,,,,CHEMBL1909395,GW633459A,CHEMBL1794063,,False,http://qudt.org/vocab/unit#Percent,1583528,=,16,True,=,,Inhibition,%,,2.14,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.14
713,,8145346,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2,,,CHEMBL1961873,,,,CHEMBL458415,GSK-2186269A,CHEMBL458415,,False,http://qudt.org/vocab/unit#Percent,1583389,=,16,True,=,,Inhibition,%,,-0.95,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.95
714,,8145570,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2,,,CHEMBL1961873,,,,CHEMBL458415,GSK-2186269A,CHEMBL458415,,False,http://qudt.org/vocab/unit#Percent,1583389,=,16,True,=,,Inhibition,%,,0.98,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.98
715,,8145694,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL101804,,CHEMBL101804,,False,http://qudt.org/vocab/unit#Percent,1583353,=,16,True,=,,Inhibition,%,,-2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.9
716,,8146079,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,,,CHEMBL1961873,,,,CHEMBL189353,GW809897X,CHEMBL189353,,False,http://qudt.org/vocab/unit#Percent,1583606,=,16,True,=,,Inhibition,%,,0.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.17
717,,8146199,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1,,,CHEMBL1961873,,,,CHEMBL218859,GW445012X,CHEMBL218859,,False,http://qudt.org/vocab/unit#Percent,1583474,=,16,True,=,,Inhibition,%,,0.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.42
718,,8146583,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL188257,GW827106X,CHEMBL188257,,False,http://qudt.org/vocab/unit#Percent,1583622,=,16,True,=,,Inhibition,%,,-0.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.94
719,,8146750,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794068,GSK-326090A,CHEMBL1794068,,False,http://qudt.org/vocab/unit#Percent,1583408,=,16,True,=,,Inhibition,%,,0.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.42
720,,8147143,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O,,,CHEMBL1961873,,,,CHEMBL1909347,,CHEMBL261129,,False,http://qudt.org/vocab/unit#Percent,1583338,=,16,True,=,,Inhibition,%,,2.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.37
721,,8147285,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477979,GW785974X,CHEMBL477979,,False,http://qudt.org/vocab/unit#Percent,1583588,=,16,True,=,,Inhibition,%,,-0.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.58
722,,8147662,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,,,CHEMBL1961873,,,,CHEMBL205966,GW659893X,CHEMBL205966,,False,http://qudt.org/vocab/unit#Percent,1583537,=,16,True,=,,Inhibition,%,,1.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.25
723,,8147849,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1,,,CHEMBL1961873,,,,CHEMBL1880739,GW305074X,CHEMBL1880739,,False,http://qudt.org/vocab/unit#Percent,1583452,=,16,True,=,,Inhibition,%,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.1
724,,8148231,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1,,,CHEMBL1961873,,,,CHEMBL434729,GW829906X,CHEMBL434729,,False,http://qudt.org/vocab/unit#Percent,1583630,=,16,True,=,,Inhibition,%,,2.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.78
725,,8148345,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909392,GW580496A,CHEMBL214689,,False,http://qudt.org/vocab/unit#Percent,1583506,=,16,True,=,,Inhibition,%,,0.92,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.92
726,,8148569,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909392,GW580496A,CHEMBL214689,,False,http://qudt.org/vocab/unit#Percent,1583506,=,16,True,=,,Inhibition,%,,1.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.52
727,,8148708,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275200,,CHEMBL275200,,False,http://qudt.org/vocab/unit#Percent,1583305,=,16,True,=,,Inhibition,%,,1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.66
728,,8149070,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275724,,CHEMBL275724,,False,http://qudt.org/vocab/unit#Percent,1583293,=,16,True,=,,Inhibition,%,,2.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.75
729,,8149229,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N,,,CHEMBL1961873,,,,CHEMBL230592,GSK-635416A,CHEMBL230592,,False,http://qudt.org/vocab/unit#Percent,1583421,=,16,True,=,,Inhibition,%,,1.45,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.45
730,,8149587,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,,,CHEMBL1961873,,,,CHEMBL1909395,GW633459A,CHEMBL1794063,,False,http://qudt.org/vocab/unit#Percent,1583528,=,16,True,=,,Inhibition,%,,2.63,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.63
731,,8149909,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1,,,CHEMBL1961873,,,,CHEMBL218932,GW432441X,CHEMBL218932,,False,http://qudt.org/vocab/unit#Percent,1583466,=,16,True,=,,Inhibition,%,,-1.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.38
732,,8150034,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL101804,,CHEMBL101804,,False,http://qudt.org/vocab/unit#Percent,1583353,=,16,True,=,,Inhibition,%,,0.56,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.56
733,,8150418,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1,,,CHEMBL1961873,,,,CHEMBL189353,GW809897X,CHEMBL189353,,False,http://qudt.org/vocab/unit#Percent,1583606,=,16,True,=,,Inhibition,%,,1.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.26
734,,8150538,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O,,,CHEMBL1961873,,,,CHEMBL1909365,GW607049C,CHEMBL243912,,False,http://qudt.org/vocab/unit#Percent,1583512,=,16,True,=,,Inhibition,%,,-0.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.12
735,,8150762,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O,,,CHEMBL1961873,,,,CHEMBL1909365,GW607049C,CHEMBL243912,,False,http://qudt.org/vocab/unit#Percent,1583512,=,16,True,=,,Inhibition,%,,0.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.72
736,,8150927,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2,,,CHEMBL1961873,,,,CHEMBL456252,GSK-2110236A,CHEMBL456252,,False,http://qudt.org/vocab/unit#Percent,1583387,=,16,True,=,,Inhibition,%,,-1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.66
737,,8151090,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794068,GSK-326090A,CHEMBL1794068,,False,http://qudt.org/vocab/unit#Percent,1583408,=,16,True,=,,Inhibition,%,,9.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,9.77
738,,8151314,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1,,,CHEMBL1961873,,,,CHEMBL495902,GW820759X,CHEMBL495902,,False,http://qudt.org/vocab/unit#Percent,1583617,=,16,True,=,,Inhibition,%,,-1.84,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.84
739,,8151491,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O,,,CHEMBL1961873,,,,CHEMBL1909347,,CHEMBL261129,,False,http://qudt.org/vocab/unit#Percent,1583338,=,16,True,=,,Inhibition,%,,1.33,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.33
740,,8151629,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL189415,GW819077X,CHEMBL189415,,False,http://qudt.org/vocab/unit#Percent,1583615,=,16,True,=,,Inhibition,%,,0.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.01
741,,8151853,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL189415,GW819077X,CHEMBL189415,,False,http://qudt.org/vocab/unit#Percent,1583615,=,16,True,=,,Inhibition,%,,0.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.27
742,,8152007,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL186213,GW827105X,CHEMBL186213,,False,http://qudt.org/vocab/unit#Percent,1583621,=,16,True,=,,Inhibition,%,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.1
743,,8152195,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL1794052,GW405841X,CHEMBL1794052,,False,http://qudt.org/vocab/unit#Percent,1583457,=,16,True,=,,Inhibition,%,,1.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.11
744,,8152419,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL1794052,GW405841X,CHEMBL1794052,,False,http://qudt.org/vocab/unit#Percent,1583457,=,16,True,=,,Inhibition,%,,2.79,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.79
745,,8152577,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,,,CHEMBL1961873,,,,CHEMBL318728,GW549390X,CHEMBL318728,,False,http://qudt.org/vocab/unit#Percent,1583485,=,16,True,=,,Inhibition,%,,2.02,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.02
746,,8152915,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909358,GW654652C,CHEMBL475932,,False,http://qudt.org/vocab/unit#Percent,1583535,=,16,True,=,,Inhibition,%,,1.47,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.47
747,,8153054,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275200,,CHEMBL275200,,False,http://qudt.org/vocab/unit#Percent,1583305,=,16,True,=,,Inhibition,%,,1.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.82
748,,8153415,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL275724,,CHEMBL275724,,False,http://qudt.org/vocab/unit#Percent,1583293,=,16,True,=,,Inhibition,%,,3.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.85
749,,8153572,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,,,CHEMBL1961873,,,,CHEMBL384407,GW616030X,CHEMBL384407,,False,http://qudt.org/vocab/unit#Percent,1583516,=,16,True,=,,Inhibition,%,,0.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.21
750,,8153796,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,,,CHEMBL1961873,,,,CHEMBL384407,GW616030X,CHEMBL384407,,False,http://qudt.org/vocab/unit#Percent,1583516,=,16,True,=,,Inhibition,%,,0.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.75
751,,8153929,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21,,,CHEMBL1961873,,,,CHEMBL506153,GW876790X,CHEMBL506153,,False,http://qudt.org/vocab/unit#Percent,1583281,=,16,True,=,,Inhibition,%,,2.49,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.49
752,,8154250,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1,,,CHEMBL1961873,,,,CHEMBL218932,GW432441X,CHEMBL218932,,False,http://qudt.org/vocab/unit#Percent,1583466,=,16,True,=,,Inhibition,%,,1.67,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.67
753,,8154376,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,,,CHEMBL1961873,,,,CHEMBL1909368,GW683134A,CHEMBL244297,,False,http://qudt.org/vocab/unit#Percent,1583547,=,16,True,=,,Inhibition,%,,-2.35,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.35
754,,8154600,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,,,CHEMBL1961873,,,,CHEMBL1909368,GW683134A,CHEMBL244297,,False,http://qudt.org/vocab/unit#Percent,1583547,=,16,True,=,,Inhibition,%,,0.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.94
755,,8154759,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,,,CHEMBL1961873,,,,CHEMBL207410,GW772405X,CHEMBL207410,,False,http://qudt.org/vocab/unit#Percent,1583573,=,16,True,=,,Inhibition,%,,-3.89,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.89
756,,8155103,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL476351,GW775608X,CHEMBL476351,,False,http://qudt.org/vocab/unit#Percent,1583574,=,16,True,=,,Inhibition,%,,-1.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.27
757,,8155279,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2,,,CHEMBL1961873,,,,CHEMBL456252,GSK-2110236A,CHEMBL456252,,False,http://qudt.org/vocab/unit#Percent,1583387,=,16,True,=,,Inhibition,%,,-1.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.26
758,,8155664,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1,,,CHEMBL1961873,,,,CHEMBL495902,GW820759X,CHEMBL495902,,False,http://qudt.org/vocab/unit#Percent,1583617,=,16,True,=,,Inhibition,%,,-0.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.57
759,,8155842,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1,,,CHEMBL1961873,,,,CHEMBL524057,GW683768X,CHEMBL524057,,False,http://qudt.org/vocab/unit#Percent,1583548,=,16,True,=,,Inhibition,%,,1.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.42
760,,8156204,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1,,,CHEMBL1961873,,,,CHEMBL183993,GW811761X,CHEMBL183993,,False,http://qudt.org/vocab/unit#Percent,1583610,=,16,True,=,,Inhibition,%,,0.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.16
761,,8156416,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,,,CHEMBL1961873,,,,CHEMBL381604,GW799251X,CHEMBL381604,,False,http://qudt.org/vocab/unit#Percent,1583596,=,16,True,=,,Inhibition,%,,2.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.48
762,,8156790,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL191705,GW621431X,CHEMBL191705,,False,http://qudt.org/vocab/unit#Percent,1583519,=,16,True,=,,Inhibition,%,,1.19,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.19
763,,8156933,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,,,CHEMBL1961873,,,,CHEMBL194062,GW572399X,CHEMBL194062,,False,http://qudt.org/vocab/unit#Percent,1583494,=,16,True,=,,Inhibition,%,,-2.68,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.68
764,,8157277,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL218720,GSK-466314A,CHEMBL218720,,False,http://qudt.org/vocab/unit#Percent,1583409,=,16,True,=,,Inhibition,%,,-3.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.01
765,,8157418,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl,,,CHEMBL1961873,,,,CHEMBL1909396,GW768505A,CHEMBL194911,,False,http://qudt.org/vocab/unit#Percent,1583567,=,16,True,=,,Inhibition,%,,2.91,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.91
766,,8157642,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL520037,GW837331X,CHEMBL520037,,False,http://qudt.org/vocab/unit#Percent,1583271,=,16,True,=,,Inhibition,%,,-2.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.83
767,,8157772,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,,,CHEMBL1961873,,,,CHEMBL1909374,GW709042A,CHEMBL243917,,False,http://qudt.org/vocab/unit#Percent,1583562,=,16,True,=,,Inhibition,%,,2.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.09
768,,8158157,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,,,CHEMBL1961873,,,,CHEMBL261849,GW632580X,CHEMBL261849,,False,http://qudt.org/vocab/unit#Percent,1583527,=,16,True,=,,Inhibition,%,,0.89,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.89
769,,8158407,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1,,,CHEMBL1961873,,,,CHEMBL237571,,CHEMBL237571,,False,http://qudt.org/vocab/unit#Percent,1583328,=,16,True,=,,Inhibition,%,,2.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.09
770,,8158565,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477182,GW769076X,CHEMBL477182,,False,http://qudt.org/vocab/unit#Percent,1583568,=,16,True,=,,Inhibition,%,,-0.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.18
771,,8158958,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL261440,,CHEMBL261440,,False,http://qudt.org/vocab/unit#Percent,1583341,=,16,True,=,,Inhibition,%,,2.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.21
772,,8159093,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1,,,CHEMBL1961873,,,,CHEMBL232601,GW846105X,CHEMBL232601,,False,http://qudt.org/vocab/unit#Percent,1583273,=,16,True,=,,Inhibition,%,,2.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.28
773,,8159317,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL507329,GW869810X,CHEMBL507329,,False,http://qudt.org/vocab/unit#Percent,1583279,=,16,True,=,,Inhibition,%,,1.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.13
774,,8159437,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL427058,GSK-466317A,CHEMBL427058,,False,http://qudt.org/vocab/unit#Percent,1583410,=,16,True,=,,Inhibition,%,,1.44,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.44
775,,8159792,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL103104,GW831090X,CHEMBL103104,,False,http://qudt.org/vocab/unit#Percent,1583267,=,16,True,=,,Inhibition,%,,2.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.85
776,,8159933,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1,,,CHEMBL1961873,,,,CHEMBL1909377,,CHEMBL268889,,False,http://qudt.org/vocab/unit#Percent,1583317,=,16,True,=,,Inhibition,%,,0.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.9
777,,8160294,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O,,,CHEMBL1961873,,,,CHEMBL1909342,,CHEMBL232405,,False,http://qudt.org/vocab/unit#Percent,1583329,=,16,True,=,,Inhibition,%,,1.87,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.87
778,,8160444,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1909407,,CHEMBL274064,,False,http://qudt.org/vocab/unit#Percent,1583284,=,16,True,=,,Inhibition,%,,-0.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.23
779,,8160668,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1,,,CHEMBL1961873,,,,CHEMBL1888586,,CHEMBL1888586,,False,http://qudt.org/vocab/unit#Percent,1583288,=,16,True,=,,Inhibition,%,,-0.79,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.79
780,,8160738,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1,,,CHEMBL1961873,,,,CHEMBL182283,GW819230X,CHEMBL182283,,False,http://qudt.org/vocab/unit#Percent,1583616,=,16,True,=,,Inhibition,%,,-1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.3
781,,8161112,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl,,,CHEMBL1961873,,,,CHEMBL1909361,GW830365A,CHEMBL363316,,False,http://qudt.org/vocab/unit#Percent,1583632,=,16,True,=,,Inhibition,%,,-5.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-5.94
782,,8161255,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1,,,CHEMBL1961873,,,,CHEMBL194062,GW572399X,CHEMBL194062,,False,http://qudt.org/vocab/unit#Percent,1583494,=,16,True,=,,Inhibition,%,,1.92,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.92
783,,8161479,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1,,,CHEMBL1961873,,,,CHEMBL361894,GW806290X,CHEMBL361894,,False,http://qudt.org/vocab/unit#Percent,1583600,=,16,True,=,,Inhibition,%,,-2.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.01
784,,8161604,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL218720,GSK-466314A,CHEMBL218720,,False,http://qudt.org/vocab/unit#Percent,1583409,=,16,True,=,,Inhibition,%,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.5
785,,8161966,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL520037,GW837331X,CHEMBL520037,,False,http://qudt.org/vocab/unit#Percent,1583271,=,16,True,=,,Inhibition,%,,1.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.37
786,,8162096,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O,,,CHEMBL1961873,,,,CHEMBL156263,,CHEMBL156263,,False,http://qudt.org/vocab/unit#Percent,1583314,=,16,True,=,,Inhibition,%,,-2.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.94
787,,8162320,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O,,,CHEMBL1961873,,,,CHEMBL156263,,CHEMBL156263,,False,http://qudt.org/vocab/unit#Percent,1583314,=,16,True,=,,Inhibition,%,,2.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.37
788,,8162480,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909372,GW700494A,CHEMBL1888322,,False,http://qudt.org/vocab/unit#Percent,1583556,=,16,True,=,,Inhibition,%,,-3.98,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.98
789,,8162733,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl,,,CHEMBL1961873,,,,CHEMBL1909384,,CHEMBL1956071,,False,http://qudt.org/vocab/unit#Percent,1583359,=,16,True,=,,Inhibition,%,,2.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.88
790,,8162881,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL477182,GW769076X,CHEMBL477182,,False,http://qudt.org/vocab/unit#Percent,1583568,=,16,True,=,,Inhibition,%,,2.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.34
791,,8163105,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1,,,CHEMBL1961873,,,,CHEMBL1794055,GW589933X,CHEMBL1794055,,False,http://qudt.org/vocab/unit#Percent,1583510,=,16,True,=,,Inhibition,%,,0.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.1
792,,8163274,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL261440,,CHEMBL261440,,False,http://qudt.org/vocab/unit#Percent,1583341,=,16,True,=,,Inhibition,%,,1.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.18
793,,8163632,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL507329,GW869810X,CHEMBL507329,,False,http://qudt.org/vocab/unit#Percent,1583279,=,16,True,=,,Inhibition,%,,2.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.48
794,,8163755,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1,,,CHEMBL1961873,,,,CHEMBL266707,,CHEMBL266707,,False,http://qudt.org/vocab/unit#Percent,1583363,=,16,True,=,,Inhibition,%,,1.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.96
795,,8164113,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1,,,CHEMBL1961873,,,,CHEMBL477069,GSK-1173862A,CHEMBL477069,,False,http://qudt.org/vocab/unit#Percent,1583374,=,16,True,=,,Inhibition,%,,3.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.05
796,,8164253,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1,,,CHEMBL1961873,,,,CHEMBL1909377,,CHEMBL268889,,False,http://qudt.org/vocab/unit#Percent,1583317,=,16,True,=,,Inhibition,%,,0.56,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.56
797,,8164477,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1,,,CHEMBL1961873,,,,CHEMBL95502,,CHEMBL95502,,False,http://qudt.org/vocab/unit#Percent,1583287,=,16,True,=,,Inhibition,%,,4.73,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.73
798,,8164632,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O,,,CHEMBL1961873,,,,CHEMBL1909342,,CHEMBL232405,,False,http://qudt.org/vocab/unit#Percent,1583329,=,16,True,=,,Inhibition,%,,2.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.93
799,,8165000,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1,,,CHEMBL1961873,,,,CHEMBL1888586,,CHEMBL1888586,,False,http://qudt.org/vocab/unit#Percent,1583288,=,16,True,=,,Inhibition,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.0
800,,8165070,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1,,,CHEMBL1961873,,,,CHEMBL182283,GW819230X,CHEMBL182283,,False,http://qudt.org/vocab/unit#Percent,1583616,=,16,True,=,,Inhibition,%,,2.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.26
801,,8165294,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12,,,CHEMBL1961873,,,,CHEMBL1895450,GSK-2220400A,CHEMBL1895450,,False,http://qudt.org/vocab/unit#Percent,1583392,=,16,True,=,,Inhibition,%,,-0.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.32
802,,8165435,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl,,,CHEMBL1961873,,,,CHEMBL1909361,GW830365A,CHEMBL363316,,False,http://qudt.org/vocab/unit#Percent,1583632,=,16,True,=,,Inhibition,%,,1.07,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.07
803,,8165802,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1,,,CHEMBL1961873,,,,CHEMBL361894,GW806290X,CHEMBL361894,,False,http://qudt.org/vocab/unit#Percent,1583600,=,16,True,=,,Inhibition,%,,7.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,7.85
804,,8165928,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1,,,CHEMBL1961873,,,,CHEMBL160937,,CHEMBL160937,,False,http://qudt.org/vocab/unit#Percent,1583316,=,16,True,=,,Inhibition,%,,-2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.0
805,,8166290,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1,,,CHEMBL1961873,,,,CHEMBL1909351,GW824645A,CHEMBL329040,,False,http://qudt.org/vocab/unit#Percent,1583618,=,16,True,=,,Inhibition,%,,-1.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.86
806,,8166644,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1,,,CHEMBL1961873,,,,CHEMBL1909413,,CHEMBL304624,,False,http://qudt.org/vocab/unit#Percent,1583325,=,16,True,=,,Inhibition,%,,-4.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.12
807,,8166745,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC,,,CHEMBL1961873,,,,CHEMBL479079,GW612286X,CHEMBL479079,,False,http://qudt.org/vocab/unit#Percent,1583514,=,16,True,=,,Inhibition,%,,-1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.6
808,,8167057,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl,,,CHEMBL1961873,,,,CHEMBL1909384,,CHEMBL1956071,,False,http://qudt.org/vocab/unit#Percent,1583359,=,16,True,=,,Inhibition,%,,2.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.25
809,,8167422,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1,,,CHEMBL1961873,,,,CHEMBL1794055,GW589933X,CHEMBL1794055,,False,http://qudt.org/vocab/unit#Percent,1583510,=,16,True,=,,Inhibition,%,,4.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.43
810,,8167586,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL233001,GW620972X,CHEMBL233001,,False,http://qudt.org/vocab/unit#Percent,1583518,=,16,True,=,,Inhibition,%,,2.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.64
811,,8167943,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2ccc(F)cc21,,,CHEMBL1961873,,,,CHEMBL426800,GW785404X,CHEMBL426800,,False,http://qudt.org/vocab/unit#Percent,1583586,=,16,True,=,,Inhibition,%,,1.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.39
812,,8168067,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1,,,CHEMBL1961873,,,,CHEMBL266707,,CHEMBL266707,,False,http://qudt.org/vocab/unit#Percent,1583363,=,16,True,=,,Inhibition,%,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.7
813,,8168291,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1,,,CHEMBL1961873,,,,CHEMBL384073,GSK-180736A,CHEMBL384073,,False,http://qudt.org/vocab/unit#Percent,1583381,=,16,True,=,,Inhibition,%,,2.07,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.07
814,,8168432,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1,,,CHEMBL1961873,,,,CHEMBL477069,GSK-1173862A,CHEMBL477069,,False,http://qudt.org/vocab/unit#Percent,1583374,=,16,True,=,,Inhibition,%,,3.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.34
815,,8168792,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1,,,CHEMBL1961873,,,,CHEMBL95502,,CHEMBL95502,,False,http://qudt.org/vocab/unit#Percent,1583287,=,16,True,=,,Inhibition,%,,0.49,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.49
816,,8168956,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL495696,GW778894X,CHEMBL495696,,False,http://qudt.org/vocab/unit#Percent,1583575,=,16,True,=,,Inhibition,%,,4.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.11
817,,8169322,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,,,CHEMBL1961873,,,,CHEMBL102936,,CHEMBL102936,,False,http://qudt.org/vocab/unit#Percent,1583352,=,16,True,=,,Inhibition,%,,-4.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.64
818,,8169626,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12,,,CHEMBL1961873,,,,CHEMBL1895450,GSK-2220400A,CHEMBL1895450,,False,http://qudt.org/vocab/unit#Percent,1583392,=,16,True,=,,Inhibition,%,,2.65,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.65
819,,8169760,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL157258,,CHEMBL157258,,False,http://qudt.org/vocab/unit#Percent,1583315,=,16,True,=,,Inhibition,%,,-4.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.26
820,,8170129,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12,,,CHEMBL1961873,,,,CHEMBL396107,GW795486X,CHEMBL396107,,False,http://qudt.org/vocab/unit#Percent,1583592,=,16,True,=,,Inhibition,%,,-4.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.93
821,,8170254,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1,,,CHEMBL1961873,,,,CHEMBL160937,,CHEMBL160937,,False,http://qudt.org/vocab/unit#Percent,1583316,=,16,True,=,,Inhibition,%,,1.87,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.87
822,,8170478,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL1909398,GW282536X,CHEMBL1909398,,False,http://qudt.org/vocab/unit#Percent,1583439,=,16,True,=,,Inhibition,%,,-0.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.09
823,,8170618,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1,,,CHEMBL1961873,,,,CHEMBL1909351,GW824645A,CHEMBL329040,,False,http://qudt.org/vocab/unit#Percent,1583618,=,16,True,=,,Inhibition,%,,1.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.25
824,,8170977,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1,,,CHEMBL1961873,,,,CHEMBL1909413,,CHEMBL304624,,False,http://qudt.org/vocab/unit#Percent,1583325,=,16,True,=,,Inhibition,%,,2.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.23
825,,8171174,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909372,GW700494A,CHEMBL1888322,,False,http://qudt.org/vocab/unit#Percent,1583556,=,16,True,=,,Inhibition,%,,1.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.11
826,,8171391,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl,,,CHEMBL1961873,,,,CHEMBL1909363,GSK-269962B,CHEMBL220241,,False,http://qudt.org/vocab/unit#Percent,1583399,=,16,True,=,,Inhibition,%,,3.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.17
827,,8171615,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl,,,CHEMBL1961873,,,,CHEMBL1909363,GSK-269962B,CHEMBL220241,,False,http://qudt.org/vocab/unit#Percent,1583399,=,16,True,=,,Inhibition,%,,1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.66
828,,8171756,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C,,,CHEMBL1961873,,,,CHEMBL463931,GSK-2163632A,CHEMBL463931,,False,http://qudt.org/vocab/unit#Percent,1583388,=,16,True,=,,Inhibition,%,,-1.47,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.47
829,,8171909,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL233001,GW620972X,CHEMBL233001,,False,http://qudt.org/vocab/unit#Percent,1583518,=,16,True,=,,Inhibition,%,,1.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.05
830,,8172133,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL69757,GW817394X,CHEMBL69757,,False,http://qudt.org/vocab/unit#Percent,1583613,=,16,True,=,,Inhibition,%,,3.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.28
831,,8172265,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2ccc(F)cc21,,,CHEMBL1961873,,,,CHEMBL426800,GW785404X,CHEMBL426800,,False,http://qudt.org/vocab/unit#Percent,1583586,=,16,True,=,,Inhibition,%,,2.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.93
832,,8172617,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1,,,CHEMBL1961873,,,,CHEMBL384073,GSK-180736A,CHEMBL384073,,False,http://qudt.org/vocab/unit#Percent,1583381,=,16,True,=,,Inhibition,%,,0.77,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.77
833,,8172759,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1,,,CHEMBL1961873,,,,CHEMBL1909404,GW581744X,CHEMBL1909404,,False,http://qudt.org/vocab/unit#Percent,1583508,=,16,True,=,,Inhibition,%,,1.46,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.46
834,,8172983,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1,,,CHEMBL1961873,,,,CHEMBL1909404,GW581744X,CHEMBL1909404,,False,http://qudt.org/vocab/unit#Percent,1583508,=,16,True,=,,Inhibition,%,,2.22,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.22
835,,8173119,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,,,CHEMBL1961873,,,,CHEMBL407113,,CHEMBL407113,,False,http://qudt.org/vocab/unit#Percent,1583350,=,16,True,=,,Inhibition,%,,1.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.83
836,,8173284,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1,,,CHEMBL1961873,,,,CHEMBL495696,GW778894X,CHEMBL495696,,False,http://qudt.org/vocab/unit#Percent,1583575,=,16,True,=,,Inhibition,%,,15.07,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,15.07
837,,8173508,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL306865,GW784752X,CHEMBL306865,,False,http://qudt.org/vocab/unit#Percent,1583585,=,16,True,=,,Inhibition,%,,2.61,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.61
838,,8173649,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,,,CHEMBL1961873,,,,CHEMBL102936,,CHEMBL102936,,False,http://qudt.org/vocab/unit#Percent,1583352,=,16,True,=,,Inhibition,%,,1.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.75
839,,8173960,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL272028,GW300660X,CHEMBL272028,,False,http://qudt.org/vocab/unit#Percent,1583448,=,16,True,=,,Inhibition,%,,-1.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.81
840,,8174092,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL157258,,CHEMBL157258,,False,http://qudt.org/vocab/unit#Percent,1583315,=,16,True,=,,Inhibition,%,,0.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.97
841,,8174316,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1,,,CHEMBL1961873,,,,CHEMBL220243,GW406731X,CHEMBL220243,,False,http://qudt.org/vocab/unit#Percent,1583459,=,16,True,=,,Inhibition,%,,-4.61,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.61
842,,8174464,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12,,,CHEMBL1961873,,,,CHEMBL396107,GW795486X,CHEMBL396107,,False,http://qudt.org/vocab/unit#Percent,1583592,=,16,True,=,,Inhibition,%,,1.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.16
843,,8174810,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1,,,CHEMBL1961873,,,,CHEMBL1909398,GW282536X,CHEMBL1909398,,False,http://qudt.org/vocab/unit#Percent,1583439,=,16,True,=,,Inhibition,%,,1.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.25
844,,8174953,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794065,GSK-554170A,CHEMBL521658,,False,http://qudt.org/vocab/unit#Percent,1583411,=,16,True,=,,Inhibition,%,,-1.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.36
845,,8175177,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL1794065,GSK-554170A,CHEMBL521658,,False,http://qudt.org/vocab/unit#Percent,1583411,=,16,True,=,,Inhibition,%,,1.24,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.24
846,,8175313,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,,,CHEMBL1961873,,,,CHEMBL359963,GW805758X,CHEMBL359963,,False,http://qudt.org/vocab/unit#Percent,1583599,=,16,True,=,,Inhibition,%,,-2.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.06
847,,8175569,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1,,,CHEMBL1961873,,,,CHEMBL1794056,GW301789X,CHEMBL1794056,,False,http://qudt.org/vocab/unit#Percent,1583450,=,16,True,=,,Inhibition,%,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.2
848,,8175956,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl,,,CHEMBL1961873,,,,CHEMBL1794073,GW770220A,CHEMBL476571,,False,http://qudt.org/vocab/unit#Percent,1583569,=,16,True,=,,Inhibition,%,,2.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.51
849,,8176109,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C,,,CHEMBL1961873,,,,CHEMBL463931,GSK-2163632A,CHEMBL463931,,False,http://qudt.org/vocab/unit#Percent,1583388,=,16,True,=,,Inhibition,%,,2.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.28
850,,8176482,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL69757,GW817394X,CHEMBL69757,,False,http://qudt.org/vocab/unit#Percent,1583613,=,16,True,=,,Inhibition,%,,1.56,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.56
851,,8176614,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1,,,CHEMBL1961873,,,,CHEMBL1794057,GW284408X,CHEMBL1794057,,False,http://qudt.org/vocab/unit#Percent,1583442,=,16,True,=,,Inhibition,%,,2.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.93
852,,8176968,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1,,,CHEMBL1961873,,,,CHEMBL208437,GW711782X,CHEMBL208437,,False,http://qudt.org/vocab/unit#Percent,1583563,=,16,True,=,,Inhibition,%,,4.92,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.92
853,,8177334,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909352,GW441806A,CHEMBL218791,,False,http://qudt.org/vocab/unit#Percent,1583472,=,16,True,=,,Inhibition,%,,1.46,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.46
854,,8177472,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1,,,CHEMBL1961873,,,,CHEMBL407113,,CHEMBL407113,,False,http://qudt.org/vocab/unit#Percent,1583350,=,16,True,=,,Inhibition,%,,-0.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.64
855,,8177860,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL306865,GW784752X,CHEMBL306865,,False,http://qudt.org/vocab/unit#Percent,1583585,=,16,True,=,,Inhibition,%,,4.07,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.07
856,,8178000,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1,,,CHEMBL1961873,,,,CHEMBL1794050,GW429374A,CHEMBL1851668,,False,http://qudt.org/vocab/unit#Percent,1583465,=,16,True,=,,Inhibition,%,,-1.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.88
857,,8178312,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL272028,GW300660X,CHEMBL272028,,False,http://qudt.org/vocab/unit#Percent,1583448,=,16,True,=,,Inhibition,%,,2.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.08
858,,8178663,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1,,,CHEMBL1961873,,,,CHEMBL220243,GW406731X,CHEMBL220243,,False,http://qudt.org/vocab/unit#Percent,1583459,=,16,True,=,,Inhibition,%,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.8
859,,8178812,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1,,,CHEMBL1961873,,,,CHEMBL479038,GW806776X,CHEMBL479038,,False,http://qudt.org/vocab/unit#Percent,1583602,=,16,True,=,,Inhibition,%,,-3.46,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.46
860,,8179036,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1,,,CHEMBL1961873,,,,CHEMBL479038,GW806776X,CHEMBL479038,,False,http://qudt.org/vocab/unit#Percent,1583602,=,16,True,=,,Inhibition,%,,0.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.85
861,,8179159,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,,,CHEMBL1961873,,,,CHEMBL512076,GSK-192082A,CHEMBL512076,,False,http://qudt.org/vocab/unit#Percent,1583384,=,16,True,=,,Inhibition,%,,-5.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-5.34
862,,8179527,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL272165,GW300657X,CHEMBL272165,,False,http://qudt.org/vocab/unit#Percent,1583447,=,16,True,=,,Inhibition,%,,-2.46,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.46
863,,8179664,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1,,,CHEMBL1961873,,,,CHEMBL359963,GW805758X,CHEMBL359963,,False,http://qudt.org/vocab/unit#Percent,1583599,=,16,True,=,,Inhibition,%,,1.84,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.84
864,,8179921,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1,,,CHEMBL1961873,,,,CHEMBL1794056,GW301789X,CHEMBL1794056,,False,http://qudt.org/vocab/unit#Percent,1583450,=,16,True,=,,Inhibition,%,,2.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.52
865,,8180299,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl,,,CHEMBL1961873,,,,CHEMBL1794073,GW770220A,CHEMBL476571,,False,http://qudt.org/vocab/unit#Percent,1583569,=,16,True,=,,Inhibition,%,,6.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,6.18
866,,8180455,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1,,,CHEMBL1961873,,,,CHEMBL188268,,CHEMBL188268,,False,http://qudt.org/vocab/unit#Percent,1583355,=,16,True,=,,Inhibition,%,,-0.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.81
867,,8180679,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1,,,CHEMBL1961873,,,,CHEMBL188268,,CHEMBL188268,,False,http://qudt.org/vocab/unit#Percent,1583355,=,16,True,=,,Inhibition,%,,2.35,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.35
868,,8180827,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL272414,GW416469X,CHEMBL272414,,False,http://qudt.org/vocab/unit#Percent,1583462,=,16,True,=,,Inhibition,%,,2.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.88
869,,8180960,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1,,,CHEMBL1961873,,,,CHEMBL1794057,GW284408X,CHEMBL1794057,,False,http://qudt.org/vocab/unit#Percent,1583442,=,16,True,=,,Inhibition,%,,2.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.88
870,,8181184,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12,,,CHEMBL1961873,,,,CHEMBL237347,GW559768X,CHEMBL237347,,False,http://qudt.org/vocab/unit#Percent,1583486,=,16,True,=,,Inhibition,%,,4.59,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.59
871,,8181315,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1,,,CHEMBL1961873,,,,CHEMBL208437,GW711782X,CHEMBL208437,,False,http://qudt.org/vocab/unit#Percent,1583563,=,16,True,=,,Inhibition,%,,0.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.82
872,,8181679,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909352,GW441806A,CHEMBL218791,,False,http://qudt.org/vocab/unit#Percent,1583472,=,16,True,=,,Inhibition,%,,2.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.18
873,,8181818,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O,,,CHEMBL1961873,,,,CHEMBL1956068,GW296115X,CHEMBL1956068,,False,http://qudt.org/vocab/unit#Percent,1583444,=,16,True,=,,Inhibition,%,,-1.07,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.07
874,,8182042,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O,,,CHEMBL1961873,,,,CHEMBL1956068,GW296115X,CHEMBL1956068,,False,http://qudt.org/vocab/unit#Percent,1583444,=,16,True,=,,Inhibition,%,,4.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.52
875,,8182205,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1,,,CHEMBL1961873,,,,CHEMBL361237,GW785804X,CHEMBL361237,,False,http://qudt.org/vocab/unit#Percent,1583587,=,16,True,=,,Inhibition,%,,3.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.41
876,,8182345,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1,,,CHEMBL1961873,,,,CHEMBL1794050,GW429374A,CHEMBL1851668,,False,http://qudt.org/vocab/unit#Percent,1583465,=,16,True,=,,Inhibition,%,,4.22,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.22
877,,8182569,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F,,,CHEMBL1961873,,,,CHEMBL188784,GW828529X,CHEMBL188784,,False,http://qudt.org/vocab/unit#Percent,1583625,=,16,True,=,,Inhibition,%,,-4.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.78
878,,8182661,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,,,CHEMBL1961873,,,,CHEMBL517123,GSK-182497A,CHEMBL517123,,False,http://qudt.org/vocab/unit#Percent,1583383,=,16,True,=,,Inhibition,%,,-3.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.18
879,,8183007,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL65884,GW817396X,CHEMBL65884,,False,http://qudt.org/vocab/unit#Percent,1583614,=,16,True,=,,Inhibition,%,,-3.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.94
880,,8183380,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL179311,GW580509X,CHEMBL179311,,False,http://qudt.org/vocab/unit#Percent,1583507,=,16,True,=,,Inhibition,%,,-4.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.04
881,,8183509,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,,,CHEMBL1961873,,,,CHEMBL512076,GSK-192082A,CHEMBL512076,,False,http://qudt.org/vocab/unit#Percent,1583384,=,16,True,=,,Inhibition,%,,6.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,6.03
882,,8183875,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL272165,GW300657X,CHEMBL272165,,False,http://qudt.org/vocab/unit#Percent,1583447,=,16,True,=,,Inhibition,%,,1.57,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.57
883,,8184011,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909394,GW621823A,CHEMBL212251,,False,http://qudt.org/vocab/unit#Percent,1583520,=,16,True,=,,Inhibition,%,,-3.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.12
884,,8184235,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl,,,CHEMBL1961873,,,,CHEMBL1909394,GW621823A,CHEMBL212251,,False,http://qudt.org/vocab/unit#Percent,1583520,=,16,True,=,,Inhibition,%,,0.98,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.98
885,,8184277,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909344,,CHEMBL406125,,False,http://qudt.org/vocab/unit#Percent,1583331,=,16,True,=,,Inhibition,%,,1.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.96
886,,8184501,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl,,,CHEMBL1961873,,,,CHEMBL1909344,,CHEMBL406125,,False,http://qudt.org/vocab/unit#Percent,1583331,=,16,True,=,,Inhibition,%,,2.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.54
887,,8184648,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL1909415,GW693881A,CHEMBL473436,,False,http://qudt.org/vocab/unit#Percent,1583551,=,16,True,=,,Inhibition,%,,7.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,7.16
888,,8185029,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL365297,GW827099X,CHEMBL365297,,False,http://qudt.org/vocab/unit#Percent,1583619,=,16,True,=,,Inhibition,%,,2.79,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.79
889,,8185178,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2,,,CHEMBL1961873,,,,CHEMBL272414,GW416469X,CHEMBL272414,,False,http://qudt.org/vocab/unit#Percent,1583462,=,16,True,=,,Inhibition,%,,0.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.86
890,,8185533,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12,,,CHEMBL1961873,,,,CHEMBL237347,GW559768X,CHEMBL237347,,False,http://qudt.org/vocab/unit#Percent,1583486,=,16,True,=,,Inhibition,%,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.6
891,,8185664,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21,,,CHEMBL1961873,,,,CHEMBL405042,GW335962X,CHEMBL405042,,False,http://qudt.org/vocab/unit#Percent,1583454,=,16,True,=,,Inhibition,%,,2.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.06
892,,8185888,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21,,,CHEMBL1961873,,,,CHEMBL405042,GW335962X,CHEMBL405042,,False,http://qudt.org/vocab/unit#Percent,1583454,=,16,True,=,,Inhibition,%,,0.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.3
893,,8186027,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL405021,,CHEMBL405021,,False,http://qudt.org/vocab/unit#Percent,1583339,=,16,True,=,,Inhibition,%,,2.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.36
894,,8186392,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL427159,GW827396X,CHEMBL427159,,False,http://qudt.org/vocab/unit#Percent,1583623,=,16,True,=,,Inhibition,%,,-0.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.54
895,,8186556,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1,,,CHEMBL1961873,,,,CHEMBL361237,GW785804X,CHEMBL361237,,False,http://qudt.org/vocab/unit#Percent,1583587,=,16,True,=,,Inhibition,%,,2.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.12
896,,8186919,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F,,,CHEMBL1961873,,,,CHEMBL188784,GW828529X,CHEMBL188784,,False,http://qudt.org/vocab/unit#Percent,1583625,=,16,True,=,,Inhibition,%,,1.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.81
897,,8187017,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,,,CHEMBL1961873,,,,CHEMBL517123,GSK-182497A,CHEMBL517123,,False,http://qudt.org/vocab/unit#Percent,1583383,=,16,True,=,,Inhibition,%,,1.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.16
898,,8187241,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1,,,CHEMBL1961873,,,,CHEMBL218088,GW435821X,CHEMBL218088,,False,http://qudt.org/vocab/unit#Percent,1583468,=,16,True,=,,Inhibition,%,,-1.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.86
899,,8187365,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL65884,GW817396X,CHEMBL65884,,False,http://qudt.org/vocab/unit#Percent,1583614,=,16,True,=,,Inhibition,%,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.4
900,,8187737,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL179311,GW580509X,CHEMBL179311,,False,http://qudt.org/vocab/unit#Percent,1583507,=,16,True,=,,Inhibition,%,,2.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.08
901,,8187866,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL185939,GW828525X,CHEMBL185939,,False,http://qudt.org/vocab/unit#Percent,1583624,=,16,True,=,,Inhibition,%,,5.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.37
902,,8188090,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL185939,GW828525X,CHEMBL185939,,False,http://qudt.org/vocab/unit#Percent,1583624,=,16,True,=,,Inhibition,%,,1.44,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.44
903,,8188233,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL270054,GW280670X,CHEMBL270054,,False,http://qudt.org/vocab/unit#Percent,1583437,=,16,True,=,,Inhibition,%,,1.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.38
904,,8188592,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL66292,PYRAZOLOPYRIMIDINE 2,CHEMBL66292,,False,http://qudt.org/vocab/unit#Percent,1583609,=,16,True,=,,Inhibition,%,,-3.29,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.29
905,,8188866,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL475761,GW784684X,CHEMBL475761,,False,http://qudt.org/vocab/unit#Percent,1583584,=,16,True,=,,Inhibition,%,,1.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.52
906,,8189014,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL1909415,GW693881A,CHEMBL473436,,False,http://qudt.org/vocab/unit#Percent,1583551,=,16,True,=,,Inhibition,%,,1.69,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.69
907,,8189394,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1,,,CHEMBL1961873,,,,CHEMBL365297,GW827099X,CHEMBL365297,,False,http://qudt.org/vocab/unit#Percent,1583619,=,16,True,=,,Inhibition,%,,2.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.18
908,,8189543,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,,,CHEMBL1961873,,,,CHEMBL207247,GW807930X,CHEMBL207247,,False,http://qudt.org/vocab/unit#Percent,1583603,=,16,True,=,,Inhibition,%,,2.92,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.92
909,,8189767,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,,,CHEMBL1961873,,,,CHEMBL207247,GW807930X,CHEMBL207247,,False,http://qudt.org/vocab/unit#Percent,1583603,=,16,True,=,,Inhibition,%,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.5
910,,8189899,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1,,,CHEMBL1961873,,,,CHEMBL517907,GW680191X,CHEMBL517907,,False,http://qudt.org/vocab/unit#Percent,1583541,=,16,True,=,,Inhibition,%,,4.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.25
911,,8190255,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O,,,CHEMBL1961873,,,,CHEMBL176857,GW442130X,CHEMBL176857,,False,http://qudt.org/vocab/unit#Percent,1583473,=,16,True,=,,Inhibition,%,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.4
912,,8190395,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL405021,,CHEMBL405021,,False,http://qudt.org/vocab/unit#Percent,1583339,=,16,True,=,,Inhibition,%,,2.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.04
913,,8190756,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL427159,GW827396X,CHEMBL427159,,False,http://qudt.org/vocab/unit#Percent,1583623,=,16,True,=,,Inhibition,%,,1.76,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.76
914,,8190920,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1,,,CHEMBL1961873,,,,CHEMBL347580,,CHEMBL347580,,False,http://qudt.org/vocab/unit#Percent,1583313,=,16,True,=,,Inhibition,%,,5.89,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.89
915,,8191144,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1,,,CHEMBL1961873,,,,CHEMBL347580,,CHEMBL347580,,False,http://qudt.org/vocab/unit#Percent,1583313,=,16,True,=,,Inhibition,%,,2.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.48
916,,8191282,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl,,,CHEMBL1961873,,,,CHEMBL1909362,GW830900A,CHEMBL187930,,False,http://qudt.org/vocab/unit#Percent,1583266,=,16,True,=,,Inhibition,%,,-4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.3
917,,8191602,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1,,,CHEMBL1961873,,,,CHEMBL218088,GW435821X,CHEMBL218088,,False,http://qudt.org/vocab/unit#Percent,1583468,=,16,True,=,,Inhibition,%,,0.71,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.71
918,,8191724,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1,,,CHEMBL1961873,,,,CHEMBL365248,GW810372X,CHEMBL365248,,False,http://qudt.org/vocab/unit#Percent,1583607,=,16,True,=,,Inhibition,%,,-3.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.64
919,,8191948,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1,,,CHEMBL1961873,,,,CHEMBL365248,GW810372X,CHEMBL365248,,False,http://qudt.org/vocab/unit#Percent,1583607,=,16,True,=,,Inhibition,%,,2.91,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.91
920,,8192097,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1,,,CHEMBL1961873,,,,CHEMBL385426,GW450241X,CHEMBL385426,,False,http://qudt.org/vocab/unit#Percent,1583478,=,16,True,=,,Inhibition,%,,-3.49,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.49
921,,8192450,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1,,,CHEMBL1961873,,,,CHEMBL269985,GW701032X,CHEMBL269985,,False,http://qudt.org/vocab/unit#Percent,1583557,=,16,True,=,,Inhibition,%,,0.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.85
922,,8192594,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1,,,CHEMBL1961873,,,,CHEMBL270054,GW280670X,CHEMBL270054,,False,http://qudt.org/vocab/unit#Percent,1583437,=,16,True,=,,Inhibition,%,,1.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.48
923,,8192954,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1,,,CHEMBL1961873,,,,CHEMBL66292,PYRAZOLOPYRIMIDINE 2,CHEMBL66292,,False,http://qudt.org/vocab/unit#Percent,1583609,=,16,True,=,,Inhibition,%,,1.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.12
924,,8193226,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,,,CHEMBL1961873,,,,CHEMBL475761,GW784684X,CHEMBL475761,,False,http://qudt.org/vocab/unit#Percent,1583584,=,16,True,=,,Inhibition,%,,2.95,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.95
925,,8193371,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O,,,CHEMBL1961873,,,,CHEMBL63728,GW644007X,CHEMBL63728,,False,http://qudt.org/vocab/unit#Percent,1583533,=,16,True,=,,Inhibition,%,,1.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.12
926,,8193595,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O,,,CHEMBL1961873,,,,CHEMBL63728,GW644007X,CHEMBL63728,,False,http://qudt.org/vocab/unit#Percent,1583533,=,16,True,=,,Inhibition,%,,2.71,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.71
927,,8193752,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1,,,CHEMBL1961873,,,,CHEMBL1794059,GW275616X,CHEMBL1794059,,False,http://qudt.org/vocab/unit#Percent,1583432,=,16,True,=,,Inhibition,%,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.9
928,,8194125,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21,,,CHEMBL1961873,,,,CHEMBL187985,,CHEMBL187985,,False,http://qudt.org/vocab/unit#Percent,1583354,=,16,True,=,,Inhibition,%,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.9
929,,8194256,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1,,,CHEMBL1961873,,,,CHEMBL517907,GW680191X,CHEMBL517907,,False,http://qudt.org/vocab/unit#Percent,1583541,=,16,True,=,,Inhibition,%,,2.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.41
930,,8194611,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O,,,CHEMBL1961873,,,,CHEMBL176857,GW442130X,CHEMBL176857,,False,http://qudt.org/vocab/unit#Percent,1583473,=,16,True,=,,Inhibition,%,,1.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.85
931,,8194754,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N,,,CHEMBL1961873,,,,CHEMBL230911,GSK-625137A,CHEMBL230911,,False,http://qudt.org/vocab/unit#Percent,1583420,=,16,True,=,,Inhibition,%,,2.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.85
932,,8194978,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N,,,CHEMBL1961873,,,,CHEMBL230911,GSK-625137A,CHEMBL230911,,False,http://qudt.org/vocab/unit#Percent,1583420,=,16,True,=,,Inhibition,%,,2.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.52
933,,8195111,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1,,,CHEMBL1961873,,,,CHEMBL330422,,CHEMBL330422,,False,http://qudt.org/vocab/unit#Percent,1583289,=,16,True,=,,Inhibition,%,,-1.44,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.44
934,,8195499,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL1789963,GW406108X,CHEMBL1789963,,False,http://qudt.org/vocab/unit#Percent,1583458,=,16,True,=,,Inhibition,%,,3.84,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.84
935,,8195638,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl,,,CHEMBL1961873,,,,CHEMBL1909362,GW830900A,CHEMBL187930,,False,http://qudt.org/vocab/unit#Percent,1583266,=,16,True,=,,Inhibition,%,,2.15,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.15
936,,8195960,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1,,,CHEMBL1961873,,,,CHEMBL485598,GSK-317354A,CHEMBL485598,,False,http://qudt.org/vocab/unit#Percent,1583406,=,16,True,=,,Inhibition,%,,-2.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.11
937,,8196301,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL1909379,,CHEMBL32464,,False,http://qudt.org/vocab/unit#Percent,1583366,=,16,True,=,,Inhibition,%,,-1.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.86
938,,8196451,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1,,,CHEMBL1961873,,,,CHEMBL385426,GW450241X,CHEMBL385426,,False,http://qudt.org/vocab/unit#Percent,1583478,=,16,True,=,,Inhibition,%,,1.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.51
939,,8196803,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1,,,CHEMBL1961873,,,,CHEMBL269985,GW701032X,CHEMBL269985,,False,http://qudt.org/vocab/unit#Percent,1583557,=,16,True,=,,Inhibition,%,,1.98,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.98
940,,8196944,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2ccccc2C)c1,,,CHEMBL1961873,,,,CHEMBL218969,GW445015X,CHEMBL218969,,False,http://qudt.org/vocab/unit#Percent,1583476,=,16,True,=,,Inhibition,%,,-0.44,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.44
941,,8197168,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)c1cncc(/C=C/c2ccccc2C)c1,,,CHEMBL1961873,,,,CHEMBL218969,GW445015X,CHEMBL218969,,False,http://qudt.org/vocab/unit#Percent,1583476,=,16,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.0
942,,8197305,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1,,,CHEMBL1961873,,,,CHEMBL188426,GW807982X,CHEMBL188426,,False,http://qudt.org/vocab/unit#Percent,1583604,=,16,True,=,,Inhibition,%,,-3.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.8
943,,8197580,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N,,,CHEMBL1961873,,,,CHEMBL231623,GSK-620503A,CHEMBL231623,,False,http://qudt.org/vocab/unit#Percent,1583419,=,16,True,=,,Inhibition,%,,2.99,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.99
944,,8197944,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL514162,GW852849X,CHEMBL514162,,False,http://qudt.org/vocab/unit#Percent,1583274,=,16,True,=,,Inhibition,%,,2.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.64
945,,8198101,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1,,,CHEMBL1961873,,,,CHEMBL1794059,GW275616X,CHEMBL1794059,,False,http://qudt.org/vocab/unit#Percent,1583432,=,16,True,=,,Inhibition,%,,2.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.37
946,,8198463,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21,,,CHEMBL1961873,,,,CHEMBL187985,,CHEMBL187985,,False,http://qudt.org/vocab/unit#Percent,1583354,=,16,True,=,,Inhibition,%,,-0.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.28
947,,8198593,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl,,,CHEMBL1961873,,,,CHEMBL1909357,GW410563A,CHEMBL478442,,False,http://qudt.org/vocab/unit#Percent,1583461,=,16,True,=,,Inhibition,%,,4.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.09
948,,8198817,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl,,,CHEMBL1961873,,,,CHEMBL1909357,GW410563A,CHEMBL478442,,False,http://qudt.org/vocab/unit#Percent,1583461,=,16,True,=,,Inhibition,%,,2.62,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.62
949,,8198948,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1,,,CHEMBL1961873,,,,CHEMBL156524,,CHEMBL156524,,False,http://qudt.org/vocab/unit#Percent,1583309,=,16,True,=,,Inhibition,%,,3.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.05
950,,8199320,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,,,CHEMBL1961873,,,,CHEMBL531804,GW301888X,CHEMBL531804,,False,http://qudt.org/vocab/unit#Percent,1583451,=,16,True,=,,Inhibition,%,,2.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.36
951,,8199454,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1,,,CHEMBL1961873,,,,CHEMBL330422,,CHEMBL330422,,False,http://qudt.org/vocab/unit#Percent,1583289,=,16,True,=,,Inhibition,%,,1.47,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.47
952,,8199678,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL379093,GW651576X,CHEMBL379093,,False,http://qudt.org/vocab/unit#Percent,1583534,=,16,True,=,,Inhibition,%,,0.71,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.71
953,,8199841,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1,,,CHEMBL1961873,,,,CHEMBL1789963,GW406108X,CHEMBL1789963,,False,http://qudt.org/vocab/unit#Percent,1583458,=,16,True,=,,Inhibition,%,,5.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.2
954,,8199979,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL267228,,CHEMBL267228,,False,http://qudt.org/vocab/unit#Percent,1583320,=,16,True,=,,Inhibition,%,,-4.02,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.02
955,,8200203,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL267228,,CHEMBL267228,,False,http://qudt.org/vocab/unit#Percent,1583320,=,16,True,=,,Inhibition,%,,2.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.42
956,,8200307,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1,,,CHEMBL1961873,,,,CHEMBL485598,GSK-317354A,CHEMBL485598,,False,http://qudt.org/vocab/unit#Percent,1583406,=,16,True,=,,Inhibition,%,,0.95,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.95
957,,8200646,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL1909379,,CHEMBL32464,,False,http://qudt.org/vocab/unit#Percent,1583366,=,16,True,=,,Inhibition,%,,1.52,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.52
958,,8200796,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1,,,CHEMBL1961873,,,,CHEMBL189459,GW833373X,CHEMBL189459,,False,http://qudt.org/vocab/unit#Percent,1583270,=,16,True,=,,Inhibition,%,,-2.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.94
959,,8201020,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1,,,CHEMBL1961873,,,,CHEMBL189459,GW833373X,CHEMBL189459,,False,http://qudt.org/vocab/unit#Percent,1583270,=,16,True,=,,Inhibition,%,,1.87,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.87
960,,8201150,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL480382,GSK-312948A,CHEMBL480382,,False,http://qudt.org/vocab/unit#Percent,1583403,=,16,True,=,,Inhibition,%,,-3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.1
961,,8201509,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1,,,CHEMBL1961873,,,,CHEMBL483748,GSK-953913A,CHEMBL483748,,False,http://qudt.org/vocab/unit#Percent,1583427,=,16,True,=,,Inhibition,%,,-1.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.18
962,,8201642,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1,,,CHEMBL1961873,,,,CHEMBL188426,GW807982X,CHEMBL188426,,False,http://qudt.org/vocab/unit#Percent,1583604,=,16,True,=,,Inhibition,%,,0.63,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.63
963,,8201866,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1,,,CHEMBL1961873,,,,CHEMBL237570,,CHEMBL237570,,False,http://qudt.org/vocab/unit#Percent,1583327,=,16,True,=,,Inhibition,%,,-4.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-4.88
964,,8201921,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N,,,CHEMBL1961873,,,,CHEMBL231623,GSK-620503A,CHEMBL231623,,False,http://qudt.org/vocab/unit#Percent,1583419,=,16,True,=,,Inhibition,%,,1.61,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.61
965,,8202145,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1,,,CHEMBL1961873,,,,CHEMBL215814,GW576484X,CHEMBL215814,,False,http://qudt.org/vocab/unit#Percent,1583501,=,16,True,=,,Inhibition,%,,4.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.38
966,,8202285,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL514162,GW852849X,CHEMBL514162,,False,http://qudt.org/vocab/unit#Percent,1583274,=,16,True,=,,Inhibition,%,,0.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.8
967,,8202452,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,,,CHEMBL1961873,,,,CHEMBL1909406,,CHEMBL313417,,False,http://qudt.org/vocab/unit#Percent,1583362,=,16,True,=,,Inhibition,%,,3.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.38
968,,8202676,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,,,CHEMBL1961873,,,,CHEMBL1909406,,CHEMBL313417,,False,http://qudt.org/vocab/unit#Percent,1583362,=,16,True,=,,Inhibition,%,,2.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.37
969,,8202801,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,,,CHEMBL1961873,,,,CHEMBL381948,GW680975X,CHEMBL381948,,False,http://qudt.org/vocab/unit#Percent,1583543,=,16,True,=,,Inhibition,%,,2.71,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.71
970,,8203155,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1,,,CHEMBL1961873,,,,CHEMBL346551,,CHEMBL346551,,False,http://qudt.org/vocab/unit#Percent,1583361,=,16,True,=,,Inhibition,%,,2.01,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.01
971,,8203286,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1,,,CHEMBL1961873,,,,CHEMBL156524,,CHEMBL156524,,False,http://qudt.org/vocab/unit#Percent,1583309,=,16,True,=,,Inhibition,%,,1.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.81
972,,8203510,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl,,,CHEMBL1961873,,,,CHEMBL1909359,GW771127A,CHEMBL514838,,False,http://qudt.org/vocab/unit#Percent,1583572,=,16,True,=,,Inhibition,%,,4.14,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.14
973,,8203656,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1,,,CHEMBL1961873,,,,CHEMBL531804,GW301888X,CHEMBL531804,,False,http://qudt.org/vocab/unit#Percent,1583451,=,16,True,=,,Inhibition,%,,1.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.94
974,,8204014,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1,,,CHEMBL1961873,,,,CHEMBL379093,GW651576X,CHEMBL379093,,False,http://qudt.org/vocab/unit#Percent,1583534,=,16,True,=,,Inhibition,%,,2.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.43
975,,8204180,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1,,,CHEMBL1961873,,,,CHEMBL374060,GW439255X,CHEMBL374060,,False,http://qudt.org/vocab/unit#Percent,1583469,=,16,True,=,,Inhibition,%,,3.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.06
976,,8204541,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl,,,CHEMBL1961873,,,,CHEMBL581096,GW440139A,CHEMBL395358,,False,http://qudt.org/vocab/unit#Percent,1583470,=,16,True,=,,Inhibition,%,,-3.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.41
977,,8204646,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL189148,GW829055X,CHEMBL189148,,False,http://qudt.org/vocab/unit#Percent,1583626,=,16,True,=,,Inhibition,%,,-3.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.75
978,,8204870,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1,,,CHEMBL1961873,,,,CHEMBL189148,GW829055X,CHEMBL189148,,False,http://qudt.org/vocab/unit#Percent,1583626,=,16,True,=,,Inhibition,%,,1.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.51
979,,8204985,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O,,,CHEMBL1961873,,,,CHEMBL66004,GW578748X,CHEMBL66004,,False,http://qudt.org/vocab/unit#Percent,1583505,=,16,True,=,,Inhibition,%,,-2.65,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.65
980,,8205358,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1,,,CHEMBL1961873,,,,CHEMBL495771,GW708336X,CHEMBL495771,,False,http://qudt.org/vocab/unit#Percent,1583560,=,16,True,=,,Inhibition,%,,-3.02,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.02
981,,8205494,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL480382,GSK-312948A,CHEMBL480382,,False,http://qudt.org/vocab/unit#Percent,1583403,=,16,True,=,,Inhibition,%,,1.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.66
982,,8205718,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCOc1nccc2c1nc(-c1nonc1N)n2CC,,,CHEMBL1961873,,,,CHEMBL188240,,CHEMBL188240,,False,http://qudt.org/vocab/unit#Percent,1583345,=,16,True,=,,Inhibition,%,,-2.37,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.37
983,,8205857,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1,,,CHEMBL1961873,,,,CHEMBL483748,GSK-953913A,CHEMBL483748,,False,http://qudt.org/vocab/unit#Percent,1583427,=,16,True,=,,Inhibition,%,,1.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.31
984,,8206213,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1,,,CHEMBL1961873,,,,CHEMBL237570,,CHEMBL237570,,False,http://qudt.org/vocab/unit#Percent,1583327,=,16,True,=,,Inhibition,%,,-0.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.25
985,,8206489,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1,,,CHEMBL1961873,,,,CHEMBL215814,GW576484X,CHEMBL215814,,False,http://qudt.org/vocab/unit#Percent,1583501,=,16,True,=,,Inhibition,%,,1.89,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.89
986,,8206632,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1,,,CHEMBL1961873,,,,CHEMBL1794053,GW407323A,CHEMBL1852697,,False,http://qudt.org/vocab/unit#Percent,1583460,=,16,True,=,,Inhibition,%,,3.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.08
987,,8207036,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCCn1c(-c2nonc2N)nc2cnccc21,,,CHEMBL1961873,,,,CHEMBL191105,,CHEMBL191105,,False,http://qudt.org/vocab/unit#Percent,1583357,=,16,True,=,,Inhibition,%,,4.22,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.22
988,,8207162,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,,,CHEMBL1961873,,,,CHEMBL381948,GW680975X,CHEMBL381948,,False,http://qudt.org/vocab/unit#Percent,1583543,=,16,True,=,,Inhibition,%,,1.76,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.76
989,,8207516,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1,,,CHEMBL1961873,,,,CHEMBL346551,,CHEMBL346551,,False,http://qudt.org/vocab/unit#Percent,1583361,=,16,True,=,,Inhibition,%,,2.54,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.54
990,,8207872,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl,,,CHEMBL1961873,,,,CHEMBL1909359,GW771127A,CHEMBL514838,,False,http://qudt.org/vocab/unit#Percent,1583572,=,16,True,=,,Inhibition,%,,3.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.25
991,,8208017,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1,,,CHEMBL1961873,,,,CHEMBL524901,GW683109X,CHEMBL524901,,False,http://qudt.org/vocab/unit#Percent,1583546,=,16,True,=,,Inhibition,%,,2.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.04
992,,8208373,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,,,CHEMBL1961873,,,,CHEMBL202891,GW679410X,CHEMBL202891,,False,http://qudt.org/vocab/unit#Percent,1583540,=,16,True,=,,Inhibition,%,,-2.78,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.78
993,,8208539,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1,,,CHEMBL1961873,,,,CHEMBL374060,GW439255X,CHEMBL374060,,False,http://qudt.org/vocab/unit#Percent,1583469,=,16,True,=,,Inhibition,%,,1.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.36
994,,8208896,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl,,,CHEMBL1961873,,,,CHEMBL581096,GW440139A,CHEMBL395358,,False,http://qudt.org/vocab/unit#Percent,1583470,=,16,True,=,,Inhibition,%,,2.33,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.33
995,,8209225,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL372474,GW678313X,CHEMBL372474,,False,http://qudt.org/vocab/unit#Percent,1583539,=,16,True,=,,Inhibition,%,,1.45,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.45
996,,8209341,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O,,,CHEMBL1961873,,,,CHEMBL66004,GW578748X,CHEMBL66004,,False,http://qudt.org/vocab/unit#Percent,1583505,=,16,True,=,,Inhibition,%,,4.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.43
997,,8209565,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1,,,CHEMBL1961873,,,,CHEMBL181361,GW693481X,CHEMBL181361,,False,http://qudt.org/vocab/unit#Percent,1583550,=,16,True,=,,Inhibition,%,,-3.29,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.29
998,,8209715,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1,,,CHEMBL1961873,,,,CHEMBL495771,GW708336X,CHEMBL495771,,False,http://qudt.org/vocab/unit#Percent,1583560,=,16,True,=,,Inhibition,%,,4.62,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.62
999,,8210075,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCOc1nccc2c1nc(-c1nonc1N)n2CC,,,CHEMBL1961873,,,,CHEMBL188240,,CHEMBL188240,,False,http://qudt.org/vocab/unit#Percent,1583345,=,16,True,=,,Inhibition,%,,1.89,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.89
1000,,8210216,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL516908,GW796920X,CHEMBL516908,,False,http://qudt.org/vocab/unit#Percent,1583594,=,16,True,=,,Inhibition,%,,-2.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.97
1001,,8210576,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,,,CHEMBL1961873,,,,CHEMBL2062290,,CHEMBL101747,,False,http://qudt.org/vocab/unit#Percent,1583348,=,16,True,=,,Inhibition,%,,-3.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.96
1002,,8210835,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1,,,CHEMBL1961873,,,,CHEMBL402108,GW708893X,CHEMBL402108,,False,http://qudt.org/vocab/unit#Percent,1583561,=,16,True,=,,Inhibition,%,,4.09,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,4.09
1003,,8210979,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1,,,CHEMBL1961873,,,,CHEMBL1794053,GW407323A,CHEMBL1852697,,False,http://qudt.org/vocab/unit#Percent,1583460,=,16,True,=,,Inhibition,%,,-0.15,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.15
1004,,8211203,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL473420,GSK-1030058A,CHEMBL473420,,False,http://qudt.org/vocab/unit#Percent,1583370,=,16,True,=,,Inhibition,%,,-0.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.1
1005,,8211373,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCCn1c(-c2nonc2N)nc2cnccc21,,,CHEMBL1961873,,,,CHEMBL191105,,CHEMBL191105,,False,http://qudt.org/vocab/unit#Percent,1583357,=,16,True,=,,Inhibition,%,,1.99,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.99
1006,,8211496,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1,,,CHEMBL1961873,,,,CHEMBL365663,GW780159X,CHEMBL365663,,False,http://qudt.org/vocab/unit#Percent,1583578,=,16,True,=,,Inhibition,%,,3.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.86
1007,,8211720,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1,,,CHEMBL1961873,,,,CHEMBL365663,GW780159X,CHEMBL365663,,False,http://qudt.org/vocab/unit#Percent,1583578,=,16,True,=,,Inhibition,%,,2.05,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.05
1008,,8211849,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL260417,,CHEMBL260417,,False,http://qudt.org/vocab/unit#Percent,1583336,=,16,True,=,,Inhibition,%,,3.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.81
1009,,8212205,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1,,,CHEMBL1961873,,,,CHEMBL483747,GSK-980961A,CHEMBL483747,,False,http://qudt.org/vocab/unit#Percent,1583430,=,16,True,=,,Inhibition,%,,1.17,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.17
1010,,8212346,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1,,,CHEMBL1961873,,,,CHEMBL524901,GW683109X,CHEMBL524901,,False,http://qudt.org/vocab/unit#Percent,1583546,=,16,True,=,,Inhibition,%,,1.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.39
1011,,8212570,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL419903,,CHEMBL419903,,False,http://qudt.org/vocab/unit#Percent,1583342,=,16,True,=,,Inhibition,%,,2.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.26
1012,,8212703,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1,,,CHEMBL1961873,,,,CHEMBL202891,GW679410X,CHEMBL202891,,False,http://qudt.org/vocab/unit#Percent,1583540,=,16,True,=,,Inhibition,%,,2.03,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.03
1013,,8212873,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL441702,GSK-270822A,CHEMBL441702,,False,http://qudt.org/vocab/unit#Percent,1583400,=,16,True,=,,Inhibition,%,,3.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.06
1014,,8213097,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL441702,GSK-270822A,CHEMBL441702,,False,http://qudt.org/vocab/unit#Percent,1583400,=,16,True,=,,Inhibition,%,,0.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.83
1015,,8213226,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nonc1-c1nc2cnccc2n1C1CC1,,,CHEMBL1961873,,,,CHEMBL185962,,CHEMBL185962,,False,http://qudt.org/vocab/unit#Percent,1583344,=,16,True,=,,Inhibition,%,,-0.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.18
1016,,8213554,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL372474,GW678313X,CHEMBL372474,,False,http://qudt.org/vocab/unit#Percent,1583539,=,16,True,=,,Inhibition,%,,0.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.38
1017,,8213891,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1,,,CHEMBL1961873,,,,CHEMBL181361,GW693481X,CHEMBL181361,,False,http://qudt.org/vocab/unit#Percent,1583550,=,16,True,=,,Inhibition,%,,1.27,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.27
1018,,8214038,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,,,CHEMBL1961873,,,,CHEMBL103098,,CHEMBL103098,,False,http://qudt.org/vocab/unit#Percent,1583346,=,16,True,=,,Inhibition,%,,-1.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.93
1019,,8214399,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL222419,GSK-237701A,CHEMBL222419,,False,http://qudt.org/vocab/unit#Percent,1583394,=,16,True,=,,Inhibition,%,,-1.67,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.67
1020,,8214533,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,,,CHEMBL1961873,,,,CHEMBL516908,GW796920X,CHEMBL516908,,False,http://qudt.org/vocab/unit#Percent,1583594,=,16,True,=,,Inhibition,%,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.2
1021,,8214757,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl,,,CHEMBL1961873,,,,CHEMBL1909381,GW575808A,CHEMBL250322,,False,http://qudt.org/vocab/unit#Percent,1583500,=,16,True,=,,Inhibition,%,,-2.94,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.94
1022,,8214909,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O,,,CHEMBL1961873,,,,CHEMBL2062290,,CHEMBL101747,,False,http://qudt.org/vocab/unit#Percent,1583348,=,16,True,=,,Inhibition,%,,-0.76,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.76
1023,,8215160,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1,,,CHEMBL1961873,,,,CHEMBL402108,GW708893X,CHEMBL402108,,False,http://qudt.org/vocab/unit#Percent,1583561,=,16,True,=,,Inhibition,%,,2.12,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.12
1024,,8215537,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F,,,CHEMBL1961873,,,,CHEMBL473420,GSK-1030058A,CHEMBL473420,,False,http://qudt.org/vocab/unit#Percent,1583370,=,16,True,=,,Inhibition,%,,1.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.88
1025,,8215701,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL1909410,GSK-259178A,CHEMBL1963561,,False,http://qudt.org/vocab/unit#Percent,1583398,=,16,True,=,,Inhibition,%,,3.45,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.45
1026,,8216044,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL450071,GSK-1392956A,CHEMBL450071,,False,http://qudt.org/vocab/unit#Percent,1583377,=,16,True,=,,Inhibition,%,,3.02,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.02
1027,,8216163,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL260417,,CHEMBL260417,,False,http://qudt.org/vocab/unit#Percent,1583336,=,16,True,=,,Inhibition,%,,3.24,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.24
1028,,8216387,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br,,,CHEMBL1961873,,,,CHEMBL481510,GW853606X,CHEMBL481510,,False,http://qudt.org/vocab/unit#Percent,1583275,=,16,True,=,,Inhibition,%,,0.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.72
1029,,8216523,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1,,,CHEMBL1961873,,,,CHEMBL483747,GSK-980961A,CHEMBL483747,,False,http://qudt.org/vocab/unit#Percent,1583430,=,16,True,=,,Inhibition,%,,2.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.26
1030,,8216885,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1,,,CHEMBL1961873,,,,CHEMBL419903,,CHEMBL419903,,False,http://qudt.org/vocab/unit#Percent,1583342,=,16,True,=,,Inhibition,%,,1.45,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.45
1031,,8217019,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1,,,CHEMBL1961873,,,,CHEMBL257113,GW734508X,CHEMBL257113,,False,http://qudt.org/vocab/unit#Percent,1583564,=,16,True,=,,Inhibition,%,,-1.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.48
1032,,8217417,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1,,,CHEMBL1961873,,,,CHEMBL1909341,GW641155A,CHEMBL194117,,False,http://qudt.org/vocab/unit#Percent,1583529,=,16,True,=,,Inhibition,%,,1.75,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.75
1033,,8217548,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nonc1-c1nc2cnccc2n1C1CC1,,,CHEMBL1961873,,,,CHEMBL185962,,CHEMBL185962,,False,http://qudt.org/vocab/unit#Percent,1583344,=,16,True,=,,Inhibition,%,,2.91,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.91
1034,,8217772,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL373751,GSK-319347A,CHEMBL373751,,False,http://qudt.org/vocab/unit#Percent,1583407,=,16,True,=,,Inhibition,%,,-0.58,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.58
1035,,8217873,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1,,,CHEMBL1961873,,,,CHEMBL160876,,CHEMBL160876,,False,http://qudt.org/vocab/unit#Percent,1583312,=,16,True,=,,Inhibition,%,,-1.49,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.49
1036,,8218212,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O,,,CHEMBL1961873,,,,CHEMBL1909414,,CHEMBL477989,,False,http://qudt.org/vocab/unit#Percent,1583324,=,16,True,=,,Inhibition,%,,-2.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-2.04
1037,,8218339,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1,,,CHEMBL1961873,,,,CHEMBL103098,,CHEMBL103098,,False,http://qudt.org/vocab/unit#Percent,1583346,=,16,True,=,,Inhibition,%,,1.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.48
1038,,8218563,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909383,GW784307A,CHEMBL67374,,False,http://qudt.org/vocab/unit#Percent,1583583,=,16,True,=,,Inhibition,%,,-3.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.06
1039,,8218706,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL222419,GSK-237701A,CHEMBL222419,,False,http://qudt.org/vocab/unit#Percent,1583394,=,16,True,=,,Inhibition,%,,3.82,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.82
1040,,8219061,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl,,,CHEMBL1961873,,,,CHEMBL1909381,GW575808A,CHEMBL250322,,False,http://qudt.org/vocab/unit#Percent,1583500,=,16,True,=,,Inhibition,%,,6.55,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,6.55
1041,,8219221,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1,,,CHEMBL1961873,,,,CHEMBL205158,GW695874X,CHEMBL205158,,False,http://qudt.org/vocab/unit#Percent,1583555,=,16,True,=,,Inhibition,%,,2.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.23
1042,,8219471,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1,,,CHEMBL1961873,,,,CHEMBL274863,,CHEMBL274863,,False,http://qudt.org/vocab/unit#Percent,1583283,=,16,True,=,,Inhibition,%,,3.35,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.35
1043,,8219856,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2coc3ncnc(N)c23)cc1,,,CHEMBL1961873,,,,CHEMBL196022,GW642125X,CHEMBL196022,,False,http://qudt.org/vocab/unit#Percent,1583530,=,16,True,=,,Inhibition,%,,0.41,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.41
1044,,8220025,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1,,,CHEMBL1961873,,,,CHEMBL1909410,GSK-259178A,CHEMBL1963561,,False,http://qudt.org/vocab/unit#Percent,1583398,=,16,True,=,,Inhibition,%,,2.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.43
1045,,8220378,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL450071,GSK-1392956A,CHEMBL450071,,False,http://qudt.org/vocab/unit#Percent,1583377,=,16,True,=,,Inhibition,%,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.5
1046,,8220716,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br,,,CHEMBL1961873,,,,CHEMBL481510,GW853606X,CHEMBL481510,,False,http://qudt.org/vocab/unit#Percent,1583275,=,16,True,=,,Inhibition,%,,1.61,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.61
1047,,8220854,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21,,,CHEMBL1961873,,,,CHEMBL175321,,CHEMBL175321,,False,http://qudt.org/vocab/unit#Percent,1583365,=,16,True,=,,Inhibition,%,,0.67,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.67
1048,,8221214,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nonc1-c1nc2cnccc2n1C1CC1,,,CHEMBL1961873,,,,CHEMBL185962,,CHEMBL185962,,False,http://qudt.org/vocab/unit#Percent,1583344,=,16,True,=,,Inhibition,%,,2.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.38
1049,,8221347,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1,,,CHEMBL1961873,,,,CHEMBL257113,GW734508X,CHEMBL257113,,False,http://qudt.org/vocab/unit#Percent,1583564,=,16,True,=,,Inhibition,%,,2.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.66
1050,,8221571,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL514261,GSK-1819799A,CHEMBL514261,,False,http://qudt.org/vocab/unit#Percent,1583382,=,16,True,=,,Inhibition,%,,2.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.04
1051,,8221736,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1,,,CHEMBL1961873,,,,CHEMBL1909341,GW641155A,CHEMBL194117,,False,http://qudt.org/vocab/unit#Percent,1583529,=,16,True,=,,Inhibition,%,,0.97,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.97
1052,,8222091,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,,,CHEMBL1961873,,,,CHEMBL373751,GSK-319347A,CHEMBL373751,,False,http://qudt.org/vocab/unit#Percent,1583407,=,16,True,=,,Inhibition,%,,10.85,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,10.85
1053,,8222189,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1,,,CHEMBL1961873,,,,CHEMBL160876,,CHEMBL160876,,False,http://qudt.org/vocab/unit#Percent,1583312,=,16,True,=,,Inhibition,%,,-0.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-0.81
1054,,8222413,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1,,,CHEMBL1961873,,,,CHEMBL191705,GW621431X,CHEMBL191705,,False,http://qudt.org/vocab/unit#Percent,1583519,=,16,True,=,,Inhibition,%,,-3.46,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-3.46
1055,,8222547,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O,,,CHEMBL1961873,,,,CHEMBL1909414,,CHEMBL477989,,False,http://qudt.org/vocab/unit#Percent,1583324,=,16,True,=,,Inhibition,%,,2.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.08
1056,,8222889,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl,,,CHEMBL1961873,,,,CHEMBL1909383,GW784307A,CHEMBL67374,,False,http://qudt.org/vocab/unit#Percent,1583583,=,16,True,=,,Inhibition,%,,1.87,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.87
1057,,8223033,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl,,,CHEMBL1961873,,,,CHEMBL1909396,GW768505A,CHEMBL194911,,False,http://qudt.org/vocab/unit#Percent,1583567,=,16,True,=,,Inhibition,%,,-1.07,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.07
1058,,8223386,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F,,,CHEMBL1961873,,,,CHEMBL1909374,GW709042A,CHEMBL243917,,False,http://qudt.org/vocab/unit#Percent,1583562,=,16,True,=,,Inhibition,%,,-1.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,-1.64
1059,,8223547,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1,,,CHEMBL1961873,,,,CHEMBL205158,GW695874X,CHEMBL205158,,False,http://qudt.org/vocab/unit#Percent,1583555,=,16,True,=,,Inhibition,%,,0.43,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.43
1060,,8223771,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,,,CHEMBL1961873,,,,CHEMBL261849,GW632580X,CHEMBL261849,,False,http://qudt.org/vocab/unit#Percent,1583527,=,16,True,=,,Inhibition,%,,1.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.04
1061,,8223797,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1,,,CHEMBL1961873,,,,CHEMBL274863,,CHEMBL274863,,False,http://qudt.org/vocab/unit#Percent,1583283,=,16,True,=,,Inhibition,%,,2.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.13
1062,,8224021,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1,,,CHEMBL1961873,,,,CHEMBL237571,,CHEMBL237571,,False,http://qudt.org/vocab/unit#Percent,1583328,=,16,True,=,,Inhibition,%,,3.69,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.69
1063,,8224183,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2coc3ncnc(N)c23)cc1,,,CHEMBL1961873,,,,CHEMBL196022,GW642125X,CHEMBL196022,,False,http://qudt.org/vocab/unit#Percent,1583530,=,16,True,=,,Inhibition,%,,1.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.48
1064,,8224353,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL233002,,CHEMBL233002,,False,http://qudt.org/vocab/unit#Percent,1583360,=,16,True,=,,Inhibition,%,,3.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,3.39
1065,,8224577,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2,,,CHEMBL1961873,,,,CHEMBL233002,,CHEMBL233002,,False,http://qudt.org/vocab/unit#Percent,1583360,=,16,True,=,,Inhibition,%,,2.64,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.64
1066,,8224712,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1,,,CHEMBL1961873,,,,CHEMBL232601,GW846105X,CHEMBL232601,,False,http://qudt.org/vocab/unit#Percent,1583273,=,16,True,=,,Inhibition,%,,2.06,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.06
1067,,8225050,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1,,,CHEMBL1961873,,,,CHEMBL427058,GSK-466317A,CHEMBL427058,,False,http://qudt.org/vocab/unit#Percent,1583410,=,16,True,=,,Inhibition,%,,2.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.04
1068,,8225184,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21,,,CHEMBL1961873,,,,CHEMBL175321,,CHEMBL175321,,False,http://qudt.org/vocab/unit#Percent,1583365,=,16,True,=,,Inhibition,%,,5.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,5.31
1069,,8225408,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1,,,CHEMBL1961873,,,,CHEMBL103104,GW831090X,CHEMBL103104,,False,http://qudt.org/vocab/unit#Percent,1583267,=,16,True,=,,Inhibition,%,,0.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.88
1070,,8225546,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nonc1-c1nc2cnccc2n1C1CC1,,,CHEMBL1961873,,,,CHEMBL185962,,CHEMBL185962,,False,http://qudt.org/vocab/unit#Percent,1583344,=,16,True,=,,Inhibition,%,,1.65,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,1.65
1071,,8225905,[],CHEMBL1962317,GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1,,,CHEMBL1961873,,,,CHEMBL514261,GSK-1819799A,CHEMBL514261,,False,http://qudt.org/vocab/unit#Percent,1583382,=,16,True,=,,Inhibition,%,,2.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,2.25
1072,,8226063,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL1961873,,,,CHEMBL1909407,,CHEMBL274064,,False,http://qudt.org/vocab/unit#Percent,1583284,=,16,True,=,,Inhibition,%,,0.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.88
1073,,8226412,[],CHEMBL1962316,GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn],B,,,BAO_0000201,BAO_0000357,single protein format,Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,,,CHEMBL1961873,,,,CHEMBL381604,GW799251X,CHEMBL381604,,False,http://qudt.org/vocab/unit#Percent,1583596,=,16,True,=,,Inhibition,%,,0.44,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Inhibition,%,UO_0000187,,0.44
1074,,10838712,[],CHEMBL2014938,Inhibition of IRAK4 at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1,,,CHEMBL2010722,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2012574,,CHEMBL2012574,,False,http://qudt.org/vocab/unit#Percent,1633209,=,1,True,=,,Inhibition,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.0
1075,,10839614,[],CHEMBL2016273,Inhibition of IRAK4 assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,,,CHEMBL2010643,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL509032,TAE-684,CHEMBL509032,,False,http://qudt.org/vocab/unit#Percent,1633217,=,1,False,=,,Activity,%,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,43.0
1076,,10839625,[],CHEMBL2015141,Inhibition of IRAK4 assessed as residual activity at 10 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,,,CHEMBL2010643,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL509032,TAE-684,CHEMBL509032,,False,http://qudt.org/vocab/unit#Percent,1633217,=,1,False,=,,Activity,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,16.0
1077,,10849715,[],CHEMBL2019674,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2016462,ACS Med. Chem. Lett.,2011.0,,CHEMBL2017214,,CHEMBL2017214,,False,http://www.openphacts.org/units/Nanomolar,1634757,>,1,True,>,,IC50,nM,,40000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,40.0
1078,,10850629,[],CHEMBL2019907,Inhibition of human IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1,,,CHEMBL2016522,ACS Med. Chem. Lett.,2011.0,"{'bei': '13.42', 'le': '0.26', 'lle': '0.86', 'sei': '8.91'}",CHEMBL1938680,,CHEMBL1938680,5.12,False,http://www.openphacts.org/units/Nanomolar,1635001,=,1,True,=,,IC50,nM,,7500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7500.0
1079,,10870930,[],CHEMBL2024840,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1,,,CHEMBL2021851,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '18.38', 'le': '0.35', 'lle': '3.64', 'sei': '8.33'}",CHEMBL1739550,,CHEMBL1739550,7.25,False,http://www.openphacts.org/units/Nanomolar,1637284,=,1,True,=,,IC50,nM,,56.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,56.0
1080,,10870931,[],CHEMBL2024840,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cnn(CC(=O)NCc4cccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1,,,CHEMBL2021851,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.79', 'le': '0.21', 'lle': '1.35', 'sei': '5.76'}",CHEMBL2022369,,CHEMBL2022369,6.06,False,http://www.openphacts.org/units/Nanomolar,1637618,=,1,True,=,,IC50,nM,,873.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,873.0
1081,,10870932,[],CHEMBL2024840,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1,,,CHEMBL2021851,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.37', 'le': '0.20', 'lle': '0.85', 'sei': '5.55'}",CHEMBL2022373,,CHEMBL2022373,5.85,False,http://www.openphacts.org/units/Nanomolar,1637622,=,1,True,=,,IC50,nM,,1423.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1423.0
1082,,10870933,[],CHEMBL2024840,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1,,,CHEMBL2021851,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.95', 'le': '0.21', 'lle': '1.57', 'sei': '5.03'}",CHEMBL2022379,,CHEMBL2022379,5.94,False,http://www.openphacts.org/units/Nanomolar,1637628,=,1,True,=,,IC50,nM,,1142.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1142.0
1083,,10870934,[],CHEMBL2024840,Inhibition of IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1,,,CHEMBL2021851,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '10.55', 'le': '0.20', 'lle': '1.40', 'sei': '5.01'}",CHEMBL2022711,,CHEMBL2022711,5.91,False,http://www.openphacts.org/units/Nanomolar,1638085,=,1,True,=,,IC50,nM,,1219.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1219.0
1084,,10925182,[],CHEMBL2046122,Inhibition of human IRAK4 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1,,,CHEMBL2040781,J. Med. Chem.,2011.0,,CHEMBL2041958,,CHEMBL2041958,,False,http://qudt.org/vocab/unit#Percent,1649522,=,1,False,=,,Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,91.0
1085,,10925183,[],CHEMBL2046122,Inhibition of human IRAK4 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting,B,,,BAO_0001103,BAO_0000357,single protein format,O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12,,,CHEMBL2040781,J. Med. Chem.,2011.0,,CHEMBL2041962,,CHEMBL2041962,,False,http://qudt.org/vocab/unit#Percent,1649526,=,1,False,=,,Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,95.0
1086,,10975695,[],CHEMBL2064934,Inhibition of Irak4 in presence of 10 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,,,CHEMBL2062488,Bioorg. Med. Chem. Lett.,2012.0,"{'bei': '15.96', 'le': '0.29', 'lle': '3.12', 'sei': '5.12'}",CHEMBL1990583,,CHEMBL1990583,6.47,False,http://www.openphacts.org/units/Nanomolar,1659316,=,1,True,=,,IC50,nM,,340.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,340.0
1087,,10978464,[],CHEMBL2066243,Inhibition of human recombinant IRAK4 expressed in insect cells using ulight-FLGFTYVAP as substrate assessed as residual activity at 1 uM after 90 mins by Cerep assay,B,,,BAO_0001103,BAO_0000219,cell-based format,N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1,,,CHEMBL2062370,J. Med. Chem.,2012.0,,CHEMBL2064515,,CHEMBL2064515,,False,http://qudt.org/vocab/unit#Percent,1660601,>,1,False,>,,Activity,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,80.0
1088,,10980260,[],CHEMBL2065119,Inhibition of IRAK4 at 10 uM by FRET assay,B,,,BAO_0000201,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2062359,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2017253,,CHEMBL2017253,,False,http://qudt.org/vocab/unit#Percent,1659908,=,1,True,=,,Inhibition,%,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,25.0
1089,,10980261,[],CHEMBL2065119,Inhibition of IRAK4 at 10 uM by FRET assay,B,,,BAO_0000201,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2062359,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2063926,,CHEMBL2063926,,False,http://qudt.org/vocab/unit#Percent,1659922,<,1,True,<,,Inhibition,%,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,15.0
1090,,10980305,[],CHEMBL2065149,Inhibition of IRAK4 by FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2062359,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2063926,,CHEMBL2063926,,False,http://www.openphacts.org/units/Nanomolar,1659922,<,1,True,<,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
1091,,12046334,[],CHEMBL2156664,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1,,,CHEMBL2151019,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2152768,,CHEMBL2152768,,False,http://qudt.org/vocab/unit#Percent,1731548,=,1,True,=,,Inhibition,%,,-0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-0.2
1092,,12074641,[],CHEMBL2161203,Inhibition of IRAK4 at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1,,,CHEMBL2157860,J. Med. Chem.,2011.0,,CHEMBL1908842,,CHEMBL1908842,,False,http://qudt.org/vocab/unit#Percent,1733200,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1093,,12150591,[],CHEMBL2188526,Inhibition of human recombinant IRAK4 by radiometric kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,,,CHEMBL2177100,J. Med. Chem.,2012.0,,CHEMBL2178352,,CHEMBL2178352,,False,http://www.openphacts.org/units/Nanomolar,1751227,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
1094,,12166120,[],CHEMBL2211593,Binding affinity to IRAK4 at 1 uM,B,,,BAO_0001103,BAO_0000357,single protein format,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,,,CHEMBL2203208,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2206921,,CHEMBL2206921,,False,http://qudt.org/vocab/unit#Percent,1760574,<,1,False,<,,Activity,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,50.0
1095,,12170797,[],CHEMBL2209925,Inhibition of IRAK4 assessed as residual activity at 1 uM,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,,,CHEMBL2203081,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2204495,,CHEMBL2204495,,False,http://qudt.org/vocab/unit#Percent,1757300,=,1,False,=,,Activity,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,90.0
1096,,12172098,[],CHEMBL2213924,Inhibition of IRAK4 assessed as residual activity at 10 uM,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,,,CHEMBL2203081,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2204495,,CHEMBL2204495,,False,http://qudt.org/vocab/unit#Percent,1757300,=,1,False,=,,Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,91.0
1097,,12173572,[],CHEMBL2211070,Inhibition of IRAK4 assessed as residual activity at 10 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,,,CHEMBL2203081,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2204495,,CHEMBL2204495,,False,http://qudt.org/vocab/unit#Percent,1757300,=,1,False,=,,Activity,%,,58.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,58.0
1098,,12195470,[],CHEMBL2210063,Inhibition of recombinant IRAK4 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP,B,,,BAO_0000192,BAO_0000357,single protein format,CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O,,,CHEMBL2203238,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2205426,,CHEMBL2205426,,False,http://www.openphacts.org/units/Nanomolar,1758583,>,1,True,>,,Ki,nM,,9900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,9900.0
1099,,12195608,[],CHEMBL2212387,Inhibition of human recombinant IRAK4 expressed in insect cells using Ulight-FLGFTYVAP as substrate assessed as residual activity at 1 uM after 90 mins relative to staurosporine,B,,,BAO_0001103,BAO_0000219,cell-based format,CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1,,,CHEMBL2203085,Bioorg. Med. Chem. Lett.,2012.0,,CHEMBL2206008,,CHEMBL2206008,,False,http://qudt.org/vocab/unit#Percent,1759409,=,1,False,=,,Activity,%,,91.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,91.8
1100,,12225934,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218926,,CHEMBL2218926,,False,http://qudt.org/vocab/unit#Percent,1763440,=,1,False,=,,Residual Activity,%,,112.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,112.0
1101,,12225935,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL266487,RO-316233,CHEMBL266487,,False,http://qudt.org/vocab/unit#Percent,1763441,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1102,,12225936,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL387187,,CHEMBL387187,,False,http://qudt.org/vocab/unit#Percent,1763442,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1103,,12225937,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL439259,,CHEMBL439259,,False,http://qudt.org/vocab/unit#Percent,1763443,=,1,False,=,,Residual Activity,%,,102.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,102.0
1104,,12225938,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL53753,,CHEMBL53753,,False,http://qudt.org/vocab/unit#Percent,1763444,=,1,False,=,,Residual Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,96.0
1105,,12225939,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ncnc2c1cnn2-c1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL65063,,CHEMBL65063,,False,http://qudt.org/vocab/unit#Percent,1763445,=,1,False,=,,Residual Activity,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,104.0
1106,,12225940,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL104279,,CHEMBL104279,,False,http://qudt.org/vocab/unit#Percent,1763446,=,1,False,=,,Residual Activity,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,0.0
1107,,12225941,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7917,TYRPHOSTIN AG-1478,CHEMBL7917,,False,http://qudt.org/vocab/unit#Percent,1763447,=,1,False,=,,Residual Activity,%,,64.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,64.0
1108,,12225942,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218927,,CHEMBL2218927,,False,http://qudt.org/vocab/unit#Percent,1763448,=,1,False,=,,Residual Activity,%,,111.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,111.0
1109,,12225943,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL174426,,CHEMBL174426,,False,http://qudt.org/vocab/unit#Percent,1763449,=,1,False,=,,Residual Activity,%,,77.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,77.0
1110,,12225944,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL203644,,CHEMBL203644,,False,http://qudt.org/vocab/unit#Percent,1763450,=,1,False,=,,Residual Activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,103.0
1111,,12225945,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL379787,,CHEMBL379787,,False,http://qudt.org/vocab/unit#Percent,1763451,=,1,False,=,,Residual Activity,%,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,13.0
1112,,12225946,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL188762,,CHEMBL188762,,False,http://qudt.org/vocab/unit#Percent,1763452,=,1,False,=,,Residual Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,96.0
1113,,12225947,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL573578,,CHEMBL573578,,False,http://qudt.org/vocab/unit#Percent,1763453,=,1,False,=,,Residual Activity,%,,105.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,105.0
1114,,12225948,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL471901,,CHEMBL471901,,False,http://qudt.org/vocab/unit#Percent,1763454,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1115,,12225949,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL86943,,CHEMBL86943,,False,http://qudt.org/vocab/unit#Percent,1763455,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1116,,12225950,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1186409,,CHEMBL1186409,,False,http://qudt.org/vocab/unit#Percent,1763456,=,1,False,=,,Residual Activity,%,,113.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,113.0
1117,,12225951,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL13045,CHELERYTHRINE,CHEMBL13045,,False,http://qudt.org/vocab/unit#Percent,1763457,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1118,,12225952,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL210833,,CHEMBL210833,,False,http://qudt.org/vocab/unit#Percent,1763458,=,1,False,=,,Residual Activity,%,,54.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,54.0
1119,,12225953,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL21156,,CHEMBL21156,,False,http://qudt.org/vocab/unit#Percent,1763459,=,1,False,=,,Residual Activity,%,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,61.0
1120,,12225954,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL266325,,CHEMBL266325,,False,http://qudt.org/vocab/unit#Percent,1763460,=,1,False,=,,Residual Activity,%,,119.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,119.0
1121,,12225955,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7939,CGP-53353,CHEMBL7939,,False,http://qudt.org/vocab/unit#Percent,1763461,=,1,False,=,,Residual Activity,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,99.0
1122,,12225956,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL596380,,CHEMBL596380,,False,http://qudt.org/vocab/unit#Percent,1763462,=,1,False,=,,Residual Activity,%,,116.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,116.0
1123,,12225957,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL101683,,CHEMBL101683,,False,http://qudt.org/vocab/unit#Percent,1763463,=,1,False,=,,Residual Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,95.0
1124,,12225958,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL331237,TRICIRIBINE,CHEMBL331237,,False,http://qudt.org/vocab/unit#Percent,1763464,=,1,False,=,,Residual Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,100.0
1125,,12225959,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL35820,,CHEMBL35820,,False,http://qudt.org/vocab/unit#Percent,1763465,=,1,False,=,,Residual Activity,%,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,49.0
1126,,12225960,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL377193,,CHEMBL377193,,False,http://qudt.org/vocab/unit#Percent,1763466,=,1,False,=,,Residual Activity,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,50.0
1127,,12225961,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL473773,,CHEMBL473773,,False,http://qudt.org/vocab/unit#Percent,1763467,=,1,False,=,,Residual Activity,%,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,44.0
1128,,12225962,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL102346,,CHEMBL102346,,False,http://qudt.org/vocab/unit#Percent,1763468,=,1,False,=,,Residual Activity,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,87.0
1129,,12225963,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL366266,,CHEMBL366266,,False,http://qudt.org/vocab/unit#Percent,1763469,=,1,False,=,,Residual Activity,%,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,45.0
1130,,12225964,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261454,,CHEMBL261454,,False,http://qudt.org/vocab/unit#Percent,1763470,=,1,False,=,,Residual Activity,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,87.0
1131,,12225965,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1289494,TIVOZANIB,CHEMBL1289494,,False,http://qudt.org/vocab/unit#Percent,1763471,=,1,False,=,,Residual Activity,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,85.0
1132,,12225966,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL258844,,CHEMBL258844,,False,http://qudt.org/vocab/unit#Percent,1763472,=,1,False,=,,Residual Activity,%,,106.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,106.0
1133,,12225967,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL104468,,CHEMBL104468,,False,http://qudt.org/vocab/unit#Percent,1763473,=,1,False,=,,Residual Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,96.0
1134,,12225968,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261849,GW632580X,CHEMBL261849,,False,http://qudt.org/vocab/unit#Percent,1763474,=,1,False,=,,Residual Activity,%,,106.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,106.0
1135,,12225969,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL596674,,CHEMBL596674,,False,http://qudt.org/vocab/unit#Percent,1763475,=,1,False,=,,Residual Activity,%,,101.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,101.0
1136,,12225970,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL120077,,CHEMBL120077,,False,http://qudt.org/vocab/unit#Percent,1763476,=,1,False,=,,Residual Activity,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,76.0
1137,,12225971,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL413,SIROLIMUS,CHEMBL413,,False,http://qudt.org/vocab/unit#Percent,1763477,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1138,,12225972,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL226838,,CHEMBL226838,,False,http://qudt.org/vocab/unit#Percent,1763478,=,1,False,=,,Residual Activity,%,,108.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,108.0
1139,,12225973,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218925,,CHEMBL2218925,,False,http://qudt.org/vocab/unit#Percent,1763479,=,1,False,=,,Residual Activity,%,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,82.0
1140,,12225974,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1398474,,CHEMBL1398474,,False,http://qudt.org/vocab/unit#Percent,1763480,=,1,False,=,,Residual Activity,%,,118.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,118.0
1141,,12225975,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(=O)c1ccc(N2CCOCC2)cc1O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1317546,,CHEMBL1317546,,False,http://qudt.org/vocab/unit#Percent,1763481,=,1,False,=,,Residual Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,95.0
1142,,12225976,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL302449,GO-6976,CHEMBL302449,,False,http://qudt.org/vocab/unit#Percent,1763482,=,1,False,=,,Residual Activity,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,-1.0
1143,,12225977,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218929,,CHEMBL2218929,,False,http://qudt.org/vocab/unit#Percent,1763483,=,1,False,=,,Residual Activity,%,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,3.0
1144,,12225978,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218930,,CHEMBL2218930,,False,http://qudt.org/vocab/unit#Percent,1763484,=,1,False,=,,Residual Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,96.0
1145,,12225979,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc2c(-c3ccncc3)c[nH]c2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL380071,,CHEMBL380071,,False,http://qudt.org/vocab/unit#Percent,1763485,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1146,,12225980,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(C=C(C#N)C#N)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL77456,TYRPHOSTIN 1,CHEMBL77456,,False,http://qudt.org/vocab/unit#Percent,1763486,=,1,False,=,,Residual Activity,%,,113.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,113.0
1147,,12225981,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL276711,SEMAXANIB,CHEMBL276711,,False,http://qudt.org/vocab/unit#Percent,1763487,=,1,False,=,,Residual Activity,%,,39.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,39.0
1148,,12225982,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1c2ccccc2-c2nc3nnnn3nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL599894,,CHEMBL599894,,False,http://qudt.org/vocab/unit#Percent,1763488,=,1,False,=,,Residual Activity,%,,129.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,129.0
1149,,12225983,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL573339,PI-103,CHEMBL573339,,False,http://qudt.org/vocab/unit#Percent,1763489,=,1,False,=,,Residual Activity,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,99.0
1150,,12225984,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261491,,CHEMBL261491,,False,http://qudt.org/vocab/unit#Percent,1763490,=,1,False,=,,Residual Activity,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,84.0
1151,,12225985,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL47940,,CHEMBL47940,,False,http://qudt.org/vocab/unit#Percent,1763491,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1152,,12225986,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL235641,,CHEMBL235641,,False,http://qudt.org/vocab/unit#Percent,1763492,=,1,False,=,,Residual Activity,%,,41.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,41.0
1153,,12225987,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218931,,CHEMBL2218931,,False,http://qudt.org/vocab/unit#Percent,1763493,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1154,,12225988,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL56543,,CHEMBL56543,,False,http://qudt.org/vocab/unit#Percent,1763494,=,1,False,=,,Residual Activity,%,,117.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,117.0
1155,,12225989,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL92461,,CHEMBL92461,,False,http://qudt.org/vocab/unit#Percent,1763495,=,1,False,=,,Residual Activity,%,,124.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,124.0
1156,,12225990,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL382590,ANILINOQUINAZOLINE1,CHEMBL382590,,False,http://qudt.org/vocab/unit#Percent,1763496,=,1,False,=,,Residual Activity,%,,115.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,115.0
1157,,12225991,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261131,DIACYLGLYCEROL KINASE INHIBITOR II,CHEMBL261131,,False,http://qudt.org/vocab/unit#Percent,1763497,=,1,False,=,,Residual Activity,%,,105.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,105.0
1158,,12225992,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL406375,,CHEMBL406375,,False,http://qudt.org/vocab/unit#Percent,1763498,=,1,False,=,,Residual Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,91.0
1159,,12225993,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL98350,LY-294002,CHEMBL98350,,False,http://qudt.org/vocab/unit#Percent,1763499,=,1,False,=,,Residual Activity,%,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,89.0
1160,,12225994,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218932,,CHEMBL2218932,,False,http://qudt.org/vocab/unit#Percent,1763500,=,1,False,=,,Residual Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,75.0
1161,,12225995,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL608533,MIDOSTAURIN,CHEMBL608533,,False,http://qudt.org/vocab/unit#Percent,1763501,=,1,False,=,,Residual Activity,%,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,53.0
1162,,12225996,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL76589,,CHEMBL76589,,False,http://qudt.org/vocab/unit#Percent,1763502,=,1,False,=,,Residual Activity,%,,109.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,109.0
1163,,12225997,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL478980,,CHEMBL478980,,False,http://qudt.org/vocab/unit#Percent,1763503,=,1,False,=,,Residual Activity,%,,117.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,117.0
1164,,12225998,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL483847,,CHEMBL483847,,False,http://qudt.org/vocab/unit#Percent,1763504,=,1,False,=,,Residual Activity,%,,115.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,115.0
1165,,12225999,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL328710,,CHEMBL328710,,False,http://qudt.org/vocab/unit#Percent,1763505,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1166,,12226000,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL479533,HERBIMYCIN,CHEMBL479533,,False,http://qudt.org/vocab/unit#Percent,1763506,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1167,,12226001,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1363184,,CHEMBL1363184,,False,http://qudt.org/vocab/unit#Percent,1763507,=,1,False,=,,Residual Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,93.0
1168,,12226002,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218934,,CHEMBL2218934,,False,http://qudt.org/vocab/unit#Percent,1763508,=,1,False,=,,Residual Activity,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,104.0
1169,,12226003,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL97771,,CHEMBL97771,,False,http://qudt.org/vocab/unit#Percent,1763509,=,1,False,=,,Residual Activity,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,98.0
1170,,12226004,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cc2ncc(-c3ccccc3)nc2cc1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7724,AG1295,CHEMBL7724,,False,http://qudt.org/vocab/unit#Percent,1763510,=,1,False,=,,Residual Activity,%,,121.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,121.0
1171,,12226005,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL383899,ANILINOPYRIMIDINE1,CHEMBL383899,,False,http://qudt.org/vocab/unit#Percent,1763511,=,1,False,=,,Residual Activity,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,50.0
1172,,12226006,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7463,GF-109203,CHEMBL7463,,False,http://qudt.org/vocab/unit#Percent,1763512,=,1,False,=,,Residual Activity,%,,121.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,121.0
1173,,12226007,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL563845,,CHEMBL563845,,False,http://qudt.org/vocab/unit#Percent,1763513,=,1,False,=,,Residual Activity,%,,127.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,127.0
1174,,12226008,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218935,,CHEMBL2218935,,False,http://qudt.org/vocab/unit#Percent,1763514,=,1,False,=,,Residual Activity,%,,124.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,124.0
1175,,12226009,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218936,,CHEMBL2218936,,False,http://qudt.org/vocab/unit#Percent,1763515,=,1,False,=,,Residual Activity,%,,64.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,64.0
1176,,12226010,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1231533,,CHEMBL1231533,,False,http://qudt.org/vocab/unit#Percent,1763516,=,1,False,=,,Residual Activity,%,,111.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,111.0
1177,,12226011,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL13485,SU-11652,CHEMBL13485,,False,http://qudt.org/vocab/unit#Percent,1763517,=,1,False,=,,Residual Activity,%,,22.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,22.0
1178,,12226012,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncc(-c3ccccc3)nc2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL71191,,CHEMBL71191,,False,http://qudt.org/vocab/unit#Percent,1763518,=,1,False,=,,Residual Activity,%,,115.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,115.0
1179,,12226013,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL388978,STAUROSPORINE,CHEMBL388978,,False,http://qudt.org/vocab/unit#Percent,1763519,=,1,False,=,,Residual Activity,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,1.0
1180,,12226014,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL28324,,CHEMBL28324,,False,http://qudt.org/vocab/unit#Percent,1763520,=,1,False,=,,Residual Activity,%,,105.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,105.0
1181,,12226015,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL191003,JNJ-7706621,CHEMBL191003,,False,http://qudt.org/vocab/unit#Percent,1763521,=,1,False,=,,Residual Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,96.0
1182,,12226016,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL64758,,CHEMBL64758,,False,http://qudt.org/vocab/unit#Percent,1763522,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1183,,12226017,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL559147,Y-27632,CHEMBL559147,,False,http://qudt.org/vocab/unit#Percent,1763523,=,1,False,=,,Residual Activity,%,,101.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,101.0
1184,,12226018,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL605003,,CHEMBL605003,,False,http://qudt.org/vocab/unit#Percent,1763524,=,1,False,=,,Residual Activity,%,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,19.0
1185,,12226019,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL235658,,CHEMBL235658,,False,http://qudt.org/vocab/unit#Percent,1763525,=,1,False,=,,Residual Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,93.0
1186,,12226020,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL111364,,CHEMBL111364,,False,http://qudt.org/vocab/unit#Percent,1763526,=,1,False,=,,Residual Activity,%,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,23.0
1187,,12226021,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL10,SB-203580,CHEMBL10,,False,http://qudt.org/vocab/unit#Percent,1763527,=,1,False,=,,Residual Activity,%,,113.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,113.0
1188,,12226022,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL222102,KU-55933,CHEMBL222102,,False,http://qudt.org/vocab/unit#Percent,1763528,=,1,False,=,,Residual Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,100.0
1189,,12226023,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL126077,INDIRUBIN-3-MONOXIME,CHEMBL126077,,False,http://qudt.org/vocab/unit#Percent,1763529,=,1,False,=,,Residual Activity,%,,41.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,41.0
1190,,12226024,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1331734,,CHEMBL1331734,,False,http://qudt.org/vocab/unit#Percent,1763530,=,1,False,=,,Residual Activity,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,86.0
1191,,12226025,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL259551,,CHEMBL259551,,False,http://qudt.org/vocab/unit#Percent,1763531,=,1,False,=,,Residual Activity,%,,66.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,66.0
1192,,12226026,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL359482,,CHEMBL359482,,False,http://qudt.org/vocab/unit#Percent,1763532,=,1,False,=,,Residual Activity,%,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,45.0
1193,,12226027,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL210618,,CHEMBL210618,,False,http://qudt.org/vocab/unit#Percent,1763533,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1194,,12226028,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL91730,,CHEMBL91730,,False,http://qudt.org/vocab/unit#Percent,1763534,=,1,False,=,,Residual Activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,103.0
1195,,12226029,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL38380,FASUDIL,CHEMBL38380,,False,http://qudt.org/vocab/unit#Percent,1763535,=,1,False,=,,Residual Activity,%,,110.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,110.0
1196,,12226030,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1221601,,CHEMBL1221601,,False,http://qudt.org/vocab/unit#Percent,1763536,=,1,False,=,,Residual Activity,%,,112.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,112.0
1197,,12226031,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL403183,,CHEMBL403183,,False,http://qudt.org/vocab/unit#Percent,1763537,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1198,,12226032,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL290904,,CHEMBL290904,,False,http://qudt.org/vocab/unit#Percent,1763538,=,1,False,=,,Residual Activity,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,85.0
1199,,12226033,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218938,,CHEMBL2218938,,False,http://qudt.org/vocab/unit#Percent,1763539,=,1,False,=,,Residual Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,75.0
1200,,12226034,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL413188,ISOGRANULATIMIDE,CHEMBL413188,,False,http://qudt.org/vocab/unit#Percent,1763540,=,1,False,=,,Residual Activity,%,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,61.0
1201,,12226035,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL281948,K-252A,CHEMBL281948,,False,http://qudt.org/vocab/unit#Percent,1763541,=,1,False,=,,Residual Activity,%,,-2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,-2.0
1202,,12226036,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL35482,,CHEMBL35482,,False,http://qudt.org/vocab/unit#Percent,1763542,=,1,False,=,,Residual Activity,%,,109.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,109.0
1203,,12226037,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL304428,,CHEMBL304428,,False,http://qudt.org/vocab/unit#Percent,1763543,=,1,False,=,,Residual Activity,%,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,38.0
1204,,12226038,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL50894,ALSTERPAULLONE,CHEMBL50894,,False,http://qudt.org/vocab/unit#Percent,1763544,=,1,False,=,,Residual Activity,%,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,78.0
1205,,12226039,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL83980,BOHEMINE,CHEMBL83980,,False,http://qudt.org/vocab/unit#Percent,1763545,=,1,False,=,,Residual Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,93.0
1206,,12226040,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL408982,,CHEMBL408982,,False,http://qudt.org/vocab/unit#Percent,1763546,=,1,False,=,,Residual Activity,%,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,89.0
1207,,12226041,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL602937,FASCAPLYSIN,CHEMBL602937,,False,http://qudt.org/vocab/unit#Percent,1763547,=,1,False,=,,Residual Activity,%,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,79.0
1208,,12226042,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL404941,,CHEMBL404941,,False,http://qudt.org/vocab/unit#Percent,1763548,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1209,,12226043,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL296586,KENPAULLONE,CHEMBL296586,,False,http://qudt.org/vocab/unit#Percent,1763549,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1210,,12226044,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL17331,PD-169316,CHEMBL17331,,False,http://qudt.org/vocab/unit#Percent,1763550,=,1,False,=,,Residual Activity,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,104.0
1211,,12226045,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL36450,,CHEMBL36450,,False,http://qudt.org/vocab/unit#Percent,1763551,=,1,False,=,,Residual Activity,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,104.0
1212,,12226046,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL260138,ALSTERPAULLONE 2,CHEMBL260138,,False,http://qudt.org/vocab/unit#Percent,1763552,=,1,False,=,,Residual Activity,%,,62.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,62.0
1213,,12226047,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261425,,CHEMBL261425,,False,http://qudt.org/vocab/unit#Percent,1763553,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1214,,12226048,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL179583,,CHEMBL179583,,False,http://qudt.org/vocab/unit#Percent,1763554,=,1,False,=,,Residual Activity,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,80.0
1215,,12226049,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1sc(=O)n(Cc2ccccc2)c1=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL284861,,CHEMBL284861,,False,http://qudt.org/vocab/unit#Percent,1763555,=,1,False,=,,Residual Activity,%,,74.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,74.0
1216,,12226050,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL257167,,CHEMBL257167,,False,http://qudt.org/vocab/unit#Percent,1763556,=,1,False,=,,Residual Activity,%,,46.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,46.0
1217,,12226051,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL155333,,CHEMBL155333,,False,http://qudt.org/vocab/unit#Percent,1763557,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1218,,12226052,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL274064,SB-220025,CHEMBL274064,,False,http://qudt.org/vocab/unit#Percent,1763558,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1219,,12226053,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL313417,,CHEMBL313417,,False,http://qudt.org/vocab/unit#Percent,1763559,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1220,,12226054,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL75680,ALOISINE A,CHEMBL75680,,False,http://qudt.org/vocab/unit#Percent,1763560,=,1,False,=,,Residual Activity,%,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,71.0
1221,,12226055,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL367625,,CHEMBL367625,,False,http://qudt.org/vocab/unit#Percent,1763561,=,1,False,=,,Residual Activity,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,85.0
1222,,12226056,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL311228,,CHEMBL311228,,False,http://qudt.org/vocab/unit#Percent,1763562,=,1,False,=,,Residual Activity,%,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,44.0
1223,,12226057,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL288064,,CHEMBL288064,,False,http://qudt.org/vocab/unit#Percent,1763563,=,1,False,=,,Residual Activity,%,,55.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,55.0
1224,,12226058,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1802727,,CHEMBL1802727,,False,http://qudt.org/vocab/unit#Percent,1763564,=,1,False,=,,Residual Activity,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,16.0
1225,,12226059,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218939,,CHEMBL2218939,,False,http://qudt.org/vocab/unit#Percent,1763565,=,1,False,=,,Residual Activity,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,80.0
1226,,12226060,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL23327,PURVALANOLA,CHEMBL23327,,False,http://qudt.org/vocab/unit#Percent,1763566,=,1,False,=,,Residual Activity,%,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,45.0
1227,,12226061,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1076555,,CHEMBL1076555,,False,http://qudt.org/vocab/unit#Percent,1763567,=,1,False,=,,Residual Activity,%,,108.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,108.0
1228,,12226062,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL306498,ALOISINE,CHEMBL306498,,False,http://qudt.org/vocab/unit#Percent,1763568,=,1,False,=,,Residual Activity,%,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,79.0
1229,,12226063,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261720,,CHEMBL261720,,False,http://qudt.org/vocab/unit#Percent,1763569,=,1,False,=,,Residual Activity,%,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,8.0
1230,,12226064,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL80713,,CHEMBL80713,,False,http://qudt.org/vocab/unit#Percent,1763570,=,1,False,=,,Residual Activity,%,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,71.0
1231,,12226065,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL259850,,CHEMBL259850,,False,http://qudt.org/vocab/unit#Percent,1763571,=,1,False,=,,Residual Activity,%,,72.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,72.0
1232,,12226066,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1c2ccccc2c2c3c(cccc13)N=N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1725279,SP-600125,CHEMBL1725279,,False,http://qudt.org/vocab/unit#Percent,1763572,=,1,False,=,,Residual Activity,%,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,36.0
1233,,12226067,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL404939,,CHEMBL404939,,False,http://qudt.org/vocab/unit#Percent,1763573,=,1,False,=,,Residual Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,75.0
1234,,12226068,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL405759,,CHEMBL405759,,False,http://qudt.org/vocab/unit#Percent,1763574,=,1,False,=,,Residual Activity,%,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,79.0
1235,,12226069,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL286721,AMINOPURVALANOL,CHEMBL286721,,False,http://qudt.org/vocab/unit#Percent,1763575,=,1,False,=,,Residual Activity,%,,39.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,39.0
1236,,12226070,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1n[nH]c2nc3ccccc3nc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL259389,QUINOXALINE1,CHEMBL259389,,False,http://qudt.org/vocab/unit#Percent,1763576,=,1,False,=,,Residual Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,93.0
1237,,12226071,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1802728,,CHEMBL1802728,,False,http://qudt.org/vocab/unit#Percent,1763577,=,1,False,=,,Residual Activity,%,,57.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,57.0
1238,,12226072,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL409450,6BIO,CHEMBL409450,,False,http://qudt.org/vocab/unit#Percent,1763578,=,1,False,=,,Residual Activity,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,35.0
1239,,12226073,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1802485,,CHEMBL1802485,,False,http://qudt.org/vocab/unit#Percent,1763579,=,1,False,=,,Residual Activity,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,76.0
1240,,12226074,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218940,,CHEMBL2218940,,False,http://qudt.org/vocab/unit#Percent,1763580,=,1,False,=,,Residual Activity,%,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,83.0
1241,,12226075,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL104264,,CHEMBL104264,,False,http://qudt.org/vocab/unit#Percent,1763581,=,1,False,=,,Residual Activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,103.0
1242,,12226076,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1182777,,CHEMBL1182777,,False,http://qudt.org/vocab/unit#Percent,1763582,=,1,False,=,,Residual Activity,%,,105.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,105.0
1243,,12226077,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL478629,DORSOMORPHIN,CHEMBL478629,,False,http://qudt.org/vocab/unit#Percent,1763583,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1244,,12226078,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL410456,,CHEMBL410456,,False,http://qudt.org/vocab/unit#Percent,1763584,=,1,False,=,,Residual Activity,%,,112.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,112.0
1245,,12226079,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL258721,,CHEMBL258721,,False,http://qudt.org/vocab/unit#Percent,1763585,=,1,False,=,,Residual Activity,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,104.0
1246,,12226080,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218941,,CHEMBL2218941,,False,http://qudt.org/vocab/unit#Percent,1763586,=,1,False,=,,Residual Activity,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,86.0
1247,,12226081,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL191384,,CHEMBL191384,,False,http://qudt.org/vocab/unit#Percent,1763587,=,1,False,=,,Residual Activity,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,80.0
1248,,12226082,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1240885,,CHEMBL1240885,,False,http://qudt.org/vocab/unit#Percent,1763588,=,1,False,=,,Residual Activity,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,88.0
1249,,12226083,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL278724,SB-202474,CHEMBL278724,,False,http://qudt.org/vocab/unit#Percent,1763589,=,1,False,=,,Residual Activity,%,,109.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,109.0
1250,,12226084,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL258805,SU-9516,CHEMBL258805,,False,http://qudt.org/vocab/unit#Percent,1763590,=,1,False,=,,Residual Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,91.0
1251,,12226085,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL270724,,CHEMBL270724,,False,http://qudt.org/vocab/unit#Percent,1763591,=,1,False,=,,Residual Activity,%,,114.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,114.0
1252,,12226086,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL221271,,CHEMBL221271,,False,http://qudt.org/vocab/unit#Percent,1763592,=,1,False,=,,Residual Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,100.0
1253,,12226087,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL272629,,CHEMBL272629,,False,http://qudt.org/vocab/unit#Percent,1763593,=,1,False,=,,Residual Activity,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,87.0
1254,,12226088,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL233001,GW620972X,CHEMBL233001,,False,http://qudt.org/vocab/unit#Percent,1763594,=,1,False,=,,Residual Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,96.0
1255,,12226089,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL522502,,CHEMBL522502,,False,http://qudt.org/vocab/unit#Percent,1763595,=,1,False,=,,Residual Activity,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,88.0
1256,,12226090,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL278041,SB-202190,CHEMBL278041,,False,http://qudt.org/vocab/unit#Percent,1763596,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1257,,12226091,[],CHEMBL2219221,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL200381,,CHEMBL200381,,False,http://qudt.org/vocab/unit#Percent,1763597,=,1,False,=,,Residual Activity,%,,64.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,64.0
1258,,12226092,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218926,,CHEMBL2218926,,False,http://qudt.org/vocab/unit#Percent,1763440,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1259,,12226093,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL266487,RO-316233,CHEMBL266487,,False,http://qudt.org/vocab/unit#Percent,1763441,=,1,False,=,,Residual Activity,%,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,27.0
1260,,12226094,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL387187,,CHEMBL387187,,False,http://qudt.org/vocab/unit#Percent,1763442,=,1,False,=,,Residual Activity,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,80.0
1261,,12226095,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL439259,,CHEMBL439259,,False,http://qudt.org/vocab/unit#Percent,1763443,=,1,False,=,,Residual Activity,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,86.0
1262,,12226096,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL53753,,CHEMBL53753,,False,http://qudt.org/vocab/unit#Percent,1763444,=,1,False,=,,Residual Activity,%,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,61.0
1263,,12226097,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ncnc2c1cnn2-c1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL65063,,CHEMBL65063,,False,http://qudt.org/vocab/unit#Percent,1763445,=,1,False,=,,Residual Activity,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,84.0
1264,,12226098,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL104279,,CHEMBL104279,,False,http://qudt.org/vocab/unit#Percent,1763446,=,1,False,=,,Residual Activity,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,-1.0
1265,,12226099,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7917,TYRPHOSTIN AG-1478,CHEMBL7917,,False,http://qudt.org/vocab/unit#Percent,1763447,=,1,False,=,,Residual Activity,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,5.0
1266,,12226100,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218927,,CHEMBL2218927,,False,http://qudt.org/vocab/unit#Percent,1763448,=,1,False,=,,Residual Activity,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,70.0
1267,,12226101,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL174426,,CHEMBL174426,,False,http://qudt.org/vocab/unit#Percent,1763449,=,1,False,=,,Residual Activity,%,,46.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,46.0
1268,,12228640,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL203644,,CHEMBL203644,,False,http://qudt.org/vocab/unit#Percent,1763450,=,1,False,=,,Residual Activity,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,98.0
1269,,12228641,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL379787,,CHEMBL379787,,False,http://qudt.org/vocab/unit#Percent,1763451,=,1,False,=,,Residual Activity,%,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,15.0
1270,,12228642,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL188762,,CHEMBL188762,,False,http://qudt.org/vocab/unit#Percent,1763452,=,1,False,=,,Residual Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,91.0
1271,,12228643,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL573578,,CHEMBL573578,,False,http://qudt.org/vocab/unit#Percent,1763453,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1272,,12228644,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL471901,,CHEMBL471901,,False,http://qudt.org/vocab/unit#Percent,1763454,=,1,False,=,,Residual Activity,%,,51.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,51.0
1273,,12228645,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL86943,,CHEMBL86943,,False,http://qudt.org/vocab/unit#Percent,1763455,=,1,False,=,,Residual Activity,%,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,49.0
1274,,12228646,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1186409,,CHEMBL1186409,,False,http://qudt.org/vocab/unit#Percent,1763456,=,1,False,=,,Residual Activity,%,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,78.0
1275,,12228647,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL13045,CHELERYTHRINE,CHEMBL13045,,False,http://qudt.org/vocab/unit#Percent,1763457,=,1,False,=,,Residual Activity,%,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,83.0
1276,,12228648,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL210833,,CHEMBL210833,,False,http://qudt.org/vocab/unit#Percent,1763458,=,1,False,=,,Residual Activity,%,,52.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,52.0
1277,,12228649,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL21156,,CHEMBL21156,,False,http://qudt.org/vocab/unit#Percent,1763459,=,1,False,=,,Residual Activity,%,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,53.0
1278,,12228650,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL266325,,CHEMBL266325,,False,http://qudt.org/vocab/unit#Percent,1763460,=,1,False,=,,Residual Activity,%,,108.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,108.0
1279,,12228651,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7939,CGP-53353,CHEMBL7939,,False,http://qudt.org/vocab/unit#Percent,1763461,=,1,False,=,,Residual Activity,%,,110.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,110.0
1280,,12228652,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL596380,,CHEMBL596380,,False,http://qudt.org/vocab/unit#Percent,1763462,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1281,,12228653,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL101683,,CHEMBL101683,,False,http://qudt.org/vocab/unit#Percent,1763463,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1282,,12228654,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL331237,TRICIRIBINE,CHEMBL331237,,False,http://qudt.org/vocab/unit#Percent,1763464,=,1,False,=,,Residual Activity,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,88.0
1283,,12228655,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL35820,,CHEMBL35820,,False,http://qudt.org/vocab/unit#Percent,1763465,=,1,False,=,,Residual Activity,%,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,18.0
1284,,12228656,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL377193,,CHEMBL377193,,False,http://qudt.org/vocab/unit#Percent,1763466,=,1,False,=,,Residual Activity,%,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,20.0
1285,,12228657,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL473773,,CHEMBL473773,,False,http://qudt.org/vocab/unit#Percent,1763467,=,1,False,=,,Residual Activity,%,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,17.0
1286,,12228658,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL102346,,CHEMBL102346,,False,http://qudt.org/vocab/unit#Percent,1763468,=,1,False,=,,Residual Activity,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,98.0
1287,,12228659,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL366266,,CHEMBL366266,,False,http://qudt.org/vocab/unit#Percent,1763469,=,1,False,=,,Residual Activity,%,,32.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,32.0
1288,,12228660,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261454,,CHEMBL261454,,False,http://qudt.org/vocab/unit#Percent,1763470,=,1,False,=,,Residual Activity,%,,101.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,101.0
1289,,12228661,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1289494,TIVOZANIB,CHEMBL1289494,,False,http://qudt.org/vocab/unit#Percent,1763471,=,1,False,=,,Residual Activity,%,,47.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,47.0
1290,,12228662,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL258844,,CHEMBL258844,,False,http://qudt.org/vocab/unit#Percent,1763472,=,1,False,=,,Residual Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,93.0
1291,,12228663,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL104468,,CHEMBL104468,,False,http://qudt.org/vocab/unit#Percent,1763473,=,1,False,=,,Residual Activity,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,88.0
1292,,12228664,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261849,GW632580X,CHEMBL261849,,False,http://qudt.org/vocab/unit#Percent,1763474,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1293,,12228665,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL596674,,CHEMBL596674,,False,http://qudt.org/vocab/unit#Percent,1763475,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1294,,12228666,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL120077,,CHEMBL120077,,False,http://qudt.org/vocab/unit#Percent,1763476,=,1,False,=,,Residual Activity,%,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,34.0
1295,,12228667,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL413,SIROLIMUS,CHEMBL413,,False,http://qudt.org/vocab/unit#Percent,1763477,=,1,False,=,,Residual Activity,%,,154.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,154.0
1296,,12228668,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL226838,,CHEMBL226838,,False,http://qudt.org/vocab/unit#Percent,1763478,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1297,,12228669,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218925,,CHEMBL2218925,,False,http://qudt.org/vocab/unit#Percent,1763479,=,1,False,=,,Residual Activity,%,,77.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,77.0
1298,,12228670,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1398474,,CHEMBL1398474,,False,http://qudt.org/vocab/unit#Percent,1763480,=,1,False,=,,Residual Activity,%,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,107.0
1299,,12228671,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(=O)c1ccc(N2CCOCC2)cc1O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1317546,,CHEMBL1317546,,False,http://qudt.org/vocab/unit#Percent,1763481,=,1,False,=,,Residual Activity,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,98.0
1300,,12228672,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL302449,GO-6976,CHEMBL302449,,False,http://qudt.org/vocab/unit#Percent,1763482,=,1,False,=,,Residual Activity,%,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,4.0
1301,,12228673,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218929,,CHEMBL2218929,,False,http://qudt.org/vocab/unit#Percent,1763483,=,1,False,=,,Residual Activity,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,1.0
1302,,12228674,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218930,,CHEMBL2218930,,False,http://qudt.org/vocab/unit#Percent,1763484,=,1,False,=,,Residual Activity,%,,106.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,106.0
1303,,12228675,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc2c(-c3ccncc3)c[nH]c2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL380071,,CHEMBL380071,,False,http://qudt.org/vocab/unit#Percent,1763485,=,1,False,=,,Residual Activity,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,99.0
1304,,12228676,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(C=C(C#N)C#N)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL77456,TYRPHOSTIN 1,CHEMBL77456,,False,http://qudt.org/vocab/unit#Percent,1763486,=,1,False,=,,Residual Activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,103.0
1305,,12228677,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL276711,SEMAXANIB,CHEMBL276711,,False,http://qudt.org/vocab/unit#Percent,1763487,=,1,False,=,,Residual Activity,%,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,13.0
1306,,12228678,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1c2ccccc2-c2nc3nnnn3nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL599894,,CHEMBL599894,,False,http://qudt.org/vocab/unit#Percent,1763488,=,1,False,=,,Residual Activity,%,,108.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,108.0
1307,,12228679,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL573339,PI-103,CHEMBL573339,,False,http://qudt.org/vocab/unit#Percent,1763489,=,1,False,=,,Residual Activity,%,,102.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,102.0
1308,,12228680,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261491,,CHEMBL261491,,False,http://qudt.org/vocab/unit#Percent,1763490,=,1,False,=,,Residual Activity,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,86.0
1309,,12228681,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL47940,,CHEMBL47940,,False,http://qudt.org/vocab/unit#Percent,1763491,=,1,False,=,,Residual Activity,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,87.0
1310,,12228682,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL235641,,CHEMBL235641,,False,http://qudt.org/vocab/unit#Percent,1763492,=,1,False,=,,Residual Activity,%,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,15.0
1311,,12228683,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218931,,CHEMBL2218931,,False,http://qudt.org/vocab/unit#Percent,1763493,=,1,False,=,,Residual Activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,103.0
1312,,12228684,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL56543,,CHEMBL56543,,False,http://qudt.org/vocab/unit#Percent,1763494,=,1,False,=,,Residual Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,100.0
1313,,12228685,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL92461,,CHEMBL92461,,False,http://qudt.org/vocab/unit#Percent,1763495,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1314,,12228686,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL382590,ANILINOQUINAZOLINE1,CHEMBL382590,,False,http://qudt.org/vocab/unit#Percent,1763496,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1315,,12228687,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261131,DIACYLGLYCEROL KINASE INHIBITOR II,CHEMBL261131,,False,http://qudt.org/vocab/unit#Percent,1763497,=,1,False,=,,Residual Activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,103.0
1316,,12228688,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL406375,,CHEMBL406375,,False,http://qudt.org/vocab/unit#Percent,1763498,=,1,False,=,,Residual Activity,%,,68.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,68.0
1317,,12228689,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL98350,LY-294002,CHEMBL98350,,False,http://qudt.org/vocab/unit#Percent,1763499,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1318,,12228690,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218932,,CHEMBL2218932,,False,http://qudt.org/vocab/unit#Percent,1763500,=,1,False,=,,Residual Activity,%,,51.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,51.0
1319,,12228691,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL608533,MIDOSTAURIN,CHEMBL608533,,False,http://qudt.org/vocab/unit#Percent,1763501,=,1,False,=,,Residual Activity,%,,47.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,47.0
1320,,12228692,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL76589,,CHEMBL76589,,False,http://qudt.org/vocab/unit#Percent,1763502,=,1,False,=,,Residual Activity,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,99.0
1321,,12228693,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL478980,,CHEMBL478980,,False,http://qudt.org/vocab/unit#Percent,1763503,=,1,False,=,,Residual Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,93.0
1322,,12228694,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL483847,,CHEMBL483847,,False,http://qudt.org/vocab/unit#Percent,1763504,=,1,False,=,,Residual Activity,%,,115.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,115.0
1323,,12228695,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL328710,,CHEMBL328710,,False,http://qudt.org/vocab/unit#Percent,1763505,=,1,False,=,,Residual Activity,%,,46.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,46.0
1324,,12228696,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL479533,HERBIMYCIN,CHEMBL479533,,False,http://qudt.org/vocab/unit#Percent,1763506,=,1,False,=,,Residual Activity,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,99.0
1325,,12228697,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1363184,,CHEMBL1363184,,False,http://qudt.org/vocab/unit#Percent,1763507,=,1,False,=,,Residual Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,96.0
1326,,12228698,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218934,,CHEMBL2218934,,False,http://qudt.org/vocab/unit#Percent,1763508,=,1,False,=,,Residual Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,91.0
1327,,12228699,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL97771,,CHEMBL97771,,False,http://qudt.org/vocab/unit#Percent,1763509,=,1,False,=,,Residual Activity,%,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,79.0
1328,,12228700,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cc2ncc(-c3ccccc3)nc2cc1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7724,AG1295,CHEMBL7724,,False,http://qudt.org/vocab/unit#Percent,1763510,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1329,,12228701,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL383899,ANILINOPYRIMIDINE1,CHEMBL383899,,False,http://qudt.org/vocab/unit#Percent,1763511,=,1,False,=,,Residual Activity,%,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,44.0
1330,,12228702,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL7463,GF-109203,CHEMBL7463,,False,http://qudt.org/vocab/unit#Percent,1763512,=,1,False,=,,Residual Activity,%,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,53.0
1331,,12228703,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL563845,,CHEMBL563845,,False,http://qudt.org/vocab/unit#Percent,1763513,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1332,,12228704,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218935,,CHEMBL2218935,,False,http://qudt.org/vocab/unit#Percent,1763514,=,1,False,=,,Residual Activity,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,80.0
1333,,12228705,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218936,,CHEMBL2218936,,False,http://qudt.org/vocab/unit#Percent,1763515,=,1,False,=,,Residual Activity,%,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,24.0
1334,,12228706,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1231533,,CHEMBL1231533,,False,http://qudt.org/vocab/unit#Percent,1763516,=,1,False,=,,Residual Activity,%,,106.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,106.0
1335,,12228707,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL13485,SU-11652,CHEMBL13485,,False,http://qudt.org/vocab/unit#Percent,1763517,=,1,False,=,,Residual Activity,%,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,7.0
1336,,12228708,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc2ncc(-c3ccccc3)nc2cc1OC,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL71191,,CHEMBL71191,,False,http://qudt.org/vocab/unit#Percent,1763518,=,1,False,=,,Residual Activity,%,,66.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,66.0
1337,,12228709,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL388978,STAUROSPORINE,CHEMBL388978,,False,http://qudt.org/vocab/unit#Percent,1763519,=,1,False,=,,Residual Activity,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,1.0
1338,,12228710,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL28324,,CHEMBL28324,,False,http://qudt.org/vocab/unit#Percent,1763520,=,1,False,=,,Residual Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,93.0
1339,,12228711,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL191003,JNJ-7706621,CHEMBL191003,,False,http://qudt.org/vocab/unit#Percent,1763521,=,1,False,=,,Residual Activity,%,,37.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,37.0
1340,,12228712,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL64758,,CHEMBL64758,,False,http://qudt.org/vocab/unit#Percent,1763522,=,1,False,=,,Residual Activity,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,76.0
1341,,12228713,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL559147,Y-27632,CHEMBL559147,,False,http://qudt.org/vocab/unit#Percent,1763523,=,1,False,=,,Residual Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,95.0
1342,,12228714,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL605003,,CHEMBL605003,,False,http://qudt.org/vocab/unit#Percent,1763524,=,1,False,=,,Residual Activity,%,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,17.0
1343,,12228715,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL235658,,CHEMBL235658,,False,http://qudt.org/vocab/unit#Percent,1763525,=,1,False,=,,Residual Activity,%,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,82.0
1344,,12228716,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL111364,,CHEMBL111364,,False,http://qudt.org/vocab/unit#Percent,1763526,=,1,False,=,,Residual Activity,%,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,13.0
1345,,12228717,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL10,SB-203580,CHEMBL10,,False,http://qudt.org/vocab/unit#Percent,1763527,=,1,False,=,,Residual Activity,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,86.0
1346,,12228718,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL222102,KU-55933,CHEMBL222102,,False,http://qudt.org/vocab/unit#Percent,1763528,=,1,False,=,,Residual Activity,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,98.0
1347,,12228719,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL126077,INDIRUBIN-3-MONOXIME,CHEMBL126077,,False,http://qudt.org/vocab/unit#Percent,1763529,=,1,False,=,,Residual Activity,%,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,6.0
1348,,12228720,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1331734,,CHEMBL1331734,,False,http://qudt.org/vocab/unit#Percent,1763530,=,1,False,=,,Residual Activity,%,,68.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,68.0
1349,,12228721,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL259551,,CHEMBL259551,,False,http://qudt.org/vocab/unit#Percent,1763531,=,1,False,=,,Residual Activity,%,,64.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,64.0
1350,,12228722,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL359482,,CHEMBL359482,,False,http://qudt.org/vocab/unit#Percent,1763532,=,1,False,=,,Residual Activity,%,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,12.0
1351,,12228723,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL210618,,CHEMBL210618,,False,http://qudt.org/vocab/unit#Percent,1763533,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1352,,12228724,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL91730,,CHEMBL91730,,False,http://qudt.org/vocab/unit#Percent,1763534,=,1,False,=,,Residual Activity,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,104.0
1353,,12228725,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL38380,FASUDIL,CHEMBL38380,,False,http://qudt.org/vocab/unit#Percent,1763535,=,1,False,=,,Residual Activity,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,99.0
1354,,12228726,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1221601,,CHEMBL1221601,,False,http://qudt.org/vocab/unit#Percent,1763536,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1355,,12228727,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL403183,,CHEMBL403183,,False,http://qudt.org/vocab/unit#Percent,1763537,=,1,False,=,,Residual Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,92.0
1356,,12228728,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL290904,,CHEMBL290904,,False,http://qudt.org/vocab/unit#Percent,1763538,=,1,False,=,,Residual Activity,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,86.0
1357,,12228729,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218938,,CHEMBL2218938,,False,http://qudt.org/vocab/unit#Percent,1763539,=,1,False,=,,Residual Activity,%,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,89.0
1358,,12228730,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL413188,ISOGRANULATIMIDE,CHEMBL413188,,False,http://qudt.org/vocab/unit#Percent,1763540,=,1,False,=,,Residual Activity,%,,56.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,56.0
1359,,12228731,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL281948,K-252A,CHEMBL281948,,False,http://qudt.org/vocab/unit#Percent,1763541,=,1,False,=,,Residual Activity,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,0.0
1360,,12228732,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL35482,,CHEMBL35482,,False,http://qudt.org/vocab/unit#Percent,1763542,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1361,,12228733,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL304428,,CHEMBL304428,,False,http://qudt.org/vocab/unit#Percent,1763543,=,1,False,=,,Residual Activity,%,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,18.0
1362,,12228734,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL50894,ALSTERPAULLONE,CHEMBL50894,,False,http://qudt.org/vocab/unit#Percent,1763544,=,1,False,=,,Residual Activity,%,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,44.0
1363,,12228735,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL83980,BOHEMINE,CHEMBL83980,,False,http://qudt.org/vocab/unit#Percent,1763545,=,1,False,=,,Residual Activity,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,76.0
1364,,12228736,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL408982,,CHEMBL408982,,False,http://qudt.org/vocab/unit#Percent,1763546,=,1,False,=,,Residual Activity,%,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,71.0
1365,,12228737,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL602937,FASCAPLYSIN,CHEMBL602937,,False,http://qudt.org/vocab/unit#Percent,1763547,=,1,False,=,,Residual Activity,%,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,78.0
1366,,12228738,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL404941,,CHEMBL404941,,False,http://qudt.org/vocab/unit#Percent,1763548,=,1,False,=,,Residual Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,75.0
1367,,12228739,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL296586,KENPAULLONE,CHEMBL296586,,False,http://qudt.org/vocab/unit#Percent,1763549,=,1,False,=,,Residual Activity,%,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,36.0
1368,,12228740,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL17331,PD-169316,CHEMBL17331,,False,http://qudt.org/vocab/unit#Percent,1763550,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1369,,12228741,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL36450,,CHEMBL36450,,False,http://qudt.org/vocab/unit#Percent,1763551,=,1,False,=,,Residual Activity,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,88.0
1370,,12228742,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL260138,ALSTERPAULLONE 2,CHEMBL260138,,False,http://qudt.org/vocab/unit#Percent,1763552,=,1,False,=,,Residual Activity,%,,28.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,28.0
1371,,12228743,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261425,,CHEMBL261425,,False,http://qudt.org/vocab/unit#Percent,1763553,=,1,False,=,,Residual Activity,%,,69.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,69.0
1372,,12228744,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL179583,,CHEMBL179583,,False,http://qudt.org/vocab/unit#Percent,1763554,=,1,False,=,,Residual Activity,%,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,79.0
1373,,12228745,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1sc(=O)n(Cc2ccccc2)c1=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL284861,,CHEMBL284861,,False,http://qudt.org/vocab/unit#Percent,1763555,=,1,False,=,,Residual Activity,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,76.0
1374,,12228746,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL257167,,CHEMBL257167,,False,http://qudt.org/vocab/unit#Percent,1763556,=,1,False,=,,Residual Activity,%,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,9.0
1375,,12228747,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL155333,,CHEMBL155333,,False,http://qudt.org/vocab/unit#Percent,1763557,=,1,False,=,,Residual Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,75.0
1376,,12228748,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL274064,SB-220025,CHEMBL274064,,False,http://qudt.org/vocab/unit#Percent,1763558,=,1,False,=,,Residual Activity,%,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,78.0
1377,,12228749,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL313417,,CHEMBL313417,,False,http://qudt.org/vocab/unit#Percent,1763559,=,1,False,=,,Residual Activity,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,87.0
1378,,12228750,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL75680,ALOISINE A,CHEMBL75680,,False,http://qudt.org/vocab/unit#Percent,1763560,=,1,False,=,,Residual Activity,%,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,26.0
1379,,12228751,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL367625,,CHEMBL367625,,False,http://qudt.org/vocab/unit#Percent,1763561,=,1,False,=,,Residual Activity,%,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,23.0
1380,,12228752,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL311228,,CHEMBL311228,,False,http://qudt.org/vocab/unit#Percent,1763562,=,1,False,=,,Residual Activity,%,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,14.0
1381,,12228753,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL288064,,CHEMBL288064,,False,http://qudt.org/vocab/unit#Percent,1763563,=,1,False,=,,Residual Activity,%,,41.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,41.0
1382,,12228754,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1802727,,CHEMBL1802727,,False,http://qudt.org/vocab/unit#Percent,1763564,=,1,False,=,,Residual Activity,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,0.0
1383,,12228755,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218939,,CHEMBL2218939,,False,http://qudt.org/vocab/unit#Percent,1763565,=,1,False,=,,Residual Activity,%,,73.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,73.0
1384,,12228756,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL23327,PURVALANOLA,CHEMBL23327,,False,http://qudt.org/vocab/unit#Percent,1763566,=,1,False,=,,Residual Activity,%,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,9.0
1385,,12228757,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1076555,,CHEMBL1076555,,False,http://qudt.org/vocab/unit#Percent,1763567,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1386,,12228758,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL306498,ALOISINE,CHEMBL306498,,False,http://qudt.org/vocab/unit#Percent,1763568,=,1,False,=,,Residual Activity,%,,65.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,65.0
1387,,12228759,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL261720,,CHEMBL261720,,False,http://qudt.org/vocab/unit#Percent,1763569,=,1,False,=,,Residual Activity,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,0.0
1388,,12228760,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL80713,,CHEMBL80713,,False,http://qudt.org/vocab/unit#Percent,1763570,=,1,False,=,,Residual Activity,%,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,71.0
1389,,12228761,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL259850,,CHEMBL259850,,False,http://qudt.org/vocab/unit#Percent,1763571,=,1,False,=,,Residual Activity,%,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,78.0
1390,,12228762,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1c2ccccc2c2c3c(cccc13)N=N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1725279,SP-600125,CHEMBL1725279,,False,http://qudt.org/vocab/unit#Percent,1763572,=,1,False,=,,Residual Activity,%,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,11.0
1391,,12228763,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL404939,,CHEMBL404939,,False,http://qudt.org/vocab/unit#Percent,1763573,=,1,False,=,,Residual Activity,%,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,83.0
1392,,12228764,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL405759,,CHEMBL405759,,False,http://qudt.org/vocab/unit#Percent,1763574,=,1,False,=,,Residual Activity,%,,69.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,69.0
1393,,12228765,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL286721,AMINOPURVALANOL,CHEMBL286721,,False,http://qudt.org/vocab/unit#Percent,1763575,=,1,False,=,,Residual Activity,%,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,7.0
1394,,12228766,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1n[nH]c2nc3ccccc3nc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL259389,QUINOXALINE1,CHEMBL259389,,False,http://qudt.org/vocab/unit#Percent,1763576,=,1,False,=,,Residual Activity,%,,67.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,67.0
1395,,12228767,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1802728,,CHEMBL1802728,,False,http://qudt.org/vocab/unit#Percent,1763577,=,1,False,=,,Residual Activity,%,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,15.0
1396,,12228768,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL409450,6BIO,CHEMBL409450,,False,http://qudt.org/vocab/unit#Percent,1763578,=,1,False,=,,Residual Activity,%,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,34.0
1397,,12228769,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1802485,,CHEMBL1802485,,False,http://qudt.org/vocab/unit#Percent,1763579,=,1,False,=,,Residual Activity,%,,47.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,47.0
1398,,12228770,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218940,,CHEMBL2218940,,False,http://qudt.org/vocab/unit#Percent,1763580,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1399,,12228771,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL104264,,CHEMBL104264,,False,http://qudt.org/vocab/unit#Percent,1763581,=,1,False,=,,Residual Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,81.0
1400,,12228772,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1182777,,CHEMBL1182777,,False,http://qudt.org/vocab/unit#Percent,1763582,=,1,False,=,,Residual Activity,%,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,89.0
1401,,12228773,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL478629,DORSOMORPHIN,CHEMBL478629,,False,http://qudt.org/vocab/unit#Percent,1763583,=,1,False,=,,Residual Activity,%,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,18.0
1402,,12228774,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL410456,,CHEMBL410456,,False,http://qudt.org/vocab/unit#Percent,1763584,=,1,False,=,,Residual Activity,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,97.0
1403,,12228775,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL258721,,CHEMBL258721,,False,http://qudt.org/vocab/unit#Percent,1763585,=,1,False,=,,Residual Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,91.0
1404,,12228776,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL2218941,,CHEMBL2218941,,False,http://qudt.org/vocab/unit#Percent,1763586,=,1,False,=,,Residual Activity,%,,48.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,48.0
1405,,12228777,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL191384,,CHEMBL191384,,False,http://qudt.org/vocab/unit#Percent,1763587,=,1,False,=,,Residual Activity,%,,31.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,31.0
1406,,12228778,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL1240885,,CHEMBL1240885,,False,http://qudt.org/vocab/unit#Percent,1763588,=,1,False,=,,Residual Activity,%,,58.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,58.0
1407,,12228779,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL278724,SB-202474,CHEMBL278724,,False,http://qudt.org/vocab/unit#Percent,1763589,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1408,,12228780,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL258805,SU-9516,CHEMBL258805,,False,http://qudt.org/vocab/unit#Percent,1763590,=,1,False,=,,Residual Activity,%,,28.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,28.0
1409,,12228781,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL270724,,CHEMBL270724,,False,http://qudt.org/vocab/unit#Percent,1763591,=,1,False,=,,Residual Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,94.0
1410,,12228782,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL221271,,CHEMBL221271,,False,http://qudt.org/vocab/unit#Percent,1763592,=,1,False,=,,Residual Activity,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,85.0
1411,,12228783,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL272629,,CHEMBL272629,,False,http://qudt.org/vocab/unit#Percent,1763593,=,1,False,=,,Residual Activity,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,70.0
1412,,12228784,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL233001,GW620972X,CHEMBL233001,,False,http://qudt.org/vocab/unit#Percent,1763594,=,1,False,=,,Residual Activity,%,,72.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,72.0
1413,,12228785,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL522502,,CHEMBL522502,,False,http://qudt.org/vocab/unit#Percent,1763595,=,1,False,=,,Residual Activity,%,,58.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,58.0
1414,,12228786,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL278041,SB-202190,CHEMBL278041,,False,http://qudt.org/vocab/unit#Percent,1763596,=,1,False,=,,Residual Activity,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,88.0
1415,,12228787,[],CHEMBL2219222,"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",B,,,BAO_0001103,BAO_0000357,single protein format,N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,,,CHEMBL2218924,Biochem. J.,2013.0,,CHEMBL200381,,CHEMBL200381,,False,http://qudt.org/vocab/unit#Percent,1763597,=,1,False,=,,Residual Activity,%,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Residual Activity,%,UO_0000187,,43.0
1416,,12647939,[],CHEMBL2329188,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2321829,J. Med. Chem.,2013.0,,CHEMBL2325895,,CHEMBL2325895,,False,http://qudt.org/vocab/unit#Percent,1852280,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
1417,,12647940,[],CHEMBL2329188,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2321829,J. Med. Chem.,2013.0,,CHEMBL2325894,,CHEMBL2325894,,False,http://qudt.org/vocab/unit#Percent,1852279,=,1,True,=,,Inhibition,%,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,11.0
1418,,12647941,[],CHEMBL2329188,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N,,,CHEMBL2321829,J. Med. Chem.,2013.0,,CHEMBL2325906,,CHEMBL2325906,,False,http://qudt.org/vocab/unit#Percent,1852292,=,1,True,=,,Inhibition,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,1.0
1419,,12647942,[],CHEMBL2329188,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C,,,CHEMBL2321829,J. Med. Chem.,2013.0,,CHEMBL2325903,,CHEMBL2325903,,False,http://qudt.org/vocab/unit#Percent,1852289,=,1,True,=,,Inhibition,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.0
1420,,12649615,[],CHEMBL2329538,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2321829,J. Med. Chem.,2013.0,,CHEMBL2325894,,CHEMBL2325894,,False,http://qudt.org/vocab/unit#Percent,1852279,=,1,True,=,,Inhibition,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,75.0
1421,,12649616,[],CHEMBL2329538,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O,,,CHEMBL2321829,J. Med. Chem.,2013.0,,CHEMBL2325904,,CHEMBL2325904,,False,http://qudt.org/vocab/unit#Percent,1852290,=,1,True,=,,Inhibition,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,1.0
1422,,12649617,[],CHEMBL2329538,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12,,,CHEMBL2321829,J. Med. Chem.,2013.0,,CHEMBL2325901,,CHEMBL2325901,,False,http://qudt.org/vocab/unit#Percent,1852287,=,1,True,=,,Inhibition,%,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,23.0
1423,,12671028,[],CHEMBL2345078,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12,,,CHEMBL2331489,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333120,,CHEMBL2333120,,False,http://qudt.org/vocab/unit#Percent,1867039,=,1,True,=,,Inhibition,%,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,18.0
1424,,12671029,[],CHEMBL2345078,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12,,,CHEMBL2331489,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333115,,CHEMBL2333115,,False,http://qudt.org/vocab/unit#Percent,1867034,=,1,True,=,,Inhibition,%,,102.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,102.0
1425,,12671030,[],CHEMBL2345078,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12,,,CHEMBL2331489,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333114,,CHEMBL2333114,,False,http://qudt.org/vocab/unit#Percent,1867033,=,1,True,=,,Inhibition,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,99.0
1426,,12671031,[],CHEMBL2345078,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12,,,CHEMBL2331489,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333112,,CHEMBL2333112,,False,http://qudt.org/vocab/unit#Percent,1867031,=,1,True,=,,Inhibition,%,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,45.0
1427,,12671032,[],CHEMBL2345078,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1,,,CHEMBL2331489,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333129,,CHEMBL2333129,,False,http://qudt.org/vocab/unit#Percent,1867049,=,1,True,=,,Inhibition,%,,-6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-6.0
1428,,12671033,[],CHEMBL2345078,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1,,,CHEMBL2331489,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333128,,CHEMBL2333128,,False,http://qudt.org/vocab/unit#Percent,1867048,=,1,True,=,,Inhibition,%,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,1.0
1429,,12671034,[],CHEMBL2345078,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12,,,CHEMBL2331489,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2333125,,CHEMBL2333125,,False,http://qudt.org/vocab/unit#Percent,1867045,=,1,True,=,,Inhibition,%,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,14.0
1430,,12673015,[],CHEMBL2339734,Inhibition of recombinant IRAK4 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1,,,CHEMBL2331324,Eur. J. Med. Chem.,2013.0,,CHEMBL2336379,,CHEMBL2336379,,False,http://qudt.org/vocab/unit#Percent,1871257,=,1,False,=,,Activity,%,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,11.0
1431,,12673016,[],CHEMBL2339734,Inhibition of recombinant IRAK4 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1,,,CHEMBL2331324,Eur. J. Med. Chem.,2013.0,,CHEMBL2336377,,CHEMBL2336377,,False,http://qudt.org/vocab/unit#Percent,1871255,=,1,False,=,,Activity,%,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,21.0
1432,,12700119,[],CHEMBL2344132,Inhibition of recombinant IRAK4 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay,B,,,BAO_0000201,BAO_0000357,single protein format,O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1,,,CHEMBL2331439,J. Med. Chem.,2013.0,,CHEMBL574646,,CHEMBL574646,,False,http://qudt.org/vocab/unit#Percent,1873720,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
1433,,12723660,[],CHEMBL2350757,Inhibition of IRAK4 (unknown origin) at 10 uM by single point assay,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1,,,CHEMBL2346515,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2347818,,CHEMBL2347818,,False,http://qudt.org/vocab/unit#Percent,1875727,=,1,True,=,,Inhibition,%,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,10.0
1434,,12724762,[],CHEMBL2352278,Inhibition of IRAK4 (unknown origin) at 1 uM by single point assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12,,,CHEMBL2346515,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2347824,,CHEMBL2347824,,False,http://qudt.org/vocab/unit#Percent,1875734,=,1,True,=,,Inhibition,%,,68.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,68.0
1435,,12724763,[],CHEMBL2352278,Inhibition of IRAK4 (unknown origin) at 1 uM by single point assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12,,,CHEMBL2346515,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2347823,,CHEMBL2347823,,False,http://qudt.org/vocab/unit#Percent,1875733,=,1,True,=,,Inhibition,%,,29.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,29.0
1436,,12728805,[],CHEMBL2352636,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 10 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1,,,CHEMBL2346597,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2348865,,CHEMBL2348865,,False,http://qudt.org/vocab/unit#Percent,1876973,=,1,False,=,,Activity,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,76.0
1437,,12729049,[],CHEMBL2351954,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1,,,CHEMBL2346597,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2348862,,CHEMBL2348862,,False,http://qudt.org/vocab/unit#Percent,1876970,=,1,False,=,,Activity,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,98.0
1438,,12729930,[],CHEMBL2351887,Inhibition of IRAK4 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1,,,CHEMBL2346629,Eur. J. Med. Chem.,2013.0,,CHEMBL2333445,,CHEMBL2333445,,False,http://qudt.org/vocab/unit#Percent,1877341,=,1,False,=,,Activity,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,92.0
1439,,12730192,[],CHEMBL2352636,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 10 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1,,,CHEMBL2346597,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2348862,,CHEMBL2348862,,False,http://qudt.org/vocab/unit#Percent,1876970,=,1,False,=,,Activity,%,,108.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,108.0
1440,,13281389,[],CHEMBL2378441,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2375236,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2376158,,CHEMBL2376158,,False,http://qudt.org/vocab/unit#Percent,1890493,=,1,True,=,,Inhibition,%,,28.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,28.0
1441,,13281390,[],CHEMBL2378441,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21,,,CHEMBL2375236,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2376154,,CHEMBL2376154,,False,http://qudt.org/vocab/unit#Percent,1890489,=,1,True,=,,Inhibition,%,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,61.0
1442,,13281391,[],CHEMBL2378441,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2375236,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2376153,,CHEMBL2376153,,False,http://qudt.org/vocab/unit#Percent,1890488,=,1,True,=,,Inhibition,%,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,13.0
1443,,13281392,[],CHEMBL2378441,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2375236,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2376152,,CHEMBL2376152,,False,http://qudt.org/vocab/unit#Percent,1890487,=,1,True,=,,Inhibition,%,,-2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-2.0
1444,,13281393,[],CHEMBL2378441,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2375236,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2376144,,CHEMBL2376144,,False,http://qudt.org/vocab/unit#Percent,1890479,=,1,True,=,,Inhibition,%,,-10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-10.0
1445,,13281394,[],CHEMBL2378441,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1,,,CHEMBL2375236,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2376143,,CHEMBL2376143,,False,http://qudt.org/vocab/unit#Percent,1890478,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
1446,,13296919,[],CHEMBL2383894,Inhibition of human CAMK4,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12,,,CHEMBL2380230,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '15.48', 'le': '0.30', 'lle': '3.13', 'sei': '5.35'}",CHEMBL2381601,,CHEMBL2381601,5.96,False,http://www.openphacts.org/units/Nanomolar,1894218,=,1,True,=,,IC50,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.1
1447,,13296920,[],CHEMBL2383896,Inhibition of human IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12,,,CHEMBL2380230,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '15.13', 'le': '0.29', 'lle': '2.99', 'sei': '5.23'}",CHEMBL2381601,,CHEMBL2381601,5.82,False,http://www.openphacts.org/units/Nanomolar,1894218,=,1,True,=,,IC50,nM,,1500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.5
1448,,13311862,[],CHEMBL2384686,Inhibition of human IRAK4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2,,,CHEMBL2380296,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '13.23', 'le': '0.25', 'lle': '3.59', 'sei': '5.98'}",CHEMBL2381116,,CHEMBL2381116,5.96,False,http://www.openphacts.org/units/Nanomolar,1893648,=,1,True,=,,IC50,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1100.0
1449,,13321300,[],CHEMBL2389956,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1,,,CHEMBL2384992,Bioorg. Med. Chem. Lett.,2013.0,"{'bei': '8.17', 'le': '0.15', 'lle': '-2.23', 'sei': '7.44'}",CHEMBL2385543,,CHEMBL2385543,4.58,False,http://www.openphacts.org/units/Nanomolar,1895722,=,1,True,=,,IC50,nM,,26000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,26.0
1450,Not Active,13360649,[],CHEMBL2400315,Inhibition of human IRAK4,B,,,BAO_0000376,BAO_0000357,single protein format,COc1ccc2c(c1)C=C(C(=O)/C=C/c1c(OC)cc(OC)cc1OC)CO2,,,CHEMBL2396526,Bioorg. Med. Chem.,2013.0,,CHEMBL2396883,,CHEMBL2396883,,False,,1902146,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1451,,13375835,[],CHEMBL2404348,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1,,,CHEMBL2401733,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2402081,,CHEMBL2402081,,False,http://qudt.org/vocab/unit#Percent,1904979,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
1452,,13419586,[],CHEMBL2423817,Inhibition of IRAK4 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1,,,CHEMBL2417369,Bioorg. Med. Chem.,2013.0,,CHEMBL2420901,,CHEMBL2420901,,False,http://qudt.org/vocab/unit#Percent,1917184,=,1,True,=,,Inhibition,%,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,13.0
1453,,13419587,[],CHEMBL2423817,Inhibition of IRAK4 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1,,,CHEMBL2417369,Bioorg. Med. Chem.,2013.0,,CHEMBL2420900,,CHEMBL2420900,,False,http://qudt.org/vocab/unit#Percent,1917183,=,1,True,=,,Inhibition,%,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,8.0
1454,,13419588,[],CHEMBL2423817,Inhibition of IRAK4 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1,,,CHEMBL2417369,Bioorg. Med. Chem.,2013.0,,CHEMBL2420899,,CHEMBL2420899,,False,http://qudt.org/vocab/unit#Percent,1917182,=,1,True,=,,Inhibition,%,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,18.0
1455,,13436434,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420551,,CHEMBL2420551,,False,http://qudt.org/vocab/unit#Percent,1916769,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1456,,13436435,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420555,,CHEMBL2420555,,False,http://qudt.org/vocab/unit#Percent,1916773,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1457,,13436436,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420573,,CHEMBL2420573,,False,http://qudt.org/vocab/unit#Percent,1916791,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1458,,13436437,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420572,,CHEMBL2420572,,False,http://qudt.org/vocab/unit#Percent,1916790,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1459,,13436438,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420570,,CHEMBL2420570,,False,http://qudt.org/vocab/unit#Percent,1916788,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1460,,13436439,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420565,,CHEMBL2420565,,False,http://qudt.org/vocab/unit#Percent,1916783,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1461,,13436440,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420564,,CHEMBL2420564,,False,http://qudt.org/vocab/unit#Percent,1916782,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1462,,13436441,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420562,,CHEMBL2420562,,False,http://qudt.org/vocab/unit#Percent,1916780,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1463,,13436442,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420560,,CHEMBL2420560,,False,http://qudt.org/vocab/unit#Percent,1916778,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1464,,13436443,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420556,,CHEMBL2420556,,False,http://qudt.org/vocab/unit#Percent,1916774,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1465,,13436444,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420587,,CHEMBL2420587,,False,http://qudt.org/vocab/unit#Percent,1916805,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1466,,13436445,[],CHEMBL2422426,Inhibition of IRAK4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1,,,CHEMBL2417377,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2420585,,CHEMBL2420585,,False,http://qudt.org/vocab/unit#Percent,1916803,<,1,True,<,,Inhibition,%,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,35.0
1467,Active,13488430,[],CHEMBL2439429,Inhibition of human IRAK4 at 1 uM,B,,,BAO_0000376,BAO_0000357,single protein format,Clc1ccc2ncc(Br)n2n1,,,CHEMBL2434857,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2436439,,CHEMBL2436439,,False,,1924953,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1468,Active,13488431,[],CHEMBL2439429,Inhibition of human IRAK4 at 1 uM,B,,,BAO_0000376,BAO_0000357,single protein format,CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1,,,CHEMBL2434857,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2436446,,CHEMBL2436446,,False,,1924960,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1469,Active,13488432,[],CHEMBL2439429,Inhibition of human IRAK4 at 1 uM,B,,,BAO_0000376,BAO_0000357,single protein format,c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1,,,CHEMBL2434857,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2436454,,CHEMBL2436454,,False,,1924969,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1470,,13490920,[],CHEMBL2446684,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1,,,CHEMBL2440060,ACS Med. Chem. Lett.,2013.0,"{'bei': '18.28', 'le': '0.35', 'lle': '2.70', 'sei': '10.13'}",CHEMBL2441273,,CHEMBL2441273,8.40,False,http://www.openphacts.org/units/Nanomolar,1927543,=,1,True,=,,IC50,nM,,3.981,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,8.4
1471,Not Active,13508512,[],CHEMBL2447622,Inhibition of IRAK4 (unknown origin) at 30 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F,,,CHEMBL2440005,Bioorg. Med. Chem. Lett.,2013.0,,CHEMBL2441375,,CHEMBL2441375,,False,,1927672,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1472,Not Active,13863474,[],CHEMBL3101875,Inhibition of IRAK4 (unknown origin) at 1 uM after 1 hr,B,,,BAO_0000376,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1,,,CHEMBL3098003,ACS Med. Chem. Lett.,2013.0,,CHEMBL3099716,,CHEMBL3099716,,False,,1956958,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1473,Not Active,13863475,[],CHEMBL3101875,Inhibition of IRAK4 (unknown origin) at 1 uM after 1 hr,B,,,BAO_0000376,BAO_0000357,single protein format,CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1,,,CHEMBL3098003,ACS Med. Chem. Lett.,2013.0,,CHEMBL3099720,,CHEMBL3099720,,False,,1956963,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1474,,13872120,[],CHEMBL3101746,Inhibition of human IRAK4 assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O,,,CHEMBL3098105,Bioorg. Med. Chem.,2014.0,,CHEMBL3099673,,CHEMBL3099673,,False,http://qudt.org/vocab/unit#Percent,1956912,=,1,False,=,,Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,93.0
1475,,13953373,[],CHEMBL3130933,Inhibition of human IRAK4 assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1,,,CHEMBL3124838,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3125728,,CHEMBL3125728,,False,http://qudt.org/vocab/unit#Percent,1971375,=,1,False,=,,Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,81.0
1476,,13954559,[],CHEMBL3130933,Inhibition of human IRAK4 assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1,,,CHEMBL3124838,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3125727,,CHEMBL3125727,,False,http://qudt.org/vocab/unit#Percent,1971374,=,1,False,=,,Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,75.0
1477,,13954725,[],CHEMBL3130933,Inhibition of human IRAK4 assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1,,,CHEMBL3124838,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3125726,,CHEMBL3125726,,False,http://qudt.org/vocab/unit#Percent,1971373,=,1,False,=,,Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,81.0
1478,,13965698,[],CHEMBL3135910,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,CNCc1ccc(-c2ncnc3[nH]cnc23)cc1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL376388,,CHEMBL376388,,False,http://qudt.org/vocab/unit#Percent,1976699,=,1,True,=,,Inhibition,%,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,15.0
1479,,13966076,[],CHEMBL3137064,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,c1cnc2[nH]ccc2c1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL389685,,CHEMBL389685,,False,http://qudt.org/vocab/unit#Percent,1976698,=,1,True,=,,Inhibition,%,,65.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,65.0
1480,,13973978,[],CHEMBL3135751,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL1928705,,CHEMBL1928705,,False,http://qudt.org/vocab/unit#Percent,1976697,=,1,True,=,,Inhibition,%,,11.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,11.5
1481,,13974069,[],CHEMBL3134729,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL1928692,,CHEMBL1928692,,False,http://qudt.org/vocab/unit#Percent,1976696,=,1,True,=,,Inhibition,%,,5.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.5
1482,,13974160,[],CHEMBL3136497,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL1928677,,CHEMBL1928677,,False,http://qudt.org/vocab/unit#Percent,1976695,=,1,True,=,,Inhibition,%,,56.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,56.5
1483,,13974251,[],CHEMBL3136107,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,NCC1CN(c2ncnc3[nH]cnc23)CCO1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL560373,,CHEMBL560373,,False,http://qudt.org/vocab/unit#Percent,1976694,=,1,True,=,,Inhibition,%,,54.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,54.5
1484,,13974989,[],CHEMBL3135155,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,c1nc(N2CCOCC2)c2nc[nH]c2n1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL271138,,CHEMBL271138,,False,http://qudt.org/vocab/unit#Percent,1976693,=,1,True,=,,Inhibition,%,,74.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,74.5
1485,,13975080,[],CHEMBL3136725,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL598194,,CHEMBL598194,,False,http://qudt.org/vocab/unit#Percent,1976692,=,1,True,=,,Inhibition,%,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,4.5
1486,,13975171,[],CHEMBL3134954,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL263664,,CHEMBL263664,,False,http://qudt.org/vocab/unit#Percent,1976691,=,1,True,=,,Inhibition,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,0.0
1487,,13975262,[],CHEMBL3137145,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,NC1CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL259141,,CHEMBL259141,,False,http://qudt.org/vocab/unit#Percent,1976690,=,1,True,=,,Inhibition,%,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,1.5
1488,,13975905,[],CHEMBL3136272,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,NCC1CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL261249,,CHEMBL261249,,False,http://qudt.org/vocab/unit#Percent,1976689,=,1,True,=,,Inhibition,%,,25.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,25.5
1489,,13975998,[],CHEMBL3136307,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL228133,,CHEMBL228133,,False,http://qudt.org/vocab/unit#Percent,1974515,=,1,True,=,,Inhibition,%,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,13.0
1490,,13976089,[],CHEMBL3136189,Inhibition of human IRAK4 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay,B,,,BAO_0000201,BAO_0000019,assay format,NCCc1ccc(-c2ncnc3[nH]cnc23)cc1,,,CHEMBL3132769,MedChemComm,2014.0,,CHEMBL227727,,CHEMBL227727,,False,http://qudt.org/vocab/unit#Percent,1976700,=,1,True,=,,Inhibition,%,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,34.0
1491,,14582526,[],CHEMBL3242527,Inhibition of human IRAK4 assessed as enzyme activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N,,,CHEMBL3232845,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3236464,,CHEMBL3236464,,False,http://qudt.org/vocab/unit#Percent,2085596,=,1,False,=,,Activity,%,,105.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,105.5
1492,,14645933,[],CHEMBL3270974,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1,,,CHEMBL3259754,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3263640,,CHEMBL3263640,,False,http://www.openphacts.org/units/Nanomolar,2102637,>,1,True,>,,IC50,nM,,50000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,50.0
1493,,14648152,[],CHEMBL3267033,Inhibition of human IRAK4 at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1,,,CHEMBL3259664,J. Med. Chem.,2014.0,,CHEMBL2380687,,CHEMBL2380687,,False,http://qudt.org/vocab/unit#Percent,2103185,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1494,,14648153,[],CHEMBL3267033,Inhibition of human IRAK4 at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1,,,CHEMBL3259664,J. Med. Chem.,2014.0,,CHEMBL3264059,,CHEMBL3264059,,False,http://qudt.org/vocab/unit#Percent,2103191,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1495,,14659363,[],CHEMBL3267570,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1,,,CHEMBL3259517,J. Med. Chem.,2014.0,,CHEMBL3264107,,CHEMBL3264107,,False,http://qudt.org/vocab/unit#Percent,2103242,=,1,True,=,,Inhibition,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.0
1496,,14659364,[],CHEMBL3267570,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC,,,CHEMBL3259517,J. Med. Chem.,2014.0,,CHEMBL3264108,,CHEMBL3264108,,False,http://qudt.org/vocab/unit#Percent,2103243,=,1,True,=,,Inhibition,%,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,9.0
1497,,14664197,[],CHEMBL3270881,Inhibition of IRAK4 (unknown origin) at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CCOC(=O)c1sc(-c2ccncc2)nc1O,,,CHEMBL3259739,Eur. J. Med. Chem.,2014.0,,CHEMBL3261228,,CHEMBL3261228,,False,http://qudt.org/vocab/unit#Percent,2099736,=,1,True,=,,Inhibition,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,100.0
1498,,14664198,[],CHEMBL3270881,Inhibition of IRAK4 (unknown origin) at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl,,,CHEMBL3259739,Eur. J. Med. Chem.,2014.0,,CHEMBL3261514,,CHEMBL3261514,,False,http://qudt.org/vocab/unit#Percent,2100056,=,1,True,=,,Inhibition,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,91.0
1499,,14664199,[],CHEMBL3270881,Inhibition of IRAK4 (unknown origin) at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1,,,CHEMBL3259739,Eur. J. Med. Chem.,2014.0,,CHEMBL3261517,,CHEMBL3261517,,False,http://qudt.org/vocab/unit#Percent,2100059,=,1,True,=,,Inhibition,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,100.0
1500,,14668871,[],CHEMBL3269294,Inhibition of IRAK4 (unknown origin) assessed as residual activity at 1 uM,B,,,BAO_0001103,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3264257,,CHEMBL3264257,,False,http://qudt.org/vocab/unit#Percent,2103415,=,1,False,=,,Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,91.0
1501,,14977385,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '20.25', 'le': '0.38', 'lle': '5.39', 'sei': '6.53'}",CHEMBL1236126,,CHEMBL1236126,8.92,False,http://www.openphacts.org/units/Nanomolar,2241887,=,1,True,=,,Ki,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.2
1502,,14977393,[],CHEMBL3372371,Inhibition of IRAK1 (unknown origin) assessed as reduction in biotin tagged phosphorylated peptide substrate1,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC[C@@H](n2cc(-c3cnc(-c4cccc(-c5cnn(C)c5)c4)nc3)cn2)C1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353212,,CHEMBL3353212,,False,http://www.openphacts.org/units/Nanomolar,2241877,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1503,,14977394,[],CHEMBL3372371,Inhibition of IRAK1 (unknown origin) assessed as reduction in biotin tagged phosphorylated peptide substrate1,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2cccc(-c3ncc(-c4cnn([C@@H]5CCCN(S(C)(=O)=O)C5)c4)cn3)c2)cn1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353211,,CHEMBL3353211,,False,http://www.openphacts.org/units/Nanomolar,2241876,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1504,,14977395,[],CHEMBL3372369,Inhibition of IRAK4 (unknown origin) by radiochemical assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2nc3ccccc3n2CCn2cc(cn2)-c2ccc(=O)n(n2)Cc2cccc1c2,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353216,,CHEMBL3353216,,False,http://www.openphacts.org/units/Nanomolar,2241881,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1505,,14977396,[],CHEMBL3372369,Inhibition of IRAK4 (unknown origin) by radiochemical assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2nc3ccccc3n2Cc2cc(ccc2O)-c2ccc(=O)n(n2)Cc2cccc1c2,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353215,,CHEMBL3353215,,False,http://www.openphacts.org/units/Nanomolar,2241880,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1506,,14977397,[],CHEMBL3372369,Inhibition of IRAK4 (unknown origin) by radiochemical assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)Cc1ccc2nc(NC(=O)c3cccc(Cn4nc(-c5cccnc5)ccc4=O)c3)[nH]c2c1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353214,,CHEMBL3353214,,False,http://www.openphacts.org/units/Nanomolar,2241879,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1507,,14977398,[],CHEMBL3372369,Inhibition of IRAK4 (unknown origin) by radiochemical assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccc(CO)cc2[nH]1)c1cccc(Cn2nc(-c3cccnc3)ccc2=O)c1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353213,,CHEMBL3353213,,False,http://www.openphacts.org/units/Nanomolar,2241878,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1508,,14977411,[],CHEMBL3380186,Inhibition of IRAK4 (unknown origin) by fluorescence polarization based kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(NC3C[C@H](C(C)(C)O)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '17.09', 'le': '0.33', 'lle': '4.86', 'sei': '6.35'}",CHEMBL3353201,,CHEMBL3353201,8.66,False,http://www.openphacts.org/units/Nanomolar,2241866,=,1,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
1509,,14977412,[],CHEMBL3380186,Inhibition of IRAK4 (unknown origin) by fluorescence polarization based kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cccc(Nc3ncc(-c4nc5ccccc5s4)c(NC4C[C@H](CO)[C@@H](O)[C@H]4O)n3)c2)CC1.Cl,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '15.67', 'le': '0.30', 'lle': '5.83', 'sei': '6.61'}",CHEMBL3353200,,CHEMBL3546140,8.59,False,http://www.openphacts.org/units/Nanomolar,2241865,=,1,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
1510,,14977413,[],CHEMBL3380186,Inhibition of IRAK4 (unknown origin) by fluorescence polarization based kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(NC3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1.Cl,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.84', 'le': '0.38', 'lle': '6.47', 'sei': '6.97'}",CHEMBL3353199,,CHEMBL3546141,9.49,False,http://www.openphacts.org/units/Nanomolar,2241864,=,1,True,=,,IC50,nM,,0.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.32
1511,,14977415,[],CHEMBL3380184,Inhibition of IRAK4 (unknown origin) by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2cccc(C(=O)Nc3ccc4nc(N5CCOCC5)sc4c3)n2)cn1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353198,,CHEMBL3353198,,False,http://www.openphacts.org/units/Nanomolar,2241863,<,1,True,<,,IC50,nM,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,50.0
1512,,14977423,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1nc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)sc1C,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.94', 'le': '0.40', 'lle': '3.69', 'sei': '9.52'}",CHEMBL3353197,,CHEMBL3353197,8.74,True,http://www.openphacts.org/units/Nanomolar,2241862,=,1,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.0018
1513,,14977424,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CC[C@H](O)C2)s1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '17.76', 'le': '0.35', 'lle': '4.57', 'sei': '7.36'}",CHEMBL3353196,,CHEMBL3353196,8.55,False,http://www.openphacts.org/units/Nanomolar,2241861,=,1,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.0028
1514,,14977425,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(Nc3ccc4ncsc4n3)cc2NC2CCOCC2)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '17.31', 'le': '0.33', 'lle': '5.36', 'sei': '6.78'}",CHEMBL3353195,,CHEMBL3353195,8.82,False,http://www.openphacts.org/units/Nanomolar,2241860,=,1,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.0015
1515,,14977426,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3cnccc3n2)cc1NC1CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.44', 'le': '0.36', 'lle': '5.07', 'sei': '7.36'}",CHEMBL3352825,,CHEMBL3352825,8.25,False,http://www.openphacts.org/units/Nanomolar,2241859,=,1,True,=,,IC50,nM,,5.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.0056
1516,,14977427,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ncc(C#N)cn2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '20.61', 'le': '0.39', 'lle': '6.13', 'sei': '6.09'}",CHEMBL3353194,,CHEMBL3353194,8.28,False,http://www.openphacts.org/units/Nanomolar,2241858,=,1,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
1517,,14977428,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ncc(Cl)cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.76', 'le': '0.40', 'lle': '4.79', 'sei': '8.53'}",CHEMBL3353193,,CHEMBL3353193,8.46,False,http://www.openphacts.org/units/Nanomolar,2241857,=,1,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
1518,,14977429,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C#N)cnc1Nc1cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '20.37', 'le': '0.38', 'lle': '5.38', 'sei': '6.87'}",CHEMBL3353192,,CHEMBL3353192,8.44,False,http://www.openphacts.org/units/Nanomolar,2241856,=,1,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
1519,,14977430,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ncc(C#N)cc2Cl)cc1NC1CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '20.20', 'le': '0.40', 'lle': '5.58', 'sei': '7.11'}",CHEMBL3353191,,CHEMBL3353191,8.74,False,http://www.openphacts.org/units/Nanomolar,2241855,=,1,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
1520,,14977431,[],CHEMBL3380182,Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ncc(C#N)cc2Cl)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '20.05', 'le': '0.40', 'lle': '5.32', 'sei': '7.09'}",CHEMBL3353190,,CHEMBL3353190,8.72,False,http://www.openphacts.org/units/Nanomolar,2241854,=,1,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
1521,,14977435,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)nc3[nH]ccc23)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.97', 'le': '0.37', 'lle': '3.01', 'sei': '10.16'}",CHEMBL3353186,,CHEMBL3353186,7.00,False,http://www.openphacts.org/units/Nanomolar,2241850,=,1,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1522,,14977436,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(F)c23)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '25.24', 'le': '0.48', 'lle': '4.62', 'sei': '12.32'}",CHEMBL3353185,,CHEMBL3353185,7.00,False,http://www.openphacts.org/units/Nanomolar,2241849,=,1,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1523,,14977437,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C#N)c23)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '24.62', 'le': '0.46', 'lle': '4.89', 'sei': '8.68'}",CHEMBL3353184,,CHEMBL3353184,7.00,False,http://www.openphacts.org/units/Nanomolar,2241848,=,1,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1524,,14977438,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4ccc(C(N)=O)cc4c23)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3361258,,CHEMBL3361258,,False,http://www.openphacts.org/units/Nanomolar,2273432,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
1525,,14977439,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(c1)sc1ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3361257,,CHEMBL3361257,,False,http://www.openphacts.org/units/Nanomolar,2273431,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
1526,,14977440,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4ccccc4c23)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3361256,,CHEMBL3361256,,False,http://www.openphacts.org/units/Nanomolar,2273430,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
1527,,14977441,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000192,BAO_0000357,single protein format,NC(=O)[C@@H](O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '20.15', 'le': '0.40', 'lle': '7.02', 'sei': '8.12'}",CHEMBL3361255,,CHEMBL3361255,9.00,False,http://www.openphacts.org/units/Nanomolar,2273429,=,1,True,=,,Ki,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.0
1528,,14977442,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000192,BAO_0000357,single protein format,NC(=O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.51', 'le': '0.38', 'lle': '5.50', 'sei': '8.97'}",CHEMBL3361254,,CHEMBL3361254,8.12,False,http://www.openphacts.org/units/Nanomolar,2273428,=,1,True,=,,Ki,nM,,7.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,7.5
1529,,14977443,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c3c(sc2n1)CCC3,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3361253,,CHEMBL3361253,,False,http://www.openphacts.org/units/Nanomolar,2273427,<=,1,True,<=,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,5.0
1530,,14977444,[],CHEMBL3380178,Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay,B,,,BAO_0000192,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4c(c23)CCC4)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '23.07', 'le': '0.45', 'lle': '3.84', 'sei': '17.79'}",CHEMBL3361252,,CHEMBL3361252,7.30,False,http://www.openphacts.org/units/Nanomolar,2273426,=,1,True,=,,Ki,nM,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,50.0
1531,,14977445,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)CCN)nc12,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.82', 'le': '0.38', 'lle': '5.20', 'sei': '7.62'}",CHEMBL3353220,,CHEMBL3353220,8.10,True,http://www.openphacts.org/units/Nanomolar,2241885,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.008
1532,,14977446,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cc(O)cnc23)CC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '22.45', 'le': '0.44', 'lle': '6.48', 'sei': '8.27'}",CHEMBL3353219,,CHEMBL3353219,9.00,True,http://www.openphacts.org/units/Nanomolar,2241884,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.001
1533,,14977447,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2cn(CCN3CCOCC3)nc2C(=O)NCCOCCc2cc(ccn2)-c2nc1cs2,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353218,,CHEMBL3353218,,False,http://www.openphacts.org/units/Nanomolar,2241883,<=,1,True,<=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1534,,14977448,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2cn(C3CCOCC3)nc2C(=O)NCCCCCc2cc(ccn2)-c2nc1cs2,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353217,,CHEMBL3353217,,False,http://www.openphacts.org/units/Nanomolar,2241882,<=,1,True,<=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1535,,14977449,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(-n2cc(-c3n[nH]c4ccccc34)nn2)cc1)N1CCOCC1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '18.70', 'le': '0.34', 'lle': '4.72', 'sei': '7.87'}",CHEMBL3353210,,CHEMBL3353210,7.00,False,http://www.openphacts.org/units/Nanomolar,2241875,=,1,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.1
1536,,14977450,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353209,,CHEMBL3353209,,False,http://www.openphacts.org/units/Nanomolar,2241874,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
1537,,14977451,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353208,,CHEMBL3353208,,False,http://www.openphacts.org/units/Nanomolar,2241873,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
1538,,14977452,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3351266,J. Med. Chem.,2015.0,,CHEMBL3353207,,CHEMBL3353207,,False,http://www.openphacts.org/units/Nanomolar,2241872,<,1,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
1539,,14977453,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '23.04', 'le': '0.43', 'lle': '6.92', 'sei': '6.21'}",CHEMBL3353206,,CHEMBL3353206,7.50,False,http://www.openphacts.org/units/Nanomolar,2241871,=,1,True,=,,IC50,nM,,32.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,32.0
1540,,14977454,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCC[C@H]1Nc1cccc2nc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)sc12,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '16.58', 'le': '0.32', 'lle': '5.97', 'sei': '6.53'}",CHEMBL3353205,,CHEMBL3353205,8.70,False,http://www.openphacts.org/units/Nanomolar,2241870,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1541,,14977455,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1cccc2nc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)sc12,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '16.57', 'le': '0.32', 'lle': '6.38', 'sei': '5.85'}",CHEMBL3353204,,CHEMBL3353204,7.80,False,http://www.openphacts.org/units/Nanomolar,2241869,=,1,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
1542,,14977456,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNCC[C@@H]2F)c1-c1nc2ccccc2s1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '18.24', 'le': '0.36', 'lle': '5.85', 'sei': '8.25'}",CHEMBL3353203,,CHEMBL3353203,7.85,False,http://www.openphacts.org/units/Nanomolar,2241868,=,1,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
1543,,14977457,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '16.83', 'le': '0.32', 'lle': '5.29', 'sei': '8.06'}",CHEMBL3353202,,CHEMBL3353202,8.22,False,http://www.openphacts.org/units/Nanomolar,2241867,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
1544,,14977458,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cl.Cn1cc(NC(=O)c2coc(-c3ccnc(NCC(F)(F)F)c3)n2)c(C(N)=O)n1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '23.50', 'le': '0.45', 'lle': '7.82', 'sei': '6.82'}",CHEMBL3353189,,CHEMBL3546135,9.62,False,http://www.openphacts.org/units/Nanomolar,2241853,=,1,True,=,,IC50,nM,,0.24,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.24
1545,,14977459,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cl.NC(=O)c1nn(-c2cccnc2)cc1NC(=O)c1coc(-c2ccnc(NCC(F)(F)F)c2)n1,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.99', 'le': '0.38', 'lle': '6.80', 'sei': '6.14'}",CHEMBL3353188,,CHEMBL3546134,9.44,False,http://www.openphacts.org/units/Nanomolar,2241852,=,1,True,=,,IC50,nM,,0.36,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.36
1546,,14977460,[],CHEMBL3380177,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2nc(C(=O)Nc3cn(C4CCOCC4)nc3C(N)=O)co2)ccn1.Cl,,,CHEMBL3351266,J. Med. Chem.,2015.0,"{'bei': '19.37', 'le': '0.36', 'lle': '5.74', 'sei': '5.56'}",CHEMBL3353187,,CHEMBL3546136,7.68,False,http://www.openphacts.org/units/Nanomolar,2241851,=,1,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
1547,,14980859,[],CHEMBL3372435,Inhibition of IRAK4 (unknown origin) in presence of 1 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1,,,CHEMBL3351882,ACS Med. Chem. Lett.,2015.0,,CHEMBL3355482,,CHEMBL3355482,,False,http://www.openphacts.org/units/Nanomolar,2250218,>,1,True,>,,IC50,nM,,100000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,100.0
1548,,14984371,[],CHEMBL3385004,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1,,,CHEMBL3352495,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3359895,,CHEMBL3359895,,False,http://qudt.org/vocab/unit#Percent,2269026,=,1,True,=,,Inhibition,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.0
1549,,14984437,[],CHEMBL3382490,Inhibition of IRAK4 (unknown origin) at 0.1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1,,,CHEMBL3352495,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3359895,,CHEMBL3359895,,False,http://qudt.org/vocab/unit#Percent,2269026,=,1,True,=,,Inhibition,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.0
1550,,15008036,[],CHEMBL3368007,Inhibition of human IRAK4 at 1 uM by radiometric Assay,B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1,,,CHEMBL3352261,Bioorg. Med. Chem.,2014.0,,CHEMBL3330255,,CHEMBL3330255,,False,http://qudt.org/vocab/unit#Percent,2246708,=,1,True,=,,Inhibition,%,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,17.0
1551,,15008037,[],CHEMBL3368007,Inhibition of human IRAK4 at 1 uM by radiometric Assay,B,,,BAO_0000201,BAO_0000357,single protein format,COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1,,,CHEMBL3352261,Bioorg. Med. Chem.,2014.0,,CHEMBL3330401,,CHEMBL3330401,,False,http://qudt.org/vocab/unit#Percent,2246739,=,1,True,=,,Inhibition,%,,-7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-7.0
1552,,15008038,[],CHEMBL3368007,Inhibition of human IRAK4 at 1 uM by radiometric Assay,B,,,BAO_0000201,BAO_0000357,single protein format,NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1,,,CHEMBL3352261,Bioorg. Med. Chem.,2014.0,,CHEMBL3330410,,CHEMBL3330410,,False,http://qudt.org/vocab/unit#Percent,2246749,=,1,True,=,,Inhibition,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,0.0
1553,,15018617,[],CHEMBL3366841,Inhibition of IRAK4 (unknown origin) at 100 nM,B,,,BAO_0000201,BAO_0000357,single protein format,O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1,,,CHEMBL3297705,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3298678,,CHEMBL3298678,,False,http://qudt.org/vocab/unit#Percent,2261007,=,1,True,=,,Inhibition,%,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.7
1554,,15053966,[],CHEMBL3369599,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1,,,CHEMBL3351352,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL3314140,,CHEMBL3314140,,False,http://www.openphacts.org/units/Nanomolar,2273692,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1555,,15058852,[],CHEMBL3371406,Inhibition of IRAK4 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay,B,,,BAO_0001103,BAO_0000357,single protein format,COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O,,,CHEMBL3351621,J. Med. Chem.,2015.0,,CHEMBL3358999,,CHEMBL3358999,,False,http://qudt.org/vocab/unit#Percent,2265613,=,1,False,=,,Activity,%,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,43.0
1556,Not Active,15062599,[],CHEMBL3367923,Inhibition of human IRAK4 by Off-chip mobility shift assay,B,,,BAO_0000376,BAO_0000357,single protein format,O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1,,,CHEMBL3351450,Bioorg. Med. Chem.,2014.0,,CHEMBL3310142,,CHEMBL3310142,,False,,2263134,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1557,,15072580,[],CHEMBL3388688,Inhibition of IRAK4 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay,B,,,BAO_0001103,BAO_0000357,single protein format,Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1,,,CHEMBL3351385,Eur. J. Med. Chem.,2014.0,,CHEMBL3338802,,CHEMBL3338802,,False,http://qudt.org/vocab/unit#Percent,2274894,=,1,False,=,,Activity,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,90.0
1558,,15091089,[],CHEMBL3381540,Inhibition of human recombinant IRAK4 expressed insect cells using Ulight-FLGFTYVAP substrate assessed as remaining enzyme activity at 1 uM after 90 mins relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1,,,CHEMBL3352815,Bioorg. Med. Chem. Lett.,2014.0,,CHEMBL2206014,,CHEMBL2206014,,False,http://qudt.org/vocab/unit#Percent,2274751,=,1,False,=,,Activity,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,90.0
1559,,15101343,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343033,,CHEMBL3343033,,False,http://www.openphacts.org/units/Nanomolar,2262311,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1560,,15101344,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(C)nc2cc1O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343034,,CHEMBL3343034,,False,http://www.openphacts.org/units/Nanomolar,2262312,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1561,,15101345,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCO,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,"{'bei': '10.72', 'le': '0.20', 'lle': '0.60', 'sei': '4.37'}",CHEMBL3343037,,CHEMBL3343037,4.61,False,http://www.openphacts.org/units/Nanomolar,2262315,=,1,True,=,,IC50,nM,,24400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,24.4
1562,,15101346,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(=O)O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343038,,CHEMBL3343038,,False,http://www.openphacts.org/units/Nanomolar,2262316,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1563,,15101347,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(N)=O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343039,,CHEMBL3343039,,False,http://www.openphacts.org/units/Nanomolar,2262317,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1564,,15101348,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(N)nc2cc1O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343040,,CHEMBL3343040,,False,http://www.openphacts.org/units/Nanomolar,2262318,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1565,,15101349,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(NCCc3ccccn3)nc2cc1O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,"{'bei': '12.31', 'le': '0.22', 'lle': '0.85', 'sei': '5.14'}",CHEMBL3343042,,CHEMBL3343042,6.24,False,http://www.openphacts.org/units/Nanomolar,2262320,=,1,True,=,,IC50,nM,,579.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.579
1566,,15101350,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)ccc1O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343044,,CHEMBL3343044,,False,http://www.openphacts.org/units/Nanomolar,2262322,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1567,,15101351,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1ccc(O)c([N+](=O)[O-])c1,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343045,,CHEMBL3343045,,False,http://www.openphacts.org/units/Nanomolar,2262323,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1568,,15101352,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343046,,CHEMBL3343046,,False,http://www.openphacts.org/units/Nanomolar,2262324,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1569,,15101353,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)c(N)cc1O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343047,,CHEMBL3343047,,False,http://www.openphacts.org/units/Nanomolar,2262325,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1570,,15101354,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1OCC(=O)O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343048,,CHEMBL3343048,,False,http://www.openphacts.org/units/Nanomolar,2262326,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1571,,15101355,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3341771,,CHEMBL3341771,,False,http://www.openphacts.org/units/Nanomolar,2262329,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1572,,15101356,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1cccc(-c2c[nH]c(=O)[nH]c2=O)c1,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343051,,CHEMBL3343051,,False,http://www.openphacts.org/units/Nanomolar,2264316,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1573,,15101357,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc1-c1c[nH]c(=O)[nH]c1=O,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343052,,CHEMBL3343052,,False,http://www.openphacts.org/units/Nanomolar,2264317,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1574,,15101358,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(N2CCC(=O)NC2=O)c1,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343055,,CHEMBL3343055,,False,http://www.openphacts.org/units/Nanomolar,2264320,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1575,,15101359,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccc(NC(=O)C3CCCCN3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343057,,CHEMBL3343057,,False,http://www.openphacts.org/units/Nanomolar,2264322,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1576,,15101360,[],CHEMBL3380801,Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)Nc1ccc(NC(=O)c2cc(OC)cc(-c3c[nH]c(=O)[nH]c3=O)c2)cc1,,,CHEMBL3351874,Bioorg. Med. Chem.,2014.0,,CHEMBL3343058,,CHEMBL3343058,,False,http://www.openphacts.org/units/Nanomolar,2264323,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1577,,15116493,[],CHEMBL3376481,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1,,,CHEMBL3351461,J. Med. Chem.,2014.0,,CHEMBL3356117,,CHEMBL3356117,,False,http://www.openphacts.org/units/Nanomolar,2254072,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
1578,,15150018,[],CHEMBL3395935,Inhibition of IRAK4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1,,,CHEMBL3393036,J. Med. Chem.,2015.0,,CHEMBL3394102,,CHEMBL3394102,,False,http://qudt.org/vocab/unit#Percent,2277712,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1579,,15150019,[],CHEMBL3395935,Inhibition of IRAK4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1,,,CHEMBL3393036,J. Med. Chem.,2015.0,,CHEMBL3394105,,CHEMBL3394105,,False,http://qudt.org/vocab/unit#Percent,2277715,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1580,,15150020,[],CHEMBL3395935,Inhibition of IRAK4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1,,,CHEMBL3393036,J. Med. Chem.,2015.0,,CHEMBL3394108,,CHEMBL3394108,,False,http://qudt.org/vocab/unit#Percent,2277718,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1581,,15150021,[],CHEMBL3395935,Inhibition of IRAK4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay,B,,,BAO_0000201,BAO_0000357,single protein format,COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC,,,CHEMBL3393036,J. Med. Chem.,2015.0,,CHEMBL3394112,,CHEMBL3394112,,False,http://qudt.org/vocab/unit#Percent,2277722,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1582,,15150022,[],CHEMBL3395935,Inhibition of IRAK4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1,,,CHEMBL3393036,J. Med. Chem.,2015.0,,CHEMBL3394118,,CHEMBL3394118,,False,http://qudt.org/vocab/unit#Percent,2277728,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1583,,15171748,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N[C@@H]2CC[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403432,,CHEMBL3403432,,False,http://www.openphacts.org/units/Nanomolar,2284926,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1584,,15171749,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.41', 'le': '0.30', 'lle': '4.22', 'sei': '5.36'}",CHEMBL2018068,,CHEMBL2018068,6.62,False,http://www.openphacts.org/units/Nanomolar,2284925,=,1,True,=,,IC50,nM,,240.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.24
1585,,15171750,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(C(F)(F)F)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403431,,CHEMBL3403431,,False,http://www.openphacts.org/units/Nanomolar,2284924,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1586,,15171751,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(C2CC2)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403430,,CHEMBL3403430,,False,http://www.openphacts.org/units/Nanomolar,2284923,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1587,,15171752,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '12.86', 'le': '0.25', 'lle': '3.75', 'sei': '3.76'}",CHEMBL3403429,,CHEMBL3403429,5.16,False,http://www.openphacts.org/units/Nanomolar,2284922,=,1,True,=,,IC50,nM,,6850.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,6.85
1588,,15171753,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.42', 'le': '0.30', 'lle': '4.81', 'sei': '4.35'}",CHEMBL2018065,,CHEMBL2018065,5.97,False,http://www.openphacts.org/units/Nanomolar,2284921,=,1,True,=,,IC50,nM,,1060.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.06
1589,,15171754,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.73', 'le': '0.35', 'lle': '5.77', 'sei': '4.82'}",CHEMBL2018064,,CHEMBL2018064,6.62,False,http://www.openphacts.org/units/Nanomolar,2284920,=,1,True,=,,IC50,nM,,240.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.24
1590,,15171755,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403428,,CHEMBL3403428,,False,http://www.openphacts.org/units/Nanomolar,2284919,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1591,,15171756,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(N)c(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.60', 'le': '0.27', 'lle': '4.85', 'sei': '3.23'}",CHEMBL3403427,,CHEMBL3403427,5.29,False,http://www.openphacts.org/units/Nanomolar,2284918,=,1,True,=,,IC50,nM,,5190.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,5.19
1592,,15171757,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403426,,CHEMBL3403426,,False,http://www.openphacts.org/units/Nanomolar,2284917,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1593,,15171758,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc(Cl)c(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.60', 'le': '0.34', 'lle': '5.27', 'sei': '4.93'}",CHEMBL2018055,,CHEMBL2018055,6.77,False,http://www.openphacts.org/units/Nanomolar,2284916,=,1,True,=,,IC50,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.17
1594,,15171759,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N[C@H]2CC[C@@H](CO)C2)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403433,,CHEMBL3403433,,False,http://www.openphacts.org/units/Nanomolar,2284927,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1595,,15171760,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N2CCOCC2)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403434,,CHEMBL3403434,,False,http://www.openphacts.org/units/Nanomolar,2284928,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1596,,15171761,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(NCC2CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL2018071,,CHEMBL2018071,,False,http://www.openphacts.org/units/Nanomolar,2284929,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1597,,15171762,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2ccccc2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403435,,CHEMBL3403435,,False,http://www.openphacts.org/units/Nanomolar,2284930,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1598,,15171763,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2ccccn2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.16', 'le': '0.36', 'lle': '6.44', 'sei': '4.43'}",CHEMBL3403436,,CHEMBL3403436,6.08,False,http://www.openphacts.org/units/Nanomolar,2284931,=,1,True,=,,IC50,nM,,830.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.83
1599,,15171764,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2nc3ccccc3o2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.64', 'le': '0.29', 'lle': '5.21', 'sei': '3.71'}",CHEMBL3403437,,CHEMBL3403437,5.59,False,http://www.openphacts.org/units/Nanomolar,2284932,=,1,True,=,,IC50,nM,,2570.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.57
1600,,15171765,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(-c2cnc(N)nc2N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)nc2ccccc21,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403438,,CHEMBL3403438,,False,http://www.openphacts.org/units/Nanomolar,2284933,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1601,,15171766,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2nc3cccnc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.76', 'le': '0.33', 'lle': '6.04', 'sei': '4.18'}",CHEMBL3403439,,CHEMBL3403439,6.28,False,http://www.openphacts.org/units/Nanomolar,2284934,=,1,True,=,,IC50,nM,,530.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.53
1602,,15171767,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2nc3ccncc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.82', 'le': '0.41', 'lle': '7.56', 'sei': '5.19'}",CHEMBL3403440,,CHEMBL3403440,7.80,False,http://www.openphacts.org/units/Nanomolar,2284935,=,1,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.016
1603,,15171768,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2nc3cnccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.35', 'le': '0.40', 'lle': '7.38', 'sei': '5.07'}",CHEMBL3403441,,CHEMBL3403441,7.62,False,http://www.openphacts.org/units/Nanomolar,2284936,=,1,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.024
1604,,15171769,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2cnc3ccccn23)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.68', 'le': '0.31', 'lle': '6.05', 'sei': '4.19'}",CHEMBL3403442,,CHEMBL3403442,5.94,False,http://www.openphacts.org/units/Nanomolar,2284937,=,1,True,=,,IC50,nM,,1140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.14
1605,,15171770,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2ccc3ccccc3n2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.01', 'le': '0.35', 'lle': '6.19', 'sei': '5.08'}",CHEMBL3403443,,CHEMBL3403443,6.98,False,http://www.openphacts.org/units/Nanomolar,2284938,=,1,True,=,,IC50,nM,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.104
1606,,15171771,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2nccs2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.48', 'le': '0.33', 'lle': '5.63', 'sei': '3.88'}",CHEMBL3403444,,CHEMBL3403444,5.33,False,http://www.openphacts.org/units/Nanomolar,2284939,=,1,True,=,,IC50,nM,,4700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.7
1607,,15171772,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2nc(-c3ccccc3)cs2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.99', 'le': '0.31', 'lle': '5.03', 'sei': '4.65'}",CHEMBL3403445,,CHEMBL3403445,6.39,False,http://www.openphacts.org/units/Nanomolar,2284940,=,1,True,=,,IC50,nM,,410.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.41
1608,,15171773,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncc(-c2ncc(-c3ccccc3)s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403446,,CHEMBL3403446,,False,http://www.openphacts.org/units/Nanomolar,2284941,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,20.0
1609,,15171774,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNc1ncc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403447,,CHEMBL3403447,,False,http://www.openphacts.org/units/Nanomolar,2284942,=,1,True,=,,IC50,nM,,1193000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1193.0
1610,,15171775,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCCNc1ncc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403448,,CHEMBL3403448,,False,http://www.openphacts.org/units/Nanomolar,2284943,=,1,True,=,,IC50,nM,,228000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,228.0
1611,,15171776,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(NCC3CC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403449,,CHEMBL3403449,,False,http://www.openphacts.org/units/Nanomolar,2284944,=,1,True,=,,IC50,nM,,333000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,333.0
1612,,15171777,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(NC3CCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403450,,CHEMBL3403450,,False,http://www.openphacts.org/units/Nanomolar,2284945,=,1,True,=,,IC50,nM,,403000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,403.0
1613,,15171778,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(NC3CCCCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403451,,CHEMBL3403451,,False,http://www.openphacts.org/units/Nanomolar,2284946,=,1,True,=,,IC50,nM,,3012000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3012.0
1614,,15171779,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(NC3CCOCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3403452,,CHEMBL3403452,,False,http://www.openphacts.org/units/Nanomolar,2284947,=,1,True,=,,IC50,nM,,1081000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1081.0
1615,,15171780,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(Nc3ccccc3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '9.74', 'le': '0.19', 'lle': '1.37', 'sei': '3.55'}",CHEMBL3403453,,CHEMBL3403453,4.38,False,http://www.openphacts.org/units/Nanomolar,2284948,=,1,True,=,,IC50,nM,,42000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,42.0
1616,,15171781,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '12.92', 'le': '0.25', 'lle': '3.29', 'sei': '4.40'}",CHEMBL3403454,,CHEMBL3403454,6.00,False,http://www.openphacts.org/units/Nanomolar,2284949,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.0
1617,,15171782,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '12.54', 'le': '0.24', 'lle': '2.98', 'sei': '4.40'}",CHEMBL3403455,,CHEMBL3403455,6.00,False,http://www.openphacts.org/units/Nanomolar,2284950,=,1,True,=,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.0
1618,,15171783,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '11.57', 'le': '0.22', 'lle': '3.42', 'sei': '3.50'}",CHEMBL3403456,,CHEMBL3403456,5.22,False,http://www.openphacts.org/units/Nanomolar,2284951,=,1,True,=,,IC50,nM,,6000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,6.0
1619,,15171784,[],CHEMBL3407004,Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3nc4ccncc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3400143,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.60', 'le': '0.26', 'lle': '4.10', 'sei': '4.37'}",CHEMBL3403457,,CHEMBL3403457,6.52,False,http://www.openphacts.org/units/Nanomolar,2284952,=,1,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.3
1620,,15173738,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,Fc1cnc2[nH]cc(-c3ncc(F)c(N[C@H]4C5CCC(CC5)[C@@H]4c4nnn[nH]4)n3)c2c1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401975,,CHEMBL3401975,,False,http://www.openphacts.org/units/Nanomolar,2283043,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1621,,15173739,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,O=P(O)(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401976,,CHEMBL3401976,,False,http://www.openphacts.org/units/Nanomolar,2283044,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1622,,15173740,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,O=P(O)(O)CC[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401977,,CHEMBL3401977,,False,http://www.openphacts.org/units/Nanomolar,2283045,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1623,,15173741,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,O=c1[nH]c(=O)n(C[C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401978,,CHEMBL3401978,,False,http://www.openphacts.org/units/Nanomolar,2283046,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1624,,15173742,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)no1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401979,,CHEMBL3401979,,False,http://www.openphacts.org/units/Nanomolar,2283047,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1625,,15173743,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,CC(=O)NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401980,,CHEMBL3401980,,False,http://www.openphacts.org/units/Nanomolar,2283048,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1626,,15173744,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)on1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401981,,CHEMBL3401981,,False,http://www.openphacts.org/units/Nanomolar,2283049,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1627,,15173745,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,O=c1nc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]o1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401982,,CHEMBL3401982,,False,http://www.openphacts.org/units/Nanomolar,2283050,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1628,,15173746,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401983,,CHEMBL3401983,,False,http://www.openphacts.org/units/Nanomolar,2283051,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1629,,15173747,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,OCC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.40', 'le': '0.25', 'lle': '2.70', 'sei': '5.21'}",CHEMBL3401984,,CHEMBL3401984,5.57,False,http://www.openphacts.org/units/Nanomolar,2283052,=,1,True,=,,Ki,nM,,2700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,2.7
1630,,15173748,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]n1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401985,,CHEMBL3401985,,False,http://www.openphacts.org/units/Nanomolar,2283053,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1631,,15173749,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401986,,CHEMBL3401986,,False,http://www.openphacts.org/units/Nanomolar,2283054,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1632,,15173750,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,CC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.72', 'le': '0.26', 'lle': '1.58', 'sei': '6.32'}",CHEMBL3401987,,CHEMBL3401987,5.48,False,http://www.openphacts.org/units/Nanomolar,2283055,=,1,True,=,,Ki,nM,,3300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,3.3
1633,,15173751,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,Cc1noc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)n1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401988,,CHEMBL3401988,,False,http://www.openphacts.org/units/Nanomolar,2283056,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1634,,15173752,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,Cc1nnc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401989,,CHEMBL3401989,,False,http://www.openphacts.org/units/Nanomolar,2283057,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1635,,15173753,[],CHEMBL3405457,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,CS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F,,,CHEMBL3399966,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3401990,,CHEMBL3401990,,False,http://www.openphacts.org/units/Nanomolar,2283058,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,uM,UO_0000065,,4.0
1636,,15251847,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL443738,,CHEMBL443738,,False,http://qudt.org/vocab/unit#Percent,2298238,=,1,False,=,,Activity,%,,60.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,60.0
1637,,15251950,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427170,,CHEMBL3427170,,False,http://qudt.org/vocab/unit#Percent,2298239,=,1,False,=,,Activity,%,,42.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,42.0
1638,,15252052,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427171,,CHEMBL3427171,,False,http://qudt.org/vocab/unit#Percent,2298240,=,1,False,=,,Activity,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,91.0
1639,,15252697,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427172,,CHEMBL3427172,,False,http://qudt.org/vocab/unit#Percent,2298241,=,1,False,=,,Activity,%,,86.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,86.0
1640,,15252799,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427173,,CHEMBL3427173,,False,http://qudt.org/vocab/unit#Percent,2298242,=,1,False,=,,Activity,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,90.0
1641,,15252901,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427174,,CHEMBL3427174,,False,http://qudt.org/vocab/unit#Percent,2298243,=,1,False,=,,Activity,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,88.0
1642,,15253575,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427175,,CHEMBL3427175,,False,http://qudt.org/vocab/unit#Percent,2298244,=,1,False,=,,Activity,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,84.0
1643,,15253677,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427176,,CHEMBL3427176,,False,http://qudt.org/vocab/unit#Percent,2298245,=,1,False,=,,Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,95.0
1644,,15253779,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427177,,CHEMBL3427177,,False,http://qudt.org/vocab/unit#Percent,2298246,=,1,False,=,,Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,96.0
1645,,15254445,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427178,,CHEMBL3427178,,False,http://qudt.org/vocab/unit#Percent,2298247,=,1,False,=,,Activity,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,94.0
1646,,15254547,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427179,,CHEMBL3427179,,False,http://qudt.org/vocab/unit#Percent,2298248,=,1,False,=,,Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,95.0
1647,,15254649,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427180,,CHEMBL3427180,,False,http://qudt.org/vocab/unit#Percent,2298249,=,1,False,=,,Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,75.0
1648,,15255340,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427181,,CHEMBL3427181,,False,http://qudt.org/vocab/unit#Percent,2298250,=,1,False,=,,Activity,%,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,79.0
1649,,15255442,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427182,,CHEMBL3427182,,False,http://qudt.org/vocab/unit#Percent,2298251,=,1,False,=,,Activity,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,76.0
1650,,15256174,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427183,,CHEMBL3427183,,False,http://qudt.org/vocab/unit#Percent,2298252,=,1,False,=,,Activity,%,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,49.0
1651,,15256276,[],CHEMBL3428234,Inhibition of IRAK4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1,,,CHEMBL3425453,Eur. J. Med. Chem.,2015.0,,CHEMBL3427184,,CHEMBL3427184,,False,http://qudt.org/vocab/unit#Percent,2298253,=,1,False,=,,Activity,%,,33.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,33.0
1652,,15623113,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2ccccc2)n1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.77', 'le': '0.32', 'lle': '3.18', 'sei': '7.34'}",CHEMBL1439445,,CHEMBL1439445,5.66,False,http://www.openphacts.org/units/Nanomolar,2484929,=,1,True,=,,IC50,nM,,2200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.2
1653,,15623114,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(-c3ccccc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.62', 'le': '0.28', 'lle': '2.02', 'sei': '7.99'}",CHEMBL3586483,,CHEMBL3586483,6.16,False,http://www.openphacts.org/units/Nanomolar,2484930,=,1,True,=,,IC50,nM,,690.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,690.0
1654,,15623115,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.95', 'le': '0.29', 'lle': '2.62', 'sei': '7.84'}",CHEMBL3586484,,CHEMBL3586484,6.77,False,http://www.openphacts.org/units/Nanomolar,2484931,=,1,True,=,,IC50,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,170.0
1655,,15623116,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1OC,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.19', 'le': '0.30', 'lle': '3.20', 'sei': '7.70'}",CHEMBL3586485,,CHEMBL3586485,7.36,False,http://www.openphacts.org/units/Nanomolar,2484932,=,1,True,=,,IC50,nM,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,44.0
1656,,15623117,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.25', 'le': '0.33', 'lle': '3.67', 'sei': '8.02'}",CHEMBL3586486,,CHEMBL3586486,7.21,False,http://www.openphacts.org/units/Nanomolar,2484933,=,1,True,=,,IC50,nM,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,61.0
1657,,15623118,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)ccn1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.06', 'le': '0.27', 'lle': '2.86', 'sei': '6.46'}",CHEMBL3586487,,CHEMBL3586487,6.41,False,http://www.openphacts.org/units/Nanomolar,2484934,=,1,True,=,,IC50,nM,,390.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,390.0
1658,,15623119,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(-c3cccnc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.71', 'le': '0.32', 'lle': '3.46', 'sei': '7.78'}",CHEMBL3586488,,CHEMBL3586488,7.00,False,http://www.openphacts.org/units/Nanomolar,2484935,=,1,True,=,,IC50,nM,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,99.0
1659,,15623120,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cn1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.30', 'le': '0.28', 'lle': '2.96', 'sei': '6.56'}",CHEMBL3586489,,CHEMBL3586489,6.51,False,http://www.openphacts.org/units/Nanomolar,2484936,=,1,True,=,,IC50,nM,,310.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,310.0
1660,,15623121,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.95', 'le': '0.33', 'lle': '3.08', 'sei': '8.34'}",CHEMBL3586490,,CHEMBL3586490,6.43,False,http://www.openphacts.org/units/Nanomolar,2484937,=,1,True,=,,IC50,nM,,370.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,370.0
1661,,15623122,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCCCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.03', 'le': '0.26', 'lle': '1.10', 'sei': '7.29'}",CHEMBL3586491,,CHEMBL3586491,5.62,False,http://www.openphacts.org/units/Nanomolar,2484938,=,1,True,=,,IC50,nM,,2400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2400.0
1662,,15623123,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCOCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.87', 'le': '0.29', 'lle': '3.02', 'sei': '7.40'}",CHEMBL3586492,,CHEMBL3586492,6.39,False,http://www.openphacts.org/units/Nanomolar,2484939,=,1,True,=,,IC50,nM,,410.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,410.0
1663,,15623124,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.68', 'le': '0.32', 'lle': '4.16', 'sei': '7.96'}",CHEMBL3586493,,CHEMBL3586493,7.10,False,http://www.openphacts.org/units/Nanomolar,2484940,=,1,True,=,,IC50,nM,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,80.0
1664,,15623125,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.42', 'le': '0.30', 'lle': '3.54', 'sei': '8.49'}",CHEMBL3586494,,CHEMBL3586494,6.82,False,http://www.openphacts.org/units/Nanomolar,2484941,=,1,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,150.0
1665,,15623126,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.52', 'le': '0.30', 'lle': '3.27', 'sei': '9.12'}",CHEMBL3586495,,CHEMBL3586495,7.33,False,http://www.openphacts.org/units/Nanomolar,2484942,=,1,True,=,,IC50,nM,,47.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,47.0
1666,,15623127,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.21', 'le': '0.28', 'lle': '3.54', 'sei': '6.92'}",CHEMBL3586496,,CHEMBL3586496,6.75,False,http://www.openphacts.org/units/Nanomolar,2484943,=,1,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
1667,,15623128,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(C(N)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.98', 'le': '0.28', 'lle': '3.93', 'sei': '5.39'}",CHEMBL3586497,,CHEMBL3586497,6.66,False,http://www.openphacts.org/units/Nanomolar,2484944,=,1,True,=,,IC50,nM,,220.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,220.0
1668,,15623129,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.96', 'le': '0.29', 'lle': '4.56', 'sei': '6.27'}",CHEMBL3586498,,CHEMBL3586498,7.17,False,http://www.openphacts.org/units/Nanomolar,2484945,=,1,True,=,,IC50,nM,,67.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,67.0
1669,,15623130,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '11.84', 'le': '0.23', 'lle': '3.07', 'sei': '4.96'}",CHEMBL3586499,,CHEMBL3586499,5.68,False,http://www.openphacts.org/units/Nanomolar,2484946,=,1,True,=,,IC50,nM,,2100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2100.0
1670,,15623131,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccccc3)n2)CC1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.08', 'le': '0.27', 'lle': '4.24', 'sei': '5.72'}",CHEMBL3586500,,CHEMBL3586500,6.55,False,http://www.openphacts.org/units/Nanomolar,2484947,=,1,True,=,,IC50,nM,,280.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,280.0
1671,,15623132,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.43', 'le': '0.28', 'lle': '4.84', 'sei': '5.78'}",CHEMBL3586501,,CHEMBL3586501,7.15,False,http://www.openphacts.org/units/Nanomolar,2484948,=,1,True,=,,IC50,nM,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,71.0
1672,,15623133,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3)n2)CC1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.30', 'le': '0.27', 'lle': '4.05', 'sei': '6.31'}",CHEMBL3586502,,CHEMBL3586502,7.23,False,http://www.openphacts.org/units/Nanomolar,2484949,=,1,True,=,,IC50,nM,,59.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,59.0
1673,,15623134,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.87', 'le': '0.29', 'lle': '4.65', 'sei': '6.46'}",CHEMBL3586503,,CHEMBL3586503,7.40,False,http://www.openphacts.org/units/Nanomolar,2484950,=,1,True,=,,IC50,nM,,40.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,40.0
1674,,15623135,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '13.50', 'le': '0.26', 'lle': '3.75', 'sei': '6.18'}",CHEMBL3586504,,CHEMBL3586504,7.07,False,http://www.openphacts.org/units/Nanomolar,2484951,=,1,True,=,,IC50,nM,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,85.0
1675,,15623136,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.75', 'le': '0.30', 'lle': '5.56', 'sei': '5.94'}",CHEMBL3586505,,CHEMBL3586505,7.57,False,http://www.openphacts.org/units/Nanomolar,2484952,=,1,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
1676,,15623137,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.20', 'le': '0.29', 'lle': '5.12', 'sei': '6.04'}",CHEMBL3586506,,CHEMBL3586506,7.70,False,http://www.openphacts.org/units/Nanomolar,2484953,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
1677,,15623138,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cnc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.01', 'le': '0.27', 'lle': '5.34', 'sei': '4.81'}",CHEMBL3586507,,CHEMBL3586507,6.75,False,http://www.openphacts.org/units/Nanomolar,2484954,=,1,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
1678,,15623139,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.17', 'le': '0.30', 'lle': '3.12', 'sei': '9.81'}",CHEMBL3586508,,CHEMBL3586508,7.89,False,http://www.openphacts.org/units/Nanomolar,2484955,=,1,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
1679,,15623140,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.34', 'le': '0.34', 'lle': '4.69', 'sei': '8.75'}",CHEMBL3586509,,CHEMBL3586509,8.15,False,http://www.openphacts.org/units/Nanomolar,2484956,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
1680,,15623141,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(N3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '19.88', 'le': '0.37', 'lle': '6.68', 'sei': '8.60'}",CHEMBL3586510,,CHEMBL3586510,8.30,False,http://www.openphacts.org/units/Nanomolar,2484957,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
1681,,15623142,[],CHEMBL3588639,Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(N3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.06', 'le': '0.35', 'lle': '7.75', 'sei': '6.66'}",CHEMBL3586511,,CHEMBL3586511,8.70,False,http://www.openphacts.org/units/Nanomolar,2484958,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1682,,15623177,[],CHEMBL3588643,Inhibition of recombinant human IRAK4 at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,,CHEMBL3586484,,CHEMBL3586484,,False,http://qudt.org/vocab/unit#Percent,2484931,>,1,True,>,,Inhibition,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,80.0
1683,,15623178,[],CHEMBL3588643,Inhibition of recombinant human IRAK4 at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,,CHEMBL3586498,,CHEMBL3586498,,False,http://qudt.org/vocab/unit#Percent,2484945,>,1,True,>,,Inhibition,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,80.0
1684,,15623179,[],CHEMBL3588643,Inhibition of recombinant human IRAK4 at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,,CHEMBL3586505,,CHEMBL3586505,,False,http://qudt.org/vocab/unit#Percent,2484952,>,1,True,>,,Inhibition,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,80.0
1685,,15623189,[],CHEMBL3588654,Inhibition of IRAK4 in human THP1-XBlue cells assessed as suppression of TLR4 agonist LPS-induced activation of NF-kappaB preincubated for 1 hr followed by LPS challenge measured after 5 hrs by secreted embryonic alkaline phosphatase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '11.72', 'le': '0.23', 'lle': '3.01', 'sei': '4.91'}",CHEMBL3586498,,CHEMBL3586498,5.62,False,http://www.openphacts.org/units/Nanomolar,2484945,=,1,True,=,,IC50,nM,,2400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.4
1686,,15623190,[],CHEMBL3588654,Inhibition of IRAK4 in human THP1-XBlue cells assessed as suppression of TLR4 agonist LPS-induced activation of NF-kappaB preincubated for 1 hr followed by LPS challenge measured after 5 hrs by secreted embryonic alkaline phosphatase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-n2nc(N3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.96', 'le': '0.31', 'lle': '5.46', 'sei': '7.34'}",CHEMBL3586510,,CHEMBL3586510,7.08,False,http://www.openphacts.org/units/Nanomolar,2484957,=,1,True,=,,IC50,nM,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,83.0
1687,,15623192,[],CHEMBL3588656,Inhibition of recombinant human IRAK4 at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3585289,ACS Med. Chem. Lett.,2015.0,,CHEMBL3586510,,CHEMBL3586510,,False,http://qudt.org/vocab/unit#Percent,2484957,>,1,True,>,,Inhibition,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,80.0
1688,,15643935,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3cccnc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '24.39', 'le': '0.45', 'lle': '7.15', 'sei': '5.79'}",CHEMBL3590435,,CHEMBL3590435,6.96,False,http://www.openphacts.org/units/Nanomolar,2487229,=,1,True,=,,IC50,nM,,110.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,110.0
1689,,15643936,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(CCCN)nc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '19.93', 'le': '0.37', 'lle': '7.11', 'sei': '4.67'}",CHEMBL3590436,,CHEMBL3590436,6.82,False,http://www.openphacts.org/units/Nanomolar,2487230,=,1,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,150.0
1690,,15643937,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(OCCN)nc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.63', 'le': '0.28', 'lle': '5.89', 'sei': '3.24'}",CHEMBL3590437,,CHEMBL3590437,5.04,False,http://www.openphacts.org/units/Nanomolar,2487231,=,1,True,=,,IC50,nM,,9200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9200.0
1691,,15643938,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(NCCN)nc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '25.34', 'le': '0.48', 'lle': '9.52', 'sei': '5.50'}",CHEMBL3590438,,CHEMBL3590438,8.70,False,http://www.openphacts.org/units/Nanomolar,2487232,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1692,,15643939,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(NC4CCCC4N)nc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.31', 'le': '0.34', 'lle': '6.91', 'sei': '4.44'}",CHEMBL3590471,,CHEMBL3590471,7.02,False,http://www.openphacts.org/units/Nanomolar,2487289,=,1,True,=,,IC50,nM,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,95.0
1693,,15643940,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@H]4CCCC[C@@H]4N)nc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '19.37', 'le': '0.36', 'lle': '7.20', 'sei': '4.87'}",CHEMBL3590472,,CHEMBL3590472,7.70,False,http://www.openphacts.org/units/Nanomolar,2487290,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
1694,,15643941,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@H]4CCCC[C@H]4N)nc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '20.37', 'le': '0.38', 'lle': '7.60', 'sei': '5.12'}",CHEMBL3590473,,CHEMBL3590473,8.10,False,http://www.openphacts.org/units/Nanomolar,2487291,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
1695,,15643942,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(N)=O)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '23.96', 'le': '0.45', 'lle': '9.02', 'sei': '6.02'}",CHEMBL3590474,,CHEMBL3590474,9.52,False,http://www.openphacts.org/units/Nanomolar,2487292,=,1,True,=,,IC50,nM,,0.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.3
1696,,15643943,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)cn1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '22.16', 'le': '0.41', 'lle': '6.45', 'sei': '6.82'}",CHEMBL3590475,,CHEMBL3590475,7.85,False,http://www.openphacts.org/units/Nanomolar,2487293,=,1,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
1697,,15643944,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,COCc1nn(C)cc1NC(=O)c1cnn2ccc(N[C@@H]3CCCC[C@@H]3N)nc12,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '20.63', 'le': '0.39', 'lle': '6.68', 'sei': '6.61'}",CHEMBL3590476,,CHEMBL3590476,8.22,False,http://www.openphacts.org/units/Nanomolar,2487294,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
1698,,15643945,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '23.98', 'le': '0.44', 'lle': '7.83', 'sei': '6.55'}",CHEMBL3590477,,CHEMBL3590477,9.10,False,http://www.openphacts.org/units/Nanomolar,2487295,=,1,True,=,,IC50,nM,,0.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.8
1699,,15643946,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '22.54', 'le': '0.43', 'lle': '7.10', 'sei': '8.27'}",CHEMBL3590478,,CHEMBL3590478,9.52,False,http://www.openphacts.org/units/Nanomolar,2487296,=,1,True,=,,IC50,nM,,0.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.3
1700,,15643947,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '23.98', 'le': '0.46', 'lle': '7.37', 'sei': '8.42'}",CHEMBL3590479,,CHEMBL3590479,9.70,False,http://www.openphacts.org/units/Nanomolar,2487297,=,1,True,=,,IC50,nM,,0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.2
1701,,15643948,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.41', 'le': '0.36', 'lle': '5.65', 'sei': '7.55'}",CHEMBL3590480,,CHEMBL3590480,8.70,False,http://www.openphacts.org/units/Nanomolar,2487298,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1702,,15643949,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(-c2nnco2)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '19.46', 'le': '0.36', 'lle': '6.77', 'sei': '5.34'}",CHEMBL3590481,,CHEMBL3590481,8.22,False,http://www.openphacts.org/units/Nanomolar,2487299,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
1703,,15643950,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(-c2ccncc2)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.70', 'le': '0.31', 'lle': '4.75', 'sei': '5.63'}",CHEMBL3590482,,CHEMBL3590482,7.21,False,http://www.openphacts.org/units/Nanomolar,2487300,=,1,True,=,,IC50,nM,,62.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,62.0
1704,,15643951,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(-c2cncnc2)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.71', 'le': '0.29', 'lle': '4.95', 'sei': '4.82'}",CHEMBL3590483,,CHEMBL3590483,6.80,False,http://www.openphacts.org/units/Nanomolar,2487301,=,1,True,=,,IC50,nM,,160.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,160.0
1705,,15643952,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(NC4CCCCC4)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.51', 'le': '0.30', 'lle': '2.84', 'sei': '7.09'}",CHEMBL3590484,,CHEMBL3590484,6.32,False,http://www.openphacts.org/units/Nanomolar,2487302,=,1,True,=,,IC50,nM,,480.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,480.0
1706,,15643953,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4O)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.13', 'le': '0.35', 'lle': '5.23', 'sei': '7.02'}",CHEMBL3590485,,CHEMBL3590485,7.68,False,http://www.openphacts.org/units/Nanomolar,2487303,=,1,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
1707,,15643954,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4O)nc23)c(C(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '20.71', 'le': '0.40', 'lle': '6.03', 'sei': '7.68'}",CHEMBL3590486,,CHEMBL3590486,8.40,False,http://www.openphacts.org/units/Nanomolar,2487304,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
1708,,15643955,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '20.29', 'le': '0.39', 'lle': '6.86', 'sei': '8.66'}",CHEMBL3590487,,CHEMBL3590487,8.00,False,http://www.openphacts.org/units/Nanomolar,2487305,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
1709,,15643956,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '23.91', 'le': '0.46', 'lle': '7.94', 'sei': '9.74'}",CHEMBL3590488,,CHEMBL3590488,9.00,False,http://www.openphacts.org/units/Nanomolar,2487306,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1710,,15643957,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC(F)(F)[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.66', 'le': '0.33', 'lle': '4.98', 'sei': '6.63'}",CHEMBL3590489,,CHEMBL3590489,7.64,False,http://www.openphacts.org/units/Nanomolar,2487307,=,1,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
1711,,15643958,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC(F)(F)[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.91', 'le': '0.35', 'lle': '5.31', 'sei': '6.85'}",CHEMBL3590490,,CHEMBL3590490,7.89,False,http://www.openphacts.org/units/Nanomolar,2487308,=,1,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
1712,,15643959,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCC(F)(F)C[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.59', 'le': '0.36', 'lle': '5.86', 'sei': '7.40'}",CHEMBL3590491,,CHEMBL3590491,8.52,False,http://www.openphacts.org/units/Nanomolar,2487309,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
1713,,15643960,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.59', 'le': '0.36', 'lle': '5.86', 'sei': '7.40'}",CHEMBL3590492,,CHEMBL3590492,8.52,False,http://www.openphacts.org/units/Nanomolar,2487310,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
1714,,15643961,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N4C[C@H](N)CC(F)(F)C4)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '20.25', 'le': '0.40', 'lle': '7.09', 'sei': '8.46'}",CHEMBL3590493,,CHEMBL3590493,9.00,False,http://www.openphacts.org/units/Nanomolar,2487311,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1715,,15643962,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N4C[C@H](N)CC(F)(F)C4)nc23)c(C(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '21.81', 'le': '0.42', 'lle': '7.47', 'sei': '8.74'}",CHEMBL3590515,,CHEMBL3590515,9.30,False,http://www.openphacts.org/units/Nanomolar,2487342,=,1,True,=,,IC50,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.5
1716,,15643963,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N4C[C@H](N)C[C@@H](F)C4)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '21.81', 'le': '0.42', 'lle': '7.69', 'sei': '8.74'}",CHEMBL3590516,,CHEMBL3590516,9.30,False,http://www.openphacts.org/units/Nanomolar,2487343,=,1,True,=,,IC50,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.5
1717,,15643964,[],CHEMBL3592269,Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N4CC[C@H](F)[C@@H](N)C4)nc23)c(C(F)(F)F)n1,,,CHEMBL3588771,ACS Med. Chem. Lett.,2015.0,"{'bei': '19.28', 'le': '0.37', 'lle': '6.61', 'sei': '7.73'}",CHEMBL3590517,,CHEMBL3590517,8.22,False,http://www.openphacts.org/units/Nanomolar,2487344,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
1718,,15649119,[],CHEMBL3595104,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1,,,CHEMBL3593212,Bioorg. Med. Chem.,2015.0,,CHEMBL3593777,,CHEMBL3593777,,False,http://www.openphacts.org/units/Nanomolar,2488153,>,1,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
1719,,15650139,[],CHEMBL3595405,Inhibition of human IRAK4 at 0.1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1,,,CHEMBL3593229,Eur. J. Med. Chem.,2015.0,,CHEMBL3593290,,CHEMBL3593290,,False,http://qudt.org/vocab/unit#Percent,2487528,=,1,True,=,,Inhibition,%,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,61.0
1720,,15666674,[],CHEMBL3603426,Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '14.32', 'le': '0.27', 'lle': '3.80', 'sei': '5.16'}",CHEMBL3601186,,CHEMBL3601186,7.03,False,http://www.openphacts.org/units/Nanomolar,2492635,=,1,True,=,,IC50,nM,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,94.0
1721,,15666675,[],CHEMBL3603426,Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.99', 'le': '0.27', 'lle': '3.52', 'sei': '5.18'}",CHEMBL3601185,,CHEMBL3601185,7.06,False,http://www.openphacts.org/units/Nanomolar,2492634,=,1,True,=,,IC50,nM,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,87.0
1722,,15666690,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(NC3CCC3)ccc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '11.55', 'le': '0.22', 'lle': '2.08', 'sei': '4.46'}",CHEMBL3601199,,CHEMBL3601199,4.92,False,http://www.openphacts.org/units/Nanomolar,2492648,=,1,True,=,,IC50,nM,,11900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11900.0
1723,,15666691,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.48', 'le': '0.26', 'lle': '3.57', 'sei': '4.03'}",CHEMBL3601198,,CHEMBL3601198,5.02,False,http://www.openphacts.org/units/Nanomolar,2492647,=,1,True,=,,IC50,nM,,9510.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9510.0
1724,,15666692,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.40', 'le': '0.26', 'lle': '3.41', 'sei': '4.85'}",CHEMBL3601197,,CHEMBL3601197,6.43,False,http://www.openphacts.org/units/Nanomolar,2492646,=,1,True,=,,IC50,nM,,373.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,373.0
1725,,15666693,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.44', 'le': '0.32', 'lle': '4.22', 'sei': '6.36'}",CHEMBL3601196,,CHEMBL3601196,7.85,False,http://www.openphacts.org/units/Nanomolar,2492645,=,1,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
1726,,15666694,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2cc(Nc3ccc(F)cc3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '12.74', 'le': '0.25', 'lle': '2.18', 'sei': '5.38'}",CHEMBL3601195,,CHEMBL3601195,5.94,False,http://www.openphacts.org/units/Nanomolar,2492644,=,1,True,=,,IC50,nM,,1140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1140.0
1727,,15666695,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2cc(NC3CCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.69', 'le': '0.30', 'lle': '3.85', 'sei': '6.05'}",CHEMBL3601194,,CHEMBL3601194,6.69,False,http://www.openphacts.org/units/Nanomolar,2492643,=,1,True,=,,IC50,nM,,204.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,204.0
1728,,15666696,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)cn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.65', 'le': '0.36', 'lle': '5.50', 'sei': '5.58'}",CHEMBL3601193,,CHEMBL3601193,6.95,False,http://www.openphacts.org/units/Nanomolar,2492642,=,1,True,=,,IC50,nM,,113.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,113.0
1729,,15666697,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.32', 'le': '0.36', 'lle': '6.17', 'sei': '6.70'}",CHEMBL3601192,,CHEMBL3601192,9.13,False,http://www.openphacts.org/units/Nanomolar,2492641,=,1,True,=,,IC50,nM,,0.74,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.74
1730,,15666698,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)n1ccc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc1=O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.55', 'le': '0.25', 'lle': '4.12', 'sei': '4.68'}",CHEMBL3601191,,CHEMBL3601191,6.81,False,http://www.openphacts.org/units/Nanomolar,2492640,=,1,True,=,,IC50,nM,,155.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,155.0
1731,,15666699,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.06', 'le': '0.28', 'lle': '4.44', 'sei': '5.20'}",CHEMBL3601070,,CHEMBL3601070,7.57,False,http://www.openphacts.org/units/Nanomolar,2492509,=,1,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
1732,,15666700,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(Nc3ccnc(OC4CC4)c3)ncc2-c2ccc3ccccc3n2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '14.70', 'le': '0.27', 'lle': '4.47', 'sei': '5.05'}",CHEMBL3601190,,CHEMBL3601190,7.36,False,http://www.openphacts.org/units/Nanomolar,2492639,=,1,True,=,,IC50,nM,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,44.0
1733,,15666701,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.06', 'le': '0.32', 'lle': '5.75', 'sei': '5.56'}",CHEMBL3601189,,CHEMBL3601189,8.10,False,http://www.openphacts.org/units/Nanomolar,2492638,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
1734,,15666702,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc(-c3ccccc3)cs2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '14.71', 'le': '0.28', 'lle': '4.71', 'sei': '4.71'}",CHEMBL3601188,,CHEMBL3601188,7.03,False,http://www.openphacts.org/units/Nanomolar,2492637,=,1,True,=,,IC50,nM,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,94.0
1735,,15666703,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.92', 'le': '0.27', 'lle': '4.12', 'sei': '4.84'}",CHEMBL3601187,,CHEMBL3601187,7.05,False,http://www.openphacts.org/units/Nanomolar,2492636,=,1,True,=,,IC50,nM,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,89.0
1736,,15666704,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.22', 'le': '0.31', 'lle': '4.73', 'sei': '5.84'}",CHEMBL3601186,,CHEMBL3601186,7.96,False,http://www.openphacts.org/units/Nanomolar,2492635,=,1,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
1737,,15666705,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.64', 'le': '0.32', 'lle': '4.86', 'sei': '6.16'}",CHEMBL3601185,,CHEMBL3601185,8.40,False,http://www.openphacts.org/units/Nanomolar,2492634,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
1738,,15666706,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2ncc(-n3cccn3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '12.63', 'le': '0.24', 'lle': '4.90', 'sei': '3.47'}",CHEMBL3601086,,CHEMBL3601086,5.22,False,http://www.openphacts.org/units/Nanomolar,2492525,=,1,True,=,,IC50,nM,,6008.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6008.0
1739,,15666707,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-n3cccn3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '14.66', 'le': '0.27', 'lle': '5.10', 'sei': '4.27'}",CHEMBL3601085,,CHEMBL3601085,6.03,False,http://www.openphacts.org/units/Nanomolar,2492524,=,1,True,=,,IC50,nM,,932.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,932.0
1740,,15666708,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3cncs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.25', 'le': '0.26', 'lle': '3.81', 'sei': '4.16'}",CHEMBL3601084,,CHEMBL3601084,5.68,False,http://www.openphacts.org/units/Nanomolar,2492523,=,1,True,=,,IC50,nM,,2107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2107.0
1741,,15666709,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3cscn3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '14.16', 'le': '0.28', 'lle': '4.20', 'sei': '4.45'}",CHEMBL3601083,,CHEMBL3601083,6.07,False,http://www.openphacts.org/units/Nanomolar,2492522,=,1,True,=,,IC50,nM,,852.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,852.0
1742,,15666710,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(Nc3ccncc3)ncc2-c2nccs2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601082,,CHEMBL3601082,,False,http://www.openphacts.org/units/Nanomolar,2492521,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20000.0
1743,,15666711,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(Nc3cccnc3)ncc2-c2nc3ccncc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.15', 'le': '0.33', 'lle': '5.94', 'sei': '5.19'}",CHEMBL3601081,,CHEMBL3601081,7.75,False,http://www.openphacts.org/units/Nanomolar,2492520,=,1,True,=,,IC50,nM,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.0
1744,,15666712,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3nc4ccncc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.01', 'le': '0.33', 'lle': '5.81', 'sei': '5.31'}",CHEMBL3601080,,CHEMBL3601080,7.92,False,http://www.openphacts.org/units/Nanomolar,2492519,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1745,,15666713,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3nc4ccncc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.06', 'le': '0.35', 'lle': '6.89', 'sei': '5.49'}",CHEMBL3601079,,CHEMBL3601079,8.70,False,http://www.openphacts.org/units/Nanomolar,2492518,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1746,,15666714,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc3ccncc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.17', 'le': '0.35', 'lle': '7.02', 'sei': '5.07'}",CHEMBL3601078,,CHEMBL3601078,8.22,False,http://www.openphacts.org/units/Nanomolar,2492517,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
1747,,15666715,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(NC3CC3)ncc2-c2nc3cnccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '14.93', 'le': '0.29', 'lle': '4.95', 'sei': '4.54'}",CHEMBL3601077,,CHEMBL3601077,6.19,False,http://www.openphacts.org/units/Nanomolar,2492516,=,1,True,=,,IC50,nM,,647.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,647.0
1748,,15666716,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1cccc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)c1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.05', 'le': '0.31', 'lle': '5.45', 'sei': '5.68'}",CHEMBL3601076,,CHEMBL3601076,7.92,False,http://www.openphacts.org/units/Nanomolar,2492515,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1749,,15666717,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.94', 'le': '0.33', 'lle': '6.34', 'sei': '5.15'}",CHEMBL3601075,,CHEMBL3601075,8.15,False,http://www.openphacts.org/units/Nanomolar,2492514,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
1750,,15666718,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(Nc3cccnc3)ncc2-c2nc3cnccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.63', 'le': '0.34', 'lle': '6.16', 'sei': '5.33'}",CHEMBL3601074,,CHEMBL3601074,7.96,False,http://www.openphacts.org/units/Nanomolar,2492513,=,1,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
1751,,15666719,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc3cnccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.50', 'le': '0.34', 'lle': '6.72', 'sei': '4.89'}",CHEMBL3601073,,CHEMBL3601073,7.92,False,http://www.openphacts.org/units/Nanomolar,2492512,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1752,,15666720,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.01', 'le': '0.33', 'lle': '5.93', 'sei': '6.02'}",CHEMBL3601072,,CHEMBL3601072,8.40,False,http://www.openphacts.org/units/Nanomolar,2492511,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
1753,,15666721,[],CHEMBL3603417,Inhibition of human IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.31', 'le': '0.35', 'lle': '6.41', 'sei': '5.71'}",CHEMBL3601071,,CHEMBL3601071,8.52,False,http://www.openphacts.org/units/Nanomolar,2492510,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
1754,,15666722,[],CHEMBL3603426,Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.02', 'le': '0.30', 'lle': '5.25', 'sei': '5.22'}",CHEMBL3601189,,CHEMBL3601189,7.60,False,http://www.openphacts.org/units/Nanomolar,2492638,=,1,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
1755,,15666723,[],CHEMBL3603426,Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry,B,,,BAO_0000190,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(Nc3ccnc(OC4CC4)c3)ncc2-c2ccc3ccccc3n2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '12.92', 'le': '0.24', 'lle': '3.58', 'sei': '4.44'}",CHEMBL3601190,,CHEMBL3601190,6.47,False,http://www.openphacts.org/units/Nanomolar,2492639,=,1,True,=,,IC50,nM,,341.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,341.0
1756,,15666724,[],CHEMBL3603426,Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Oc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.26', 'le': '0.25', 'lle': '3.54', 'sei': '4.58'}",CHEMBL3601070,,CHEMBL3601070,6.67,False,http://www.openphacts.org/units/Nanomolar,2492509,=,1,True,=,,IC50,nM,,216.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,216.0
1757,,15666725,[],CHEMBL3603426,Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.36', 'le': '0.28', 'lle': '4.30', 'sei': '5.33'}",CHEMBL3601192,,CHEMBL3601192,7.26,False,http://www.openphacts.org/units/Nanomolar,2492641,=,1,True,=,,IC50,nM,,55.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,55.0
1758,,15666726,[],CHEMBL3603426,Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '11.44', 'le': '0.22', 'lle': '1.83', 'sei': '4.43'}",CHEMBL3601196,,CHEMBL3601196,5.46,False,http://www.openphacts.org/units/Nanomolar,2492645,=,1,True,=,,IC50,nM,,3452.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3452.0
1759,,15667060,[],CHEMBL3603432,"Potency index, ratio of IC50 for inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene to IC50 for human IRAK4 (unknown origin)",B,,,BAO_0000179,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601185,,CHEMBL3601185,,False,,2492634,=,1,False,=,,Ratio IC50,,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,10.0
1760,,15667061,[],CHEMBL3603432,"Potency index, ratio of IC50 for inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene to IC50 for human IRAK4 (unknown origin)",B,,,BAO_0000179,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601186,,CHEMBL3601186,,False,,2492635,=,1,False,=,,Ratio IC50,,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,10.0
1761,,15667062,[],CHEMBL3603432,"Potency index, ratio of IC50 for inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene to IC50 for human IRAK4 (unknown origin)",B,,,BAO_0000179,BAO_0000219,cell-based format,COc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601189,,CHEMBL3601189,,False,,2492638,=,1,False,=,,Ratio IC50,,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,10.0
1762,,15667063,[],CHEMBL3603432,"Potency index, ratio of IC50 for inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene to IC50 for human IRAK4 (unknown origin)",B,,,BAO_0000179,BAO_0000219,cell-based format,OC[C@H]1C[C@@H](Nc2nc(Nc3ccnc(OC4CC4)c3)ncc2-c2ccc3ccccc3n2)[C@H](O)[C@@H]1O,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601190,,CHEMBL3601190,,False,,2492639,=,1,False,=,,Ratio IC50,,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,10.0
1763,,15667064,[],CHEMBL3603432,"Potency index, ratio of IC50 for inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene to IC50 for human IRAK4 (unknown origin)",B,,,BAO_0000179,BAO_0000219,cell-based format,CC(C)Oc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601070,,CHEMBL3601070,,False,,2492509,=,1,False,=,,Ratio IC50,,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,10.0
1764,,15667065,[],CHEMBL3603432,"Potency index, ratio of IC50 for inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene to IC50 for human IRAK4 (unknown origin)",B,,,BAO_0000179,BAO_0000219,cell-based format,Cc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601192,,CHEMBL3601192,,False,,2492641,=,1,False,=,,Ratio IC50,,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,10.0
1765,,15667066,[],CHEMBL3603432,"Potency index, ratio of IC50 for inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene to IC50 for human IRAK4 (unknown origin)",B,,,BAO_0000179,BAO_0000219,cell-based format,Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1,,,CHEMBL3600286,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3601196,,CHEMBL3601196,,False,,2492645,>,1,False,>,,Ratio IC50,,,240.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,240.0
1766,,15686143,[],CHEMBL3606973,Inhibition of IRAK4 (unknown origin) at 250 nM by radioactive filter-binding assay,B,,,BAO_0000201,BAO_0000357,single protein format,c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1,,,CHEMBL3603808,Bioorg. Med. Chem.,2015.0,,CHEMBL3605055,,CHEMBL3605055,,False,http://qudt.org/vocab/unit#Percent,2495082,>=,1,True,>=,,Inhibition,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,80.0
1767,,15686164,[],CHEMBL3606880,Inhibition of IRAK4 (unknown origin) at 2 uM by radioactive filter-binding assay,B,,,BAO_0000201,BAO_0000357,single protein format,NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I,,,CHEMBL3603808,Bioorg. Med. Chem.,2015.0,,CHEMBL3605056,,CHEMBL3605056,,False,http://qudt.org/vocab/unit#Percent,2495085,>=,1,True,>=,,Inhibition,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,80.0
1768,,15734943,[],CHEMBL3625601,Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.62', 'le': '0.28', 'lle': '3.80', 'sei': '6.55'}",CHEMBL3622530,,CHEMBL3622530,6.24,False,http://www.openphacts.org/units/Nanomolar,2504893,=,1,True,=,,IC50,nM,,580.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,580.0
1769,,15734944,[],CHEMBL3625601,Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNC[C@H](O)C2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.12', 'le': '0.29', 'lle': '5.46', 'sei': '5.61'}",CHEMBL3622525,,CHEMBL3622525,6.48,False,http://www.openphacts.org/units/Nanomolar,2504888,=,1,True,=,,IC50,nM,,333.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,333.0
1770,,15734945,[],CHEMBL3625601,Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.31', 'le': '0.32', 'lle': '4.68', 'sei': '7.07'}",CHEMBL3622518,,CHEMBL3622518,6.73,False,http://www.openphacts.org/units/Nanomolar,2504881,=,1,True,=,,IC50,nM,,187.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,187.0
1771,,15734946,[],CHEMBL3625601,Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '13.98', 'le': '0.27', 'lle': '6.03', 'sei': '4.47'}",CHEMBL3621219,,CHEMBL3621219,6.43,False,http://www.openphacts.org/units/Nanomolar,2504880,=,1,True,=,,IC50,nM,,375.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,375.0
1772,,15734947,[],CHEMBL3625601,Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '13.55', 'le': '0.26', 'lle': '4.73', 'sei': '5.09'}",CHEMBL3622516,,CHEMBL3622516,6.85,False,http://www.openphacts.org/units/Nanomolar,2504878,=,1,True,=,,IC50,nM,,141.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,141.0
1773,,15734948,[],CHEMBL3625601,Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.21', 'le': '0.30', 'lle': '5.76', 'sei': '4.85'}",CHEMBL3622513,,CHEMBL3622513,6.54,False,http://www.openphacts.org/units/Nanomolar,2504875,=,1,True,=,,IC50,nM,,292.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,292.0
1774,,15734949,[],CHEMBL3625601,Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.03', 'le': '0.31', 'lle': '5.95', 'sei': '5.28'}",CHEMBL3622512,,CHEMBL3622512,7.11,False,http://www.openphacts.org/units/Nanomolar,2504874,=,1,True,=,,IC50,nM,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,78.0
1775,,15734950,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)cc(C)n1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.15', 'le': '0.27', 'lle': '4.68', 'sei': '4.48'}",CHEMBL3622532,,CHEMBL3622532,7.00,False,http://www.openphacts.org/units/Nanomolar,2504895,=,1,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
1776,,15734951,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1C[C@@H](Nc2nc(NC3CC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.30', 'le': '0.30', 'lle': '4.49', 'sei': '5.13'}",CHEMBL3622531,,CHEMBL3622531,6.33,False,http://www.openphacts.org/units/Nanomolar,2504894,=,1,True,=,,IC50,nM,,470.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,470.0
1777,,15734952,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.48', 'le': '0.32', 'lle': '4.59', 'sei': '7.39'}",CHEMBL3622530,,CHEMBL3622530,7.03,False,http://www.openphacts.org/units/Nanomolar,2504893,=,1,True,=,,IC50,nM,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,93.0
1778,,15734953,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.65', 'le': '0.28', 'lle': '3.81', 'sei': '6.57'}",CHEMBL3622529,,CHEMBL3622529,6.25,False,http://www.openphacts.org/units/Nanomolar,2504892,=,1,True,=,,IC50,nM,,565.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,565.0
1779,,15734954,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCC[C@@H](O)C2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.84', 'le': '0.29', 'lle': '3.74', 'sei': '6.14'}",CHEMBL3622528,,CHEMBL3622528,6.34,False,http://www.openphacts.org/units/Nanomolar,2504891,=,1,True,=,,IC50,nM,,454.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,454.0
1780,,15734955,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCNCC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.77', 'le': '0.33', 'lle': '4.87', 'sei': '7.27'}",CHEMBL3622527,,CHEMBL3622527,6.92,False,http://www.openphacts.org/units/Nanomolar,2504890,=,1,True,=,,IC50,nM,,121.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,121.0
1781,,15734956,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.88', 'le': '0.29', 'lle': '4.78', 'sei': '5.65'}",CHEMBL3622526,,CHEMBL3622526,6.35,False,http://www.openphacts.org/units/Nanomolar,2504889,=,1,True,=,,IC50,nM,,450.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,450.0
1782,,15734957,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNC[C@H](O)C2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.50', 'le': '0.32', 'lle': '6.05', 'sei': '6.13'}",CHEMBL3622525,,CHEMBL3622525,7.07,False,http://www.openphacts.org/units/Nanomolar,2504888,=,1,True,=,,IC50,nM,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,85.0
1783,,15734958,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCCC[C@H]1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '12.75', 'le': '0.25', 'lle': '3.65', 'sei': '5.00'}",CHEMBL3622524,,CHEMBL3622524,5.62,False,http://www.openphacts.org/units/Nanomolar,2504887,=,1,True,=,,IC50,nM,,2429.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2429.0
1784,,15734959,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.65', 'le': '0.32', 'lle': '4.66', 'sei': '7.46'}",CHEMBL3622523,,CHEMBL3622523,7.10,False,http://www.openphacts.org/units/Nanomolar,2504886,=,1,True,=,,IC50,nM,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,79.0
1785,,15734960,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.45', 'le': '0.30', 'lle': '4.02', 'sei': '6.04'}",CHEMBL3622522,,CHEMBL3622522,6.59,False,http://www.openphacts.org/units/Nanomolar,2504885,=,1,True,=,,IC50,nM,,258.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,258.0
1786,,15734961,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.12', 'le': '0.29', 'lle': '4.06', 'sei': '7.47'}",CHEMBL3622521,,CHEMBL3622521,6.45,False,http://www.openphacts.org/units/Nanomolar,2504884,=,1,True,=,,IC50,nM,,354.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,354.0
1787,,15734962,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.68', 'le': '0.36', 'lle': '5.78', 'sei': '7.82'}",CHEMBL3622520,,CHEMBL3622520,7.44,False,http://www.openphacts.org/units/Nanomolar,2504883,=,1,True,=,,IC50,nM,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,36.0
1788,,15734963,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.58', 'le': '0.30', 'lle': '4.55', 'sei': '6.52'}",CHEMBL3622519,,CHEMBL3622519,6.21,False,http://www.openphacts.org/units/Nanomolar,2504882,=,1,True,=,,IC50,nM,,620.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,620.0
1789,,15734964,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '18.72', 'le': '0.36', 'lle': '5.67', 'sei': '8.11'}",CHEMBL3622518,,CHEMBL3622518,7.72,False,http://www.openphacts.org/units/Nanomolar,2504881,=,1,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
1790,,15734965,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.32', 'le': '0.34', 'lle': '7.56', 'sei': '5.53'}",CHEMBL3621219,,CHEMBL3621219,7.96,False,http://www.openphacts.org/units/Nanomolar,2504880,=,1,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
1791,,15734966,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.59', 'le': '0.30', 'lle': '7.06', 'sei': '5.34'}",CHEMBL3622517,,CHEMBL3622517,7.37,False,http://www.openphacts.org/units/Nanomolar,2504879,=,1,True,=,,IC50,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,43.0
1792,,15734967,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.97', 'le': '0.29', 'lle': '5.45', 'sei': '5.62'}",CHEMBL3622516,,CHEMBL3622516,7.57,False,http://www.openphacts.org/units/Nanomolar,2504878,=,1,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
1793,,15734968,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(F)(F)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '13.92', 'le': '0.28', 'lle': '5.07', 'sei': '5.10'}",CHEMBL3622515,,CHEMBL3622515,6.87,False,http://www.openphacts.org/units/Nanomolar,2504877,=,1,True,=,,IC50,nM,,135.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,135.0
1794,,15734969,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.10', 'le': '0.31', 'lle': '5.82', 'sei': '5.47'}",CHEMBL3622514,,CHEMBL3622514,7.37,False,http://www.openphacts.org/units/Nanomolar,2504876,=,1,True,=,,IC50,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,43.0
1795,,15734970,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '16.70', 'le': '0.33', 'lle': '6.40', 'sei': '5.33'}",CHEMBL3622513,,CHEMBL3622513,7.17,False,http://www.openphacts.org/units/Nanomolar,2504875,=,1,True,=,,IC50,nM,,67.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,67.0
1796,,15734971,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.46', 'le': '0.34', 'lle': '6.58', 'sei': '5.75'}",CHEMBL3622512,,CHEMBL3622512,7.75,False,http://www.openphacts.org/units/Nanomolar,2504874,=,1,True,=,,IC50,nM,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.0
1797,,15734972,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.11', 'le': '0.30', 'lle': '5.68', 'sei': '4.69'}",CHEMBL3622511,,CHEMBL3622511,6.31,False,http://www.openphacts.org/units/Nanomolar,2504873,=,1,True,=,,IC50,nM,,490.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,490.0
1798,,15734973,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.35', 'le': '0.31', 'lle': '5.17', 'sei': '4.91'}",CHEMBL3622188,,CHEMBL3622188,6.45,False,http://www.openphacts.org/units/Nanomolar,2504461,=,1,True,=,,IC50,nM,,352.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,352.0
1799,,15734974,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(OC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '12.99', 'le': '0.25', 'lle': '4.28', 'sei': '4.11'}",CHEMBL3622187,,CHEMBL3622187,5.77,False,http://www.openphacts.org/units/Nanomolar,2504460,=,1,True,=,,IC50,nM,,1688.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1688.0
1800,,15734975,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.93', 'le': '0.29', 'lle': '5.98', 'sei': '3.85'}",CHEMBL3622186,,CHEMBL3622186,5.83,False,http://www.openphacts.org/units/Nanomolar,2504459,=,1,True,=,,IC50,nM,,1487.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1487.0
1801,,15734976,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '14.94', 'le': '0.29', 'lle': '4.89', 'sei': '4.58'}",CHEMBL3622185,,CHEMBL3622185,6.01,False,http://www.openphacts.org/units/Nanomolar,2504458,=,1,True,=,,IC50,nM,,972.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,972.0
1802,,15734977,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '15.95', 'le': '0.31', 'lle': '5.33', 'sei': '4.72'}",CHEMBL3622184,,CHEMBL3622184,6.20,False,http://www.openphacts.org/units/Nanomolar,2504457,=,1,True,=,,IC50,nM,,635.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,635.0
1803,,15734978,[],CHEMBL3625600,Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '17.70', 'le': '0.35', 'lle': '6.46', 'sei': '5.30'}",CHEMBL3622183,,CHEMBL3622183,7.60,False,http://www.openphacts.org/units/Nanomolar,2504456,=,1,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
1804,,15735003,[],CHEMBL3625606,Inhibition of IRAK4 in human PBMC assessed as reduction of IL1beta-induced TNFalpha production treated 30 mins before IL1beta stimulation measured after 5 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '13.87', 'le': '0.27', 'lle': '3.67', 'sei': '6.01'}",CHEMBL3622518,,CHEMBL3622518,5.72,False,http://www.openphacts.org/units/Nanomolar,2504881,=,1,True,=,,IC50,nM,,1900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.9
1805,,15735004,[],CHEMBL3625715,Inhibition of IRAK4 in human PBMC assessed as reduction of TLR 7/8 agonist R848-induced TNFalpha production treated 30 mins before R848 stimulation measured after 5 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3621203,ACS Med. Chem. Lett.,2015.0,"{'bei': '13.03', 'le': '0.25', 'lle': '3.33', 'sei': '5.65'}",CHEMBL3622518,,CHEMBL3622518,5.38,False,http://www.openphacts.org/units/Nanomolar,2504881,=,1,True,=,,IC50,nM,,4200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.2
1806,,15754940,[],CHEMBL3631832,Inhibition of IRAK4 (unknown origin) at 1 uM by FRET method,B,,,BAO_0000201,BAO_0000357,single protein format,N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1,,,CHEMBL3627690,J. Med. Chem.,2015.0,,CHEMBL3629013,,CHEMBL3629013,,False,http://qudt.org/vocab/unit#Percent,2508066,=,1,True,=,,Inhibition,%,,19.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,19.5
1807,,15756951,[],CHEMBL3631259,Inhibition of IRAK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1,,,CHEMBL3627608,Bioorg. Med. Chem.,2015.0,,CHEMBL166031,,CHEMBL166031,,False,http://qudt.org/vocab/unit#Percent,2507618,=,1,True,=,,Inhibition,%,,24.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,24.72
1808,,15757772,[],CHEMBL3631259,Inhibition of IRAK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3627608,Bioorg. Med. Chem.,2015.0,,CHEMBL3628627,,CHEMBL3628627,,False,http://qudt.org/vocab/unit#Percent,2507619,=,1,True,=,,Inhibition,%,,-50.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-50.81
1809,,15758751,[],CHEMBL3631259,Inhibition of IRAK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,B,,,BAO_0000201,BAO_0000357,single protein format,COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC,,,CHEMBL3627608,Bioorg. Med. Chem.,2015.0,,CHEMBL3628628,,CHEMBL3628628,,False,http://qudt.org/vocab/unit#Percent,2507620,=,1,True,=,,Inhibition,%,,13.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,13.9
1810,,15774006,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '22.54', 'le': '0.43', 'lle': '7.10', 'sei': '8.27'}",CHEMBL3590478,,CHEMBL3590478,9.52,True,http://www.openphacts.org/units/Nanomolar,2511285,=,1,True,=,,IC50,nM,,0.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.3
1811,,15774007,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.59', 'le': '0.40', 'lle': '6.28', 'sei': '7.55'}",CHEMBL3634378,,CHEMBL3634378,8.70,False,http://www.openphacts.org/units/Nanomolar,2511282,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1812,,15774008,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.70', 'le': '0.38', 'lle': '5.28', 'sei': '8.12'}",CHEMBL3634379,,CHEMBL3634379,8.30,False,http://www.openphacts.org/units/Nanomolar,2511283,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
1813,,15774009,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.48', 'le': '0.41', 'lle': '5.62', 'sei': '8.13'}",CHEMBL3634380,,CHEMBL3634380,9.00,False,http://www.openphacts.org/units/Nanomolar,2511284,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1814,,15774010,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.98', 'le': '0.46', 'lle': '7.37', 'sei': '8.42'}",CHEMBL3590479,,CHEMBL3590479,9.70,True,http://www.openphacts.org/units/Nanomolar,2511281,=,1,True,=,,IC50,nM,,0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.2
1815,,15774011,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.00', 'le': '0.44', 'lle': '6.97', 'sei': '8.08'}",CHEMBL3634381,,CHEMBL3634381,9.30,False,http://www.openphacts.org/units/Nanomolar,2511286,=,1,True,=,,IC50,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.5
1816,,15774012,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '22.31', 'le': '0.42', 'lle': '6.06', 'sei': '8.80'}",CHEMBL3634382,,CHEMBL3634382,9.00,False,http://www.openphacts.org/units/Nanomolar,2511287,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1817,,15774013,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.01', 'le': '0.46', 'lle': '6.40', 'sei': '8.76'}",CHEMBL3634383,,CHEMBL3634383,9.70,False,http://www.openphacts.org/units/Nanomolar,2511288,=,1,True,=,,IC50,nM,,0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.2
1818,,15774014,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '16.85', 'le': '0.33', 'lle': '4.84', 'sei': '6.44'}",CHEMBL3634384,,CHEMBL3634384,7.42,False,http://www.openphacts.org/units/Nanomolar,2511289,=,1,True,=,,IC50,nM,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,38.0
1819,,15774015,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.35', 'le': '0.38', 'lle': '5.94', 'sei': '7.40'}",CHEMBL3634501,,CHEMBL3634501,8.52,False,http://www.openphacts.org/units/Nanomolar,2511431,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
1820,,15774016,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3634502,,CHEMBL3634502,,False,http://www.openphacts.org/units/Nanomolar,2511432,<,1,True,<,,IC50,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.5
1821,,15774017,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '21.30', 'le': '0.41', 'lle': '6.80', 'sei': '8.60'}",CHEMBL3634503,,CHEMBL3634503,8.70,False,http://www.openphacts.org/units/Nanomolar,2511433,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1822,,15774018,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '22.09', 'le': '0.42', 'lle': '6.50', 'sei': '10.19'}",CHEMBL3634504,,CHEMBL3634504,9.00,False,http://www.openphacts.org/units/Nanomolar,2511434,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1823,,15774019,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '21.38', 'le': '0.43', 'lle': '6.24', 'sei': '9.40'}",CHEMBL3634505,,CHEMBL3634505,9.10,False,http://www.openphacts.org/units/Nanomolar,2511435,=,1,True,=,,IC50,nM,,0.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.8
1824,,15774020,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3634506,,CHEMBL3634506,,False,http://www.openphacts.org/units/Nanomolar,2511436,<,1,True,<,,IC50,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.5
1825,,15774021,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.05', 'le': '0.44', 'lle': '7.18', 'sei': '8.90'}",CHEMBL3634507,,CHEMBL3634507,9.00,False,http://www.openphacts.org/units/Nanomolar,2511437,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1826,,15774022,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.23', 'le': '0.44', 'lle': '6.63', 'sei': '10.25'}",CHEMBL3634508,,CHEMBL3634508,9.05,False,http://www.openphacts.org/units/Nanomolar,2511438,=,1,True,=,,IC50,nM,,0.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.9
1827,,15774023,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.07', 'le': '0.46', 'lle': '6.62', 'sei': '9.71'}",CHEMBL3634509,,CHEMBL3634509,9.40,False,http://www.openphacts.org/units/Nanomolar,2511439,=,1,True,=,,IC50,nM,,0.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.4
1828,,15774024,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCCNC4)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.98', 'le': '0.46', 'lle': '7.49', 'sei': '9.59'}",CHEMBL3634510,,CHEMBL3634510,9.70,False,http://www.openphacts.org/units/Nanomolar,2511440,=,1,True,=,,IC50,nM,,0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.2
1829,,15774025,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCCNC4)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '22.64', 'le': '0.43', 'lle': '6.94', 'sei': '9.05'}",CHEMBL3634511,,CHEMBL3634511,9.15,False,http://www.openphacts.org/units/Nanomolar,2511441,=,1,True,=,,IC50,nM,,0.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.7
1830,,15774026,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3634512,,CHEMBL3634512,,False,http://www.openphacts.org/units/Nanomolar,2511442,<,1,True,<,,IC50,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.5
1831,,15774027,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.14', 'le': '0.46', 'lle': '6.95', 'sei': '7.82'}",CHEMBL3634513,,CHEMBL3634513,9.00,False,http://www.openphacts.org/units/Nanomolar,2511443,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1832,,15774028,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.20', 'le': '0.46', 'lle': '6.34', 'sei': '8.80'}",CHEMBL3634514,,CHEMBL3634514,9.00,False,http://www.openphacts.org/units/Nanomolar,2511444,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1833,,15774029,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.46', 'le': '0.48', 'lle': '6.51', 'sei': '8.60'}",CHEMBL3634613,,CHEMBL3634613,9.52,False,http://www.openphacts.org/units/Nanomolar,2511575,=,1,True,=,,IC50,nM,,0.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.3
1834,,15774030,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.98', 'le': '0.44', 'lle': '7.83', 'sei': '6.55'}",CHEMBL3590477,,CHEMBL3590477,9.10,True,http://www.openphacts.org/units/Nanomolar,2511576,=,1,True,=,,IC50,nM,,0.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.8
1835,,15774031,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.72', 'le': '0.44', 'lle': '7.73', 'sei': '6.48'}",CHEMBL3634614,,CHEMBL3634614,9.00,False,http://www.openphacts.org/units/Nanomolar,2511577,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1836,,15774032,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '24.19', 'le': '0.45', 'lle': '7.28', 'sei': '7.26'}",CHEMBL3634615,,CHEMBL3634615,9.15,False,http://www.openphacts.org/units/Nanomolar,2511578,=,1,True,=,,IC50,nM,,0.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.7
1837,,15774033,[],CHEMBL3637446,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '23.70', 'le': '0.46', 'lle': '7.17', 'sei': '6.99'}",CHEMBL3634616,,CHEMBL3634616,9.40,False,http://www.openphacts.org/units/Nanomolar,2511579,=,1,True,=,,IC50,nM,,0.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.4
1838,,15774034,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.05', 'le': '0.37', 'lle': '5.63', 'sei': '6.99'}",CHEMBL3590478,,CHEMBL3590478,8.05,False,http://www.openphacts.org/units/Nanomolar,2511285,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
1839,,15774035,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.51', 'le': '0.34', 'lle': '4.98', 'sei': '6.42'}",CHEMBL3634378,,CHEMBL3634378,7.40,False,http://www.openphacts.org/units/Nanomolar,2511282,=,1,True,=,,IC50,nM,,40.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,40.0
1840,,15774036,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.46', 'le': '0.33', 'lle': '4.34', 'sei': '7.19'}",CHEMBL3634379,,CHEMBL3634379,7.36,False,http://www.openphacts.org/units/Nanomolar,2511283,=,1,True,=,,IC50,nM,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,44.0
1841,,15774037,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.52', 'le': '0.35', 'lle': '4.32', 'sei': '6.95'}",CHEMBL3634380,,CHEMBL3634380,7.70,False,http://www.openphacts.org/units/Nanomolar,2511284,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
1842,,15774038,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.76', 'le': '0.40', 'lle': '6.07', 'sei': '7.29'}",CHEMBL3590479,,CHEMBL3590479,8.40,False,http://www.openphacts.org/units/Nanomolar,2511281,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
1843,,15774039,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.78', 'le': '0.38', 'lle': '5.67', 'sei': '6.95'}",CHEMBL3634381,,CHEMBL3634381,8.00,False,http://www.openphacts.org/units/Nanomolar,2511286,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
1844,,15774040,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.84', 'le': '0.36', 'lle': '4.66', 'sei': '7.43'}",CHEMBL3634382,,CHEMBL3634382,7.60,False,http://www.openphacts.org/units/Nanomolar,2511287,=,1,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
1845,,15774041,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.22', 'le': '0.40', 'lle': '5.22', 'sei': '7.70'}",CHEMBL3634383,,CHEMBL3634383,8.52,False,http://www.openphacts.org/units/Nanomolar,2511288,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
1846,,15774042,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '14.88', 'le': '0.29', 'lle': '3.97', 'sei': '5.69'}",CHEMBL3634384,,CHEMBL3634384,6.55,False,http://www.openphacts.org/units/Nanomolar,2511289,=,1,True,=,,IC50,nM,,280.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,280.0
1847,,15774043,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '15.56', 'le': '0.30', 'lle': '4.27', 'sei': '5.95'}",CHEMBL3634501,,CHEMBL3634501,6.85,False,http://www.openphacts.org/units/Nanomolar,2511431,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,140.0
1848,,15774044,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.40', 'le': '0.37', 'lle': '6.02', 'sei': '7.83'}",CHEMBL3634502,,CHEMBL3634502,7.92,False,http://www.openphacts.org/units/Nanomolar,2511432,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1849,,15774045,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.29', 'le': '0.35', 'lle': '5.57', 'sei': '7.38'}",CHEMBL3634503,,CHEMBL3634503,7.47,False,http://www.openphacts.org/units/Nanomolar,2511433,=,1,True,=,,IC50,nM,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,34.0
1850,,15774046,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.07', 'le': '0.37', 'lle': '5.27', 'sei': '8.80'}",CHEMBL3634504,,CHEMBL3634504,7.77,False,http://www.openphacts.org/units/Nanomolar,2511434,=,1,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
1851,,15774047,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.17', 'le': '0.38', 'lle': '5.29', 'sei': '8.43'}",CHEMBL3634505,,CHEMBL3634505,8.15,False,http://www.openphacts.org/units/Nanomolar,2511435,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
1852,,15774048,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '21.83', 'le': '0.42', 'lle': '6.70', 'sei': '8.42'}",CHEMBL3634506,,CHEMBL3634506,8.52,False,http://www.openphacts.org/units/Nanomolar,2511436,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
1853,,15774049,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.52', 'le': '0.37', 'lle': '5.80', 'sei': '7.53'}",CHEMBL3634507,,CHEMBL3634507,7.62,False,http://www.openphacts.org/units/Nanomolar,2511437,=,1,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
1854,,15774050,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '21.32', 'le': '0.40', 'lle': '5.88', 'sei': '9.40'}",CHEMBL3634508,,CHEMBL3634508,8.30,False,http://www.openphacts.org/units/Nanomolar,2511438,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
1855,,15774051,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.92', 'le': '0.42', 'lle': '5.74', 'sei': '8.81'}",CHEMBL3634509,,CHEMBL3634509,8.52,False,http://www.openphacts.org/units/Nanomolar,2511439,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
1856,,15774052,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCCNC4)nc23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.04', 'le': '0.36', 'lle': '5.49', 'sei': '7.61'}",CHEMBL3634510,,CHEMBL3634510,7.70,False,http://www.openphacts.org/units/Nanomolar,2511440,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
1857,,15774053,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCCNC4)nn23)c(C(F)F)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.89', 'le': '0.38', 'lle': '5.84', 'sei': '7.95'}",CHEMBL3634511,,CHEMBL3634511,8.05,False,http://www.openphacts.org/units/Nanomolar,2511441,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
1858,,15774054,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.37', 'le': '0.40', 'lle': '5.87', 'sei': '6.88'}",CHEMBL3634512,,CHEMBL3634512,7.92,False,http://www.openphacts.org/units/Nanomolar,2511442,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1859,,15774055,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.51', 'le': '0.38', 'lle': '5.54', 'sei': '6.59'}",CHEMBL3634513,,CHEMBL3634513,7.58,False,http://www.openphacts.org/units/Nanomolar,2511443,=,1,True,=,,IC50,nM,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,26.0
1860,,15774056,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.33', 'le': '0.40', 'lle': '5.23', 'sei': '7.71'}",CHEMBL3634514,,CHEMBL3634514,7.89,False,http://www.openphacts.org/units/Nanomolar,2511444,=,1,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
1861,,15774057,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.09', 'le': '0.41', 'lle': '5.14', 'sei': '7.36'}",CHEMBL3634613,,CHEMBL3634613,8.15,False,http://www.openphacts.org/units/Nanomolar,2511575,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
1862,,15774058,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.88', 'le': '0.39', 'lle': '6.65', 'sei': '5.70'}",CHEMBL3590477,,CHEMBL3590477,7.92,False,http://www.openphacts.org/units/Nanomolar,2511576,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1863,,15774059,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.04', 'le': '0.37', 'lle': '6.33', 'sei': '5.47'}",CHEMBL3634614,,CHEMBL3634614,7.60,False,http://www.openphacts.org/units/Nanomolar,2511577,=,1,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
1864,,15774060,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.93', 'le': '0.39', 'lle': '6.05', 'sei': '6.28'}",CHEMBL3634615,,CHEMBL3634615,7.92,False,http://www.openphacts.org/units/Nanomolar,2511578,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1865,,15774061,[],CHEMBL3637447,Inhibition of IRAK4 in human PBMC,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1,,,CHEMBL3632465,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.29', 'le': '0.39', 'lle': '5.82', 'sei': '5.98'}",CHEMBL3634616,,CHEMBL3634616,8.05,False,http://www.openphacts.org/units/Nanomolar,2511579,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
1866,,16376456,[],CHEMBL3734480,Inhibition of recombinant human IRAK4 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay,B,,,BAO_0000201,BAO_0000357,single protein format,Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O,,,CHEMBL3727354,,2011.0,,CHEMBL3732044,,CHEMBL1929247,,False,http://qudt.org/vocab/unit#Percent,2728897,=,38,True,=,,Inhibition,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.0
1867,,16379663,[],CHEMBL3738560,Inhibition of IRAK4 (unknown origin) at 200 nM by electrophoretic mobility shift assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O,,,CHEMBL3734671,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3735816,,CHEMBL3735816,,False,http://qudt.org/vocab/unit#Percent,2735299,=,1,True,=,,Inhibition,%,,-3.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-3.8
1868,,16379664,[],CHEMBL3738560,Inhibition of IRAK4 (unknown origin) at 200 nM by electrophoretic mobility shift assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O,,,CHEMBL3734671,Bioorg. Med. Chem. Lett.,2015.0,,CHEMBL3735890,,CHEMBL3735890,,False,http://qudt.org/vocab/unit#Percent,2735304,=,1,True,=,,Inhibition,%,,-0.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-0.6
1869,,16388304,[],CHEMBL3737361,Inhibition of IRAK4 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP,B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2,,,CHEMBL3734692,Eur. J. Med. Chem.,2015.0,,CHEMBL3091673,,CHEMBL3091673,,False,http://qudt.org/vocab/unit#Percent,2736824,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
1870,,16391758,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2[nH]1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.81', 'le': '0.33', 'lle': '2.49', 'sei': '5.30'}",CHEMBL208116,,CHEMBL208116,5.35,False,http://www.openphacts.org/units/Nanomolar,2734901,=,1,True,=,,Ki,nM,,4500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,4500.0
1871,,16391759,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2n1CCCO)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.69', 'le': '0.39', 'lle': '4.69', 'sei': '6.72'}",CHEMBL3735096,,CHEMBL3735096,7.42,False,http://www.openphacts.org/units/Nanomolar,2734902,=,1,True,=,,Ki,nM,,38.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,38.5
1872,,16391760,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2n1[C@H]1CC[C@H](O)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.55', 'le': '0.39', 'lle': '4.38', 'sei': '7.42'}",CHEMBL3734846,,CHEMBL3734846,8.19,False,http://www.openphacts.org/units/Nanomolar,2734903,=,1,True,=,,Ki,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,6.5
1873,,16391761,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '21.33', 'le': '0.40', 'lle': '4.74', 'sei': '7.98'}",CHEMBL3735949,,CHEMBL3735949,8.80,False,http://www.openphacts.org/units/Nanomolar,2734904,=,1,True,=,,Ki,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.6
1874,,16391762,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2n1[C@H]1CC[C@H](CO)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.87', 'le': '0.37', 'lle': '4.13', 'sei': '7.43'}",CHEMBL3735044,,CHEMBL3735044,8.19,False,http://www.openphacts.org/units/Nanomolar,2734905,=,1,True,=,,Ki,nM,,6.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,6.4
1875,,16391763,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2n1[C@H]1CC[C@@H](CO)C1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.35', 'le': '0.38', 'lle': '4.44', 'sei': '7.35'}",CHEMBL3735247,,CHEMBL3735247,8.11,False,http://www.openphacts.org/units/Nanomolar,2734906,=,1,True,=,,Ki,nM,,7.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,7.8
1876,,16391764,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(F)ccc2n1[C@H]1CC[C@H](CO)C1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.98', 'le': '0.37', 'lle': '4.29', 'sei': '7.22'}",CHEMBL3736469,,CHEMBL3736469,7.96,False,http://www.openphacts.org/units/Nanomolar,2734907,=,1,True,=,,Ki,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,11.0
1877,,16391765,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CO)ccc2n1[C@H]1CC[C@H](O)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.39', 'le': '0.36', 'lle': '4.79', 'sei': '6.10'}",CHEMBL3735975,,CHEMBL3735975,7.96,False,http://www.openphacts.org/units/Nanomolar,2734908,=,1,True,=,,Ki,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,11.0
1878,,16391766,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1[C@H]1CC[C@H](O)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.91', 'le': '0.33', 'lle': '3.89', 'sei': '7.53'}",CHEMBL3735673,,CHEMBL3735673,8.55,False,http://www.openphacts.org/units/Nanomolar,2734909,=,1,True,=,,Ki,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,2.8
1879,,16391767,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCOCC3)ccc2n1[C@H]1CC[C@H](O)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.56', 'le': '0.33', 'lle': '4.91', 'sei': '6.86'}",CHEMBL3735523,,CHEMBL3735523,8.42,False,http://www.openphacts.org/units/Nanomolar,2734910,=,1,True,=,,Ki,nM,,3.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.8
1880,,16391768,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCCC3=O)ccc2n1[C@H]1CC[C@H](O)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '19.48', 'le': '0.36', 'lle': '5.50', 'sei': '7.12'}",CHEMBL3734872,,CHEMBL3734872,9.30,False,http://www.openphacts.org/units/Nanomolar,2734911,=,1,True,=,,Ki,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.5
1881,,16391769,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.62', 'le': '0.35', 'lle': '4.24', 'sei': '8.06'}",CHEMBL3734854,,CHEMBL3734854,9.15,False,http://www.openphacts.org/units/Nanomolar,2734912,=,1,True,=,,Ki,nM,,0.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.7
1882,,16391770,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc(C(F)(F)F)c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.22', 'le': '0.35', 'lle': '3.36', 'sei': '13.32'}",CHEMBL3736036,,CHEMBL3736036,9.38,False,http://www.openphacts.org/units/Nanomolar,2734913,=,1,True,=,,Ki,nM,,0.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.42
1883,,16391771,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1-c1ccccc1)c1cccc([N+](=O)[O-])c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.75', 'le': '0.32', 'lle': '2.92', 'sei': '8.67'}",CHEMBL3735719,,CHEMBL3735719,8.09,False,http://www.openphacts.org/units/Nanomolar,2734914,=,1,True,=,,Ki,nM,,8.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,8.2
1884,,16391772,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1-c1ccccc1)c1cccc(C(F)(F)F)c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.87', 'le': '0.33', 'lle': '2.27', 'sei': '17.05'}",CHEMBL3736278,,CHEMBL3736278,8.55,False,http://www.openphacts.org/units/Nanomolar,2734915,=,1,True,=,,Ki,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,2.8
1885,,16391773,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1-c1ccc(CCO)cc1)c1cccc(C(F)(F)F)c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '17.00', 'le': '0.32', 'lle': '3.07', 'sei': '12.62'}",CHEMBL3736465,,CHEMBL3736465,8.89,False,http://www.openphacts.org/units/Nanomolar,2734916,=,1,True,=,,Ki,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.3
1886,,16391774,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,CC(C)(C)C(=O)Nc1ccc2c(c1)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2[C@H]1CC[C@@H](CO)CC1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '18.33', 'le': '0.35', 'lle': '3.45', 'sei': '9.84'}",CHEMBL3735504,,CHEMBL3735504,9.47,False,http://www.openphacts.org/units/Nanomolar,2734917,=,1,True,=,,Ki,nM,,0.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.34
1887,,16391775,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1nc2ccc(CO)cc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc(C(F)(F)F)c1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '20.83', 'le': '0.40', 'lle': '4.80', 'sei': '10.66'}",CHEMBL3734814,,CHEMBL3734814,9.32,False,http://www.openphacts.org/units/Nanomolar,2734918,=,1,True,=,,Ki,nM,,0.48,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.48
1888,,16391776,[],CHEMBL3737182,Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2-c1ccc(CCCO)cc1,,,CHEMBL3734693,Bioorg. Med. Chem. Lett.,2015.0,"{'bei': '13.21', 'le': '0.25', 'lle': '1.76', 'sei': '5.00'}",CHEMBL3735448,,CHEMBL3735448,6.82,False,http://www.openphacts.org/units/Nanomolar,2734919,=,1,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.15
1889,,16413461,[],CHEMBL3742719,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1,,,CHEMBL3739276,J. Med. Chem.,2015.0,,CHEMBL3741589,,CHEMBL3741589,,False,http://www.openphacts.org/units/Nanomolar,2738383,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
1890,,16417196,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3747699,,CHEMBL3747699,,False,http://qudt.org/vocab/unit#Percent,2741464,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
1891,,16417197,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3746959,,CHEMBL3746959,,False,http://qudt.org/vocab/unit#Percent,2741467,=,1,True,=,,Inhibition,%,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,24.0
1892,,16417198,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3746022,,CHEMBL3746022,,False,http://qudt.org/vocab/unit#Percent,2741469,=,1,True,=,,Inhibition,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.0
1893,,16417199,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3745734,,CHEMBL3745734,,False,http://qudt.org/vocab/unit#Percent,2741474,=,1,True,=,,Inhibition,%,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.0
1894,,16417200,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3747351,,CHEMBL3747351,,False,http://qudt.org/vocab/unit#Percent,2741594,=,1,True,=,,Inhibition,%,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,12.0
1895,,16417201,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3747023,,CHEMBL3747023,,False,http://qudt.org/vocab/unit#Percent,2741598,=,1,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.0
1896,,16417202,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3746951,,CHEMBL3746951,,False,http://qudt.org/vocab/unit#Percent,2741609,=,1,True,=,,Inhibition,%,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,10.0
1897,,16417203,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3746973,,CHEMBL3746973,,False,http://qudt.org/vocab/unit#Percent,2741610,=,1,True,=,,Inhibition,%,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,19.0
1898,,16417204,[],CHEMBL3750763,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3745857,,CHEMBL3745857,,False,http://qudt.org/vocab/unit#Percent,2741791,=,1,True,=,,Inhibition,%,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,8.0
1899,,16421920,[],CHEMBL3750402,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL3745712,J. Med. Chem.,2015.0,,CHEMBL3651966,,CHEMBL3651966,,False,http://www.openphacts.org/units/Nanomolar,2742405,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
1900,,16425299,[],CHEMBL3751085,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1,,,CHEMBL3745631,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3746293,,CHEMBL3746293,,False,http://qudt.org/vocab/unit#Percent,2743029,=,1,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.0
1901,,16428150,[],CHEMBL3748848,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2c(cc1-c1cnn(CCCN(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,,,CHEMBL3745656,J. Med. Chem.,2015.0,"{'bei': '14.24', 'le': '0.26', 'lle': '1.34', 'sei': '8.53'}",CHEMBL3746678,,CHEMBL3746678,6.63,False,http://www.openphacts.org/units/Nanomolar,2742422,=,1,True,=,,IC50,nM,,234.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,234.0
1902,,16428151,[],CHEMBL3748848,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,,,CHEMBL3745656,J. Med. Chem.,2015.0,"{'bei': '13.60', 'le': '0.25', 'lle': '1.91', 'sei': '6.68'}",CHEMBL3735401,,CHEMBL3735401,6.33,False,http://www.openphacts.org/units/Nanomolar,2742175,=,1,True,=,,IC50,nM,,465.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,465.0
1903,,16429059,[],CHEMBL3750797,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21,,,CHEMBL3745672,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3747489,,CHEMBL3747489,,False,http://qudt.org/vocab/unit#Percent,2741473,=,1,True,=,,Inhibition,%,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,8.0
1904,,16431867,[],CHEMBL3748221,Inhibition of human IRAK4 using MBP as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,,,CHEMBL3745707,Bioorg. Med. Chem.,2016.0,,CHEMBL3745885,,CHEMBL3745885,,False,http://www.openphacts.org/units/Nanomolar,2741358,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
1905,,16442767,[],CHEMBL3757421,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cn2cc(-c3cnc(N)c(OC(C)C(F)(F)F)n3)ccc2n1,,,CHEMBL3751828,Bioorg. Med. Chem. Lett.,2016.0,"{'bei': '16.74', 'le': '0.32', 'lle': '3.71', 'sei': '5.93'}",CHEMBL3753450,,CHEMBL3753450,6.37,False,http://www.openphacts.org/units/Nanomolar,2745335,=,1,True,=,,IC50,nM,,430.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.43
1906,,16450875,[],CHEMBL3762891,Inhibition of IRAK4 (unknown origin) at 100 nM,B,,,BAO_0000201,BAO_0000357,single protein format,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,,,CHEMBL3758169,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3758502,,CHEMBL3758502,,False,http://qudt.org/vocab/unit#Percent,2747903,=,1,True,=,,Inhibition,%,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,4.3
1907,,16451726,[],CHEMBL3762891,Inhibition of IRAK4 (unknown origin) at 100 nM,B,,,BAO_0000201,BAO_0000357,single protein format,CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21,,,CHEMBL3758169,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3758602,,CHEMBL3758602,,False,http://qudt.org/vocab/unit#Percent,2748043,=,1,True,=,,Inhibition,%,,16.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,16.9
1908,,16495105,[],CHEMBL3776223,Inhibition of N-terminal His6-tagged recombinant human IRAK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,,,CHEMBL3774357,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3775317,,CHEMBL3775317,,False,http://qudt.org/vocab/unit#Percent,2763273,=,1,False,=,,Activity,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,5.0
1909,,16496024,[],CHEMBL3776223,Inhibition of N-terminal His6-tagged recombinant human IRAK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,,,CHEMBL3774357,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3774885,,CHEMBL3774885,,False,http://qudt.org/vocab/unit#Percent,2763281,=,1,False,=,,Activity,%,,-3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,-3.0
1910,Not Active,16497490,[],CHEMBL3777933,Inhibition of human IRAK4 (14 to 460 residues) at 1 uM by radioactive [33P]-ATP filter binding assay,B,,,BAO_0000376,BAO_0000357,single protein format,O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12,,,CHEMBL3774338,J. Med. Chem.,2016.0,,CHEMBL3774537,,CHEMBL3774537,,False,,2762476,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1911,,16507163,[],CHEMBL3779013,Inhibition of recombinant IRAK4 (unknown origin) assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1,,,CHEMBL3774312,Eur. J. Med. Chem.,2016.0,,CHEMBL3774632,,CHEMBL3774632,,False,http://qudt.org/vocab/unit#Percent,2763236,>=,1,False,>=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
1912,,16508211,[],CHEMBL3776223,Inhibition of N-terminal His6-tagged recombinant human IRAK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,,,CHEMBL3774357,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3775576,,CHEMBL3775576,,False,http://qudt.org/vocab/unit#Percent,2763260,=,1,False,=,,Activity,%,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,9.0
1913,,16559715,[],CHEMBL3794935,Inhibition of full length human N-terminal GST-tagged IRAK4 (1 to 460 residues) expressed in baculovirus expression system using fluorescence labelled IRAK1 peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(Nc1ccccc1)c1n[nH]c2ccccc12,,,CHEMBL3792292,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL508964,,CHEMBL508964,,False,http://qudt.org/vocab/unit#Percent,2771300,=,1,True,=,,Inhibition,%,,19.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,19.7
1914,,16559716,[],CHEMBL3794935,Inhibition of full length human N-terminal GST-tagged IRAK4 (1 to 460 residues) expressed in baculovirus expression system using fluorescence labelled IRAK1 peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12,,,CHEMBL3792292,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3793843,,CHEMBL3793843,,False,http://qudt.org/vocab/unit#Percent,2771323,=,1,True,=,,Inhibition,%,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.6
1915,,16559717,[],CHEMBL3794935,Inhibition of full length human N-terminal GST-tagged IRAK4 (1 to 460 residues) expressed in baculovirus expression system using fluorescence labelled IRAK1 peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12,,,CHEMBL3792292,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3792850,,CHEMBL3792850,,False,http://qudt.org/vocab/unit#Percent,2771325,=,1,True,=,,Inhibition,%,,-1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.9
1916,,16565476,[],CHEMBL3804242,Inhibition of N-terminal GST-tagged human IRAK4 expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method,B,,,BAO_0000190,BAO_0000019,assay format,C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C,,,CHEMBL3797131,Bioorg. Med. Chem.,2016.0,,CHEMBL3798011,,CHEMBL3798011,,False,http://www.openphacts.org/units/Nanomolar,2775878,>,1,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
1917,,16578391,[],CHEMBL3802263,Inhibition of partial length wild type human IRAK4 expressed in mammalian system assessed as enzyme activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000019,assay format,CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F,,,CHEMBL3797029,Bioorg. Med. Chem.,2016.0,,CHEMBL3798256,,CHEMBL3798256,,False,http://qudt.org/vocab/unit#Percent,2775186,=,1,False,=,,Activity,%,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,99.0
1918,,16580640,[],CHEMBL3802867,Inhibition of N-terminal GST-tagged human IRAK4 expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method,B,,,BAO_0000201,BAO_0000019,assay format,CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C,,,CHEMBL3797131,Bioorg. Med. Chem.,2016.0,,CHEMBL3798713,,CHEMBL3798713,,False,http://qudt.org/vocab/unit#Percent,2775778,=,1,True,=,,Inhibition,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,91.0
1919,,16580641,[],CHEMBL3802867,Inhibition of N-terminal GST-tagged human IRAK4 expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method,B,,,BAO_0000201,BAO_0000019,assay format,CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C,,,CHEMBL3797131,Bioorg. Med. Chem.,2016.0,,CHEMBL3798933,,CHEMBL3798933,,False,http://qudt.org/vocab/unit#Percent,2775779,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
1920,,16595525,[],CHEMBL3811145,Inhibition of full length recombinant human N-terminal His6-tagged IRAK4 expressed in baculovirus infected Sf21 cells assessed as residual activity at 300 uM in presence of radiolabelled ATP by radiometric assay relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C,,,CHEMBL3808386,J. Med. Chem.,2016.0,,CHEMBL3809381,,CHEMBL3809381,,False,http://qudt.org/vocab/unit#Percent,2780741,=,1,False,=,,Activity,%,,68.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,68.0
1921,,16595531,[],CHEMBL3811139,Inhibition of full length recombinant human N-terminal His6-tagged IRAK4 expressed in baculovirus infected Sf21 cells assessed as residual activity at 30 uM in presence of radiolabelled ATP by radiometric assay relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)CC,,,CHEMBL3808386,J. Med. Chem.,2016.0,,CHEMBL3808687,,CHEMBL3808687,,False,http://qudt.org/vocab/unit#Percent,2780738,=,1,False,=,,Activity,%,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,12.0
1922,,16611931,[],CHEMBL3815424,Inhibition of human IRAK4 (14 to 460 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay,B,,,BAO_0001103,BAO_0000357,single protein format,Nc1nccc(-c2c[nH]c3ncccc23)n1,,,CHEMBL3813616,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL405665,MERIOLIN 1,CHEMBL405665,,False,http://qudt.org/vocab/unit#Percent,2781844,=,1,False,=,,Activity,%,,-36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,-36.0
1923,,16614508,[],CHEMBL3816706,Inhibition of human IRAK4 at 1 uM using MBP as substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3813650,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3815093,,CHEMBL3815093,,False,http://qudt.org/vocab/unit#Percent,2781972,=,1,True,=,,Inhibition,%,,-16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-16.0
1924,,16618189,[],CHEMBL3817244,Inhibition of full length recombinant human His-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,,,CHEMBL3813614,ACS Med. Chem. Lett.,2016.0,,CHEMBL3813842,PAXALISIB,CHEMBL3813842,,False,http://qudt.org/vocab/unit#Percent,2781546,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
1925,,16627528,[],CHEMBL3820340,Inhibition of full length recombinant human N-terminal His6-tagged IRAK4 expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1,,,CHEMBL3817791,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3819210,,CHEMBL3819210,,False,http://qudt.org/vocab/unit#Percent,2784983,=,1,True,=,,Inhibition,%,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,3.0
1926,,16627529,[],CHEMBL3820340,Inhibition of full length recombinant human N-terminal His6-tagged IRAK4 expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1,,,CHEMBL3817791,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL3818239,,CHEMBL3818239,,False,http://qudt.org/vocab/unit#Percent,2784967,=,1,True,=,,Inhibition,%,,-6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-6.0
1927,,16641996,[],CHEMBL3826406,Inhibition of His-tagged full-length human IRAK4 expressed in baculovirus system at 100 nM by Z-lyte assay,B,,,BAO_0000201,BAO_0000019,assay format,O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,,,CHEMBL3822377,Eur. J. Med. Chem.,2016.0,,CHEMBL3824119,,CHEMBL3824119,,False,http://qudt.org/vocab/unit#Percent,2786372,=,1,True,=,,Inhibition,%,,-6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-6.0
1928,,16654231,[],CHEMBL3829766,Inhibition of human IRAK4 (14 to 460 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay,B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1,,,CHEMBL3826966,Bioorg. Med. Chem. Lett.,2016.0,,CHEMBL1077604,ROHITUKINE,CHEMBL1077604,,False,http://qudt.org/vocab/unit#Percent,2787395,=,1,False,=,,Activity,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,75.0
1929,,16804169,[],CHEMBL3869760,Inhibition of human recombinant full length His-tagged IRAK4 expressed in baculovirus expression system at 200 nM by Z'-LYTE assay,B,,,BAO_0000201,BAO_0000019,assay format,Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1,,,CHEMBL3868614,Bioorg Med Chem Lett,2016.0,,CHEMBL3979920,MIVAVOTINIB,CHEMBL3979920,,False,http://qudt.org/vocab/unit#Percent,2809393,=,1,True,=,,Inhibition,%,,51.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,51.0
1930,,16837441,[],CHEMBL3876073,Inhibition of human recombinant full length His-tagged IRAK4 expressed in baculovirus expression system,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21,,,CHEMBL3875183,Bioorg Med Chem Lett,2017.0,"{'bei': '12.94', 'le': '0.24', 'lle': '0.76', 'sei': '6.38'}",CHEMBL3884319,,CHEMBL3884319,5.00,False,http://www.openphacts.org/units/Nanomolar,2815468,=,1,True,=,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10000.0
1931,,16896858,[],CHEMBL3882365,Inhibition of human IRAK4 using myelin basic protein as substrate in presence of [gamma-33P]-ATP,B,,,BAO_0000376,BAO_0000357,single protein format,Cc1ccc(N/C=C2\C(=O)CCc3c2oc2c(Cl)c(Cl)c(O)cc32)cc1,,,CHEMBL3882247,,2013.0,,CHEMBL3920024,,CHEMBL3920024,,False,,2829591,,38,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
1932,312097,17692363,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.12', 'le': '0.38', 'lle': '5.21', 'sei': '8.41'}",CHEMBL4108325,,CHEMBL4108325,8.82,False,http://www.openphacts.org/units/Nanomolar,2836029,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
1933,312098,17692364,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(CO)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.29', 'le': '0.32', 'lle': '5.05', 'sei': '7.03'}",CHEMBL4109207,,CHEMBL4109207,8.80,False,http://www.openphacts.org/units/Nanomolar,2836030,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
1934,337136,17714966,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)ccc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.03', 'le': '0.37', 'lle': '4.92', 'sei': '8.24'}",CHEMBL4109437,,CHEMBL4109437,8.48,False,http://www.openphacts.org/units/Nanomolar,2845194,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
1935,337137,17714967,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.82', 'le': '0.39', 'lle': '6.09', 'sei': '7.59'}",CHEMBL4111587,,CHEMBL4111587,8.80,False,http://www.openphacts.org/units/Nanomolar,2845195,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
1936,337138,17714968,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.29', 'le': '0.36', 'lle': '6.28', 'sei': '7.19'}",CHEMBL4106870,,CHEMBL4106870,9.00,False,http://www.openphacts.org/units/Nanomolar,2845196,=,37,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1937,337139,17714969,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '21.57', 'le': '0.40', 'lle': '6.29', 'sei': '7.64'}",CHEMBL4115161,,CHEMBL4115161,8.85,False,http://www.openphacts.org/units/Nanomolar,2845197,=,37,True,=,,IC50,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.4
1938,337140,17714970,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC(F)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '18.60', 'le': '0.36', 'lle': '5.53', 'sei': '7.46'}",CHEMBL4109217,,CHEMBL4109217,8.64,False,http://www.openphacts.org/units/Nanomolar,2845198,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
1939,337141,17714971,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.62', 'le': '0.38', 'lle': '5.90', 'sei': '7.77'}",CHEMBL4108575,,CHEMBL4108575,9.00,False,http://www.openphacts.org/units/Nanomolar,2845199,=,37,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
1940,337142,17714972,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.85', 'le': '0.35', 'lle': '6.08', 'sei': '7.03'}",CHEMBL4109973,,CHEMBL4109973,8.80,False,http://www.openphacts.org/units/Nanomolar,2845200,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
1941,337143,17714973,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.80', 'le': '0.35', 'lle': '6.05', 'sei': '7.01'}",CHEMBL4109973,,CHEMBL4109973,8.77,False,http://www.openphacts.org/units/Nanomolar,2845200,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
1942,337144,17714974,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.03', 'le': '0.38', 'lle': '6.90', 'sei': '6.48'}",CHEMBL3984144,,CHEMBL3984144,8.82,False,http://www.openphacts.org/units/Nanomolar,2845201,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
1943,337145,17714975,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.41', 'le': '0.36', 'lle': '5.25', 'sei': '7.55'}",CHEMBL4114980,,CHEMBL4114980,8.74,False,http://www.openphacts.org/units/Nanomolar,2845202,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
1944,337146,17714976,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '21.57', 'le': '0.40', 'lle': '5.77', 'sei': '7.57'}",CHEMBL3965584,,CHEMBL3965584,8.77,False,http://www.openphacts.org/units/Nanomolar,2845203,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
1945,337147,17714977,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.55', 'le': '0.36', 'lle': '6.00', 'sei': '7.01'}",CHEMBL3925564,,CHEMBL3925564,8.77,False,http://www.openphacts.org/units/Nanomolar,2845204,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
1946,337148,17714978,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC12CC3CC(CC(C3)C1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '15.33', 'le': '0.28', 'lle': '3.41', 'sei': '6.84'}",CHEMBL4108089,,CHEMBL4108089,7.92,False,http://www.openphacts.org/units/Nanomolar,2845205,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
1947,337149,17714979,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC12CCC(O)(CC1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '18.19', 'le': '0.33', 'lle': '4.54', 'sei': '6.76'}",CHEMBL3986164,,CHEMBL3986164,7.83,False,http://www.openphacts.org/units/Nanomolar,2845206,=,37,True,=,,IC50,nM,,14.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.8
1948,337150,17714980,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCCOC(C)(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.01', 'le': '0.35', 'lle': '4.21', 'sei': '7.88'}",CHEMBL3947682,,CHEMBL3947682,8.26,False,http://www.openphacts.org/units/Nanomolar,2845207,=,37,True,=,,IC50,nM,,5.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.5
1949,337151,17714981,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC12CCC(O)(CC1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '18.11', 'le': '0.34', 'lle': '5.93', 'sei': '6.56'}",CHEMBL4107911,,CHEMBL4107911,8.92,False,http://www.openphacts.org/units/Nanomolar,2845208,=,37,True,=,,IC50,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.2
1950,337152,17714982,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.44', 'le': '0.38', 'lle': '5.82', 'sei': '7.70'}",CHEMBL4114460,,CHEMBL4114460,8.92,False,http://www.openphacts.org/units/Nanomolar,2845209,=,37,True,=,,IC50,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.2
1951,337153,17714983,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.44', 'le': '0.38', 'lle': '5.73', 'sei': '7.49'}",CHEMBL4108677,,CHEMBL4108677,8.68,False,http://www.openphacts.org/units/Nanomolar,2845210,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
1952,337154,17714984,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.77', 'le': '0.35', 'lle': '4.90', 'sei': '7.33'}",CHEMBL4112445,,CHEMBL4112445,8.49,False,http://www.openphacts.org/units/Nanomolar,2845211,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
1953,337155,17714985,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(CNc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)COC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.67', 'le': '0.33', 'lle': '5.66', 'sei': '6.59'}",CHEMBL4109689,,CHEMBL4109689,8.24,False,http://www.openphacts.org/units/Nanomolar,2845212,=,37,True,=,,IC50,nM,,5.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.7
1954,337156,17714986,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CCO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.01', 'le': '0.36', 'lle': '6.33', 'sei': '6.35'}",CHEMBL4110098,,CHEMBL4110098,8.64,False,http://www.openphacts.org/units/Nanomolar,2845213,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
1955,337157,17714987,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CCO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.24', 'le': '0.36', 'lle': '6.43', 'sei': '6.43'}",CHEMBL4110098,,CHEMBL4110098,8.74,False,http://www.openphacts.org/units/Nanomolar,2845213,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
1956,337158,17714988,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.22', 'le': '0.38', 'lle': '5.64', 'sei': '7.41'}",CHEMBL3947755,,CHEMBL3947755,8.59,False,http://www.openphacts.org/units/Nanomolar,2845214,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
1957,337159,17714989,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.98', 'le': '0.36', 'lle': '6.39', 'sei': '6.51'}",CHEMBL4107813,,CHEMBL4107813,8.85,False,http://www.openphacts.org/units/Nanomolar,2845215,=,37,True,=,,IC50,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.4
1958,337160,17714990,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.91', 'le': '0.35', 'lle': '6.36', 'sei': '6.48'}",CHEMBL4107813,,CHEMBL4107813,8.82,False,http://www.openphacts.org/units/Nanomolar,2845215,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
1959,337161,17714991,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.44', 'le': '0.35', 'lle': '6.14', 'sei': '6.32'}",CHEMBL4107813,,CHEMBL4107813,8.60,False,http://www.openphacts.org/units/Nanomolar,2845215,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
1960,337162,17714992,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.85', 'le': '0.35', 'lle': '6.34', 'sei': '6.46'}",CHEMBL4107813,,CHEMBL4107813,8.80,False,http://www.openphacts.org/units/Nanomolar,2845215,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
1961,337163,17714993,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1(O)CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.33', 'le': '0.34', 'lle': '6.09', 'sei': '6.28'}",CHEMBL4112750,,CHEMBL4112750,8.55,False,http://www.openphacts.org/units/Nanomolar,2845216,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
1962,337164,17714994,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.63', 'le': '0.35', 'lle': '6.24', 'sei': '6.74'}",CHEMBL4111055,,CHEMBL4111055,8.43,False,http://www.openphacts.org/units/Nanomolar,2845217,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
1963,337165,17714995,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCC[C@H]1O,,,CHEMBL3886172,,2015.0,"{'bei': '18.56', 'le': '0.35', 'lle': '6.20', 'sei': '6.36'}",CHEMBL4114949,,CHEMBL4114949,8.66,False,http://www.openphacts.org/units/Nanomolar,2845218,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
1964,337166,17714996,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.99', 'le': '0.37', 'lle': '4.59', 'sei': '9.20'}",CHEMBL4113064,,CHEMBL4113064,8.47,False,http://www.openphacts.org/units/Nanomolar,2845219,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
1965,337167,17714997,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.32', 'le': '0.36', 'lle': '5.22', 'sei': '8.61'}",CHEMBL4113144,,CHEMBL4113144,8.72,False,http://www.openphacts.org/units/Nanomolar,2845220,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
1966,337168,17714998,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ccc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.41', 'le': '0.38', 'lle': '4.81', 'sei': '8.85'}",CHEMBL4107964,,CHEMBL4107964,8.15,False,http://www.openphacts.org/units/Nanomolar,2845221,=,37,True,=,,IC50,nM,,7.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.1
1967,337169,17714999,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.16', 'le': '0.38', 'lle': '4.79', 'sei': '8.99'}",CHEMBL4113223,,CHEMBL4113223,8.28,False,http://www.openphacts.org/units/Nanomolar,2845222,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
1968,337170,17715000,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CNc1cc(-n2ccc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.70', 'le': '0.37', 'lle': '5.58', 'sei': '7.73'}",CHEMBL4107696,,CHEMBL4107696,8.68,False,http://www.openphacts.org/units/Nanomolar,2845223,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
1969,337171,17715001,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CCNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.58', 'le': '0.36', 'lle': '4.95', 'sei': '8.40'}",CHEMBL3890249,,CHEMBL3890249,8.51,False,http://www.openphacts.org/units/Nanomolar,2845224,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
1970,337172,17715002,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(Cl)ccc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.31', 'le': '0.36', 'lle': '3.59', 'sei': '10.01'}",CHEMBL4114474,,CHEMBL4114474,7.93,False,http://www.openphacts.org/units/Nanomolar,2845225,=,37,True,=,,IC50,nM,,11.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.8
1971,337173,17715003,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(F)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '21.07', 'le': '0.40', 'lle': '5.58', 'sei': '9.55'}",CHEMBL4115151,,CHEMBL4115151,8.80,False,http://www.openphacts.org/units/Nanomolar,2845226,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
1972,337174,17715004,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '22.37', 'le': '0.42', 'lle': '6.49', 'sei': '8.54'}",CHEMBL4110834,,CHEMBL4110834,8.96,False,http://www.openphacts.org/units/Nanomolar,2845227,=,37,True,=,,IC50,nM,,1.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.1
1973,337175,17715005,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cncnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.66', 'le': '0.37', 'lle': '6.45', 'sei': '7.62'}",CHEMBL4112273,,CHEMBL4112273,8.70,False,http://www.openphacts.org/units/Nanomolar,2845228,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
1974,337176,17715006,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cncnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '21.89', 'le': '0.41', 'lle': '6.49', 'sei': '8.31'}",CHEMBL4114107,,CHEMBL4114107,8.72,False,http://www.openphacts.org/units/Nanomolar,2845229,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
1975,337177,17715007,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CNc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.27', 'le': '0.35', 'lle': '6.03', 'sei': '6.28'}",CHEMBL4108237,,CHEMBL4108237,7.87,False,http://www.openphacts.org/units/Nanomolar,2845230,=,37,True,=,,IC50,nM,,13.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.6
1976,337178,17715008,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CCNC(=O)c1cnc(-n2ccc3cncnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.37', 'le': '0.36', 'lle': '5.92', 'sei': '7.20'}",CHEMBL3894977,,CHEMBL3894977,8.22,False,http://www.openphacts.org/units/Nanomolar,2845231,=,37,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
1977,337179,17715009,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '21.90', 'le': '0.41', 'lle': '5.85', 'sei': '7.98'}",CHEMBL3969623,,CHEMBL3969623,8.38,False,http://www.openphacts.org/units/Nanomolar,2845232,=,37,True,=,,IC50,nM,,4.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.2
1978,337180,17715010,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.72', 'le': '0.32', 'lle': '4.59', 'sei': '6.30'}",CHEMBL4112370,,CHEMBL4112370,7.63,False,http://www.openphacts.org/units/Nanomolar,2845233,=,37,True,=,,IC50,nM,,23.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.2
1979,337181,17715011,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '18.25', 'le': '0.34', 'lle': '5.08', 'sei': '6.36'}",CHEMBL4107137,,CHEMBL4107137,8.66,False,http://www.openphacts.org/units/Nanomolar,2845234,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
1980,337182,17715012,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCCOC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.62', 'le': '0.36', 'lle': '4.59', 'sei': '7.87'}",CHEMBL3908695,,CHEMBL3908695,8.25,False,http://www.openphacts.org/units/Nanomolar,2845235,=,37,True,=,,IC50,nM,,5.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.6
1981,337183,17715013,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '21.57', 'le': '0.40', 'lle': '6.29', 'sei': '7.64'}",CHEMBL4109646,,CHEMBL4109646,8.85,False,http://www.openphacts.org/units/Nanomolar,2845236,=,37,True,=,,IC50,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.4
1982,337184,17715014,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.70', 'le': '0.39', 'lle': '5.93', 'sei': '7.33'}",CHEMBL4109646,,CHEMBL4109646,8.49,False,http://www.openphacts.org/units/Nanomolar,2845236,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
1983,337185,17715015,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(S(N)(=O)=O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.22', 'le': '0.31', 'lle': '6.20', 'sei': '4.95'}",CHEMBL4107511,,CHEMBL4107511,8.72,False,http://www.openphacts.org/units/Nanomolar,2845237,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
1984,337186,17715016,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.11', 'le': '0.32', 'lle': '4.48', 'sei': '6.68'}",CHEMBL4111310,,CHEMBL4111310,8.36,False,http://www.openphacts.org/units/Nanomolar,2845238,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
1985,337187,17715017,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.72', 'le': '0.34', 'lle': '5.97', 'sei': '6.33'}",CHEMBL4112912,,CHEMBL4112912,8.62,False,http://www.openphacts.org/units/Nanomolar,2845239,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
1986,337188,17715018,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC(F)(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.46', 'le': '0.35', 'lle': '5.38', 'sei': '7.53'}",CHEMBL4115586,,CHEMBL4115586,8.72,False,http://www.openphacts.org/units/Nanomolar,2845240,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
1987,337189,17715019,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.96', 'le': '0.31', 'lle': '4.91', 'sei': '6.03'}",CHEMBL4111696,,CHEMBL4111696,8.74,False,http://www.openphacts.org/units/Nanomolar,2845241,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
1988,337190,17715020,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.38', 'le': '0.30', 'lle': '5.21', 'sei': '5.82'}",CHEMBL4107577,,CHEMBL4107577,8.44,False,http://www.openphacts.org/units/Nanomolar,2845242,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
1989,337191,17715021,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(C(N)=O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '5.63', 'sei': '5.41'}",CHEMBL4110867,,CHEMBL4110867,8.60,False,http://www.openphacts.org/units/Nanomolar,2845243,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
1990,337192,17715022,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(NS(C)(=O)=O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.00', 'le': '0.31', 'lle': '5.57', 'sei': '5.45'}",CHEMBL4109266,,CHEMBL4109266,8.82,False,http://www.openphacts.org/units/Nanomolar,2845244,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
1991,337193,17715023,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '17.02', 'le': '0.33', 'lle': '5.84', 'sei': '5.50'}",CHEMBL3914563,,CHEMBL3914563,8.57,False,http://www.openphacts.org/units/Nanomolar,2845245,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
1992,337194,17715024,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)c1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.03', 'le': '0.32', 'lle': '4.70', 'sei': '6.46'}",CHEMBL4110722,,CHEMBL4110722,8.80,False,http://www.openphacts.org/units/Nanomolar,2845246,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
1993,337195,17715025,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(C(N)=O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '17.44', 'le': '0.32', 'lle': '5.77', 'sei': '5.50'}",CHEMBL4109312,,CHEMBL4109312,8.74,False,http://www.openphacts.org/units/Nanomolar,2845247,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
1994,337196,17715026,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CC[C@@](C)(O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.97', 'le': '0.34', 'lle': '5.65', 'sei': '6.53'}",CHEMBL4114114,,CHEMBL4114114,8.89,False,http://www.openphacts.org/units/Nanomolar,2845248,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
1995,337197,17715027,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CC[C@](C)(O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.07', 'le': '0.32', 'lle': '5.20', 'sei': '6.20'}",CHEMBL4114551,,CHEMBL4114551,8.44,False,http://www.openphacts.org/units/Nanomolar,2845249,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
1996,337198,17715028,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNS(C)(=O)=O,,,CHEMBL3886172,,2015.0,"{'bei': '19.00', 'le': '0.37', 'lle': '7.00', 'sei': '5.91'}",CHEMBL3946114,,CHEMBL3946114,8.39,False,http://www.openphacts.org/units/Nanomolar,2845250,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
1997,337199,17715029,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2ncsc2c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.01', 'le': '0.32', 'lle': '4.29', 'sei': '6.81'}",CHEMBL4109550,,CHEMBL4109550,8.77,False,http://www.openphacts.org/units/Nanomolar,2845251,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
1998,337200,17715030,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1(F)CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.83', 'le': '0.35', 'lle': '5.38', 'sei': '7.62'}",CHEMBL4106742,,CHEMBL4106742,8.82,False,http://www.openphacts.org/units/Nanomolar,2845252,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
1999,337201,17715031,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1,,,CHEMBL3886172,,2015.0,"{'bei': '18.14', 'le': '0.33', 'lle': '5.02', 'sei': '6.28'}",CHEMBL4107134,,CHEMBL4107134,8.77,False,http://www.openphacts.org/units/Nanomolar,2845253,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2000,337202,17715032,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(-n2cccn2)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '16.72', 'le': '0.31', 'lle': '4.71', 'sei': '6.56'}",CHEMBL4106842,,CHEMBL4106842,8.77,False,http://www.openphacts.org/units/Nanomolar,2845254,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2001,337203,17715033,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(-n2cncn2)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '16.51', 'le': '0.30', 'lle': '5.22', 'sei': '5.92'}",CHEMBL4113542,,CHEMBL4113542,8.68,False,http://www.openphacts.org/units/Nanomolar,2845255,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
2002,337204,17715034,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nnnc1-c1ccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '16.44', 'le': '0.30', 'lle': '5.82', 'sei': '5.57'}",CHEMBL4110352,,CHEMBL4110352,8.89,False,http://www.openphacts.org/units/Nanomolar,2845256,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2003,337205,17715035,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(=O)NC1CCS(=O)(=O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.26', 'le': '0.33', 'lle': '7.40', 'sei': '5.38'}",CHEMBL3921524,,CHEMBL3921524,8.55,False,http://www.openphacts.org/units/Nanomolar,2845257,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2004,337206,17715036,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(CO)c1,,,CHEMBL3886172,,2015.0,"{'bei': '18.06', 'le': '0.33', 'lle': '5.45', 'sei': '6.48'}",CHEMBL4110216,,CHEMBL4110216,8.82,False,http://www.openphacts.org/units/Nanomolar,2845258,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2005,337207,17715037,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)[C@H](C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.06', 'le': '0.36', 'lle': '5.41', 'sei': '7.51'}",CHEMBL3946796,,CHEMBL3946796,8.70,False,http://www.openphacts.org/units/Nanomolar,2845259,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
2006,337208,17715038,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCc2nc(N)sc2C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.68', 'le': '0.32', 'lle': '4.44', 'sei': '5.86'}",CHEMBL3906640,,CHEMBL3906640,7.88,False,http://www.openphacts.org/units/Nanomolar,2845260,=,37,True,=,,IC50,nM,,13.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.1
2007,337209,17715039,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cccnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.94', 'le': '0.39', 'lle': '5.29', 'sei': '9.09'}",CHEMBL4110704,,CHEMBL4110704,8.37,False,http://www.openphacts.org/units/Nanomolar,2845261,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2008,337210,17715040,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.13', 'le': '0.36', 'lle': '5.17', 'sei': '7.01'}",CHEMBL4109047,,CHEMBL4109047,8.12,False,http://www.openphacts.org/units/Nanomolar,2845262,=,37,True,=,,IC50,nM,,7.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.6
2009,337211,17715041,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.34', 'le': '0.40', 'lle': '5.09', 'sei': '9.58'}",CHEMBL4115627,,CHEMBL4115627,8.82,False,http://www.openphacts.org/units/Nanomolar,2845263,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2010,337212,17715042,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.89', 'le': '0.36', 'lle': '6.28', 'sei': '6.31'}",CHEMBL4112926,,CHEMBL4112926,8.59,False,http://www.openphacts.org/units/Nanomolar,2845264,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2011,337213,17715043,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.30', 'le': '0.36', 'lle': '5.64', 'sei': '7.37'}",CHEMBL4110348,,CHEMBL4110348,8.54,False,http://www.openphacts.org/units/Nanomolar,2845265,=,37,True,=,,IC50,nM,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.9
2012,337214,17715044,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)ccc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.30', 'le': '0.32', 'lle': '4.19', 'sei': '7.10'}",CHEMBL3920819,,CHEMBL3920819,7.94,False,http://www.openphacts.org/units/Nanomolar,2845266,=,37,True,=,,IC50,nM,,11.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.6
2013,337215,17715045,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.49', 'le': '0.36', 'lle': '5.81', 'sei': '7.18'}",CHEMBL3902828,,CHEMBL3902828,8.96,False,http://www.openphacts.org/units/Nanomolar,2845267,=,37,True,=,,IC50,nM,,1.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.1
2014,337216,17715046,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.02', 'le': '0.33', 'lle': '5.18', 'sei': '6.89'}",CHEMBL3973778,,CHEMBL3973778,7.85,False,http://www.openphacts.org/units/Nanomolar,2845268,=,37,True,=,,IC50,nM,,14.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.2
2015,337217,17715047,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC2CCOCC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.50', 'le': '0.33', 'lle': '5.92', 'sei': '6.79'}",CHEMBL3911840,,CHEMBL3911840,8.36,False,http://www.openphacts.org/units/Nanomolar,2845269,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2016,337218,17715048,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC2CCOCC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.40', 'le': '0.32', 'lle': '5.73', 'sei': '6.75'}",CHEMBL3978710,,CHEMBL3978710,8.31,False,http://www.openphacts.org/units/Nanomolar,2845270,=,37,True,=,,IC50,nM,,4.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.9
2017,337219,17715049,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.44', 'le': '0.34', 'lle': '5.22', 'sei': '7.06'}",CHEMBL3958009,,CHEMBL3958009,8.03,False,http://www.openphacts.org/units/Nanomolar,2845271,=,37,True,=,,IC50,nM,,9.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.3
2018,337220,17715050,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.21', 'le': '0.32', 'lle': '4.98', 'sei': '6.31'}",CHEMBL3986991,,CHEMBL3986991,7.88,False,http://www.openphacts.org/units/Nanomolar,2845272,=,37,True,=,,IC50,nM,,13.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.3
2019,337221,17715051,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CCOCC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.25', 'le': '0.30', 'lle': '5.23', 'sei': '6.08'}",CHEMBL3954007,,CHEMBL3954007,8.15,False,http://www.openphacts.org/units/Nanomolar,2845273,=,37,True,=,,IC50,nM,,7.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.1
2020,337222,17715052,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.06', 'le': '0.35', 'lle': '5.68', 'sei': '6.99'}",CHEMBL3929809,,CHEMBL3929809,8.72,False,http://www.openphacts.org/units/Nanomolar,2845274,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2021,337223,17715053,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CCOCC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.25', 'le': '0.30', 'lle': '5.09', 'sei': '6.08'}",CHEMBL3962798,,CHEMBL3962798,8.15,False,http://www.openphacts.org/units/Nanomolar,2845275,=,37,True,=,,IC50,nM,,7.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.1
2022,337224,17715054,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2N[C@@H](C)CO)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.84', 'le': '0.33', 'lle': '6.36', 'sei': '5.85'}",CHEMBL3938824,,CHEMBL3938824,8.48,False,http://www.openphacts.org/units/Nanomolar,2845276,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2023,337225,17715055,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(=O)NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.89', 'le': '0.33', 'lle': '4.79', 'sei': '6.99'}",CHEMBL3895223,,CHEMBL3895223,8.72,False,http://www.openphacts.org/units/Nanomolar,2845277,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2024,337226,17715056,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(=O)NC2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.91', 'le': '0.33', 'lle': '5.02', 'sei': '6.97'}",CHEMBL3926706,,CHEMBL3926706,8.70,False,http://www.openphacts.org/units/Nanomolar,2845278,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
2025,337227,17715057,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.52', 'le': '0.34', 'lle': '5.23', 'sei': '7.03'}",CHEMBL3889742,,CHEMBL3889742,8.77,False,http://www.openphacts.org/units/Nanomolar,2845279,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2026,337228,17715058,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2CCC(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.53', 'le': '0.31', 'lle': '5.05', 'sei': '6.08'}",CHEMBL3917746,,CHEMBL3917746,8.08,False,http://www.openphacts.org/units/Nanomolar,2845280,=,37,True,=,,IC50,nM,,8.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.4
2027,337229,17715059,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.08', 'le': '0.35', 'lle': '5.62', 'sei': '7.03'}",CHEMBL3902828,,CHEMBL3902828,8.77,False,http://www.openphacts.org/units/Nanomolar,2845267,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2028,337230,17715060,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H]([N+](=O)[O-])CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.53', 'le': '0.34', 'lle': '4.86', 'sei': '5.98'}",CHEMBL3970825,,CHEMBL3970825,8.29,False,http://www.openphacts.org/units/Nanomolar,2845281,=,37,True,=,,IC50,nM,,5.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.1
2029,337231,17715061,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.22', 'le': '0.36', 'lle': '4.68', 'sei': '7.64'}",CHEMBL3904136,,CHEMBL3904136,8.85,False,http://www.openphacts.org/units/Nanomolar,2845282,=,37,True,=,,IC50,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.4
2030,337232,17715062,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.47', 'le': '0.32', 'lle': '4.80', 'sei': '6.20'}",CHEMBL3932139,,CHEMBL3932139,8.31,False,http://www.openphacts.org/units/Nanomolar,2845283,=,37,True,=,,IC50,nM,,4.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.9
2031,337233,17715063,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.27', 'le': '0.37', 'lle': '5.33', 'sei': '7.32'}",CHEMBL3958699,,CHEMBL3958699,8.48,False,http://www.openphacts.org/units/Nanomolar,2845284,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2032,337234,17715064,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](C)(O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.28', 'le': '0.36', 'lle': '4.80', 'sei': '7.20'}",CHEMBL3911745,,CHEMBL3911745,8.34,False,http://www.openphacts.org/units/Nanomolar,2845285,=,37,True,=,,IC50,nM,,4.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.6
2033,337235,17715065,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.26', 'le': '0.36', 'lle': '4.82', 'sei': '7.42'}",CHEMBL3921034,,CHEMBL3921034,8.60,False,http://www.openphacts.org/units/Nanomolar,2845286,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2034,337236,17715066,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CS[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.07', 'le': '0.35', 'lle': '3.59', 'sei': '8.48'}",CHEMBL3948840,,CHEMBL3948840,8.11,False,http://www.openphacts.org/units/Nanomolar,2845287,=,37,True,=,,IC50,nM,,7.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.8
2035,337237,17715067,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](S(C)(=O)=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.57', 'le': '0.34', 'lle': '5.24', 'sei': '6.51'}",CHEMBL3947754,,CHEMBL3947754,8.44,False,http://www.openphacts.org/units/Nanomolar,2845288,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2036,337238,17715068,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CCOCC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.18', 'le': '0.31', 'lle': '5.49', 'sei': '6.08'}",CHEMBL3973807,,CHEMBL3973807,8.46,False,http://www.openphacts.org/units/Nanomolar,2845289,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2037,337239,17715069,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.32', 'le': '0.35', 'lle': '5.82', 'sei': '6.76'}",CHEMBL3956425,,CHEMBL3956425,8.77,False,http://www.openphacts.org/units/Nanomolar,2845290,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2038,337240,17715070,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2Nc2cccc(C(N)=O)c2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.08', 'le': '0.29', 'lle': '5.19', 'sei': '4.86'}",CHEMBL3985083,,CHEMBL3985083,8.41,False,http://www.openphacts.org/units/Nanomolar,2845291,=,37,True,=,,IC50,nM,,3.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.9
2039,337241,17715071,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1F,,,CHEMBL3886172,,2015.0,"{'bei': '18.00', 'le': '0.34', 'lle': '6.05', 'sei': '6.97'}",CHEMBL4107284,,CHEMBL4107284,8.72,False,http://www.openphacts.org/units/Nanomolar,2845292,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2040,337242,17715072,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1F,,,CHEMBL3886172,,2015.0,"{'bei': '18.05', 'le': '0.34', 'lle': '6.07', 'sei': '6.99'}",CHEMBL4107284,,CHEMBL4107284,8.74,False,http://www.openphacts.org/units/Nanomolar,2845292,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2041,337243,17715073,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1F,,,CHEMBL3886172,,2015.0,"{'bei': '17.45', 'le': '0.33', 'lle': '5.79', 'sei': '6.76'}",CHEMBL4107284,,CHEMBL4107284,8.46,False,http://www.openphacts.org/units/Nanomolar,2845292,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2042,337244,17715074,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '19.21', 'le': '0.36', 'lle': '5.57', 'sei': '7.77'}",CHEMBL4112434,,CHEMBL4112434,9.00,False,http://www.openphacts.org/units/Nanomolar,2845293,=,37,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
2043,337245,17715075,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.97', 'le': '0.36', 'lle': '5.46', 'sei': '7.67'}",CHEMBL4112434,,CHEMBL4112434,8.89,False,http://www.openphacts.org/units/Nanomolar,2845293,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2044,337246,17715076,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(F)(F)C1O,,,CHEMBL3886172,,2015.0,"{'bei': '16.07', 'le': '0.31', 'lle': '5.21', 'sei': '6.10'}",CHEMBL4108104,,CHEMBL4108104,8.30,False,http://www.openphacts.org/units/Nanomolar,2845294,=,37,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
2045,337247,17715077,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(F)(F)C1O,,,CHEMBL3886172,,2015.0,"{'bei': '16.18', 'le': '0.31', 'lle': '5.27', 'sei': '6.14'}",CHEMBL4108104,,CHEMBL4108104,8.36,False,http://www.openphacts.org/units/Nanomolar,2845294,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2046,337248,17715078,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CF)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.84', 'le': '0.40', 'lle': '6.30', 'sei': '8.31'}",CHEMBL4109783,,CHEMBL4109783,8.72,False,http://www.openphacts.org/units/Nanomolar,2845295,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2047,337249,17715079,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](CF)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.80', 'le': '0.36', 'lle': '6.04', 'sei': '6.48'}",CHEMBL4107902,,CHEMBL4107902,8.34,False,http://www.openphacts.org/units/Nanomolar,2845296,=,37,True,=,,IC50,nM,,4.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.6
2048,337250,17715080,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](CF)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.27', 'le': '0.39', 'lle': '6.06', 'sei': '8.08'}",CHEMBL4108187,,CHEMBL4108187,8.48,False,http://www.openphacts.org/units/Nanomolar,2845297,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2049,337251,17715081,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CF)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.61', 'le': '0.37', 'lle': '5.79', 'sei': '7.82'}",CHEMBL3928854,,CHEMBL3928854,8.21,False,http://www.openphacts.org/units/Nanomolar,2845298,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2050,337252,17715082,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.48', 'le': '0.37', 'lle': '5.72', 'sei': '7.44'}",CHEMBL3904382,,CHEMBL3904382,8.62,False,http://www.openphacts.org/units/Nanomolar,2845299,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2051,337253,17715083,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.76', 'le': '0.37', 'lle': '5.84', 'sei': '7.55'}",CHEMBL4106949,,CHEMBL4106949,8.74,False,http://www.openphacts.org/units/Nanomolar,2845300,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2052,337254,17715084,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.69', 'le': '0.37', 'lle': '5.41', 'sei': '7.21'}",CHEMBL3914423,,CHEMBL3914423,8.36,False,http://www.openphacts.org/units/Nanomolar,2845301,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2053,337255,17715085,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.54', 'le': '0.37', 'lle': '5.34', 'sei': '7.16'}",CHEMBL4110597,,CHEMBL4110597,8.29,False,http://www.openphacts.org/units/Nanomolar,2845302,=,37,True,=,,IC50,nM,,5.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.1
2054,337256,17715086,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CF)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.68', 'le': '0.35', 'lle': '5.98', 'sei': '6.43'}",CHEMBL3981034,,CHEMBL3981034,8.28,False,http://www.openphacts.org/units/Nanomolar,2845303,=,37,True,=,,IC50,nM,,5.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.2
2055,337257,17715087,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2N[C@@H](C)CF)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.29', 'le': '0.30', 'lle': '5.31', 'sei': '5.66'}",CHEMBL3953153,,CHEMBL3953153,7.80,False,http://www.openphacts.org/units/Nanomolar,2845304,=,37,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
2056,337258,17715088,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ccc3cc(C(N)=O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.48', 'le': '0.37', 'lle': '6.56', 'sei': '6.18'}",CHEMBL4110658,,CHEMBL4110658,8.35,False,http://www.openphacts.org/units/Nanomolar,2845305,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2057,337259,17715089,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C(N)=O)cnc32)cc1NC1CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.30', 'le': '0.34', 'lle': '6.00', 'sei': '6.15'}",CHEMBL4114139,,CHEMBL4114139,8.32,False,http://www.openphacts.org/units/Nanomolar,2845306,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2058,337260,17715090,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)OC(C)(C)C(=O)NCCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '16.63', 'le': '0.31', 'lle': '5.87', 'sei': '5.41'}",CHEMBL3949459,,CHEMBL3949459,8.17,False,http://www.openphacts.org/units/Nanomolar,2845307,=,37,True,=,,IC50,nM,,6.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.7
2059,337261,17715091,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNC(=O)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.07', 'le': '0.34', 'lle': '6.39', 'sei': '5.60'}",CHEMBL3922141,,CHEMBL3922141,8.12,False,http://www.openphacts.org/units/Nanomolar,2845308,=,37,True,=,,IC50,nM,,7.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.5
2060,337262,17715092,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.84', 'le': '0.39', 'lle': '5.72', 'sei': '8.16'}",CHEMBL4108617,,CHEMBL4108617,8.55,False,http://www.openphacts.org/units/Nanomolar,2845309,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2061,337263,17715093,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)ccc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.31', 'le': '0.38', 'lle': '5.27', 'sei': '7.68'}",CHEMBL3897707,,CHEMBL3897707,8.05,False,http://www.openphacts.org/units/Nanomolar,2845310,=,37,True,=,,IC50,nM,,8.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.9
2062,337264,17715094,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '18.57', 'le': '0.35', 'lle': '4.82', 'sei': '7.79'}",CHEMBL4113092,,CHEMBL4113092,8.39,False,http://www.openphacts.org/units/Nanomolar,2845311,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2063,337265,17715095,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.13', 'le': '0.36', 'lle': '5.07', 'sei': '8.02'}",CHEMBL4113092,,CHEMBL4113092,8.64,False,http://www.openphacts.org/units/Nanomolar,2845311,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2064,337266,17715096,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(CO)CF,,,CHEMBL3886172,,2015.0,"{'bei': '17.81', 'le': '0.34', 'lle': '6.30', 'sei': '6.00'}",CHEMBL4115333,,CHEMBL4115333,8.17,False,http://www.openphacts.org/units/Nanomolar,2845312,=,37,True,=,,IC50,nM,,6.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.8
2065,337267,17715097,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.76', 'le': '0.37', 'lle': '6.65', 'sei': '6.68'}",CHEMBL4115518,,CHEMBL4115518,8.33,False,http://www.openphacts.org/units/Nanomolar,2845313,=,37,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
2066,337268,17715098,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.18', 'le': '0.38', 'lle': '6.24', 'sei': '6.67'}",CHEMBL3948538,,CHEMBL3948538,8.59,False,http://www.openphacts.org/units/Nanomolar,2845314,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2067,337269,17715099,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cncnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.43', 'le': '0.38', 'lle': '6.54', 'sei': '6.93'}",CHEMBL4107673,,CHEMBL4107673,8.16,False,http://www.openphacts.org/units/Nanomolar,2845315,=,37,True,=,,IC50,nM,,6.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.9
2068,337270,17715100,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.50', 'le': '0.35', 'lle': '5.45', 'sei': '7.31'}",CHEMBL4107578,,CHEMBL4107578,8.35,False,http://www.openphacts.org/units/Nanomolar,2845316,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2069,337271,17715101,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.66', 'le': '0.39', 'lle': '5.63', 'sei': '8.11'}",CHEMBL4107169,,CHEMBL4107169,8.51,False,http://www.openphacts.org/units/Nanomolar,2845317,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2070,337272,17715102,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.70', 'le': '0.39', 'lle': '5.44', 'sei': '8.16'}",CHEMBL4109623,,CHEMBL4109623,8.57,False,http://www.openphacts.org/units/Nanomolar,2845318,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
2071,337273,17715103,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.91', 'le': '0.37', 'lle': '6.23', 'sei': '6.36'}",CHEMBL4109995,,CHEMBL4109995,8.19,False,http://www.openphacts.org/units/Nanomolar,2845319,=,37,True,=,,IC50,nM,,6.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.4
2072,337274,17715104,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.16', 'le': '0.38', 'lle': '6.44', 'sei': '6.63'}",CHEMBL4110250,,CHEMBL4110250,8.54,False,http://www.openphacts.org/units/Nanomolar,2845320,=,37,True,=,,IC50,nM,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.9
2073,337275,17715105,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.62', 'le': '0.32', 'lle': '5.78', 'sei': '5.87'}",CHEMBL3894635,,CHEMBL3894635,8.08,False,http://www.openphacts.org/units/Nanomolar,2845321,=,37,True,=,,IC50,nM,,8.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.3
2074,337276,17715106,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.52', 'le': '0.35', 'lle': '6.54', 'sei': '6.27'}",CHEMBL4115033,,CHEMBL4115033,8.66,False,http://www.openphacts.org/units/Nanomolar,2845322,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2075,337277,17715107,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '5.82', 'sei': '5.76'}",CHEMBL4108784,,CHEMBL4108784,7.94,False,http://www.openphacts.org/units/Nanomolar,2845323,=,37,True,=,,IC50,nM,,11.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.4
2076,337278,17715108,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.51', 'le': '0.33', 'lle': '6.07', 'sei': '5.93'}",CHEMBL4108784,,CHEMBL4108784,8.19,False,http://www.openphacts.org/units/Nanomolar,2845323,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
2077,337279,17715109,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.44', 'le': '0.39', 'lle': '6.34', 'sei': '6.96'}",CHEMBL4108811,,CHEMBL4108811,8.21,False,http://www.openphacts.org/units/Nanomolar,2845324,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2078,337280,17715110,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.08', 'le': '0.36', 'lle': '5.86', 'sei': '6.48'}",CHEMBL4112884,,CHEMBL4112884,8.35,False,http://www.openphacts.org/units/Nanomolar,2845325,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2079,337281,17715111,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.09', 'le': '0.37', 'lle': '5.79', 'sei': '6.36'}",CHEMBL3923273,,CHEMBL3923273,8.19,False,http://www.openphacts.org/units/Nanomolar,2845326,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
2080,337282,17715112,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(F)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '17.03', 'le': '0.33', 'lle': '5.42', 'sei': '6.15'}",CHEMBL4108994,,CHEMBL4108994,7.92,False,http://www.openphacts.org/units/Nanomolar,2845327,=,37,True,=,,IC50,nM,,11.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.9
2081,337283,17715113,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.18', 'le': '0.36', 'lle': '5.28', 'sei': '6.88'}",CHEMBL3985561,,CHEMBL3985561,8.85,False,http://www.openphacts.org/units/Nanomolar,2845328,=,37,True,=,,IC50,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.4
2082,337284,17715114,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(O)(CC)[C@H](F)CNC(=O)c1cnc(-n2ncc3cncnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '18.70', 'le': '0.35', 'lle': '5.38', 'sei': '6.82'}",CHEMBL4115569,,CHEMBL4115569,8.03,False,http://www.openphacts.org/units/Nanomolar,2845329,=,37,True,=,,IC50,nM,,9.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.3
2083,337285,17715115,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.08', 'le': '0.33', 'lle': '3.70', 'sei': '7.67'}",CHEMBL3948919,,CHEMBL3948919,8.05,False,http://www.openphacts.org/units/Nanomolar,2845330,=,37,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
2084,337286,17715116,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.42', 'le': '0.32', 'lle': '5.66', 'sei': '5.67'}",CHEMBL3905839,,CHEMBL3905839,7.83,False,http://www.openphacts.org/units/Nanomolar,2845331,=,37,True,=,,IC50,nM,,14.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.8
2085,337287,17715117,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(Cl)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.56', 'le': '0.34', 'lle': '4.93', 'sei': '7.25'}",CHEMBL3914366,,CHEMBL3914366,8.25,False,http://www.openphacts.org/units/Nanomolar,2845332,=,37,True,=,,IC50,nM,,5.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.6
2086,337288,17715118,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.43', 'le': '0.39', 'lle': '6.33', 'sei': '6.80'}",CHEMBL4111012,,CHEMBL4111012,8.51,False,http://www.openphacts.org/units/Nanomolar,2845333,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2087,337289,17715119,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NCCN1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.84', 'le': '0.35', 'lle': '5.57', 'sei': '8.15'}",CHEMBL3907661,,CHEMBL3907661,7.92,False,http://www.openphacts.org/units/Nanomolar,2845334,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
2088,337290,17715120,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '19.67', 'le': '0.37', 'lle': '5.37', 'sei': '7.77'}",CHEMBL4112161,,CHEMBL4112161,8.15,False,http://www.openphacts.org/units/Nanomolar,2845335,=,37,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
2089,337291,17715121,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.26', 'le': '0.37', 'lle': '5.65', 'sei': '7.64'}",CHEMBL4113637,,CHEMBL4113637,8.02,False,http://www.openphacts.org/units/Nanomolar,2845336,=,37,True,=,,IC50,nM,,9.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.5
2090,337292,17715122,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(F)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.78', 'le': '0.38', 'lle': '5.67', 'sei': '7.88'}",CHEMBL4111435,,CHEMBL4111435,8.28,False,http://www.openphacts.org/units/Nanomolar,2845337,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2091,337293,17715123,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(Br)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.48', 'le': '0.38', 'lle': '5.14', 'sei': '7.98'}",CHEMBL4106606,,CHEMBL4106606,8.38,False,http://www.openphacts.org/units/Nanomolar,2845338,=,37,True,=,,IC50,nM,,4.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.2
2092,337294,17715124,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.90', 'le': '0.34', 'lle': '6.38', 'sei': '5.79'}",CHEMBL4115100,,CHEMBL4115100,8.62,False,http://www.openphacts.org/units/Nanomolar,2845339,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2093,337295,17715125,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.88', 'le': '0.33', 'lle': '5.70', 'sei': '5.99'}",CHEMBL3900682,,CHEMBL3900682,8.24,False,http://www.openphacts.org/units/Nanomolar,2845340,=,37,True,=,,IC50,nM,,5.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.8
2094,337296,17715126,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](S(C)(=O)=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.96', 'le': '0.33', 'lle': '5.58', 'sei': '5.73'}",CHEMBL3953510,,CHEMBL3953510,8.17,False,http://www.openphacts.org/units/Nanomolar,2845341,=,37,True,=,,IC50,nM,,6.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.8
2095,337297,17715127,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.28', 'le': '0.34', 'lle': '5.88', 'sei': '6.12'}",CHEMBL3900682,,CHEMBL3900682,8.42,False,http://www.openphacts.org/units/Nanomolar,2845340,=,37,True,=,,IC50,nM,,3.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.8
2096,337298,17715128,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.63', 'le': '0.33', 'lle': '5.30', 'sei': '6.62'}",CHEMBL4109402,,CHEMBL4109402,8.52,False,http://www.openphacts.org/units/Nanomolar,2845342,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2097,337299,17715129,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.36', 'le': '0.34', 'lle': '5.78', 'sei': '6.14'}",CHEMBL3925644,,CHEMBL3925644,8.46,False,http://www.openphacts.org/units/Nanomolar,2845343,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2098,337300,17715130,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCc2nc(N)sc2C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.98', 'le': '0.32', 'lle': '5.21', 'sei': '5.45'}",CHEMBL3894101,,CHEMBL3894101,8.04,False,http://www.openphacts.org/units/Nanomolar,2845344,=,37,True,=,,IC50,nM,,9.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.1
2099,337301,17715131,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](NS(C)(=O)=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.79', 'le': '0.33', 'lle': '6.24', 'sei': '5.39'}",CHEMBL3916631,,CHEMBL3916631,8.34,False,http://www.openphacts.org/units/Nanomolar,2845345,=,37,True,=,,IC50,nM,,4.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.6
2100,337302,17715132,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)(F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.99', 'le': '0.34', 'lle': '5.34', 'sei': '6.20'}",CHEMBL3986395,,CHEMBL3986395,7.98,False,http://www.openphacts.org/units/Nanomolar,2845346,=,37,True,=,,IC50,nM,,10.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.5
2101,337303,17715133,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc(-c3ccnnc3)n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.44', 'le': '0.35', 'lle': '5.50', 'sei': '6.69'}",CHEMBL4106933,,CHEMBL4106933,7.88,False,http://www.openphacts.org/units/Nanomolar,2845347,=,37,True,=,,IC50,nM,,13.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.1
2102,337304,17715134,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(F)(F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.78', 'le': '0.32', 'lle': '6.14', 'sei': '5.69'}",CHEMBL4112724,,CHEMBL4112724,8.48,False,http://www.openphacts.org/units/Nanomolar,2845348,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2103,337305,17715135,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2cnc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.48', 'le': '0.37', 'lle': '5.95', 'sei': '6.64'}",CHEMBL4115670,,CHEMBL4115670,7.82,False,http://www.openphacts.org/units/Nanomolar,2845349,=,37,True,=,,IC50,nM,,15.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.1
2104,337306,17715136,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2cnc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.25', 'le': '0.38', 'lle': '6.98', 'sei': '5.86'}",CHEMBL4113937,,CHEMBL4113937,8.43,False,http://www.openphacts.org/units/Nanomolar,2845350,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
2105,337307,17715137,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2cnc3cnc(NCCO)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.68', 'le': '0.36', 'lle': '7.33', 'sei': '5.73'}",CHEMBL4109831,,CHEMBL4109831,8.60,False,http://www.openphacts.org/units/Nanomolar,2845351,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2106,337308,17715138,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2ccnn2C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.33', 'le': '0.32', 'lle': '5.23', 'sei': '6.46'}",CHEMBL3940719,,CHEMBL3940719,8.64,False,http://www.openphacts.org/units/Nanomolar,2845352,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2107,337309,17715139,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](F)(c2ccnn2C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.94', 'le': '0.31', 'lle': '4.10', 'sei': '7.48'}",CHEMBL3893606,,CHEMBL3893606,8.48,False,http://www.openphacts.org/units/Nanomolar,2845353,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2108,337310,17715140,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2nccs2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.55', 'le': '0.31', 'lle': '4.17', 'sei': '6.45'}",CHEMBL3921623,,CHEMBL3921623,8.30,False,http://www.openphacts.org/units/Nanomolar,2845354,=,37,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
2109,337311,17715141,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2nccn2C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.43', 'le': '0.30', 'lle': '4.78', 'sei': '6.13'}",CHEMBL3898331,,CHEMBL3898331,8.19,False,http://www.openphacts.org/units/Nanomolar,2845355,=,37,True,=,,IC50,nM,,6.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.4
2110,337312,17715142,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2cccnc2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.04', 'le': '0.31', 'lle': '4.37', 'sei': '6.56'}",CHEMBL3969520,,CHEMBL3969520,8.44,False,http://www.openphacts.org/units/Nanomolar,2845356,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2111,337313,17715143,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2ccccn2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.01', 'le': '0.31', 'lle': '4.36', 'sei': '6.55'}",CHEMBL3899111,,CHEMBL3899111,8.43,False,http://www.openphacts.org/units/Nanomolar,2845357,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
2112,337314,17715144,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2ccncc2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.26', 'le': '0.32', 'lle': '4.48', 'sei': '6.64'}",CHEMBL3974716,,CHEMBL3974716,8.55,False,http://www.openphacts.org/units/Nanomolar,2845358,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2113,337315,17715145,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](F)(c2nccs2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.43', 'le': '0.31', 'lle': '3.17', 'sei': '7.63'}",CHEMBL3912832,,CHEMBL3912832,8.28,False,http://www.openphacts.org/units/Nanomolar,2845359,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2114,337316,17715146,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](F)(c2nccn2C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.71', 'le': '0.31', 'lle': '3.99', 'sei': '7.37'}",CHEMBL3982704,,CHEMBL3982704,8.37,False,http://www.openphacts.org/units/Nanomolar,2845360,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2115,337317,17715147,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@@](F)(c2nccn2C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.47', 'le': '0.32', 'lle': '4.36', 'sei': '7.71'}",CHEMBL3945800,,CHEMBL3945800,8.74,False,http://www.openphacts.org/units/Nanomolar,2845361,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2116,337318,17715148,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCC2(CC1)NC(=O)NC2=O,,,CHEMBL3886172,,2015.0,"{'bei': '17.24', 'le': '0.32', 'lle': '6.03', 'sei': '5.45'}",CHEMBL3925452,,CHEMBL3925452,8.39,False,http://www.openphacts.org/units/Nanomolar,2845362,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2117,337319,17715149,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@@H]1CC=C(c2ccncc2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.30', 'le': '0.31', 'lle': '3.39', 'sei': '7.61'}",CHEMBL4110687,,CHEMBL4110687,8.26,False,http://www.openphacts.org/units/Nanomolar,2845363,=,37,True,=,,IC50,nM,,5.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.5
2118,337320,17715150,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cnc(N(C)C)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.09', 'le': '0.36', 'lle': '5.93', 'sei': '7.83'}",CHEMBL4107163,,CHEMBL4107163,8.47,False,http://www.openphacts.org/units/Nanomolar,2845364,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2119,337321,17715151,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '21.39', 'le': '0.40', 'lle': '6.83', 'sei': '6.78'}",CHEMBL4111162,,CHEMBL4111162,8.89,False,http://www.openphacts.org/units/Nanomolar,2845365,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2120,337322,17715152,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cnc(NCC(C)(C)O)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.89', 'le': '0.34', 'lle': '6.06', 'sei': '6.36'}",CHEMBL4106447,,CHEMBL4106447,8.72,False,http://www.openphacts.org/units/Nanomolar,2845366,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2121,337323,17715153,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cnc(NCCO)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.08', 'le': '0.36', 'lle': '6.89', 'sei': '6.39'}",CHEMBL4106756,,CHEMBL4106756,8.77,False,http://www.openphacts.org/units/Nanomolar,2845367,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2122,337324,17715154,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cnc(N4CC[C@H](O)C4)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.13', 'le': '0.32', 'lle': '6.27', 'sei': '6.48'}",CHEMBL3949060,,CHEMBL3949060,8.32,False,http://www.openphacts.org/units/Nanomolar,2845368,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2123,337325,17715155,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cnc(N4CC[C@@H](O)C4)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '6.28', 'sei': '6.48'}",CHEMBL4108854,,CHEMBL4108854,8.33,False,http://www.openphacts.org/units/Nanomolar,2845369,=,37,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
2124,337326,17715156,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)OP(=O)(O)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.50', 'le': '0.31', 'lle': '5.37', 'sei': '4.47'}",CHEMBL4110998,,CHEMBL4110998,7.83,False,http://www.openphacts.org/units/Nanomolar,2845370,=,37,True,=,,IC50,nM,,14.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.7
2125,337327,17715157,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.18', 'le': '0.38', 'lle': '6.24', 'sei': '6.67'}",CHEMBL3948538,,CHEMBL3948538,8.59,False,http://www.openphacts.org/units/Nanomolar,2845371,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2126,337328,17715158,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.09', 'le': '0.37', 'lle': '5.68', 'sei': '6.58'}",CHEMBL4107281,,CHEMBL4107281,8.47,False,http://www.openphacts.org/units/Nanomolar,2845372,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2127,337329,17715159,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.43', 'le': '0.39', 'lle': '6.33', 'sei': '6.80'}",CHEMBL4111012,,CHEMBL4111012,8.51,False,http://www.openphacts.org/units/Nanomolar,2845333,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2128,337330,17715160,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.92', 'le': '0.34', 'lle': '5.23', 'sei': '6.75'}",CHEMBL4107905,,CHEMBL4107905,7.71,False,http://www.openphacts.org/units/Nanomolar,2845373,=,37,True,=,,IC50,nM,,19.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.4
2129,337331,17715161,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.76', 'le': '0.35', 'lle': '5.63', 'sei': '6.20'}",CHEMBL3933351,,CHEMBL3933351,7.98,False,http://www.openphacts.org/units/Nanomolar,2845374,=,37,True,=,,IC50,nM,,10.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.4
2130,337332,17715162,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '17.88', 'le': '0.33', 'lle': '5.99', 'sei': '5.88'}",CHEMBL4111430,,CHEMBL4111430,8.09,False,http://www.openphacts.org/units/Nanomolar,2845375,=,37,True,=,,IC50,nM,,8.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.1
2131,337333,17715163,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCC(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.53', 'le': '0.36', 'lle': '5.28', 'sei': '7.19'}",CHEMBL3954925,,CHEMBL3954925,8.47,False,http://www.openphacts.org/units/Nanomolar,2845376,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2132,337334,17715164,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '21.73', 'le': '0.40', 'lle': '5.16', 'sei': '7.56'}",CHEMBL3930830,,CHEMBL3930830,8.20,False,http://www.openphacts.org/units/Nanomolar,2845377,=,37,True,=,,IC50,nM,,6.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.3
2133,337335,17715165,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.46', 'le': '0.37', 'lle': '5.55', 'sei': '7.26'}",CHEMBL4110810,,CHEMBL4110810,8.55,False,http://www.openphacts.org/units/Nanomolar,2845378,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2134,337336,17715166,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCCN1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.36', 'le': '0.32', 'lle': '5.83', 'sei': '6.44'}",CHEMBL3955569,,CHEMBL3955569,7.79,False,http://www.openphacts.org/units/Nanomolar,2845379,=,37,True,=,,IC50,nM,,16.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.3
2135,337337,17715167,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)[C@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.43', 'le': '0.33', 'lle': '5.29', 'sei': '6.19'}",CHEMBL3933400,,CHEMBL3933400,7.97,False,http://www.openphacts.org/units/Nanomolar,2845380,=,37,True,=,,IC50,nM,,10.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.6
2136,337338,17715168,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)[C@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.38', 'le': '0.35', 'lle': '5.73', 'sei': '6.53'}",CHEMBL3933400,,CHEMBL3933400,8.41,False,http://www.openphacts.org/units/Nanomolar,2845380,=,37,True,=,,IC50,nM,,3.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.9
2137,337339,17715169,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCN1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.12', 'le': '0.35', 'lle': '6.74', 'sei': '6.87'}",CHEMBL3942383,,CHEMBL3942383,8.31,False,http://www.openphacts.org/units/Nanomolar,2845381,=,37,True,=,,IC50,nM,,4.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.9
2138,337340,17715170,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CCF)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.83', 'le': '0.34', 'lle': '5.46', 'sei': '6.33'}",CHEMBL4111866,,CHEMBL4111866,8.15,False,http://www.openphacts.org/units/Nanomolar,2845382,=,37,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
2139,337341,17715171,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(=O)N1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.48', 'le': '0.32', 'lle': '6.74', 'sei': '5.68'}",CHEMBL3954542,,CHEMBL3954542,7.84,False,http://www.openphacts.org/units/Nanomolar,2845383,=,37,True,=,,IC50,nM,,14.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.4
2140,337342,17715172,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.60', 'le': '0.36', 'lle': '6.19', 'sei': '5.92'}",CHEMBL3980058,,CHEMBL3980058,7.99,False,http://www.openphacts.org/units/Nanomolar,2845384,=,37,True,=,,IC50,nM,,10.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.3
2141,337343,17715173,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOP(=O)(CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C)OCC,,,CHEMBL3886172,,2015.0,"{'bei': '16.06', 'le': '0.31', 'lle': '4.30', 'sei': '5.41'}",CHEMBL3965756,,CHEMBL3965756,7.80,False,http://www.openphacts.org/units/Nanomolar,2845385,=,37,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
2142,337344,17715174,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC1CCS(=O)(=O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.23', 'le': '0.33', 'lle': '6.15', 'sei': '5.48'}",CHEMBL3894314,,CHEMBL3894314,7.82,False,http://www.openphacts.org/units/Nanomolar,2845386,=,37,True,=,,IC50,nM,,15.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.3
2143,337345,17715175,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCN1CCS(=O)(=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.77', 'le': '0.33', 'lle': '7.12', 'sei': '5.55'}",CHEMBL3947585,,CHEMBL3947585,8.09,False,http://www.openphacts.org/units/Nanomolar,2845387,=,37,True,=,,IC50,nM,,8.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.1
2144,337346,17715176,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '18.80', 'le': '0.35', 'lle': '6.15', 'sei': '5.75'}",CHEMBL3919803,,CHEMBL3919803,7.91,False,http://www.openphacts.org/units/Nanomolar,2845388,=,37,True,=,,IC50,nM,,12.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.4
2145,337347,17715177,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCCc1ncn[nH]1,,,CHEMBL3886172,,2015.0,"{'bei': '18.19', 'le': '0.33', 'lle': '5.84', 'sei': '5.22'}",CHEMBL3956279,,CHEMBL3956279,7.83,False,http://www.openphacts.org/units/Nanomolar,2845389,=,37,True,=,,IC50,nM,,14.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.8
2146,337348,17715178,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)N[C@H]3CC[C@H](C(C)(C)O)CC3)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.46', 'le': '0.33', 'lle': '3.87', 'sei': '7.49'}",CHEMBL3932227,,CHEMBL3932227,7.87,False,http://www.openphacts.org/units/Nanomolar,2845390,=,37,True,=,,IC50,nM,,13.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.6
2147,337349,17715179,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '18.59', 'le': '0.35', 'lle': '5.04', 'sei': '7.16'}",CHEMBL4108910,,CHEMBL4108910,8.43,False,http://www.openphacts.org/units/Nanomolar,2845391,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
2148,337350,17715180,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCOCC2)nc1,,,CHEMBL3886172,,2015.0,"{'bei': '17.26', 'le': '0.32', 'lle': '5.36', 'sei': '6.23'}",CHEMBL3905289,,CHEMBL3905289,8.35,False,http://www.openphacts.org/units/Nanomolar,2845392,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2149,337351,17715181,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '18.84', 'le': '0.34', 'lle': '4.95', 'sei': '5.51'}",CHEMBL3942281,,CHEMBL3942281,7.81,False,http://www.openphacts.org/units/Nanomolar,2845393,=,37,True,=,,IC50,nM,,15.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.5
2150,337352,17715182,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)C[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.25', 'le': '0.30', 'lle': '4.78', 'sei': '5.60'}",CHEMBL3910861,,CHEMBL3910861,7.71,False,http://www.openphacts.org/units/Nanomolar,2845394,=,37,True,=,,IC50,nM,,19.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.5
2151,337353,17715183,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCNS(C)(=O)=O,,,CHEMBL3886172,,2015.0,"{'bei': '17.69', 'le': '0.34', 'lle': '7.04', 'sei': '5.06'}",CHEMBL3943142,,CHEMBL3943142,7.83,False,http://www.openphacts.org/units/Nanomolar,2845395,=,37,True,=,,IC50,nM,,14.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.9
2152,337354,17715184,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CCCCO1,,,CHEMBL3886172,,2015.0,"{'bei': '18.89', 'le': '0.35', 'lle': '4.99', 'sei': '6.95'}",CHEMBL3953023,,CHEMBL3953023,8.19,False,http://www.openphacts.org/units/Nanomolar,2845396,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
2153,337355,17715185,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCOCC2)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.70', 'le': '0.31', 'lle': '5.09', 'sei': '6.03'}",CHEMBL3973052,,CHEMBL3973052,8.08,False,http://www.openphacts.org/units/Nanomolar,2845397,=,37,True,=,,IC50,nM,,8.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.4
2154,337356,17715186,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCOCC2)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '17.18', 'le': '0.31', 'lle': '4.69', 'sei': '6.85'}",CHEMBL3923977,,CHEMBL3923977,8.29,False,http://www.openphacts.org/units/Nanomolar,2845398,=,37,True,=,,IC50,nM,,5.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.1
2155,337357,17715187,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cc2cc[nH]c2cn1,,,CHEMBL3886172,,2015.0,"{'bei': '19.20', 'le': '0.35', 'lle': '4.76', 'sei': '6.12'}",CHEMBL3910394,,CHEMBL3910394,8.40,False,http://www.openphacts.org/units/Nanomolar,2845399,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2156,337358,17715188,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnc(N2CCOCC2)nc1,,,CHEMBL3886172,,2015.0,"{'bei': '16.87', 'le': '0.31', 'lle': '5.78', 'sei': '5.57'}",CHEMBL3938325,,CHEMBL3938325,8.17,False,http://www.openphacts.org/units/Nanomolar,2845400,=,37,True,=,,IC50,nM,,6.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.7
2157,337359,17715189,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(OCCN(C)C)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.55', 'le': '0.30', 'lle': '4.94', 'sei': '6.00'}",CHEMBL3901331,,CHEMBL3901331,8.04,False,http://www.openphacts.org/units/Nanomolar,2845401,=,37,True,=,,IC50,nM,,9.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.2
2158,337360,17715190,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(CN2CCOCC2)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '16.45', 'le': '0.30', 'lle': '4.58', 'sei': '6.75'}",CHEMBL3954291,,CHEMBL3954291,8.17,False,http://www.openphacts.org/units/Nanomolar,2845402,=,37,True,=,,IC50,nM,,6.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.8
2159,337361,17715191,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCNCC2)nc1,,,CHEMBL3886172,,2015.0,"{'bei': '17.15', 'le': '0.31', 'lle': '5.72', 'sei': '6.05'}",CHEMBL3895880,,CHEMBL3895880,8.28,False,http://www.openphacts.org/units/Nanomolar,2845403,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2160,337362,17715192,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N(C)C)nc1,,,CHEMBL3886172,,2015.0,"{'bei': '18.49', 'le': '0.34', 'lle': '4.94', 'sei': '6.55'}",CHEMBL3900811,,CHEMBL3900811,8.16,False,http://www.openphacts.org/units/Nanomolar,2845404,=,37,True,=,,IC50,nM,,6.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.9
2161,337363,17715193,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '18.89', 'le': '0.35', 'lle': '6.70', 'sei': '5.83'}",CHEMBL4110155,,CHEMBL4110155,8.02,False,http://www.openphacts.org/units/Nanomolar,2845405,=,37,True,=,,IC50,nM,,9.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.6
2162,337364,17715194,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(=O)N[C@@H](C)CO,,,CHEMBL3886172,,2015.0,"{'bei': '16.80', 'le': '0.32', 'lle': '6.80', 'sei': '4.99'}",CHEMBL3911443,,CHEMBL3911443,7.87,False,http://www.openphacts.org/units/Nanomolar,2845406,=,37,True,=,,IC50,nM,,13.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.4
2163,337365,17715195,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C(F)F)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.42', 'le': '0.33', 'lle': '4.44', 'sei': '7.48'}",CHEMBL4112067,,CHEMBL4112067,7.85,False,http://www.openphacts.org/units/Nanomolar,2845407,=,37,True,=,,IC50,nM,,14.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.2
2164,337366,17715196,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(O)C(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.65', 'le': '0.37', 'lle': '6.05', 'sei': '6.71'}",CHEMBL4115189,,CHEMBL4115189,8.64,False,http://www.openphacts.org/units/Nanomolar,2845408,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2165,337367,17715197,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(O)C(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.21', 'le': '0.36', 'lle': '5.85', 'sei': '6.56'}",CHEMBL4115189,,CHEMBL4115189,8.44,False,http://www.openphacts.org/units/Nanomolar,2845408,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2166,337368,17715198,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.28', 'le': '0.34', 'lle': '6.62', 'sei': '5.59'}",CHEMBL4110079,,CHEMBL4110079,8.33,False,http://www.openphacts.org/units/Nanomolar,2845409,=,37,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
2167,337369,17715199,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.27', 'le': '0.34', 'lle': '6.04', 'sei': '5.95'}",CHEMBL3925280,,CHEMBL3925280,8.21,False,http://www.openphacts.org/units/Nanomolar,2845410,=,37,True,=,,IC50,nM,,6.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.1
2168,337370,17715200,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.38', 'le': '0.32', 'lle': '4.56', 'sei': '5.60'}",CHEMBL3900741,,CHEMBL3900741,7.94,False,http://www.openphacts.org/units/Nanomolar,2845411,=,37,True,=,,IC50,nM,,11.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.6
2169,337371,17715201,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.77', 'le': '0.35', 'lle': '6.39', 'sei': '5.92'}",CHEMBL3944351,,CHEMBL3944351,8.17,False,http://www.openphacts.org/units/Nanomolar,2845412,=,37,True,=,,IC50,nM,,6.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.7
2170,337372,17715202,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.57', 'le': '0.38', 'lle': '6.08', 'sei': '6.28'}",CHEMBL3916413,,CHEMBL3916413,8.09,False,http://www.openphacts.org/units/Nanomolar,2845413,=,37,True,=,,IC50,nM,,8.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.1
2171,337373,17715203,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '21.03', 'le': '0.39', 'lle': '6.27', 'sei': '6.43'}",CHEMBL3916413,,CHEMBL3916413,8.28,False,http://www.openphacts.org/units/Nanomolar,2845413,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2172,337374,17715204,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(c2ncccn2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.17', 'le': '0.30', 'lle': '5.10', 'sei': '5.67'}",CHEMBL3946151,,CHEMBL3946151,7.80,False,http://www.openphacts.org/units/Nanomolar,2845414,=,37,True,=,,IC50,nM,,15.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.7
2173,337375,17715205,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCN(C)CC2)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.39', 'le': '0.30', 'lle': '5.23', 'sei': '6.36'}",CHEMBL3970192,,CHEMBL3970192,8.14,False,http://www.openphacts.org/units/Nanomolar,2845415,=,37,True,=,,IC50,nM,,7.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.3
2174,337376,17715206,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(=O)N1CCN(C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.26', 'le': '0.32', 'lle': '6.81', 'sei': '6.21'}",CHEMBL3898994,,CHEMBL3898994,8.21,False,http://www.openphacts.org/units/Nanomolar,2845416,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2175,337377,17715207,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.83', 'le': '0.35', 'lle': '6.94', 'sei': '6.00'}",CHEMBL3951199,,CHEMBL3951199,8.28,False,http://www.openphacts.org/units/Nanomolar,2845417,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2176,337378,17715208,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.32', 'le': '0.34', 'lle': '5.02', 'sei': '6.37'}",CHEMBL3908035,,CHEMBL3908035,8.20,False,http://www.openphacts.org/units/Nanomolar,2845418,=,37,True,=,,IC50,nM,,6.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.3
2177,337379,17715209,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@@H]1CCCN(S(C)(=O)=O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.17', 'le': '0.31', 'lle': '6.14', 'sei': '5.35'}",CHEMBL4111238,,CHEMBL4111238,7.80,False,http://www.openphacts.org/units/Nanomolar,2845419,=,37,True,=,,IC50,nM,,15.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.7
2178,337380,17715210,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CCCN(S(C)(=O)=O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '15.96', 'le': '0.31', 'lle': '6.04', 'sei': '5.28'}",CHEMBL3962443,,CHEMBL3962443,7.70,False,http://www.openphacts.org/units/Nanomolar,2845420,=,37,True,=,,IC50,nM,,19.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.8
2179,337381,17715211,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2ccc(NC(=O)c3cnc(-n4ncc5cc(C#N)cnc54)cc3NC(C)C)cn2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.96', 'le': '0.29', 'lle': '4.40', 'sei': '6.10'}",CHEMBL3931480,,CHEMBL3931480,8.17,False,http://www.openphacts.org/units/Nanomolar,2845421,=,37,True,=,,IC50,nM,,6.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.8
2180,337382,17715212,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.21', 'le': '0.36', 'lle': '7.10', 'sei': '6.12'}",CHEMBL3951199,,CHEMBL3951199,8.44,False,http://www.openphacts.org/units/Nanomolar,2845417,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2181,337383,17715213,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.69', 'le': '0.35', 'lle': '6.87', 'sei': '5.95'}",CHEMBL3951199,,CHEMBL3951199,8.21,False,http://www.openphacts.org/units/Nanomolar,2845417,=,37,True,=,,IC50,nM,,6.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.1
2182,337384,17715214,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCN(C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.47', 'le': '0.32', 'lle': '6.00', 'sei': '6.12'}",CHEMBL3932579,,CHEMBL3932579,8.08,False,http://www.openphacts.org/units/Nanomolar,2845422,=,37,True,=,,IC50,nM,,8.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.3
2183,337385,17715215,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '16.86', 'le': '0.32', 'lle': '6.38', 'sei': '5.04'}",CHEMBL3890756,,CHEMBL3890756,8.51,False,http://www.openphacts.org/units/Nanomolar,2845423,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2184,337386,17715216,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.48', 'le': '0.36', 'lle': '5.51', 'sei': '6.56'}",CHEMBL3922334,,CHEMBL3922334,8.44,False,http://www.openphacts.org/units/Nanomolar,2845424,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2185,337387,17715217,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCN(C2COC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.99', 'le': '0.30', 'lle': '6.22', 'sei': '5.71'}",CHEMBL3983180,,CHEMBL3983180,8.07,False,http://www.openphacts.org/units/Nanomolar,2845425,=,37,True,=,,IC50,nM,,8.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.5
2186,337388,17715218,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2ccc(NC(=O)c3cnc(-n4ncc5cc(C#N)cnc54)cc3NC(C)C)nc2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.64', 'le': '0.29', 'lle': '4.23', 'sei': '5.98'}",CHEMBL3913330,,CHEMBL3913330,8.00,False,http://www.openphacts.org/units/Nanomolar,2845426,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
2187,337389,17715219,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCNC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.70', 'le': '0.35', 'lle': '6.77', 'sei': '5.77'}",CHEMBL3940416,,CHEMBL3940416,8.12,False,http://www.openphacts.org/units/Nanomolar,2845427,=,37,True,=,,IC50,nM,,7.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.5
2188,337390,17715220,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(=O)N1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.30', 'le': '0.31', 'lle': '6.40', 'sei': '5.67'}",CHEMBL4110754,,CHEMBL4110754,7.83,False,http://www.openphacts.org/units/Nanomolar,2845428,=,37,True,=,,IC50,nM,,14.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.7
2189,337391,17715221,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(=O)N1CCN(S(C)(=O)=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '14.44', 'le': '0.28', 'lle': '7.37', 'sei': '4.84'}",CHEMBL4115604,,CHEMBL4115604,8.05,False,http://www.openphacts.org/units/Nanomolar,2845429,=,37,True,=,,IC50,nM,,8.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.9
2190,337392,17715222,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NCC(F)C1(O)COC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.27', 'le': '0.36', 'lle': '6.08', 'sei': '7.18'}",CHEMBL3927743,,CHEMBL3927743,8.20,False,http://www.openphacts.org/units/Nanomolar,2845430,=,37,True,=,,IC50,nM,,6.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.3
2191,337393,17715223,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccncc1,,,CHEMBL3886172,,2015.0,"{'bei': '20.17', 'le': '0.37', 'lle': '5.73', 'sei': '7.09'}",CHEMBL3954452,,CHEMBL3954452,8.60,False,http://www.openphacts.org/units/Nanomolar,2845431,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2192,337394,17715224,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(F)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '19.12', 'le': '0.35', 'lle': '4.86', 'sei': '7.82'}",CHEMBL3986533,,CHEMBL3986533,8.48,False,http://www.openphacts.org/units/Nanomolar,2845432,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2193,337395,17715225,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '18.59', 'le': '0.34', 'lle': '4.98', 'sei': '7.19'}",CHEMBL3944928,,CHEMBL3944928,8.47,False,http://www.openphacts.org/units/Nanomolar,2845433,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2194,337396,17715226,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.17', 'le': '0.38', 'lle': '6.96', 'sei': '5.74'}",CHEMBL4109233,,CHEMBL4109233,8.89,False,http://www.openphacts.org/units/Nanomolar,2845434,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2195,337397,17715227,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NCC1CC1C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.55', 'le': '0.33', 'lle': '5.64', 'sei': '5.08'}",CHEMBL3953652,,CHEMBL3953652,7.87,False,http://www.openphacts.org/units/Nanomolar,2845435,=,37,True,=,,IC50,nM,,13.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.5
2196,337398,17715228,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)NS(C)(=O)=O,,,CHEMBL3886172,,2015.0,"{'bei': '17.40', 'le': '0.34', 'lle': '6.62', 'sei': '5.29'}",CHEMBL3922475,,CHEMBL3922475,8.19,False,http://www.openphacts.org/units/Nanomolar,2845436,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
2197,337399,17715229,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)NS(C)(=O)=O,,,CHEMBL3886172,,2015.0,"{'bei': '18.32', 'le': '0.36', 'lle': '7.05', 'sei': '5.57'}",CHEMBL3922475,,CHEMBL3922475,8.62,False,http://www.openphacts.org/units/Nanomolar,2845436,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2198,337400,17715230,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CCN(C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.22', 'le': '0.36', 'lle': '5.62', 'sei': '7.68'}",CHEMBL3931392,,CHEMBL3931392,8.59,False,http://www.openphacts.org/units/Nanomolar,2845437,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2199,337401,17715231,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCc1nc(Cc2ccccc2)no1,,,CHEMBL3886172,,2015.0,"{'bei': '16.91', 'le': '0.31', 'lle': '4.94', 'sei': '5.66'}",CHEMBL3898909,,CHEMBL3898909,8.35,False,http://www.openphacts.org/units/Nanomolar,2845438,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2200,337402,17715232,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(C2COC2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.98', 'le': '0.33', 'lle': '5.44', 'sei': '5.88'}",CHEMBL3973484,,CHEMBL3973484,7.97,False,http://www.openphacts.org/units/Nanomolar,2845439,=,37,True,=,,IC50,nM,,10.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.6
2201,337403,17715233,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(N(C[SH](=O)=O)S(C)(=O)=O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '14.15', 'le': '0.28', 'lle': '6.63', 'sei': '4.69'}",CHEMBL3923791,,CHEMBL3923791,8.44,False,http://www.openphacts.org/units/Nanomolar,2845440,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2202,337404,17715234,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '18.23', 'le': '0.33', 'lle': '5.36', 'sei': '6.39'}",CHEMBL3963886,,CHEMBL3963886,8.80,False,http://www.openphacts.org/units/Nanomolar,2845441,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
2203,337405,17715235,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(C2CCOCC2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.54', 'le': '0.30', 'lle': '4.49', 'sei': '5.75'}",CHEMBL3936270,,CHEMBL3936270,7.80,False,http://www.openphacts.org/units/Nanomolar,2845442,=,37,True,=,,IC50,nM,,15.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.9
2204,337406,17715236,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(S(=O)(=O)C(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.24', 'le': '0.31', 'lle': '5.85', 'sei': '5.68'}",CHEMBL3966110,,CHEMBL3966110,8.29,False,http://www.openphacts.org/units/Nanomolar,2845443,=,37,True,=,,IC50,nM,,5.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.1
2205,337407,17715237,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C(=O)C(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.29', 'le': '0.30', 'lle': '4.85', 'sei': '6.00'}",CHEMBL3977923,,CHEMBL3977923,7.73,False,http://www.openphacts.org/units/Nanomolar,2845444,=,37,True,=,,IC50,nM,,18.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.6
2206,337408,17715238,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](NC(=O)[C@H](C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.73', 'le': '0.31', 'lle': '6.16', 'sei': '5.20'}",CHEMBL3903828,,CHEMBL3903828,8.21,False,http://www.openphacts.org/units/Nanomolar,2845445,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2207,337409,17715239,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]CC(=O)N1CCC(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.21', 'le': '0.30', 'lle': '5.31', 'sei': '6.08'}",CHEMBL3921909,,CHEMBL3921909,8.10,False,http://www.openphacts.org/units/Nanomolar,2845446,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
2208,337410,17715240,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1cccnc1,,,CHEMBL3886172,,2015.0,"{'bei': '19.53', 'le': '0.36', 'lle': '5.46', 'sei': '6.86'}",CHEMBL3949690,,CHEMBL3949690,8.33,False,http://www.openphacts.org/units/Nanomolar,2845447,=,37,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
2209,337411,17715241,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCC(C)(O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.23', 'le': '0.32', 'lle': '5.55', 'sei': '5.52'}",CHEMBL3927317,,CHEMBL3927317,8.23,False,http://www.openphacts.org/units/Nanomolar,2845448,=,37,True,=,,IC50,nM,,5.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.9
2210,337412,17715242,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C(=O)C2CN(S(C)(=O)=O)C2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '14.14', 'le': '0.27', 'lle': '6.88', 'sei': '4.81'}",CHEMBL3958341,,CHEMBL3958341,8.00,False,http://www.openphacts.org/units/Nanomolar,2845449,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
2211,337413,17715243,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCC(F)(F)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.93', 'le': '0.32', 'lle': '4.62', 'sei': '6.36'}",CHEMBL3902784,,CHEMBL3902784,8.19,False,http://www.openphacts.org/units/Nanomolar,2845450,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
2212,337414,17715244,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(=O)NCc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.13', 'le': '0.29', 'lle': '4.63', 'sei': '5.80'}",CHEMBL4114914,,CHEMBL4114914,7.77,False,http://www.openphacts.org/units/Nanomolar,2845451,=,37,True,=,,IC50,nM,,16.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.9
2213,337415,17715245,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(C2CN(S(C)(=O)=O)C2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.57', 'le': '0.30', 'lle': '6.34', 'sei': '4.95'}",CHEMBL3932554,,CHEMBL3932554,8.11,False,http://www.openphacts.org/units/Nanomolar,2845452,=,37,True,=,,IC50,nM,,7.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.8
2214,337416,17715246,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(Cl)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.64', 'le': '0.37', 'lle': '5.68', 'sei': '6.40'}",CHEMBL4112570,,CHEMBL4112570,8.39,False,http://www.openphacts.org/units/Nanomolar,2845453,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2215,337417,17715247,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.46', 'le': '0.37', 'lle': '5.81', 'sei': '6.64'}",CHEMBL4114010,,CHEMBL4114010,8.55,False,http://www.openphacts.org/units/Nanomolar,2845454,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2216,337418,17715248,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)Nc1cc(-n2ncc3cc(Cl)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.80', 'le': '0.37', 'lle': '5.62', 'sei': '6.66'}",CHEMBL3895603,,CHEMBL3895603,8.72,False,http://www.openphacts.org/units/Nanomolar,2845455,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2217,337419,17715249,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.72', 'le': '0.33', 'lle': '4.78', 'sei': '6.33'}",CHEMBL3946848,,CHEMBL3946848,8.00,False,http://www.openphacts.org/units/Nanomolar,2845456,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
2218,337420,17715250,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.95', 'le': '0.37', 'lle': '6.03', 'sei': '6.81'}",CHEMBL4107447,,CHEMBL4107447,8.77,False,http://www.openphacts.org/units/Nanomolar,2845457,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2219,337421,17715251,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](NC(=O)[C@@H](C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.48', 'le': '0.31', 'lle': '6.04', 'sei': '5.12'}",CHEMBL4108032,,CHEMBL4108032,8.09,False,http://www.openphacts.org/units/Nanomolar,2845458,=,37,True,=,,IC50,nM,,8.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.2
2220,337422,17715252,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.00', 'le': '0.37', 'lle': '4.70', 'sei': '7.80'}",CHEMBL3910109,,CHEMBL3910109,8.47,False,http://www.openphacts.org/units/Nanomolar,2845459,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2221,337423,17715253,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.95', 'le': '0.36', 'lle': '5.59', 'sei': '6.47'}",CHEMBL3967712,,CHEMBL3967712,8.33,False,http://www.openphacts.org/units/Nanomolar,2845460,=,37,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
2222,337424,17715254,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCS(=O)(=O)N1CCC(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.57', 'le': '0.32', 'lle': '6.18', 'sei': '5.64'}",CHEMBL3934549,,CHEMBL3934549,8.23,False,http://www.openphacts.org/units/Nanomolar,2845461,=,37,True,=,,IC50,nM,,5.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.9
2223,337425,17715255,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCC(O)(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.71', 'le': '0.33', 'lle': '5.51', 'sei': '6.13'}",CHEMBL3923198,,CHEMBL3923198,8.46,False,http://www.openphacts.org/units/Nanomolar,2845462,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2224,337426,17715256,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.59', 'le': '0.37', 'lle': '6.08', 'sei': '6.66'}",CHEMBL4111088,,CHEMBL4111088,8.57,False,http://www.openphacts.org/units/Nanomolar,2845463,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
2225,337427,17715257,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.80', 'le': '0.37', 'lle': '6.68', 'sei': '5.82'}",CHEMBL4106804,,CHEMBL4106804,9.00,False,http://www.openphacts.org/units/Nanomolar,2845464,=,37,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
2226,337428,17715258,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)=C1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.52', 'le': '0.33', 'lle': '4.60', 'sei': '6.69'}",CHEMBL3938709,,CHEMBL3938709,7.87,False,http://www.openphacts.org/units/Nanomolar,2845465,=,37,True,=,,IC50,nM,,13.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.4
2227,337429,17715259,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F,,,CHEMBL3886172,,2015.0,"{'bei': '19.71', 'le': '0.37', 'lle': '5.81', 'sei': '6.48'}",CHEMBL4109739,,CHEMBL4109739,8.72,False,http://www.openphacts.org/units/Nanomolar,2845466,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2228,337430,17715260,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@@H]1CC[C@@H](C(C)(C)O)OC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.58', 'le': '0.33', 'lle': '5.59', 'sei': '5.91'}",CHEMBL4108191,,CHEMBL4108191,8.15,False,http://www.openphacts.org/units/Nanomolar,2845467,=,37,True,=,,IC50,nM,,7.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.1
2229,337431,17715261,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C(F)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '17.49', 'le': '0.34', 'lle': '5.50', 'sei': '6.51'}",CHEMBL4107224,,CHEMBL4107224,8.39,False,http://www.openphacts.org/units/Nanomolar,2845468,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2230,337432,17715262,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '21.32', 'le': '0.39', 'lle': '5.07', 'sei': '7.69'}",CHEMBL3924274,,CHEMBL3924274,8.35,False,http://www.openphacts.org/units/Nanomolar,2845469,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2231,337433,17715263,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NCCC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.27', 'le': '0.37', 'lle': '5.58', 'sei': '6.10'}",CHEMBL3985063,,CHEMBL3985063,8.20,False,http://www.openphacts.org/units/Nanomolar,2845470,=,37,True,=,,IC50,nM,,6.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.3
2232,337434,17715264,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.35', 'le': '0.36', 'lle': '6.48', 'sei': '5.68'}",CHEMBL4112913,,CHEMBL4112913,8.80,False,http://www.openphacts.org/units/Nanomolar,2845471,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
2233,337435,17715265,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C(F)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '17.43', 'le': '0.34', 'lle': '6.15', 'sei': '5.57'}",CHEMBL4107426,,CHEMBL4107426,8.62,False,http://www.openphacts.org/units/Nanomolar,2845472,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2234,337436,17715266,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '21.54', 'le': '0.39', 'lle': '5.35', 'sei': '7.73'}",CHEMBL3952777,,CHEMBL3952777,8.39,False,http://www.openphacts.org/units/Nanomolar,2845473,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2235,337437,17715267,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.80', 'le': '0.38', 'lle': '5.59', 'sei': '6.29'}",CHEMBL3907387,,CHEMBL3907387,8.46,False,http://www.openphacts.org/units/Nanomolar,2845474,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2236,337438,17715268,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(CC(C)(C)O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.35', 'le': '0.32', 'lle': '5.24', 'sei': '5.44'}",CHEMBL3967229,,CHEMBL3967229,7.97,False,http://www.openphacts.org/units/Nanomolar,2845475,=,37,True,=,,IC50,nM,,10.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.7
2237,337439,17715269,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '22.94', 'le': '0.42', 'lle': '6.59', 'sei': '5.97'}",CHEMBL3961524,,CHEMBL3961524,8.04,False,http://www.openphacts.org/units/Nanomolar,2845476,=,37,True,=,,IC50,nM,,9.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.2
2238,337440,17715270,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)NS(C)(=O)=O,,,CHEMBL3886172,,2015.0,"{'bei': '17.17', 'le': '0.33', 'lle': '6.36', 'sei': '5.38'}",CHEMBL3891636,,CHEMBL3891636,8.32,False,http://www.openphacts.org/units/Nanomolar,2845477,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2239,337441,17715271,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NCCC(C)(C)F,,,CHEMBL3886172,,2015.0,"{'bei': '20.49', 'le': '0.38', 'lle': '5.74', 'sei': '6.47'}",CHEMBL3976685,,CHEMBL3976685,8.70,False,http://www.openphacts.org/units/Nanomolar,2845478,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
2240,337442,17715272,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F,,,CHEMBL3886172,,2015.0,"{'bei': '19.94', 'le': '0.38', 'lle': '5.20', 'sei': '7.85'}",CHEMBL4111152,,CHEMBL4111152,8.52,False,http://www.openphacts.org/units/Nanomolar,2845479,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2241,337443,17715273,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(S(=O)(=O)NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '14.72', 'le': '0.29', 'lle': '5.80', 'sei': '4.90'}",CHEMBL3917045,,CHEMBL3917045,7.74,False,http://www.openphacts.org/units/Nanomolar,2845480,=,37,True,=,,IC50,nM,,18.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.4
2242,337444,17715274,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.25', 'le': '0.36', 'lle': '5.30', 'sei': '7.09'}",CHEMBL3986782,,CHEMBL3986782,8.35,False,http://www.openphacts.org/units/Nanomolar,2845481,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2243,337445,17715275,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1c[nH]cn1,,,CHEMBL3886172,,2015.0,"{'bei': '20.05', 'le': '0.37', 'lle': '6.13', 'sei': '6.07'}",CHEMBL3955423,,CHEMBL3955423,8.33,False,http://www.openphacts.org/units/Nanomolar,2845482,=,37,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
2244,337446,17715276,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.63', 'le': '0.37', 'lle': '4.81', 'sei': '7.41'}",CHEMBL4111593,,CHEMBL4111593,8.04,False,http://www.openphacts.org/units/Nanomolar,2845483,=,37,True,=,,IC50,nM,,9.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.2
2245,337447,17715277,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNS(=O)(=O)N1CCC(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.74', 'le': '0.31', 'lle': '6.66', 'sei': '4.96'}",CHEMBL3960714,,CHEMBL3960714,7.83,False,http://www.openphacts.org/units/Nanomolar,2845484,=,37,True,=,,IC50,nM,,14.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.7
2246,337448,17715278,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)OC(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '16.54', 'le': '0.32', 'lle': '4.27', 'sei': '6.68'}",CHEMBL4109109,,CHEMBL4109109,7.86,False,http://www.openphacts.org/units/Nanomolar,2845485,=,37,True,=,,IC50,nM,,13.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.7
2247,337449,17715279,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(O)(C1CC1)C1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.69', 'le': '0.31', 'lle': '4.84', 'sei': '6.19'}",CHEMBL4112547,,CHEMBL4112547,7.97,False,http://www.openphacts.org/units/Nanomolar,2845486,=,37,True,=,,IC50,nM,,10.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.7
2248,337450,17715280,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.04', 'le': '0.35', 'lle': '6.23', 'sei': '6.37'}",CHEMBL3900682,,CHEMBL3900682,8.77,False,http://www.openphacts.org/units/Nanomolar,2845487,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2249,337451,17715281,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.71', 'le': '0.33', 'lle': '6.15', 'sei': '5.15'}",CHEMBL3983043,,CHEMBL3983043,8.42,False,http://www.openphacts.org/units/Nanomolar,2845488,=,37,True,=,,IC50,nM,,3.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.8
2250,337452,17715282,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.98', 'le': '0.37', 'lle': '6.09', 'sei': '6.29'}",CHEMBL3909749,,CHEMBL3909749,8.10,False,http://www.openphacts.org/units/Nanomolar,2845489,=,37,True,=,,IC50,nM,,7.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.9
2251,337453,17715283,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H](C)CO,,,CHEMBL3886172,,2015.0,"{'bei': '20.81', 'le': '0.39', 'lle': '6.18', 'sei': '6.36'}",CHEMBL3894173,,CHEMBL3894173,8.19,False,http://www.openphacts.org/units/Nanomolar,2845490,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
2252,337454,17715284,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H](C)CO,,,CHEMBL3886172,,2015.0,"{'bei': '20.25', 'le': '0.38', 'lle': '5.99', 'sei': '6.41'}",CHEMBL3922192,,CHEMBL3922192,8.25,False,http://www.openphacts.org/units/Nanomolar,2845491,=,37,True,=,,IC50,nM,,5.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.6
2253,337455,17715285,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '18.72', 'le': '0.35', 'lle': '5.93', 'sei': '5.92'}",CHEMBL4114108,,CHEMBL4114108,8.51,False,http://www.openphacts.org/units/Nanomolar,2845492,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2254,337456,17715286,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC1(C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.93', 'le': '0.38', 'lle': '5.80', 'sei': '6.08'}",CHEMBL3892469,,CHEMBL3892469,8.17,False,http://www.openphacts.org/units/Nanomolar,2845493,=,37,True,=,,IC50,nM,,6.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.7
2255,337457,17715287,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)N[C@H](C)C1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.19', 'le': '0.35', 'lle': '5.14', 'sei': '5.77'}",CHEMBL4111880,,CHEMBL4111880,7.76,False,http://www.openphacts.org/units/Nanomolar,2845494,=,37,True,=,,IC50,nM,,17.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.3
2256,337458,17715288,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC1CCCCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.55', 'le': '0.36', 'lle': '5.03', 'sei': '6.08'}",CHEMBL3978447,,CHEMBL3978447,8.18,False,http://www.openphacts.org/units/Nanomolar,2845495,=,37,True,=,,IC50,nM,,6.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.6
2257,337459,17715289,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]C1(NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2NC(C)C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.48', 'le': '0.37', 'lle': '5.99', 'sei': '5.92'}",CHEMBL3964003,,CHEMBL3964003,8.22,False,http://www.openphacts.org/units/Nanomolar,2845496,=,37,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
2258,337460,17715290,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.99', 'le': '0.39', 'lle': '5.71', 'sei': '5.90'}",CHEMBL3970139,,CHEMBL3970139,7.94,False,http://www.openphacts.org/units/Nanomolar,2845497,=,37,True,=,,IC50,nM,,11.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.4
2259,337461,17715291,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC1C=CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.77', 'le': '0.36', 'lle': '5.41', 'sei': '5.91'}",CHEMBL3893544,,CHEMBL3893544,7.96,False,http://www.openphacts.org/units/Nanomolar,2845498,=,37,True,=,,IC50,nM,,11.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.1
2260,337462,17715292,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](C)F,,,CHEMBL3886172,,2015.0,"{'bei': '20.18', 'le': '0.38', 'lle': '5.82', 'sei': '5.95'}",CHEMBL4108625,,CHEMBL4108625,8.00,False,http://www.openphacts.org/units/Nanomolar,2845499,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
2261,337463,17715293,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.40', 'le': '0.34', 'lle': '5.31', 'sei': '7.06'}",CHEMBL3950330,,CHEMBL3950330,8.31,False,http://www.openphacts.org/units/Nanomolar,2845500,=,37,True,=,,IC50,nM,,4.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.9
2262,337464,17715294,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F,,,CHEMBL3886172,,2015.0,"{'bei': '19.15', 'le': '0.38', 'lle': '4.26', 'sei': '9.87'}",CHEMBL4111778,,CHEMBL4111778,8.37,False,http://www.openphacts.org/units/Nanomolar,2845501,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2263,337465,17715295,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.24', 'le': '0.37', 'lle': '6.06', 'sei': '6.37'}",CHEMBL3916358,,CHEMBL3916358,8.21,False,http://www.openphacts.org/units/Nanomolar,2845502,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2264,337466,17715296,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '19.07', 'le': '0.36', 'lle': '4.61', 'sei': '7.27'}",CHEMBL3920766,,CHEMBL3920766,7.89,False,http://www.openphacts.org/units/Nanomolar,2845503,=,37,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
2265,337467,17715297,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.98', 'le': '0.34', 'lle': '6.56', 'sei': '5.73'}",CHEMBL4113330,,CHEMBL4113330,7.90,False,http://www.openphacts.org/units/Nanomolar,2845504,=,37,True,=,,IC50,nM,,12.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.6
2266,337468,17715298,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cnc(NC[C@@H](F)C(C)(C)O)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '14.85', 'le': '0.29', 'lle': '5.34', 'sei': '5.15'}",CHEMBL4109992,,CHEMBL4109992,7.73,False,http://www.openphacts.org/units/Nanomolar,2845505,=,37,True,=,,IC50,nM,,18.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.5
2267,337469,17715299,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.93', 'le': '0.37', 'lle': '6.13', 'sei': '6.59'}",CHEMBL3948538,,CHEMBL3948538,8.48,False,http://www.openphacts.org/units/Nanomolar,2845314,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2268,337470,17715300,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.88', 'le': '0.37', 'lle': '6.32', 'sei': '6.54'}",CHEMBL4110250,,CHEMBL4110250,8.42,False,http://www.openphacts.org/units/Nanomolar,2845320,=,37,True,=,,IC50,nM,,3.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.8
2269,337471,17715301,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.15', 'le': '0.36', 'lle': '5.80', 'sei': '6.33'}",CHEMBL4112023,,CHEMBL4112023,8.15,False,http://www.openphacts.org/units/Nanomolar,2845506,=,37,True,=,,IC50,nM,,7.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.1
2270,337472,17715302,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.08', 'le': '0.36', 'lle': '5.86', 'sei': '6.48'}",CHEMBL4112848,,CHEMBL4112848,8.35,False,http://www.openphacts.org/units/Nanomolar,2845507,=,37,True,=,,IC50,nM,,4.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.5
2271,337473,17715303,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2cnc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.31', 'le': '0.38', 'lle': '5.27', 'sei': '8.00'}",CHEMBL4115184,,CHEMBL4115184,8.40,False,http://www.openphacts.org/units/Nanomolar,2845508,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2272,337474,17715304,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.82', 'le': '0.35', 'lle': '5.88', 'sei': '7.01'}",CHEMBL4112745,,CHEMBL4112745,8.00,False,http://www.openphacts.org/units/Nanomolar,2845509,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
2273,337475,17715305,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2cnc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.80', 'le': '0.37', 'lle': '6.79', 'sei': '5.63'}",CHEMBL4109597,,CHEMBL4109597,8.72,False,http://www.openphacts.org/units/Nanomolar,2845510,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2274,337476,17715306,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2cnc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F,,,CHEMBL3886172,,2015.0,"{'bei': '18.86', 'le': '0.36', 'lle': '4.74', 'sei': '7.43'}",CHEMBL4113524,,CHEMBL4113524,8.06,False,http://www.openphacts.org/units/Nanomolar,2845511,=,37,True,=,,IC50,nM,,8.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.7
2275,337477,17715307,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(Nc2cc(-n3cnc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.33', 'le': '0.36', 'lle': '5.97', 'sei': '6.57'}",CHEMBL4113284,,CHEMBL4113284,8.46,False,http://www.openphacts.org/units/Nanomolar,2845512,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2276,337478,17715308,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.83', 'le': '0.34', 'lle': '5.56', 'sei': '6.68'}",CHEMBL4106513,,CHEMBL4106513,7.87,False,http://www.openphacts.org/units/Nanomolar,2845513,=,37,True,=,,IC50,nM,,13.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.5
2277,337479,17715309,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.39', 'le': '0.33', 'lle': '6.01', 'sei': '5.89'}",CHEMBL4112539,,CHEMBL4112539,8.13,False,http://www.openphacts.org/units/Nanomolar,2845514,=,37,True,=,,IC50,nM,,7.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.4
2278,337480,17715310,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2cnc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F,,,CHEMBL3886172,,2015.0,"{'bei': '20.18', 'le': '0.38', 'lle': '6.01', 'sei': '6.83'}",CHEMBL4111656,,CHEMBL4111656,8.44,False,http://www.openphacts.org/units/Nanomolar,2845515,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2279,337481,17715311,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.31', 'le': '0.33', 'lle': '6.16', 'sei': '6.06'}",CHEMBL4111280,,CHEMBL4111280,8.89,False,http://www.openphacts.org/units/Nanomolar,2845516,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2280,337482,17715312,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(C2COC2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.30', 'le': '0.32', 'lle': '6.70', 'sei': '5.61'}",CHEMBL4107087,,CHEMBL4107087,8.74,False,http://www.openphacts.org/units/Nanomolar,2845517,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2281,337483,17715313,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(C2CCOCC2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.90', 'le': '0.30', 'lle': '5.66', 'sei': '5.44'}",CHEMBL4110171,,CHEMBL4110171,8.48,False,http://www.openphacts.org/units/Nanomolar,2845518,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2282,337484,17715314,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.66', 'le': '0.31', 'lle': '5.15', 'sei': '5.91'}",CHEMBL4112374,,CHEMBL4112374,8.66,False,http://www.openphacts.org/units/Nanomolar,2845519,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2283,337485,17715315,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.52', 'le': '0.33', 'lle': '5.13', 'sei': '7.04'}",CHEMBL4106743,,CHEMBL4106743,8.64,False,http://www.openphacts.org/units/Nanomolar,2845520,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2284,337486,17715316,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(C2CCOCC2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.08', 'le': '0.29', 'lle': '4.59', 'sei': '6.20'}",CHEMBL4108001,,CHEMBL4108001,8.19,False,http://www.openphacts.org/units/Nanomolar,2845521,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
2285,337487,17715317,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.50', 'le': '0.32', 'lle': '5.74', 'sei': '5.98'}",CHEMBL4109434,,CHEMBL4109434,8.77,False,http://www.openphacts.org/units/Nanomolar,2845522,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2286,337488,17715318,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.12', 'le': '0.32', 'lle': '4.91', 'sei': '7.10'}",CHEMBL4115019,,CHEMBL4115019,8.72,False,http://www.openphacts.org/units/Nanomolar,2845523,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2287,337489,17715319,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '18.05', 'le': '0.34', 'lle': '6.13', 'sei': '5.88'}",CHEMBL4106715,,CHEMBL4106715,8.62,False,http://www.openphacts.org/units/Nanomolar,2845524,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2288,337490,17715320,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.46', 'le': '0.31', 'lle': '5.41', 'sei': '5.88'}",CHEMBL4109952,,CHEMBL4109952,8.62,False,http://www.openphacts.org/units/Nanomolar,2845525,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2289,337491,17715321,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '18.01', 'le': '0.35', 'lle': '5.50', 'sei': '7.14'}",CHEMBL4110545,,CHEMBL4110545,8.77,False,http://www.openphacts.org/units/Nanomolar,2845526,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2290,337492,17715322,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)n1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.88', 'le': '0.33', 'lle': '4.63', 'sei': '6.89'}",CHEMBL4109253,,CHEMBL4109253,8.46,False,http://www.openphacts.org/units/Nanomolar,2845527,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2291,337493,17715323,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.99', 'le': '0.34', 'lle': '5.38', 'sei': '7.24'}",CHEMBL4110464,,CHEMBL4110464,8.89,False,http://www.openphacts.org/units/Nanomolar,2845528,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2292,337494,17715324,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.31', 'le': '0.33', 'lle': '5.01', 'sei': '7.19'}",CHEMBL4107445,,CHEMBL4107445,8.82,False,http://www.openphacts.org/units/Nanomolar,2845529,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2293,337495,17715325,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.53', 'le': '0.34', 'lle': '5.27', 'sei': '6.95'}",CHEMBL4109693,,CHEMBL4109693,8.54,False,http://www.openphacts.org/units/Nanomolar,2845530,=,37,True,=,,IC50,nM,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.9
2294,337496,17715326,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)n1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.70', 'le': '0.33', 'lle': '4.54', 'sei': '6.81'}",CHEMBL4112222,,CHEMBL4112222,8.37,False,http://www.openphacts.org/units/Nanomolar,2845531,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2295,337497,17715327,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.74', 'le': '0.31', 'lle': '6.38', 'sei': '5.45'}",CHEMBL4113624,,CHEMBL4113624,8.49,False,http://www.openphacts.org/units/Nanomolar,2845532,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
2296,337498,17715328,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.61', 'le': '0.33', 'lle': '5.70', 'sei': '6.50'}",CHEMBL4107529,,CHEMBL4107529,8.59,False,http://www.openphacts.org/units/Nanomolar,2845533,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2297,337499,17715329,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)(F)Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.62', 'le': '0.32', 'lle': '5.65', 'sei': '5.98'}",CHEMBL4113628,,CHEMBL4113628,8.77,False,http://www.openphacts.org/units/Nanomolar,2845534,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2298,337500,17715330,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCn1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '15.67', 'le': '0.31', 'lle': '5.21', 'sei': '6.14'}",CHEMBL4107168,,CHEMBL4107168,8.10,False,http://www.openphacts.org/units/Nanomolar,2845535,=,37,True,=,,IC50,nM,,7.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.9
2299,337501,17715331,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CCCF)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.12', 'le': '0.34', 'lle': '5.28', 'sei': '7.24'}",CHEMBL4111498,,CHEMBL4111498,8.89,False,http://www.openphacts.org/units/Nanomolar,2845536,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2300,337502,17715332,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CCCF)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.92', 'le': '0.32', 'lle': '5.79', 'sei': '5.88'}",CHEMBL4108464,,CHEMBL4108464,8.62,False,http://www.openphacts.org/units/Nanomolar,2845537,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2301,337503,17715333,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)(F)Cn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.24', 'le': '0.32', 'lle': '4.82', 'sei': '7.10'}",CHEMBL4114244,,CHEMBL4114244,8.72,False,http://www.openphacts.org/units/Nanomolar,2845538,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2302,337504,17715334,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CCCF)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.54', 'le': '0.33', 'lle': '4.98', 'sei': '6.99'}",CHEMBL4109034,,CHEMBL4109034,8.59,False,http://www.openphacts.org/units/Nanomolar,2845539,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2303,337505,17715335,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.36', 'le': '0.31', 'lle': '5.05', 'sei': '6.49'}",CHEMBL4115559,,CHEMBL4115559,8.68,False,http://www.openphacts.org/units/Nanomolar,2845540,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
2304,337506,17715336,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '18.72', 'le': '0.35', 'lle': '5.83', 'sei': '6.67'}",CHEMBL4106801,,CHEMBL4106801,8.92,False,http://www.openphacts.org/units/Nanomolar,2845541,=,37,True,=,,IC50,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.2
2305,337507,17715337,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cnn(C2CCOCC2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.18', 'le': '0.30', 'lle': '5.20', 'sei': '6.03'}",CHEMBL4107855,,CHEMBL4107855,8.62,False,http://www.openphacts.org/units/Nanomolar,2845542,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2306,337508,17715338,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CCC#N)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.57', 'le': '0.32', 'lle': '5.32', 'sei': '5.79'}",CHEMBL4115117,,CHEMBL4115117,8.48,False,http://www.openphacts.org/units/Nanomolar,2845543,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2307,337509,17715339,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.03', 'le': '0.32', 'lle': '6.01', 'sei': '5.97'}",CHEMBL4109866,,CHEMBL4109866,8.74,False,http://www.openphacts.org/units/Nanomolar,2845544,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2308,337510,17715340,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CCC#N)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.27', 'le': '0.32', 'lle': '6.30', 'sei': '5.09'}",CHEMBL4111974,,CHEMBL4111974,8.68,False,http://www.openphacts.org/units/Nanomolar,2845545,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
2309,337511,17715341,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CCC#N)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.74', 'le': '0.33', 'lle': '5.41', 'sei': '5.85'}",CHEMBL4109280,,CHEMBL4109280,8.57,False,http://www.openphacts.org/units/Nanomolar,2845546,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
2310,337512,17715342,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)Cn1cc(Nc2cc(-n3cnc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.85', 'le': '0.32', 'lle': '5.77', 'sei': '5.86'}",CHEMBL4109898,,CHEMBL4109898,8.59,False,http://www.openphacts.org/units/Nanomolar,2845547,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2311,337513,17715343,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Cn1cc(Nc2cc(-n3cnc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1)OC(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '15.43', 'le': '0.29', 'lle': '5.51', 'sei': '5.52'}",CHEMBL4113184,,CHEMBL4113184,8.60,False,http://www.openphacts.org/units/Nanomolar,2845548,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2312,337514,17715344,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.37', 'le': '0.32', 'lle': '5.66', 'sei': '5.82'}",CHEMBL4113237,,CHEMBL4113237,8.54,False,http://www.openphacts.org/units/Nanomolar,2845549,=,37,True,=,,IC50,nM,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.9
2313,337515,17715345,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.17', 'le': '0.34', 'lle': '4.94', 'sei': '7.01'}",CHEMBL4109113,,CHEMBL4109113,8.60,False,http://www.openphacts.org/units/Nanomolar,2845550,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2314,337516,17715346,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.17', 'le': '0.34', 'lle': '4.94', 'sei': '7.01'}",CHEMBL4107733,,CHEMBL4107733,8.60,False,http://www.openphacts.org/units/Nanomolar,2845551,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2315,337517,17715347,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1cc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '18.05', 'le': '0.34', 'lle': '5.37', 'sei': '6.62'}",CHEMBL4111230,,CHEMBL4111230,8.85,False,http://www.openphacts.org/units/Nanomolar,2845552,=,37,True,=,,IC50,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.4
2316,337518,17715348,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.06', 'le': '0.33', 'lle': '5.64', 'sei': '7.04'}",CHEMBL4109920,,CHEMBL4109920,8.64,False,http://www.openphacts.org/units/Nanomolar,2845553,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2317,337519,17715349,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(S(C)(=O)=O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.15', 'le': '0.33', 'lle': '7.78', 'sei': '5.01'}",CHEMBL4113747,,CHEMBL4113747,9.05,False,http://www.openphacts.org/units/Nanomolar,2845554,=,37,True,=,,IC50,nM,,0.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.9
2318,337520,17715350,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)n1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.95', 'le': '0.32', 'lle': '6.78', 'sei': '5.02'}",CHEMBL4114115,,CHEMBL4114115,8.82,False,http://www.openphacts.org/units/Nanomolar,2845555,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2319,337521,17715351,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '18.30', 'le': '0.34', 'lle': '6.48', 'sei': '5.79'}",CHEMBL4111561,,CHEMBL4111561,8.48,False,http://www.openphacts.org/units/Nanomolar,2845556,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2320,337522,17715352,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.61', 'le': '0.33', 'lle': '4.92', 'sei': '6.29'}",CHEMBL3932942,,CHEMBL3932942,7.95,False,http://www.openphacts.org/units/Nanomolar,2845557,=,37,True,=,,IC50,nM,,11.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.2
2321,337523,17715353,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '18.60', 'le': '0.35', 'lle': '5.37', 'sei': '6.65'}",CHEMBL3971510,,CHEMBL3971510,8.40,False,http://www.openphacts.org/units/Nanomolar,2845558,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2322,337524,17715354,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.69', 'le': '0.31', 'lle': '4.35', 'sei': '6.15'}",CHEMBL3945366,,CHEMBL3945366,7.77,False,http://www.openphacts.org/units/Nanomolar,2845559,=,37,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
2323,337525,17715355,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.63', 'le': '0.33', 'lle': '4.93', 'sei': '6.50'}",CHEMBL3938766,,CHEMBL3938766,8.21,False,http://www.openphacts.org/units/Nanomolar,2845560,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2324,337526,17715356,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.92', 'le': '0.32', 'lle': '5.49', 'sei': '6.01'}",CHEMBL3910846,,CHEMBL3910846,8.15,False,http://www.openphacts.org/units/Nanomolar,2845561,=,37,True,=,,IC50,nM,,7.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.1
2325,337527,17715357,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '19.33', 'le': '0.36', 'lle': '5.82', 'sei': '6.69'}",CHEMBL3920482,,CHEMBL3920482,8.46,False,http://www.openphacts.org/units/Nanomolar,2845562,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2326,337528,17715358,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(C(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.74', 'le': '0.33', 'lle': '3.93', 'sei': '8.34'}",CHEMBL4108814,,CHEMBL4108814,8.55,False,http://www.openphacts.org/units/Nanomolar,2845563,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2327,337529,17715359,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.80', 'le': '0.32', 'lle': '4.95', 'sei': '6.85'}",CHEMBL4115485,,CHEMBL4115485,8.66,False,http://www.openphacts.org/units/Nanomolar,2845564,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2328,337530,17715360,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2Nc2cnn(CC(F)F)c2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '14.68', 'le': '0.28', 'lle': '4.12', 'sei': '5.50'}",CHEMBL3918080,,CHEMBL3918080,8.07,False,http://www.openphacts.org/units/Nanomolar,2845565,=,37,True,=,,IC50,nM,,8.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.6
2329,337531,17715361,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)C(F)(F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.39', 'le': '0.29', 'lle': '5.15', 'sei': '5.58'}",CHEMBL3937950,,CHEMBL3937950,8.18,False,http://www.openphacts.org/units/Nanomolar,2845566,=,37,True,=,,IC50,nM,,6.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.6
2330,337532,17715362,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.57', 'le': '0.34', 'lle': '5.53', 'sei': '6.77'}",CHEMBL4113759,,CHEMBL4113759,8.31,False,http://www.openphacts.org/units/Nanomolar,2845567,=,37,True,=,,IC50,nM,,4.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.9
2331,337533,17715363,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '19.21', 'le': '0.36', 'lle': '6.28', 'sei': '6.65'}",CHEMBL4108510,,CHEMBL4108510,8.89,False,http://www.openphacts.org/units/Nanomolar,2845568,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2332,337534,17715364,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(C(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.93', 'le': '0.32', 'lle': '4.47', 'sei': '6.60'}",CHEMBL4113207,,CHEMBL4113207,8.11,False,http://www.openphacts.org/units/Nanomolar,2845569,=,37,True,=,,IC50,nM,,7.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.8
2333,337535,17715365,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1Nc1cnn(C(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.51', 'le': '0.31', 'lle': '5.38', 'sei': '5.62'}",CHEMBL4110222,,CHEMBL4110222,8.24,False,http://www.openphacts.org/units/Nanomolar,2845570,=,37,True,=,,IC50,nM,,5.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.7
2334,337536,17715366,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.39', 'le': '0.33', 'lle': '4.11', 'sei': '8.39'}",CHEMBL4112525,,CHEMBL4112525,8.60,False,http://www.openphacts.org/units/Nanomolar,2845571,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2335,337537,17715367,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.69', 'le': '0.32', 'lle': '4.89', 'sei': '6.81'}",CHEMBL4111627,,CHEMBL4111627,8.60,False,http://www.openphacts.org/units/Nanomolar,2845572,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2336,337538,17715368,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cc(C2CC2)n[nH]1,,,CHEMBL3886172,,2015.0,"{'bei': '18.30', 'le': '0.34', 'lle': '6.09', 'sei': '5.69'}",CHEMBL4112384,,CHEMBL4112384,8.96,False,http://www.openphacts.org/units/Nanomolar,2845573,=,37,True,=,,IC50,nM,,1.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.1
2337,337539,17715369,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)[nH]n1,,,CHEMBL3886172,,2015.0,"{'bei': '17.71', 'le': '0.33', 'lle': '5.91', 'sei': '5.21'}",CHEMBL4113185,,CHEMBL4113185,8.21,False,http://www.openphacts.org/units/Nanomolar,2845574,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2338,337540,17715370,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)[nH]n1,,,CHEMBL3886172,,2015.0,"{'bei': '16.92', 'le': '0.32', 'lle': '5.20', 'sei': '5.28'}",CHEMBL4107677,,CHEMBL4107677,8.32,False,http://www.openphacts.org/units/Nanomolar,2845575,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2339,337541,17715371,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccn(CC(F)F)n1,,,CHEMBL3886172,,2015.0,"{'bei': '16.57', 'le': '0.31', 'lle': '5.78', 'sei': '5.81'}",CHEMBL4110422,,CHEMBL4110422,8.51,False,http://www.openphacts.org/units/Nanomolar,2845576,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2340,337542,17715372,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccn(CC(F)(F)F)n1,,,CHEMBL3886172,,2015.0,"{'bei': '16.45', 'le': '0.31', 'lle': '5.71', 'sei': '5.97'}",CHEMBL4107994,,CHEMBL4107994,8.74,False,http://www.openphacts.org/units/Nanomolar,2845577,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2341,337543,17715373,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nccc1Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.74', 'le': '0.31', 'lle': '5.76', 'sei': '5.29'}",CHEMBL4111673,,CHEMBL4111673,7.76,False,http://www.openphacts.org/units/Nanomolar,2845578,=,37,True,=,,IC50,nM,,17.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.5
2342,337544,17715374,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(-c2ncccn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.73', 'le': '0.31', 'lle': '6.57', 'sei': '5.12'}",CHEMBL4107792,,CHEMBL4107792,8.82,False,http://www.openphacts.org/units/Nanomolar,2845579,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2343,337545,17715375,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(-c2ncc(F)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.12', 'le': '0.30', 'lle': '6.42', 'sei': '5.10'}",CHEMBL4109069,,CHEMBL4109069,8.80,False,http://www.openphacts.org/units/Nanomolar,2845580,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
2344,337546,17715376,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cc(-c2ccccc2)n[nH]1,,,CHEMBL3886172,,2015.0,"{'bei': '16.07', 'le': '0.30', 'lle': '4.78', 'sei': '5.36'}",CHEMBL4114476,,CHEMBL4114476,8.44,False,http://www.openphacts.org/units/Nanomolar,2845581,=,37,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
2345,337547,17715377,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)n(C)n1,,,CHEMBL3886172,,2015.0,"{'bei': '17.08', 'le': '0.32', 'lle': '5.84', 'sei': '5.56'}",CHEMBL4109108,,CHEMBL4109108,8.15,False,http://www.openphacts.org/units/Nanomolar,2845582,=,37,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
2346,337548,17715378,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)ccc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.41', 'le': '0.32', 'lle': '3.22', 'sei': '7.77'}",CHEMBL3964745,,CHEMBL3964745,8.00,False,http://www.openphacts.org/units/Nanomolar,2845583,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
2347,337549,17715379,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC12CCC(O)(CC1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '18.19', 'le': '0.33', 'lle': '4.54', 'sei': '6.76'}",CHEMBL3986164,,CHEMBL3986164,7.83,False,http://www.openphacts.org/units/Nanomolar,2845206,=,37,True,=,,IC50,nM,,14.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.8
2348,337550,17715380,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(S(N)(=O)=O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.22', 'le': '0.31', 'lle': '6.20', 'sei': '4.95'}",CHEMBL4107511,,CHEMBL4107511,8.72,False,http://www.openphacts.org/units/Nanomolar,2845237,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2349,337551,17715381,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCCOC(C)(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.01', 'le': '0.35', 'lle': '4.21', 'sei': '7.88'}",CHEMBL3947682,,CHEMBL3947682,8.26,False,http://www.openphacts.org/units/Nanomolar,2845207,=,37,True,=,,IC50,nM,,5.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.5
2350,337552,17715382,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.11', 'le': '0.32', 'lle': '4.48', 'sei': '6.68'}",CHEMBL4111310,,CHEMBL4111310,8.36,False,http://www.openphacts.org/units/Nanomolar,2845238,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2351,337553,17715383,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)/C=C/Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.83', 'le': '0.33', 'lle': '5.49', 'sei': '6.11'}",CHEMBL4107316,,CHEMBL4107316,8.32,False,http://www.openphacts.org/units/Nanomolar,2845584,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2352,337554,17715384,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@@](F)(c2nccn2C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.69', 'le': '0.31', 'lle': '3.98', 'sei': '7.37'}",CHEMBL3945800,,CHEMBL3945800,8.36,False,http://www.openphacts.org/units/Nanomolar,2845585,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2353,337555,17715385,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2ncoc2c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.46', 'le': '0.32', 'lle': '4.70', 'sei': '6.15'}",CHEMBL4110814,,CHEMBL4110814,8.72,False,http://www.openphacts.org/units/Nanomolar,2845586,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2354,337556,17715386,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.01', 'le': '0.36', 'lle': '6.33', 'sei': '6.35'}",CHEMBL4115108,,CHEMBL4115108,8.64,False,http://www.openphacts.org/units/Nanomolar,2845587,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2355,337557,17715387,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CNc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '15.87', 'le': '0.29', 'lle': '4.29', 'sei': '6.01'}",CHEMBL4109159,,CHEMBL4109159,7.74,False,http://www.openphacts.org/units/Nanomolar,2845588,=,37,True,=,,IC50,nM,,18.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.4
2356,337558,17715388,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[N+]1=C(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC=N1,,,CHEMBL3886172,,2015.0,"{'bei': '17.74', 'le': '0.33', 'lle': '6.25', 'sei': '6.27'}",CHEMBL4107861,,CHEMBL4107861,8.22,False,http://www.openphacts.org/units/Nanomolar,2845589,=,37,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
2357,337559,17715389,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCCC(F)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '18.28', 'le': '0.35', 'lle': '5.24', 'sei': '7.55'}",CHEMBL4115121,,CHEMBL4115121,8.74,False,http://www.openphacts.org/units/Nanomolar,2845590,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2358,337560,17715390,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CCF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.27', 'le': '0.36', 'lle': '5.51', 'sei': '7.59'}",CHEMBL4107752,,CHEMBL4107752,8.80,False,http://www.openphacts.org/units/Nanomolar,2845591,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
2359,337561,17715391,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CCF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.74', 'le': '0.35', 'lle': '5.26', 'sei': '7.38'}",CHEMBL4107752,,CHEMBL4107752,8.55,False,http://www.openphacts.org/units/Nanomolar,2845591,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2360,337562,17715392,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(F)cnc43)cc2NC2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.46', 'le': '0.35', 'lle': '4.15', 'sei': '9.06'}",CHEMBL3977557,,CHEMBL3977557,8.34,False,http://www.openphacts.org/units/Nanomolar,2845592,=,37,True,=,,IC50,nM,,4.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.6
2361,337563,17715393,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.24', 'le': '0.35', 'lle': '4.89', 'sei': '7.62'}",CHEMBL3908153,,CHEMBL3908153,8.82,False,http://www.openphacts.org/units/Nanomolar,2845593,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2362,337564,17715394,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1F,,,CHEMBL3886172,,2015.0,"{'bei': '17.30', 'le': '0.32', 'lle': '4.79', 'sei': '6.21'}",CHEMBL4108627,,CHEMBL4108627,8.68,False,http://www.openphacts.org/units/Nanomolar,2845594,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
2363,337565,17715395,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(-c2ncc[nH]2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.54', 'le': '0.30', 'lle': '4.42', 'sei': '6.00'}",CHEMBL4113582,,CHEMBL4113582,8.68,False,http://www.openphacts.org/units/Nanomolar,2845595,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
2364,337566,17715396,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CO)Nc1cc(-n2ccc3cc(F)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.48', 'le': '0.35', 'lle': '5.27', 'sei': '7.73'}",CHEMBL3915404,,CHEMBL3915404,8.68,False,http://www.openphacts.org/units/Nanomolar,2845596,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
2365,337567,17715397,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1nnnc1-c1ccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '15.12', 'le': '0.28', 'lle': '4.84', 'sei': '5.26'}",CHEMBL4112477,,CHEMBL4112477,8.39,False,http://www.openphacts.org/units/Nanomolar,2845597,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2366,337568,17715398,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '20.06', 'le': '0.38', 'lle': '5.19', 'sei': '8.39'}",CHEMBL4108325,,CHEMBL4108325,8.80,False,http://www.openphacts.org/units/Nanomolar,2836029,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
2367,337569,17715399,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)[C@H](F)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.59', 'le': '0.30', 'lle': '5.59', 'sei': '5.52'}",CHEMBL4114127,,CHEMBL4114127,8.00,False,http://www.openphacts.org/units/Nanomolar,2845598,=,37,True,=,,IC50,nM,,9.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.9
2368,337570,17715400,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2nn[nH]c2c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.51', 'le': '0.32', 'lle': '5.59', 'sei': '5.55'}",CHEMBL4110300,,CHEMBL4110300,8.74,False,http://www.openphacts.org/units/Nanomolar,2845599,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2369,337571,17715401,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.53', 'le': '0.38', 'lle': '7.06', 'sei': '7.19'}",CHEMBL4106613,,CHEMBL4106613,9.00,False,http://www.openphacts.org/units/Nanomolar,2845600,=,37,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
2370,337572,17715402,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2[nH]ncc2c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.26', 'le': '0.32', 'lle': '4.85', 'sei': '5.95'}",CHEMBL4113337,,CHEMBL4113337,8.60,False,http://www.openphacts.org/units/Nanomolar,2845601,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2371,337573,17715403,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2nc[nH]c2c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.22', 'le': '0.32', 'lle': '4.84', 'sei': '5.94'}",CHEMBL4112058,,CHEMBL4112058,8.59,False,http://www.openphacts.org/units/Nanomolar,2845602,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2372,337574,17715404,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.27', 'le': '0.36', 'lle': '6.39', 'sei': '6.97'}",CHEMBL4111861,,CHEMBL4111861,8.72,False,http://www.openphacts.org/units/Nanomolar,2845603,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2373,337575,17715405,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.84', 'le': '0.35', 'lle': '6.19', 'sei': '6.81'}",CHEMBL3984663,,CHEMBL3984663,8.52,False,http://www.openphacts.org/units/Nanomolar,2845604,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2374,337576,17715406,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCC(C(C)(O)C2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.13', 'le': '0.32', 'lle': '3.78', 'sei': '7.20'}",CHEMBL3914855,,CHEMBL3914855,8.34,False,http://www.openphacts.org/units/Nanomolar,2845605,=,37,True,=,,IC50,nM,,4.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.6
2375,337577,17715407,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(CO)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.73', 'le': '0.31', 'lle': '5.19', 'sei': '6.08'}",CHEMBL4108787,,CHEMBL4108787,8.28,False,http://www.openphacts.org/units/Nanomolar,2845606,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2376,337578,17715408,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCC(C(C)(O)C2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.28', 'le': '0.32', 'lle': '3.85', 'sei': '7.26'}",CHEMBL3914855,,CHEMBL3914855,8.41,False,http://www.openphacts.org/units/Nanomolar,2845605,=,37,True,=,,IC50,nM,,3.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.9
2377,337579,17715409,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C[SH](=O)=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.18', 'le': '0.33', 'lle': '6.40', 'sei': '6.22'}",CHEMBL3900602,,CHEMBL3900602,8.28,False,http://www.openphacts.org/units/Nanomolar,2845607,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2378,337580,17715410,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C,,,CHEMBL3886172,,2015.0,"{'bei': '19.05', 'le': '0.36', 'lle': '4.62', 'sei': '8.22'}",CHEMBL4115629,,CHEMBL4115629,8.62,False,http://www.openphacts.org/units/Nanomolar,2845608,=,37,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
2379,337581,17715411,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncc(F)cn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.11', 'le': '0.30', 'lle': '6.07', 'sei': '6.09'}",CHEMBL4110783,,CHEMBL4110783,8.82,False,http://www.openphacts.org/units/Nanomolar,2845609,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2380,337582,17715412,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.98', 'le': '0.35', 'lle': '5.21', 'sei': '7.38'}",CHEMBL4109005,,CHEMBL4109005,8.55,False,http://www.openphacts.org/units/Nanomolar,2845610,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2381,337583,17715413,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.55', 'le': '0.35', 'lle': '5.02', 'sei': '7.21'}",CHEMBL3977735,,CHEMBL3977735,8.36,False,http://www.openphacts.org/units/Nanomolar,2845611,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2382,337584,17715414,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNS(=O)(=O)N1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.16', 'le': '0.31', 'lle': '7.27', 'sei': '5.37'}",CHEMBL3907139,,CHEMBL3907139,8.28,False,http://www.openphacts.org/units/Nanomolar,2845612,=,37,True,=,,IC50,nM,,5.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.2
2383,337585,17715415,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)NCCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.01', 'le': '0.37', 'lle': '7.21', 'sei': '5.89'}",CHEMBL3921676,,CHEMBL3921676,8.36,False,http://www.openphacts.org/units/Nanomolar,2845613,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2384,337586,17715416,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.64', 'le': '0.33', 'lle': '4.25', 'sei': '7.10'}",CHEMBL4112226,,CHEMBL4112226,8.23,False,http://www.openphacts.org/units/Nanomolar,2845614,=,37,True,=,,IC50,nM,,5.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.9
2385,337587,17715417,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1O,,,CHEMBL3886172,,2015.0,"{'bei': '18.48', 'le': '0.35', 'lle': '7.36', 'sei': '5.96'}",CHEMBL4115149,,CHEMBL4115149,8.66,False,http://www.openphacts.org/units/Nanomolar,2845615,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2386,337588,17715418,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1O,,,CHEMBL3886172,,2015.0,"{'bei': '17.76', 'le': '0.33', 'lle': '7.02', 'sei': '5.72'}",CHEMBL4115149,,CHEMBL4115149,8.32,False,http://www.openphacts.org/units/Nanomolar,2845615,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2387,337589,17715419,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N1CC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '14.86', 'le': '0.28', 'lle': '4.83', 'sei': '5.49'}",CHEMBL4113532,,CHEMBL4113532,7.99,False,http://www.openphacts.org/units/Nanomolar,2845616,=,37,True,=,,IC50,nM,,10.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.3
2388,337590,17715420,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1F,,,CHEMBL3886172,,2015.0,"{'bei': '17.32', 'le': '0.33', 'lle': '5.87', 'sei': '6.51'}",CHEMBL4108427,,CHEMBL4108427,8.15,False,http://www.openphacts.org/units/Nanomolar,2845617,=,37,True,=,,IC50,nM,,7.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.1
2389,337591,17715421,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1F,,,CHEMBL3886172,,2015.0,"{'bei': '17.66', 'le': '0.33', 'lle': '6.03', 'sei': '6.64'}",CHEMBL4108427,,CHEMBL4108427,8.31,False,http://www.openphacts.org/units/Nanomolar,2845617,=,37,True,=,,IC50,nM,,4.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.9
2390,337592,17715422,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1c1c[nH]cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.36', 'le': '0.32', 'lle': '5.66', 'sei': '5.87'}",CHEMBL4115463,,CHEMBL4115463,8.48,False,http://www.openphacts.org/units/Nanomolar,2845618,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2391,337593,17715423,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.93', 'le': '0.36', 'lle': '6.29', 'sei': '6.32'}",CHEMBL4115108,,CHEMBL4115108,8.60,False,http://www.openphacts.org/units/Nanomolar,2845587,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2392,337594,17715424,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.78', 'le': '0.35', 'lle': '6.23', 'sei': '6.27'}",CHEMBL4115108,,CHEMBL4115108,8.54,False,http://www.openphacts.org/units/Nanomolar,2845587,=,37,True,=,,IC50,nM,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.9
2393,337595,17715425,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCN(S(C)(=O)=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.13', 'le': '0.32', 'lle': '6.80', 'sei': '5.72'}",CHEMBL4108543,,CHEMBL4108543,8.77,False,http://www.openphacts.org/units/Nanomolar,2845619,=,37,True,=,,IC50,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.7
2394,337596,17715426,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCN(c2ccccc2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.71', 'le': '0.29', 'lle': '4.30', 'sei': '7.14'}",CHEMBL4113871,,CHEMBL4113871,8.51,False,http://www.openphacts.org/units/Nanomolar,2845620,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2395,337597,17715427,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(S(C)(=O)=O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.78', 'le': '0.33', 'lle': '7.31', 'sei': '5.80'}",CHEMBL4111288,,CHEMBL4111288,8.89,False,http://www.openphacts.org/units/Nanomolar,2845621,=,37,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
2396,337598,17715428,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCNC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.40', 'le': '0.33', 'lle': '5.96', 'sei': '6.14'}",CHEMBL4115090,,CHEMBL4115090,7.86,False,http://www.openphacts.org/units/Nanomolar,2845622,=,37,True,=,,IC50,nM,,13.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.9
2397,337599,17715429,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(=O)N1CCN(C)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.76', 'le': '0.35', 'lle': '7.02', 'sei': '7.25'}",CHEMBL3931002,,CHEMBL3931002,8.64,False,http://www.openphacts.org/units/Nanomolar,2845623,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2398,337600,17715430,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.18', 'le': '0.32', 'lle': '6.47', 'sei': '6.05'}",CHEMBL4112117,,CHEMBL4112117,8.24,False,http://www.openphacts.org/units/Nanomolar,2845624,=,37,True,=,,IC50,nM,,5.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.8
2399,337601,17715431,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CC[C@@H](Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.30', 'le': '0.32', 'lle': '6.38', 'sei': '6.27'}",CHEMBL4109546,,CHEMBL4109546,8.54,False,http://www.openphacts.org/units/Nanomolar,2845625,=,37,True,=,,IC50,nM,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.9
2400,337602,17715432,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.95', 'le': '0.30', 'lle': '5.55', 'sei': '5.95'}",CHEMBL4108168,,CHEMBL4108168,8.10,False,http://www.openphacts.org/units/Nanomolar,2845626,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
2401,337603,17715433,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(-n2ccnc2)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '15.24', 'le': '0.28', 'lle': '3.94', 'sei': '5.98'}",CHEMBL4106687,,CHEMBL4106687,8.00,False,http://www.openphacts.org/units/Nanomolar,2845627,=,37,True,=,,IC50,nM,,10.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.1
2402,337604,17715434,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CN(c2ncc(F)cn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.30', 'le': '0.30', 'lle': '6.34', 'sei': '6.00'}",CHEMBL4111218,,CHEMBL4111218,8.70,False,http://www.openphacts.org/units/Nanomolar,2845628,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
2403,337605,17715435,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(C(=O)CC(F)(F)F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '14.94', 'le': '0.29', 'lle': '5.29', 'sei': '6.16'}",CHEMBL4113034,,CHEMBL4113034,8.39,False,http://www.openphacts.org/units/Nanomolar,2845629,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2404,337606,17715436,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CC[C@@H](Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.51', 'le': '0.33', 'lle': '6.54', 'sei': '6.14'}",CHEMBL4110862,,CHEMBL4110862,8.92,False,http://www.openphacts.org/units/Nanomolar,2845630,=,37,True,=,,IC50,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.2
2405,337607,17715437,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C(N)=O)cnc32)cc1NCC1CNC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.41', 'le': '0.33', 'lle': '7.18', 'sei': '5.55'}",CHEMBL4108062,,CHEMBL4108062,8.17,False,http://www.openphacts.org/units/Nanomolar,2845631,=,37,True,=,,IC50,nM,,6.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.7
2406,337608,17715438,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CN(S(C)(=O)=O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.53', 'le': '0.32', 'lle': '7.33', 'sei': '5.56'}",CHEMBL4113763,,CHEMBL4113763,8.52,False,http://www.openphacts.org/units/Nanomolar,2845632,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2407,337609,17715439,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(C(=O)CC#N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.46', 'le': '0.31', 'lle': '6.48', 'sei': '5.34'}",CHEMBL4112814,,CHEMBL4112814,8.54,False,http://www.openphacts.org/units/Nanomolar,2845633,=,37,True,=,,IC50,nM,,2.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.9
2408,337610,17715440,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNS(C)(=O)=O,,,CHEMBL3886172,,2015.0,"{'bei': '18.20', 'le': '0.36', 'lle': '7.97', 'sei': '5.14'}",CHEMBL3917759,,CHEMBL3917759,8.33,False,http://www.openphacts.org/units/Nanomolar,2845634,=,37,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
2409,337611,17715441,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)NCCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.05', 'le': '0.33', 'lle': '7.08', 'sei': '5.46'}",CHEMBL3954359,,CHEMBL3954359,8.24,False,http://www.openphacts.org/units/Nanomolar,2845635,=,37,True,=,,IC50,nM,,5.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.7
2410,337612,17715442,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCCN1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.95', 'le': '0.32', 'lle': '6.52', 'sei': '6.54'}",CHEMBL4106614,,CHEMBL4106614,8.40,False,http://www.openphacts.org/units/Nanomolar,2845636,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2411,337613,17715443,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.60', 'le': '0.33', 'lle': '6.73', 'sei': '6.00'}",CHEMBL4114846,,CHEMBL4114846,8.72,False,http://www.openphacts.org/units/Nanomolar,2845637,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2412,337614,17715444,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.15', 'le': '0.30', 'lle': '4.79', 'sei': '6.20'}",CHEMBL4115525,,CHEMBL4115525,7.76,False,http://www.openphacts.org/units/Nanomolar,2845638,=,37,True,=,,IC50,nM,,17.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.4
2413,337615,17715445,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1COCCN1CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.63', 'le': '0.29', 'lle': '5.71', 'sei': '6.21'}",CHEMBL4114135,,CHEMBL4114135,7.97,False,http://www.openphacts.org/units/Nanomolar,2845639,=,37,True,=,,IC50,nM,,10.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.8
2414,337616,17715446,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1COCC1(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '17.31', 'le': '0.33', 'lle': '5.88', 'sei': '6.76'}",CHEMBL4108188,,CHEMBL4108188,8.46,False,http://www.openphacts.org/units/Nanomolar,2845640,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2415,337617,17715447,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1COCC1(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '16.50', 'le': '0.31', 'lle': '5.48', 'sei': '6.44'}",CHEMBL4108188,,CHEMBL4108188,8.06,False,http://www.openphacts.org/units/Nanomolar,2845640,=,37,True,=,,IC50,nM,,8.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.7
2416,337618,17715448,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](C(N)=O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.58', 'le': '0.33', 'lle': '6.33', 'sei': '5.61'}",CHEMBL4106665,,CHEMBL4106665,8.92,False,http://www.openphacts.org/units/Nanomolar,2845641,=,37,True,=,,IC50,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.2
2417,337619,17715449,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCCC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.11', 'le': '0.37', 'lle': '5.16', 'sei': '7.51'}",CHEMBL3977494,,CHEMBL3977494,8.70,False,http://www.openphacts.org/units/Nanomolar,2845642,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
2418,337620,17715450,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(NCC(F)(F)F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '14.92', 'le': '0.29', 'lle': '4.55', 'sei': '6.39'}",CHEMBL4114212,,CHEMBL4114212,8.17,False,http://www.openphacts.org/units/Nanomolar,2845643,=,37,True,=,,IC50,nM,,6.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.8
2419,337621,17715451,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(NCC(F)(F)F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '15.28', 'le': '0.29', 'lle': '4.75', 'sei': '6.54'}",CHEMBL4114212,,CHEMBL4114212,8.37,False,http://www.openphacts.org/units/Nanomolar,2845643,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2420,337622,17715452,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.97', 'le': '0.34', 'lle': '5.95', 'sei': '5.90'}",CHEMBL4110735,,CHEMBL4110735,8.37,False,http://www.openphacts.org/units/Nanomolar,2845644,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2421,337623,17715453,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.19', 'le': '0.34', 'lle': '6.05', 'sei': '5.97'}",CHEMBL4110735,,CHEMBL4110735,8.47,False,http://www.openphacts.org/units/Nanomolar,2845644,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2422,337624,17715454,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.52', 'le': '0.33', 'lle': '5.73', 'sei': '5.75'}",CHEMBL4110735,,CHEMBL4110735,8.15,False,http://www.openphacts.org/units/Nanomolar,2845644,=,37,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
2423,337625,17715455,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.31', 'le': '0.34', 'lle': '6.10', 'sei': '6.01'}",CHEMBL4110735,,CHEMBL4110735,8.52,False,http://www.openphacts.org/units/Nanomolar,2845644,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2424,337626,17715456,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.44', 'le': '0.36', 'lle': '6.58', 'sei': '6.81'}",CHEMBL3975254,,CHEMBL3975254,8.52,False,http://www.openphacts.org/units/Nanomolar,2845645,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2425,337627,17715457,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.94', 'le': '0.37', 'lle': '6.80', 'sei': '6.99'}",CHEMBL3975254,,CHEMBL3975254,8.74,False,http://www.openphacts.org/units/Nanomolar,2845645,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2426,337628,17715458,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(O)[C@H](C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.03', 'le': '0.30', 'lle': '4.62', 'sei': '5.85'}",CHEMBL3960922,,CHEMBL3960922,7.96,False,http://www.openphacts.org/units/Nanomolar,2845646,=,37,True,=,,IC50,nM,,10.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.9
2427,337629,17715459,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.88', 'le': '0.35', 'lle': '4.65', 'sei': '7.28'}",CHEMBL3984250,,CHEMBL3984250,8.43,False,http://www.openphacts.org/units/Nanomolar,2845647,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
2428,337630,17715460,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)COC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.60', 'le': '0.30', 'lle': '4.28', 'sei': '6.32'}",CHEMBL4112197,,CHEMBL4112197,8.24,False,http://www.openphacts.org/units/Nanomolar,2845648,=,37,True,=,,IC50,nM,,5.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.7
2429,337631,17715461,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC(C)(C)O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.54', 'le': '0.30', 'lle': '5.35', 'sei': '5.81'}",CHEMBL4110685,,CHEMBL4110685,8.21,False,http://www.openphacts.org/units/Nanomolar,2845649,=,37,True,=,,IC50,nM,,6.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.1
2430,337632,17715462,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)C(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '14.93', 'le': '0.28', 'lle': '4.25', 'sei': '6.33'}",CHEMBL4107826,,CHEMBL4107826,7.88,False,http://www.openphacts.org/units/Nanomolar,2845650,=,37,True,=,,IC50,nM,,13.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.2
2431,337633,17715463,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.52', 'le': '0.31', 'lle': '4.94', 'sei': '6.34'}",CHEMBL4115180,,CHEMBL4115180,8.27,False,http://www.openphacts.org/units/Nanomolar,2845651,=,37,True,=,,IC50,nM,,5.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.4
2432,337634,17715464,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)OC(C)C)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.17', 'le': '0.31', 'lle': '4.61', 'sei': '6.38'}",CHEMBL4114483,,CHEMBL4114483,8.32,False,http://www.openphacts.org/units/Nanomolar,2845652,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2433,337635,17715465,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.85', 'le': '0.32', 'lle': '4.90', 'sei': '7.13'}",CHEMBL4107848,,CHEMBL4107848,8.64,False,http://www.openphacts.org/units/Nanomolar,2845653,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2434,337636,17715466,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC4CCCC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.53', 'le': '0.29', 'lle': '4.09', 'sei': '6.90'}",CHEMBL4110095,,CHEMBL4110095,8.37,False,http://www.openphacts.org/units/Nanomolar,2845654,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2435,337637,17715467,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)C4CC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.85', 'le': '0.30', 'lle': '4.76', 'sei': '6.49'}",CHEMBL4107960,,CHEMBL4107960,7.87,False,http://www.openphacts.org/units/Nanomolar,2845655,=,37,True,=,,IC50,nM,,13.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.5
2436,337638,17715468,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](F)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.94', 'le': '0.38', 'lle': '5.92', 'sei': '7.62'}",CHEMBL4112802,,CHEMBL4112802,8.82,False,http://www.openphacts.org/units/Nanomolar,2845656,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2437,337639,17715469,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](F)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.01', 'le': '0.38', 'lle': '5.95', 'sei': '7.64'}",CHEMBL3921810,,CHEMBL3921810,8.85,False,http://www.openphacts.org/units/Nanomolar,2845657,=,37,True,=,,IC50,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.4
2438,337640,17715470,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.62', 'le': '0.32', 'lle': '4.83', 'sei': '6.56'}",CHEMBL4113892,,CHEMBL4113892,8.55,False,http://www.openphacts.org/units/Nanomolar,2845658,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2439,337641,17715471,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1C[C@H](C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.78', 'le': '0.33', 'lle': '5.71', 'sei': '6.46'}",CHEMBL4114306,,CHEMBL4114306,8.80,False,http://www.openphacts.org/units/Nanomolar,2845659,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
2440,337642,17715472,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.04', 'le': '0.32', 'lle': '4.99', 'sei': '7.01'}",CHEMBL4112394,,CHEMBL4112394,8.49,False,http://www.openphacts.org/units/Nanomolar,2845660,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
2441,337643,17715473,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC4CCCCC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '14.96', 'le': '0.28', 'lle': '3.60', 'sei': '6.82'}",CHEMBL4106835,,CHEMBL4106835,8.27,False,http://www.openphacts.org/units/Nanomolar,2845661,=,37,True,=,,IC50,nM,,5.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.4
2442,337644,17715474,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.06', 'le': '0.30', 'lle': '4.33', 'sei': '6.98'}",CHEMBL4113859,,CHEMBL4113859,8.46,False,http://www.openphacts.org/units/Nanomolar,2845662,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2443,337645,17715475,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.02', 'le': '0.30', 'lle': '4.94', 'sei': '6.18'}",CHEMBL4111603,,CHEMBL4111603,8.23,False,http://www.openphacts.org/units/Nanomolar,2845663,=,37,True,=,,IC50,nM,,5.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.9
2444,337646,17715476,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)NCc4ccccc4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '14.40', 'le': '0.27', 'lle': '4.01', 'sei': '6.07'}",CHEMBL4114411,,CHEMBL4114411,8.09,False,http://www.openphacts.org/units/Nanomolar,2845664,=,37,True,=,,IC50,nM,,8.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.2
2445,337647,17715477,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)Cc4ccccc4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.84', 'le': '0.30', 'lle': '4.72', 'sei': '7.14'}",CHEMBL4107665,,CHEMBL4107665,8.66,False,http://www.openphacts.org/units/Nanomolar,2845665,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2446,337648,17715478,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1,,,CHEMBL3886172,,2015.0,"{'bei': '15.29', 'le': '0.29', 'lle': '4.39', 'sei': '6.06'}",CHEMBL4108657,,CHEMBL4108657,8.07,False,http://www.openphacts.org/units/Nanomolar,2845666,=,37,True,=,,IC50,nM,,8.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.6
2447,337649,17715479,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(O)c1,,,CHEMBL3886172,,2015.0,"{'bei': '18.72', 'le': '0.35', 'lle': '4.36', 'sei': '7.70'}",CHEMBL4109209,,CHEMBL4109209,8.92,False,http://www.openphacts.org/units/Nanomolar,2845667,=,37,True,=,,IC50,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.2
2448,337650,17715480,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC4CCOCC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '14.16', 'le': '0.27', 'lle': '4.34', 'sei': '6.02'}",CHEMBL4107475,,CHEMBL4107475,7.85,False,http://www.openphacts.org/units/Nanomolar,2845668,=,37,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
2449,337651,17715481,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC(C)(C)C)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.27', 'le': '0.31', 'lle': '4.44', 'sei': '7.07'}",CHEMBL4115268,,CHEMBL4115268,8.57,False,http://www.openphacts.org/units/Nanomolar,2845669,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
2450,337652,17715482,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ccc3cc(CNC(=O)C4CCOC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '15.15', 'le': '0.29', 'lle': '5.25', 'sei': '6.12'}",CHEMBL4113687,,CHEMBL4113687,7.98,False,http://www.openphacts.org/units/Nanomolar,2845670,=,37,True,=,,IC50,nM,,10.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.5
2451,337653,17715483,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)c1cnc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)s1,,,CHEMBL3886172,,2015.0,"{'bei': '16.12', 'le': '0.31', 'lle': '5.51', 'sei': '5.22'}",CHEMBL4111235,,CHEMBL4111235,8.46,False,http://www.openphacts.org/units/Nanomolar,2845671,=,37,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
2452,337654,17715484,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1,,,CHEMBL3886172,,2015.0,"{'bei': '17.72', 'le': '0.33', 'lle': '5.45', 'sei': '5.63'}",CHEMBL4114850,,CHEMBL4114850,8.59,False,http://www.openphacts.org/units/Nanomolar,2845672,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2453,337655,17715485,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccc(C#N)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '17.72', 'le': '0.33', 'lle': '5.45', 'sei': '5.63'}",CHEMBL4111578,,CHEMBL4111578,8.59,False,http://www.openphacts.org/units/Nanomolar,2845673,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2454,337656,17715486,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccc2ncsc2c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.62', 'le': '0.32', 'lle': '4.71', 'sei': '6.06'}",CHEMBL4113432,,CHEMBL4113432,8.59,False,http://www.openphacts.org/units/Nanomolar,2845674,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2455,337657,17715487,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C(N)=O)cnc32)cc1Nc1ccc2ncoc2c1,,,CHEMBL3886172,,2015.0,"{'bei': '16.96', 'le': '0.32', 'lle': '6.16', 'sei': '5.05'}",CHEMBL4110605,,CHEMBL4110605,8.80,False,http://www.openphacts.org/units/Nanomolar,2845675,=,37,True,=,,IC50,nM,,1.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.6
2456,337658,17715488,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccc(-n2cncn2)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '16.01', 'le': '0.30', 'lle': '5.58', 'sei': '5.29'}",CHEMBL4107103,,CHEMBL4107103,8.43,False,http://www.openphacts.org/units/Nanomolar,2845676,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
2457,337659,17715489,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nnnc1-c1ccc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '15.74', 'le': '0.29', 'lle': '6.06', 'sei': '4.95'}",CHEMBL4108900,,CHEMBL4108900,8.52,False,http://www.openphacts.org/units/Nanomolar,2845677,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2458,337660,17715490,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1F,,,CHEMBL3886172,,2015.0,"{'bei': '16.88', 'le': '0.31', 'lle': '5.20', 'sei': '5.56'}",CHEMBL4108684,,CHEMBL4108684,8.48,False,http://www.openphacts.org/units/Nanomolar,2845678,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2459,337661,17715491,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nnnc1-c1ccc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1,,,CHEMBL3886172,,2015.0,"{'bei': '15.36', 'le': '0.28', 'lle': '5.86', 'sei': '4.83'}",CHEMBL4108900,,CHEMBL4108900,8.32,False,http://www.openphacts.org/units/Nanomolar,2845677,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2460,337662,17715492,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2ccc(Nc3cc(-n4ncc5cc(C#N)cnc54)ncc3C(=O)NC[C@@H](F)C(C)(C)O)cc2)s1,,,CHEMBL3886172,,2015.0,"{'bei': '14.24', 'le': '0.27', 'lle': '3.84', 'sei': '5.14'}",CHEMBL4107570,,CHEMBL4107570,7.94,False,http://www.openphacts.org/units/Nanomolar,2845679,=,37,True,=,,IC50,nM,,11.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.4
2461,337663,17715493,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc(Nc3cc(-n4ncc5cc(C#N)cnc54)ncc3C(=O)NC[C@@H](F)C(C)(C)O)cc2)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.05', 'le': '0.30', 'lle': '4.99', 'sei': '5.91'}",CHEMBL4108172,,CHEMBL4108172,8.66,False,http://www.openphacts.org/units/Nanomolar,2845680,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2462,337664,17715494,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncc(F)cn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '15.06', 'le': '0.28', 'lle': '6.11', 'sei': '5.24'}",CHEMBL4108248,,CHEMBL4108248,8.26,False,http://www.openphacts.org/units/Nanomolar,2845681,=,37,True,=,,IC50,nM,,5.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.5
2463,337665,17715495,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CCN(c2ncc(F)cn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '14.56', 'le': '0.27', 'lle': '5.84', 'sei': '5.06'}",CHEMBL3891037,,CHEMBL3891037,7.99,False,http://www.openphacts.org/units/Nanomolar,2845682,=,37,True,=,,IC50,nM,,10.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.3
2464,337666,17715496,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncc(F)cn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.09', 'le': '0.30', 'lle': '6.67', 'sei': '5.59'}",CHEMBL4108248,,CHEMBL4108248,8.82,False,http://www.openphacts.org/units/Nanomolar,2845681,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2465,337667,17715497,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCN(c2ccccc2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.48', 'le': '0.29', 'lle': '4.79', 'sei': '6.36'}",CHEMBL4112812,,CHEMBL4112812,8.40,False,http://www.openphacts.org/units/Nanomolar,2845683,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2466,337668,17715498,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cnc(N2CC[C@@H](Nc3cc(-n4ncc5cc(C#N)cnc54)ncc3C(=O)NC[C@@H](F)C(C)(C)O)C2)nc1,,,CHEMBL3886172,,2015.0,"{'bei': '14.43', 'le': '0.27', 'lle': '6.07', 'sei': '4.85'}",CHEMBL4115327,,CHEMBL4115327,8.09,False,http://www.openphacts.org/units/Nanomolar,2845684,=,37,True,=,,IC50,nM,,8.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.1
2467,337669,17715499,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncccn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '15.39', 'le': '0.29', 'lle': '6.16', 'sei': '5.18'}",CHEMBL4108523,,CHEMBL4108523,8.17,False,http://www.openphacts.org/units/Nanomolar,2845685,=,37,True,=,,IC50,nM,,6.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.8
2468,337670,17715500,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(C(=O)c2ccc(F)cc2F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '13.53', 'le': '0.25', 'lle': '4.89', 'sei': '5.38'}",CHEMBL4106997,,CHEMBL4106997,8.02,False,http://www.openphacts.org/units/Nanomolar,2845686,=,37,True,=,,IC50,nM,,9.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.6
2469,337671,17715501,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CN(c2ncc(F)cn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '15.34', 'le': '0.29', 'lle': '6.44', 'sei': '5.20'}",CHEMBL4106523,,CHEMBL4106523,8.20,False,http://www.openphacts.org/units/Nanomolar,2845687,=,37,True,=,,IC50,nM,,6.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.3
2470,337672,17715502,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCN(c2ncc(F)cn2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.15', 'le': '0.28', 'lle': '5.98', 'sei': '5.40'}",CHEMBL4108818,,CHEMBL4108818,8.52,False,http://www.openphacts.org/units/Nanomolar,2845688,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2471,337673,17715503,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CN(c2ncc(Cl)cn2)C1,,,CHEMBL3886172,,2015.0,"{'bei': '14.23', 'le': '0.27', 'lle': '5.57', 'sei': '4.97'}",CHEMBL4107090,,CHEMBL4107090,7.84,False,http://www.openphacts.org/units/Nanomolar,2845689,=,37,True,=,,IC50,nM,,14.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.4
2472,337674,17715504,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CC(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.39', 'le': '0.31', 'lle': '6.75', 'sei': '5.14'}",CHEMBL4109155,,CHEMBL4109155,8.14,False,http://www.openphacts.org/units/Nanomolar,2845690,=,37,True,=,,IC50,nM,,7.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.3
2473,337675,17715505,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)N1CC(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.00', 'le': '0.30', 'lle': '6.39', 'sei': '5.16'}",CHEMBL4106902,,CHEMBL4106902,8.17,False,http://www.openphacts.org/units/Nanomolar,2845691,=,37,True,=,,IC50,nM,,6.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.8
2474,337676,17715506,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.50', 'le': '0.35', 'lle': '6.66', 'sei': '6.08'}",CHEMBL4111056,,CHEMBL4111056,8.39,False,http://www.openphacts.org/units/Nanomolar,2845692,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2475,337677,17715507,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.77', 'le': '0.33', 'lle': '6.33', 'sei': '5.84'}",CHEMBL3965205,,CHEMBL3965205,8.06,False,http://www.openphacts.org/units/Nanomolar,2845693,=,37,True,=,,IC50,nM,,8.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.7
2476,337678,17715508,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.19', 'le': '0.36', 'lle': '7.09', 'sei': '6.11'}",CHEMBL4114375,,CHEMBL4114375,8.43,False,http://www.openphacts.org/units/Nanomolar,2845694,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
2477,337679,17715509,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.89', 'le': '0.32', 'lle': '5.40', 'sei': '6.81'}",CHEMBL4110283,,CHEMBL4110283,7.78,False,http://www.openphacts.org/units/Nanomolar,2845695,=,37,True,=,,IC50,nM,,16.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.6
2478,337680,17715510,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCOC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.59', 'le': '0.33', 'lle': '6.24', 'sei': '5.78'}",CHEMBL4111056,,CHEMBL4111056,7.97,False,http://www.openphacts.org/units/Nanomolar,2845692,=,37,True,=,,IC50,nM,,10.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.6
2479,337681,17715511,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(N2CCc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.65', 'le': '0.33', 'lle': '6.08', 'sei': '6.30'}",CHEMBL4111891,,CHEMBL4111891,7.78,False,http://www.openphacts.org/units/Nanomolar,2845696,=,37,True,=,,IC50,nM,,16.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.8
2480,337682,17715512,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.47', 'le': '0.35', 'lle': '6.39', 'sei': '6.99'}",CHEMBL4111375,,CHEMBL4111375,7.99,False,http://www.openphacts.org/units/Nanomolar,2845697,=,37,True,=,,IC50,nM,,10.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.3
2481,337683,17715513,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.60', 'le': '0.35', 'lle': '5.78', 'sei': '6.92'}",CHEMBL4115046,,CHEMBL4115046,7.90,False,http://www.openphacts.org/units/Nanomolar,2845698,=,37,True,=,,IC50,nM,,12.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.6
2482,337684,17715514,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC2COC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.59', 'le': '0.33', 'lle': '5.68', 'sei': '6.20'}",CHEMBL3973967,,CHEMBL3973967,7.87,False,http://www.openphacts.org/units/Nanomolar,2845699,=,37,True,=,,IC50,nM,,13.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.4
2483,337685,17715515,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.86', 'le': '0.35', 'lle': '6.56', 'sei': '5.76'}",CHEMBL3890485,,CHEMBL3890485,7.95,False,http://www.openphacts.org/units/Nanomolar,2845700,=,37,True,=,,IC50,nM,,11.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.2
2484,337686,17715516,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COCC1(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '16.87', 'le': '0.32', 'lle': '6.29', 'sei': '5.99'}",CHEMBL4106712,,CHEMBL4106712,8.26,False,http://www.openphacts.org/units/Nanomolar,2845701,=,37,True,=,,IC50,nM,,5.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.5
2485,337687,17715517,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC2COC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '5.59', 'sei': '5.91'}",CHEMBL3976033,,CHEMBL3976033,8.15,False,http://www.openphacts.org/units/Nanomolar,2845702,=,37,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
2486,337688,17715518,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(Cl)cnc43)cc2NC2COC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.92', 'le': '0.33', 'lle': '4.87', 'sei': '7.19'}",CHEMBL3943289,,CHEMBL3943289,8.21,False,http://www.openphacts.org/units/Nanomolar,2845703,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
2487,337689,17715519,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.45', 'le': '0.38', 'lle': '6.02', 'sei': '7.04'}",CHEMBL3956976,,CHEMBL3956976,8.29,False,http://www.openphacts.org/units/Nanomolar,2845704,=,37,True,=,,IC50,nM,,5.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.1
2488,337690,17715520,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cc2cnn(-c3cc(NC4COC4)c(C(=O)NCCC4CC4)cn3)c2nc1N,,,CHEMBL3886172,,2015.0,"{'bei': '19.63', 'le': '0.36', 'lle': '6.60', 'sei': '5.71'}",CHEMBL3891376,,CHEMBL3891376,8.21,False,http://www.openphacts.org/units/Nanomolar,2845705,=,37,True,=,,IC50,nM,,6.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.1
2489,337691,17715521,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.36', 'le': '0.38', 'lle': '6.67', 'sei': '5.76'}",CHEMBL3951721,,CHEMBL3951721,8.28,False,http://www.openphacts.org/units/Nanomolar,2845706,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2490,337692,17715522,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.14', 'le': '0.37', 'lle': '6.61', 'sei': '5.89'}",CHEMBL3980604,,CHEMBL3980604,8.47,False,http://www.openphacts.org/units/Nanomolar,2845707,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2491,337693,17715523,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1,,,CHEMBL3886172,,2015.0,"{'bei': '20.71', 'le': '0.38', 'lle': '6.08', 'sei': '6.89'}",CHEMBL3979646,,CHEMBL3979646,8.11,False,http://www.openphacts.org/units/Nanomolar,2845708,=,37,True,=,,IC50,nM,,7.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.8
2492,337694,17715524,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.16', 'le': '0.33', 'lle': '5.52', 'sei': '6.92'}",CHEMBL4110170,,CHEMBL4110170,7.90,False,http://www.openphacts.org/units/Nanomolar,2845709,=,37,True,=,,IC50,nM,,12.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.5
2493,337695,17715525,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCC(F)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '17.31', 'le': '0.33', 'lle': '5.41', 'sei': '6.45'}",CHEMBL4111939,,CHEMBL4111939,8.30,False,http://www.openphacts.org/units/Nanomolar,2845710,=,37,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
2494,337696,17715526,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cnc(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)cn1,,,CHEMBL3886172,,2015.0,"{'bei': '17.92', 'le': '0.33', 'lle': '5.14', 'sei': '5.36'}",CHEMBL3914088,,CHEMBL3914088,7.70,False,http://www.openphacts.org/units/Nanomolar,2845711,=,37,True,=,,IC50,nM,,20.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.1
2495,337697,17715527,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(CNc1cc(-n2ncc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)N1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.04', 'le': '0.30', 'lle': '6.62', 'sei': '5.99'}",CHEMBL4115236,,CHEMBL4115236,7.80,False,http://www.openphacts.org/units/Nanomolar,2845712,=,37,True,=,,IC50,nM,,15.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.7
2496,337698,17715528,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCc1nn[nH]n1,,,CHEMBL3886172,,2015.0,"{'bei': '19.25', 'le': '0.35', 'lle': '6.81', 'sei': '4.76'}",CHEMBL3923081,,CHEMBL3923081,7.76,False,http://www.openphacts.org/units/Nanomolar,2845713,=,37,True,=,,IC50,nM,,17.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.2
2497,337699,17715529,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(N2CCc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.77', 'le': '0.35', 'lle': '5.30', 'sei': '7.01'}",CHEMBL4107885,,CHEMBL4107885,8.00,False,http://www.openphacts.org/units/Nanomolar,2845714,=,37,True,=,,IC50,nM,,9.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.9
2498,337700,17715530,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.57', 'le': '0.37', 'lle': '6.09', 'sei': '6.25'}",CHEMBL4109995,,CHEMBL4109995,8.05,False,http://www.openphacts.org/units/Nanomolar,2845319,=,37,True,=,,IC50,nM,,8.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.9
2499,337701,17715531,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@H](CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.80', 'le': '0.32', 'lle': '5.94', 'sei': '5.29'}",CHEMBL4107384,,CHEMBL4107384,7.89,False,http://www.openphacts.org/units/Nanomolar,2845715,=,37,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
2500,337702,17715532,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(C)(C)N1CCOCC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.19', 'le': '0.29', 'lle': '5.92', 'sei': '5.64'}",CHEMBL4115086,,CHEMBL4115086,7.97,False,http://www.openphacts.org/units/Nanomolar,2845716,=,37,True,=,,IC50,nM,,10.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.7
2501,337703,17715533,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCc1cocn1,,,CHEMBL3886172,,2015.0,"{'bei': '16.83', 'le': '0.31', 'lle': '5.69', 'sei': '5.05'}",CHEMBL4115545,,CHEMBL4115545,7.82,False,http://www.openphacts.org/units/Nanomolar,2845717,=,37,True,=,,IC50,nM,,15.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.2
2502,337704,17715534,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.65', 'le': '0.33', 'lle': '6.33', 'sei': '5.40'}",CHEMBL4107049,,CHEMBL4107049,8.04,False,http://www.openphacts.org/units/Nanomolar,2845718,=,37,True,=,,IC50,nM,,9.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.1
2503,337705,17715535,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.69', 'le': '0.33', 'lle': '6.35', 'sei': '5.41'}",CHEMBL4107049,,CHEMBL4107049,8.06,False,http://www.openphacts.org/units/Nanomolar,2845718,=,37,True,=,,IC50,nM,,8.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.8
2504,337706,17715536,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '17.47', 'le': '0.33', 'lle': '5.62', 'sei': '6.07'}",CHEMBL4112231,,CHEMBL4112231,7.82,False,http://www.openphacts.org/units/Nanomolar,2845719,=,37,True,=,,IC50,nM,,15.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.3
2505,337707,17715537,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)(CO)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.74', 'le': '0.32', 'lle': '6.27', 'sei': '5.32'}",CHEMBL4107607,,CHEMBL4107607,7.93,False,http://www.openphacts.org/units/Nanomolar,2845720,=,37,True,=,,IC50,nM,,11.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.8
2506,337708,17715538,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.16', 'le': '0.34', 'lle': '5.26', 'sei': '6.40'}",CHEMBL4114915,,CHEMBL4114915,8.24,False,http://www.openphacts.org/units/Nanomolar,2845721,=,37,True,=,,IC50,nM,,5.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.8
2507,337709,17715539,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.92', 'le': '0.37', 'lle': '6.95', 'sei': '5.49'}",CHEMBL4110619,,CHEMBL4110619,8.49,False,http://www.openphacts.org/units/Nanomolar,2845722,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
2508,337710,17715540,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.49', 'le': '0.37', 'lle': '6.66', 'sei': '5.55'}",CHEMBL4107116,,CHEMBL4107116,8.59,False,http://www.openphacts.org/units/Nanomolar,2845723,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2509,337711,17715541,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.19', 'le': '0.38', 'lle': '6.96', 'sei': '5.84'}",CHEMBL4106938,,CHEMBL4106938,8.41,False,http://www.openphacts.org/units/Nanomolar,2845724,=,37,True,=,,IC50,nM,,3.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.9
2510,337712,17715542,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1cc(-n2ncc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.81', 'le': '0.38', 'lle': '6.91', 'sei': '5.54'}",CHEMBL4108507,,CHEMBL4108507,7.97,False,http://www.openphacts.org/units/Nanomolar,2845725,=,37,True,=,,IC50,nM,,10.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.7
2511,337713,17715543,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC1(F)CCC1,,,CHEMBL3886172,,2015.0,"{'bei': '17.20', 'le': '0.32', 'lle': '5.25', 'sei': '6.27'}",CHEMBL4115287,,CHEMBL4115287,8.08,False,http://www.openphacts.org/units/Nanomolar,2845726,=,37,True,=,,IC50,nM,,8.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.4
2512,337714,17715544,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](F)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.99', 'le': '0.36', 'lle': '6.12', 'sei': '6.54'}",CHEMBL4108028,,CHEMBL4108028,8.42,False,http://www.openphacts.org/units/Nanomolar,2845727,=,37,True,=,,IC50,nM,,3.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.8
2513,337715,17715545,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](F)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.91', 'le': '0.36', 'lle': '6.09', 'sei': '6.51'}",CHEMBL3933904,,CHEMBL3933904,8.39,False,http://www.openphacts.org/units/Nanomolar,2845728,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2514,337716,17715546,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C(=O)C2CN(S(C)(=O)=O)C2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '14.14', 'le': '0.27', 'lle': '6.88', 'sei': '4.81'}",CHEMBL3958341,,CHEMBL3958341,8.00,False,http://www.openphacts.org/units/Nanomolar,2845449,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
2515,337717,17715547,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.22', 'le': '0.32', 'lle': '6.15', 'sei': '5.21'}",CHEMBL4112662,,CHEMBL4112662,8.07,False,http://www.openphacts.org/units/Nanomolar,2845729,=,37,True,=,,IC50,nM,,8.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.5
2516,337718,17715548,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCNS(C)(=O)=O,,,CHEMBL3886172,,2015.0,"{'bei': '15.88', 'le': '0.31', 'lle': '7.52', 'sei': '4.58'}",CHEMBL4112120,,CHEMBL4112120,8.01,False,http://www.openphacts.org/units/Nanomolar,2845730,=,37,True,=,,IC50,nM,,9.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.7
2517,337719,17715549,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCNC(=O)OC(C)(C)C(F)(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '13.54', 'le': '0.26', 'lle': '4.86', 'sei': '4.70'}",CHEMBL4107060,,CHEMBL4107060,7.86,False,http://www.openphacts.org/units/Nanomolar,2845731,=,37,True,=,,IC50,nM,,13.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.8
2518,337720,17715550,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.35', 'le': '0.35', 'lle': '6.65', 'sei': '5.61'}",CHEMBL3910622,,CHEMBL3910622,8.36,False,http://www.openphacts.org/units/Nanomolar,2845732,=,37,True,=,,IC50,nM,,4.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.4
2519,337721,17715551,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](CO)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.04', 'le': '0.36', 'lle': '5.90', 'sei': '6.70'}",CHEMBL3896654,,CHEMBL3896654,8.39,False,http://www.openphacts.org/units/Nanomolar,2845733,=,37,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
2520,337722,17715552,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](F)CNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '19.02', 'le': '0.36', 'lle': '6.84', 'sei': '5.63'}",CHEMBL3924209,,CHEMBL3924209,8.72,False,http://www.openphacts.org/units/Nanomolar,2845734,=,37,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
2521,337723,17715553,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](F)CNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '18.69', 'le': '0.35', 'lle': '6.69', 'sei': '5.54'}",CHEMBL4113645,,CHEMBL4113645,8.57,False,http://www.openphacts.org/units/Nanomolar,2845735,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
2522,337724,17715554,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '20.10', 'le': '0.38', 'lle': '6.20', 'sei': '6.64'}",CHEMBL4112023,,CHEMBL4112023,8.55,False,http://www.openphacts.org/units/Nanomolar,2845506,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2523,337725,17715555,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)(C)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.42', 'le': '0.31', 'lle': '5.35', 'sei': '5.59'}",CHEMBL4107330,,CHEMBL4107330,7.71,False,http://www.openphacts.org/units/Nanomolar,2845736,=,37,True,=,,IC50,nM,,19.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.6
2524,337726,17715556,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(O)CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.20', 'le': '0.32', 'lle': '5.02', 'sei': '6.20'}",CHEMBL4115550,,CHEMBL4115550,7.76,False,http://www.openphacts.org/units/Nanomolar,2845737,=,37,True,=,,IC50,nM,,17.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.5
2525,337727,17715557,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCCF,,,CHEMBL3886172,,2015.0,"{'bei': '18.66', 'le': '0.35', 'lle': '5.98', 'sei': '6.43'}",CHEMBL4108324,,CHEMBL4108324,8.28,False,http://www.openphacts.org/units/Nanomolar,2845738,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2526,337728,17715558,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(O)CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.16', 'le': '0.32', 'lle': '5.00', 'sei': '6.18'}",CHEMBL4115550,,CHEMBL4115550,7.74,False,http://www.openphacts.org/units/Nanomolar,2845737,=,37,True,=,,IC50,nM,,18.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.2
2527,337729,17715559,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(O)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '16.63', 'le': '0.31', 'lle': '5.86', 'sei': '5.24'}",CHEMBL4111216,,CHEMBL4111216,7.81,False,http://www.openphacts.org/units/Nanomolar,2845739,=,37,True,=,,IC50,nM,,15.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.6
2528,337730,17715560,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCOC(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '16.29', 'le': '0.31', 'lle': '5.60', 'sei': '5.64'}",CHEMBL4109694,,CHEMBL4109694,7.78,False,http://www.openphacts.org/units/Nanomolar,2845740,=,37,True,=,,IC50,nM,,16.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.6
2529,337731,17715561,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)CCNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.10', 'le': '0.32', 'lle': '5.66', 'sei': '5.37'}",CHEMBL4112418,,CHEMBL4112418,8.32,False,http://www.openphacts.org/units/Nanomolar,2845741,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2530,337732,17715562,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.55', 'le': '0.33', 'lle': '5.20', 'sei': '6.43'}",CHEMBL4110610,,CHEMBL4110610,8.28,False,http://www.openphacts.org/units/Nanomolar,2845742,=,37,True,=,,IC50,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.3
2531,337733,17715563,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)OC(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '15.52', 'le': '0.30', 'lle': '4.89', 'sei': '5.69'}",CHEMBL4113240,,CHEMBL4113240,7.85,False,http://www.openphacts.org/units/Nanomolar,2845743,=,37,True,=,,IC50,nM,,14.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.2
2532,337734,17715564,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](F)CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.20', 'le': '0.34', 'lle': '4.56', 'sei': '7.65'}",CHEMBL4112464,,CHEMBL4112464,8.03,False,http://www.openphacts.org/units/Nanomolar,2845744,=,37,True,=,,IC50,nM,,9.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.3
2533,337735,17715565,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)OC(F)F,,,CHEMBL3886172,,2015.0,"{'bei': '15.87', 'le': '0.32', 'lle': '4.43', 'sei': '7.16'}",CHEMBL4112958,,CHEMBL4112958,8.17,False,http://www.openphacts.org/units/Nanomolar,2845745,=,37,True,=,,IC50,nM,,6.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.7
2534,337736,17715566,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(F)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL3886172,,2015.0,"{'bei': '17.96', 'le': '0.34', 'lle': '5.52', 'sei': '6.38'}",CHEMBL4109670,,CHEMBL4109670,8.21,False,http://www.openphacts.org/units/Nanomolar,2845746,=,37,True,=,,IC50,nM,,6.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.1
2535,337737,17715567,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.57', 'le': '0.35', 'lle': '5.77', 'sei': '6.31'}",CHEMBL4113245,,CHEMBL4113245,8.12,False,http://www.openphacts.org/units/Nanomolar,2845747,=,37,True,=,,IC50,nM,,7.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.5
2536,337738,17715568,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.04', 'le': '0.30', 'lle': '5.13', 'sei': '5.64'}",CHEMBL4112293,,CHEMBL4112293,8.40,False,http://www.openphacts.org/units/Nanomolar,2845748,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2537,337739,17715569,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@@](C)(O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.95', 'le': '0.32', 'lle': '5.77', 'sei': '5.64'}",CHEMBL4115045,,CHEMBL4115045,8.40,False,http://www.openphacts.org/units/Nanomolar,2845749,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2538,337740,17715570,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@](C)(O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.94', 'le': '0.30', 'lle': '5.27', 'sei': '5.30'}",CHEMBL4114343,,CHEMBL4114343,7.90,False,http://www.openphacts.org/units/Nanomolar,2845750,=,37,True,=,,IC50,nM,,12.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.6
2539,337741,17715571,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.60', 'le': '0.32', 'lle': '5.52', 'sei': '6.11'}",CHEMBL4113269,,CHEMBL4113269,7.64,False,http://www.openphacts.org/units/Nanomolar,2845751,=,37,True,=,,IC50,nM,,22.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,22.7
2540,337742,17715572,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.48', 'le': '0.33', 'lle': '5.93', 'sei': '6.43'}",CHEMBL4113269,,CHEMBL4113269,8.05,False,http://www.openphacts.org/units/Nanomolar,2845751,=,37,True,=,,IC50,nM,,8.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.9
2541,337743,17715573,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.85', 'le': '0.32', 'lle': '5.64', 'sei': '6.20'}",CHEMBL4113269,,CHEMBL4113269,7.76,False,http://www.openphacts.org/units/Nanomolar,2845751,=,37,True,=,,IC50,nM,,17.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.4
2542,337744,17715574,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CCC[C@@H](Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '15.76', 'le': '0.30', 'lle': '4.98', 'sei': '5.54'}",CHEMBL3919364,,CHEMBL3919364,8.25,False,http://www.openphacts.org/units/Nanomolar,2845752,=,37,True,=,,IC50,nM,,5.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.6
2543,337745,17715575,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CCC(O)(CC1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '17.33', 'le': '0.32', 'lle': '6.16', 'sei': '5.74'}",CHEMBL4111058,,CHEMBL4111058,8.55,False,http://www.openphacts.org/units/Nanomolar,2845753,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2544,337746,17715576,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.64', 'le': '0.32', 'lle': '4.98', 'sei': '6.30'}",CHEMBL4108659,,CHEMBL4108659,8.11,False,http://www.openphacts.org/units/Nanomolar,2845754,=,37,True,=,,IC50,nM,,7.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.7
2545,337747,17715577,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.72', 'le': '0.34', 'lle': '5.51', 'sei': '6.71'}",CHEMBL4108659,,CHEMBL4108659,8.64,False,http://www.openphacts.org/units/Nanomolar,2845754,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2546,337748,17715578,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(N2CCc3cc(C#N)cnc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '18.76', 'le': '0.35', 'lle': '5.50', 'sei': '6.97'}",CHEMBL4113091,,CHEMBL4113091,7.96,False,http://www.openphacts.org/units/Nanomolar,2845755,=,37,True,=,,IC50,nM,,10.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.9
2547,337749,17715579,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.78', 'le': '0.32', 'lle': '5.67', 'sei': '5.74'}",CHEMBL3980538,,CHEMBL3980538,8.55,False,http://www.openphacts.org/units/Nanomolar,2845756,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2548,337750,17715580,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.81', 'le': '0.34', 'lle': '5.14', 'sei': '7.85'}",CHEMBL4113443,,CHEMBL4113443,8.24,False,http://www.openphacts.org/units/Nanomolar,2845757,=,37,True,=,,IC50,nM,,5.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.8
2549,337751,17715581,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.16', 'le': '0.35', 'lle': '5.30', 'sei': '8.00'}",CHEMBL4113443,,CHEMBL4113443,8.40,False,http://www.openphacts.org/units/Nanomolar,2845757,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2550,337752,17715582,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.31', 'le': '0.35', 'lle': '5.37', 'sei': '8.07'}",CHEMBL4113443,,CHEMBL4113443,8.47,False,http://www.openphacts.org/units/Nanomolar,2845757,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2551,337753,17715583,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.16', 'le': '0.35', 'lle': '5.30', 'sei': '8.00'}",CHEMBL4113443,,CHEMBL4113443,8.40,False,http://www.openphacts.org/units/Nanomolar,2845757,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
2552,337754,17715584,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC2COC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.44', 'le': '0.29', 'lle': '6.04', 'sei': '5.52'}",CHEMBL4113585,,CHEMBL4113585,8.28,False,http://www.openphacts.org/units/Nanomolar,2845758,=,37,True,=,,IC50,nM,,5.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.2
2553,337755,17715585,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC(=O)C2CC2)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.10', 'le': '0.28', 'lle': '5.50', 'sei': '5.25'}",CHEMBL4114030,,CHEMBL4114030,8.28,False,http://www.openphacts.org/units/Nanomolar,2845759,=,37,True,=,,IC50,nM,,5.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.2
2554,337756,17715586,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CC3CC(CC(O)(C3)C1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '16.26', 'le': '0.30', 'lle': '5.66', 'sei': '5.82'}",CHEMBL4110124,,CHEMBL4110124,8.68,False,http://www.openphacts.org/units/Nanomolar,2845760,=,37,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
2555,337757,17715587,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.44', 'le': '0.35', 'lle': '5.83', 'sei': '6.72'}",CHEMBL4110840,,CHEMBL4110840,8.66,False,http://www.openphacts.org/units/Nanomolar,2845761,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2556,337758,17715588,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '19.08', 'le': '0.36', 'lle': '6.13', 'sei': '6.96'}",CHEMBL4110840,,CHEMBL4110840,8.96,False,http://www.openphacts.org/units/Nanomolar,2845761,=,37,True,=,,IC50,nM,,1.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.1
2557,337759,17715589,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.40', 'le': '0.35', 'lle': '5.81', 'sei': '6.71'}",CHEMBL4110840,,CHEMBL4110840,8.64,False,http://www.openphacts.org/units/Nanomolar,2845761,=,37,True,=,,IC50,nM,,2.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.3
2558,337760,17715590,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1,,,CHEMBL3886172,,2015.0,"{'bei': '16.34', 'le': '0.32', 'lle': '4.82', 'sei': '6.77'}",CHEMBL3930748,,CHEMBL3930748,8.48,False,http://www.openphacts.org/units/Nanomolar,2845762,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2559,337761,17715591,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2N[C@@H]2CCCC[C@H]2F)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.89', 'le': '0.30', 'lle': '5.48', 'sei': '5.18'}",CHEMBL4112444,,CHEMBL4112444,8.48,False,http://www.openphacts.org/units/Nanomolar,2845763,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2560,337762,17715592,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2N[C@H]2CCCC[C@@H]2F)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '16.22', 'le': '0.30', 'lle': '5.66', 'sei': '5.29'}",CHEMBL3919786,,CHEMBL3919786,8.66,False,http://www.openphacts.org/units/Nanomolar,2845764,=,37,True,=,,IC50,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.2
2561,337763,17715593,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC1CC1,,,CHEMBL3886172,,2015.0,"{'bei': '19.31', 'le': '0.36', 'lle': '6.79', 'sei': '5.47'}",CHEMBL4110746,,CHEMBL4110746,8.47,False,http://www.openphacts.org/units/Nanomolar,2845765,=,37,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
2562,337764,17715594,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC12CC3CC(CC(O)(C3)C1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '15.65', 'le': '0.29', 'lle': '5.99', 'sei': '4.91'}",CHEMBL4115542,,CHEMBL4115542,8.59,False,http://www.openphacts.org/units/Nanomolar,2845766,=,37,True,=,,IC50,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.6
2563,337765,17715595,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC(=O)C(F)F)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '15.18', 'le': '0.29', 'lle': '5.85', 'sei': '5.37'}",CHEMBL4107389,,CHEMBL4107389,8.48,False,http://www.openphacts.org/units/Nanomolar,2845767,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2564,337766,17715596,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC(=O)c2ccccc2F)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '13.95', 'le': '0.26', 'lle': '4.59', 'sei': '5.33'}",CHEMBL4112863,,CHEMBL4112863,8.41,False,http://www.openphacts.org/units/Nanomolar,2845768,=,37,True,=,,IC50,nM,,3.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.9
2565,337767,17715597,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CC(C1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '19.45', 'le': '0.36', 'lle': '6.25', 'sei': '6.79'}",CHEMBL4111872,,CHEMBL4111872,8.74,False,http://www.openphacts.org/units/Nanomolar,2845769,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2566,337768,17715598,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CC3CC(CC(O)(C3)C1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '15.91', 'le': '0.30', 'lle': '4.52', 'sei': '6.62'}",CHEMBL4112867,,CHEMBL4112867,8.52,False,http://www.openphacts.org/units/Nanomolar,2845770,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
2567,337769,17715599,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC12CC(C1)C2,,,CHEMBL3886172,,2015.0,"{'bei': '19.00', 'le': '0.35', 'lle': '6.75', 'sei': '5.70'}",CHEMBL4108474,,CHEMBL4108474,8.82,False,http://www.openphacts.org/units/Nanomolar,2845771,=,37,True,=,,IC50,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.5
2568,337770,17715600,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.00', 'le': '0.32', 'lle': '6.11', 'sei': '5.12'}",CHEMBL4109707,,CHEMBL4109707,7.93,False,http://www.openphacts.org/units/Nanomolar,2845772,=,37,True,=,,IC50,nM,,11.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.7
2569,337771,17715601,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.30', 'le': '0.32', 'lle': '6.25', 'sei': '5.21'}",CHEMBL4109707,,CHEMBL4109707,8.07,False,http://www.openphacts.org/units/Nanomolar,2845772,=,37,True,=,,IC50,nM,,8.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.5
2570,337772,17715602,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(N)C1,,,CHEMBL3886172,,2015.0,"{'bei': '18.21', 'le': '0.34', 'lle': '6.67', 'sei': '5.49'}",CHEMBL4109707,,CHEMBL4109707,8.49,False,http://www.openphacts.org/units/Nanomolar,2845772,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
2571,337773,17715603,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)[C@H]1CC[C@H](Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1,,,CHEMBL3886172,,2015.0,"{'bei': '14.88', 'le': '0.28', 'lle': '5.17', 'sei': '5.19'}",CHEMBL4108546,,CHEMBL4108546,8.19,False,http://www.openphacts.org/units/Nanomolar,2845773,=,37,True,=,,IC50,nM,,6.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.4
2572,337774,17715604,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1C[C@H]1CO,,,CHEMBL3886172,,2015.0,"{'bei': '18.34', 'le': '0.34', 'lle': '7.00', 'sei': '5.58'}",CHEMBL3982186,,CHEMBL3982186,8.32,False,http://www.openphacts.org/units/Nanomolar,2845774,=,37,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
2573,337775,17715605,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1C[C@H]1CO,,,CHEMBL3886172,,2015.0,"{'bei': '18.23', 'le': '0.34', 'lle': '6.95', 'sei': '5.55'}",CHEMBL3982186,,CHEMBL3982186,8.27,False,http://www.openphacts.org/units/Nanomolar,2845774,=,37,True,=,,IC50,nM,,5.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.4
2574,337776,17715606,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CC(F)(F)C1,,,CHEMBL3886172,,2015.0,"{'bei': '17.67', 'le': '0.34', 'lle': '5.63', 'sei': '6.50'}",CHEMBL4113934,,CHEMBL4113934,8.37,False,http://www.openphacts.org/units/Nanomolar,2845775,=,37,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
2575,337777,17715607,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1N[C@@H]1C[C@H]1CO,,,CHEMBL3886172,,2015.0,"{'bei': '17.63', 'le': '0.35', 'lle': '6.06', 'sei': '6.52'}",CHEMBL3951794,,CHEMBL3951794,8.16,False,http://www.openphacts.org/units/Nanomolar,2845776,=,37,True,=,,IC50,nM,,6.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.9
2576,337778,17715608,[],CHEMBL3887118,"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1N[C@@H]1C[C@H]1CO,,,CHEMBL3886172,,2015.0,"{'bei': '17.24', 'le': '0.34', 'lle': '5.88', 'sei': '6.37'}",CHEMBL3951794,,CHEMBL3951794,7.98,False,http://www.openphacts.org/units/Nanomolar,2845776,=,37,True,=,,IC50,nM,,10.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.5
2577,338590,17716295,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3903671,,CHEMBL3903671,,False,http://www.openphacts.org/units/Nanomolar,2846362,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2578,338591,17716296,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(=NO)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3894869,,CHEMBL3894869,,False,http://www.openphacts.org/units/Nanomolar,2846363,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2579,338592,17716297,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CON=C1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3922852,,CHEMBL3922852,,False,http://www.openphacts.org/units/Nanomolar,2846364,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2580,338593,17716298,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNC(=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3893657,,CHEMBL3893657,,False,http://www.openphacts.org/units/Nanomolar,2846365,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2581,338594,17716299,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(N(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3925181,,CHEMBL3925181,,False,http://www.openphacts.org/units/Nanomolar,2846366,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2582,338595,17716300,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3900908,,CHEMBL3900908,,False,http://www.openphacts.org/units/Nanomolar,2846367,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2583,338596,17716301,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586493,,CHEMBL3586493,,False,http://www.openphacts.org/units/Nanomolar,2846368,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2584,338597,17716302,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3897856,,CHEMBL3897856,,False,http://www.openphacts.org/units/Nanomolar,2846369,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2585,338598,17716303,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(Cl)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3931431,,CHEMBL3931431,,False,http://www.openphacts.org/units/Nanomolar,2846370,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2586,338599,17716304,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(F)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3984259,,CHEMBL3984259,,False,http://www.openphacts.org/units/Nanomolar,2846371,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2587,338600,17716305,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C(F)(F)F)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3952231,,CHEMBL3952231,,False,http://www.openphacts.org/units/Nanomolar,2846372,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2588,338601,17716306,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3935941,,CHEMBL3935941,,False,http://www.openphacts.org/units/Nanomolar,2846373,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2589,338602,17716307,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(OC(F)(F)F)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3942404,,CHEMBL3942404,,False,http://www.openphacts.org/units/Nanomolar,2846374,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2590,338603,17716308,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-n1nc(C2CCNCC2)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3908722,,CHEMBL3908722,,False,http://www.openphacts.org/units/Nanomolar,2846375,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2591,338604,17716309,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3982170,,CHEMBL3982170,,False,http://www.openphacts.org/units/Nanomolar,2846376,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2592,338605,17716310,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586501,,CHEMBL3586501,,False,http://www.openphacts.org/units/Nanomolar,2846377,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2593,338606,17716311,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3586499,,CHEMBL3586499,,False,http://www.openphacts.org/units/Nanomolar,2846378,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2594,338607,17716312,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586498,,CHEMBL3586498,,False,http://www.openphacts.org/units/Nanomolar,2846379,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2595,338608,17716313,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(OC(F)(F)F)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3952093,,CHEMBL3952093,,False,http://www.openphacts.org/units/Nanomolar,2846380,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2596,338609,17716314,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccccc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3586500,,CHEMBL3586500,,False,http://www.openphacts.org/units/Nanomolar,2846381,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2597,338610,17716315,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3957369,,CHEMBL3957369,,False,http://www.openphacts.org/units/Nanomolar,2846382,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2598,338611,17716316,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(F)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3914020,,CHEMBL3914020,,False,http://www.openphacts.org/units/Nanomolar,2846383,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2599,338612,17716317,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(S(=O)(=O)C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3968371,,CHEMBL3968371,,False,http://www.openphacts.org/units/Nanomolar,2846384,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2600,338613,17716318,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3951041,,CHEMBL3951041,,False,http://www.openphacts.org/units/Nanomolar,2846385,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2601,338614,17716319,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3979995,,CHEMBL3979995,,False,http://www.openphacts.org/units/Nanomolar,2846386,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2602,338615,17716320,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3897625,,CHEMBL3897625,,False,http://www.openphacts.org/units/Nanomolar,2846387,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2603,338616,17716321,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(OC(F)(F)F)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3952093,,CHEMBL3952093,,False,http://www.openphacts.org/units/Nanomolar,2846380,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2604,338617,17716322,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(F)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3906627,,CHEMBL3906627,,False,http://www.openphacts.org/units/Nanomolar,2846388,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2605,338618,17716323,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(Cl)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3980372,,CHEMBL3980372,,False,http://www.openphacts.org/units/Nanomolar,2846389,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2606,338619,17716324,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(S(=O)(=O)C(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3981292,,CHEMBL3981292,,False,http://www.openphacts.org/units/Nanomolar,2846390,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2607,338620,17716325,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3586496,,CHEMBL3586496,,False,http://www.openphacts.org/units/Nanomolar,2846391,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2608,338621,17716326,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(OC)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3892227,,CHEMBL3892227,,False,http://www.openphacts.org/units/Nanomolar,2846392,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2609,338622,17716327,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(C(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3957749,,CHEMBL3957749,,False,http://www.openphacts.org/units/Nanomolar,2846393,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2610,338623,17716328,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(F)cc3F)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3889905,,CHEMBL3889905,,False,http://www.openphacts.org/units/Nanomolar,2846394,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2611,338624,17716329,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(N)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586497,,CHEMBL3586497,,False,http://www.openphacts.org/units/Nanomolar,2846395,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2612,338625,17716330,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586494,,CHEMBL3586494,,False,http://www.openphacts.org/units/Nanomolar,2846396,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2613,338626,17716331,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586495,,CHEMBL3586495,,False,http://www.openphacts.org/units/Nanomolar,2846397,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2614,338627,17716332,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936469,,CHEMBL3936469,,False,http://www.openphacts.org/units/Nanomolar,2846398,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2615,338628,17716333,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3892790,,CHEMBL3892790,,False,http://www.openphacts.org/units/Nanomolar,2846399,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2616,338629,17716334,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3953074,,CHEMBL3953074,,False,http://www.openphacts.org/units/Nanomolar,2846400,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2617,338630,17716335,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(CC(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3975410,,CHEMBL3975410,,False,http://www.openphacts.org/units/Nanomolar,2846401,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2618,338631,17716336,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCNC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3963633,,CHEMBL3963633,,False,http://www.openphacts.org/units/Nanomolar,2846402,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2619,338632,17716337,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(S(C)(=O)=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3970676,,CHEMBL3970676,,False,http://www.openphacts.org/units/Nanomolar,2846403,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2620,338633,17716338,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(S(=O)(=O)C4CC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3938948,,CHEMBL3938948,,False,http://www.openphacts.org/units/Nanomolar,2846404,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2621,338634,17716339,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(CC3CCOCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3962848,,CHEMBL3962848,,False,http://www.openphacts.org/units/Nanomolar,2846405,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2622,338635,17716340,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCOCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586492,,CHEMBL3586492,,False,http://www.openphacts.org/units/Nanomolar,2846406,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2623,338636,17716341,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3957868,,CHEMBL3957868,,False,http://www.openphacts.org/units/Nanomolar,2846407,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2624,338637,17716342,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(F)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3981389,,CHEMBL3981389,,False,http://www.openphacts.org/units/Nanomolar,2846408,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2625,338638,17716343,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(F)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3952633,,CHEMBL3952633,,False,http://www.openphacts.org/units/Nanomolar,2846409,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2626,338639,17716344,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(Cl)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3934835,,CHEMBL3934835,,False,http://www.openphacts.org/units/Nanomolar,2846410,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2627,338640,17716345,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(Cl)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3910472,,CHEMBL3910472,,False,http://www.openphacts.org/units/Nanomolar,2846411,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2628,338641,17716346,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C2CC2)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3897735,,CHEMBL3897735,,False,http://www.openphacts.org/units/Nanomolar,2846412,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2629,338642,17716347,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3586502,,CHEMBL3586502,,False,http://www.openphacts.org/units/Nanomolar,2846413,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2630,338643,17716348,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(C2CC2)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3955922,,CHEMBL3955922,,False,http://www.openphacts.org/units/Nanomolar,2846414,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2631,338644,17716349,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3908634,,CHEMBL3908634,,False,http://www.openphacts.org/units/Nanomolar,2846415,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2632,338645,17716350,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3899755,,CHEMBL3899755,,False,http://www.openphacts.org/units/Nanomolar,2846416,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2633,338646,17716351,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3586503,,CHEMBL3586503,,False,http://www.openphacts.org/units/Nanomolar,2846417,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2634,338647,17716352,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3912316,,CHEMBL3912316,,False,http://www.openphacts.org/units/Nanomolar,2846418,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2635,338648,17716353,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3936754,,CHEMBL3936754,,False,http://www.openphacts.org/units/Nanomolar,2846419,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2636,338649,17716354,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3913498,,CHEMBL3913498,,False,http://www.openphacts.org/units/Nanomolar,2846420,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2637,338650,17716355,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3941465,,CHEMBL3941465,,False,http://www.openphacts.org/units/Nanomolar,2846421,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2638,338651,17716356,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3918974,,CHEMBL3918974,,False,http://www.openphacts.org/units/Nanomolar,2846422,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2639,338652,17716357,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3922358,,CHEMBL3922358,,False,http://www.openphacts.org/units/Nanomolar,2846423,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2640,338653,17716358,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3904807,,CHEMBL3904807,,False,http://www.openphacts.org/units/Nanomolar,2846424,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2641,338654,17716359,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c(Cl)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3920053,,CHEMBL3920053,,False,http://www.openphacts.org/units/Nanomolar,2846425,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2642,338655,17716360,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)c(Cl)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3986856,,CHEMBL3986856,,False,http://www.openphacts.org/units/Nanomolar,2846426,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2643,338656,17716361,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1cc(F)cc(F)c1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3917117,,CHEMBL3917117,,False,http://www.openphacts.org/units/Nanomolar,2846427,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2644,338657,17716362,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1-n1nc(C2CCNCC2)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3901586,,CHEMBL3901586,,False,http://www.openphacts.org/units/Nanomolar,2846428,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2645,338658,17716363,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1-n1nc(C2CCN(C(C)C)CC2)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3926115,,CHEMBL3926115,,False,http://www.openphacts.org/units/Nanomolar,2846429,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2646,338659,17716364,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(Br)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3944066,,CHEMBL3944066,,False,http://www.openphacts.org/units/Nanomolar,2846430,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2647,338660,17716365,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(Br)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3973551,,CHEMBL3973551,,False,http://www.openphacts.org/units/Nanomolar,2846431,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2648,338661,17716366,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3949384,,CHEMBL3949384,,False,http://www.openphacts.org/units/Nanomolar,2846432,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2649,338662,17716367,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3586504,,CHEMBL3586504,,False,http://www.openphacts.org/units/Nanomolar,2846433,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2650,338663,17716368,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3586508,,CHEMBL3586508,,False,http://www.openphacts.org/units/Nanomolar,2846434,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2651,338664,17716369,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3950375,,CHEMBL3950375,,False,http://www.openphacts.org/units/Nanomolar,2846435,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2652,338665,17716370,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(CC(F)(F)F)CC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3932601,,CHEMBL3932601,,False,http://www.openphacts.org/units/Nanomolar,2846436,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2653,338666,17716371,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1c(F)cc(C2CC2)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3901098,,CHEMBL3901098,,False,http://www.openphacts.org/units/Nanomolar,2846437,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2654,338667,17716372,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1C1CCOCC1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3923644,,CHEMBL3923644,,False,http://www.openphacts.org/units/Nanomolar,2846438,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2655,338668,17716373,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3COCCN3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3926498,,CHEMBL3926498,,False,http://www.openphacts.org/units/Nanomolar,2846439,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2656,338669,17716374,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3970117,,CHEMBL3970117,,False,http://www.openphacts.org/units/Nanomolar,2846440,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2657,338670,17716375,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3894436,,CHEMBL3894436,,False,http://www.openphacts.org/units/Nanomolar,2846441,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2658,338671,17716376,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CNC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3938085,,CHEMBL3938085,,False,http://www.openphacts.org/units/Nanomolar,2846442,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2659,338672,17716377,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(S(C)(=O)=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3910160,,CHEMBL3910160,,False,http://www.openphacts.org/units/Nanomolar,2846443,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2660,338673,17716378,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(S(=O)(=O)C4CC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3902196,,CHEMBL3902196,,False,http://www.openphacts.org/units/Nanomolar,2846444,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2661,338674,17716379,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(S(=O)(=O)C4CCCC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3908242,,CHEMBL3908242,,False,http://www.openphacts.org/units/Nanomolar,2846445,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2662,338675,17716380,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COCCS(=O)(=O)N1CC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3932829,,CHEMBL3932829,,False,http://www.openphacts.org/units/Nanomolar,2846446,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2663,338676,17716381,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CNC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3894958,,CHEMBL3894958,,False,http://www.openphacts.org/units/Nanomolar,2846447,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2664,338677,17716382,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3927390,,CHEMBL3927390,,False,http://www.openphacts.org/units/Nanomolar,2846448,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2665,338678,17716383,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CN(C3CCC3)C2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3955009,,CHEMBL3955009,,False,http://www.openphacts.org/units/Nanomolar,2846449,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2666,338679,17716384,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3982787,,CHEMBL3982787,,False,http://www.openphacts.org/units/Nanomolar,2846450,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2667,338680,17716385,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3(C)CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3909414,,CHEMBL3909414,,False,http://www.openphacts.org/units/Nanomolar,2846451,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2668,338681,17716386,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3(C)CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3971526,,CHEMBL3971526,,False,http://www.openphacts.org/units/Nanomolar,2846452,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2669,338682,17716387,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3900405,,CHEMBL3900405,,False,http://www.openphacts.org/units/Nanomolar,2846453,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2670,338683,17716388,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586491,,CHEMBL3586491,,False,http://www.openphacts.org/units/Nanomolar,2846454,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2671,338684,17716389,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(NC=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3928306,,CHEMBL3928306,,False,http://www.openphacts.org/units/Nanomolar,2846455,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2672,338685,17716390,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(C(=O)N(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3940487,,CHEMBL3940487,,False,http://www.openphacts.org/units/Nanomolar,2846456,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2673,338686,17716391,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(C(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3912499,,CHEMBL3912499,,False,http://www.openphacts.org/units/Nanomolar,2846457,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2674,338687,17716392,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCS(=O)(=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3978471,,CHEMBL3978471,,False,http://www.openphacts.org/units/Nanomolar,2846458,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2675,338688,17716393,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(N[SH](=O)=O)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3917931,,CHEMBL3917931,,False,http://www.openphacts.org/units/Nanomolar,2846459,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2676,338689,17716394,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3F)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3962393,,CHEMBL3962393,,False,http://www.openphacts.org/units/Nanomolar,2846460,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2677,338690,17716395,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3954648,,CHEMBL3954648,,False,http://www.openphacts.org/units/Nanomolar,2846461,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2678,338691,17716396,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(N)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3894435,,CHEMBL3894435,,False,http://www.openphacts.org/units/Nanomolar,2846462,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2679,338692,17716397,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(NS(C)(=O)=O)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3969090,,CHEMBL3969090,,False,http://www.openphacts.org/units/Nanomolar,2846463,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2680,338693,17716398,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3904543,,CHEMBL3904543,,False,http://www.openphacts.org/units/Nanomolar,2846464,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2681,338694,17716399,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(NC=O)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3975374,,CHEMBL3975374,,False,http://www.openphacts.org/units/Nanomolar,2846465,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2682,338695,17716400,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(C4CC4)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3916738,,CHEMBL3916738,,False,http://www.openphacts.org/units/Nanomolar,2846466,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2683,338696,17716401,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3944644,,CHEMBL3944644,,False,http://www.openphacts.org/units/Nanomolar,2846467,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2684,338697,17716402,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3922205,,CHEMBL3922205,,False,http://www.openphacts.org/units/Nanomolar,2846468,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2685,338698,17716403,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCCOC4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3953368,,CHEMBL3953368,,False,http://www.openphacts.org/units/Nanomolar,2846469,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2686,338699,17716404,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3931124,,CHEMBL3931124,,False,http://www.openphacts.org/units/Nanomolar,2846470,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2687,338700,17716405,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3958620,,CHEMBL3958620,,False,http://www.openphacts.org/units/Nanomolar,2846471,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2688,338701,17716406,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(=O)CO)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3943605,,CHEMBL3943605,,False,http://www.openphacts.org/units/Nanomolar,2846472,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2689,338702,17716407,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(=O)CCN(C)C)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3969713,,CHEMBL3969713,,False,http://www.openphacts.org/units/Nanomolar,2846473,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2690,338703,17716408,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCC(=O)N1CCC(c2cc(NC(=O)c3cnn4cc(Br)cnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3909014,,CHEMBL3909014,,False,http://www.openphacts.org/units/Nanomolar,2846474,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2691,338704,17716409,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(CC(N)=O)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936946,,CHEMBL3936946,,False,http://www.openphacts.org/units/Nanomolar,2846475,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2692,338705,17716410,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(=O)C4(O)CCC4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3980126,,CHEMBL3980126,,False,http://www.openphacts.org/units/Nanomolar,2846476,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2693,338706,17716411,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(=O)C4CN(C)CCO4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3954623,,CHEMBL3954623,,False,http://www.openphacts.org/units/Nanomolar,2846477,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2694,338707,17716412,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCC(c2cc(NC(=O)c3cnn4cc(Br)cnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3972075,,CHEMBL3972075,,False,http://www.openphacts.org/units/Nanomolar,2846478,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2695,338708,17716413,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3942465,,CHEMBL3942465,,False,http://www.openphacts.org/units/Nanomolar,2846479,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2696,338709,17716414,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(NC=O)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3966782,,CHEMBL3966782,,False,http://www.openphacts.org/units/Nanomolar,2846480,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2697,338710,17716415,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1cnc2c(C(=O)Nc3cc(C4CCN(S(C)(=O)=O)CC4)nn3-c3ccc(C)cc3)cnn2c1,,,CHEMBL3886319,,2015.0,,CHEMBL3933496,,CHEMBL3933496,,False,http://www.openphacts.org/units/Nanomolar,2846481,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2698,338711,17716416,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(C)cnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3955658,,CHEMBL3955658,,False,http://www.openphacts.org/units/Nanomolar,2846482,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2699,338712,17716417,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cccnc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586488,,CHEMBL3586488,,False,http://www.openphacts.org/units/Nanomolar,2846483,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2700,338713,17716418,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cc(NC(=O)C3=c4nccc[n+]4=NC3)n(-c3ccc(C)cc3)n2)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL4108170,,CHEMBL4108170,,False,http://www.openphacts.org/units/Nanomolar,2846484,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2701,338714,17716419,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586486,,CHEMBL3586486,,False,http://www.openphacts.org/units/Nanomolar,2846485,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2702,338715,17716420,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(-c2ccncc2)nn1-c1ccc(F)cc1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3890992,,CHEMBL3890992,,False,http://www.openphacts.org/units/Nanomolar,2846486,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2703,338716,17716421,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3915495,,CHEMBL3915495,,False,http://www.openphacts.org/units/Nanomolar,2846487,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2704,338717,17716422,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1F,,,CHEMBL3886319,,2015.0,,CHEMBL3895084,,CHEMBL3895084,,False,http://www.openphacts.org/units/Nanomolar,2846488,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2705,338718,17716423,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)ccn1,,,CHEMBL3886319,,2015.0,,CHEMBL3586487,,CHEMBL3586487,,False,http://www.openphacts.org/units/Nanomolar,2846489,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2706,338719,17716424,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586490,,CHEMBL3586490,,False,http://www.openphacts.org/units/Nanomolar,2846490,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2707,338720,17716425,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586484,,CHEMBL3586484,,False,http://www.openphacts.org/units/Nanomolar,2846491,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2708,338721,17716426,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3cccc(F)c3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3892251,,CHEMBL3892251,,False,http://www.openphacts.org/units/Nanomolar,2846492,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2709,338722,17716427,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1OC,,,CHEMBL3886319,,2015.0,,CHEMBL3586485,,CHEMBL3586485,,False,http://www.openphacts.org/units/Nanomolar,2846493,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2710,338723,17716428,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3926919,,CHEMBL3926919,,False,http://www.openphacts.org/units/Nanomolar,2846494,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2711,338724,17716429,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(F)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3951115,,CHEMBL3951115,,False,http://www.openphacts.org/units/Nanomolar,2846495,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2712,338725,17716430,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cncc(F)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3919757,,CHEMBL3919757,,False,http://www.openphacts.org/units/Nanomolar,2846496,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2713,338726,17716431,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cncnc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3891709,,CHEMBL3891709,,False,http://www.openphacts.org/units/Nanomolar,2846497,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2714,338727,17716432,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3=CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3900568,,CHEMBL3900568,,False,http://www.openphacts.org/units/Nanomolar,2846498,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2715,338728,17716433,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3=CCN(S(C)(=O)=O)CC3)cc2NC(=O)C2=c3nccc[n+]3=NC2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL4106868,,CHEMBL4106868,,False,http://www.openphacts.org/units/Nanomolar,2846499,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2716,338729,17716434,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3=CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3905240,,CHEMBL3905240,,False,http://www.openphacts.org/units/Nanomolar,2846500,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2717,338730,17716435,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3976036,,CHEMBL3976036,,False,http://www.openphacts.org/units/Nanomolar,2846501,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2718,338731,17716436,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(CN3CCCC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3914235,,CHEMBL3914235,,False,http://www.openphacts.org/units/Nanomolar,2846502,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2719,338732,17716437,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(CN4CCCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3980882,,CHEMBL3980882,,False,http://www.openphacts.org/units/Nanomolar,2846503,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2720,338733,17716438,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(CN4CCN(C)CC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3927487,,CHEMBL3927487,,False,http://www.openphacts.org/units/Nanomolar,2846504,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2721,338734,17716439,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(CN4CCOCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3899446,,CHEMBL3899446,,False,http://www.openphacts.org/units/Nanomolar,2846505,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2722,338735,17716440,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C2CC2)cn1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3932967,,CHEMBL3932967,,False,http://www.openphacts.org/units/Nanomolar,2846506,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2723,338736,17716441,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3960442,,CHEMBL3960442,,False,http://www.openphacts.org/units/Nanomolar,2846507,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2724,338737,17716442,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(C2CC2)cn1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3906500,,CHEMBL3906500,,False,http://www.openphacts.org/units/Nanomolar,2846508,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2725,338738,17716443,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3586506,,CHEMBL3586506,,False,http://www.openphacts.org/units/Nanomolar,2846509,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2726,338739,17716444,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(C2CC2)cn1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3918584,,CHEMBL3918584,,False,http://www.openphacts.org/units/Nanomolar,2846510,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2727,338740,17716445,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3946452,,CHEMBL3946452,,False,http://www.openphacts.org/units/Nanomolar,2846511,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2728,338741,17716446,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3924029,,CHEMBL3924029,,False,http://www.openphacts.org/units/Nanomolar,2846512,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2729,338742,17716447,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586505,,CHEMBL3586505,,False,http://www.openphacts.org/units/Nanomolar,2846513,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2730,338743,17716448,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3899414,,CHEMBL3899414,,False,http://www.openphacts.org/units/Nanomolar,2846514,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2731,338744,17716449,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586505,,CHEMBL3586505,,False,http://www.openphacts.org/units/Nanomolar,2846513,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2732,338745,17716450,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3931420,,CHEMBL3931420,,False,http://www.openphacts.org/units/Nanomolar,2846515,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2733,338746,17716451,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(CN)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3899909,,CHEMBL3899909,,False,http://www.openphacts.org/units/Nanomolar,2846516,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2734,338747,17716452,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3922501,,CHEMBL3922501,,False,http://www.openphacts.org/units/Nanomolar,2846517,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2735,338748,17716453,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3894494,,CHEMBL3894494,,False,http://www.openphacts.org/units/Nanomolar,2846518,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2736,338749,17716454,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3945782,,CHEMBL3945782,,False,http://www.openphacts.org/units/Nanomolar,2846519,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2737,338750,17716455,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(C)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3921423,,CHEMBL3921423,,False,http://www.openphacts.org/units/Nanomolar,2846520,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2738,338751,17716456,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(CO)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3936900,,CHEMBL3936900,,False,http://www.openphacts.org/units/Nanomolar,2846521,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2739,338752,17716457,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](N)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL4107218,,CHEMBL4107218,,False,http://www.openphacts.org/units/Nanomolar,2846522,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2740,338753,17716458,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](N)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3908966,,CHEMBL3908966,,False,http://www.openphacts.org/units/Nanomolar,2846523,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2741,338754,17716459,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C=O)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3933431,,CHEMBL3933431,,False,http://www.openphacts.org/units/Nanomolar,2846524,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2742,338755,17716460,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3COCCN3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3978540,,CHEMBL3978540,,False,http://www.openphacts.org/units/Nanomolar,2846525,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2743,338756,17716461,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3949446,,CHEMBL3949446,,False,http://www.openphacts.org/units/Nanomolar,2846526,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2744,338757,17716462,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3949446,,CHEMBL3949446,,False,http://www.openphacts.org/units/Nanomolar,2846526,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2745,338758,17716463,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3933937,,CHEMBL3933937,,False,http://www.openphacts.org/units/Nanomolar,2846527,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2746,338759,17716464,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586507,,CHEMBL3586507,,False,http://www.openphacts.org/units/Nanomolar,2846528,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2747,338760,17716465,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3984189,,CHEMBL3984189,,False,http://www.openphacts.org/units/Nanomolar,2846529,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2748,338761,17716466,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3973605,,CHEMBL3973605,,False,http://www.openphacts.org/units/Nanomolar,2846530,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2749,338762,17716467,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccccn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3940677,,CHEMBL3940677,,False,http://www.openphacts.org/units/Nanomolar,2846531,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2750,338763,17716468,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1C,,,CHEMBL3886319,,2015.0,,CHEMBL3985571,,CHEMBL3985571,,False,http://www.openphacts.org/units/Nanomolar,2846532,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2751,338764,17716469,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nn(C)c2nc(-n3nc(C4CCN(S(C)(=O)=O)CC4)cc3NC(=O)c3cnn4cccnc34)ccc12,,,CHEMBL3886319,,2015.0,,CHEMBL3956904,,CHEMBL3956904,,False,http://www.openphacts.org/units/Nanomolar,2846533,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2752,338765,17716470,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(CN)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3963960,,CHEMBL3963960,,False,http://www.openphacts.org/units/Nanomolar,2846534,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2753,338766,17716471,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)cc2NC(=O)c2ncn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3968759,,CHEMBL3968759,,False,http://www.openphacts.org/units/Nanomolar,2846535,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2754,338767,17716472,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3962404,,CHEMBL3962404,,False,http://www.openphacts.org/units/Nanomolar,2846536,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2755,338768,17716473,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cn3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3945877,,CHEMBL3945877,,False,http://www.openphacts.org/units/Nanomolar,2846537,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2756,338769,17716474,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3909061,,CHEMBL3909061,,False,http://www.openphacts.org/units/Nanomolar,2846538,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2757,338770,17716475,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3903061,,CHEMBL3903061,,False,http://www.openphacts.org/units/Nanomolar,2846539,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2758,338771,17716476,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(NC(=O)c2cnn3cccnc23)n(-c2ccc(C)cn2)n1,,,CHEMBL3886319,,2015.0,,CHEMBL3920387,,CHEMBL3920387,,False,http://www.openphacts.org/units/Nanomolar,2846540,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2759,338772,17716477,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)NCC1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3931506,,CHEMBL3931506,,False,http://www.openphacts.org/units/Nanomolar,2846541,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2760,338773,17716478,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(CN)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3938253,,CHEMBL3938253,,False,http://www.openphacts.org/units/Nanomolar,2846542,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2761,338774,17716479,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCC(N)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3962169,,CHEMBL3962169,,False,http://www.openphacts.org/units/Nanomolar,2846543,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2762,338775,17716480,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(CCN)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3913530,,CHEMBL3913530,,False,http://www.openphacts.org/units/Nanomolar,2846544,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2763,338776,17716481,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ncc[nH]3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3903995,,CHEMBL3903995,,False,http://www.openphacts.org/units/Nanomolar,2846545,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2764,338777,17716482,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3nccn3S(C)(=O)=O)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3904526,,CHEMBL3904526,,False,http://www.openphacts.org/units/Nanomolar,2846546,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2765,338778,17716483,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCNCC2)nn1-c1nccs1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3975355,,CHEMBL3975355,,False,http://www.openphacts.org/units/Nanomolar,2846547,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2766,338779,17716484,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3958433,,CHEMBL3958433,,False,http://www.openphacts.org/units/Nanomolar,2846548,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2767,338780,17716485,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1cnc2c(C(=O)Nc3cc(C4CCN(S(C)(=O)=O)CC4)nn3-c3ccc(C)cn3)cnn2c1,,,CHEMBL3886319,,2015.0,,CHEMBL3964623,,CHEMBL3964623,,False,http://www.openphacts.org/units/Nanomolar,2846549,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2768,338781,17716486,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(NC=O)cnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3890086,,CHEMBL3890086,,False,http://www.openphacts.org/units/Nanomolar,2846550,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2769,338782,17716487,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C#Cc1cnc2c(C(=O)Nc3cc(C4CCN(S(C)(=O)=O)CC4)nn3-c3ccc(C)cn3)cnn2c1,,,CHEMBL3886319,,2015.0,,CHEMBL3920512,,CHEMBL3920512,,False,http://www.openphacts.org/units/Nanomolar,2846551,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2770,338783,17716488,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cc(Br)cnc34)n(-c3ccc(C)cn3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3976316,,CHEMBL3976316,,False,http://www.openphacts.org/units/Nanomolar,2846552,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2771,338784,17716489,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cc(C5CC5)cnc34)n(-c3ccc(C)cn3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3950439,,CHEMBL3950439,,False,http://www.openphacts.org/units/Nanomolar,2846553,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2772,338785,17716490,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(NC(=O)c3cnn4cc(Cl)cnc34)n(-c3ccc(C)cn3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3927995,,CHEMBL3927995,,False,http://www.openphacts.org/units/Nanomolar,2846554,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2773,338786,17716491,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3898528,,CHEMBL3898528,,False,http://www.openphacts.org/units/Nanomolar,2846555,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2774,338787,17716492,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586510,,CHEMBL3586510,,False,http://www.openphacts.org/units/Nanomolar,2846556,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2775,338788,17716493,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586511,,CHEMBL3586511,,False,http://www.openphacts.org/units/Nanomolar,2846557,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2776,338789,17716494,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586511,,CHEMBL3586511,,False,http://www.openphacts.org/units/Nanomolar,2846557,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2777,338790,17716495,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3972016,,CHEMBL3972016,,False,http://www.openphacts.org/units/Nanomolar,2846558,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2778,338791,17716496,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCOCC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3954582,,CHEMBL3954582,,False,http://www.openphacts.org/units/Nanomolar,2846559,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2779,338792,17716497,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3980091,,CHEMBL3980091,,False,http://www.openphacts.org/units/Nanomolar,2846560,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2780,338793,17716498,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3920277,,CHEMBL3920277,,False,http://www.openphacts.org/units/Nanomolar,2846561,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2781,338794,17716499,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCN(C)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3948096,,CHEMBL3948096,,False,http://www.openphacts.org/units/Nanomolar,2846562,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2782,338795,17716500,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936996,,CHEMBL3936996,,False,http://www.openphacts.org/units/Nanomolar,2846563,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2783,338796,17716501,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)N1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3909063,,CHEMBL3909063,,False,http://www.openphacts.org/units/Nanomolar,2846564,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2784,338797,17716502,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3909526,,CHEMBL3909526,,False,http://www.openphacts.org/units/Nanomolar,2846565,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2785,338798,17716503,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3914414,,CHEMBL3914414,,False,http://www.openphacts.org/units/Nanomolar,2846566,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2786,338799,17716504,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3980194,,CHEMBL3980194,,False,http://www.openphacts.org/units/Nanomolar,2846567,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2787,338800,17716505,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COCC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3951282,,CHEMBL3951282,,False,http://www.openphacts.org/units/Nanomolar,2846568,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2788,338801,17716506,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)c4ncccc4F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3898449,,CHEMBL3898449,,False,http://www.openphacts.org/units/Nanomolar,2846569,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2789,338802,17716507,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C(=O)N4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3965902,,CHEMBL3965902,,False,http://www.openphacts.org/units/Nanomolar,2846570,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2790,338803,17716508,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C(=O)N4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3901110,,CHEMBL3901110,,False,http://www.openphacts.org/units/Nanomolar,2846571,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2791,338804,17716509,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)c4cccc(F)n4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3972248,,CHEMBL3972248,,False,http://www.openphacts.org/units/Nanomolar,2846572,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2792,338805,17716510,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCN(C5CC5)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3974126,,CHEMBL3974126,,False,http://www.openphacts.org/units/Nanomolar,2846573,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2793,338806,17716511,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)c4nccs4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3934792,,CHEMBL3934792,,False,http://www.openphacts.org/units/Nanomolar,2846574,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2794,338807,17716512,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4ccccc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3968849,,CHEMBL3968849,,False,http://www.openphacts.org/units/Nanomolar,2846575,>,37,True,>,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2795,338808,17716513,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(CC(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3897686,,CHEMBL3897686,,False,http://www.openphacts.org/units/Nanomolar,2846576,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2796,338809,17716514,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3924798,,CHEMBL3924798,,False,http://www.openphacts.org/units/Nanomolar,2846577,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2797,338810,17716515,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(CC4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3955114,,CHEMBL3955114,,False,http://www.openphacts.org/units/Nanomolar,2846578,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2798,338811,17716516,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4nccs4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3912320,,CHEMBL3912320,,False,http://www.openphacts.org/units/Nanomolar,2846579,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2799,338812,17716517,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4ccsc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3940314,,CHEMBL3940314,,False,http://www.openphacts.org/units/Nanomolar,2846580,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2800,338813,17716518,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4ccncc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936851,,CHEMBL3936851,,False,http://www.openphacts.org/units/Nanomolar,2846581,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2801,338814,17716519,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4cccnc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3969956,,CHEMBL3969956,,False,http://www.openphacts.org/units/Nanomolar,2846582,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2802,338815,17716520,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4ccccn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3929117,,CHEMBL3929117,,False,http://www.openphacts.org/units/Nanomolar,2846583,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2803,338816,17716521,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CN2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3897604,,CHEMBL3897604,,False,http://www.openphacts.org/units/Nanomolar,2846584,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2804,338817,17716522,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(CC4CCOC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3920200,,CHEMBL3920200,,False,http://www.openphacts.org/units/Nanomolar,2846585,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2805,338818,17716523,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4cncs4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3892202,,CHEMBL3892202,,False,http://www.openphacts.org/units/Nanomolar,2846586,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2806,338819,17716524,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4ccn[nH]4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3915439,,CHEMBL3915439,,False,http://www.openphacts.org/units/Nanomolar,2846587,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2807,338820,17716525,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4cscn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3890937,,CHEMBL3890937,,False,http://www.openphacts.org/units/Nanomolar,2846588,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2808,338821,17716526,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4ncco4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3934570,,CHEMBL3934570,,False,http://www.openphacts.org/units/Nanomolar,2846589,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2809,338822,17716527,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(Cc4cn[nH]c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3906601,,CHEMBL3906601,,False,http://www.openphacts.org/units/Nanomolar,2846590,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2810,338823,17716528,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CNC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3963677,,CHEMBL3963677,,False,http://www.openphacts.org/units/Nanomolar,2846591,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2811,338824,17716529,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)NC(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3905346,,CHEMBL3905346,,False,http://www.openphacts.org/units/Nanomolar,2846592,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2812,338825,17716530,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)NC(C)(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936608,,CHEMBL3936608,,False,http://www.openphacts.org/units/Nanomolar,2846593,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2813,338826,17716531,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3966402,,CHEMBL3966402,,False,http://www.openphacts.org/units/Nanomolar,2846594,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2814,338827,17716532,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3948951,,CHEMBL3948951,,False,http://www.openphacts.org/units/Nanomolar,2846595,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2815,338828,17716533,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3974894,,CHEMBL3974894,,False,http://www.openphacts.org/units/Nanomolar,2846596,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2816,338829,17716534,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)OC(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3894089,,CHEMBL3894089,,False,http://www.openphacts.org/units/Nanomolar,2846597,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2817,338830,17716535,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)OCCF)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3922099,,CHEMBL3922099,,False,http://www.openphacts.org/units/Nanomolar,2846598,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2818,338831,17716536,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3899478,,CHEMBL3899478,,False,http://www.openphacts.org/units/Nanomolar,2846599,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2819,338832,17716537,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCS(=O)(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3958640,,CHEMBL3958640,,False,http://www.openphacts.org/units/Nanomolar,2846600,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2820,338833,17716538,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(S(C)(=O)=O)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3971750,,CHEMBL3971750,,False,http://www.openphacts.org/units/Nanomolar,2846601,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2821,338834,17716539,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(S(=O)(=O)C5CC5)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3900598,,CHEMBL3900598,,False,http://www.openphacts.org/units/Nanomolar,2846602,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2822,338835,17716540,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(S(=O)(=O)C(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3966073,,CHEMBL3966073,,False,http://www.openphacts.org/units/Nanomolar,2846603,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2823,338836,17716541,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(S(=O)(=O)CF)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936244,,CHEMBL3936244,,False,http://www.openphacts.org/units/Nanomolar,2846604,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2824,338837,17716542,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3974589,,CHEMBL3974589,,False,http://www.openphacts.org/units/Nanomolar,2846605,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2825,338838,17716543,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3948588,,CHEMBL3948588,,False,http://www.openphacts.org/units/Nanomolar,2846606,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2826,338839,17716544,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(C(F)(F)F)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3949661,,CHEMBL3949661,,False,http://www.openphacts.org/units/Nanomolar,2846607,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2827,338840,17716545,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(N(C)S(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3921884,,CHEMBL3921884,,False,http://www.openphacts.org/units/Nanomolar,2846608,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2828,338841,17716546,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(NS(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3958308,,CHEMBL3958308,,False,http://www.openphacts.org/units/Nanomolar,2846609,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2829,338842,17716547,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(C#N)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3927286,,CHEMBL3927286,,False,http://www.openphacts.org/units/Nanomolar,2846610,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2830,338843,17716548,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC5CC54)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3900252,,CHEMBL3900252,,False,http://www.openphacts.org/units/Nanomolar,2846611,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2831,338844,17716549,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC5(CCC(=O)N5)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3971390,,CHEMBL3971390,,False,http://www.openphacts.org/units/Nanomolar,2846612,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2832,338845,17716550,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CC(C(C)(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3980247,,CHEMBL3980247,,False,http://www.openphacts.org/units/Nanomolar,2846613,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2833,338846,17716551,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CC5(CCCC5)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3906519,,CHEMBL3906519,,False,http://www.openphacts.org/units/Nanomolar,2846614,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2834,338847,17716552,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CC(C#N)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3968683,,CHEMBL3968683,,False,http://www.openphacts.org/units/Nanomolar,2846615,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2835,338848,17716553,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(F)(F)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3897519,,CHEMBL3897519,,False,http://www.openphacts.org/units/Nanomolar,2846616,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2836,338849,17716554,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)CC(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3911353,,CHEMBL3911353,,False,http://www.openphacts.org/units/Nanomolar,2846617,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2837,338850,17716555,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)OC(C)(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3905205,,CHEMBL3905205,,False,http://www.openphacts.org/units/Nanomolar,2846618,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2838,338851,17716556,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(N(C)S(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3952402,,CHEMBL3952402,,False,http://www.openphacts.org/units/Nanomolar,2846619,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2839,338852,17716557,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(NS(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3981196,,CHEMBL3981196,,False,http://www.openphacts.org/units/Nanomolar,2846620,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2840,338853,17716558,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCCOC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3943689,,CHEMBL3943689,,False,http://www.openphacts.org/units/Nanomolar,2846621,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2841,338854,17716559,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(C#N)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3969785,,CHEMBL3969785,,False,http://www.openphacts.org/units/Nanomolar,2846622,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2842,338855,17716560,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(C2CCN(C3CCN(c4ccc(F)cc4)C3)CC2)nn1-c1ccccn1)c1cnn2cccnc12,,,CHEMBL3886319,,2015.0,,CHEMBL3946284,,CHEMBL3946284,,False,http://www.openphacts.org/units/Nanomolar,2846623,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2843,338856,17716561,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCN(C5CC5)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3920485,,CHEMBL3920485,,False,http://www.openphacts.org/units/Nanomolar,2846624,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2844,338857,17716562,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCc5ccncc5C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3937404,,CHEMBL3937404,,False,http://www.openphacts.org/units/Nanomolar,2846625,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2845,338858,17716563,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CC(N(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3909465,,CHEMBL3909465,,False,http://www.openphacts.org/units/Nanomolar,2846626,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2846,338859,17716564,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3586509,,CHEMBL3586509,,False,http://www.openphacts.org/units/Nanomolar,2846627,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2847,338860,17716565,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(C(F)(F)F)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936302,,CHEMBL3936302,,False,http://www.openphacts.org/units/Nanomolar,2846628,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2848,338861,17716566,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC(C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3951560,,CHEMBL3951560,,False,http://www.openphacts.org/units/Nanomolar,2846629,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2849,338862,17716567,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CC[C@@H](C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL4109386,,CHEMBL4109386,,False,http://www.openphacts.org/units/Nanomolar,2846630,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2850,338863,17716568,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3912863,,CHEMBL3912863,,False,http://www.openphacts.org/units/Nanomolar,2846631,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2851,338864,17716569,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCN(C)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3950483,,CHEMBL3950483,,False,http://www.openphacts.org/units/Nanomolar,2846632,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2852,338865,17716570,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)N1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cn4)n3)CC2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3908856,,CHEMBL3908856,,False,http://www.openphacts.org/units/Nanomolar,2846633,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2853,338866,17716571,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCCC(C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936809,,CHEMBL3936809,,False,http://www.openphacts.org/units/Nanomolar,2846634,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2854,338867,17716572,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(CC(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3921310,,CHEMBL3921310,,False,http://www.openphacts.org/units/Nanomolar,2846635,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2855,338868,17716573,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cn4)n3)CC2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3945694,,CHEMBL3945694,,False,http://www.openphacts.org/units/Nanomolar,2846636,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2856,338869,17716574,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cn3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3894394,,CHEMBL3894394,,False,http://www.openphacts.org/units/Nanomolar,2846637,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2857,338870,17716575,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(CC4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3922407,,CHEMBL3922407,,False,http://www.openphacts.org/units/Nanomolar,2846638,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2858,338871,17716576,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4Cc5ccccc5C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3899809,,CHEMBL3899809,,False,http://www.openphacts.org/units/Nanomolar,2846639,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2859,338872,17716577,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(CC4CCOC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3931326,,CHEMBL3931326,,False,http://www.openphacts.org/units/Nanomolar,2846640,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2860,338873,17716578,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4cncs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3942315,,CHEMBL3942315,,False,http://www.openphacts.org/units/Nanomolar,2846641,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2861,338874,17716579,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ccc5c(c4)C(=O)NC5)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3984714,,CHEMBL3984714,,False,http://www.openphacts.org/units/Nanomolar,2846642,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2862,338875,17716580,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4cnc(N(C)C)s4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3956292,,CHEMBL3956292,,False,http://www.openphacts.org/units/Nanomolar,2846643,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2863,338876,17716581,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ccn[nH]4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3928721,,CHEMBL3928721,,False,http://www.openphacts.org/units/Nanomolar,2846644,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2864,338877,17716582,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4cscn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3967389,,CHEMBL3967389,,False,http://www.openphacts.org/units/Nanomolar,2846645,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2865,338878,17716583,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ncco4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3934160,,CHEMBL3934160,,False,http://www.openphacts.org/units/Nanomolar,2846646,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2866,338879,17716584,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4cccnc4F)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3972693,,CHEMBL3972693,,False,http://www.openphacts.org/units/Nanomolar,2846647,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2867,338880,17716585,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncc(CN2CCCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3943129,,CHEMBL3943129,,False,http://www.openphacts.org/units/Nanomolar,2846648,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2868,338881,17716586,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ccc(F)cn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3980732,,CHEMBL3980732,,False,http://www.openphacts.org/units/Nanomolar,2846649,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2869,338882,17716587,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ccc(C5(C#N)COC5)cc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL4114655,,CHEMBL4114655,,False,http://www.openphacts.org/units/Nanomolar,2846650,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2870,338883,17716588,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4cn[nH]c4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3892745,,CHEMBL3892745,,False,http://www.openphacts.org/units/Nanomolar,2846651,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2871,338884,17716589,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4cccc5c4CNC5=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3961746,,CHEMBL3961746,,False,http://www.openphacts.org/units/Nanomolar,2846652,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2872,338885,17716590,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ccc(S(C)(=O)=O)cc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3926943,,CHEMBL3926943,,False,http://www.openphacts.org/units/Nanomolar,2846653,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2873,338886,17716591,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(CC4CC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3957973,,CHEMBL3957973,,False,http://www.openphacts.org/units/Nanomolar,2846654,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2874,338887,17716592,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4nccs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3921515,,CHEMBL3921515,,False,http://www.openphacts.org/units/Nanomolar,2846655,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2875,338888,17716593,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ccncc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3949312,,CHEMBL3949312,,False,http://www.openphacts.org/units/Nanomolar,2846656,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2876,338889,17716594,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4cccnc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3948235,,CHEMBL3948235,,False,http://www.openphacts.org/units/Nanomolar,2846657,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2877,338890,17716595,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCCN(Cc4ccccn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3974264,,CHEMBL3974264,,False,http://www.openphacts.org/units/Nanomolar,2846658,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2878,338891,17716596,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CN2CCCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3935887,,CHEMBL3935887,,False,http://www.openphacts.org/units/Nanomolar,2846659,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2879,338892,17716597,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1nccc1CN1CCCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3965787,,CHEMBL3965787,,False,http://www.openphacts.org/units/Nanomolar,2846660,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2880,338893,17716598,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4cnccn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3959961,,CHEMBL3959961,,False,http://www.openphacts.org/units/Nanomolar,2846661,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2881,338894,17716599,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4cn[nH]c4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3894449,,CHEMBL3894449,,False,http://www.openphacts.org/units/Nanomolar,2846662,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2882,338895,17716600,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4ccn[nH]4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3941904,,CHEMBL3941904,,False,http://www.openphacts.org/units/Nanomolar,2846663,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2883,338896,17716601,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4nccs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3972812,,CHEMBL3972812,,False,http://www.openphacts.org/units/Nanomolar,2846664,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2884,338897,17716602,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4ccccn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3986993,,CHEMBL3986993,,False,http://www.openphacts.org/units/Nanomolar,2846665,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2885,338898,17716603,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4ccncc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3958291,,CHEMBL3958291,,False,http://www.openphacts.org/units/Nanomolar,2846666,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2886,338899,17716604,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4cncnc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3981799,,CHEMBL3981799,,False,http://www.openphacts.org/units/Nanomolar,2846667,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2887,338900,17716605,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4cc(C)on4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3921734,,CHEMBL3921734,,False,http://www.openphacts.org/units/Nanomolar,2846668,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2888,338901,17716606,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4cncs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3944185,,CHEMBL3944185,,False,http://www.openphacts.org/units/Nanomolar,2846669,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2889,338902,17716607,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncccc1CN1CC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)C1,,,CHEMBL3886319,,2015.0,,CHEMBL3952252,,CHEMBL3952252,,False,http://www.openphacts.org/units/Nanomolar,2846670,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2890,338903,17716608,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4cccnc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3931740,,CHEMBL3931740,,False,http://www.openphacts.org/units/Nanomolar,2846671,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2891,338904,17716609,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(CN2CC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)n1,,,CHEMBL3886319,,2015.0,,CHEMBL3898670,,CHEMBL3898670,,False,http://www.openphacts.org/units/Nanomolar,2846672,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2892,338905,17716610,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4ncco4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3909042,,CHEMBL3909042,,False,http://www.openphacts.org/units/Nanomolar,2846673,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2893,338906,17716611,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncc(CN2CC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3936975,,CHEMBL3936975,,False,http://www.openphacts.org/units/Nanomolar,2846674,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2894,338907,17716612,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CN(Cc4cocn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3914393,,CHEMBL3914393,,False,http://www.openphacts.org/units/Nanomolar,2846675,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2895,338908,17716613,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3975331,,CHEMBL3975331,,False,http://www.openphacts.org/units/Nanomolar,2846676,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2896,338909,17716614,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3353209,,CHEMBL3353209,,True,http://www.openphacts.org/units/Nanomolar,2846677,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2897,338910,17716615,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3353208,,CHEMBL3353208,,True,http://www.openphacts.org/units/Nanomolar,2846678,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2898,338911,17716616,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3353207,,CHEMBL3353207,,True,http://www.openphacts.org/units/Nanomolar,2846679,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2899,338912,17716617,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3951256,,CHEMBL3951256,,False,http://www.openphacts.org/units/Nanomolar,2846680,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2900,338913,17716618,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(N3CCN(CC(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3963318,,CHEMBL3963318,,False,http://www.openphacts.org/units/Nanomolar,2846681,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2901,338914,17716619,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3892790,,CHEMBL3892790,,False,http://www.openphacts.org/units/Nanomolar,2846399,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2902,338915,17716620,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cnn(C)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3890904,,CHEMBL3890904,,False,http://www.openphacts.org/units/Nanomolar,2846682,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2903,338916,17716621,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cncc(N4CCN(C)CC4)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3972219,,CHEMBL3972219,,False,http://www.openphacts.org/units/Nanomolar,2846683,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2904,338917,17716622,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccnc(CN4CCCCC4)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3901086,,CHEMBL3901086,,False,http://www.openphacts.org/units/Nanomolar,2846684,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2905,338918,17716623,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccnc(CO)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3906006,,CHEMBL3906006,,False,http://www.openphacts.org/units/Nanomolar,2846685,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2906,338919,17716624,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(CO)nc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3918603,,CHEMBL3918603,,False,http://www.openphacts.org/units/Nanomolar,2846686,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2907,338920,17716625,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccnn3C)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3914986,,CHEMBL3914986,,False,http://www.openphacts.org/units/Nanomolar,2846687,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2908,338921,17716626,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cncc(CO)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3890521,,CHEMBL3890521,,False,http://www.openphacts.org/units/Nanomolar,2846688,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2909,338922,17716627,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cnn(CCS(C)(=O)=O)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3891604,,CHEMBL3891604,,False,http://www.openphacts.org/units/Nanomolar,2846689,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2910,338923,17716628,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3conc3C)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3960624,,CHEMBL3960624,,False,http://www.openphacts.org/units/Nanomolar,2846690,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2911,338924,17716629,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3csc(N4CCOCC4)n3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3900596,,CHEMBL3900596,,False,http://www.openphacts.org/units/Nanomolar,2846691,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2912,338925,17716630,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)C4CC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3961753,,CHEMBL3961753,,False,http://www.openphacts.org/units/Nanomolar,2846692,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2913,338926,17716631,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(=O)n(C)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3971655,,CHEMBL3971655,,False,http://www.openphacts.org/units/Nanomolar,2846693,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2914,338927,17716632,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(C)(=O)=O)cc3C(F)(F)F)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,"{'bei': '12.95', 'le': '0.25', 'lle': '2.43', 'sei': '6.29'}",CHEMBL3942073,,CHEMBL3942073,7.00,False,http://www.openphacts.org/units/Nanomolar,2846694,=,37,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2915,338928,17716633,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3c(F)cccc3OCc3ccccc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3945695,,CHEMBL3945695,,False,http://www.openphacts.org/units/Nanomolar,2846695,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2916,338929,17716634,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)S(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)c(C)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3971842,,CHEMBL3971842,,False,http://www.openphacts.org/units/Nanomolar,2846696,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2917,338930,17716635,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)C(C)C)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3933253,,CHEMBL3933253,,False,http://www.openphacts.org/units/Nanomolar,2846697,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2918,338931,17716636,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3960718,,CHEMBL3960718,,False,http://www.openphacts.org/units/Nanomolar,2846698,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2919,338932,17716637,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)S(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3924317,,CHEMBL3924317,,False,http://www.openphacts.org/units/Nanomolar,2846699,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2920,338933,17716638,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3955427,,CHEMBL3955427,,False,http://www.openphacts.org/units/Nanomolar,2846700,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2921,338934,17716639,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N(C)C)cc3C)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3918899,,CHEMBL3918899,,False,http://www.openphacts.org/units/Nanomolar,2846701,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2922,338935,17716640,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3cccc(NS(C)(=O)=O)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3946723,,CHEMBL3946723,,False,http://www.openphacts.org/units/Nanomolar,2846702,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2923,338936,17716641,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CNS(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3912286,,CHEMBL3912286,,False,http://www.openphacts.org/units/Nanomolar,2846703,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2924,338937,17716642,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3985685,,CHEMBL3985685,,False,http://www.openphacts.org/units/Nanomolar,2846704,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2925,338938,17716643,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(C(=O)N(C)C)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3909327,,CHEMBL3909327,,False,http://www.openphacts.org/units/Nanomolar,2846705,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2926,338939,17716644,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3973751,,CHEMBL3973751,,False,http://www.openphacts.org/units/Nanomolar,2846706,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2927,338940,17716645,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(C)(=O)=O)nc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3897287,,CHEMBL3897287,,False,http://www.openphacts.org/units/Nanomolar,2846707,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2928,338941,17716646,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCS(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3968413,,CHEMBL3968413,,False,http://www.openphacts.org/units/Nanomolar,2846708,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2929,338942,17716647,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N(C)C)cc3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3892596,,CHEMBL3892596,,False,http://www.openphacts.org/units/Nanomolar,2846709,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2930,338943,17716648,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3=CC(=O)N(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3967335,,CHEMBL3967335,,False,http://www.openphacts.org/units/Nanomolar,2846710,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2931,338944,17716649,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(-c3ccnc(N)c3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3981649,,CHEMBL3981649,,False,http://www.openphacts.org/units/Nanomolar,2846711,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2932,338945,17716650,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4noc5ccccc45)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3964604,,CHEMBL3964604,,False,http://www.openphacts.org/units/Nanomolar,2846712,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2933,338946,17716651,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc5ccccc45)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3971677,,CHEMBL3971677,,False,http://www.openphacts.org/units/Nanomolar,2846713,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2934,338947,17716652,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4ccncc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3969158,,CHEMBL3969158,,False,http://www.openphacts.org/units/Nanomolar,2846714,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2935,338948,17716653,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cc1OC,,,CHEMBL3886319,,2015.0,,CHEMBL3938166,,CHEMBL3938166,,False,http://www.openphacts.org/units/Nanomolar,2846715,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2936,338949,17716654,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cc(F)cc(F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3967745,,CHEMBL3967745,,False,http://www.openphacts.org/units/Nanomolar,2846716,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2937,338950,17716655,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC[S+]([O-])N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3950362,,CHEMBL3950362,,False,http://www.openphacts.org/units/Nanomolar,2846717,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2938,338951,17716656,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccccc4C#N)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3976249,,CHEMBL3976249,,False,http://www.openphacts.org/units/Nanomolar,2846718,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2939,338952,17716657,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])CCC(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3899780,,CHEMBL3899780,,False,http://www.openphacts.org/units/Nanomolar,2846719,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2940,338953,17716658,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4sc(C)nc4C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3964132,,CHEMBL3964132,,False,http://www.openphacts.org/units/Nanomolar,2846720,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2941,338954,17716659,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(F)c(F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3932526,,CHEMBL3932526,,False,http://www.openphacts.org/units/Nanomolar,2846721,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2942,338955,17716660,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(F)cc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3960163,,CHEMBL3960163,,False,http://www.openphacts.org/units/Nanomolar,2846722,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2943,338956,17716661,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3945811,,CHEMBL3945811,,False,http://www.openphacts.org/units/Nanomolar,2846723,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2944,338957,17716662,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3975182,,CHEMBL3975182,,False,http://www.openphacts.org/units/Nanomolar,2846724,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2945,338958,17716663,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCCC[S+]([O-])N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3894684,,CHEMBL3894684,,False,http://www.openphacts.org/units/Nanomolar,2846725,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2946,338959,17716664,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(F)cc4F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3926214,,CHEMBL3926214,,False,http://www.openphacts.org/units/Nanomolar,2846726,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2947,338960,17716665,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(C(F)(F)F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3986973,,CHEMBL3986973,,False,http://www.openphacts.org/units/Nanomolar,2846727,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2948,338961,17716666,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)c(OC)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3917215,,CHEMBL3917215,,False,http://www.openphacts.org/units/Nanomolar,2846728,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2949,338962,17716667,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])C4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3916129,,CHEMBL3916129,,False,http://www.openphacts.org/units/Nanomolar,2846729,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2950,338963,17716668,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(C#N)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3940643,,CHEMBL3940643,,False,http://www.openphacts.org/units/Nanomolar,2846730,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2951,338964,17716669,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cnn(C)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3903627,,CHEMBL3903627,,False,http://www.openphacts.org/units/Nanomolar,2846731,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2952,338965,17716670,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cn(C)cn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3947203,,CHEMBL3947203,,False,http://www.openphacts.org/units/Nanomolar,2846732,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2953,338966,17716671,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc5ccccc5c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3926793,,CHEMBL3926793,,False,http://www.openphacts.org/units/Nanomolar,2846733,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2954,338967,17716672,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccccc4F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3959174,,CHEMBL3959174,,False,http://www.openphacts.org/units/Nanomolar,2846734,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2955,338968,17716673,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3937335,,CHEMBL3937335,,False,http://www.openphacts.org/units/Nanomolar,2846735,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2956,338969,17716674,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(C#N)cc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3909398,,CHEMBL3909398,,False,http://www.openphacts.org/units/Nanomolar,2846736,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2957,338970,17716675,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(C(F)(F)F)cc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3946225,,CHEMBL3946225,,False,http://www.openphacts.org/units/Nanomolar,2846737,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2958,338971,17716676,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(Cl)nc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3914760,,CHEMBL3914760,,False,http://www.openphacts.org/units/Nanomolar,2846738,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2959,338972,17716677,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(N5CCOCC5)nc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3951493,,CHEMBL3951493,,False,http://www.openphacts.org/units/Nanomolar,2846739,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2960,338973,17716678,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc5ncsc5c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3923780,,CHEMBL3923780,,False,http://www.openphacts.org/units/Nanomolar,2846740,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2961,338974,17716679,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)c1,,,CHEMBL3886319,,2015.0,,CHEMBL3926860,,CHEMBL3926860,,False,http://www.openphacts.org/units/Nanomolar,2846741,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2962,338975,17716680,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cn(C)c(C)n4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3936227,,CHEMBL3936227,,False,http://www.openphacts.org/units/Nanomolar,2846742,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2963,338976,17716681,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4ccccc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3972442,,CHEMBL3972442,,False,http://www.openphacts.org/units/Nanomolar,2846743,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2964,338977,17716682,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccnc4Cl)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3942826,,CHEMBL3942826,,False,http://www.openphacts.org/units/Nanomolar,2846744,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2965,338978,17716683,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cn1,,,CHEMBL3886319,,2015.0,,CHEMBL3955046,,CHEMBL3955046,,False,http://www.openphacts.org/units/Nanomolar,2846745,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2966,338979,17716684,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4c(Cl)cccc4Cl)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3983691,,CHEMBL3983691,,False,http://www.openphacts.org/units/Nanomolar,2846746,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2967,338980,17716685,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(Cl)cc4Cl)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3969501,,CHEMBL3969501,,False,http://www.openphacts.org/units/Nanomolar,2846747,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2968,338981,17716686,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4cccnc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3894857,,CHEMBL3894857,,False,http://www.openphacts.org/units/Nanomolar,2846748,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2969,338982,17716687,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(Cl)s4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3941016,,CHEMBL3941016,,False,http://www.openphacts.org/units/Nanomolar,2846749,>,37,True,>,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2970,338983,17716688,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(C(F)(F)F)n4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3970564,,CHEMBL3970564,,False,http://www.openphacts.org/units/Nanomolar,2846750,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2971,338984,17716689,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])CCc4ccccc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3946350,,CHEMBL3946350,,False,http://www.openphacts.org/units/Nanomolar,2846751,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2972,338985,17716690,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc5cccnc45)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3978837,,CHEMBL3978837,,False,http://www.openphacts.org/units/Nanomolar,2846752,<,37,True,<,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1000.0
2973,338986,17716691,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4ccccn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886319,,2015.0,,CHEMBL3891363,,CHEMBL3891363,,False,http://www.openphacts.org/units/Nanomolar,2846753,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2974,338987,17716692,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1,,,CHEMBL3886319,,2015.0,,CHEMBL3919434,,CHEMBL3919434,,False,http://www.openphacts.org/units/Nanomolar,2846754,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2975,338988,17716693,[],CHEMBL3887430,"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1,,,CHEMBL3886319,,2015.0,,CHEMBL3972360,,CHEMBL3972360,,False,http://www.openphacts.org/units/Nanomolar,2846755,<,37,True,<,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
2976,360843,17736426,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc[nH]1,,,CHEMBL3886488,,2016.0,"{'bei': '21.62', 'le': '0.42', 'lle': '3.56', 'sei': '8.31'}",CHEMBL3898966,,CHEMBL3898966,7.60,False,http://www.openphacts.org/units/Nanomolar,2859042,=,37,True,=,,IC50,nM,,25.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.3
2977,360844,17736427,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1-c1nnc(C(=O)N2CC[C@@H](O)C2)s1,,,CHEMBL3886488,,2016.0,"{'bei': '17.82', 'le': '0.36', 'lle': '5.22', 'sei': '6.67'}",CHEMBL3906505,,CHEMBL3906505,8.60,False,http://www.openphacts.org/units/Nanomolar,2859043,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
2978,360845,17736428,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CCC(O)C2)s1,,,CHEMBL3886488,,2016.0,"{'bei': '17.76', 'le': '0.35', 'lle': '4.57', 'sei': '7.36'}",CHEMBL3934248,,CHEMBL3934248,8.55,False,http://www.openphacts.org/units/Nanomolar,2859044,=,37,True,=,,IC50,nM,,2.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.8
2979,360846,17736429,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CCC(O)C2)s1,,,CHEMBL3886488,,2016.0,"{'bei': '17.64', 'le': '0.35', 'lle': '4.51', 'sei': '7.31'}",CHEMBL3934248,,CHEMBL3934248,8.49,False,http://www.openphacts.org/units/Nanomolar,2859044,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
2980,360847,17736430,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NC1CCN(C(=O)c2nnc(-c3cnc(Nc4ccc5ncsc5c4)cc3NC(C)C)s2)C1,,,CHEMBL3886488,,2016.0,"{'bei': '16.23', 'le': '0.32', 'lle': '4.36', 'sei': '6.78'}",CHEMBL3907736,,CHEMBL3907736,8.48,False,http://www.openphacts.org/units/Nanomolar,2859045,=,37,True,=,,IC50,nM,,3.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.3
2981,360848,17736431,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc(Nc2cc(Nc3ccc4ncsc4c3)ncc2-c2nnc(C(=O)N3CC[C@@H](O)C3)s2)cc1,,,CHEMBL3886488,,2016.0,"{'bei': '14.83', 'le': '0.29', 'lle': '4.23', 'sei': '5.85'}",CHEMBL3935695,,CHEMBL3935695,8.49,False,http://www.openphacts.org/units/Nanomolar,2859046,=,37,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
2982,360849,17736432,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1nc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)sc1C,,,CHEMBL3886488,,2016.0,"{'bei': '13.27', 'le': '0.27', 'lle': '0.16', 'sei': '6.76'}",CHEMBL3901125,,CHEMBL3901125,6.02,False,http://www.openphacts.org/units/Nanomolar,2859047,=,37,True,=,,IC50,nM,,960.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,960.7
2983,360850,17736433,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1sc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)nc1C(=O)NCCCN1CCCCC1,,,CHEMBL3886488,,2016.0,"{'bei': '15.59', 'le': '0.31', 'lle': '2.28', 'sei': '9.01'}",CHEMBL3925654,,CHEMBL3925654,8.57,False,http://www.openphacts.org/units/Nanomolar,2859048,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
2984,360851,17736434,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1nc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)sc1C,,,CHEMBL3886488,,2016.0,"{'bei': '19.94', 'le': '0.40', 'lle': '3.69', 'sei': '9.52'}",CHEMBL3353197,,CHEMBL3353197,8.74,False,http://www.openphacts.org/units/Nanomolar,2859049,=,37,True,=,,IC50,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.8
2985,360852,17736435,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)N2CCN(c3ccc(F)cc3F)CC2)cs1,,,CHEMBL3886488,,2016.0,"{'bei': '10.34', 'le': '0.20', 'lle': '-0.50', 'sei': '7.09'}",CHEMBL3963873,,CHEMBL3963873,6.12,False,http://www.openphacts.org/units/Nanomolar,2859050,=,37,True,=,,IC50,nM,,763.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,763.8
2986,360853,17736436,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)N2CCC3(CC2)C(=O)NCN3c2ccccc2)cs1,,,CHEMBL3886488,,2016.0,"{'bei': '9.99', 'le': '0.19', 'lle': '0.29', 'sei': '5.41'}",CHEMBL3894727,,CHEMBL3894727,6.24,False,http://www.openphacts.org/units/Nanomolar,2859051,=,37,True,=,,IC50,nM,,575.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,575.9
2987,360854,17736437,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NCC2CCCCC2)cs1,,,CHEMBL3886488,,2016.0,"{'bei': '12.04', 'le': '0.24', 'lle': '-0.59', 'sei': '6.64'}",CHEMBL3921439,,CHEMBL3921439,6.10,False,http://www.openphacts.org/units/Nanomolar,2859052,=,37,True,=,,IC50,nM,,795.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,795.0
2988,360855,17736438,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NCC2CCCO2)cs1,,,CHEMBL3886488,,2016.0,"{'bei': '15.40', 'le': '0.31', 'lle': '2.33', 'sei': '7.54'}",CHEMBL3984346,,CHEMBL3984346,7.62,False,http://www.openphacts.org/units/Nanomolar,2859053,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
2989,360856,17736439,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NC[C@H](O)c2ccccc2)cs1,,,CHEMBL3886488,,2016.0,"{'bei': '14.29', 'le': '0.28', 'lle': '1.75', 'sei': '6.77'}",CHEMBL3936414,,CHEMBL3936414,7.58,False,http://www.openphacts.org/units/Nanomolar,2859054,=,37,True,=,,IC50,nM,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,26.0
2990,360857,17736440,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NCCCN2CCCC2)cs1,,,CHEMBL3886488,,2016.0,"{'bei': '16.31', 'le': '0.32', 'lle': '2.92', 'sei': '8.95'}",CHEMBL3905639,,CHEMBL3905639,8.51,False,http://www.openphacts.org/units/Nanomolar,2859055,=,37,True,=,,IC50,nM,,3.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.1
2991,360858,17736441,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)nc1NC(=O)OC(C)(C)C,,,CHEMBL3886488,,2016.0,"{'bei': '12.61', 'le': '0.24', 'lle': '-0.51', 'sei': '5.30'}",CHEMBL3945308,,CHEMBL3945308,6.06,False,http://www.openphacts.org/units/Nanomolar,2859056,=,37,True,=,,IC50,nM,,875.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,875.0
2992,360859,17736442,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(N)=O)co1,,,CHEMBL3886488,,2016.0,"{'bei': '21.72', 'le': '0.42', 'lle': '4.56', 'sei': '7.20'}",CHEMBL3913888,,CHEMBL3913888,8.57,False,http://www.openphacts.org/units/Nanomolar,2859057,=,37,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
2993,360860,17736443,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc(C#N)cc2)ncc1-c1nnc(NC[C@@H](F)CO)o1,,,CHEMBL3886488,,2016.0,"{'bei': '18.57', 'le': '0.35', 'lle': '4.33', 'sei': '5.79'}",CHEMBL3917340,,CHEMBL3917340,7.64,False,http://www.openphacts.org/units/Nanomolar,2859058,=,37,True,=,,IC50,nM,,22.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,22.9
2994,360861,17736444,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(NC2CNC2)o1,,,CHEMBL3886488,,2016.0,"{'bei': '17.94', 'le': '0.35', 'lle': '3.89', 'sei': '6.72'}",CHEMBL3987067,,CHEMBL3987067,7.58,False,http://www.openphacts.org/units/Nanomolar,2859059,=,37,True,=,,IC50,nM,,26.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,26.4
2995,360862,17736445,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(N2CCN(CCO)CC2)o1,,,CHEMBL3886488,,2016.0,"{'bei': '15.80', 'le': '0.31', 'lle': '4.18', 'sei': '6.58'}",CHEMBL3973407,,CHEMBL3973407,7.59,False,http://www.openphacts.org/units/Nanomolar,2859060,=,37,True,=,,IC50,nM,,25.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.4
2996,360863,17736446,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(N2CCN(CCN3CCOCC3)CC2)o1,,,CHEMBL3886488,,2016.0,"{'bei': '13.93', 'le': '0.27', 'lle': '3.90', 'sei': '7.11'}",CHEMBL3947284,,CHEMBL3947284,7.66,False,http://www.openphacts.org/units/Nanomolar,2859061,=,37,True,=,,IC50,nM,,22.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,22.1
2997,360864,17736447,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(-c2ccc(F)c(S(=O)(=O)NC(C)(C)C)c2)o1,,,CHEMBL3886488,,2016.0,"{'bei': '10.61', 'le': '0.21', 'lle': '-0.02', 'sei': '4.57'}",CHEMBL3968119,,CHEMBL3968119,6.17,False,http://www.openphacts.org/units/Nanomolar,2859062,=,37,True,=,,IC50,nM,,675.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,675.9
2998,360865,17736448,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(-c2cccc(C(N)=O)c2)o1,,,CHEMBL3886488,,2016.0,"{'bei': '13.25', 'le': '0.25', 'lle': '1.18', 'sei': '4.74'}",CHEMBL3906831,,CHEMBL3906831,6.25,False,http://www.openphacts.org/units/Nanomolar,2859063,=,37,True,=,,IC50,nM,,564.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,564.2
2999,360866,17736449,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1nnc(-c2cnc(Nc3ccc4ncsc4c3)cc2N[C@H](CO)Cc2ccccc2)o1,,,CHEMBL3886488,,2016.0,"{'bei': '15.61', 'le': '0.30', 'lle': '4.01', 'sei': '5.00'}",CHEMBL3892921,,CHEMBL3892921,7.61,False,http://www.openphacts.org/units/Nanomolar,2859064,=,37,True,=,,IC50,nM,,24.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.5
3000,360867,17736450,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CCC(N)CC2)o1,,,CHEMBL3886488,,2016.0,"{'bei': '15.96', 'le': '0.31', 'lle': '3.77', 'sei': '5.65'}",CHEMBL3939893,,CHEMBL3939893,7.64,False,http://www.openphacts.org/units/Nanomolar,2859065,=,37,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
3001,360868,17736451,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)n1,,,CHEMBL3886488,,2016.0,"{'bei': '15.86', 'le': '0.30', 'lle': '0.88', 'sei': '8.63'}",CHEMBL3920407,,CHEMBL3920407,6.21,False,http://www.openphacts.org/units/Nanomolar,2859066,=,37,True,=,,IC50,nM,,615.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,615.8
3002,360869,17736452,[],CHEMBL3887888,"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1ccc2cn[nH]c2c1,,,CHEMBL3886488,,2016.0,"{'bei': '15.21', 'le': '0.29', 'lle': '0.29', 'sei': '7.76'}",CHEMBL3892422,,CHEMBL3892422,6.09,False,http://www.openphacts.org/units/Nanomolar,2859067,=,37,True,=,,IC50,nM,,812.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,812.8
3003,360924,17736507,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.36', 'le': '0.34', 'lle': '6.17', 'sei': '5.37'}",CHEMBL4109195,,CHEMBL4109195,7.70,False,http://www.openphacts.org/units/Nanomolar,2859102,=,37,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
3004,360925,17736508,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '15.81', 'le': '0.31', 'lle': '6.02', 'sei': '3.91'}",CHEMBL4108513,,CHEMBL4108513,6.16,False,http://www.openphacts.org/units/Nanomolar,2859103,=,37,True,=,,IC50,nM,,694.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,694.0
3005,360926,17736509,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.70', 'le': '0.35', 'lle': '6.46', 'sei': '5.30'}",CHEMBL3622183,,CHEMBL3622183,7.60,True,http://www.openphacts.org/units/Nanomolar,2859104,=,37,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
3006,360927,17736510,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.38', 'le': '0.30', 'lle': '5.12', 'sei': '4.91'}",CHEMBL4108381,,CHEMBL4108381,7.04,False,http://www.openphacts.org/units/Nanomolar,2859105,=,37,True,=,,IC50,nM,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,92.0
3007,360928,17736511,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '15.81', 'le': '0.31', 'lle': '5.44', 'sei': '4.76'}",CHEMBL4108971,,CHEMBL4108971,6.82,False,http://www.openphacts.org/units/Nanomolar,2859106,=,37,True,=,,IC50,nM,,151.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,151.0
3008,360929,17736512,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.14', 'le': '0.26', 'lle': '3.89', 'sei': '4.32'}",CHEMBL4107413,,CHEMBL4107413,6.20,False,http://www.openphacts.org/units/Nanomolar,2859107,=,37,True,=,,IC50,nM,,636.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,636.0
3009,360930,17736513,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '14.93', 'le': '0.29', 'lle': '5.98', 'sei': '3.85'}",CHEMBL3622186,,CHEMBL3622186,5.83,True,http://www.openphacts.org/units/Nanomolar,2859108,=,37,True,=,,IC50,nM,,1487.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1487.0
3010,360931,17736514,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.18', 'le': '0.26', 'lle': '5.09', 'sei': '4.09'}",CHEMBL4114035,,CHEMBL4114035,6.24,False,http://www.openphacts.org/units/Nanomolar,2859109,=,37,True,=,,IC50,nM,,575.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,575.0
3011,360932,17736515,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CC(F)(F)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.53', 'le': '0.27', 'lle': '4.72', 'sei': '4.53'}",CHEMBL4113480,,CHEMBL4113480,6.49,False,http://www.openphacts.org/units/Nanomolar,2859110,=,37,True,=,,IC50,nM,,324.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,324.0
3012,360933,17736516,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '11.37', 'le': '0.23', 'lle': '5.86', 'sei': '3.46'}",CHEMBL4110755,,CHEMBL4110755,6.26,False,http://www.openphacts.org/units/Nanomolar,2859111,=,37,True,=,,IC50,nM,,545.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,545.0
3013,360934,17736517,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2COC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.58', 'le': '0.27', 'lle': '5.68', 'sei': '3.96'}",CHEMBL4111171,,CHEMBL4111171,6.05,False,http://www.openphacts.org/units/Nanomolar,2859112,=,37,True,=,,IC50,nM,,892.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,892.0
3014,360935,17736518,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.17', 'le': '0.29', 'lle': '7.96', 'sei': '4.42'}",CHEMBL4109175,,CHEMBL4109175,7.60,False,http://www.openphacts.org/units/Nanomolar,2859113,=,37,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
3015,360936,17736519,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC3(COC3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.07', 'le': '0.33', 'lle': '7.65', 'sei': '5.60'}",CHEMBL4109337,,CHEMBL4109337,8.05,False,http://www.openphacts.org/units/Nanomolar,2859114,=,37,True,=,,IC50,nM,,8.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.9
3016,360937,17736520,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CC2(CN(c3nc(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)c(-c4nc5ccccc5s4)c(=O)[nH]3)C2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '15.04', 'le': '0.30', 'lle': '8.61', 'sei': '4.80'}",CHEMBL4112534,,CHEMBL4112534,8.25,False,http://www.openphacts.org/units/Nanomolar,2859115,=,37,True,=,,IC50,nM,,5.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.6
3017,360938,17736521,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(OC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.99', 'le': '0.25', 'lle': '4.28', 'sei': '4.11'}",CHEMBL3622187,,CHEMBL3622187,5.77,False,http://www.openphacts.org/units/Nanomolar,2859116,=,37,True,=,,IC50,nM,,1686.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1686.0
3018,360939,17736522,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC3(CNC3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.40', 'le': '0.34', 'lle': '8.22', 'sei': '5.58'}",CHEMBL4114620,,CHEMBL4114620,8.19,False,http://www.openphacts.org/units/Nanomolar,2859117,=,37,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
3019,360940,17736523,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCC1,,,CHEMBL3886492,,2015.0,"{'bei': '12.61', 'le': '0.25', 'lle': '3.85', 'sei': '4.02'}",CHEMBL4109106,,CHEMBL4109106,5.77,False,http://www.openphacts.org/units/Nanomolar,2859118,=,37,True,=,,IC50,nM,,1693.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1693.0
3020,360941,17736524,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '17.69', 'le': '0.33', 'lle': '7.68', 'sei': '5.58'}",CHEMBL4110461,,CHEMBL4110461,8.02,False,http://www.openphacts.org/units/Nanomolar,2859119,=,37,True,=,,IC50,nM,,9.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.5
3021,360942,17736525,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '16.92', 'le': '0.32', 'lle': '6.15', 'sei': '5.67'}",CHEMBL4114295,,CHEMBL4114295,7.64,False,http://www.openphacts.org/units/Nanomolar,2859120,=,37,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
3022,360943,17736526,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '17.65', 'le': '0.33', 'lle': '6.26', 'sei': '5.38'}",CHEMBL4114137,,CHEMBL4114137,7.72,False,http://www.openphacts.org/units/Nanomolar,2859121,=,37,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
3023,360944,17736527,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccccn1,,,CHEMBL3886492,,2015.0,"{'bei': '16.08', 'le': '0.30', 'lle': '5.92', 'sei': '4.34'}",CHEMBL4115438,,CHEMBL4115438,6.23,False,http://www.openphacts.org/units/Nanomolar,2859122,=,37,True,=,,IC50,nM,,590.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,590.0
3024,360945,17736528,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nccs1,,,CHEMBL3886492,,2015.0,"{'bei': '15.13', 'le': '0.30', 'lle': '5.58', 'sei': '4.15'}",CHEMBL4106852,,CHEMBL4106852,5.95,False,http://www.openphacts.org/units/Nanomolar,2859123,=,37,True,=,,IC50,nM,,1114.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1114.0
3025,360946,17736529,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1cscn1,,,CHEMBL3886492,,2015.0,"{'bei': '14.61', 'le': '0.29', 'lle': '5.38', 'sei': '4.01'}",CHEMBL4112749,,CHEMBL4112749,5.75,False,http://www.openphacts.org/units/Nanomolar,2859124,=,37,True,=,,IC50,nM,,1791.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1791.0
3026,360947,17736530,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.32', 'le': '0.34', 'lle': '7.56', 'sei': '5.53'}",CHEMBL3621219,,CHEMBL3621219,7.96,True,http://www.openphacts.org/units/Nanomolar,2859125,=,37,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
3027,360948,17736531,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.46', 'le': '0.34', 'lle': '6.58', 'sei': '5.75'}",CHEMBL3622512,,CHEMBL3622512,7.75,True,http://www.openphacts.org/units/Nanomolar,2859126,=,37,True,=,,IC50,nM,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.0
3028,360949,17736532,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.10', 'le': '0.31', 'lle': '5.82', 'sei': '5.47'}",CHEMBL3622514,,CHEMBL3622514,7.37,True,http://www.openphacts.org/units/Nanomolar,2859127,=,37,True,=,,IC50,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,43.0
3029,360950,17736533,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(F)(F)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.92', 'le': '0.28', 'lle': '5.07', 'sei': '5.10'}",CHEMBL3622515,,CHEMBL3622515,6.87,False,http://www.openphacts.org/units/Nanomolar,2859128,=,37,True,=,,IC50,nM,,134.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,134.8
3030,360951,17736534,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.59', 'le': '0.30', 'lle': '7.06', 'sei': '5.34'}",CHEMBL3622517,,CHEMBL3622517,7.37,True,http://www.openphacts.org/units/Nanomolar,2859129,=,37,True,=,,IC50,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,43.0
3031,360952,17736535,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.95', 'le': '0.29', 'lle': '5.44', 'sei': '5.62'}",CHEMBL3622516,,CHEMBL3622516,7.56,False,http://www.openphacts.org/units/Nanomolar,2859130,=,37,True,=,,IC50,nM,,27.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.5
3032,360953,17736536,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '15.01', 'le': '0.30', 'lle': '5.64', 'sei': '4.66'}",CHEMBL3622511,,CHEMBL3622511,6.27,False,http://www.openphacts.org/units/Nanomolar,2859131,=,37,True,=,,IC50,nM,,542.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,542.0
3033,360954,17736537,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.70', 'le': '0.33', 'lle': '6.40', 'sei': '5.33'}",CHEMBL3622513,,CHEMBL3622513,7.17,True,http://www.openphacts.org/units/Nanomolar,2859132,=,37,True,=,,IC50,nM,,67.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,67.0
3034,360955,17736538,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCOCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '17.89', 'le': '0.36', 'lle': '8.03', 'sei': '5.27'}",CHEMBL4110611,,CHEMBL4110611,7.58,False,http://www.openphacts.org/units/Nanomolar,2859133,=,37,True,=,,IC50,nM,,26.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,26.6
3035,360956,17736539,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCC(C(F)(F)F)CC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.36', 'le': '0.29', 'lle': '5.53', 'sei': '5.22'}",CHEMBL4106833,,CHEMBL4106833,7.03,False,http://www.openphacts.org/units/Nanomolar,2859134,=,37,True,=,,IC50,nM,,93.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,93.6
3036,360957,17736540,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCOCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.98', 'le': '0.30', 'lle': '7.18', 'sei': '4.64'}",CHEMBL4112994,,CHEMBL4112994,6.67,False,http://www.openphacts.org/units/Nanomolar,2859135,=,37,True,=,,IC50,nM,,213.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,213.5
3037,360958,17736541,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCCCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.71', 'le': '0.30', 'lle': '5.88', 'sei': '4.85'}",CHEMBL4111327,,CHEMBL4111327,6.53,False,http://www.openphacts.org/units/Nanomolar,2859136,=,37,True,=,,IC50,nM,,296.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,296.4
3038,360959,17736542,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.91', 'le': '0.27', 'lle': '6.24', 'sei': '3.98'}",CHEMBL4108483,,CHEMBL4108483,6.18,False,http://www.openphacts.org/units/Nanomolar,2859137,=,37,True,=,,IC50,nM,,656.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,656.0
3039,360960,17736543,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.43', 'le': '0.24', 'lle': '5.37', 'sei': '3.67'}",CHEMBL4114568,,CHEMBL4114568,5.70,False,http://www.openphacts.org/units/Nanomolar,2859138,=,37,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2000.0
3040,360961,17736544,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N[C@@H]2CCCNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '11.20', 'le': '0.22', 'lle': '4.57', 'sei': '3.40'}",CHEMBL4112550,,CHEMBL4112550,5.29,False,http://www.openphacts.org/units/Nanomolar,2859139,=,37,True,=,,IC50,nM,,5123.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5123.0
3041,360962,17736545,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N[C@H]2CCCNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '11.36', 'le': '0.22', 'lle': '4.65', 'sei': '3.46'}",CHEMBL4110006,,CHEMBL4110006,5.37,False,http://www.openphacts.org/units/Nanomolar,2859140,=,37,True,=,,IC50,nM,,4260.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4260.0
3042,360963,17736546,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COCCCNc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '15.65', 'le': '0.31', 'lle': '6.21', 'sei': '4.73'}",CHEMBL4113907,,CHEMBL4113907,7.22,False,http://www.openphacts.org/units/Nanomolar,2859141,=,37,True,=,,IC50,nM,,60.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,60.0
3043,360964,17736547,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(O)[C@H](Nc2nc(NC3CCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C[C@H](CO)[C@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '13.85', 'le': '0.27', 'lle': '4.42', 'sei': '4.42'}",CHEMBL4113715,,CHEMBL4113715,6.34,False,http://www.openphacts.org/units/Nanomolar,2859142,=,37,True,=,,IC50,nM,,459.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,459.0
3044,360965,17736548,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '15.15', 'le': '0.30', 'lle': '5.08', 'sei': '5.78'}",CHEMBL4114443,,CHEMBL4114443,7.14,False,http://www.openphacts.org/units/Nanomolar,2859143,=,37,True,=,,IC50,nM,,72.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,72.0
3045,360966,17736549,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C[C@@H](Nc2nc[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '15.71', 'le': '0.31', 'lle': '3.85', 'sei': '5.46'}",CHEMBL4110321,,CHEMBL4110321,6.07,False,http://www.openphacts.org/units/Nanomolar,2859144,=,37,True,=,,IC50,nM,,850.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,850.0
3046,360967,17736550,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C[C@@H](Nc2nc(N3CCC(c4cncnc4)CC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '13.95', 'le': '0.27', 'lle': '4.24', 'sei': '5.45'}",CHEMBL4113503,,CHEMBL4113503,7.64,False,http://www.openphacts.org/units/Nanomolar,2859145,=,37,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
3047,360968,17736551,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1C[C@@H](Nc2nc(NC3CCC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '15.24', 'le': '0.30', 'lle': '4.89', 'sei': '5.01'}",CHEMBL3929267,,CHEMBL3929267,7.19,False,http://www.openphacts.org/units/Nanomolar,2859146,=,37,True,=,,IC50,nM,,65.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,65.0
3048,360969,17736552,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)[C@H](O)[C@@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '18.97', 'le': '0.35', 'lle': '6.94', 'sei': '6.72'}",CHEMBL3901315,,CHEMBL3901315,8.30,False,http://www.openphacts.org/units/Nanomolar,2859147,=,37,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
3049,360970,17736553,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '17.22', 'le': '0.34', 'lle': '6.21', 'sei': '6.18'}",CHEMBL3936790,,CHEMBL3936790,7.64,False,http://www.openphacts.org/units/Nanomolar,2859148,=,37,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
3050,360971,17736554,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(N[C@@H]2CC[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.65', 'le': '0.27', 'lle': '3.34', 'sei': '4.58'}",CHEMBL4111135,,CHEMBL4111135,5.65,False,http://www.openphacts.org/units/Nanomolar,2859149,=,37,True,=,,IC50,nM,,2261.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2261.0
3051,360972,17736555,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(NC[C@H](O)CO)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.61', 'le': '0.27', 'lle': '3.49', 'sei': '4.28'}",CHEMBL3931304,,CHEMBL3931304,5.27,False,http://www.openphacts.org/units/Nanomolar,2859150,=,37,True,=,,IC50,nM,,5327.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5327.0
3052,360973,17736556,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)cc(C)n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.43', 'le': '0.28', 'lle': '4.82', 'sei': '4.57'}",CHEMBL3622532,,CHEMBL3622532,7.14,False,http://www.openphacts.org/units/Nanomolar,2859151,=,37,True,=,,IC50,nM,,73.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,73.0
3053,360974,17736557,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(Nc2cncnc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.82', 'le': '0.27', 'lle': '5.37', 'sei': '3.82'}",CHEMBL4107000,,CHEMBL4107000,6.46,False,http://www.openphacts.org/units/Nanomolar,2859152,=,37,True,=,,IC50,nM,,345.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,345.0
3054,360975,17736558,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(Nc2ccc(F)cc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.54', 'le': '0.26', 'lle': '4.11', 'sei': '4.57'}",CHEMBL4108856,,CHEMBL4108856,6.55,False,http://www.openphacts.org/units/Nanomolar,2859153,=,37,True,=,,IC50,nM,,284.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,284.0
3055,360976,17736559,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(Nc2ccccc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.93', 'le': '0.27', 'lle': '4.19', 'sei': '4.52'}",CHEMBL4108417,,CHEMBL4108417,6.49,False,http://www.openphacts.org/units/Nanomolar,2859154,=,37,True,=,,IC50,nM,,327.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,327.0
3056,360977,17736560,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(Nc2ccncc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.26', 'le': '0.26', 'lle': '4.48', 'sei': '3.96'}",CHEMBL4114262,,CHEMBL4114262,6.18,False,http://www.openphacts.org/units/Nanomolar,2859155,=,37,True,=,,IC50,nM,,654.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,654.0
3057,360978,17736561,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2cnccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '19.35', 'le': '0.38', 'lle': '7.68', 'sei': '5.50'}",CHEMBL4107142,,CHEMBL4107142,8.60,False,http://www.openphacts.org/units/Nanomolar,2859156,=,37,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
3058,360979,17736562,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nccc2sc(-c3c(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)nc(N4CCOCC4)[nH]c3=O)nc12,,,CHEMBL3886492,,2015.0,"{'bei': '17.02', 'le': '0.33', 'lle': '7.98', 'sei': '5.15'}",CHEMBL4112827,,CHEMBL4112827,8.08,False,http://www.openphacts.org/units/Nanomolar,2859157,=,37,True,=,,IC50,nM,,8.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.4
3059,360980,17736563,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2sc(-c3c(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)nc(N4CCOCC4)[nH]c3=O)nc2c(C)n1,,,CHEMBL3886492,,2015.0,"{'bei': '12.35', 'le': '0.24', 'lle': '5.62', 'sei': '3.85'}",CHEMBL4113923,,CHEMBL4113923,6.04,False,http://www.openphacts.org/units/Nanomolar,2859158,=,37,True,=,,IC50,nM,,923.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,923.0
3060,360981,17736564,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc(-c2ccc(F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '16.39', 'le': '0.32', 'lle': '7.20', 'sei': '5.74'}",CHEMBL4115519,,CHEMBL4115519,8.25,False,http://www.openphacts.org/units/Nanomolar,2859159,=,37,True,=,,IC50,nM,,5.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.6
3061,360982,17736565,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc(-c2ccc(F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '15.25', 'le': '0.30', 'lle': '5.45', 'sei': '5.68'}",CHEMBL4113814,,CHEMBL4113814,7.65,False,http://www.openphacts.org/units/Nanomolar,2859160,=,37,True,=,,IC50,nM,,22.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,22.5
3062,360983,17736566,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '15.35', 'le': '0.31', 'lle': '5.17', 'sei': '4.91'}",CHEMBL3622188,,CHEMBL3622188,6.45,True,http://www.openphacts.org/units/Nanomolar,2859161,=,37,True,=,,IC50,nM,,352.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,352.0
3063,360984,17736567,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '14.75', 'le': '0.29', 'lle': '4.81', 'sei': '4.52'}",CHEMBL3622185,,CHEMBL3622185,5.93,False,http://www.openphacts.org/units/Nanomolar,2859162,=,37,True,=,,IC50,nM,,1162.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1162.0
3064,360985,17736568,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '15.95', 'le': '0.31', 'lle': '5.33', 'sei': '4.72'}",CHEMBL3622184,,CHEMBL3622184,6.20,True,http://www.openphacts.org/units/Nanomolar,2859163,=,37,True,=,,IC50,nM,,635.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,635.0
3065,360986,17736569,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.74', 'le': '0.30', 'lle': '7.15', 'sei': '5.59'}",CHEMBL4109600,,CHEMBL4109600,8.43,False,http://www.openphacts.org/units/Nanomolar,2859164,=,37,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
3066,360987,17736570,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3cncnc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.32', 'le': '0.29', 'lle': '6.47', 'sei': '5.12'}",CHEMBL4112396,,CHEMBL4112396,8.21,False,http://www.openphacts.org/units/Nanomolar,2859165,=,37,True,=,,IC50,nM,,6.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.2
3067,360988,17736571,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.10', 'le': '0.31', 'lle': '6.02', 'sei': '6.05'}",CHEMBL3622516,,CHEMBL3622516,8.14,False,http://www.openphacts.org/units/Nanomolar,2859130,=,37,True,=,,IC50,nM,,7.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.2
3068,360989,17736572,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC2(CCN(c3nc(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)C1=O,,,CHEMBL3886492,,2015.0,"{'bei': '14.90', 'le': '0.29', 'lle': '7.05', 'sei': '5.20'}",CHEMBL4110192,,CHEMBL4110192,8.06,False,http://www.openphacts.org/units/Nanomolar,2859166,=,37,True,=,,IC50,nM,,8.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.8
3069,360990,17736573,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(n3ccnn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.11', 'le': '0.29', 'lle': '6.94', 'sei': '4.80'}",CHEMBL4108757,,CHEMBL4108757,7.93,False,http://www.openphacts.org/units/Nanomolar,2859167,=,37,True,=,,IC50,nM,,11.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.8
3070,360991,17736574,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3ccccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.81', 'le': '0.28', 'lle': '5.58', 'sei': '5.37'}",CHEMBL4109711,,CHEMBL4109711,7.92,False,http://www.openphacts.org/units/Nanomolar,2859168,=,37,True,=,,IC50,nM,,12.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.1
3071,360992,17736575,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3cnccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.75', 'le': '0.28', 'lle': '6.16', 'sei': '4.93'}",CHEMBL4106730,,CHEMBL4106730,7.90,False,http://www.openphacts.org/units/Nanomolar,2859169,=,37,True,=,,IC50,nM,,12.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.5
3072,360993,17736576,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3cccnc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.73', 'le': '0.28', 'lle': '5.54', 'sei': '5.34'}",CHEMBL4112769,,CHEMBL4112769,7.88,False,http://www.openphacts.org/units/Nanomolar,2859170,=,37,True,=,,IC50,nM,,13.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.3
3073,360994,17736577,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)C1CN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '15.26', 'le': '0.31', 'lle': '7.96', 'sei': '4.59'}",CHEMBL4113003,,CHEMBL4113003,7.75,False,http://www.openphacts.org/units/Nanomolar,2859171,=,37,True,=,,IC50,nM,,17.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.9
3074,360995,17736578,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3ccncc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.44', 'le': '0.28', 'lle': '5.38', 'sei': '5.24'}",CHEMBL4109857,,CHEMBL4109857,7.72,False,http://www.openphacts.org/units/Nanomolar,2859172,=,37,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
3075,360996,17736579,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(N)/C=C(\N)C1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.21', 'le': '0.28', 'lle': '7.33', 'sei': '4.06'}",CHEMBL4115266,,CHEMBL4115266,7.71,False,http://www.openphacts.org/units/Nanomolar,2859173,=,37,True,=,,IC50,nM,,19.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.4
3076,360997,17736580,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCc3cnccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.96', 'le': '0.29', 'lle': '6.06', 'sei': '5.14'}",CHEMBL4111167,,CHEMBL4111167,7.58,False,http://www.openphacts.org/units/Nanomolar,2859174,=,37,True,=,,IC50,nM,,26.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,26.4
3077,360998,17736581,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(Cc3nccs3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '11.96', 'le': '0.24', 'lle': '5.31', 'sei': '4.41'}",CHEMBL4114067,,CHEMBL4114067,6.65,False,http://www.openphacts.org/units/Nanomolar,2859175,=,37,True,=,,IC50,nM,,226.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,226.0
3078,360999,17736582,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3ccncc3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.43', 'le': '0.28', 'lle': '5.56', 'sei': '5.09'}",CHEMBL4106558,,CHEMBL4106558,7.51,False,http://www.openphacts.org/units/Nanomolar,2859176,=,37,True,=,,IC50,nM,,30.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.9
3079,361000,17736583,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '12.39', 'le': '0.25', 'lle': '7.01', 'sei': '3.87'}",CHEMBL4109175,,CHEMBL4109175,6.65,False,http://www.openphacts.org/units/Nanomolar,2859113,=,37,True,=,,IC50,nM,,225.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,225.0
3080,361001,17736584,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3ccccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.92', 'le': '0.27', 'lle': '5.10', 'sei': '5.05'}",CHEMBL4109711,,CHEMBL4109711,7.44,False,http://www.openphacts.org/units/Nanomolar,2859168,=,37,True,=,,IC50,nM,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,36.0
3081,361002,17736585,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)CNCC1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '13.68', 'le': '0.27', 'lle': '7.59', 'sei': '3.92'}",CHEMBL4112163,,CHEMBL4112163,7.43,False,http://www.openphacts.org/units/Nanomolar,2859177,=,37,True,=,,IC50,nM,,36.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,36.7
3082,361003,17736586,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(Cn3cccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.88', 'le': '0.25', 'lle': '5.25', 'sei': '4.54'}",CHEMBL4108397,,CHEMBL4108397,6.92,False,http://www.openphacts.org/units/Nanomolar,2859178,=,37,True,=,,IC50,nM,,119.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,119.0
3083,361004,17736587,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CNC2(CCN(c3nc(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)O1,,,CHEMBL3886492,,2015.0,"{'bei': '12.69', 'le': '0.25', 'lle': None, 'sei': '3.88'}",CHEMBL4112779,,CHEMBL4112779,6.71,False,http://www.openphacts.org/units/Nanomolar,2859179,=,37,True,=,,IC50,nM,,196.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,196.0
3084,361005,17736588,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3ccccn3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.88', 'le': '0.25', 'lle': '4.76', 'sei': '4.55'}",CHEMBL4107519,,CHEMBL4107519,6.71,False,http://www.openphacts.org/units/Nanomolar,2859180,=,37,True,=,,IC50,nM,,197.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,197.0
3085,361006,17736589,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '18.72', 'le': '0.36', 'lle': '5.67', 'sei': '8.11'}",CHEMBL3622518,,CHEMBL3622518,7.72,True,http://www.openphacts.org/units/Nanomolar,2859181,=,37,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
3086,361007,17736590,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.98', 'le': '0.31', 'lle': '4.54', 'sei': '6.93'}",CHEMBL3898529,,CHEMBL3898529,6.59,False,http://www.openphacts.org/units/Nanomolar,2859182,=,37,True,=,,IC50,nM,,255.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,255.0
3087,361008,17736591,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.94', 'le': '0.33', 'lle': '5.09', 'sei': '7.09'}",CHEMBL3919163,,CHEMBL3919163,6.75,False,http://www.openphacts.org/units/Nanomolar,2859183,=,37,True,=,,IC50,nM,,177.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,177.0
3088,361009,17736592,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.58', 'le': '0.30', 'lle': '4.55', 'sei': '6.52'}",CHEMBL3622519,,CHEMBL3622519,6.21,True,http://www.openphacts.org/units/Nanomolar,2859184,=,37,True,=,,IC50,nM,,620.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,620.0
3089,361010,17736593,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '18.68', 'le': '0.36', 'lle': '5.78', 'sei': '7.82'}",CHEMBL3622520,,CHEMBL3622520,7.44,True,http://www.openphacts.org/units/Nanomolar,2859185,=,37,True,=,,IC50,nM,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,36.0
3090,361011,17736594,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCNCC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.77', 'le': '0.33', 'lle': '4.87', 'sei': '7.27'}",CHEMBL3622527,,CHEMBL3622527,6.92,True,http://www.openphacts.org/units/Nanomolar,2859186,=,37,True,=,,IC50,nM,,121.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,121.0
3091,361012,17736595,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '14.88', 'le': '0.29', 'lle': '4.78', 'sei': '5.65'}",CHEMBL3622526,,CHEMBL3622526,6.35,True,http://www.openphacts.org/units/Nanomolar,2859187,=,37,True,=,,IC50,nM,,450.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,450.0
3092,361013,17736596,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '15.45', 'le': '0.30', 'lle': '4.02', 'sei': '6.04'}",CHEMBL3622522,,CHEMBL3622522,6.59,True,http://www.openphacts.org/units/Nanomolar,2859188,=,37,True,=,,IC50,nM,,258.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,258.0
3093,361014,17736597,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCCC[C@H]1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.75', 'le': '0.25', 'lle': '3.65', 'sei': '5.00'}",CHEMBL3622524,,CHEMBL3622524,5.62,True,http://www.openphacts.org/units/Nanomolar,2859189,=,37,True,=,,IC50,nM,,2429.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2429.0
3094,361015,17736598,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.74', 'le': '0.34', 'lle': '5.13', 'sei': '7.95'}",CHEMBL3971525,,CHEMBL3971525,7.57,False,http://www.openphacts.org/units/Nanomolar,2859190,=,37,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
3095,361016,17736599,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.66', 'le': '0.35', 'lle': '5.60', 'sei': '7.97'}",CHEMBL4108348,,CHEMBL4108348,7.58,False,http://www.openphacts.org/units/Nanomolar,2859191,=,37,True,=,,IC50,nM,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,26.0
3096,361017,17736600,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '16.62', 'le': '0.33', 'lle': '5.06', 'sei': '6.57'}",CHEMBL4106923,,CHEMBL4106923,6.26,False,http://www.openphacts.org/units/Nanomolar,2859192,=,37,True,=,,IC50,nM,,554.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,554.0
3097,361018,17736601,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '15.12', 'le': '0.29', 'lle': '4.06', 'sei': '7.47'}",CHEMBL3622521,,CHEMBL3622521,6.45,True,http://www.openphacts.org/units/Nanomolar,2859193,=,37,True,=,,IC50,nM,,354.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,354.0
3098,361019,17736602,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCCC(O)C2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.44', 'le': '0.26', 'lle': '3.14', 'sei': '5.56'}",CHEMBL3900669,,CHEMBL3900669,5.74,False,http://www.openphacts.org/units/Nanomolar,2859194,=,37,True,=,,IC50,nM,,1803.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1803.0
3099,361020,17736603,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(F)ccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '18.76', 'le': '0.37', 'lle': '5.89', 'sei': '8.49'}",CHEMBL4111712,,CHEMBL4111712,8.08,False,http://www.openphacts.org/units/Nanomolar,2859195,=,37,True,=,,IC50,nM,,8.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.4
3100,361021,17736604,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '16.69', 'le': '0.33', 'lle': '4.92', 'sei': '8.01'}",CHEMBL4109278,,CHEMBL4109278,7.62,False,http://www.openphacts.org/units/Nanomolar,2859196,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
3101,361022,17736605,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12,,,CHEMBL3886492,,2015.0,"{'bei': '19.28', 'le': '0.38', 'lle': '6.49', 'sei': '7.63'}",CHEMBL4107242,,CHEMBL4107242,8.24,False,http://www.openphacts.org/units/Nanomolar,2859197,=,37,True,=,,IC50,nM,,5.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.7
3102,361023,17736606,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(C2CC2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '15.81', 'le': '0.31', 'lle': '4.59', 'sei': '6.69'}",CHEMBL4107485,,CHEMBL4107485,6.36,False,http://www.openphacts.org/units/Nanomolar,2859198,=,37,True,=,,IC50,nM,,433.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,433.0
3103,361024,17736607,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nccs1,,,CHEMBL3886492,,2015.0,"{'bei': '15.83', 'le': '0.31', 'lle': '4.85', 'sei': '6.03'}",CHEMBL4115048,,CHEMBL4115048,5.74,False,http://www.openphacts.org/units/Nanomolar,2859199,=,37,True,=,,IC50,nM,,1830.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1830.0
3104,361025,17736608,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.66', 'le': '0.31', 'lle': '4.70', 'sei': '6.20'}",CHEMBL4109716,,CHEMBL4109716,5.90,False,http://www.openphacts.org/units/Nanomolar,2859200,=,37,True,=,,IC50,nM,,1271.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1271.0
3105,361026,17736609,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(OC(F)(F)F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '10.81', 'le': '0.21', 'lle': '2.19', 'sei': '5.41'}",CHEMBL4109251,,CHEMBL4109251,5.65,False,http://www.openphacts.org/units/Nanomolar,2859201,=,37,True,=,,IC50,nM,,2246.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2246.0
3106,361027,17736610,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.65', 'le': '0.32', 'lle': '4.66', 'sei': '7.46'}",CHEMBL3622523,,CHEMBL3622523,7.10,True,http://www.openphacts.org/units/Nanomolar,2859202,=,37,True,=,,IC50,nM,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,79.0
3107,361028,17736611,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNC[C@H](O)C2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.50', 'le': '0.32', 'lle': '6.05', 'sei': '6.13'}",CHEMBL3622525,,CHEMBL3622525,7.07,True,http://www.openphacts.org/units/Nanomolar,2859203,=,37,True,=,,IC50,nM,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,85.0
3108,361029,17736612,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.03', 'le': '0.31', 'lle': '4.56', 'sei': '6.95'}",CHEMBL3949920,,CHEMBL3949920,6.61,False,http://www.openphacts.org/units/Nanomolar,2859204,=,37,True,=,,IC50,nM,,244.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,244.0
3109,361030,17736613,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '16.74', 'le': '0.31', 'lle': '4.67', 'sei': '7.40'}",CHEMBL3979957,,CHEMBL3979957,7.04,False,http://www.openphacts.org/units/Nanomolar,2859205,=,37,True,=,,IC50,nM,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,91.0
3110,361031,17736614,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCC[C@@H](O)C2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.84', 'le': '0.29', 'lle': '3.74', 'sei': '6.14'}",CHEMBL3622528,,CHEMBL3622528,6.34,True,http://www.openphacts.org/units/Nanomolar,2859206,=,37,True,=,,IC50,nM,,454.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,454.0
3111,361032,17736615,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.74', 'le': '0.29', 'lle': '4.69', 'sei': '6.13'}",CHEMBL4111811,,CHEMBL4111811,5.83,False,http://www.openphacts.org/units/Nanomolar,2859207,=,37,True,=,,IC50,nM,,1474.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1474.0
3112,361033,17736616,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)nc1,,,CHEMBL3886492,,2015.0,"{'bei': '16.36', 'le': '0.31', 'lle': '4.92', 'sei': '6.37'}",CHEMBL4109853,,CHEMBL4109853,6.06,False,http://www.openphacts.org/units/Nanomolar,2859208,=,37,True,=,,IC50,nM,,872.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,872.0
3113,361034,17736617,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2c(C3CC3)nccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.74', 'le': '0.34', 'lle': '5.73', 'sei': '7.45'}",CHEMBL4107471,,CHEMBL4107471,8.05,False,http://www.openphacts.org/units/Nanomolar,2859209,=,37,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
3114,361035,17736618,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccc(F)cc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.04', 'le': '0.33', 'lle': '5.15', 'sei': '7.71'}",CHEMBL4107194,,CHEMBL4107194,7.34,False,http://www.openphacts.org/units/Nanomolar,2859210,=,37,True,=,,IC50,nM,,46.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,46.0
3115,361036,17736619,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cnccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '19.16', 'le': '0.37', 'lle': '6.48', 'sei': '7.33'}",CHEMBL4109845,,CHEMBL4109845,7.92,False,http://www.openphacts.org/units/Nanomolar,2859211,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
3116,361037,17736620,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCC2)nc(NC2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '19.51', 'le': '0.36', 'lle': '4.87', 'sei': '8.87'}",CHEMBL3967770,,CHEMBL3967770,7.62,False,http://www.openphacts.org/units/Nanomolar,2859212,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
3117,361038,17736621,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCCC2)nc(NC2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '17.97', 'le': '0.33', 'lle': '4.13', 'sei': '8.46'}",CHEMBL3932684,,CHEMBL3932684,7.27,False,http://www.openphacts.org/units/Nanomolar,2859213,=,37,True,=,,IC50,nM,,54.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,54.0
3118,361039,17736622,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nc(NC3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '16.72', 'le': '0.31', 'lle': '5.11', 'sei': '7.86'}",CHEMBL3964751,,CHEMBL3964751,7.01,False,http://www.openphacts.org/units/Nanomolar,2859214,=,37,True,=,,IC50,nM,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,97.0
3119,361040,17736623,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2c(C3CC3)nccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.86', 'le': '0.34', 'lle': '4.60', 'sei': '8.16'}",CHEMBL4110413,,CHEMBL4110413,8.07,False,http://www.openphacts.org/units/Nanomolar,2859215,=,37,True,=,,IC50,nM,,8.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.6
3120,361041,17736624,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2c(C3CC3)nccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.95', 'le': '0.35', 'lle': '4.77', 'sei': '7.95'}",CHEMBL4115029,,CHEMBL4115029,7.85,False,http://www.openphacts.org/units/Nanomolar,2859216,=,37,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
3121,361042,17736625,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4c(C5CC5)nccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.38', 'le': '0.31', 'lle': '6.60', 'sei': '5.99'}",CHEMBL4111648,,CHEMBL4111648,8.16,False,http://www.openphacts.org/units/Nanomolar,2859217,=,37,True,=,,IC50,nM,,6.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.9
3122,361043,17736626,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4c(C5CC5)nccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '16.12', 'le': '0.31', 'lle': '5.29', 'sei': '7.37'}",CHEMBL4107356,,CHEMBL4107356,7.52,False,http://www.openphacts.org/units/Nanomolar,2859218,=,37,True,=,,IC50,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.0
3123,361044,17736627,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '17.65', 'le': '0.33', 'lle': '5.05', 'sei': '7.80'}",CHEMBL4109374,,CHEMBL4109374,7.42,False,http://www.openphacts.org/units/Nanomolar,2859219,=,37,True,=,,IC50,nM,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,38.0
3124,361045,17736628,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '14.90', 'le': '0.28', 'lle': '3.90', 'sei': '6.58'}",CHEMBL3902218,,CHEMBL3902218,6.27,False,http://www.openphacts.org/units/Nanomolar,2859220,=,37,True,=,,IC50,nM,,541.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,541.0
3125,361046,17736629,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '14.24', 'le': '0.28', 'lle': '3.63', 'sei': '6.38'}",CHEMBL3622529,,CHEMBL3622529,6.07,False,http://www.openphacts.org/units/Nanomolar,2859221,=,37,True,=,,IC50,nM,,847.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,847.0
3126,361047,17736630,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '16.28', 'le': '0.32', 'lle': '4.50', 'sei': '7.30'}",CHEMBL3622530,,CHEMBL3622530,6.94,False,http://www.openphacts.org/units/Nanomolar,2859222,=,37,True,=,,IC50,nM,,114.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,114.0
3127,361048,17736631,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2CO)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.70', 'le': '0.27', 'lle': '4.65', 'sei': '5.25'}",CHEMBL4112526,,CHEMBL4112526,6.06,False,http://www.openphacts.org/units/Nanomolar,2859223,=,37,True,=,,IC50,nM,,864.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,864.0
3128,361049,17736632,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1,,,CHEMBL3886492,,2015.0,"{'bei': '16.44', 'le': '0.32', 'lle': '4.57', 'sei': '7.37'}",CHEMBL4112492,,CHEMBL4112492,7.01,False,http://www.openphacts.org/units/Nanomolar,2859224,=,37,True,=,,IC50,nM,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,97.0
3129,361050,17736633,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1COCCN1c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '13.53', 'le': '0.26', 'lle': '3.33', 'sei': '6.06'}",CHEMBL4115332,,CHEMBL4115332,5.77,False,http://www.openphacts.org/units/Nanomolar,2859225,=,37,True,=,,IC50,nM,,1691.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1691.0
3130,361051,17736634,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '14.92', 'le': '0.29', 'lle': '3.93', 'sei': '6.69'}",CHEMBL3893092,,CHEMBL3893092,6.37,False,http://www.openphacts.org/units/Nanomolar,2859226,=,37,True,=,,IC50,nM,,431.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,431.0
3131,361052,17736635,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOC(CCO)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.87', 'le': '0.31', 'lle': '5.44', 'sei': '6.28'}",CHEMBL4111657,,CHEMBL4111657,7.24,False,http://www.openphacts.org/units/Nanomolar,2859227,=,37,True,=,,IC50,nM,,57.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,57.0
3132,361053,17736636,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOC(C(F)(F)F)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.94', 'le': '0.28', 'lle': '3.72', 'sei': '7.04'}",CHEMBL4107634,,CHEMBL4107634,6.70,False,http://www.openphacts.org/units/Nanomolar,2859228,=,37,True,=,,IC50,nM,,201.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,201.0
3133,361054,17736637,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1,,,CHEMBL3886492,,2015.0,"{'bei': '15.52', 'le': '0.30', 'lle': '4.01', 'sei': '7.19'}",CHEMBL4114259,,CHEMBL4114259,6.84,False,http://www.openphacts.org/units/Nanomolar,2859229,=,37,True,=,,IC50,nM,,145.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,145.0
3134,361055,17736638,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.57', 'le': '0.32', 'lle': '5.17', 'sei': '7.93'}",CHEMBL4110364,,CHEMBL4110364,8.10,False,http://www.openphacts.org/units/Nanomolar,2859230,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3135,361056,17736639,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.15', 'le': '0.27', 'lle': '3.17', 'sei': '7.61'}",CHEMBL4107171,,CHEMBL4107171,7.77,False,http://www.openphacts.org/units/Nanomolar,2859231,=,37,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
3136,361057,17736640,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cnccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.54', 'le': '0.32', 'lle': '5.77', 'sei': '7.04'}",CHEMBL4110266,,CHEMBL4110266,8.10,False,http://www.openphacts.org/units/Nanomolar,2859232,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3137,361058,17736641,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccc(C(F)(F)F)cn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.30', 'le': '0.28', 'lle': '4.01', 'sei': '7.80'}",CHEMBL4107379,,CHEMBL4107379,7.96,False,http://www.openphacts.org/units/Nanomolar,2859233,=,37,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
3138,361059,17736642,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ncccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.34', 'le': '0.31', 'lle': '5.67', 'sei': '6.96'}",CHEMBL4109605,,CHEMBL4109605,8.00,False,http://www.openphacts.org/units/Nanomolar,2859234,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3139,361060,17736643,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cccc(Cl)n3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.53', 'le': '0.29', 'lle': '4.01', 'sei': '7.45'}",CHEMBL4109180,,CHEMBL4109180,7.60,False,http://www.openphacts.org/units/Nanomolar,2859235,=,37,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
3140,361061,17736644,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.83', 'le': '0.32', 'lle': '5.29', 'sei': '8.06'}",CHEMBL3353202,,CHEMBL3353202,8.22,True,http://www.openphacts.org/units/Nanomolar,2859236,=,37,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
3141,361062,17736645,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nonc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.85', 'le': '0.31', 'lle': '5.59', 'sei': '6.11'}",CHEMBL4107481,,CHEMBL4107481,7.82,False,http://www.openphacts.org/units/Nanomolar,2859237,=,37,True,=,,IC50,nM,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.0
3142,361063,17736646,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCn3cc(C(F)(F)F)nc3C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.45', 'le': '0.26', 'lle': '3.50', 'sei': '6.70'}",CHEMBL4108601,,CHEMBL4108601,6.95,False,http://www.openphacts.org/units/Nanomolar,2859238,=,37,True,=,,IC50,nM,,113.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,113.0
3143,361064,17736647,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)nc1,,,CHEMBL3886492,,2015.0,"{'bei': '16.01', 'le': '0.31', 'lle': '5.36', 'sei': '7.46'}",CHEMBL4115508,,CHEMBL4115508,8.30,False,http://www.openphacts.org/units/Nanomolar,2859239,=,37,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
3144,361065,17736648,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccnc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)c1,,,CHEMBL3886492,,2015.0,"{'bei': '15.85', 'le': '0.30', 'lle': '5.28', 'sei': '7.39'}",CHEMBL4108950,,CHEMBL4108950,8.22,False,http://www.openphacts.org/units/Nanomolar,2859240,=,37,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.0
3145,361066,17736649,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.42', 'le': '0.30', 'lle': '5.06', 'sei': '7.19'}",CHEMBL4112861,,CHEMBL4112861,8.00,False,http://www.openphacts.org/units/Nanomolar,2859241,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3146,361067,17736650,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccc(Cl)cn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.48', 'le': '0.31', 'lle': '4.51', 'sei': '7.93'}",CHEMBL4112990,,CHEMBL4112990,8.10,False,http://www.openphacts.org/units/Nanomolar,2859242,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3147,361068,17736651,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cc(Cl)ccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.38', 'le': '0.31', 'lle': '4.46', 'sei': '7.88'}",CHEMBL4112572,,CHEMBL4112572,8.05,False,http://www.openphacts.org/units/Nanomolar,2859243,=,37,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
3148,361069,17736652,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccccc3F)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.42', 'le': '0.30', 'lle': '4.12', 'sei': '8.74'}",CHEMBL4114283,,CHEMBL4114283,7.80,False,http://www.openphacts.org/units/Nanomolar,2859244,=,37,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
3149,361070,17736653,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)c(Cl)c1,,,CHEMBL3886492,,2015.0,"{'bei': '13.26', 'le': '0.27', 'lle': '4.37', 'sei': '6.45'}",CHEMBL4107151,,CHEMBL4107151,7.96,False,http://www.openphacts.org/units/Nanomolar,2859245,=,37,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
3150,361071,17736654,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccccc3C(F)(F)F)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.22', 'le': '0.26', 'lle': '2.79', 'sei': '8.24'}",CHEMBL4111358,,CHEMBL4111358,7.35,False,http://www.openphacts.org/units/Nanomolar,2859246,=,37,True,=,,IC50,nM,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,45.0
3151,361072,17736655,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3nccs3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.01', 'le': '0.32', 'lle': '4.93', 'sei': '7.76'}",CHEMBL4111572,,CHEMBL4111572,7.92,False,http://www.openphacts.org/units/Nanomolar,2859247,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
3152,361073,17736656,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1cc(F)ccc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '13.46', 'le': '0.27', 'lle': '4.77', 'sei': '6.37'}",CHEMBL4110394,,CHEMBL4110394,7.85,False,http://www.openphacts.org/units/Nanomolar,2859248,=,37,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
3153,361074,17736657,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccccc3Cl)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.50', 'le': '0.29', 'lle': '3.38', 'sei': '8.49'}",CHEMBL4109283,,CHEMBL4109283,7.57,False,http://www.openphacts.org/units/Nanomolar,2859249,=,37,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
3154,361075,17736658,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cccc(C(F)(F)F)c3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.28', 'le': '0.26', 'lle': '2.82', 'sei': '8.27'}",CHEMBL4107958,,CHEMBL4107958,7.38,False,http://www.openphacts.org/units/Nanomolar,2859250,=,37,True,=,,IC50,nM,,42.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,42.0
3155,361076,17736659,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccc(Cl)c(Cl)c3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.02', 'le': '0.27', 'lle': '2.40', 'sei': '8.12'}",CHEMBL4115196,,CHEMBL4115196,7.24,False,http://www.openphacts.org/units/Nanomolar,2859251,=,37,True,=,,IC50,nM,,57.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,57.0
3156,361077,17736660,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)cc1,,,CHEMBL3886492,,2015.0,"{'bei': '15.45', 'le': '0.30', 'lle': '4.45', 'sei': '8.13'}",CHEMBL4109064,,CHEMBL4109064,8.00,False,http://www.openphacts.org/units/Nanomolar,2859252,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3157,361078,17736661,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ccc4c(c3)OCO4)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.97', 'le': '0.29', 'lle': '4.69', 'sei': '7.39'}",CHEMBL4112018,,CHEMBL4112018,7.96,False,http://www.openphacts.org/units/Nanomolar,2859253,=,37,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
3158,361079,17736662,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccccc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.22', 'le': '0.28', 'lle': '5.11', 'sei': '6.52'}",CHEMBL4112091,,CHEMBL4112091,8.05,False,http://www.openphacts.org/units/Nanomolar,2859254,=,37,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
3159,361080,17736663,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)sn1,,,CHEMBL3886492,,2015.0,"{'bei': '15.92', 'le': '0.32', 'lle': '4.80', 'sei': '7.93'}",CHEMBL4111001,,CHEMBL4111001,8.10,False,http://www.openphacts.org/units/Nanomolar,2859255,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3160,361081,17736664,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnccc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '16.11', 'le': '0.31', 'lle': '4.86', 'sei': '7.93'}",CHEMBL4109650,,CHEMBL4109650,8.10,False,http://www.openphacts.org/units/Nanomolar,2859256,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3161,361082,17736665,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)cn1,,,CHEMBL3886492,,2015.0,"{'bei': '15.66', 'le': '0.30', 'lle': '5.43', 'sei': '7.20'}",CHEMBL4111862,,CHEMBL4111862,7.70,False,http://www.openphacts.org/units/Nanomolar,2859257,=,37,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
3162,361083,17736666,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(C)c(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.79', 'le': '0.28', 'lle': '4.72', 'sei': '6.66'}",CHEMBL4114946,,CHEMBL4114946,7.66,False,http://www.openphacts.org/units/Nanomolar,2859258,=,37,True,=,,IC50,nM,,22.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,22.0
3163,361084,17736667,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(OC)c(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)c1,,,CHEMBL3886492,,2015.0,"{'bei': '14.34', 'le': '0.28', 'lle': '4.30', 'sei': '7.30'}",CHEMBL4114351,,CHEMBL4114351,7.85,False,http://www.openphacts.org/units/Nanomolar,2859259,=,37,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
3164,361085,17736668,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3nnc(C4CC4)o3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.57', 'le': '0.28', 'lle': '4.77', 'sei': '5.91'}",CHEMBL4115314,,CHEMBL4115314,7.57,False,http://www.openphacts.org/units/Nanomolar,2859260,=,37,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
3165,361086,17736669,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3nncs3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.53', 'le': '0.31', 'lle': '5.31', 'sei': '6.70'}",CHEMBL4115348,,CHEMBL4115348,7.70,False,http://www.openphacts.org/units/Nanomolar,2859261,=,37,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
3166,361087,17736670,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@@H]1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '16.62', 'le': '0.31', 'lle': '4.92', 'sei': '8.08'}",CHEMBL4110138,,CHEMBL4110138,7.21,False,http://www.openphacts.org/units/Nanomolar,2859262,=,37,True,=,,IC50,nM,,62.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,62.0
3167,361088,17736671,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '16.24', 'le': '0.30', 'lle': '5.41', 'sei': '6.32'}",CHEMBL4107689,,CHEMBL4107689,7.27,False,http://www.openphacts.org/units/Nanomolar,2859263,=,37,True,=,,IC50,nM,,54.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,54.0
3168,361089,17736672,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '15.69', 'le': '0.29', 'lle': '4.51', 'sei': '7.63'}",CHEMBL4111716,,CHEMBL4111716,6.80,False,http://www.openphacts.org/units/Nanomolar,2859264,=,37,True,=,,IC50,nM,,158.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,158.0
3169,361090,17736673,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(O)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.94', 'le': '0.35', 'lle': '5.98', 'sei': '7.25'}",CHEMBL4106994,,CHEMBL4106994,7.70,False,http://www.openphacts.org/units/Nanomolar,2859265,=,37,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
3170,361091,17736674,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC3CC3C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.56', 'le': '0.34', 'lle': '4.86', 'sei': '8.69'}",CHEMBL4113418,,CHEMBL4113418,7.47,False,http://www.openphacts.org/units/Nanomolar,2859266,=,37,True,=,,IC50,nM,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,34.0
3171,361092,17736675,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '16.49', 'le': '0.32', 'lle': '6.11', 'sei': '6.24'}",CHEMBL4106779,,CHEMBL4106779,7.50,False,http://www.openphacts.org/units/Nanomolar,2859267,=,37,True,=,,IC50,nM,,32.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,32.0
3172,361093,17736676,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC(O)(C(F)(F)F)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '16.82', 'le': '0.32', 'lle': '5.48', 'sei': '7.29'}",CHEMBL4108780,,CHEMBL4108780,7.75,False,http://www.openphacts.org/units/Nanomolar,2859268,=,37,True,=,,IC50,nM,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.0
3173,361094,17736677,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(O)CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '13.54', 'le': '0.25', 'lle': '3.78', 'sei': '5.18'}",CHEMBL4114884,,CHEMBL4114884,5.50,False,http://www.openphacts.org/units/Nanomolar,2859269,=,37,True,=,,IC50,nM,,3147.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3147.0
3174,361095,17736678,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '16.98', 'le': '0.31', 'lle': '5.02', 'sei': '6.95'}",CHEMBL4107887,,CHEMBL4107887,7.38,False,http://www.openphacts.org/units/Nanomolar,2859270,=,37,True,=,,IC50,nM,,42.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,42.0
3175,361096,17736679,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C[C@@H]1O,,,CHEMBL3886492,,2015.0,"{'bei': '16.95', 'le': '0.32', 'lle': '6.06', 'sei': '6.41'}",CHEMBL4108230,,CHEMBL4108230,7.40,False,http://www.openphacts.org/units/Nanomolar,2859271,=,37,True,=,,IC50,nM,,40.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,40.0
3176,361097,17736680,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC3CC2CS(=O)(=O)C3)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.27', 'le': '0.28', 'lle': '5.09', 'sei': '5.71'}",CHEMBL4109957,,CHEMBL4109957,6.86,False,http://www.openphacts.org/units/Nanomolar,2859272,=,37,True,=,,IC50,nM,,139.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,139.0
3177,361098,17736681,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC(F)[C@@H](F)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.22', 'le': '0.34', 'lle': '5.12', 'sei': '9.04'}",CHEMBL4111100,,CHEMBL4111100,7.77,False,http://www.openphacts.org/units/Nanomolar,2859273,=,37,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
3178,361099,17736682,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(C)CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '18.21', 'le': '0.34', 'lle': '5.29', 'sei': '8.05'}",CHEMBL4114571,,CHEMBL4114571,7.66,False,http://www.openphacts.org/units/Nanomolar,2859274,=,37,True,=,,IC50,nM,,22.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,22.0
3179,361100,17736683,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC[C@H](F)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '19.31', 'le': '0.36', 'lle': '5.19', 'sei': '9.18'}",CHEMBL3892729,,CHEMBL3892729,7.89,False,http://www.openphacts.org/units/Nanomolar,2859275,=,37,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
3180,361101,17736684,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '17.73', 'le': '0.33', 'lle': '5.09', 'sei': '7.83'}",CHEMBL4114417,,CHEMBL4114417,7.46,False,http://www.openphacts.org/units/Nanomolar,2859276,=,37,True,=,,IC50,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,35.0
3181,361102,17736685,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC[C@@H](CO)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.75', 'le': '0.35', 'lle': '5.92', 'sei': '7.43'}",CHEMBL4115050,,CHEMBL4115050,7.89,False,http://www.openphacts.org/units/Nanomolar,2859277,=,37,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
3182,361103,17736686,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC[C@H](CO)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.61', 'le': '0.34', 'lle': '5.85', 'sei': '7.37'}",CHEMBL3983208,,CHEMBL3983208,7.82,False,http://www.openphacts.org/units/Nanomolar,2859278,=,37,True,=,,IC50,nM,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.0
3183,361104,17736687,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(O)CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '17.86', 'le': '0.33', 'lle': '5.40', 'sei': '7.07'}",CHEMBL4109668,,CHEMBL4109668,7.51,False,http://www.openphacts.org/units/Nanomolar,2859279,=,37,True,=,,IC50,nM,,31.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,31.0
3184,361105,17736688,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCC2c2ccncc2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '11.76', 'le': '0.21', 'lle': '1.61', 'sei': '5.56'}",CHEMBL4113028,,CHEMBL4113028,5.50,False,http://www.openphacts.org/units/Nanomolar,2859280,=,37,True,=,,IC50,nM,,3180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3180.0
3185,361106,17736689,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC[C@H]2CF)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '16.73', 'le': '0.31', 'lle': '3.98', 'sei': '8.23'}",CHEMBL4112330,,CHEMBL4112330,7.07,False,http://www.openphacts.org/units/Nanomolar,2859281,=,37,True,=,,IC50,nM,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,85.0
3186,361107,17736690,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)C1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '16.45', 'le': '0.31', 'lle': '4.63', 'sei': '6.95'}",CHEMBL4106539,,CHEMBL4106539,7.38,False,http://www.openphacts.org/units/Nanomolar,2859282,=,37,True,=,,IC50,nM,,42.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,42.0
3187,361108,17736691,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4ccc5ccccc5n4)c(=O)[nH]3)C2C1,,,CHEMBL3886492,,2015.0,"{'bei': '13.21', 'le': '0.24', 'lle': '3.39', 'sei': '6.81'}",CHEMBL4106466,,CHEMBL4106466,6.07,False,http://www.openphacts.org/units/Nanomolar,2859283,=,37,True,=,,IC50,nM,,851.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,851.0
3188,361109,17736692,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '18.04', 'le': '0.33', 'lle': '5.22', 'sei': '7.97'}",CHEMBL4115098,,CHEMBL4115098,7.58,False,http://www.openphacts.org/units/Nanomolar,2859284,=,37,True,=,,IC50,nM,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,26.0
3189,361110,17736693,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3ccccc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '16.22', 'le': '0.30', 'lle': '3.27', 'sei': '9.07'}",CHEMBL4112653,,CHEMBL4112653,7.80,False,http://www.openphacts.org/units/Nanomolar,2859285,=,37,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
3190,361111,17736694,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.71', 'le': '0.29', 'lle': '2.93', 'sei': '9.04'}",CHEMBL4111161,,CHEMBL4111161,7.77,False,http://www.openphacts.org/units/Nanomolar,2859286,=,37,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
3191,361112,17736695,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1C1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.44', 'le': '0.28', 'lle': '3.35', 'sei': '8.29'}",CHEMBL4107317,,CHEMBL4107317,7.89,False,http://www.openphacts.org/units/Nanomolar,2859287,=,37,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
3192,361113,17736696,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3ccccc3C(F)(F)F)CC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '13.66', 'le': '0.26', 'lle': '1.94', 'sei': '8.72'}",CHEMBL4115028,,CHEMBL4115028,7.50,False,http://www.openphacts.org/units/Nanomolar,2859288,=,37,True,=,,IC50,nM,,32.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,32.0
3193,361114,17736697,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nsc(C2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4ccc5ccccc5n4)c(=O)[nH]3)CC2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '13.65', 'le': '0.26', 'lle': '3.17', 'sei': '6.14'}",CHEMBL4111157,,CHEMBL4111157,6.86,False,http://www.openphacts.org/units/Nanomolar,2859289,=,37,True,=,,IC50,nM,,138.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,138.0
3194,361115,17736698,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4ccc5ccccc5n4)c(=O)[nH]3)CC2)[nH]n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.82', 'le': '0.27', 'lle': '3.62', 'sei': '6.26'}",CHEMBL4111747,,CHEMBL4111747,7.18,False,http://www.openphacts.org/units/Nanomolar,2859290,=,37,True,=,,IC50,nM,,66.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,66.0
3195,361116,17736699,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(c3cccc(F)n3)CC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.71', 'le': '0.27', 'lle': '3.28', 'sei': '7.43'}",CHEMBL4115026,,CHEMBL4115026,7.35,False,http://www.openphacts.org/units/Nanomolar,2859291,=,37,True,=,,IC50,nM,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,45.0
3196,361117,17736700,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC3CC2CN3)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '16.22', 'le': '0.30', 'lle': '5.07', 'sei': '6.91'}",CHEMBL4111164,,CHEMBL4111164,6.77,False,http://www.openphacts.org/units/Nanomolar,2859292,=,37,True,=,,IC50,nM,,169.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,169.0
3197,361118,17736701,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(N2CC3CC2CN3c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)cc1,,,CHEMBL3886492,,2015.0,"{'bei': '11.69', 'le': '0.21', 'lle': '2.49', 'sei': '6.22'}",CHEMBL4109321,,CHEMBL4109321,6.12,False,http://www.openphacts.org/units/Nanomolar,2859293,=,37,True,=,,IC50,nM,,757.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,757.0
3198,361119,17736702,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2o1,,,CHEMBL3886492,,2015.0,"{'bei': '14.49', 'le': '0.27', 'lle': '4.16', 'sei': '5.30'}",CHEMBL4107335,,CHEMBL4107335,5.74,False,http://www.openphacts.org/units/Nanomolar,2859294,=,37,True,=,,IC50,nM,,1802.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1802.0
3199,361120,17736703,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.20', 'le': '0.29', 'lle': '4.14', 'sei': '6.59'}",CHEMBL4114246,,CHEMBL4114246,6.27,False,http://www.openphacts.org/units/Nanomolar,2859295,=,37,True,=,,IC50,nM,,537.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,537.0
3200,361121,17736704,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1cncc(-n2cccc2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '12.93', 'le': '0.24', 'lle': '4.44', 'sei': '4.83'}",CHEMBL4112508,,CHEMBL4112508,5.46,False,http://www.openphacts.org/units/Nanomolar,2859296,=,37,True,=,,IC50,nM,,3457.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3457.0
3201,361122,17736705,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ccccn1,,,CHEMBL3886492,,2015.0,"{'bei': '14.93', 'le': '0.28', 'lle': '4.49', 'sei': '5.59'}",CHEMBL4108199,,CHEMBL4108199,5.32,False,http://www.openphacts.org/units/Nanomolar,2859297,=,37,True,=,,IC50,nM,,4759.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4759.0
3202,361123,17736706,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cccc(C(F)(F)F)c2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '13.52', 'le': '0.27', 'lle': '3.27', 'sei': '7.20'}",CHEMBL4114234,,CHEMBL4114234,6.85,False,http://www.openphacts.org/units/Nanomolar,2859298,=,37,True,=,,IC50,nM,,141.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,141.0
3203,361124,17736707,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccccc2F)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '15.82', 'le': '0.31', 'lle': '4.52', 'sei': '7.59'}",CHEMBL4106984,,CHEMBL4106984,7.22,False,http://www.openphacts.org/units/Nanomolar,2859299,=,37,True,=,,IC50,nM,,60.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,60.0
3204,361125,17736708,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(Cl)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '14.41', 'le': '0.29', 'lle': '3.61', 'sei': '7.16'}",CHEMBL4107260,,CHEMBL4107260,6.82,False,http://www.openphacts.org/units/Nanomolar,2859300,=,37,True,=,,IC50,nM,,153.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,153.0
3205,361126,17736709,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cc(F)cc(F)c2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '14.76', 'le': '0.29', 'lle': '4.16', 'sei': '7.36'}",CHEMBL4113174,,CHEMBL4113174,7.00,False,http://www.openphacts.org/units/Nanomolar,2859301,=,37,True,=,,IC50,nM,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,99.0
3206,361127,17736710,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cccc(F)c2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '16.20', 'le': '0.32', 'lle': '4.70', 'sei': '7.77'}",CHEMBL4108838,,CHEMBL4108838,7.40,False,http://www.openphacts.org/units/Nanomolar,2859302,=,37,True,=,,IC50,nM,,40.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,40.0
3207,361128,17736711,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cc(F)ccc2F)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '14.85', 'le': '0.29', 'lle': '4.21', 'sei': '7.40'}",CHEMBL4109478,,CHEMBL4109478,7.05,False,http://www.openphacts.org/units/Nanomolar,2859303,=,37,True,=,,IC50,nM,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,90.0
3208,361129,17736712,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(C(F)(F)F)cn2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '11.07', 'le': '0.22', 'lle': '2.65', 'sei': '5.20'}",CHEMBL4112080,,CHEMBL4112080,5.62,False,http://www.openphacts.org/units/Nanomolar,2859304,=,37,True,=,,IC50,nM,,2403.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2403.0
3209,361130,17736713,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccccn2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '17.47', 'le': '0.34', 'lle': '5.72', 'sei': '7.11'}",CHEMBL4112124,,CHEMBL4112124,7.68,False,http://www.openphacts.org/units/Nanomolar,2859305,=,37,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
3210,361131,17736714,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CN3CCC2CC3)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.65', 'le': '0.32', 'lle': '4.91', 'sei': '8.45'}",CHEMBL3942146,,CHEMBL3942146,7.30,False,http://www.openphacts.org/units/Nanomolar,2859306,=,37,True,=,,IC50,nM,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,50.0
3211,361132,17736715,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '15.62', 'le': '0.30', 'lle': '4.39', 'sei': '6.77'}",CHEMBL3970853,,CHEMBL3970853,6.45,False,http://www.openphacts.org/units/Nanomolar,2859307,=,37,True,=,,IC50,nM,,359.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,359.0
3212,361133,17736716,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1,,,CHEMBL3886492,,2015.0,"{'bei': '16.54', 'le': '0.32', 'lle': '4.77', 'sei': '7.17'}",CHEMBL4110771,,CHEMBL4110771,6.82,False,http://www.openphacts.org/units/Nanomolar,2859308,=,37,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,150.0
3213,361134,17736717,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@@H]3CN[C@H]2C3)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.83', 'le': '0.31', 'lle': '4.67', 'sei': '7.06'}",CHEMBL4112425,,CHEMBL4112425,6.72,False,http://www.openphacts.org/units/Nanomolar,2859309,=,37,True,=,,IC50,nM,,191.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,191.0
3214,361135,17736718,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNCC(F)(F)C2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.60', 'le': '0.27', 'lle': '3.81', 'sei': '6.41'}",CHEMBL4113113,,CHEMBL4113113,6.10,False,http://www.openphacts.org/units/Nanomolar,2859310,=,37,True,=,,IC50,nM,,792.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,792.0
3215,361136,17736719,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNCC[C@@H]2F)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '18.24', 'le': '0.36', 'lle': '5.85', 'sei': '8.25'}",CHEMBL3353203,,CHEMBL3353203,7.85,True,http://www.openphacts.org/units/Nanomolar,2859311,=,37,True,=,,IC50,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14.0
3216,361137,17736720,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-n2cccc2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.53', 'le': '0.36', 'lle': '6.24', 'sei': '7.91'}",CHEMBL4109565,,CHEMBL4109565,7.92,False,http://www.openphacts.org/units/Nanomolar,2859312,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
3217,361138,17736721,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1cccc(-n2cccc2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.97', 'le': '0.30', 'lle': '5.11', 'sei': '6.73'}",CHEMBL4114603,,CHEMBL4114603,6.73,False,http://www.openphacts.org/units/Nanomolar,2859313,=,37,True,=,,IC50,nM,,185.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,185.0
3218,361139,17736722,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CCCN1c1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.99', 'le': '0.28', 'lle': '5.63', 'sei': '5.71'}",CHEMBL4107488,,CHEMBL4107488,6.59,False,http://www.openphacts.org/units/Nanomolar,2859314,=,37,True,=,,IC50,nM,,258.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,258.0
3219,361140,17736723,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-n2cccn2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '16.54', 'le': '0.32', 'lle': '6.01', 'sei': '6.27'}",CHEMBL4108289,,CHEMBL4108289,7.09,False,http://www.openphacts.org/units/Nanomolar,2859315,=,37,True,=,,IC50,nM,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,82.0
3220,361141,17736724,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-c2ccccc2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.59', 'le': '0.36', 'lle': '5.59', 'sei': '8.57'}",CHEMBL4108981,,CHEMBL4108981,8.15,False,http://www.openphacts.org/units/Nanomolar,2859316,=,37,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
3221,361142,17736725,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-n2ccnc2)n1,,,CHEMBL3886492,,2015.0,"{'bei': '19.60', 'le': '0.38', 'lle': '7.32', 'sei': '7.43'}",CHEMBL4111400,,CHEMBL4111400,8.40,False,http://www.openphacts.org/units/Nanomolar,2859317,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
3222,361143,17736726,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ncc(F)cn1,,,CHEMBL3886492,,2015.0,"{'bei': '17.73', 'le': '0.34', 'lle': '6.29', 'sei': '6.16'}",CHEMBL4108414,,CHEMBL4108414,6.66,False,http://www.openphacts.org/units/Nanomolar,2859318,=,37,True,=,,IC50,nM,,220.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,220.0
3223,361144,17736727,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1,,,CHEMBL3886492,,2015.0,"{'bei': '17.77', 'le': '0.33', 'lle': '6.08', 'sei': '5.70'}",CHEMBL4109510,,CHEMBL4109510,6.78,False,http://www.openphacts.org/units/Nanomolar,2859319,=,37,True,=,,IC50,nM,,167.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,167.0
3224,361145,17736728,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)c1,,,CHEMBL3886492,,2015.0,"{'bei': '13.76', 'le': '0.26', 'lle': '4.55', 'sei': '4.41'}",CHEMBL4115220,,CHEMBL4115220,5.25,False,http://www.openphacts.org/units/Nanomolar,2859320,=,37,True,=,,IC50,nM,,5621.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5621.0
3225,361146,17736729,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)nc1,,,CHEMBL3886492,,2015.0,"{'bei': '18.59', 'le': '0.35', 'lle': '6.39', 'sei': '5.96'}",CHEMBL4109344,,CHEMBL4109344,7.09,False,http://www.openphacts.org/units/Nanomolar,2859321,=,37,True,=,,IC50,nM,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,81.0
3226,361147,17736730,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ccc(C2CC2)cn1,,,CHEMBL3886492,,2015.0,"{'bei': '15.87', 'le': '0.30', 'lle': '4.58', 'sei': '6.61'}",CHEMBL4114134,,CHEMBL4114134,6.29,False,http://www.openphacts.org/units/Nanomolar,2859322,=,37,True,=,,IC50,nM,,512.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,512.0
3227,361148,17736731,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1cc2ccccc2cn1,,,CHEMBL3886492,,2015.0,"{'bei': '15.58', 'le': '0.29', 'lle': '4.34', 'sei': '6.65'}",CHEMBL4111965,,CHEMBL4111965,6.33,False,http://www.openphacts.org/units/Nanomolar,2859323,=,37,True,=,,IC50,nM,,466.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,466.0
3228,361149,17736732,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.51', 'le': '0.28', 'lle': '3.14', 'sei': '7.17'}",CHEMBL4109087,,CHEMBL4109087,6.16,False,http://www.openphacts.org/units/Nanomolar,2859324,=,37,True,=,,IC50,nM,,690.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,690.0
3229,361150,17736733,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '13.35', 'le': '0.26', 'lle': '2.44', 'sei': '6.81'}",CHEMBL4111756,,CHEMBL4111756,5.85,False,http://www.openphacts.org/units/Nanomolar,2859325,=,37,True,=,,IC50,nM,,1400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1400.0
3230,361151,17736734,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '13.65', 'le': '0.26', 'lle': '2.38', 'sei': '7.19'}",CHEMBL4115260,,CHEMBL4115260,6.18,False,http://www.openphacts.org/units/Nanomolar,2859326,=,37,True,=,,IC50,nM,,660.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,660.0
3231,361152,17736735,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(CC3CC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.92', 'le': '0.27', 'lle': '2.67', 'sei': '7.53'}",CHEMBL4111214,,CHEMBL4111214,6.47,False,http://www.openphacts.org/units/Nanomolar,2859327,=,37,True,=,,IC50,nM,,340.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,340.0
3232,361153,17736736,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(C3CCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.21', 'le': '0.25', 'lle': '2.20', 'sei': '7.14'}",CHEMBL4113648,,CHEMBL4113648,6.14,False,http://www.openphacts.org/units/Nanomolar,2859328,=,37,True,=,,IC50,nM,,730.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,730.0
3233,361154,17736737,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(C3CCCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.97', 'le': '0.25', 'lle': '1.88', 'sei': '7.22'}",CHEMBL4107435,,CHEMBL4107435,6.21,False,http://www.openphacts.org/units/Nanomolar,2859329,=,37,True,=,,IC50,nM,,620.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,620.0
3234,361155,17736738,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(C3CCCCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.88', 'le': '0.25', 'lle': '1.63', 'sei': '7.39'}",CHEMBL4112221,,CHEMBL4112221,6.35,False,http://www.openphacts.org/units/Nanomolar,2859330,=,37,True,=,,IC50,nM,,450.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,450.0
3235,361156,17736739,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(C3CCOC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.03', 'le': '0.27', 'lle': '3.56', 'sei': '7.09'}",CHEMBL4113086,,CHEMBL4113086,6.75,False,http://www.openphacts.org/units/Nanomolar,2859331,=,37,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
3236,361157,17736740,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(C3CCOCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.85', 'le': '0.25', 'lle': '2.79', 'sei': '6.68'}",CHEMBL4106963,,CHEMBL4106963,6.36,False,http://www.openphacts.org/units/Nanomolar,2859332,=,37,True,=,,IC50,nM,,440.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,440.0
3237,361158,17736741,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '13.14', 'le': '0.27', 'lle': '4.07', 'sei': '5.35'}",CHEMBL4108247,,CHEMBL4108247,6.42,False,http://www.openphacts.org/units/Nanomolar,2859333,=,37,True,=,,IC50,nM,,380.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,380.0
3238,361159,17736742,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCS(=O)(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '12.45', 'le': '0.25', 'lle': '3.52', 'sei': '5.21'}",CHEMBL4115626,,CHEMBL4115626,6.26,False,http://www.openphacts.org/units/Nanomolar,2859334,=,37,True,=,,IC50,nM,,550.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,550.0
3239,361160,17736743,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)S(=O)(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '12.92', 'le': '0.26', 'lle': '3.55', 'sei': '5.56'}",CHEMBL4110934,,CHEMBL4110934,6.68,False,http://www.openphacts.org/units/Nanomolar,2859335,=,37,True,=,,IC50,nM,,210.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,210.0
3240,361161,17736744,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(S(=O)(=O)C3CC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.15', 'le': '0.26', 'lle': '3.89', 'sei': '5.64'}",CHEMBL4108284,,CHEMBL4108284,6.77,False,http://www.openphacts.org/units/Nanomolar,2859336,=,37,True,=,,IC50,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,170.0
3241,361162,17736745,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.02', 'le': '0.27', 'lle': '3.41', 'sei': '5.85'}",CHEMBL4106530,,CHEMBL4106530,6.57,False,http://www.openphacts.org/units/Nanomolar,2859337,=,37,True,=,,IC50,nM,,270.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,270.0
3242,361163,17736746,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.33', 'le': '0.28', 'lle': '3.97', 'sei': '5.82'}",CHEMBL4109570,,CHEMBL4109570,6.70,False,http://www.openphacts.org/units/Nanomolar,2859338,=,37,True,=,,IC50,nM,,200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,200.0
3243,361164,17736747,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.02', 'le': '0.27', 'lle': '3.41', 'sei': '6.16'}",CHEMBL4113721,,CHEMBL4113721,6.35,False,http://www.openphacts.org/units/Nanomolar,2859339,=,37,True,=,,IC50,nM,,450.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,450.0
3244,361165,17736748,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(c3ccccn3)CC2)nc(NC2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.83', 'le': '0.26', 'lle': '2.75', 'sei': '6.82'}",CHEMBL3961880,,CHEMBL3961880,6.75,False,http://www.openphacts.org/units/Nanomolar,2859340,=,37,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
3245,361166,17736749,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(c3cnccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.80', 'le': '0.26', 'lle': '3.36', 'sei': '6.04'}",CHEMBL4115128,,CHEMBL4115128,6.75,False,http://www.openphacts.org/units/Nanomolar,2859341,=,37,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
3246,361167,17736750,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(c3ncccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.48', 'le': '0.26', 'lle': '3.21', 'sei': '5.89'}",CHEMBL4107847,,CHEMBL4107847,6.58,False,http://www.openphacts.org/units/Nanomolar,2859342,=,37,True,=,,IC50,nM,,260.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,260.0
3247,361168,17736751,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.46', 'le': '0.28', 'lle': '3.06', 'sei': '7.13'}",CHEMBL4112564,,CHEMBL4112564,7.05,False,http://www.openphacts.org/units/Nanomolar,2859343,=,37,True,=,,IC50,nM,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,89.0
3248,361169,17736752,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCC(O)CO)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.62', 'le': '0.25', 'lle': '4.44', 'sei': '4.12'}",CHEMBL3977868,,CHEMBL3977868,5.09,False,http://www.openphacts.org/units/Nanomolar,2859344,=,37,True,=,,IC50,nM,,8100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8100.0
3249,361170,17736753,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@H]1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.37', 'le': '0.28', 'lle': '4.13', 'sei': '5.06'}",CHEMBL3985891,,CHEMBL3985891,5.52,False,http://www.openphacts.org/units/Nanomolar,2859345,=,37,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3000.0
3250,361171,17736754,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CCCNC1,,,CHEMBL3886492,,2015.0,"{'bei': '16.00', 'le': '0.31', 'lle': '4.38', 'sei': '7.17'}",CHEMBL3960645,,CHEMBL3960645,6.82,False,http://www.openphacts.org/units/Nanomolar,2859346,=,37,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,150.0
3251,361172,17736755,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.00', 'le': '0.27', 'lle': '4.63', 'sei': '4.28'}",CHEMBL3900615,,CHEMBL3900615,5.41,False,http://www.openphacts.org/units/Nanomolar,2859347,=,37,True,=,,IC50,nM,,3900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3900.0
3252,361173,17736756,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N=C(N)CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.92', 'le': '0.33', 'lle': '5.29', 'sei': '4.90'}",CHEMBL3971772,,CHEMBL3971772,6.52,False,http://www.openphacts.org/units/Nanomolar,2859348,=,37,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,300.0
3253,361174,17736757,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCNCCO)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.87', 'le': '0.29', 'lle': '5.31', 'sei': '5.37'}",CHEMBL3940395,,CHEMBL3940395,6.19,False,http://www.openphacts.org/units/Nanomolar,2859349,=,37,True,=,,IC50,nM,,640.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,640.0
3254,361175,17736758,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '13.88', 'le': '0.27', 'lle': '3.53', 'sei': '6.85'}",CHEMBL3908895,,CHEMBL3908895,5.92,False,http://www.openphacts.org/units/Nanomolar,2859350,=,37,True,=,,IC50,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1200.0
3255,361176,17736759,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.97', 'le': '0.33', 'lle': '5.25', 'sei': '6.85'}",CHEMBL3931358,,CHEMBL3931358,6.52,False,http://www.openphacts.org/units/Nanomolar,2859351,=,37,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,300.0
3256,361177,17736760,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCC2CCCCN2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.59', 'le': '0.26', 'lle': '3.36', 'sei': '6.09'}",CHEMBL3903386,,CHEMBL3903386,5.80,False,http://www.openphacts.org/units/Nanomolar,2859352,=,37,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1600.0
3257,361178,17736761,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCCC1CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.94', 'le': '0.25', 'lle': '2.92', 'sei': '6.60'}",CHEMBL3983202,,CHEMBL3983202,5.70,False,http://www.openphacts.org/units/Nanomolar,2859353,=,37,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2000.0
3258,361179,17736762,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCNCC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.44', 'le': '0.32', 'lle': '6.06', 'sei': '7.38'}",CHEMBL3957950,,CHEMBL3957950,7.26,False,http://www.openphacts.org/units/Nanomolar,2859354,=,37,True,=,,IC50,nM,,55.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,55.0
3259,361180,17736763,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCCC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '19.74', 'le': '0.38', 'lle': '5.92', 'sei': '10.07'}",CHEMBL3945726,,CHEMBL3945726,8.70,False,http://www.openphacts.org/units/Nanomolar,2859355,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
3260,361181,17736764,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCC(O)CC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.38', 'le': '0.26', 'lle': '4.36', 'sei': '5.73'}",CHEMBL3917833,,CHEMBL3917833,6.11,False,http://www.openphacts.org/units/Nanomolar,2859356,=,37,True,=,,IC50,nM,,780.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,780.0
3261,361182,17736765,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.26', 'le': '0.26', 'lle': '3.27', 'sei': '6.55'}",CHEMBL3906814,,CHEMBL3906814,5.66,False,http://www.openphacts.org/units/Nanomolar,2859357,=,37,True,=,,IC50,nM,,2200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2200.0
3262,361183,17736766,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.47', 'le': '0.28', 'lle': '3.94', 'sei': '6.71'}",CHEMBL3974245,,CHEMBL3974245,5.80,False,http://www.openphacts.org/units/Nanomolar,2859358,=,37,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1600.0
3263,361184,17736767,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCCNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.27', 'le': '0.24', 'lle': '3.66', 'sei': '4.53'}",CHEMBL3971606,,CHEMBL3971606,5.09,False,http://www.openphacts.org/units/Nanomolar,2859359,=,37,True,=,,IC50,nM,,8200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8200.0
3264,361185,17736768,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(CO)Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.14', 'le': '0.32', 'lle': '4.41', 'sei': '6.27'}",CHEMBL3900478,,CHEMBL3900478,6.48,False,http://www.openphacts.org/units/Nanomolar,2859360,=,37,True,=,,IC50,nM,,330.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,330.0
3265,361186,17736769,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCCC1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.56', 'le': '0.30', 'lle': '4.07', 'sei': '6.08'}",CHEMBL3982860,,CHEMBL3982860,6.64,False,http://www.openphacts.org/units/Nanomolar,2859361,=,37,True,=,,IC50,nM,,230.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,230.0
3266,361187,17736770,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCc2ncc[nH]2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.93', 'le': '0.31', 'lle': '4.48', 'sei': '6.03'}",CHEMBL3909500,,CHEMBL3909500,6.75,False,http://www.openphacts.org/units/Nanomolar,2859362,=,37,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
3267,361188,17736771,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.76', 'le': '0.31', 'lle': '4.43', 'sei': '5.91'}",CHEMBL3983974,,CHEMBL3983974,6.11,False,http://www.openphacts.org/units/Nanomolar,2859363,=,37,True,=,,IC50,nM,,780.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,780.0
3268,361189,17736772,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@H](CO)Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.04', 'le': '0.26', 'lle': '2.90', 'sei': '5.42'}",CHEMBL4108815,,CHEMBL4108815,5.60,False,http://www.openphacts.org/units/Nanomolar,2859364,=,37,True,=,,IC50,nM,,2500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2500.0
3269,361190,17736773,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@H]2c3ccccc3C[C@H]2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '11.01', 'le': '0.21', 'lle': '2.13', 'sei': '4.92'}",CHEMBL4110843,,CHEMBL4110843,5.08,False,http://www.openphacts.org/units/Nanomolar,2859365,=,37,True,=,,IC50,nM,,8300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8300.0
3270,361191,17736774,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCC(O)CC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.52', 'le': '0.28', 'lle': '3.61', 'sei': '6.01'}",CHEMBL3895042,,CHEMBL3895042,6.21,False,http://www.openphacts.org/units/Nanomolar,2859366,=,37,True,=,,IC50,nM,,620.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,620.0
3271,361192,17736775,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CCCCC2O)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.28', 'le': '0.24', 'lle': '2.65', 'sei': '5.08'}",CHEMBL3961723,,CHEMBL3961723,5.25,False,http://www.openphacts.org/units/Nanomolar,2859367,=,37,True,=,,IC50,nM,,5600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5600.0
3272,361193,17736776,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC(CO)CO)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.25', 'le': '0.34', 'lle': '6.31', 'sei': '5.63'}",CHEMBL3892724,,CHEMBL3892724,6.96,False,http://www.openphacts.org/units/Nanomolar,2859368,=,37,True,=,,IC50,nM,,110.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,110.0
3273,361194,17736777,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCC2CCNCC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.20', 'le': '0.30', 'lle': '4.19', 'sei': '6.81'}",CHEMBL3957399,,CHEMBL3957399,6.48,False,http://www.openphacts.org/units/Nanomolar,2859369,=,37,True,=,,IC50,nM,,330.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,330.0
3274,361195,17736778,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1nc(N2CCOCC2)[nH]c(=O)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.69', 'le': '0.27', 'lle': '4.00', 'sei': '6.71'}",CHEMBL3977526,,CHEMBL3977526,5.80,False,http://www.openphacts.org/units/Nanomolar,2859370,=,37,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1600.0
3275,361196,17736779,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCNCCO)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.04', 'le': '0.28', 'lle': '5.35', 'sei': '5.35'}",CHEMBL3985495,,CHEMBL3985495,6.17,False,http://www.openphacts.org/units/Nanomolar,2859371,=,37,True,=,,IC50,nM,,670.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,670.0
3276,361197,17736780,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '14.61', 'le': '0.27', 'lle': '3.81', 'sei': '7.11'}",CHEMBL3982323,,CHEMBL3982323,6.14,False,http://www.openphacts.org/units/Nanomolar,2859372,=,37,True,=,,IC50,nM,,720.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,720.0
3277,361198,17736781,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NC2CNC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '18.03', 'le': '0.33', 'lle': '5.61', 'sei': '7.17'}",CHEMBL3893206,,CHEMBL3893206,6.82,False,http://www.openphacts.org/units/Nanomolar,2859373,=,37,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,150.0
3278,361199,17736782,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCC2CCCCN2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '15.38', 'le': '0.28', 'lle': '4.09', 'sei': '6.80'}",CHEMBL3962227,,CHEMBL3962227,6.47,False,http://www.openphacts.org/units/Nanomolar,2859374,=,37,True,=,,IC50,nM,,340.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,340.0
3279,361200,17736783,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCCC1CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '13.34', 'le': '0.25', 'lle': '3.08', 'sei': '6.71'}",CHEMBL3902184,,CHEMBL3902184,5.80,False,http://www.openphacts.org/units/Nanomolar,2859375,=,37,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1600.0
3280,361201,17736784,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCCC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '12.78', 'le': '0.24', 'lle': '2.83', 'sei': '6.43'}",CHEMBL3976387,,CHEMBL3976387,5.55,False,http://www.openphacts.org/units/Nanomolar,2859376,=,37,True,=,,IC50,nM,,2800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2800.0
3281,361202,17736785,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '12.63', 'le': '0.23', 'lle': '2.98', 'sei': '6.15'}",CHEMBL3970164,,CHEMBL3970164,5.31,False,http://www.openphacts.org/units/Nanomolar,2859377,=,37,True,=,,IC50,nM,,4900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4900.0
3282,361203,17736786,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CCCNC1,,,CHEMBL3886492,,2015.0,"{'bei': '16.38', 'le': '0.30', 'lle': '4.51', 'sei': '7.24'}",CHEMBL3940600,,CHEMBL3940600,6.89,False,http://www.openphacts.org/units/Nanomolar,2859378,=,37,True,=,,IC50,nM,,130.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,130.0
3283,361204,17736787,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCC(O)CO)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '14.52', 'le': '0.27', 'lle': '5.18', 'sei': '4.67'}",CHEMBL3963673,,CHEMBL3963673,5.77,False,http://www.openphacts.org/units/Nanomolar,2859379,=,37,True,=,,IC50,nM,,1700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1700.0
3284,361205,17736788,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCC(O)CC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '12.56', 'le': '0.23', 'lle': '3.97', 'sei': '5.31'}",CHEMBL3976959,,CHEMBL3976959,5.66,False,http://www.openphacts.org/units/Nanomolar,2859380,=,37,True,=,,IC50,nM,,2200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2200.0
3285,361206,17736789,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCC2)c1-c1ccc2ccccc2n1,,,CHEMBL3886492,,2015.0,"{'bei': '12.63', 'le': '0.23', 'lle': '2.98', 'sei': '6.15'}",CHEMBL3970164,,CHEMBL3970164,5.31,False,http://www.openphacts.org/units/Nanomolar,2859377,=,37,True,=,,IC50,nM,,4900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4900.0
3286,361207,17736790,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(C2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.60', 'le': '0.30', 'lle': '3.32', 'sei': '6.98'}",CHEMBL4113026,,CHEMBL4113026,6.42,False,http://www.openphacts.org/units/Nanomolar,2859381,=,37,True,=,,IC50,nM,,380.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,380.0
3287,361208,17736791,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOC(CO)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.65', 'le': '0.32', 'lle': '5.96', 'sei': '6.38'}",CHEMBL4107195,,CHEMBL4107195,7.37,False,http://www.openphacts.org/units/Nanomolar,2859382,=,37,True,=,,IC50,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,43.0
3288,361209,17736792,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COCC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1,,,CHEMBL3886492,,2015.0,"{'bei': '15.53', 'le': '0.30', 'lle': '5.03', 'sei': '6.79'}",CHEMBL4108111,,CHEMBL4108111,7.09,False,http://www.openphacts.org/units/Nanomolar,2859383,=,37,True,=,,IC50,nM,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,81.0
3289,361210,17736793,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1,,,CHEMBL3886492,,2015.0,"{'bei': '14.82', 'le': '0.29', 'lle': '5.80', 'sei': '5.60'}",CHEMBL4114042,,CHEMBL4114042,6.96,False,http://www.openphacts.org/units/Nanomolar,2859384,=,37,True,=,,IC50,nM,,110.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,110.0
3290,361211,17736794,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.90', 'le': '0.29', 'lle': '3.28', 'sei': '6.63'}",CHEMBL4109721,,CHEMBL4109721,5.70,False,http://www.openphacts.org/units/Nanomolar,2859385,=,37,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2000.0
3291,361212,17736795,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '19.25', 'le': '0.37', 'lle': '4.85', 'sei': '8.30'}",CHEMBL4110426,,CHEMBL4110426,7.13,False,http://www.openphacts.org/units/Nanomolar,2859386,=,37,True,=,,IC50,nM,,74.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,74.0
3292,361213,17736796,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '16.14', 'le': '0.31', 'lle': '3.40', 'sei': '7.98'}",CHEMBL4108005,,CHEMBL4108005,6.85,False,http://www.openphacts.org/units/Nanomolar,2859387,=,37,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,140.0
3293,361214,17736797,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N[C@H]2c3ccccc3C[C@@H]2O)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '11.64', 'le': '0.22', 'lle': '2.24', 'sei': '4.80'}",CHEMBL4110386,,CHEMBL4110386,5.52,False,http://www.openphacts.org/units/Nanomolar,2859388,=,37,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3000.0
3294,361215,17736798,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCO)c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '16.78', 'le': '0.33', 'lle': '5.08', 'sei': '6.33'}",CHEMBL4106632,,CHEMBL4106632,6.72,False,http://www.openphacts.org/units/Nanomolar,2859389,=,37,True,=,,IC50,nM,,190.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,190.0
3295,361216,17736799,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '16.34', 'le': '0.32', 'lle': '4.37', 'sei': '7.57'}",CHEMBL4113386,,CHEMBL4113386,7.20,False,http://www.openphacts.org/units/Nanomolar,2859390,=,37,True,=,,IC50,nM,,63.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,63.0
3296,361217,17736800,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC(C)O1,,,CHEMBL3886492,,2015.0,"{'bei': '14.81', 'le': '0.29', 'lle': '3.70', 'sei': '6.85'}",CHEMBL4115548,,CHEMBL4115548,6.52,False,http://www.openphacts.org/units/Nanomolar,2859391,=,37,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,300.0
3297,361218,17736801,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '20.07', 'le': '0.39', 'lle': '5.15', 'sei': '9.26'}",CHEMBL4112758,,CHEMBL4112758,7.96,False,http://www.openphacts.org/units/Nanomolar,2859392,=,37,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
3298,361219,17736802,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CC(C)CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '14.24', 'le': '0.28', 'lle': '2.55', 'sei': '7.27'}",CHEMBL4112264,,CHEMBL4112264,6.24,False,http://www.openphacts.org/units/Nanomolar,2859393,=,37,True,=,,IC50,nM,,570.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,570.0
3299,361220,17736803,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '16.87', 'le': '0.33', 'lle': '3.71', 'sei': '8.33'}",CHEMBL4109926,,CHEMBL4109926,7.16,False,http://www.openphacts.org/units/Nanomolar,2859394,=,37,True,=,,IC50,nM,,69.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,69.0
3300,361221,17736804,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N[C@H]2c3ccccc3C[C@H]2O)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '11.80', 'le': '0.23', 'lle': '2.32', 'sei': '4.87'}",CHEMBL4111508,,CHEMBL4111508,5.60,False,http://www.openphacts.org/units/Nanomolar,2859395,=,37,True,=,,IC50,nM,,2500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2500.0
3301,361222,17736805,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N[C@@H]2c3ccccc3C[C@@H]2O)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.48', 'le': '0.24', 'lle': '2.64', 'sei': '5.15'}",CHEMBL4112528,,CHEMBL4112528,5.92,False,http://www.openphacts.org/units/Nanomolar,2859396,=,37,True,=,,IC50,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1200.0
3302,361223,17736806,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC3CCC(C2)O3)nc(NC2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.80', 'le': '0.32', 'lle': '4.79', 'sei': '7.74'}",CHEMBL3928207,,CHEMBL3928207,7.37,False,http://www.openphacts.org/units/Nanomolar,2859397,=,37,True,=,,IC50,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,43.0
3303,361224,17736807,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1nc(NC2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1)[C@H]1CC[C@H](O)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '14.10', 'le': '0.27', 'lle': '3.46', 'sei': '6.04'}",CHEMBL3892709,,CHEMBL3892709,6.41,False,http://www.openphacts.org/units/Nanomolar,2859398,=,37,True,=,,IC50,nM,,390.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,390.0
3304,361225,17736808,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)CNc1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '14.11', 'le': '0.28', 'lle': '4.53', 'sei': '4.09'}",CHEMBL4112188,,CHEMBL4112188,5.64,False,http://www.openphacts.org/units/Nanomolar,2859399,=,37,True,=,,IC50,nM,,2300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2300.0
3305,361226,17736809,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@@H](Nc2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)Cc2ccccc2N1,,,CHEMBL3886492,,2015.0,"{'bei': '10.42', 'le': '0.20', 'lle': '1.65', 'sei': '4.22'}",CHEMBL4107784,,CHEMBL4107784,5.23,False,http://www.openphacts.org/units/Nanomolar,2859400,=,37,True,=,,IC50,nM,,5900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5900.0
3306,361227,17736810,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1C[C@H](Nc2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)Cc2ccccc2N1,,,CHEMBL3886492,,2015.0,"{'bei': '10.07', 'le': '0.19', 'lle': '1.47', 'sei': '4.08'}",CHEMBL4111555,,CHEMBL4111555,5.05,False,http://www.openphacts.org/units/Nanomolar,2859401,=,37,True,=,,IC50,nM,,8900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8900.0
3307,361228,17736811,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(CO)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.36', 'le': '0.32', 'lle': '4.79', 'sei': '6.79'}",CHEMBL4113183,,CHEMBL4113183,7.21,False,http://www.openphacts.org/units/Nanomolar,2859402,=,37,True,=,,IC50,nM,,62.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,62.0
3308,361229,17736812,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC[C@H](O)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '18.52', 'le': '0.36', 'lle': '5.86', 'sei': '7.19'}",CHEMBL4107486,,CHEMBL4107486,7.64,False,http://www.openphacts.org/units/Nanomolar,2859403,=,37,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
3309,361230,17736813,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(Cc1ccccc1)c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '14.57', 'le': '0.28', 'lle': '2.66', 'sei': '7.57'}",CHEMBL4111977,,CHEMBL4111977,6.51,False,http://www.openphacts.org/units/Nanomolar,2859404,=,37,True,=,,IC50,nM,,310.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,310.0
3310,361231,17736814,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1,,,CHEMBL3886492,,2015.0,"{'bei': '16.23', 'le': '0.32', 'lle': '4.56', 'sei': '7.27'}",CHEMBL4108358,,CHEMBL4108358,6.92,False,http://www.openphacts.org/units/Nanomolar,2859405,=,37,True,=,,IC50,nM,,120.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,120.0
3311,361232,17736815,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.41', 'le': '0.34', 'lle': '3.95', 'sei': '8.32'}",CHEMBL4115147,,CHEMBL4115147,7.15,False,http://www.openphacts.org/units/Nanomolar,2859406,=,37,True,=,,IC50,nM,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,71.0
3312,361233,17736816,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1)[C@H](CO)c1ccccc1,,,CHEMBL3886492,,2015.0,"{'bei': '13.85', 'le': '0.27', 'lle': '3.22', 'sei': '6.22'}",CHEMBL4113079,,CHEMBL4113079,6.60,False,http://www.openphacts.org/units/Nanomolar,2859407,=,37,True,=,,IC50,nM,,250.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,250.0
3313,361234,17736817,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(NCCO)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.42', 'le': '0.32', 'lle': '4.74', 'sei': '5.52'}",CHEMBL4112772,,CHEMBL4112772,6.35,False,http://www.openphacts.org/units/Nanomolar,2859408,=,37,True,=,,IC50,nM,,450.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,450.0
3314,361235,17736818,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(F)(F)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.92', 'le': '0.31', 'lle': '3.66', 'sei': '8.27'}",CHEMBL4112969,,CHEMBL4112969,7.11,False,http://www.openphacts.org/units/Nanomolar,2859409,=,37,True,=,,IC50,nM,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,78.0
3315,361236,17736819,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3CCCCC3C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.95', 'le': '0.27', 'lle': '2.25', 'sei': '7.54'}",CHEMBL4113046,,CHEMBL4113046,6.48,False,http://www.openphacts.org/units/Nanomolar,2859410,=,37,True,=,,IC50,nM,,330.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,330.0
3316,361237,17736820,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCCCN1c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1,,,CHEMBL3886492,,2015.0,"{'bei': '15.43', 'le': '0.30', 'lle': '2.96', 'sei': '7.62'}",CHEMBL4111300,,CHEMBL4111300,6.55,False,http://www.openphacts.org/units/Nanomolar,2859411,=,37,True,=,,IC50,nM,,280.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,280.0
3317,361238,17736821,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC[C@@H](O)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '18.83', 'le': '0.37', 'lle': '5.99', 'sei': '7.32'}",CHEMBL4107909,,CHEMBL4107909,7.77,False,http://www.openphacts.org/units/Nanomolar,2859412,=,37,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
3318,361239,17736822,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '13.99', 'le': '0.27', 'lle': '4.47', 'sei': '5.97'}",CHEMBL4110865,,CHEMBL4110865,6.35,False,http://www.openphacts.org/units/Nanomolar,2859413,=,37,True,=,,IC50,nM,,450.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,450.0
3319,361240,17736823,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CC3(COC3)C2)nc(NC2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '17.91', 'le': '0.35', 'lle': '5.55', 'sei': '7.99'}",CHEMBL3955522,,CHEMBL3955522,7.60,False,http://www.openphacts.org/units/Nanomolar,2859414,=,37,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
3320,361241,17736824,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.69', 'le': '0.30', 'lle': '5.72', 'sei': '5.39'}",CHEMBL4107588,,CHEMBL4107588,7.13,False,http://www.openphacts.org/units/Nanomolar,2859415,=,37,True,=,,IC50,nM,,74.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,74.0
3321,361242,17736825,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(c2ccc(Cl)cc2)CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1,,,CHEMBL3886492,,2015.0,"{'bei': '10.43', 'le': '0.21', 'lle': '0.98', 'sei': '5.89'}",CHEMBL4113216,,CHEMBL4113216,5.60,False,http://www.openphacts.org/units/Nanomolar,2859416,=,37,True,=,,IC50,nM,,2500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2500.0
3322,361243,17736826,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1,,,CHEMBL3886492,,2015.0,"{'bei': '14.46', 'le': '0.28', 'lle': '5.10', 'sei': '4.98'}",CHEMBL4106733,,CHEMBL4106733,6.60,False,http://www.openphacts.org/units/Nanomolar,2859417,=,37,True,=,,IC50,nM,,250.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,250.0
3323,361244,17736827,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1,,,CHEMBL3886492,,2015.0,"{'bei': '13.92', 'le': '0.27', 'lle': '4.76', 'sei': '5.55'}",CHEMBL4109340,,CHEMBL4109340,6.75,False,http://www.openphacts.org/units/Nanomolar,2859418,=,37,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
3324,361245,17736828,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.56', 'le': '0.30', 'lle': '4.48', 'sei': '5.91'}",CHEMBL4115340,,CHEMBL4115340,6.62,False,http://www.openphacts.org/units/Nanomolar,2859419,=,37,True,=,,IC50,nM,,240.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,240.0
3325,361246,17736829,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1)OCc1ccccc1,,,CHEMBL3886492,,2015.0,"{'bei': '12.51', 'le': '0.24', 'lle': '2.89', 'sei': '5.63'}",CHEMBL4112383,,CHEMBL4112383,7.00,False,http://www.openphacts.org/units/Nanomolar,2859420,=,37,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
3326,361247,17736830,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3(CCN(c4ncccn4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.95', 'le': '0.28', 'lle': '4.81', 'sei': '6.89'}",CHEMBL4107849,,CHEMBL4107849,7.92,False,http://www.openphacts.org/units/Nanomolar,2859421,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
3327,361248,17736831,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC2(CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)C2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '16.36', 'le': '0.32', 'lle': '4.88', 'sei': '8.54'}",CHEMBL4110996,,CHEMBL4110996,7.62,False,http://www.openphacts.org/units/Nanomolar,2859422,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
3328,361249,17736832,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC2(CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)C2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '15.98', 'le': '0.31', 'lle': '5.23', 'sei': '7.42'}",CHEMBL4110921,,CHEMBL4110921,7.89,False,http://www.openphacts.org/units/Nanomolar,2859423,=,37,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
3329,361250,17736833,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3(CCN(Cc4ccccc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.97', 'le': '0.27', 'lle': '3.26', 'sei': '8.49'}",CHEMBL4111625,,CHEMBL4111625,7.57,False,http://www.openphacts.org/units/Nanomolar,2859424,=,37,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
3330,361251,17736834,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3(CCN(S(=O)(=O)c4ccccc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '12.91', 'le': '0.25', 'lle': '4.14', 'sei': '6.19'}",CHEMBL4107129,,CHEMBL4107129,7.64,False,http://www.openphacts.org/units/Nanomolar,2859425,=,37,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
3331,361252,17736835,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc2c(c1)CN(c1nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]1)CC2,,,CHEMBL3886492,,2015.0,"{'bei': '15.43', 'le': '0.29', 'lle': '3.95', 'sei': '6.53'}",CHEMBL4111179,,CHEMBL4111179,7.31,False,http://www.openphacts.org/units/Nanomolar,2859426,=,37,True,=,,IC50,nM,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,49.0
3332,361253,17736836,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(N2CCC3(CCN(c4nc(N[C@@H]5CCCNC5)c(-c5nc6ccccc6s5)c(=O)[nH]4)C3)C2)cc1,,,CHEMBL3886492,,2015.0,"{'bei': '13.77', 'le': '0.26', 'lle': '3.35', 'sei': '7.80'}",CHEMBL4114255,,CHEMBL4114255,7.68,False,http://www.openphacts.org/units/Nanomolar,2859427,=,37,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
3333,361254,17736837,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3(CCN(c4ccc(Cl)cc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.04', 'le': '0.26', 'lle': '2.36', 'sei': '8.22'}",CHEMBL4113697,,CHEMBL4113697,7.33,False,http://www.openphacts.org/units/Nanomolar,2859428,=,37,True,=,,IC50,nM,,47.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,47.0
3334,361255,17736838,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC(NCc3ccccc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.49', 'le': '0.26', 'lle': '2.99', 'sei': '7.10'}",CHEMBL4112885,,CHEMBL4112885,6.96,False,http://www.openphacts.org/units/Nanomolar,2859429,=,37,True,=,,IC50,nM,,110.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,110.0
3335,361256,17736839,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1,,,CHEMBL3886492,,2015.0,"{'bei': '15.03', 'le': '0.29', 'lle': '4.71', 'sei': '6.11'}",CHEMBL4110923,,CHEMBL4110923,7.03,False,http://www.openphacts.org/units/Nanomolar,2859430,=,37,True,=,,IC50,nM,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,94.0
3336,361257,17736840,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3(CCN(c4ccccc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.55', 'le': '0.28', 'lle': '3.36', 'sei': '8.61'}",CHEMBL4114391,,CHEMBL4114391,7.68,False,http://www.openphacts.org/units/Nanomolar,2859431,=,37,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
3337,361258,17736841,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3(CC2)CNC3)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '16.38', 'le': '0.32', 'lle': '5.00', 'sei': '7.55'}",CHEMBL4115124,,CHEMBL4115124,7.40,False,http://www.openphacts.org/units/Nanomolar,2859432,=,37,True,=,,IC50,nM,,40.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,40.0
3338,361259,17736842,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N1CC2(CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)C1,,,CHEMBL3886492,,2015.0,"{'bei': '13.72', 'le': '0.27', 'lle': '3.52', 'sei': '6.55'}",CHEMBL4113392,,CHEMBL4113392,7.57,False,http://www.openphacts.org/units/Nanomolar,2859433,=,37,True,=,,IC50,nM,,27.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,27.0
3339,361260,17736843,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(C(F)(F)F)ccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.89', 'le': '0.30', 'lle': '4.08', 'sei': '7.52'}",CHEMBL4112012,,CHEMBL4112012,7.16,False,http://www.openphacts.org/units/Nanomolar,2859434,=,37,True,=,,IC50,nM,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,70.0
3340,361261,17736844,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cccc(C(F)(F)F)c2s1,,,CHEMBL3886492,,2015.0,"{'bei': '13.08', 'le': '0.26', 'lle': '3.21', 'sei': '6.60'}",CHEMBL4114583,,CHEMBL4114583,6.28,False,http://www.openphacts.org/units/Nanomolar,2859435,=,37,True,=,,IC50,nM,,520.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,520.0
3341,361262,17736845,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cccc(Cl)c2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.09', 'le': '0.31', 'lle': '4.04', 'sei': '7.09'}",CHEMBL4114416,,CHEMBL4114416,6.75,False,http://www.openphacts.org/units/Nanomolar,2859436,=,37,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
3342,361263,17736846,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2nc(-c3c(NC4CCCNC4)nc(N4CCOCC4)[nH]c3=O)sc12,,,CHEMBL3886492,,2015.0,"{'bei': '14.62', 'le': '0.28', 'lle': '3.88', 'sei': '6.55'}",CHEMBL3941496,,CHEMBL3941496,6.24,False,http://www.openphacts.org/units/Nanomolar,2859437,=,37,True,=,,IC50,nM,,580.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,580.0
3343,361264,17736847,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1,,,CHEMBL3886492,,2015.0,"{'bei': '17.12', 'le': '0.33', 'lle': '4.94', 'sei': '7.67'}",CHEMBL4108358,,CHEMBL4108358,7.30,False,http://www.openphacts.org/units/Nanomolar,2859405,=,37,True,=,,IC50,nM,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,50.0
3344,361265,17736848,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1,,,CHEMBL3886492,,2015.0,"{'bei': '12.56', 'le': '0.24', 'lle': '2.55', 'sei': '6.18'}",CHEMBL4113534,,CHEMBL4113534,5.89,False,http://www.openphacts.org/units/Nanomolar,2859438,=,37,True,=,,IC50,nM,,1300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1300.0
3345,361266,17736849,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(Cl)ccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '18.12', 'le': '0.37', 'lle': '5.40', 'sei': '8.51'}",CHEMBL4108791,,CHEMBL4108791,8.10,False,http://www.openphacts.org/units/Nanomolar,2859439,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3346,361267,17736850,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cccc(C3CC3)c2s1,,,CHEMBL3886492,,2015.0,"{'bei': '11.81', 'le': '0.23', 'lle': '2.43', 'sei': '5.62'}",CHEMBL4106474,,CHEMBL4106474,5.35,False,http://www.openphacts.org/units/Nanomolar,2859440,=,37,True,=,,IC50,nM,,4500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4500.0
3347,361268,17736851,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(Br)ccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '15.71', 'le': '0.35', 'lle': '4.91', 'sei': '8.11'}",CHEMBL4112923,,CHEMBL4112923,7.72,False,http://www.openphacts.org/units/Nanomolar,2859441,=,37,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
3348,361269,17736852,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(C3CC3)ccc2s1,,,CHEMBL3886492,,2015.0,"{'bei': '14.32', 'le': '0.28', 'lle': '3.56', 'sei': '6.81'}",CHEMBL4112199,,CHEMBL4112199,6.48,False,http://www.openphacts.org/units/Nanomolar,2859442,=,37,True,=,,IC50,nM,,330.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,330.0
3349,361270,17736853,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1,,,CHEMBL3886492,,2015.0,"{'bei': '17.56', 'le': '0.34', 'lle': '6.85', 'sei': '5.79'}",CHEMBL4111047,,CHEMBL4111047,8.00,False,http://www.openphacts.org/units/Nanomolar,2859443,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3350,361271,17736854,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1,,,CHEMBL3886492,,2015.0,"{'bei': '18.97', 'le': '0.37', 'lle': '6.38', 'sei': '6.98'}",CHEMBL4107459,,CHEMBL4107459,8.30,False,http://www.openphacts.org/units/Nanomolar,2859444,=,37,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
3351,361272,17736855,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '14.45', 'le': '0.28', 'lle': '4.11', 'sei': '7.54'}",CHEMBL4109750,,CHEMBL4109750,7.70,False,http://www.openphacts.org/units/Nanomolar,2859445,=,37,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
3352,361273,17736856,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(c3ncccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '14.39', 'le': '0.28', 'lle': '4.70', 'sei': '6.68'}",CHEMBL4108607,,CHEMBL4108607,7.68,False,http://www.openphacts.org/units/Nanomolar,2859446,=,37,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
3353,361274,17736857,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '14.41', 'le': '0.27', 'lle': '2.81', 'sei': '8.43'}",CHEMBL4106577,,CHEMBL4106577,7.24,False,http://www.openphacts.org/units/Nanomolar,2859447,=,37,True,=,,IC50,nM,,57.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,57.0
3354,361275,17736858,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1,,,CHEMBL3886492,,2015.0,"{'bei': '10.48', 'le': '0.20', 'lle': '0.84', 'sei': '6.13'}",CHEMBL4106577,,CHEMBL4106577,5.27,False,http://www.openphacts.org/units/Nanomolar,2859447,=,37,True,=,,IC50,nM,,5400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5400.0
3355,361276,17736859,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCC[C@@H]1Nc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12,,,CHEMBL3886492,,2015.0,"{'bei': '14.52', 'le': '0.28', 'lle': '4.89', 'sei': '5.72'}",CHEMBL4108331,,CHEMBL4108331,7.62,False,http://www.openphacts.org/units/Nanomolar,2859448,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
3356,361277,17736860,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCC[C@@H]1Nc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12,,,CHEMBL3886492,,2015.0,"{'bei': '13.64', 'le': '0.26', 'lle': '4.42', 'sei': '5.37'}",CHEMBL4108331,,CHEMBL4108331,7.16,False,http://www.openphacts.org/units/Nanomolar,2859448,=,37,True,=,,IC50,nM,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,70.0
3357,361278,17736861,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCC[C@H]1Nc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12,,,CHEMBL3886492,,2015.0,"{'bei': '16.58', 'le': '0.32', 'lle': '5.97', 'sei': '6.53'}",CHEMBL4113995,,CHEMBL4113995,8.70,False,http://www.openphacts.org/units/Nanomolar,2859449,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
3358,361279,17736862,[],CHEMBL3887893,"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).",B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12,,,CHEMBL3886492,,2015.0,"{'bei': '16.57', 'le': '0.32', 'lle': '6.38', 'sei': '5.85'}",CHEMBL4109051,,CHEMBL4109051,7.80,False,http://www.openphacts.org/units/Nanomolar,2859450,=,37,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
3359,364759,17739902,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cc(O)cnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '22.45', 'le': '0.44', 'lle': '6.48', 'sei': '8.27'}",CHEMBL3353219,,CHEMBL3353219,9.00,False,http://www.openphacts.org/units/Nanomolar,2861277,=,37,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.0
3360,364760,17739903,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2cc3ncccc3cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '21.67', 'le': '0.40', 'lle': '6.00', 'sei': '8.58'}",CHEMBL3950656,,CHEMBL3950656,8.70,False,http://www.openphacts.org/units/Nanomolar,2861278,=,37,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
3361,364761,17739904,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2nc(NCCO)ccc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '22.52', 'le': '0.42', 'lle': '6.58', 'sei': '7.50'}",CHEMBL3979633,,CHEMBL3979633,8.52,False,http://www.openphacts.org/units/Nanomolar,2861279,=,37,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
3362,364762,17739905,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2cc(C(=O)Nc3ccccc3)ccc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '17.89', 'le': '0.33', 'lle': '4.99', 'sei': '7.14'}",CHEMBL3920056,,CHEMBL3920056,8.40,False,http://www.openphacts.org/units/Nanomolar,2861280,=,37,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
3363,364763,17739906,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '20.76', 'le': '0.40', 'lle': '5.07', 'sei': '10.03'}",CHEMBL3890299,,CHEMBL3890299,8.30,False,http://www.openphacts.org/units/Nanomolar,2861281,=,37,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
3364,364764,17739907,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1O[C@H]1CC[C@@H](O)CC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.39', 'le': '0.37', 'lle': '3.98', 'sei': '8.39'}",CHEMBL3967068,,CHEMBL3967068,8.15,False,http://www.openphacts.org/units/Nanomolar,2861282,=,37,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
3365,364765,17739908,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)CCN)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.82', 'le': '0.38', 'lle': '5.20', 'sei': '7.62'}",CHEMBL3353220,,CHEMBL3353220,8.10,False,http://www.openphacts.org/units/Nanomolar,2861283,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3366,364766,17739909,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1cnn2ccccc12,,,CHEMBL3886519,,2016.0,"{'bei': '21.80', 'le': '0.39', 'lle': '3.97', 'sei': '12.95'}",CHEMBL3895793,,CHEMBL3895793,8.10,False,http://www.openphacts.org/units/Nanomolar,2861284,=,37,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3367,364767,17739910,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1cnn2cc(O)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '23.99', 'le': '0.44', 'lle': '5.81', 'sei': '7.92'}",CHEMBL3978719,,CHEMBL3978719,8.05,False,http://www.openphacts.org/units/Nanomolar,2861285,=,37,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
3368,364768,17739911,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2nc(NCCO)ccc2cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '20.23', 'le': '0.39', 'lle': '5.10', 'sei': '7.32'}",CHEMBL3904732,,CHEMBL3904732,8.00,False,http://www.openphacts.org/units/Nanomolar,2861286,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3369,364769,17739912,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCCN)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '20.28', 'le': '0.39', 'lle': '5.13', 'sei': '6.95'}",CHEMBL3943097,,CHEMBL3943097,8.00,False,http://www.openphacts.org/units/Nanomolar,2861287,=,37,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3370,364770,17739913,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1O[C@H]1CC[C@H](O)CC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.93', 'le': '0.36', 'lle': '3.79', 'sei': '8.19'}",CHEMBL3972673,,CHEMBL3972673,7.96,False,http://www.openphacts.org/units/Nanomolar,2861288,=,37,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
3371,364771,17739914,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '20.34', 'le': '0.39', 'lle': '3.44', 'sei': '11.15'}",CHEMBL3929293,,CHEMBL3929293,7.92,False,http://www.openphacts.org/units/Nanomolar,2861289,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
3372,364772,17739915,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2cc3ncccc3cc2NC(=O)c2csc3cncnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '18.93', 'le': '0.36', 'lle': '4.25', 'sei': '8.16'}",CHEMBL3953525,,CHEMBL3953525,7.92,False,http://www.openphacts.org/units/Nanomolar,2861290,=,37,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
3373,364773,17739916,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1O[C@@H]1CC[C@@H](O)C1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.25', 'le': '0.37', 'lle': '4.04', 'sei': '8.05'}",CHEMBL4108668,,CHEMBL4108668,7.82,False,http://www.openphacts.org/units/Nanomolar,2861291,=,37,True,=,,IC50,nM,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.0
3374,364774,17739917,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1cnn2cc(O)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.27', 'le': '0.38', 'lle': '5.19', 'sei': '7.52'}",CHEMBL3944798,,CHEMBL3944798,7.75,False,http://www.openphacts.org/units/Nanomolar,2861292,=,37,True,=,,IC50,nM,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.0
3375,364775,17739918,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '23.02', 'le': '0.44', 'lle': '4.24', 'sei': '10.06'}",CHEMBL3822972,,CHEMBL3822972,7.75,False,http://www.openphacts.org/units/Nanomolar,2861293,=,37,True,=,,IC50,nM,,18.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,18.0
3376,364776,17739919,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(O)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.96', 'le': '0.37', 'lle': '4.62', 'sei': '7.01'}",CHEMBL3939426,,CHEMBL3939426,7.64,False,http://www.openphacts.org/units/Nanomolar,2861294,=,37,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
3377,364777,17739920,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1OC1CCC(O)CC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.12', 'le': '0.35', 'lle': '3.45', 'sei': '7.84'}",CHEMBL3902455,,CHEMBL3902455,7.62,False,http://www.openphacts.org/units/Nanomolar,2861295,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
3378,364778,17739921,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCCCC1)c1cnn2nc(O)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '20.44', 'le': '0.40', 'lle': '4.89', 'sei': '7.97'}",CHEMBL3930442,,CHEMBL3930442,7.62,False,http://www.openphacts.org/units/Nanomolar,2861296,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
3379,364779,17739922,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CC(C)Oc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.65', 'le': '0.36', 'lle': '3.59', 'sei': '7.84'}",CHEMBL3893473,,CHEMBL3893473,7.62,False,http://www.openphacts.org/units/Nanomolar,2861297,=,37,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
3380,364780,17739923,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1cnn2nc(O)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.75', 'le': '0.37', 'lle': '5.61', 'sei': '6.52'}",CHEMBL3917961,,CHEMBL3917961,7.55,False,http://www.openphacts.org/units/Nanomolar,2861298,=,37,True,=,,IC50,nM,,28.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,28.0
3381,364781,17739924,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1OC1CCC(O)CC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.68', 'le': '0.34', 'lle': '4.33', 'sei': '7.42'}",CHEMBL3951842,,CHEMBL3951842,7.54,False,http://www.openphacts.org/units/Nanomolar,2861299,=,37,True,=,,IC50,nM,,29.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,29.0
3382,364782,17739925,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)CCO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.41', 'le': '0.35', 'lle': '4.61', 'sei': '7.50'}",CHEMBL3924130,,CHEMBL3924130,7.54,False,http://www.openphacts.org/units/Nanomolar,2861300,=,37,True,=,,IC50,nM,,29.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,29.0
3383,364783,17739926,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '19.51', 'le': '0.38', 'lle': '4.70', 'sei': '8.48'}",CHEMBL3960537,,CHEMBL3960537,7.51,False,http://www.openphacts.org/units/Nanomolar,2861301,=,37,True,=,,IC50,nM,,31.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,31.0
3384,364784,17739927,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '19.51', 'le': '0.38', 'lle': '4.70', 'sei': '8.48'}",CHEMBL3960537,,CHEMBL3960537,7.51,False,http://www.openphacts.org/units/Nanomolar,2861301,=,37,True,=,,IC50,nM,,31.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,31.0
3385,364785,17739928,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '19.51', 'le': '0.38', 'lle': '4.70', 'sei': '8.48'}",CHEMBL3960537,,CHEMBL3960537,7.51,False,http://www.openphacts.org/units/Nanomolar,2861301,=,37,True,=,,IC50,nM,,31.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,31.0
3386,364786,17739929,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CCOc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.97', 'le': '0.36', 'lle': '3.84', 'sei': '7.69'}",CHEMBL3909778,,CHEMBL3909778,7.48,False,http://www.openphacts.org/units/Nanomolar,2861302,=,37,True,=,,IC50,nM,,33.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,33.0
3387,364787,17739930,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cnc2c(C(=O)Nc3cc(Cl)ccc3N3CCC(CO)CC3)cnn2c1,,,CHEMBL3886519,,2016.0,"{'bei': '17.99', 'le': '0.35', 'lle': '4.63', 'sei': '8.13'}",CHEMBL3946548,,CHEMBL3946548,7.48,False,http://www.openphacts.org/units/Nanomolar,2861303,=,37,True,=,,IC50,nM,,33.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,33.0
3388,364788,17739931,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cc(CO)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '20.40', 'le': '0.39', 'lle': '3.86', 'sei': '8.84'}",CHEMBL3915121,,CHEMBL3915121,7.46,False,http://www.openphacts.org/units/Nanomolar,2861304,=,37,True,=,,IC50,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,35.0
3389,364789,17739932,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '19.31', 'le': '0.38', 'lle': '4.62', 'sei': '8.39'}",CHEMBL3960537,,CHEMBL3960537,7.43,False,http://www.openphacts.org/units/Nanomolar,2861301,=,37,True,=,,IC50,nM,,37.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,37.0
3390,364790,17739933,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1OC1CCNCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.05', 'le': '0.35', 'lle': '4.74', 'sei': '7.92'}",CHEMBL3957189,,CHEMBL3957189,7.40,False,http://www.openphacts.org/units/Nanomolar,2861305,=,37,True,=,,IC50,nM,,40.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,40.0
3391,364791,17739934,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '23.07', 'le': '0.42', 'lle': '4.83', 'sei': '9.05'}",CHEMBL3952937,,CHEMBL3952937,7.37,False,http://www.openphacts.org/units/Nanomolar,2861306,=,37,True,=,,IC50,nM,,43.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,43.0
3392,364792,17739935,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc2N1,,,CHEMBL3886519,,2016.0,"{'bei': '17.98', 'le': '0.33', 'lle': '5.63', 'sei': '6.53'}",CHEMBL3981674,,CHEMBL3981674,7.31,False,http://www.openphacts.org/units/Nanomolar,2861307,=,37,True,=,,IC50,nM,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,49.0
3393,364793,17739936,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CCO)Oc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.90', 'le': '0.34', 'lle': '3.28', 'sei': '7.52'}",CHEMBL3958152,,CHEMBL3958152,7.31,False,http://www.openphacts.org/units/Nanomolar,2861308,=,37,True,=,,IC50,nM,,49.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,49.0
3394,364794,17739937,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2cc(-c3ccc(CO)cc3)c(NC(=O)c3cnn4cccnc34)cc2[nH]1,,,CHEMBL3886519,,2016.0,"{'bei': '18.33', 'le': '0.33', 'lle': '3.35', 'sei': '7.64'}",CHEMBL3892637,,CHEMBL3892637,7.28,False,http://www.openphacts.org/units/Nanomolar,2861309,=,37,True,=,,IC50,nM,,52.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,52.0
3395,364795,17739938,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cc(O)cnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '16.96', 'le': '0.33', 'lle': '4.16', 'sei': '8.46'}",CHEMBL3969222,,CHEMBL3969222,7.28,False,http://www.openphacts.org/units/Nanomolar,2861310,=,37,True,=,,IC50,nM,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,53.0
3396,364796,17739939,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '18.15', 'le': '0.35', 'lle': '5.15', 'sei': '6.69'}",CHEMBL3941139,,CHEMBL3941139,7.28,False,http://www.openphacts.org/units/Nanomolar,2861311,=,37,True,=,,IC50,nM,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,53.0
3397,364797,17739940,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N[C@H](C)CO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.59', 'le': '0.34', 'lle': '3.91', 'sei': '6.59'}",CHEMBL4112700,,CHEMBL4112700,7.20,False,http://www.openphacts.org/units/Nanomolar,2861312,=,37,True,=,,IC50,nM,,63.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,63.0
3398,364798,17739941,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '17.95', 'le': '0.35', 'lle': '4.82', 'sei': '6.78'}",CHEMBL3907051,,CHEMBL3907051,7.16,False,http://www.openphacts.org/units/Nanomolar,2861313,=,37,True,=,,IC50,nM,,69.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,69.0
3399,364799,17739942,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1csc2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.80', 'le': '0.36', 'lle': '2.74', 'sei': '10.93'}",CHEMBL3891503,,CHEMBL3891503,7.16,False,http://www.openphacts.org/units/Nanomolar,2861314,=,37,True,=,,IC50,nM,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,70.0
3400,364800,17739943,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.51', 'le': '0.36', 'lle': '4.30', 'sei': '8.63'}",CHEMBL3919571,,CHEMBL3919571,7.14,False,http://www.openphacts.org/units/Nanomolar,2861315,=,37,True,=,,IC50,nM,,72.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,72.0
3401,364801,17739944,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NC3CC3)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.22', 'le': '0.35', 'lle': '3.06', 'sei': '8.01'}",CHEMBL3903936,,CHEMBL3903936,7.13,False,http://www.openphacts.org/units/Nanomolar,2861316,=,37,True,=,,IC50,nM,,74.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,74.0
3402,364802,17739945,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1,,,CHEMBL3886519,,2016.0,"{'bei': '18.45', 'le': '0.36', 'lle': '4.28', 'sei': '8.60'}",CHEMBL3889839,,CHEMBL3889839,7.12,False,http://www.openphacts.org/units/Nanomolar,2861317,=,37,True,=,,IC50,nM,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,76.0
3403,364803,17739946,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCCO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.00', 'le': '0.35', 'lle': '4.22', 'sei': '6.52'}",CHEMBL3905293,,CHEMBL3905293,7.12,False,http://www.openphacts.org/units/Nanomolar,2861318,=,37,True,=,,IC50,nM,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,76.0
3404,364804,17739947,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCc1ccc(-c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)cc1,,,CHEMBL3886519,,2016.0,"{'bei': '18.77', 'le': '0.36', 'lle': '3.33', 'sei': '8.31'}",CHEMBL3976077,,CHEMBL3976077,7.09,False,http://www.openphacts.org/units/Nanomolar,2861319,=,37,True,=,,IC50,nM,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,81.0
3405,364805,17739948,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCC(O)CO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.65', 'le': '0.32', 'lle': '4.82', 'sei': '5.47'}",CHEMBL3899862,,CHEMBL3899862,7.09,False,http://www.openphacts.org/units/Nanomolar,2861320,=,37,True,=,,IC50,nM,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,82.0
3406,364806,17739949,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2cc(N3CCCCC3)c(NC(=O)c3cnn4cccnc34)cc2N1,,,CHEMBL3886519,,2016.0,"{'bei': '18.62', 'le': '0.34', 'lle': '4.54', 'sei': '7.65'}",CHEMBL3965265,,CHEMBL3965265,7.01,False,http://www.openphacts.org/units/Nanomolar,2861321,=,37,True,=,,IC50,nM,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,98.0
3407,364807,17739950,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.37', 'le': '0.35', 'lle': '3.19', 'sei': '8.93'}",CHEMBL3898083,,CHEMBL3898083,7.00,False,http://www.openphacts.org/units/Nanomolar,2861322,=,37,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
3408,364808,17739951,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCCCN)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.13', 'le': '0.33', 'lle': '3.74', 'sei': '6.08'}",CHEMBL3925304,,CHEMBL3925304,7.00,False,http://www.openphacts.org/units/Nanomolar,2861323,=,37,True,=,,IC50,nM,,101.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,101.0
3409,364809,17739952,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCCOc1cc2ncccc2cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.41', 'le': '0.35', 'lle': '3.77', 'sei': '6.78'}",CHEMBL3983893,,CHEMBL3983893,6.99,False,http://www.openphacts.org/units/Nanomolar,2861324,=,37,True,=,,IC50,nM,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,103.0
3410,364810,17739953,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc2c(C(=O)Nc3cc(Cl)ccc3OC3CCC(O)CC3)cnn2c1,,,CHEMBL3886519,,2016.0,"{'bei': '16.22', 'le': '0.32', 'lle': '4.55', 'sei': '5.29'}",CHEMBL3953542,,CHEMBL3953542,6.97,False,http://www.openphacts.org/units/Nanomolar,2861325,=,37,True,=,,IC50,nM,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,107.0
3411,364811,17739954,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCN)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.45', 'le': '0.38', 'lle': '3.99', 'sei': '6.82'}",CHEMBL3942983,,CHEMBL3942983,6.97,False,http://www.openphacts.org/units/Nanomolar,2861326,=,37,True,=,,IC50,nM,,107.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,107.0
3412,364812,17739955,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1O[C@@H]1CC[C@H](O)C1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.01', 'le': '0.33', 'lle': '3.13', 'sei': '7.11'}",CHEMBL3975753,,CHEMBL3975753,6.91,False,http://www.openphacts.org/units/Nanomolar,2861327,=,37,True,=,,IC50,nM,,122.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,122.0
3413,364813,17739956,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2ccccc2cc1OC1CCC(O)CC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.16', 'le': '0.31', 'lle': '3.09', 'sei': '7.78'}",CHEMBL3937613,,CHEMBL3937613,6.91,False,http://www.openphacts.org/units/Nanomolar,2861328,=,37,True,=,,IC50,nM,,124.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,124.0
3414,364814,17739957,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1OC1CCNCC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.02', 'le': '0.33', 'lle': '3.28', 'sei': '7.75'}",CHEMBL3967276,,CHEMBL3967276,6.90,False,http://www.openphacts.org/units/Nanomolar,2861329,=,37,True,=,,IC50,nM,,125.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,125.0
3415,364815,17739958,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(CCO)C(C)C)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.76', 'le': '0.30', 'lle': '3.19', 'sei': '6.86'}",CHEMBL3895108,,CHEMBL3895108,6.90,False,http://www.openphacts.org/units/Nanomolar,2861330,=,37,True,=,,IC50,nM,,127.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,127.0
3416,364816,17739959,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1OCCCO)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.09', 'le': '0.35', 'lle': '3.63', 'sei': '7.08'}",CHEMBL3919594,,CHEMBL3919594,6.88,False,http://www.openphacts.org/units/Nanomolar,2861331,=,37,True,=,,IC50,nM,,131.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,131.0
3417,364817,17739960,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2c(N)cccc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '18.82', 'le': '0.35', 'lle': '5.14', 'sei': '6.00'}",CHEMBL3951738,,CHEMBL3951738,6.88,False,http://www.openphacts.org/units/Nanomolar,2861332,=,37,True,=,,IC50,nM,,133.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,133.0
3418,364818,17739961,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(O)CC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.47', 'le': '0.36', 'lle': '4.27', 'sei': '8.30'}",CHEMBL3980609,,CHEMBL3980609,6.87,False,http://www.openphacts.org/units/Nanomolar,2861333,=,37,True,=,,IC50,nM,,136.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,136.0
3419,364819,17739962,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(Br)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.74', 'le': '0.33', 'lle': '2.78', 'sei': '7.73'}",CHEMBL3909577,,CHEMBL3909577,6.86,False,http://www.openphacts.org/units/Nanomolar,2861334,=,37,True,=,,IC50,nM,,137.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,137.0
3420,364820,17739963,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1O[C@H]1CC[C@@H](O)CC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.90', 'le': '0.35', 'lle': '2.55', 'sei': '8.09'}",CHEMBL3941034,,CHEMBL3941034,6.83,False,http://www.openphacts.org/units/Nanomolar,2861335,=,37,True,=,,IC50,nM,,149.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,149.0
3421,364821,17739964,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc(NC(=O)c2cnn3cccnc23)c1N1CCCCC1,,,CHEMBL3886519,,2016.0,"{'bei': '20.23', 'le': '0.37', 'lle': '4.26', 'sei': '7.69'}",CHEMBL3974236,,CHEMBL3974236,6.81,False,http://www.openphacts.org/units/Nanomolar,2861336,=,37,True,=,,IC50,nM,,156.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,156.0
3422,364822,17739965,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2csc3cncnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '16.86', 'le': '0.34', 'lle': '3.01', 'sei': '8.05'}",CHEMBL3944795,,CHEMBL3944795,6.78,False,http://www.openphacts.org/units/Nanomolar,2861337,=,37,True,=,,IC50,nM,,167.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,167.0
3423,364823,17739966,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2ccccc2cc1OC1CCC(O)C1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.38', 'le': '0.32', 'lle': '3.32', 'sei': '7.61'}",CHEMBL3982232,,CHEMBL3982232,6.75,False,http://www.openphacts.org/units/Nanomolar,2861338,=,37,True,=,,IC50,nM,,177.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,177.0
3424,364824,17739967,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(CO)ccc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.07', 'le': '0.35', 'lle': '4.24', 'sei': '8.10'}",CHEMBL3950081,,CHEMBL3950081,6.70,False,http://www.openphacts.org/units/Nanomolar,2861339,=,37,True,=,,IC50,nM,,199.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,199.0
3425,364825,17739968,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc2c(C(=O)Nc3cc(Cl)ccc3O[C@H]3CC[C@@H](O)CC3)cnn2c1,,,CHEMBL3886519,,2016.0,"{'bei': '15.57', 'le': '0.30', 'lle': '4.27', 'sei': '5.08'}",CHEMBL3890971,,CHEMBL3890971,6.69,False,http://www.openphacts.org/units/Nanomolar,2861340,=,37,True,=,,IC50,nM,,203.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,203.0
3426,364826,17739969,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1-c1ccc(CO)cc1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.58', 'le': '0.34', 'lle': '2.87', 'sei': '8.38'}",CHEMBL3958762,,CHEMBL3958762,6.66,False,http://www.openphacts.org/units/Nanomolar,2861341,=,37,True,=,,IC50,nM,,218.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,218.0
3427,364827,17739970,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2[nH]ncc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '21.53', 'le': '0.39', 'lle': '4.77', 'sei': '6.83'}",CHEMBL3926826,,CHEMBL3926826,6.64,False,http://www.openphacts.org/units/Nanomolar,2861342,=,37,True,=,,IC50,nM,,231.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,231.0
3428,364828,17739971,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '17.80', 'le': '0.35', 'lle': '4.04', 'sei': '7.45'}",CHEMBL3902377,,CHEMBL3902377,6.60,False,http://www.openphacts.org/units/Nanomolar,2861343,=,37,True,=,,IC50,nM,,251.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,251.0
3429,364829,17739972,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cnc2c(C(=O)Nc3cc(Cl)ccc3N3CCC(CN)CC3)cnn2c1,,,CHEMBL3886519,,2016.0,"{'bei': '15.90', 'le': '0.31', 'lle': '3.78', 'sei': '6.74'}",CHEMBL3939338,,CHEMBL3939338,6.59,False,http://www.openphacts.org/units/Nanomolar,2861344,=,37,True,=,,IC50,nM,,254.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,254.0
3430,364830,17739973,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2cc(C)[nH]c2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '20.52', 'le': '0.38', 'lle': '3.81', 'sei': '7.82'}",CHEMBL3911370,,CHEMBL3911370,6.59,False,http://www.openphacts.org/units/Nanomolar,2861345,=,37,True,=,,IC50,nM,,255.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,255.0
3431,364831,17739974,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCC(C)C)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.12', 'le': '0.31', 'lle': '2.00', 'sei': '7.38'}",CHEMBL3933655,,CHEMBL3933655,6.57,False,http://www.openphacts.org/units/Nanomolar,2861346,=,37,True,=,,IC50,nM,,271.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,271.0
3432,364832,17739975,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc(Cl)cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.80', 'le': '0.39', 'lle': '2.16', 'sei': '10.20'}",CHEMBL3961117,,CHEMBL3961117,6.54,False,http://www.openphacts.org/units/Nanomolar,2861347,=,37,True,=,,IC50,nM,,290.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,290.0
3433,364833,17739976,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc2ncccc2c1)c1csc2cnc(NCCO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.85', 'le': '0.34', 'lle': '3.62', 'sei': '6.52'}",CHEMBL3975532,,CHEMBL3975532,6.52,False,http://www.openphacts.org/units/Nanomolar,2861348,=,37,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,300.0
3434,364834,17739977,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cnc2c(C(=O)Nc3cc(Cl)ccc3OC3CCC(O)CC3)cnn2c1,,,CHEMBL3886519,,2016.0,"{'bei': '15.64', 'le': '0.31', 'lle': '3.19', 'sei': '6.66'}",CHEMBL3901226,,CHEMBL3901226,6.52,False,http://www.openphacts.org/units/Nanomolar,2861349,=,37,True,=,,IC50,nM,,301.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,301.0
3435,364835,17739978,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(CO)C1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.84', 'le': '0.33', 'lle': '3.34', 'sei': '7.34'}",CHEMBL3919293,,CHEMBL3919293,6.51,False,http://www.openphacts.org/units/Nanomolar,2861350,=,37,True,=,,IC50,nM,,306.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,306.0
3436,364836,17739979,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.03', 'le': '0.37', 'lle': '3.27', 'sei': '10.40'}",CHEMBL3947085,,CHEMBL3947085,6.51,False,http://www.openphacts.org/units/Nanomolar,2861351,=,37,True,=,,IC50,nM,,312.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,312.0
3437,364837,17739980,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.28', 'le': '0.36', 'lle': '2.87', 'sei': '10.40'}",CHEMBL3924734,,CHEMBL3924734,6.50,False,http://www.openphacts.org/units/Nanomolar,2861352,=,37,True,=,,IC50,nM,,314.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,314.0
3438,364838,17739981,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2ccccc2cc1OCCCO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.90', 'le': '0.33', 'lle': '3.59', 'sei': '7.31'}",CHEMBL3955819,,CHEMBL3955819,6.49,False,http://www.openphacts.org/units/Nanomolar,2861353,=,37,True,=,,IC50,nM,,327.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,327.0
3439,364839,17739982,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1O[C@H]1CC[C@H](O)CC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.02', 'le': '0.33', 'lle': '2.19', 'sei': '7.67'}",CHEMBL3900127,,CHEMBL3900127,6.47,False,http://www.openphacts.org/units/Nanomolar,2861354,=,37,True,=,,IC50,nM,,338.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,338.0
3440,364840,17739983,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ccc(CO)cc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.50', 'le': '0.34', 'lle': '3.81', 'sei': '7.26'}",CHEMBL3928107,,CHEMBL3928107,6.45,False,http://www.openphacts.org/units/Nanomolar,2861355,=,37,True,=,,IC50,nM,,358.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,358.0
3441,364841,17739984,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)C1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.28', 'le': '0.34', 'lle': '3.51', 'sei': '7.26'}",CHEMBL3929903,,CHEMBL3929903,6.44,False,http://www.openphacts.org/units/Nanomolar,2861356,=,37,True,=,,IC50,nM,,361.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,361.0
3442,364842,17739985,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OCCCO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.36', 'le': '0.36', 'lle': '3.97', 'sei': '7.17'}",CHEMBL3898402,,CHEMBL3898402,6.37,False,http://www.openphacts.org/units/Nanomolar,2861357,=,37,True,=,,IC50,nM,,430.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,430.0
3443,364843,17739986,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)C(C)C)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.62', 'le': '0.30', 'lle': '2.01', 'sei': '7.93'}",CHEMBL3920995,,CHEMBL3920995,6.37,False,http://www.openphacts.org/units/Nanomolar,2861358,=,37,True,=,,IC50,nM,,432.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,432.0
3444,364844,17739987,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(C)c1ncc2scc(C(=O)Nc3cc(Cl)ccc3OC)c2n1,,,CHEMBL3886519,,2016.0,"{'bei': '16.27', 'le': '0.33', 'lle': '1.91', 'sei': '9.44'}",CHEMBL3892984,,CHEMBL3892984,6.36,False,http://www.openphacts.org/units/Nanomolar,2861359,=,37,True,=,,IC50,nM,,436.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,436.0
3445,364845,17739988,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OCCCCO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.63', 'le': '0.35', 'lle': '3.57', 'sei': '7.17'}",CHEMBL3944326,,CHEMBL3944326,6.36,False,http://www.openphacts.org/units/Nanomolar,2861360,=,37,True,=,,IC50,nM,,437.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,437.0
3446,364846,17739989,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1OC1CCNC1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.20', 'le': '0.31', 'lle': '3.11', 'sei': '7.12'}",CHEMBL3919932,,CHEMBL3919932,6.34,False,http://www.openphacts.org/units/Nanomolar,2861361,=,37,True,=,,IC50,nM,,455.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,455.0
3447,364847,17739990,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccccc2)ccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.37', 'le': '0.30', 'lle': '3.10', 'sei': '6.50'}",CHEMBL3935363,,CHEMBL3935363,6.34,False,http://www.openphacts.org/units/Nanomolar,2861362,=,37,True,=,,IC50,nM,,455.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,455.0
3448,364848,17739991,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.38', 'le': '0.32', 'lle': '3.02', 'sei': '7.14'}",CHEMBL3907425,,CHEMBL3907425,6.34,False,http://www.openphacts.org/units/Nanomolar,2861363,=,37,True,=,,IC50,nM,,459.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,459.0
3449,364849,17739992,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCCC(O)C1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.01', 'le': '0.33', 'lle': '3.72', 'sei': '7.64'}",CHEMBL3962911,,CHEMBL3962911,6.32,False,http://www.openphacts.org/units/Nanomolar,2861364,=,37,True,=,,IC50,nM,,474.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,474.0
3450,364850,17739993,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCNCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.00', 'le': '0.33', 'lle': '3.55', 'sei': '7.85'}",CHEMBL3931955,,CHEMBL3931955,6.32,False,http://www.openphacts.org/units/Nanomolar,2861365,=,37,True,=,,IC50,nM,,476.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,476.0
3451,364851,17739994,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCNCC1)c1csc2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.30', 'le': '0.33', 'lle': '1.99', 'sei': '10.00'}",CHEMBL3902407,,CHEMBL3902407,6.32,False,http://www.openphacts.org/units/Nanomolar,2861366,=,37,True,=,,IC50,nM,,476.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,476.0
3452,364852,17739995,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1-c1ccc(O)cc1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.33', 'le': '0.33', 'lle': '2.31', 'sei': '7.95'}",CHEMBL3926861,,CHEMBL3926861,6.32,False,http://www.openphacts.org/units/Nanomolar,2861367,=,37,True,=,,IC50,nM,,477.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,477.0
3453,364853,17739996,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(O)C1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.63', 'le': '0.34', 'lle': '4.10', 'sei': '7.62'}",CHEMBL3918045,,CHEMBL3918045,6.31,False,http://www.openphacts.org/units/Nanomolar,2861368,=,37,True,=,,IC50,nM,,493.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,493.0
3454,364854,17739997,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OCCC(O)CO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.71', 'le': '0.33', 'lle': '4.54', 'sei': '5.78'}",CHEMBL3945929,,CHEMBL3945929,6.30,False,http://www.openphacts.org/units/Nanomolar,2861369,=,37,True,=,,IC50,nM,,506.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,506.0
3455,364855,17739998,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '16.96', 'le': '0.33', 'lle': '3.90', 'sei': '9.56'}",CHEMBL3909110,,CHEMBL3909110,6.29,False,http://www.openphacts.org/units/Nanomolar,2861370,=,37,True,=,,IC50,nM,,512.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,512.0
3456,364856,17739999,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OCc1cnco1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.00', 'le': '0.33', 'lle': '3.09', 'sei': '6.65'}",CHEMBL3940589,,CHEMBL3940589,6.29,False,http://www.openphacts.org/units/Nanomolar,2861371,=,37,True,=,,IC50,nM,,516.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,516.0
3457,364857,17740000,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCOCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.56', 'le': '0.34', 'lle': '3.81', 'sei': '8.75'}",CHEMBL3903575,,CHEMBL3903575,6.28,False,http://www.openphacts.org/units/Nanomolar,2861372,=,37,True,=,,IC50,nM,,523.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,523.0
3458,364858,17740001,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1-c1ccccc1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.98', 'le': '0.34', 'lle': '1.97', 'sei': '10.58'}",CHEMBL3931566,,CHEMBL3931566,6.27,False,http://www.openphacts.org/units/Nanomolar,2861373,=,37,True,=,,IC50,nM,,534.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,534.0
3459,364859,17740002,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1,,,CHEMBL3886519,,2016.0,"{'bei': '16.85', 'le': '0.33', 'lle': '3.83', 'sei': '7.06'}",CHEMBL3938296,,CHEMBL3938296,6.25,False,http://www.openphacts.org/units/Nanomolar,2861374,=,37,True,=,,IC50,nM,,564.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,564.0
3460,364860,17740003,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2cc[nH]c2cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.19', 'le': '0.37', 'lle': '2.79', 'sei': '7.79'}",CHEMBL3962215,,CHEMBL3962215,6.22,False,http://www.openphacts.org/units/Nanomolar,2861375,=,37,True,=,,IC50,nM,,596.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,596.0
3461,364861,17740004,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCCC(O)C1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.07', 'le': '0.31', 'lle': '2.90', 'sei': '7.01'}",CHEMBL3915142,,CHEMBL3915142,6.22,False,http://www.openphacts.org/units/Nanomolar,2861376,=,37,True,=,,IC50,nM,,605.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,605.0
3462,364862,17740005,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ccccc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.52', 'le': '0.35', 'lle': '3.07', 'sei': '9.07'}",CHEMBL3979848,,CHEMBL3979848,6.21,False,http://www.openphacts.org/units/Nanomolar,2861377,=,37,True,=,,IC50,nM,,613.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,613.0
3463,364863,17740006,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)NCCCO)ccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.77', 'le': '0.31', 'lle': '5.09', 'sei': '5.26'}",CHEMBL3896014,,CHEMBL3896014,6.19,False,http://www.openphacts.org/units/Nanomolar,2861378,=,37,True,=,,IC50,nM,,640.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,640.0
3464,364864,17740007,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCC(CO)C1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.64', 'le': '0.32', 'lle': '3.74', 'sei': '7.48'}",CHEMBL3892585,,CHEMBL3892585,6.19,False,http://www.openphacts.org/units/Nanomolar,2861379,=,37,True,=,,IC50,nM,,650.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,650.0
3465,364865,17740008,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.14', 'le': '0.36', 'lle': '2.90', 'sei': '8.97'}",CHEMBL3900722,,CHEMBL3900722,6.14,False,http://www.openphacts.org/units/Nanomolar,2861380,=,37,True,=,,IC50,nM,,717.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,717.0
3466,364866,17740009,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.42', 'le': '0.38', 'lle': '3.43', 'sei': '9.81'}",CHEMBL3971885,,CHEMBL3971885,6.13,False,http://www.openphacts.org/units/Nanomolar,2861381,=,37,True,=,,IC50,nM,,739.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,739.0
3467,364867,17740010,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1,,,CHEMBL3886519,,2016.0,"{'bei': '17.14', 'le': '0.33', 'lle': '3.95', 'sei': '6.91'}",CHEMBL3909791,,CHEMBL3909791,6.12,False,http://www.openphacts.org/units/Nanomolar,2861382,=,37,True,=,,IC50,nM,,766.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,766.0
3468,364868,17740011,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2cc[nH]c2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.86', 'le': '0.36', 'lle': '3.63', 'sei': '7.24'}",CHEMBL3976860,,CHEMBL3976860,6.10,False,http://www.openphacts.org/units/Nanomolar,2861383,=,37,True,=,,IC50,nM,,787.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,787.0
3469,364869,17740012,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.13', 'le': '0.40', 'lle': '2.74', 'sei': '10.29'}",CHEMBL3922946,,CHEMBL3922946,6.10,False,http://www.openphacts.org/units/Nanomolar,2861384,=,37,True,=,,IC50,nM,,798.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,798.0
3470,364870,17740013,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1C1CCCCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.18', 'le': '0.33', 'lle': '1.42', 'sei': '10.28'}",CHEMBL3963416,,CHEMBL3963416,6.10,False,http://www.openphacts.org/units/Nanomolar,2861385,=,37,True,=,,IC50,nM,,799.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,799.0
3471,364871,17740014,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)NCCCO)ccc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.73', 'le': '0.31', 'lle': '4.02', 'sei': '5.36'}",CHEMBL3960060,,CHEMBL3960060,6.08,False,http://www.openphacts.org/units/Nanomolar,2861386,=,37,True,=,,IC50,nM,,833.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,833.0
3472,364872,17740015,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(NCCO)c1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.74', 'le': '0.29', 'lle': '3.61', 'sei': '6.32'}",CHEMBL3938382,,CHEMBL3938382,5.99,False,http://www.openphacts.org/units/Nanomolar,2861387,=,37,True,=,,IC50,nM,,1029.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1029.0
3473,364873,17740016,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ncoc1COc1ccc(Cl)cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.92', 'le': '0.30', 'lle': '1.51', 'sei': '6.63'}",CHEMBL3947045,,CHEMBL3947045,5.98,False,http://www.openphacts.org/units/Nanomolar,2861388,=,37,True,=,,IC50,nM,,1050.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1050.0
3474,364874,17740017,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccccc1-c1ccccc1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.81', 'le': '0.34', 'lle': '2.26', 'sei': '9.97'}",CHEMBL3922728,,CHEMBL3922728,5.91,False,http://www.openphacts.org/units/Nanomolar,2861389,=,37,True,=,,IC50,nM,,1224.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1224.0
3475,364875,17740018,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CCO)Oc1ccc(Cl)cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.89', 'le': '0.31', 'lle': '1.70', 'sei': '6.92'}",CHEMBL3951642,,CHEMBL3951642,5.84,False,http://www.openphacts.org/units/Nanomolar,2861390,=,37,True,=,,IC50,nM,,1459.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1459.0
3476,364876,17740019,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCC(Oc2ccc(Cl)cc2NC(=O)c2csc3cncnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '14.48', 'le': '0.30', 'lle': '1.58', 'sei': '6.47'}",CHEMBL3923938,,CHEMBL3923938,5.83,False,http://www.openphacts.org/units/Nanomolar,2861391,=,37,True,=,,IC50,nM,,1471.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1471.0
3477,364877,17740020,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCCCCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.74', 'le': '0.31', 'lle': '1.80', 'sei': '9.31'}",CHEMBL3927810,,CHEMBL3927810,5.82,False,http://www.openphacts.org/units/Nanomolar,2861392,=,37,True,=,,IC50,nM,,1503.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1503.0
3478,364878,17740021,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)C1)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.92', 'le': '0.31', 'lle': '1.93', 'sei': '6.90'}",CHEMBL3929326,,CHEMBL3929326,5.82,False,http://www.openphacts.org/units/Nanomolar,2861393,=,37,True,=,,IC50,nM,,1521.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1521.0
3479,364879,17740022,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ncoc1COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.14', 'le': '0.29', 'lle': '2.30', 'sei': '6.14'}",CHEMBL3975370,,CHEMBL3975370,5.81,False,http://www.openphacts.org/units/Nanomolar,2861394,=,37,True,=,,IC50,nM,,1553.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1553.0
3480,364880,17740023,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)NCCO)ccc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.55', 'le': '0.30', 'lle': '4.12', 'sei': '5.10'}",CHEMBL3946035,,CHEMBL3946035,5.79,False,http://www.openphacts.org/units/Nanomolar,2861395,=,37,True,=,,IC50,nM,,1619.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1619.0
3481,364881,17740024,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.12', 'le': '0.38', 'lle': '3.15', 'sei': '8.45'}",CHEMBL3922067,,CHEMBL3922067,5.79,False,http://www.openphacts.org/units/Nanomolar,2861396,=,37,True,=,,IC50,nM,,1633.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1633.0
3482,364882,17740025,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.63', 'le': '0.33', 'lle': '3.11', 'sei': '7.42'}",CHEMBL3946413,,CHEMBL3946413,5.77,False,http://www.openphacts.org/units/Nanomolar,2861397,=,37,True,=,,IC50,nM,,1710.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1710.0
3483,364883,17740026,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1-c1cccc(O)c1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.59', 'le': '0.30', 'lle': '1.68', 'sei': '7.15'}",CHEMBL3937694,,CHEMBL3937694,5.69,False,http://www.openphacts.org/units/Nanomolar,2861398,=,37,True,=,,IC50,nM,,2047.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2047.0
3484,364884,17740027,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCCO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.47', 'le': '0.30', 'lle': '2.29', 'sei': '5.90'}",CHEMBL3937006,,CHEMBL3937006,5.69,False,http://www.openphacts.org/units/Nanomolar,2861399,=,37,True,=,,IC50,nM,,2062.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2062.0
3485,364885,17740028,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Br)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.33', 'le': '0.37', 'lle': '2.92', 'sei': '8.27'}",CHEMBL3928663,,CHEMBL3928663,5.67,False,http://www.openphacts.org/units/Nanomolar,2861400,=,37,True,=,,IC50,nM,,2144.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2144.0
3486,364886,17740029,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.69', 'le': '0.37', 'lle': '2.05', 'sei': '8.82'}",CHEMBL3959696,,CHEMBL3959696,5.66,False,http://www.openphacts.org/units/Nanomolar,2861401,=,37,True,=,,IC50,nM,,2200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2200.0
3487,364887,17740030,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCO)c1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.36', 'le': '0.32', 'lle': '3.60', 'sei': '6.84'}",CHEMBL3923236,,CHEMBL3923236,5.66,False,http://www.openphacts.org/units/Nanomolar,2861402,=,37,True,=,,IC50,nM,,2203.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2203.0
3488,364888,17740031,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1Oc1ccc(O)cc1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.85', 'le': '0.29', 'lle': '1.52', 'sei': '6.37'}",CHEMBL3950976,,CHEMBL3950976,5.65,False,http://www.openphacts.org/units/Nanomolar,2861403,=,37,True,=,,IC50,nM,,2221.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2221.0
3489,364889,17740032,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](CO)Nc1ncc2scc(C(=O)Nc3cc(Cl)ccc3OC)c2n1,,,CHEMBL3886519,,2016.0,"{'bei': '13.89', 'le': '0.29', 'lle': '1.86', 'sei': '5.87'}",CHEMBL3957438,,CHEMBL3957438,5.65,False,http://www.openphacts.org/units/Nanomolar,2861404,=,37,True,=,,IC50,nM,,2226.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2226.0
3490,364890,17740033,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.91', 'le': '0.31', 'lle': '2.64', 'sei': '5.86'}",CHEMBL3982737,,CHEMBL3982737,5.65,False,http://www.openphacts.org/units/Nanomolar,2861405,=,37,True,=,,IC50,nM,,2237.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2237.0
3491,364891,17740034,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(CO)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '13.55', 'le': '0.27', 'lle': '2.84', 'sei': '5.18'}",CHEMBL3933884,,CHEMBL3933884,5.65,False,http://www.openphacts.org/units/Nanomolar,2861406,=,37,True,=,,IC50,nM,,2253.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2253.0
3492,364892,17740035,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(N)=O)ccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.14', 'le': '0.34', 'lle': '4.56', 'sei': '5.06'}",CHEMBL3940306,,CHEMBL3940306,5.65,False,http://www.openphacts.org/units/Nanomolar,2861407,=,37,True,=,,IC50,nM,,2256.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2256.0
3493,364893,17740036,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.36', 'le': '0.32', 'lle': '1.97', 'sei': '8.23'}",CHEMBL3955381,,CHEMBL3955381,5.64,False,http://www.openphacts.org/units/Nanomolar,2861408,=,37,True,=,,IC50,nM,,2280.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2280.0
3494,364894,17740037,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nc2ccccc2n1CCCO)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.95', 'le': '0.31', 'lle': '2.96', 'sei': '6.07'}",CHEMBL3927769,,CHEMBL3927769,5.64,False,http://www.openphacts.org/units/Nanomolar,2861409,=,37,True,=,,IC50,nM,,2310.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2310.0
3495,364895,17740038,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC[C@@H](O)CO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.54', 'le': '0.31', 'lle': '4.27', 'sei': '5.17'}",CHEMBL3893767,,CHEMBL3893767,5.64,False,http://www.openphacts.org/units/Nanomolar,2861410,=,37,True,=,,IC50,nM,,2311.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2311.0
3496,364896,17740039,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCCOc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.57', 'le': '0.31', 'lle': '2.57', 'sei': '7.22'}",CHEMBL3969172,,CHEMBL3969172,5.62,False,http://www.openphacts.org/units/Nanomolar,2861411,=,37,True,=,,IC50,nM,,2419.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2419.0
3497,364897,17740040,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OCCCO)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.42', 'le': '0.32', 'lle': '2.25', 'sei': '6.65'}",CHEMBL3941333,,CHEMBL3941333,5.61,False,http://www.openphacts.org/units/Nanomolar,2861412,=,37,True,=,,IC50,nM,,2452.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2452.0
3498,364898,17740041,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCCC(CO)C1)c1cnn2nccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.50', 'le': '0.28', 'lle': '3.37', 'sei': '5.86'}",CHEMBL3913349,,CHEMBL3913349,5.61,False,http://www.openphacts.org/units/Nanomolar,2861413,=,37,True,=,,IC50,nM,,2465.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2465.0
3499,364899,17740042,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OCc1cccc(O)c1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.13', 'le': '0.27', 'lle': '1.66', 'sei': '6.29'}",CHEMBL3959468,,CHEMBL3959468,5.58,False,http://www.openphacts.org/units/Nanomolar,2861414,=,37,True,=,,IC50,nM,,2626.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2626.0
3500,364900,17740043,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OC)c(NC(=O)c2cnn3cccnc23)cc1Cl,,,CHEMBL3886519,,2016.0,"{'bei': '16.72', 'le': '0.33', 'lle': '2.91', 'sei': '7.15'}",CHEMBL3904350,,CHEMBL3904350,5.56,False,http://www.openphacts.org/units/Nanomolar,2861415,=,37,True,=,,IC50,nM,,2738.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2738.0
3501,364901,17740044,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,C=Cc1ccc(OC)c(NC(=O)c2cnn3cccnc23)c1,,,CHEMBL3886519,,2016.0,"{'bei': '18.89', 'le': '0.35', 'lle': '2.93', 'sei': '8.12'}",CHEMBL3903890,,CHEMBL3903890,5.56,False,http://www.openphacts.org/units/Nanomolar,2861416,=,37,True,=,,IC50,nM,,2748.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2748.0
3502,364902,17740045,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc(NCCCO)c1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.06', 'le': '0.26', 'lle': '2.78', 'sei': '5.85'}",CHEMBL3931877,,CHEMBL3931877,5.54,False,http://www.openphacts.org/units/Nanomolar,2861417,=,37,True,=,,IC50,nM,,2849.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2849.0
3503,364903,17740046,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1CCCCO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.04', 'le': '0.31', 'lle': '2.58', 'sei': '6.95'}",CHEMBL3909411,,CHEMBL3909411,5.53,False,http://www.openphacts.org/units/Nanomolar,2861418,=,37,True,=,,IC50,nM,,2949.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2949.0
3504,364904,17740047,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)NCCO)ccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.56', 'le': '0.29', 'lle': '4.82', 'sei': '4.69'}",CHEMBL3940896,,CHEMBL3940896,5.53,False,http://www.openphacts.org/units/Nanomolar,2861419,=,37,True,=,,IC50,nM,,2961.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2961.0
3505,364905,17740048,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(CCO)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '12.80', 'le': '0.25', 'lle': '2.67', 'sei': '5.06'}",CHEMBL3918335,,CHEMBL3918335,5.52,False,http://www.openphacts.org/units/Nanomolar,2861420,=,37,True,=,,IC50,nM,,3045.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3045.0
3506,364906,17740049,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(N)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1,,,CHEMBL3886519,,2016.0,"{'bei': '14.32', 'le': '0.28', 'lle': '2.70', 'sei': '6.22'}",CHEMBL3937953,,CHEMBL3937953,5.51,False,http://www.openphacts.org/units/Nanomolar,2861421,=,37,True,=,,IC50,nM,,3083.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3083.0
3507,364907,17740050,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCCO)c1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.20', 'le': '0.30', 'lle': '3.02', 'sei': '6.61'}",CHEMBL3980233,,CHEMBL3980233,5.47,False,http://www.openphacts.org/units/Nanomolar,2861422,=,37,True,=,,IC50,nM,,3395.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3395.0
3508,364908,17740051,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.13', 'le': '0.36', 'lle': '1.25', 'sei': '10.66'}",CHEMBL3954918,,CHEMBL3954918,5.46,False,http://www.openphacts.org/units/Nanomolar,2861423,=,37,True,=,,IC50,nM,,3461.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3461.0
3509,364909,17740052,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCC1CCN(c2ccc(Cl)cc2NC(=O)c2csc3cncnc23)CC1,,,CHEMBL3886519,,2016.0,"{'bei': '13.10', 'le': '0.27', 'lle': '1.42', 'sei': '7.77'}",CHEMBL3896123,,CHEMBL3896123,5.45,False,http://www.openphacts.org/units/Nanomolar,2861424,=,37,True,=,,IC50,nM,,3545.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3545.0
3510,364910,17740053,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(/C=C/CO)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.75', 'le': '0.31', 'lle': '3.43', 'sei': '6.12'}",CHEMBL3924141,,CHEMBL3924141,5.43,False,http://www.openphacts.org/units/Nanomolar,2861425,=,37,True,=,,IC50,nM,,3698.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3698.0
3511,364911,17740054,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.21', 'le': '0.35', 'lle': '3.12', 'sei': '7.92'}",CHEMBL3925792,,CHEMBL3925792,5.42,False,http://www.openphacts.org/units/Nanomolar,2861426,=,37,True,=,,IC50,nM,,3769.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3769.0
3512,364912,17740055,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.02', 'le': '0.35', 'lle': '2.22', 'sei': '9.14'}",CHEMBL3897697,,CHEMBL3897697,5.42,False,http://www.openphacts.org/units/Nanomolar,2861427,=,37,True,=,,IC50,nM,,3796.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3796.0
3513,364913,17740056,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(S(C)(=O)=O)ccc1NC(=O)c1ccn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.63', 'le': '0.31', 'lle': '3.40', 'sei': '6.01'}",CHEMBL3962309,,CHEMBL3962309,5.40,False,http://www.openphacts.org/units/Nanomolar,2861428,=,37,True,=,,IC50,nM,,4011.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4011.0
3514,364914,17740057,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1Oc1cccc(O)c1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.16', 'le': '0.27', 'lle': '1.26', 'sei': '6.08'}",CHEMBL3903182,,CHEMBL3903182,5.39,False,http://www.openphacts.org/units/Nanomolar,2861429,=,37,True,=,,IC50,nM,,4047.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4047.0
3515,364915,17740058,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2cnc(N(C)CCO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '13.70', 'le': '0.28', 'lle': '2.35', 'sei': '6.15'}",CHEMBL3969867,,CHEMBL3969867,5.38,False,http://www.openphacts.org/units/Nanomolar,2861430,=,37,True,=,,IC50,nM,,4133.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4133.0
3516,364916,17740059,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(NC(=O)c2cnn3cccnc23)c(OC)c1,,,CHEMBL3886519,,2016.0,"{'bei': '18.04', 'le': '0.33', 'lle': '3.38', 'sei': '6.92'}",CHEMBL3940329,,CHEMBL3940329,5.38,False,http://www.openphacts.org/units/Nanomolar,2861431,=,37,True,=,,IC50,nM,,4169.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4169.0
3517,364917,17740060,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(F)cc1NC(=O)c1cnn2ccccc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.81', 'le': '0.35', 'lle': '2.64', 'sei': '9.65'}",CHEMBL3978235,,CHEMBL3978235,5.37,False,http://www.openphacts.org/units/Nanomolar,2861432,=,37,True,=,,IC50,nM,,4302.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4302.0
3518,364918,17740061,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.87', 'le': '0.29', 'lle': '3.18', 'sei': '5.66'}",CHEMBL3964473,,CHEMBL3964473,5.37,False,http://www.openphacts.org/units/Nanomolar,2861433,=,37,True,=,,IC50,nM,,4305.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4305.0
3519,364919,17740062,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1Oc1ccccc1)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.62', 'le': '0.28', 'lle': '0.90', 'sei': '7.78'}",CHEMBL3889847,,CHEMBL3889847,5.33,False,http://www.openphacts.org/units/Nanomolar,2861434,=,37,True,=,,IC50,nM,,4647.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4647.0
3520,364920,17740063,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2ccc(NCCO)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.11', 'le': '0.29', 'lle': '1.72', 'sei': '6.39'}",CHEMBL3958889,,CHEMBL3958889,5.33,False,http://www.openphacts.org/units/Nanomolar,2861435,=,37,True,=,,IC50,nM,,4655.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4655.0
3521,364921,17740064,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC[C@H](O)CO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.70', 'le': '0.29', 'lle': '3.96', 'sei': '4.89'}",CHEMBL4113932,,CHEMBL4113932,5.33,False,http://www.openphacts.org/units/Nanomolar,2861436,=,37,True,=,,IC50,nM,,4664.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4664.0
3522,364922,17740065,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1N1CCCCC1CO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '13.77', 'le': '0.27', 'lle': '2.32', 'sei': '6.42'}",CHEMBL3953084,,CHEMBL3953084,5.31,False,http://www.openphacts.org/units/Nanomolar,2861437,=,37,True,=,,IC50,nM,,4848.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4848.0
3523,364923,17740066,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2ccccc2)ccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.34', 'le': '0.28', 'lle': '1.62', 'sei': '7.71'}",CHEMBL3986051,,CHEMBL3986051,5.28,False,http://www.openphacts.org/units/Nanomolar,2861438,=,37,True,=,,IC50,nM,,5205.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5205.0
3524,364924,17740067,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(OC)c(NC(=O)c2cnn3cccnc23)c1,,,CHEMBL3886519,,2016.0,"{'bei': '17.65', 'le': '0.32', 'lle': '2.68', 'sei': '7.63'}",CHEMBL3916291,,CHEMBL3916291,5.23,False,http://www.openphacts.org/units/Nanomolar,2861439,=,37,True,=,,IC50,nM,,5885.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5885.0
3525,364925,17740068,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2ccccc2)c(C)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '14.58', 'le': '0.26', 'lle': '1.26', 'sei': '7.63'}",CHEMBL3943272,,CHEMBL3943272,5.23,False,http://www.openphacts.org/units/Nanomolar,2861440,=,37,True,=,,IC50,nM,,5941.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5941.0
3526,364926,17740069,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(C)cc(C)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '17.50', 'le': '0.32', 'lle': '2.58', 'sei': '7.57'}",CHEMBL3969406,,CHEMBL3969406,5.19,False,http://www.openphacts.org/units/Nanomolar,2861441,=,37,True,=,,IC50,nM,,6516.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6516.0
3527,364927,17740070,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1NC(=O)c1csc2cncnc12,,,CHEMBL3886519,,2016.0,"{'bei': '18.17', 'le': '0.35', 'lle': '2.23', 'sei': '8.08'}",CHEMBL3930843,,CHEMBL3930843,5.18,False,http://www.openphacts.org/units/Nanomolar,2861442,=,37,True,=,,IC50,nM,,6559.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6559.0
3528,364928,17740071,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn2ncc(C(=O)Nc3cc(Cl)ccc3OC3CCC(O)CC3)c2n1,,,CHEMBL3886519,,2016.0,"{'bei': '12.93', 'le': '0.25', 'lle': '1.55', 'sei': '5.84'}",CHEMBL3958335,,CHEMBL3958335,5.18,False,http://www.openphacts.org/units/Nanomolar,2861443,=,37,True,=,,IC50,nM,,6561.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6561.0
3529,364929,17740072,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '19.14', 'le': '0.35', 'lle': '3.14', 'sei': '7.49'}",CHEMBL3955028,,CHEMBL3955028,5.13,False,http://www.openphacts.org/units/Nanomolar,2861444,=,37,True,=,,IC50,nM,,7337.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7337.0
3530,364930,17740073,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)N(C)C)ccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.08', 'le': '0.28', 'lle': '3.43', 'sei': '5.76'}",CHEMBL3987115,,CHEMBL3987115,5.12,False,http://www.openphacts.org/units/Nanomolar,2861445,=,37,True,=,,IC50,nM,,7651.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7651.0
3531,364931,17740074,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(NC(C)=O)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.72', 'le': '0.29', 'lle': '3.16', 'sei': '5.24'}",CHEMBL3952668,,CHEMBL3952668,5.11,False,http://www.openphacts.org/units/Nanomolar,2861446,=,37,True,=,,IC50,nM,,7697.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7697.0
3532,364932,17740075,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)Nc2ccccc2)c(Cl)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '12.09', 'le': '0.23', 'lle': '1.20', 'sei': '5.23'}",CHEMBL3921461,,CHEMBL3921461,5.10,False,http://www.openphacts.org/units/Nanomolar,2861447,=,37,True,=,,IC50,nM,,7915.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7915.0
3533,364933,17740076,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCNC(C)=O)nc12,,,CHEMBL3886519,,2016.0,"{'bei': '12.13', 'le': '0.25', 'lle': '1.94', 'sei': '4.84'}",CHEMBL3943924,,CHEMBL3943924,5.09,False,http://www.openphacts.org/units/Nanomolar,2861448,=,37,True,=,,IC50,nM,,8087.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8087.0
3534,364934,17740077,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCCO)cc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.56', 'le': '0.29', 'lle': '3.16', 'sei': '5.72'}",CHEMBL3915971,,CHEMBL3915971,5.08,False,http://www.openphacts.org/units/Nanomolar,2861449,=,37,True,=,,IC50,nM,,8361.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8361.0
3535,364935,17740078,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(CO)ccc1NC(=O)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '16.97', 'le': '0.31', 'lle': '3.58', 'sei': '5.70'}",CHEMBL3939266,,CHEMBL3939266,5.06,False,http://www.openphacts.org/units/Nanomolar,2861450,=,37,True,=,,IC50,nM,,8673.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8673.0
3536,364936,17740079,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(CCCO)cnc12,,,CHEMBL3886519,,2016.0,"{'bei': '11.30', 'le': '0.22', 'lle': '1.79', 'sei': '4.61'}",CHEMBL3914726,,CHEMBL3914726,5.03,False,http://www.openphacts.org/units/Nanomolar,2861451,=,37,True,=,,IC50,nM,,9417.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9417.0
3537,364937,17740080,[],CHEMBL3887963,"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cc(Cl)ccc1OCCO)c1cnn2cccnc12,,,CHEMBL3886519,,2016.0,"{'bei': '15.93', 'le': '0.31', 'lle': '3.29', 'sei': '5.97'}",CHEMBL3957910,,CHEMBL3957910,5.30,False,http://www.openphacts.org/units/Nanomolar,2861452,=,37,True,=,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
3538,412025,17776740,[],CHEMBL3888668,"Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1,,,CHEMBL3886794,,2016.0,,CHEMBL3903725,,CHEMBL3903725,,False,http://www.openphacts.org/units/Nanomolar,2886096,>,37,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10000.0
3539,Inactive,17908486,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3590106,ULIXERTINIB,CHEMBL3590106,,False,http://www.openphacts.org/units/Nanomolar,2973634,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3540,Inactive,17908487,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2103842,VARLITINIB,CHEMBL2103842,,False,http://www.openphacts.org/units/Nanomolar,2973425,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3541,Inactive,17908488,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23,,,CHEMBL3991601,Science,2017.0,,CHEMBL462018,TRICIRIBINE PHOSPHATE,CHEMBL462018,,False,http://www.openphacts.org/units/Nanomolar,2973465,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3542,Inactive,17908489,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL598797,CUDC-101,CHEMBL598797,,False,http://www.openphacts.org/units/Nanomolar,2973535,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3543,Inactive,17908490,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,,,CHEMBL3991601,Science,2017.0,,CHEMBL572878,TOZASERTIB,CHEMBL572878,,False,http://www.openphacts.org/units/Nanomolar,2973549,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3544,Inactive,17908491,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1,,,CHEMBL3991601,Science,2017.0,,CHEMBL482767,SNS-314,CHEMBL482767,,False,http://www.openphacts.org/units/Nanomolar,2973457,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3545,Inactive,17908492,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,,,CHEMBL3991601,Science,2017.0,,CHEMBL91829,RUBOXISTAURIN,CHEMBL91829,,False,http://www.openphacts.org/units/Nanomolar,2973637,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3546,Inactive,17908493,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL507361,MIRDAMETINIB,CHEMBL507361,,False,http://www.openphacts.org/units/Nanomolar,2973472,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3547,Inactive,17908494,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL601719,CRIZOTINIB,CHEMBL601719,,False,http://www.openphacts.org/units/Nanomolar,2973551,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3548,Inactive,17908495,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL502835,NINTEDANIB,CHEMBL502835,,False,http://www.openphacts.org/units/Nanomolar,2973470,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3549,Active,17908496,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.97', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.97'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,,,CHEMBL3991601,Science,2017.0,"{'bei': '17.98', 'le': '0.36', 'lle': '3.99', 'sei': '6.77'}",CHEMBL2041933,AZD-7762,CHEMBL2041933,6.52,False,http://www.openphacts.org/units/Nanomolar,2973464,=,48,True,=,,Kd,nM,,304.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,304.0
3550,Inactive,17908497,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3039517,RABUSERTIB,CHEMBL3039517,,False,http://www.openphacts.org/units/Nanomolar,2973424,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3551,Inactive,17908498,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL2220486,LUCITANIB,CHEMBL2220486,,False,http://www.openphacts.org/units/Nanomolar,2973416,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3552,Inactive,17908499,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL254760,MGCD-265,CHEMBL254760,,False,http://www.openphacts.org/units/Nanomolar,2973492,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3553,Inactive,17908500,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL2107832,PIMASERTIB,CHEMBL2107832,,False,http://www.openphacts.org/units/Nanomolar,2973612,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3554,Inactive,17908501,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545076,LY-2584702,CHEMBL3545076,,False,http://www.openphacts.org/units/Nanomolar,2973616,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3555,Inactive,17908502,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL38380,FASUDIL,CHEMBL38380,,False,http://www.openphacts.org/units/Nanomolar,2973653,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3556,Inactive,17908503,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3301612,ENCORAFENIB,CHEMBL3301612,,False,http://www.openphacts.org/units/Nanomolar,2973649,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3557,Inactive,17908504,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545154,POZIOTINIB,CHEMBL3545154,,False,http://www.openphacts.org/units/Nanomolar,2973434,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3558,Inactive,17908505,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,,,CHEMBL3991601,Science,2017.0,,CHEMBL377300,BRIVANIB,CHEMBL377300,,False,http://www.openphacts.org/units/Nanomolar,2973515,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3559,Inactive,17908506,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL1090090,VX-702,CHEMBL1090090,,False,http://www.openphacts.org/units/Nanomolar,2973420,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3560,Inactive,17908507,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1088751,PH-797804,CHEMBL1088751,,False,http://www.openphacts.org/units/Nanomolar,2973540,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3561,Inactive,17908508,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,,,CHEMBL3991601,Science,2017.0,,CHEMBL1908394,GSK-461364,CHEMBL1908394,,False,http://www.openphacts.org/units/Nanomolar,2973571,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3562,Inactive,17908509,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2403108,CERITINIB,CHEMBL2403108,,False,http://www.openphacts.org/units/Nanomolar,2973427,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3563,Inactive,17908510,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2103875,TRAMETINIB,CHEMBL2103875,,False,http://www.openphacts.org/units/Nanomolar,2973629,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3564,Inactive,17908511,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC,,,CHEMBL3991601,Science,2017.0,,CHEMBL283120,AXL-1717,CHEMBL283120,,False,http://www.openphacts.org/units/Nanomolar,2973598,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3565,Inactive,17908512,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL3188267,CAPMATINIB,CHEMBL3188267,,False,http://www.openphacts.org/units/Nanomolar,2973421,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3566,Inactive,17908513,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL31965,CANERTINIB,CHEMBL31965,,False,http://www.openphacts.org/units/Nanomolar,2973494,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3567,Active,17908514,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.98', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.98'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12,,,CHEMBL3991601,Science,2017.0,"{'bei': '12.00', 'le': '0.23', 'lle': '1.63', 'sei': '5.74'}",CHEMBL1983111,,CHEMBL1983111,5.69,False,http://www.openphacts.org/units/Nanomolar,2973433,=,48,True,=,,Kd,nM,,2023.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,2023.0
3568,Inactive,17908515,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545215,BMS-911543,CHEMBL3545215,,False,http://www.openphacts.org/units/Nanomolar,2973606,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3569,Inactive,17908516,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL3991929,,CHEMBL4116008,,False,http://www.openphacts.org/units/Nanomolar,2973507,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3570,Inactive,17908517,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,,,CHEMBL3991601,Science,2017.0,,CHEMBL1289494,TIVOZANIB,CHEMBL1289494,,False,http://www.openphacts.org/units/Nanomolar,2973509,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3571,Inactive,17908518,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545366,VOXTALISIB,CHEMBL3545366,,False,http://www.openphacts.org/units/Nanomolar,2973633,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3572,Active,17908519,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.92', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.92'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1,,,CHEMBL3991601,Science,2017.0,"{'bei': '10.41', 'le': '0.20', 'lle': '3.06', 'sei': '4.75'}",CHEMBL3301622,GILTERITINIB,CHEMBL3301622,5.75,False,http://www.openphacts.org/units/Nanomolar,2973469,=,48,True,=,,Kd,nM,,1757.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,1757.0
3573,Inactive,17908520,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2138625,,CHEMBL2138625,,False,http://www.openphacts.org/units/Nanomolar,2973463,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3574,Inactive,17908521,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3039525,GOLVATINIB,CHEMBL3039525,,False,http://www.openphacts.org/units/Nanomolar,2973423,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3575,Inactive,17908522,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL572881,MOTESANIB,CHEMBL572881,,False,http://www.openphacts.org/units/Nanomolar,2973533,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3576,Inactive,17908523,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3182444,MK-5108,CHEMBL3182444,,False,http://www.openphacts.org/units/Nanomolar,2973593,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3577,Inactive,17908524,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C,,,CHEMBL3991601,Science,2017.0,,CHEMBL1233528,VOLASERTIB,CHEMBL1233528,,False,http://www.openphacts.org/units/Nanomolar,2973462,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3578,Inactive,17908525,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL2376648,,CHEMBL2376648,,False,http://www.openphacts.org/units/Nanomolar,2973625,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3579,Inactive,17908526,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL3991601,Science,2017.0,,CHEMBL536151,,CHEMBL536151,,False,http://www.openphacts.org/units/Nanomolar,2973548,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3580,Inactive,17908527,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2087361,ICOTINIB,CHEMBL2087361,,False,http://www.openphacts.org/units/Nanomolar,2973419,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3581,Active,17908528,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.98', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.98'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1,,,CHEMBL3991601,Science,2017.0,"{'bei': '14.04', 'le': '0.27', 'lle': '2.10', 'sei': '5.80'}",CHEMBL482967,CYC-116,CHEMBL482967,5.17,False,http://www.openphacts.org/units/Nanomolar,2973466,=,48,True,=,,Kd,nM,,6719.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,6719.0
3582,Inactive,17908529,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,,,CHEMBL3991601,Science,2017.0,,CHEMBL477772,PAZOPANIB,CHEMBL477772,,False,http://www.openphacts.org/units/Nanomolar,2973642,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3583,Inactive,17908530,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL1615025,TAK-733,CHEMBL1615025,,False,http://www.openphacts.org/units/Nanomolar,2973547,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3584,Inactive,17908531,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL513909,BI-2536,CHEMBL513909,,False,http://www.openphacts.org/units/Nanomolar,2973502,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3585,Inactive,17908532,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL3544944,BMS-863233,CHEMBL3544944,,False,http://www.openphacts.org/units/Nanomolar,2973468,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3586,Inactive,17908533,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2364611,GALUNISERTIB,CHEMBL2364611,,False,http://www.openphacts.org/units/Nanomolar,2973651,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3587,Inactive,17908534,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL3264002,,CHEMBL3264002,,False,http://www.openphacts.org/units/Nanomolar,2973572,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3588,Inactive,17908535,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3184679,AZD-4547,CHEMBL3184679,,False,http://www.openphacts.org/units/Nanomolar,2973589,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3589,Inactive,17908536,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545308,ROCILETINIB,CHEMBL3545308,,False,http://www.openphacts.org/units/Nanomolar,2973537,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3590,Inactive,17908537,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12,,,CHEMBL3991601,Science,2017.0,,CHEMBL3120215,OSI-027,CHEMBL3120215,,False,http://www.openphacts.org/units/Nanomolar,2973618,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3591,Inactive,17908538,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1946170,REGORAFENIB,CHEMBL1946170,,False,http://www.openphacts.org/units/Nanomolar,2973657,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3592,Inactive,17908539,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,,,CHEMBL3991601,Science,2017.0,,CHEMBL576982,QUIZARTINIB,CHEMBL576982,,False,http://www.openphacts.org/units/Nanomolar,2973636,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3593,Inactive,17908540,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O,,,CHEMBL3991601,Science,2017.0,,CHEMBL3182621,AZD-8330,CHEMBL3182621,,False,http://www.openphacts.org/units/Nanomolar,2973586,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3594,Inactive,17908541,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,,,,CHEMBL3991601,Science,2017.0,,CHEMBL4084193,,CHEMBL4084193,,False,http://www.openphacts.org/units/Nanomolar,2973459,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3595,Inactive,17908542,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL445813,AT-7519,CHEMBL445813,,False,http://www.openphacts.org/units/Nanomolar,2973591,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3596,Inactive,17908543,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL1614701,SELUMETINIB,CHEMBL1614701,,False,http://www.openphacts.org/units/Nanomolar,2973504,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3597,Inactive,17908544,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1336,SORAFENIB,CHEMBL1336,,False,http://www.openphacts.org/units/Nanomolar,2973523,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3598,Active,17908545,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.97', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.97'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1,,,CHEMBL3991601,Science,2017.0,"{'bei': '13.77', 'le': '0.28', 'lle': '0.67', 'sei': '8.57'}",CHEMBL3688339,,CHEMBL3688339,6.71,False,http://www.openphacts.org/units/Nanomolar,2973508,=,48,True,=,,Kd,nM,,194.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,194.0
3599,Inactive,17908546,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL551064,AEW-541,CHEMBL551064,,False,http://www.openphacts.org/units/Nanomolar,2973467,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3600,Inactive,17908547,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL253969,OSI-632,CHEMBL253969,,False,http://www.openphacts.org/units/Nanomolar,2973418,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3601,Inactive,17908548,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL3408248,,CHEMBL3408248,,False,http://www.openphacts.org/units/Nanomolar,2973440,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3602,Inactive,17908549,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1236682,REFAMETINIB,CHEMBL1236682,,False,http://www.openphacts.org/units/Nanomolar,2973645,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3603,Inactive,17908550,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3991934,,CHEMBL3991934,,False,http://www.openphacts.org/units/Nanomolar,2973554,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3604,Inactive,17908551,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3699142,,CHEMBL3699142,,False,http://www.openphacts.org/units/Nanomolar,2973436,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3605,Inactive,17908552,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1614707,MUBRITINIB,CHEMBL1614707,,False,http://www.openphacts.org/units/Nanomolar,2973584,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3606,Inactive,17908553,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1241855,RIGOSERTIB,CHEMBL1241855,,False,http://www.openphacts.org/units/Nanomolar,2973486,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3607,Inactive,17908554,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL571546,TIRBANIBULIN,CHEMBL571546,,False,http://www.openphacts.org/units/Nanomolar,2973528,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3608,Inactive,17908555,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2028663,DABRAFENIB,CHEMBL2028663,,False,http://www.openphacts.org/units/Nanomolar,2973518,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3609,Inactive,17908556,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3186534,RIVOCERANIB,CHEMBL3186534,,False,http://www.openphacts.org/units/Nanomolar,2973525,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3610,Inactive,17908557,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL3334567,SAVOLITINIB,CHEMBL3334567,,False,http://www.openphacts.org/units/Nanomolar,2973520,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3611,Inactive,17908558,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3991933,,CHEMBL3991933,,False,http://www.openphacts.org/units/Nanomolar,2973622,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3612,Inactive,17908559,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL2103882,TIVANTINIB,CHEMBL2103882,,False,http://www.openphacts.org/units/Nanomolar,2973655,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3613,Inactive,17908560,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL3991601,Science,2017.0,,CHEMBL2103839,RIDAFOROLIMUS,CHEMBL2103839,,False,http://www.openphacts.org/units/Nanomolar,2973615,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3614,Inactive,17908561,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1173655,AFATINIB,CHEMBL1173655,,False,http://www.openphacts.org/units/Nanomolar,2973652,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3615,Inactive,17908562,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C,,,CHEMBL3991601,Science,2017.0,,CHEMBL411907,SONOLISIB,CHEMBL411907,,False,http://www.openphacts.org/units/Nanomolar,2973473,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3616,Inactive,17908563,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL587723,AEE-788,CHEMBL587723,,False,http://www.openphacts.org/units/Nanomolar,2973534,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3617,Inactive,17908564,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1873475,IBRUTINIB,CHEMBL1873475,,False,http://www.openphacts.org/units/Nanomolar,2973449,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3618,Inactive,17908565,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2035187,PACRITINIB,CHEMBL2035187,,False,http://www.openphacts.org/units/Nanomolar,2973475,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3619,Inactive,17908566,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,,,CHEMBL3991601,Science,2017.0,,CHEMBL494089,GSK-690693,CHEMBL494089,,False,http://www.openphacts.org/units/Nanomolar,2973579,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3620,Inactive,17908567,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2048872,,CHEMBL2048872,,False,http://www.openphacts.org/units/Nanomolar,2973474,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3621,Inactive,17908568,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1078178,MOMELOTINIB,CHEMBL1078178,,False,http://www.openphacts.org/units/Nanomolar,2973500,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3622,Inactive,17908569,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2140408,AMG-900,CHEMBL2140408,,False,http://www.openphacts.org/units/Nanomolar,2973556,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3623,Inactive,17908570,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,,,CHEMBL3991601,Science,2017.0,,CHEMBL296468,BMS-387032,CHEMBL296468,,False,http://www.openphacts.org/units/Nanomolar,2973641,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3624,Inactive,17908571,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL460702,BMS-777607,CHEMBL460702,,False,http://www.openphacts.org/units/Nanomolar,2973513,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3625,Active,17908572,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.99', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.99'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,,,CHEMBL3991601,Science,2017.0,"{'bei': '11.24', 'le': '0.22', 'lle': '1.05', 'sei': '5.96'}",CHEMBL3544932,TAK-901,CHEMBL3544932,5.67,False,http://www.openphacts.org/units/Nanomolar,2973557,=,48,True,=,,Kd,nM,,2133.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,2133.0
3626,Inactive,17908573,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12,,,CHEMBL3991601,Science,2017.0,,CHEMBL3426621,RIPASUDIL,CHEMBL3426621,,False,http://www.openphacts.org/units/Nanomolar,2973577,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3627,Inactive,17908574,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,,,CHEMBL3991601,Science,2017.0,,CHEMBL607707,PELITINIB,CHEMBL607707,,False,http://www.openphacts.org/units/Nanomolar,2973526,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3628,Inactive,17908575,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F,,,CHEMBL3991601,Science,2017.0,,CHEMBL3039513,DECERNOTINIB,CHEMBL3039513,,False,http://www.openphacts.org/units/Nanomolar,2973544,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3629,Inactive,17908576,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL553,ERLOTINIB,CHEMBL553,,False,http://www.openphacts.org/units/Nanomolar,2973495,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3630,Inactive,17908577,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1421,DASATINIB,CHEMBL1421,,False,http://www.openphacts.org/units/Nanomolar,2973490,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3631,Active,17908578,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.79', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.79'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,,,CHEMBL3991601,Science,2017.0,"{'bei': '11.77', 'le': '0.23', 'lle': '3.68', 'sei': '5.04'}",CHEMBL1822792,MK-2461,CHEMBL1822792,5.83,False,http://www.openphacts.org/units/Nanomolar,2973483,=,48,True,=,,Kd,nM,,1475.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,1475.0
3632,Inactive,17908579,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1088752,LOSMAPIMOD,CHEMBL1088752,,False,http://www.openphacts.org/units/Nanomolar,2973496,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3633,Inactive,17908580,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2110732,DACOMITINIB,CHEMBL2110732,,False,http://www.openphacts.org/units/Nanomolar,2973583,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3634,Inactive,17908581,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,,,CHEMBL3991601,Science,2017.0,,CHEMBL2029988,CEP-32496,CHEMBL2029988,,False,http://www.openphacts.org/units/Nanomolar,2973573,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3635,Active,17908582,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.99', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.99'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,,,CHEMBL3991601,Science,2017.0,"{'bei': '9.95', 'le': '0.18', 'lle': '2.01', 'sei': '5.02'}",CHEMBL564829,MILCICLIB,CHEMBL564829,4.58,False,http://www.openphacts.org/units/Nanomolar,2973450,=,48,True,=,,Kd,nM,,26123.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,26123.0
3636,Inactive,17908583,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL496102,AMG-208,CHEMBL496102,,False,http://www.openphacts.org/units/Nanomolar,2973499,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3637,Inactive,17908584,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,,,CHEMBL3991601,Science,2017.0,,CHEMBL1289601,LENVATINIB,CHEMBL1289601,,False,http://www.openphacts.org/units/Nanomolar,2973631,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3638,Inactive,17908585,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,,,CHEMBL3991601,Science,2017.0,,CHEMBL180022,NERATINIB,CHEMBL180022,,False,http://www.openphacts.org/units/Nanomolar,2973588,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3639,Active,17908586,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.94', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.94'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,,,CHEMBL3991601,Science,2017.0,"{'bei': '12.07', 'le': '0.25', 'lle': '0.14', 'sei': '9.97'}",CHEMBL3544983,TESEVATINIB,CHEMBL3544983,5.93,False,http://www.openphacts.org/units/Nanomolar,2973503,=,48,True,=,,Kd,nM,,1174.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,1174.0
3640,Inactive,17908587,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,,,CHEMBL3991601,Science,2017.0,,CHEMBL1801204,AZD-8055,CHEMBL1801204,,False,http://www.openphacts.org/units/Nanomolar,2973646,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3641,Inactive,17908588,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545328,XL-019,CHEMBL3545328,,False,http://www.openphacts.org/units/Nanomolar,2973601,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3642,Inactive,17908589,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL1614710,OSI-930,CHEMBL1614710,,False,http://www.openphacts.org/units/Nanomolar,2973643,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3643,Active,17908590,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.97', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.97'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,,,CHEMBL3991601,Science,2017.0,"{'bei': '12.42', 'le': '0.23', 'lle': '3.81', 'sei': '5.15'}",CHEMBL1721885,SU-014813,CHEMBL1721885,5.50,False,http://www.openphacts.org/units/Nanomolar,2973531,=,48,True,=,,Kd,nM,,3178.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,3178.0
3644,Inactive,17908591,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,,,CHEMBL3991601,Science,2017.0,,CHEMBL488436,AZD-5438,CHEMBL488436,,False,http://www.openphacts.org/units/Nanomolar,2973485,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3645,Active,17908592,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.95', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.95'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,,,CHEMBL3991601,Science,2017.0,"{'bei': '16.05', 'le': '0.29', 'lle': '3.59', 'sei': '7.96'}",CHEMBL603469,LESTAURTINIB,CHEMBL603469,7.06,False,http://www.openphacts.org/units/Nanomolar,2973576,=,48,True,=,,Kd,nM,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,88.0
3646,Inactive,17908593,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2001019,PF-04217903,CHEMBL2001019,,False,http://www.openphacts.org/units/Nanomolar,2973510,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3647,Inactive,17908594,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545157,TIDEGLUSIB,CHEMBL3545157,,False,http://www.openphacts.org/units/Nanomolar,2973456,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3648,Inactive,17908595,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3218575,PILARALISIB,CHEMBL3218575,,False,http://www.openphacts.org/units/Nanomolar,2973501,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3649,Inactive,17908596,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL592445,GEDATOLISIB,CHEMBL592445,,False,http://www.openphacts.org/units/Nanomolar,2973489,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3650,Active,17908597,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.67', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.67'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,,,CHEMBL3991601,Science,2017.0,"{'bei': '10.97', 'le': '0.22', 'lle': '2.43', 'sei': '4.31'}",CHEMBL1084546,PF-00562271,CHEMBL1084546,5.57,False,http://www.openphacts.org/units/Nanomolar,2973600,=,48,True,=,,Kd,nM,,2693.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,2693.0
3651,Inactive,17908598,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2105759,BARICITINIB,CHEMBL2105759,,False,http://www.openphacts.org/units/Nanomolar,2973632,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3652,Inactive,17908599,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL495727,AT-9283,CHEMBL495727,,False,http://www.openphacts.org/units/Nanomolar,2973521,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3653,Inactive,17908600,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL400402,,CHEMBL400402,,False,http://www.openphacts.org/units/Nanomolar,2973590,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3654,Inactive,17908601,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1289926,AXITINIB,CHEMBL1289926,,False,http://www.openphacts.org/units/Nanomolar,2973656,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3655,Inactive,17908602,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL521851,PICTILISIB,CHEMBL521851,,False,http://www.openphacts.org/units/Nanomolar,2973570,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3656,Inactive,17908603,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545360,ASP-3026,CHEMBL3545360,,False,http://www.openphacts.org/units/Nanomolar,2973422,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3657,Inactive,17908604,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1236107,SGX-523,CHEMBL1236107,,False,http://www.openphacts.org/units/Nanomolar,2973650,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3658,Inactive,17908605,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL24828,VANDETANIB,CHEMBL24828,,False,http://www.openphacts.org/units/Nanomolar,2973451,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3659,Active,17908606,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.95', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.95'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,,,CHEMBL3991601,Science,2017.0,"{'bei': '14.45', 'le': '0.27', 'lle': '3.13', 'sei': '6.03'}",CHEMBL522892,DOVITINIB,CHEMBL522892,5.67,False,http://www.openphacts.org/units/Nanomolar,2973484,=,48,True,=,,Kd,nM,,2126.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,2126.0
3660,Inactive,17908607,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL514201,TALMAPIMOD,CHEMBL514201,,False,http://www.openphacts.org/units/Nanomolar,2973519,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3661,Inactive,17908608,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL1236962,OMIPALISIB,CHEMBL1236962,,False,http://www.openphacts.org/units/Nanomolar,2973561,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3662,Inactive,17908609,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL565612,SOTRASTAURIN,CHEMBL565612,,False,http://www.openphacts.org/units/Nanomolar,2973529,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3663,Inactive,17908610,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL941,IMATINIB,CHEMBL941,,False,http://www.openphacts.org/units/Nanomolar,2973538,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3664,Inactive,17908611,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,,,CHEMBL3991601,Science,2017.0,,CHEMBL2103830,FOSTAMATINIB,CHEMBL2103830,,False,http://www.openphacts.org/units/Nanomolar,2973654,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3665,Inactive,17908612,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1231124,AZD-1480,CHEMBL1231124,,False,http://www.openphacts.org/units/Nanomolar,2973505,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3666,Inactive,17908613,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3907479,FGFR INHIBITOR DEBIO 1347,CHEMBL3907479,,False,http://www.openphacts.org/units/Nanomolar,2973491,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3667,Inactive,17908614,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3348923,MLN-2480,CHEMBL3348923,,False,http://www.openphacts.org/units/Nanomolar,2973619,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3668,Inactive,17908615,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3301607,FILGOTINIB,CHEMBL3301607,,False,http://www.openphacts.org/units/Nanomolar,2973635,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3669,Inactive,17908616,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL206834,BAFETINIB,CHEMBL206834,,False,http://www.openphacts.org/units/Nanomolar,2973614,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3670,Inactive,17908617,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,,,CHEMBL3991601,Science,2017.0,,CHEMBL384304,RG-547,CHEMBL384304,,False,http://www.openphacts.org/units/Nanomolar,2973564,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3671,Inactive,17908618,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=c1[nH]ccc2cc(OC3CCNCC3)ccc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL1667969,SAR-407899,CHEMBL1667969,,False,http://www.openphacts.org/units/Nanomolar,2973639,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3672,Inactive,17908619,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,,,CHEMBL3991601,Science,2017.0,,CHEMBL3353410,OSIMERTINIB,CHEMBL3353410,,False,http://www.openphacts.org/units/Nanomolar,2973541,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3673,Inactive,17908620,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1952329,SGI-1776,CHEMBL1952329,,False,http://www.openphacts.org/units/Nanomolar,2973437,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3674,Active,17908621,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.91', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.91'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC,,,CHEMBL3991601,Science,2017.0,"{'bei': '15.02', 'le': '0.28', 'lle': '1.37', 'sei': '5.84'}",CHEMBL405130,WHI-P131,CHEMBL405130,4.47,False,http://www.openphacts.org/units/Nanomolar,2973514,=,48,True,=,,Kd,nM,,34145.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,34145.0
3675,Inactive,17908622,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3,,,CHEMBL3991601,Science,2017.0,,CHEMBL3109738,,CHEMBL3109738,,False,http://www.openphacts.org/units/Nanomolar,2973446,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3676,Inactive,17908623,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2396661,ALPELISIB,CHEMBL2396661,,False,http://www.openphacts.org/units/Nanomolar,2973605,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3677,Inactive,17908624,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1090479,GSK-1070916,CHEMBL1090479,,False,http://www.openphacts.org/units/Nanomolar,2973530,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3678,Inactive,17908625,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL3991601,Science,2017.0,,CHEMBL413,SIROLIMUS,CHEMBL413,,False,http://www.openphacts.org/units/Nanomolar,2973524,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3679,Inactive,17908626,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL571948,Y-39983,CHEMBL571948,,False,http://www.openphacts.org/units/Nanomolar,2973609,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3680,Inactive,17908627,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2,,,CHEMBL3991601,Science,2017.0,,CHEMBL1094408,NMS-1286937,CHEMBL1094408,,False,http://www.openphacts.org/units/Nanomolar,2973617,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3681,Inactive,17908628,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1950289,TANZISERTIB,CHEMBL1950289,,False,http://www.openphacts.org/units/Nanomolar,2973488,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3682,Inactive,17908629,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3301610,ABEMACICLIB,CHEMBL3301610,,False,http://www.openphacts.org/units/Nanomolar,2973415,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3683,Inactive,17908630,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2165191,AZD-6482,CHEMBL2165191,,False,http://www.openphacts.org/units/Nanomolar,2973610,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3684,Inactive,17908631,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3128043,PF-03758309,CHEMBL3128043,,False,http://www.openphacts.org/units/Nanomolar,2973644,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3685,Inactive,17908632,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL255863,NILOTINIB,CHEMBL255863,,False,http://www.openphacts.org/units/Nanomolar,2973543,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3686,Inactive,17908633,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL259084,MLN-8054,CHEMBL259084,,False,http://www.openphacts.org/units/Nanomolar,2973448,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3687,Inactive,17908634,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL939,GEFITINIB,CHEMBL939,,False,http://www.openphacts.org/units/Nanomolar,2973621,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3688,Active,17908635,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.99', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.99'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1,,,CHEMBL3991601,Science,2017.0,"{'bei': '13.77', 'le': '0.25', 'lle': '2.19', 'sei': '7.79'}",CHEMBL2105728,CRENOLANIB,CHEMBL2105728,6.11,False,http://www.openphacts.org/units/Nanomolar,2973638,=,48,True,=,,Kd,nM,,778.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,778.0
3689,Inactive,17908636,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL403989,TG100-801,CHEMBL403989,,False,http://www.openphacts.org/units/Nanomolar,2973608,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3690,Inactive,17908637,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2079588,TELATINIB,CHEMBL2079588,,False,http://www.openphacts.org/units/Nanomolar,2973603,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3691,Inactive,17908638,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL2103840,DINACICLIB,CHEMBL2103840,,False,http://www.openphacts.org/units/Nanomolar,2973546,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3692,Inactive,17908639,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,,,CHEMBL3991601,Science,2017.0,,CHEMBL1230607,PHA-793887,CHEMBL1230607,,False,http://www.openphacts.org/units/Nanomolar,2973527,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3693,Inactive,17908640,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1079175,MK-2206,CHEMBL1079175,,False,http://www.openphacts.org/units/Nanomolar,2973517,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3694,Inactive,17908641,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1233300,HYDROXYFASUDIL,CHEMBL1233300,,False,http://www.openphacts.org/units/Nanomolar,2973431,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3695,Inactive,17908642,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3544964,RAVOXERTINIB,CHEMBL3544964,,False,http://www.openphacts.org/units/Nanomolar,2973569,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3696,Inactive,17908643,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3991927,,CHEMBL3991927,,False,http://www.openphacts.org/units/Nanomolar,2973506,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3697,Inactive,17908644,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2216870,IDELALISIB,CHEMBL2216870,,False,http://www.openphacts.org/units/Nanomolar,2973592,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3698,Inactive,17908645,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL1879463,DACTOLISIB,CHEMBL1879463,,False,http://www.openphacts.org/units/Nanomolar,2973647,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3699,Inactive,17908646,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,,,CHEMBL3991601,Science,2017.0,,CHEMBL3218576,COPANLISIB,CHEMBL3218576,,False,http://www.openphacts.org/units/Nanomolar,2973482,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3700,Inactive,17908647,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3991931,,CHEMBL3991931,,False,http://www.openphacts.org/units/Nanomolar,2973585,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3701,Inactive,17908648,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL3991935,,CHEMBL3969723,,False,http://www.openphacts.org/units/Nanomolar,2973542,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3702,Active,17908649,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.96', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.96'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,,,CHEMBL3991601,Science,2017.0,"{'bei': '10.63', 'le': '0.20', 'lle': '1.20', 'sei': '8.61'}",CHEMBL1171837,PONATINIB,CHEMBL1171837,5.66,False,http://www.openphacts.org/units/Nanomolar,2973522,=,48,True,=,,Kd,nM,,2190.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,2190.0
3703,Inactive,17908650,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2017974,BUPARLISIB,CHEMBL2017974,,False,http://www.openphacts.org/units/Nanomolar,2973626,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3704,Uncertain,17908651,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.9', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.9'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1,,,CHEMBL3991601,Science,2017.0,"{'bei': '14.34', 'le': '0.32', 'lle': '3.46', 'sei': '6.27'}",CHEMBL2386889,SCH-900776,CHEMBL2386889,5.40,False,http://www.openphacts.org/units/Nanomolar,2973594,=,48,True,=,,Kd,nM,,4014.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,4014.0
3705,Active,17908652,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.94', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.94'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3991601,Science,2017.0,"{'bei': '17.21', 'le': '0.31', 'lle': '4.39', 'sei': '8.49'}",CHEMBL281948,K-252A,CHEMBL281948,8.05,False,http://www.openphacts.org/units/Nanomolar,2973607,=,48,True,=,,Kd,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,9.0
3706,Inactive,17908653,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2323775,MK-8033,CHEMBL2323775,,False,http://www.openphacts.org/units/Nanomolar,2973461,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3707,Inactive,17908654,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545396,BMS-690514,CHEMBL3545396,,False,http://www.openphacts.org/units/Nanomolar,2973568,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3708,Inactive,17908655,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2103851,AMUVATINIB,CHEMBL2103851,,False,http://www.openphacts.org/units/Nanomolar,2973640,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3709,Inactive,17908656,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL3991601,Science,2017.0,,CHEMBL608533,MIDOSTAURIN,CHEMBL608533,,False,http://www.openphacts.org/units/Nanomolar,2973428,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3710,Inactive,17908657,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3813873,PEXIDARTINIB,CHEMBL3813873,,False,http://www.openphacts.org/units/Nanomolar,2973630,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3711,Uncertain,17908658,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.82', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.82'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,,,CHEMBL3991601,Science,2017.0,"{'bei': '12.53', 'le': '0.23', 'lle': '2.21', 'sei': '6.74'}",CHEMBL574737,UCN-01,CHEMBL574737,6.05,False,http://www.openphacts.org/units/Nanomolar,2973497,=,48,True,=,,Kd,nM,,895.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,895.0
3712,Inactive,17908659,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1614713,CC-401,CHEMBL1614713,,False,http://www.openphacts.org/units/Nanomolar,2973574,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3713,Inactive,17908660,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3218578,BGT-226,CHEMBL3218578,,False,http://www.openphacts.org/units/Nanomolar,2973566,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3714,Inactive,17908661,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL288441,BOSUTINIB,CHEMBL288441,,False,http://www.openphacts.org/units/Nanomolar,2973545,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3715,Inactive,17908662,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1908391,MASITINIB,CHEMBL1908391,,False,http://www.openphacts.org/units/Nanomolar,2973565,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3716,Inactive,17908663,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL1614766,RO-4987655,CHEMBL1614766,,False,http://www.openphacts.org/units/Nanomolar,2973562,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3717,Inactive,17908664,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL124660,TANDUTINIB,CHEMBL124660,,False,http://www.openphacts.org/units/Nanomolar,2973447,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3718,Inactive,17908665,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL230011,TG100-115,CHEMBL230011,,False,http://www.openphacts.org/units/Nanomolar,2973560,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3719,Inactive,17908666,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3991932,,CHEMBL3991932,,False,http://www.openphacts.org/units/Nanomolar,2973536,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3720,Inactive,17908667,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL428690,ALVOCIDIB,CHEMBL428690,,False,http://www.openphacts.org/units/Nanomolar,2973441,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3721,Active,17908668,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.85', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.85'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,,,CHEMBL3991601,Science,2017.0,"{'bei': '14.01', 'le': '0.26', 'lle': '2.25', 'sei': '7.23'}",CHEMBL535,SUNITINIB,CHEMBL535,5.58,False,http://www.openphacts.org/units/Nanomolar,2973417,=,48,True,=,,Kd,nM,,2625.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,2625.0
3722,Inactive,17908669,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1944698,ZOTIRACICLIB,CHEMBL1944698,,False,http://www.openphacts.org/units/Nanomolar,2973487,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3723,Inactive,17908670,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2133806,JNJ-38877605,CHEMBL2133806,,False,http://www.openphacts.org/units/Nanomolar,2973599,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3724,Inactive,17908671,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL3991601,Science,2017.0,,CHEMBL1908360,EVEROLIMUS,CHEMBL1908360,,False,http://www.openphacts.org/units/Nanomolar,2973480,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3725,Inactive,17908672,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,,,CHEMBL3991601,Science,2017.0,,CHEMBL189963,PALBOCICLIB,CHEMBL189963,,False,http://www.openphacts.org/units/Nanomolar,2973581,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3726,Inactive,17908673,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3989868,TUCATINIB,CHEMBL3989868,,False,http://www.openphacts.org/units/Nanomolar,2973493,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3727,Inactive,17908674,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2180604,TAK-593,CHEMBL2180604,,False,http://www.openphacts.org/units/Nanomolar,2973597,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3728,Inactive,17908675,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1976040,ADAVOSERTIB,CHEMBL1976040,,False,http://www.openphacts.org/units/Nanomolar,2973498,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3729,Inactive,17908676,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545307,MERESTINIB,CHEMBL3545307,,False,http://www.openphacts.org/units/Nanomolar,2973624,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3730,Inactive,17908677,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1983268,ENTRECTINIB,CHEMBL1983268,,False,http://www.openphacts.org/units/Nanomolar,2973532,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3731,Active,17908678,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.96', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.96'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1,,,CHEMBL3991601,Science,2017.0,"{'bei': '13.31', 'le': '0.25', 'lle': '3.59', 'sei': '4.42'}",CHEMBL3545137,PF-00477736,CHEMBL3545137,5.58,False,http://www.openphacts.org/units/Nanomolar,2973511,=,48,True,=,,Kd,nM,,2607.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,2607.0
3732,Inactive,17908679,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL3991601,Science,2017.0,,CHEMBL1201182,TEMSIROLIMUS,CHEMBL1201182,,False,http://www.openphacts.org/units/Nanomolar,2973623,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3733,Inactive,17908680,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL2219422,AFURESERTIB,CHEMBL2219422,,False,http://www.openphacts.org/units/Nanomolar,2973455,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3734,Inactive,17908681,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545110,RIBOCICLIB,CHEMBL3545110,,False,http://www.openphacts.org/units/Nanomolar,2973443,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3735,Inactive,17908682,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545083,RGB-286638,CHEMBL3545083,,False,http://www.openphacts.org/units/Nanomolar,2973516,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3736,Inactive,17908683,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1234354,PF-04691502,CHEMBL1234354,,False,http://www.openphacts.org/units/Nanomolar,2973452,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3737,Inactive,17908684,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL3187723,BINIMETINIB,CHEMBL3187723,,False,http://www.openphacts.org/units/Nanomolar,2973582,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3738,Inactive,17908685,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F,,,CHEMBL3991601,Science,2017.0,,CHEMBL3188551,GSK-2636771,CHEMBL3188551,,False,http://www.openphacts.org/units/Nanomolar,2973481,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3739,Inactive,17908686,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2408045,SAPITINIB,CHEMBL2408045,,False,http://www.openphacts.org/units/Nanomolar,2973453,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3740,Inactive,17908687,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL14762,SELICICLIB,CHEMBL14762,,False,http://www.openphacts.org/units/Nanomolar,2973575,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3741,Inactive,17908688,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL372764,PERIFOSINE,CHEMBL372764,,False,http://www.openphacts.org/units/Nanomolar,2973458,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3742,Inactive,17908689,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL1230165,SILMITASERTIB,CHEMBL1230165,,False,http://www.openphacts.org/units/Nanomolar,2973628,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3743,Inactive,17908690,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL217092,SARACATINIB,CHEMBL217092,,False,http://www.openphacts.org/units/Nanomolar,2973439,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3744,Inactive,17908691,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,,,CHEMBL3991601,Science,2017.0,,CHEMBL1738797,ALECTINIB,CHEMBL1738797,,False,http://www.openphacts.org/units/Nanomolar,2973435,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3745,Inactive,17908692,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2325741,CAPIVASERTIB,CHEMBL2325741,,False,http://www.openphacts.org/units/Nanomolar,2973559,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3746,Inactive,17908693,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL215152,AZD-1152-HQPA,CHEMBL215152,,False,http://www.openphacts.org/units/Nanomolar,2973430,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3747,Inactive,17908694,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL402548,DANUSERTIB,CHEMBL402548,,False,http://www.openphacts.org/units/Nanomolar,2973555,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3748,Inactive,17908695,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1,,,CHEMBL3991601,Science,2017.0,,CHEMBL270995,BRIVANIB ALANINATE,CHEMBL270995,,False,http://www.openphacts.org/units/Nanomolar,2973539,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3749,Active,17908696,"[{'comments': None, 'relation': '=', 'result_flag': 1, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'r', 'standard_units': None, 'standard_value': '0.98', 'text_value': None, 'type': 'r', 'units': None, 'value': '0.98'}]",CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,,,CHEMBL3991601,Science,2017.0,"{'bei': '8.37', 'le': '0.15', 'lle': '-1.42', 'sei': '3.77'}",CHEMBL1738757,REBASTINIB,CHEMBL1738757,4.63,False,http://www.openphacts.org/units/Nanomolar,2973604,=,48,True,=,,Kd,nM,,23194.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,23194.0
3750,Inactive,17908697,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3402762,TEPOTINIB,CHEMBL3402762,,False,http://www.openphacts.org/units/Nanomolar,2973580,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3751,Inactive,17908698,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL221959,TOFACITINIB,CHEMBL221959,,False,http://www.openphacts.org/units/Nanomolar,2973611,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3752,Inactive,17908699,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O,,,CHEMBL3991601,Science,2017.0,,CHEMBL274654,ORANTINIB,CHEMBL274654,,False,http://www.openphacts.org/units/Nanomolar,2973432,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3753,Inactive,17908700,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,,,CHEMBL3991601,Science,2017.0,,CHEMBL1645462,AC-480,CHEMBL1645462,,False,http://www.openphacts.org/units/Nanomolar,2973454,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3754,Inactive,17908701,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,,,CHEMBL3991601,Science,2017.0,,CHEMBL1922094,APITOLISIB,CHEMBL1922094,,False,http://www.openphacts.org/units/Nanomolar,2973460,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3755,Inactive,17908702,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3545085,XL-228,CHEMBL3545085,,False,http://www.openphacts.org/units/Nanomolar,2973426,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3756,Inactive,17908703,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,,,CHEMBL3991601,Science,2017.0,,CHEMBL1229517,VEMURAFENIB,CHEMBL1229517,,False,http://www.openphacts.org/units/Nanomolar,2973627,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3757,Inactive,17908704,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2146883,COBIMETINIB,CHEMBL2146883,,False,http://www.openphacts.org/units/Nanomolar,2973558,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3758,Inactive,17908705,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL2336325,VISTUSERTIB,CHEMBL2336325,,False,http://www.openphacts.org/units/Nanomolar,2973445,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3759,Inactive,17908706,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,,,CHEMBL3991601,Science,2017.0,,CHEMBL554,LAPATINIB,CHEMBL554,,False,http://www.openphacts.org/units/Nanomolar,2973429,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3760,Inactive,17908707,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1091644,LINSITINIB,CHEMBL1091644,,False,http://www.openphacts.org/units/Nanomolar,2973442,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3761,Inactive,17908708,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL101253,VATALANIB,CHEMBL101253,,False,http://www.openphacts.org/units/Nanomolar,2973602,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3762,Inactive,17908709,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1230609,FORETINIB,CHEMBL1230609,,False,http://www.openphacts.org/units/Nanomolar,2973444,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3763,Inactive,17908710,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,,,CHEMBL3991601,Science,2017.0,,CHEMBL1614725,TAK-285,CHEMBL1614725,,False,http://www.openphacts.org/units/Nanomolar,2973479,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3764,Inactive,17908711,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL223360,LINIFANIB,CHEMBL223360,,False,http://www.openphacts.org/units/Nanomolar,2973512,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3765,Inactive,17908712,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,,,CHEMBL3991601,Science,2017.0,,CHEMBL475251,R-406,CHEMBL475251,,False,http://www.openphacts.org/units/Nanomolar,2973613,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3766,Inactive,17908713,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3544960,AT-13148,CHEMBL3544960,,False,http://www.openphacts.org/units/Nanomolar,2973578,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3767,Inactive,17908714,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1287853,FEDRATINIB,CHEMBL1287853,,False,http://www.openphacts.org/units/Nanomolar,2973587,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3768,Inactive,17908715,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL300138,ENZASTAURIN,CHEMBL300138,,False,http://www.openphacts.org/units/Nanomolar,2973550,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3769,Inactive,17908716,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3137331,DEFACTINIB,CHEMBL3137331,,False,http://www.openphacts.org/units/Nanomolar,2973648,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3770,Inactive,17908717,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,,,CHEMBL3991601,Science,2017.0,,CHEMBL575448,BMS-754807,CHEMBL575448,,False,http://www.openphacts.org/units/Nanomolar,2973476,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3771,Inactive,17908718,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,,,CHEMBL3991601,Science,2017.0,,CHEMBL483158,ALISERTIB,CHEMBL483158,,False,http://www.openphacts.org/units/Nanomolar,2973567,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3772,Inactive,17908719,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1,,,CHEMBL3991601,Science,2017.0,,CHEMBL3544966,GSK-1059615,CHEMBL3544966,,False,http://www.openphacts.org/units/Nanomolar,2973620,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3773,Inactive,17908720,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL491473,CEDIRANIB,CHEMBL491473,,False,http://www.openphacts.org/units/Nanomolar,2973477,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3774,Inactive,17908721,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1789941,RUXOLITINIB,CHEMBL1789941,,False,http://www.openphacts.org/units/Nanomolar,2973596,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3775,Inactive,17908722,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,,,CHEMBL3991601,Science,2017.0,,CHEMBL1908397,KW-2449,CHEMBL1908397,,False,http://www.openphacts.org/units/Nanomolar,2973471,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3776,Inactive,17908723,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1,,,CHEMBL3991601,Science,2017.0,,CHEMBL482968,ENMD-2076,CHEMBL482968,,False,http://www.openphacts.org/units/Nanomolar,2973552,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3777,Inactive,17908724,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O,,,CHEMBL3991601,Science,2017.0,,CHEMBL415049,BARASERTIB,CHEMBL415049,,False,http://www.openphacts.org/units/Nanomolar,2973438,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3778,Inactive,17908725,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,,,CHEMBL3991601,Science,2017.0,,CHEMBL558752,RAF-265,CHEMBL558752,,False,http://www.openphacts.org/units/Nanomolar,2973595,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3779,Inactive,17908726,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl,,,CHEMBL3991601,Science,2017.0,,CHEMBL3137336,UPROSERTIB,CHEMBL3137336,,False,http://www.openphacts.org/units/Nanomolar,2973553,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3780,Inactive,17908727,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,,,CHEMBL3991601,Science,2017.0,,CHEMBL2105717,CABOZANTINIB,CHEMBL2105717,,False,http://www.openphacts.org/units/Nanomolar,2973563,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3781,Inactive,17908728,[],CHEMBL3991742,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",B,,,BAO_0000034,BAO_0000220,subcellular format,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,,,CHEMBL3991601,Science,2017.0,,CHEMBL483321,CP-724714,CHEMBL483321,,False,http://www.openphacts.org/units/Nanomolar,2973478,>,48,True,>,,Kd,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd apparent,nM,UO_0000065,,30000.0
3782,,17979253,[],CHEMBL3998058,Inhibition of full length recombinant human His-tagged IRAK4 expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21,,,CHEMBL3997765,MedChemComm,2016.0,,CHEMBL4061152,,CHEMBL4061152,,False,http://qudt.org/vocab/unit#Percent,2978717,=,1,True,=,,Inhibition,%,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,3.0
3783,,18073881,[],CHEMBL4015942,Inhibition of full length N-terminal His6-tagged human IRAK4 at 909 uM preincubated for 120 mins followed by 5-FAM-LPTSPITTTYFFFKKK-COOH substrate addition in presence of ATP measured after 120 mins by Caliper assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Oc1ccccc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,,CHEMBL4093989,,CHEMBL4093989,,False,http://qudt.org/vocab/unit#Percent,2995863,>,1,True,>,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
3784,,18073882,[],CHEMBL4015943,Inhibition of IRAK4 catalytic domain (unknown origin) at 236 uM by 1D STD NMR method,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)Oc1ccccc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,,CHEMBL4093989,,CHEMBL4093989,,False,http://qudt.org/vocab/unit#Percent,2995863,>,1,True,>,,Inhibition,%,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,10.0
3785,,18073883,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccccc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '23.77', 'le': '0.45', 'lle': '2.69', 'sei': '8.14'}",CHEMBL4093989,,CHEMBL4093989,4.26,False,http://www.openphacts.org/units/Nanomolar,2995863,=,1,True,=,,IC50,nM,,55000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,55.0
3786,,18073884,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2ccccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '24.78', 'le': '0.46', 'lle': '2.95', 'sei': '10.86'}",CHEMBL4104133,,CHEMBL4104133,5.68,False,http://www.openphacts.org/units/Nanomolar,2995864,=,1,True,=,,IC50,nM,,2087.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2087.0
3787,,18073885,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(-c3ccc(C#N)cc3)cccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.62', 'le': '0.39', 'lle': '2.88', 'sei': '9.39'}",CHEMBL4086222,,CHEMBL4086222,7.14,False,http://www.openphacts.org/units/Nanomolar,2995865,=,1,True,=,,IC50,nM,,71.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,71.9
3788,,18073886,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(O[C@@H]3CCCNC3)ccnc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '20.75', 'le': '0.39', 'lle': '4.59', 'sei': '7.91'}",CHEMBL4061493,,CHEMBL4061493,6.84,False,http://www.openphacts.org/units/Nanomolar,2995866,=,1,True,=,,IC50,nM,,146.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,146.0
3789,,18073887,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(O[C@@H]3CCCNC3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.00', 'le': '0.39', 'lle': '4.67', 'sei': '8.00'}",CHEMBL4089619,,CHEMBL4089619,6.92,False,http://www.openphacts.org/units/Nanomolar,2995867,=,1,True,=,,IC50,nM,,121.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,121.0
3790,,18073888,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '24.28', 'le': '0.46', 'lle': '6.56', 'sei': '8.05'}",CHEMBL4092338,,CHEMBL4092338,8.34,False,http://www.openphacts.org/units/Nanomolar,2995868,=,1,True,=,,IC50,nM,,4.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.6
3791,,18073889,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(OC[C@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '17.69', 'le': '0.33', 'lle': '4.30', 'sei': '5.87'}",CHEMBL4064661,,CHEMBL4064661,6.08,False,http://www.openphacts.org/units/Nanomolar,2995869,=,1,True,=,,IC50,nM,,840.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,840.0
3792,,18073890,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '25.75', 'le': '0.48', 'lle': '7.12', 'sei': '7.84'}",CHEMBL4100091,,CHEMBL4100091,8.12,False,http://www.openphacts.org/units/Nanomolar,2995870,=,1,True,=,,IC50,nM,,7.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.6
3793,,18073891,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '23.14', 'le': '0.43', 'lle': '6.23', 'sei': '7.36'}",CHEMBL4073250,,CHEMBL4073250,7.62,False,http://www.openphacts.org/units/Nanomolar,2995871,=,1,True,=,,IC50,nM,,23.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.9
3794,,18073892,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)ccnc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '26.10', 'le': '0.49', 'lle': '7.23', 'sei': '7.95'}",CHEMBL4061890,,CHEMBL4061890,8.23,False,http://www.openphacts.org/units/Nanomolar,2995872,=,1,True,=,,IC50,nM,,5.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.9
3795,,18073893,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)cccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '28.27', 'le': '0.53', 'lle': '7.29', 'sei': '9.80'}",CHEMBL4083655,,CHEMBL4083655,8.89,False,http://www.openphacts.org/units/Nanomolar,2995873,=,1,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
3796,,18073894,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)C[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '26.02', 'le': '0.49', 'lle': '7.32', 'sei': '8.28'}",CHEMBL4070515,,CHEMBL4070515,8.57,False,http://www.openphacts.org/units/Nanomolar,2995874,=,1,True,=,,IC50,nM,,2.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.7
3797,,18073895,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '27.09', 'le': '0.51', 'lle': '7.66', 'sei': '8.98'}",CHEMBL4091434,,CHEMBL4091434,9.30,False,http://www.openphacts.org/units/Nanomolar,2995875,=,1,True,=,,IC50,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.5
3798,,18073896,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '24.86', 'le': '0.47', 'lle': '6.86', 'sei': '8.58'}",CHEMBL4103497,,CHEMBL4103497,8.89,False,http://www.openphacts.org/units/Nanomolar,2995876,=,1,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
3799,,18073897,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '22.03', 'le': '0.42', 'lle': '7.05', 'sei': '7.02'}",CHEMBL4079243,,CHEMBL4079243,7.92,False,http://www.openphacts.org/units/Nanomolar,2995877,=,1,True,=,,IC50,nM,,12.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.1
3800,,18073898,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H](C)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.94', 'le': '0.41', 'lle': '6.04', 'sei': '7.28'}",CHEMBL4076912,,CHEMBL4076912,7.54,False,http://www.openphacts.org/units/Nanomolar,2995878,=,1,True,=,,IC50,nM,,29.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,29.2
3801,,18073899,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@H](C)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '24.56', 'le': '0.46', 'lle': '6.94', 'sei': '8.14'}",CHEMBL4061801,,CHEMBL4061801,8.43,False,http://www.openphacts.org/units/Nanomolar,2995879,=,1,True,=,,IC50,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.7
3802,,18073900,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H]4C[C@H]34)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '25.41', 'le': '0.47', 'lle': '7.46', 'sei': '8.03'}",CHEMBL4075552,,CHEMBL4075552,8.32,False,http://www.openphacts.org/units/Nanomolar,2995880,=,1,True,=,,IC50,nM,,4.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.8
3803,,18073901,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H]4[C@@H](C)[C@H]34)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '25.25', 'le': '0.47', 'lle': '7.52', 'sei': '8.33'}",CHEMBL4084228,,CHEMBL4084228,8.62,False,http://www.openphacts.org/units/Nanomolar,2995881,=,1,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
3804,,18073902,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H](F)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '27.42', 'le': '0.52', 'lle': '8.33', 'sei': '9.20'}",CHEMBL4093120,,CHEMBL4093120,9.52,False,http://www.openphacts.org/units/Nanomolar,2995882,=,1,True,=,,IC50,nM,,0.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.3
3805,,18073903,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@H](F)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '25.11', 'le': '0.48', 'lle': '7.53', 'sei': '8.42'}",CHEMBL4071526,,CHEMBL4071526,8.72,False,http://www.openphacts.org/units/Nanomolar,2995883,=,1,True,=,,IC50,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.9
3806,,18073904,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '26.84', 'le': '0.51', 'lle': '8.12', 'sei': '9.37'}",CHEMBL4081711,PF-06650833,CHEMBL4081711,9.70,False,http://www.openphacts.org/units/Nanomolar,2995884,=,1,True,=,,IC50,nM,,0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.2
3807,,18073905,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '27.67', 'le': '0.53', 'lle': '8.42', 'sei': '9.66'}",CHEMBL4066705,,CHEMBL4066705,10.00,False,http://www.openphacts.org/units/Nanomolar,2995885,=,1,True,=,,IC50,nM,,0.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.1
3808,,18073906,[],CHEMBL4015944,Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@]4(F)[C@@H](C)[C@H]34)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '25.66', 'le': '0.48', 'lle': '8.03', 'sei': '8.91'}",CHEMBL4085199,,CHEMBL4085199,9.22,False,http://www.openphacts.org/units/Nanomolar,2995886,=,1,True,=,,IC50,nM,,0.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.6
3809,,18073928,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(O[C@@H]3CCCNC3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '17.64', 'le': '0.33', 'lle': '3.56', 'sei': '6.72'}",CHEMBL4089619,,CHEMBL4089619,5.81,False,http://www.openphacts.org/units/Nanomolar,2995867,=,1,True,=,,IC50,nM,,1552.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1552.0
3810,,18073929,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '20.02', 'le': '0.38', 'lle': '5.10', 'sei': '6.64'}",CHEMBL4092338,,CHEMBL4092338,6.88,False,http://www.openphacts.org/units/Nanomolar,2995868,=,1,True,=,,IC50,nM,,133.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,133.0
3811,Not Determined,18073930,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc2c(OC[C@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,,CHEMBL4064661,,CHEMBL4064661,,False,,2995869,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
3812,,18073931,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '20.49', 'le': '0.38', 'lle': '5.46', 'sei': '6.24'}",CHEMBL4100091,,CHEMBL4100091,6.46,False,http://www.openphacts.org/units/Nanomolar,2995870,=,1,True,=,,IC50,nM,,347.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,347.0
3813,,18073932,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '18.74', 'le': '0.35', 'lle': '4.78', 'sei': '5.96'}",CHEMBL4073250,,CHEMBL4073250,6.17,False,http://www.openphacts.org/units/Nanomolar,2995871,=,1,True,=,,IC50,nM,,672.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,672.0
3814,,18073933,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)ccnc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '17.99', 'le': '0.34', 'lle': '4.67', 'sei': '5.48'}",CHEMBL4061890,,CHEMBL4061890,5.67,False,http://www.openphacts.org/units/Nanomolar,2995872,=,1,True,=,,IC50,nM,,2118.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2118.0
3815,,18073934,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)cccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '23.64', 'le': '0.44', 'lle': '5.83', 'sei': '8.20'}",CHEMBL4083655,,CHEMBL4083655,7.43,False,http://www.openphacts.org/units/Nanomolar,2995873,=,1,True,=,,IC50,nM,,37.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,37.1
3816,,18073935,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)C[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '22.11', 'le': '0.41', 'lle': '6.03', 'sei': '7.03'}",CHEMBL4070515,,CHEMBL4070515,7.28,False,http://www.openphacts.org/units/Nanomolar,2995874,=,1,True,=,,IC50,nM,,52.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,52.3
3817,,18073936,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '23.43', 'le': '0.44', 'lle': '6.41', 'sei': '7.77'}",CHEMBL4091434,,CHEMBL4091434,8.05,False,http://www.openphacts.org/units/Nanomolar,2995875,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
3818,,18073937,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.11', 'le': '0.40', 'lle': '5.52', 'sei': '7.29'}",CHEMBL4103497,,CHEMBL4103497,7.55,False,http://www.openphacts.org/units/Nanomolar,2995876,=,1,True,=,,IC50,nM,,28.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,28.4
3819,,18073938,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '17.89', 'le': '0.34', 'lle': '5.56', 'sei': '5.70'}",CHEMBL4079243,,CHEMBL4079243,6.43,False,http://www.openphacts.org/units/Nanomolar,2995877,=,1,True,=,,IC50,nM,,373.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,373.0
3820,,18073939,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H](C)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '16.15', 'le': '0.30', 'lle': '4.06', 'sei': '5.36'}",CHEMBL4076912,,CHEMBL4076912,5.55,False,http://www.openphacts.org/units/Nanomolar,2995878,=,1,True,=,,IC50,nM,,2836.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2836.0
3821,,18073940,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@H](C)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '20.56', 'le': '0.39', 'lle': '5.57', 'sei': '6.82'}",CHEMBL4061801,,CHEMBL4061801,7.06,False,http://www.openphacts.org/units/Nanomolar,2995879,=,1,True,=,,IC50,nM,,87.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,87.1
3822,,18073941,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H]4C[C@H]34)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.20', 'le': '0.39', 'lle': '6.08', 'sei': '6.70'}",CHEMBL4075552,,CHEMBL4075552,6.94,False,http://www.openphacts.org/units/Nanomolar,2995880,=,1,True,=,,IC50,nM,,115.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,115.0
3823,,18073942,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H]4[C@@H](C)[C@H]34)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.34', 'le': '0.40', 'lle': '6.18', 'sei': '7.03'}",CHEMBL4084228,,CHEMBL4084228,7.28,False,http://www.openphacts.org/units/Nanomolar,2995881,=,1,True,=,,IC50,nM,,52.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,52.1
3824,,18073943,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@@H](F)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '22.73', 'le': '0.43', 'lle': '6.71', 'sei': '7.63'}",CHEMBL4093120,,CHEMBL4093120,7.90,False,http://www.openphacts.org/units/Nanomolar,2995882,=,1,True,=,,IC50,nM,,12.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.7
3825,,18073944,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@H](F)[C@H]3C)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.68', 'le': '0.41', 'lle': '6.34', 'sei': '7.27'}",CHEMBL4071526,,CHEMBL4071526,7.53,False,http://www.openphacts.org/units/Nanomolar,2995883,=,1,True,=,,IC50,nM,,29.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,29.5
3826,,18073945,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '24.07', 'le': '0.46', 'lle': '7.12', 'sei': '8.40'}",CHEMBL4081711,PF-06650833,CHEMBL4081711,8.70,False,http://www.openphacts.org/units/Nanomolar,2995884,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,2.4,2.0
3827,,18073946,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '22.66', 'le': '0.43', 'lle': '6.61', 'sei': '7.91'}",CHEMBL4066705,,CHEMBL4066705,8.19,False,http://www.openphacts.org/units/Nanomolar,2995885,=,1,True,=,,IC50,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.5
3828,,18073947,[],CHEMBL4015947,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@H]3NC(=O)[C@]4(F)[C@@H](C)[C@H]34)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '21.63', 'le': '0.41', 'lle': '6.58', 'sei': '7.51'}",CHEMBL4085199,,CHEMBL4085199,7.78,False,http://www.openphacts.org/units/Nanomolar,2995886,=,1,True,=,,IC50,nM,,16.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.8
3829,Active,18073979,[],CHEMBL4015959,Inhibition of IRAK4 in human THP1 cell lysate,B,,,BAO_0000376,BAO_0000019,assay format,CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O,,,CHEMBL4014327,J Med Chem,2017.0,,CHEMBL4092338,,CHEMBL4092338,,False,,2995868,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
3830,,18074000,[],CHEMBL4015981,Inhibition of recombinant human full length His-tagged IRAK4 expressed in baculovirus at 200 nM,B,,,BAO_0000201,BAO_0000019,assay format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,,CHEMBL4081711,PF-06650833,CHEMBL4081711,,False,http://qudt.org/vocab/unit#Percent,2995884,=,1,True,=,,Inhibition,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,100.0
3831,,18074005,[],CHEMBL4015987,Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production by measuring plasma protein binding corrected IC50 after 3 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '24.07', 'le': '0.46', 'lle': '7.12', 'sei': '8.40'}",CHEMBL4081711,PF-06650833,CHEMBL4081711,8.70,False,http://www.openphacts.org/units/Nanomolar,2995884,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
3832,,18074006,[],CHEMBL4015988,Inhibition of IRAK4 in human whole blood assessed as reduction R848-induced IL-6 secretion by measuring plasma protein binding corrected IC50 preincubated for 30 mins prior to R848 addition after 4 hrs,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,"{'bei': '24.07', 'le': '0.46', 'lle': '7.12', 'sei': '8.40'}",CHEMBL4081711,PF-06650833,CHEMBL4081711,8.70,False,http://www.openphacts.org/units/Nanomolar,2995884,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.0
3833,,18074009,[],CHEMBL4015991,Inhibition of IRAK4 in human THP1 cell lysate at 200 nM,B,,,BAO_0000201,BAO_0000019,assay format,CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F,,,CHEMBL4014327,J Med Chem,2017.0,,CHEMBL4081711,PF-06650833,CHEMBL4081711,,False,http://qudt.org/vocab/unit#Percent,2995884,>,1,True,>,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
3834,Not Active,18091339,[],CHEMBL4019848,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000376,BAO_0000357,single protein format,O/N=c1\cc(-c2cc3cccn3cn2)oc2ccc(OCCN3CCOCC3)cc12,,,CHEMBL4017520,J Med Chem,2017.0,,CHEMBL4067875,,CHEMBL4067875,,False,,2999783,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
3835,,18101904,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC(F)(F)CC4)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '22.95', 'le': '0.43', 'lle': '4.56', 'sei': '13.14'}",CHEMBL4069200,,CHEMBL4069200,8.52,False,http://www.openphacts.org/units/Nanomolar,3001966,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
3836,,18101905,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '24.17', 'le': '0.45', 'lle': '5.59', 'sei': '11.01'}",CHEMBL4070214,,CHEMBL4070214,8.15,False,http://www.openphacts.org/units/Nanomolar,3001967,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
3837,,18101906,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Oc2ncnc3ccc([N+](=O)[O-])cc23)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4079234,,CHEMBL4079234,,False,http://www.openphacts.org/units/Nanomolar,3001947,=,1,False,=,,INH,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,2000.0
3838,,18101907,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4097259,,CHEMBL4097259,,False,http://www.openphacts.org/units/Nanomolar,3001948,=,1,False,=,,INH,nM,,1800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,1800.0
3839,,18101908,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(Br)cc23)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4068395,,CHEMBL4068395,,False,http://www.openphacts.org/units/Nanomolar,3001949,=,1,False,=,,INH,nM,,290.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,290.0
3840,,18101909,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4089544,,CHEMBL4089544,,False,http://www.openphacts.org/units/Nanomolar,3001950,=,1,False,=,,INH,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,1100.0
3841,,18101910,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C#N)cc23)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4083650,,CHEMBL4083650,,False,http://www.openphacts.org/units/Nanomolar,3001951,=,1,False,=,,INH,nM,,770.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,770.0
3842,,18101911,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4101649,,CHEMBL4101649,,False,http://www.openphacts.org/units/Nanomolar,3001952,=,1,False,=,,INH,nM,,620.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,620.0
3843,,18101912,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CCc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4072093,,CHEMBL4072093,,False,http://www.openphacts.org/units/Nanomolar,3001953,=,1,False,=,,INH,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,1200.0
3844,,18101913,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CC(C)c1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4099061,,CHEMBL4099061,,False,http://www.openphacts.org/units/Nanomolar,3001954,=,1,False,=,,INH,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,1100.0
3845,,18101914,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C4CC4)cc23)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4063472,,CHEMBL4063472,,False,http://www.openphacts.org/units/Nanomolar,3001955,=,1,False,=,,INH,nM,,2500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,2500.0
3846,,18101915,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@H](Nc2ncnc3cc(F)c(F)cc23)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4090409,,CHEMBL4090409,,False,http://www.openphacts.org/units/Nanomolar,3001957,>,1,False,>,,INH,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,10000.0
3847,,18101916,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4082572,,CHEMBL4082572,,False,http://www.openphacts.org/units/Nanomolar,3001959,=,1,False,=,,INH,nM,,1400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,1400.0
3848,,18101917,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC4)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4060699,,CHEMBL4060699,,False,http://www.openphacts.org/units/Nanomolar,3001960,=,1,False,=,,INH,nM,,620.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,620.0
3849,,18101918,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCCC4)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4059675,,CHEMBL4059675,,False,http://www.openphacts.org/units/Nanomolar,3001961,=,1,False,=,,INH,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,300.0
3850,,18101919,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC(F)CC4)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '24.11', 'le': '0.45', 'lle': '4.86', 'sei': '13.14'}",CHEMBL4096446,,CHEMBL4096446,8.52,False,http://www.openphacts.org/units/Nanomolar,3001965,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
3851,,18101920,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCN(S(=O)(=O)C5CC5)CC4)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '19.35', 'le': '0.38', 'lle': '6.19', 'sei': '8.34'}",CHEMBL4060511,,CHEMBL4060511,8.52,False,http://www.openphacts.org/units/Nanomolar,3001964,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.0
3852,,18101921,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '19.53', 'le': '0.38', 'lle': '6.30', 'sei': '7.92'}",CHEMBL4088745,,CHEMBL4088745,8.10,False,http://www.openphacts.org/units/Nanomolar,3001963,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
3853,,18101922,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '22.17', 'le': '0.41', 'lle': '5.30', 'sei': '11.41'}",CHEMBL4087971,,CHEMBL4087971,7.77,False,http://www.openphacts.org/units/Nanomolar,3001962,=,1,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
3854,,18101923,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCCC4)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '24.34', 'le': '0.45', 'lle': '4.50', 'sei': '12.07'}",CHEMBL4059675,,CHEMBL4059675,7.82,False,http://www.openphacts.org/units/Nanomolar,3001961,=,1,True,=,,IC50,nM,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.0
3855,,18101924,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC4)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '24.25', 'le': '0.44', 'lle': '4.53', 'sei': '11.50'}",CHEMBL4060699,,CHEMBL4060699,7.46,False,http://www.openphacts.org/units/Nanomolar,3001960,=,1,True,=,,IC50,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,35.0
3856,,18101925,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '28.03', 'le': '0.51', 'lle': '5.31', 'sei': '8.55'}",CHEMBL4082572,,CHEMBL4082572,7.50,False,http://www.openphacts.org/units/Nanomolar,3001959,=,1,True,=,,IC50,nM,,32.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,32.0
3857,,18101926,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2cc1C,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '19.84', 'le': '0.37', 'lle': '2.39', 'sei': '14.42'}",CHEMBL4069378,,CHEMBL4069378,5.92,False,http://www.openphacts.org/units/Nanomolar,3001958,=,1,True,=,,IC50,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1200.0
3858,,18101927,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3cc(F)c(F)cc23)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '21.29', 'le': '0.40', 'lle': '3.33', 'sei': '15.89'}",CHEMBL4090409,,CHEMBL4090409,6.52,False,http://www.openphacts.org/units/Nanomolar,3001957,=,1,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,300.0
3859,,18101928,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2cc1OC,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '15.53', 'le': '0.29', 'lle': '2.20', 'sei': '8.62'}",CHEMBL4091329,,CHEMBL4091329,5.13,False,http://www.openphacts.org/units/Nanomolar,3001956,=,1,True,=,,IC50,nM,,7400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7400.0
3860,,18101929,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C4CC4)cc23)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '25.51', 'le': '0.47', 'lle': '4.13', 'sei': '19.30'}",CHEMBL4063472,,CHEMBL4063472,7.92,False,http://www.openphacts.org/units/Nanomolar,3001955,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
3861,,18101930,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '24.95', 'le': '0.46', 'lle': '3.76', 'sei': '18.99'}",CHEMBL4099061,,CHEMBL4099061,7.80,False,http://www.openphacts.org/units/Nanomolar,3001954,=,1,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
3862,,18101931,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '26.03', 'le': '0.48', 'lle': '4.29', 'sei': '18.93'}",CHEMBL4072093,,CHEMBL4072093,7.77,False,http://www.openphacts.org/units/Nanomolar,3001953,=,1,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,17.0
3863,,18101932,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '23.78', 'le': '0.46', 'lle': '4.12', 'sei': '19.60'}",CHEMBL4101649,,CHEMBL4101649,8.05,False,http://www.openphacts.org/units/Nanomolar,3001952,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.0
3864,,18101933,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C#N)cc23)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '27.61', 'le': '0.51', 'lle': '5.36', 'sei': '12.58'}",CHEMBL4083650,,CHEMBL4083650,8.15,False,http://www.openphacts.org/units/Nanomolar,3001951,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
3865,,18101934,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '25.95', 'le': '0.48', 'lle': '4.88', 'sei': '15.50'}",CHEMBL4089544,,CHEMBL4089544,7.80,False,http://www.openphacts.org/units/Nanomolar,3001950,=,1,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,16.0
3866,,18101935,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(Br)cc23)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '22.90', 'le': '0.52', 'lle': '4.32', 'sei': '19.49'}",CHEMBL4068395,,CHEMBL4068395,8.00,False,http://www.openphacts.org/units/Nanomolar,3001949,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3867,,18101936,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '27.15', 'le': '0.50', 'lle': '4.50', 'sei': '18.81'}",CHEMBL4097259,,CHEMBL4097259,7.72,False,http://www.openphacts.org/units/Nanomolar,3001948,=,1,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
3868,,18101937,[],CHEMBL4022135,Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Oc2ncnc3ccc([N+](=O)[O-])cc23)CC1,,,CHEMBL4020773,Bioorg Med Chem Lett,2017.0,"{'bei': '22.87', 'le': '0.43', 'lle': '4.45', 'sei': '8.89'}",CHEMBL4079234,,CHEMBL4079234,7.24,False,http://www.openphacts.org/units/Nanomolar,3001947,=,1,True,=,,IC50,nM,,58.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,58.0
3869,,18101938,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CN1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4087971,,CHEMBL4087971,,False,http://www.openphacts.org/units/Nanomolar,3001962,=,1,False,=,,INH,nM,,274.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,274.0
3870,,18101939,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,CS(=O)(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4088745,,CHEMBL4088745,,False,http://www.openphacts.org/units/Nanomolar,3001963,=,1,False,=,,INH,nM,,330.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,330.0
3871,,18101940,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCN(S(=O)(=O)C5CC5)CC4)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4060511,,CHEMBL4060511,,False,http://www.openphacts.org/units/Nanomolar,3001964,=,1,False,=,,INH,nM,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,80.0
3872,,18101941,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC(F)CC4)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4096446,,CHEMBL4096446,,False,http://www.openphacts.org/units/Nanomolar,3001965,=,1,False,=,,INH,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,100.0
3873,,18101942,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC(F)(F)CC4)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4069200,,CHEMBL4069200,,False,http://www.openphacts.org/units/Nanomolar,3001966,=,1,False,=,,INH,nM,,200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,200.0
3874,,18101943,[],CHEMBL4022136,Inhibition of IRAK4 in human whole blood assessed as reduction in R848-stimulated TNF alpha production preincubated for 30 mins followed by R848 addition measured after 5 hrs,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1,Non standard unit for type,Units for this activity type are unusual and may be incorrect (or the standard_type may be incorrect),CHEMBL4020773,Bioorg Med Chem Lett,2017.0,,CHEMBL4070214,,CHEMBL4070214,,False,http://www.openphacts.org/units/Nanomolar,3001967,=,1,False,=,,INH,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,nM,UO_0000065,,300.0
3875,,18114308,[],CHEMBL4025186,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,,,CHEMBL4024706,Eur J Med Chem,2017.0,,CHEMBL4077123,,CHEMBL4077123,,False,http://qudt.org/vocab/unit#Percent,3003997,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
3876,,18122094,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.39', 'le': '0.31', 'lle': '4.60', 'sei': '8.33'}",CHEMBL4104802,,CHEMBL4104802,7.47,False,http://www.openphacts.org/units/Nanomolar,3005181,=,1,True,=,,IC50,nM,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.034
3877,,18122095,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.96', 'le': '0.32', 'lle': '4.50', 'sei': '8.38'}",CHEMBL4080574,,CHEMBL4080574,7.24,False,http://www.openphacts.org/units/Nanomolar,3005180,=,1,True,=,,IC50,nM,,58.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.058
3878,,18122096,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Oc2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.02', 'le': '0.36', 'lle': '3.45', 'sei': '10.36'}",CHEMBL4097089,,CHEMBL4097089,6.55,False,http://www.openphacts.org/units/Nanomolar,3005179,=,1,True,=,,IC50,nM,,280.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.28
3879,,18122097,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](N(C)c2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '17.90', 'le': '0.34', 'lle': '3.24', 'sei': '11.17'}",CHEMBL4069890,,CHEMBL4069890,6.40,False,http://www.openphacts.org/units/Nanomolar,3005178,=,1,True,=,,IC50,nM,,400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.4
3880,,18122098,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.05', 'le': '0.39', 'lle': '4.09', 'sei': '10.94'}",CHEMBL4089379,,CHEMBL4089379,7.23,False,http://www.openphacts.org/units/Nanomolar,3005177,=,1,True,=,,IC50,nM,,59.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.059
3881,,18122099,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCOC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '20.91', 'le': '0.39', 'lle': '4.04', 'sei': '10.87'}",CHEMBL4061227,,CHEMBL4061227,7.18,False,http://www.openphacts.org/units/Nanomolar,3005176,=,1,True,=,,IC50,nM,,66.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.066
3882,,18122100,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '22.67', 'le': '0.42', 'lle': '4.72', 'sei': '11.30'}",CHEMBL4081502,,CHEMBL4081502,7.47,False,http://www.openphacts.org/units/Nanomolar,3005175,=,1,True,=,,IC50,nM,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.034
3883,,18122101,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.02', 'le': '0.36', 'lle': '3.52', 'sei': '9.49'}",CHEMBL4081502,,CHEMBL4081502,6.27,False,http://www.openphacts.org/units/Nanomolar,3005174,=,1,True,=,,IC50,nM,,540.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.54
3884,,18122102,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '17.23', 'le': '0.32', 'lle': '2.59', 'sei': '8.59'}",CHEMBL4075333,,CHEMBL4075333,5.68,False,http://www.openphacts.org/units/Nanomolar,3005173,=,1,True,=,,IC50,nM,,2100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.1
3885,,18122103,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '17.97', 'le': '0.34', 'lle': '2.83', 'sei': '8.96'}",CHEMBL4075333,,CHEMBL4075333,5.92,False,http://www.openphacts.org/units/Nanomolar,3005172,=,1,True,=,,IC50,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.2
3886,,18122104,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '23.32', 'le': '0.43', 'lle': '3.74', 'sei': '13.44'}",CHEMBL4097418,,CHEMBL4097418,7.64,False,http://www.openphacts.org/units/Nanomolar,3005171,=,1,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.023
3887,,18122105,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '23.53', 'le': '0.44', 'lle': '3.87', 'sei': '12.98'}",CHEMBL4078625,,CHEMBL4078625,7.38,False,http://www.openphacts.org/units/Nanomolar,3005170,=,1,True,=,,IC50,nM,,42.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.042
3888,,18122106,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '23.80', 'le': '0.44', 'lle': '4.00', 'sei': '12.54'}",CHEMBL4091013,,CHEMBL4091013,7.12,False,http://www.openphacts.org/units/Nanomolar,3005169,=,1,True,=,,IC50,nM,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.075
3889,,18122107,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(F)(F)F)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '20.17', 'le': '0.39', 'lle': '3.34', 'sei': '11.62'}",CHEMBL4063127,,CHEMBL4063127,6.60,False,http://www.openphacts.org/units/Nanomolar,3005168,=,1,True,=,,IC50,nM,,250.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.25
3890,,18122108,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(C)(C)C)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.31', 'le': '0.36', 'lle': '2.55', 'sei': '10.72'}",CHEMBL4064168,,CHEMBL4064168,6.09,False,http://www.openphacts.org/units/Nanomolar,3005167,=,1,True,=,,IC50,nM,,810.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.81
3891,,18122109,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '25.01', 'le': '0.47', 'lle': '4.17', 'sei': '13.26'}",CHEMBL4085735,,CHEMBL4085735,7.54,False,http://www.openphacts.org/units/Nanomolar,3005166,=,1,True,=,,IC50,nM,,29.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.029
3892,,18122110,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '25.05', 'le': '0.47', 'lle': '4.39', 'sei': '12.67'}",CHEMBL4077215,,CHEMBL4077215,7.20,False,http://www.openphacts.org/units/Nanomolar,3005165,=,1,True,=,,IC50,nM,,63.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.063
3893,,18122111,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '22.57', 'le': '0.42', 'lle': '3.61', 'sei': '10.30'}",CHEMBL4093475,,CHEMBL4093475,5.85,False,http://www.openphacts.org/units/Nanomolar,3005164,=,1,True,=,,IC50,nM,,1400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.4
3894,,18122112,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '25.07', 'le': '0.47', 'lle': '4.30', 'sei': '12.06'}",CHEMBL4063689,,CHEMBL4063689,6.85,False,http://www.openphacts.org/units/Nanomolar,3005163,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.14
3895,,18122113,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2[nH]1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL4086053,,CHEMBL4086053,,False,http://www.openphacts.org/units/Nanomolar,3005162,>,1,True,>,,IC50,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,30.0
3896,,18122114,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.14', 'le': '0.30', 'lle': '1.78', 'sei': '8.16'}",CHEMBL4105582,,CHEMBL4105582,4.64,False,http://www.openphacts.org/units/Nanomolar,3005161,=,1,True,=,,IC50,nM,,23000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,23.0
3897,,18122115,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]c4c(c23)CCC4)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.27', 'le': '0.36', 'lle': '3.04', 'sei': '10.15'}",CHEMBL4087705,,CHEMBL4087705,5.77,False,http://www.openphacts.org/units/Nanomolar,3005160,=,1,True,=,,IC50,nM,,1700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.7
3898,,18122116,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.36', 'le': '0.36', 'lle': '2.10', 'sei': '12.36'}",CHEMBL4097847,,CHEMBL4097847,5.08,False,http://www.openphacts.org/units/Nanomolar,3005159,=,1,True,=,,IC50,nM,,8400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,8.4
3899,,18122117,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1csc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.48', 'le': '0.37', 'lle': '2.09', 'sei': '13.07'}",CHEMBL4079819,,CHEMBL4079819,5.37,False,http://www.openphacts.org/units/Nanomolar,3005158,=,1,True,=,,IC50,nM,,4300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.3
3900,,18122118,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2s1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.74', 'le': '0.37', 'lle': '2.16', 'sei': '13.26'}",CHEMBL4096351,,CHEMBL4096351,5.44,False,http://www.openphacts.org/units/Nanomolar,3005157,=,1,True,=,,IC50,nM,,3600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3.6
3901,,18122119,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1sc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.40', 'le': '0.36', 'lle': '2.01', 'sei': '13.65'}",CHEMBL4069060,,CHEMBL4069060,5.60,False,http://www.openphacts.org/units/Nanomolar,3005156,=,1,True,=,,IC50,nM,,2500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.5
3902,,18122120,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4c(c23)CCC4)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.94', 'le': '0.39', 'lle': '2.85', 'sei': '15.37'}",CHEMBL3361252,,CHEMBL3361252,6.31,False,http://www.openphacts.org/units/Nanomolar,3005155,=,1,True,=,,IC50,nM,,490.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.49
3903,,18122121,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,N#Cc1cnc2[nH]cc(C3CCOCC3)c2c1N[C@H]1CC[C@H](N2CCOCC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '17.71', 'le': '0.33', 'lle': '3.87', 'sei': '8.41'}",CHEMBL4079194,,CHEMBL4079194,7.25,False,http://www.openphacts.org/units/Nanomolar,3005192,=,1,True,=,,IC50,nM,,56.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.056
3904,,18122122,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,c1cc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.91', 'le': '0.37', 'lle': '4.15', 'sei': '12.27'}",CHEMBL4104915,,CHEMBL4104915,7.66,False,http://www.openphacts.org/units/Nanomolar,3005191,=,1,True,=,,IC50,nM,,22.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.022
3905,,18122123,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,c1nc(S[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '20.86', 'le': '0.41', 'lle': '4.81', 'sei': '13.27'}",CHEMBL4087063,,CHEMBL4087063,8.40,False,http://www.openphacts.org/units/Nanomolar,3005190,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.004
3906,,18122124,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,c1nc(O[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.36', 'le': '0.36', 'lle': '4.61', 'sei': '10.32'}",CHEMBL4067302,,CHEMBL4067302,7.48,False,http://www.openphacts.org/units/Nanomolar,3005189,=,1,True,=,,IC50,nM,,33.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.033
3907,,18122125,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,c1nc(N[C@H]2CC[C@@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.20', 'le': '0.30', 'lle': '3.33', 'sei': '8.29'}",CHEMBL4094760,,CHEMBL4094760,6.24,False,http://www.openphacts.org/units/Nanomolar,3005188,=,1,True,=,,IC50,nM,,570.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.57
3908,,18122126,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1C(=O)C[C@@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@@H]21,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.22', 'le': '0.36', 'lle': '5.57', 'sei': '10.07'}",CHEMBL4078222,,CHEMBL4078222,8.70,False,http://www.openphacts.org/units/Nanomolar,3005187,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.002
3909,,18122127,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1C(=O)C[C@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@H]21,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.22', 'le': '0.36', 'lle': '5.57', 'sei': '10.07'}",CHEMBL4102501,,CHEMBL4102501,8.70,False,http://www.openphacts.org/units/Nanomolar,3005186,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.002
3910,,18122128,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)C(=O)C1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '17.70', 'le': '0.33', 'lle': '4.67', 'sei': '9.31'}",CHEMBL4086115,,CHEMBL4086115,8.05,False,http://www.openphacts.org/units/Nanomolar,3005185,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.009
3911,,18122129,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.53', 'le': '0.40', 'lle': '5.39', 'sei': '11.02'}",CHEMBL4064608,,CHEMBL4064608,8.30,False,http://www.openphacts.org/units/Nanomolar,3005184,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.005
3912,,18122130,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.26', 'le': '0.36', 'lle': '5.56', 'sei': '8.91'}",CHEMBL4067181,,CHEMBL4067181,8.52,False,http://www.openphacts.org/units/Nanomolar,3005183,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.003
3913,,18122131,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CS(=O)(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '14.82', 'le': '0.29', 'lle': '4.70', 'sei': '6.63'}",CHEMBL4088438,,CHEMBL4088438,6.85,False,http://www.openphacts.org/units/Nanomolar,3005182,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.14
3914,,18122132,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)C(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.71', 'le': '0.35', 'lle': '5.65', 'sei': '9.51'}",CHEMBL4104802,,CHEMBL4104802,8.52,False,http://www.openphacts.org/units/Nanomolar,3005181,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.003
3915,,18122133,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '20.39', 'le': '0.38', 'lle': '5.96', 'sei': '10.07'}",CHEMBL4080574,,CHEMBL4080574,8.70,False,http://www.openphacts.org/units/Nanomolar,3005180,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.002
3916,,18122134,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Oc2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.36', 'le': '0.40', 'lle': '4.26', 'sei': '11.63'}",CHEMBL4097089,,CHEMBL4097089,7.36,False,http://www.openphacts.org/units/Nanomolar,3005179,=,1,True,=,,IC50,nM,,44.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.044
3917,,18122135,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](N(C)c2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.80', 'le': '0.35', 'lle': '3.56', 'sei': '11.73'}",CHEMBL4069890,,CHEMBL4069890,6.72,False,http://www.openphacts.org/units/Nanomolar,3005178,=,1,True,=,,IC50,nM,,190.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.19
3918,,18122136,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '23.94', 'le': '0.45', 'lle': '5.08', 'sei': '12.44'}",CHEMBL4089379,,CHEMBL4089379,8.22,True,http://www.openphacts.org/units/Nanomolar,3005177,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.006
3919,,18122137,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCOC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '22.70', 'le': '0.43', 'lle': '4.66', 'sei': '11.80'}",CHEMBL4061227,,CHEMBL4061227,7.80,False,http://www.openphacts.org/units/Nanomolar,3005176,=,1,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.016
3920,,18122138,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '24.58', 'le': '0.46', 'lle': '5.35', 'sei': '12.26'}",CHEMBL4081502,,CHEMBL4081502,8.10,False,http://www.openphacts.org/units/Nanomolar,3005175,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.008
3921,,18122139,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.01', 'le': '0.39', 'lle': '4.17', 'sei': '10.47'}",CHEMBL4081502,,CHEMBL4081502,6.92,False,http://www.openphacts.org/units/Nanomolar,3005174,=,1,True,=,,IC50,nM,,120.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.12
3922,,18122140,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.89', 'le': '0.37', 'lle': '3.46', 'sei': '9.92'}",CHEMBL4075333,,CHEMBL4075333,6.55,False,http://www.openphacts.org/units/Nanomolar,3005173,=,1,True,=,,IC50,nM,,280.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.28
3923,,18122141,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.94', 'le': '0.37', 'lle': '3.48', 'sei': '9.94'}",CHEMBL4075333,,CHEMBL4075333,6.57,False,http://www.openphacts.org/units/Nanomolar,3005172,=,1,True,=,,IC50,nM,,270.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.27
3924,,18122142,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '25.11', 'le': '0.47', 'lle': '4.32', 'sei': '14.46'}",CHEMBL4097418,,CHEMBL4097418,8.22,False,http://www.openphacts.org/units/Nanomolar,3005171,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.006
3925,,18122143,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '27.19', 'le': '0.51', 'lle': '5.01', 'sei': '14.99'}",CHEMBL4078625,,CHEMBL4078625,8.52,False,http://www.openphacts.org/units/Nanomolar,3005170,=,1,True,=,,IC50,nM,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.003
3926,,18122144,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CC4)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '26.58', 'le': '0.49', 'lle': '4.84', 'sei': '14.00'}",CHEMBL4091013,,CHEMBL4091013,7.96,False,http://www.openphacts.org/units/Nanomolar,3005169,=,1,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.011
3927,,18122145,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(F)(F)F)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.40', 'le': '0.42', 'lle': '3.74', 'sei': '12.32'}",CHEMBL4063127,,CHEMBL4063127,7.00,False,http://www.openphacts.org/units/Nanomolar,3005168,=,1,True,=,,IC50,nM,,99.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.099
3928,,18122146,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(C)(C)C)c23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.73', 'le': '0.41', 'lle': '3.31', 'sei': '12.06'}",CHEMBL4064168,,CHEMBL4064168,6.85,False,http://www.openphacts.org/units/Nanomolar,3005167,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.14
3929,,18122147,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '27.54', 'le': '0.52', 'lle': '4.93', 'sei': '14.60'}",CHEMBL4085735,,CHEMBL4085735,8.30,True,http://www.openphacts.org/units/Nanomolar,3005166,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.005
3930,,18122148,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '27.44', 'le': '0.51', 'lle': '5.08', 'sei': '13.87'}",CHEMBL4077215,,CHEMBL4077215,7.89,False,http://www.openphacts.org/units/Nanomolar,3005165,=,1,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.013
3931,,18122149,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '23.88', 'le': '0.45', 'lle': '3.95', 'sei': '10.90'}",CHEMBL4093475,,CHEMBL4093475,6.19,True,http://www.openphacts.org/units/Nanomolar,3005164,=,1,True,=,,IC50,nM,,640.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.64
3932,,18122150,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '30.36', 'le': '0.57', 'lle': '5.75', 'sei': '14.60'}",CHEMBL4063689,,CHEMBL4063689,8.30,True,http://www.openphacts.org/units/Nanomolar,3005163,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.005
3933,,18122151,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2[nH]1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL4086053,,CHEMBL4086053,,False,http://www.openphacts.org/units/Nanomolar,3005162,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
3934,,18122152,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '17.56', 'le': '0.33', 'lle': '2.19', 'sei': '8.88'}",CHEMBL4105582,,CHEMBL4105582,5.05,False,http://www.openphacts.org/units/Nanomolar,3005161,=,1,True,=,,IC50,nM,,9000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,9.0
3935,,18122153,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]c4c(c23)CCC4)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.33', 'le': '0.40', 'lle': '3.66', 'sei': '11.24'}",CHEMBL4087705,,CHEMBL4087705,6.39,False,http://www.openphacts.org/units/Nanomolar,3005160,=,1,True,=,,IC50,nM,,410.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.41
3936,,18122154,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.42', 'le': '0.39', 'lle': '2.39', 'sei': '13.07'}",CHEMBL4097847,,CHEMBL4097847,5.37,True,http://www.openphacts.org/units/Nanomolar,3005159,=,1,True,=,,IC50,nM,,4300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.3
3937,,18122155,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1csc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.35', 'le': '0.38', 'lle': '2.34', 'sei': '13.69'}",CHEMBL4079819,,CHEMBL4079819,5.62,False,http://www.openphacts.org/units/Nanomolar,3005158,=,1,True,=,,IC50,nM,,2400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.4
3938,,18122156,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2s1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.96', 'le': '0.40', 'lle': '2.52', 'sei': '14.12'}",CHEMBL4096351,,CHEMBL4096351,5.80,False,http://www.openphacts.org/units/Nanomolar,3005157,=,1,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.6
3939,,18122157,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1sc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '19.13', 'le': '0.38', 'lle': '2.23', 'sei': '14.19'}",CHEMBL4069060,,CHEMBL4069060,5.82,False,http://www.openphacts.org/units/Nanomolar,3005156,=,1,True,=,,IC50,nM,,1500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.5
3940,,18122158,[],CHEMBL4026982,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4c(c23)CCC4)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.66', 'le': '0.43', 'lle': '3.39', 'sei': '16.70'}",CHEMBL3361252,,CHEMBL3361252,6.85,False,http://www.openphacts.org/units/Nanomolar,3005155,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.14
3941,,18122159,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '14.96', 'le': '0.30', 'lle': '4.77', 'sei': '6.69'}",CHEMBL4088438,,CHEMBL4088438,6.92,False,http://www.openphacts.org/units/Nanomolar,3005182,=,1,True,=,,IC50,nM,,120.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.12
3942,,18122160,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.01', 'le': '0.30', 'lle': '4.13', 'sei': '7.41'}",CHEMBL4067181,,CHEMBL4067181,7.09,False,http://www.openphacts.org/units/Nanomolar,3005183,=,1,True,=,,IC50,nM,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.082
3943,,18122161,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.89', 'le': '0.36', 'lle': '4.37', 'sei': '9.67'}",CHEMBL4064608,,CHEMBL4064608,7.28,False,http://www.openphacts.org/units/Nanomolar,3005184,=,1,True,=,,IC50,nM,,52.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.052
3944,,18122162,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)C1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '14.45', 'le': '0.27', 'lle': '3.19', 'sei': '7.60'}",CHEMBL4086115,,CHEMBL4086115,6.57,False,http://www.openphacts.org/units/Nanomolar,3005185,=,1,True,=,,IC50,nM,,270.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.27
3945,,18122163,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1C(=O)C[C@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@H]21,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.30', 'le': '0.31', 'lle': '4.25', 'sei': '8.54'}",CHEMBL4102501,,CHEMBL4102501,7.38,False,http://www.openphacts.org/units/Nanomolar,3005186,=,1,True,=,,IC50,nM,,42.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.042
3946,,18122164,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1C(=O)C[C@@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@@H]21,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.39', 'le': '0.31', 'lle': '4.29', 'sei': '8.59'}",CHEMBL4078222,,CHEMBL4078222,7.42,False,http://www.openphacts.org/units/Nanomolar,3005187,=,1,True,=,,IC50,nM,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.038
3947,,18122165,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '14.29', 'le': '0.27', 'lle': '2.60', 'sei': '7.32'}",CHEMBL4094760,,CHEMBL4094760,5.51,False,http://www.openphacts.org/units/Nanomolar,3005188,=,1,True,=,,IC50,nM,,3100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,3.1
3948,,18122166,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,c1nc(O[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '17.58', 'le': '0.33', 'lle': '3.93', 'sei': '9.37'}",CHEMBL4067302,,CHEMBL4067302,6.80,False,http://www.openphacts.org/units/Nanomolar,3005189,=,1,True,=,,IC50,nM,,160.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.16
3949,,18122167,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,c1nc(S[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '18.52', 'le': '0.36', 'lle': '3.87', 'sei': '11.78'}",CHEMBL4087063,,CHEMBL4087063,7.46,False,http://www.openphacts.org/units/Nanomolar,3005190,=,1,True,=,,IC50,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.035
3950,,18122168,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,c1cc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '16.82', 'le': '0.32', 'lle': '2.96', 'sei': '10.36'}",CHEMBL4104915,,CHEMBL4104915,6.47,False,http://www.openphacts.org/units/Nanomolar,3005191,=,1,True,=,,IC50,nM,,340.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.34
3951,,18122169,[],CHEMBL4026983,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cnc2[nH]cc(C3CCOCC3)c2c1N[C@H]1CC[C@H](N2CCOCC2)CC1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '15.93', 'le': '0.30', 'lle': '3.14', 'sei': '7.57'}",CHEMBL4079194,,CHEMBL4079194,6.52,False,http://www.openphacts.org/units/Nanomolar,3005192,=,1,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.3
3952,,18122271,[],CHEMBL4027002,Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected Sf21 insect cells at 0.1 uM relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL4064608,,CHEMBL4064608,,False,http://qudt.org/vocab/unit#Percent,3005184,>,1,True,>,,Inhibition,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,75.0
3953,,18122275,[],CHEMBL4027007,Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected Sf21 insect cells,B,,,BAO_0000190,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '21.53', 'le': '0.40', 'lle': '5.39', 'sei': '11.02'}",CHEMBL4064608,,CHEMBL4064608,8.30,False,http://www.openphacts.org/units/Nanomolar,3005184,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.005
3954,,18122276,[],CHEMBL4027008,Binding affinity to wild type human IRAK4 (M1 to S460) expressed in mammalian expression system,B,,,BAO_0000034,BAO_0000019,assay format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,"{'bei': '23.75', 'le': '0.45', 'lle': '6.24', 'sei': '12.16'}",CHEMBL4064608,,CHEMBL4064608,9.15,False,http://www.openphacts.org/units/Nanomolar,3005184,=,1,True,=,,Kd,nM,,0.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,uM,UO_0000065,,0.0007
3955,Dose-dependent effect,18122309,[],CHEMBL4027046,Inhibition of IRAK4 in human OCI-LY10 cells harboring MYD88 mutation assessed as reduction in IKBalpha phosphorylation after 14 hrs by Western blot analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL4064608,,CHEMBL4064608,,False,,3005184,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
3956,Not Active,18122310,[],CHEMBL4027047,Inhibition of IRAK4 in human OCI-LY10 cells harboring MYD88 mutation assessed as reduction in IKBalpha phosphorylation up to 3.3 uM after 14 hrs by Western blot analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL4064608,,CHEMBL4064608,,False,,3005184,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
3957,Active,18122314,[],CHEMBL4027050,Inhibition of IRAK4 in human OCI-LY10 cells harboring MYD88 mutation assessed as reduction in IKBalpha phosphorylation at greater than 0.37 uM after 14 hrs by Western blot analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL4064608,,CHEMBL4064608,,False,,3005184,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
3958,Active,18122315,[],CHEMBL4027051,Inhibition of IRAK4 in human OCI-LY10 cells harboring MYD88 mutation assessed as reduction in IKBalpha phosphorylation at 3 nM after 14 hrs by Western blot analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL1873475,IBRUTINIB,CHEMBL1873475,,False,,3005193,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
3959,Active,18122316,[],CHEMBL4027052,Inhibition of IRAK4 in human OCI-LY10 cells harboring MYD88 mutation assessed as reduction in IKBalpha phosphorylation at greater than 0.37 uM after 14 hrs in presence of ibrutinib by Western blot analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4024763,J Med Chem,2017.0,,CHEMBL4064608,,CHEMBL4064608,,False,,3005184,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
3960,,18153093,[],CHEMBL4034345,Inhibition of IRAK4 Lysine 2 labelling site (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,c1cc(-c2c[nH]c3cnccc23)ccn1,,,CHEMBL4033637,Bioorg Med Chem Lett,2017.0,,CHEMBL4084955,,CHEMBL4084955,,False,http://qudt.org/vocab/unit#Percent,3011476,=,1,True,=,,Inhibition,%,,0.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,0.8
3961,,18153306,[],CHEMBL4034344,Inhibition of IRAK4 Lysine 1 labelling site (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,c1cc(-c2c[nH]c3cnccc23)ccn1,,,CHEMBL4033637,Bioorg Med Chem Lett,2017.0,,CHEMBL4084955,,CHEMBL4084955,,False,http://qudt.org/vocab/unit#Percent,3011476,=,1,True,=,,Inhibition,%,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,3.5
3962,,18203710,[],CHEMBL4043997,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl,,,CHEMBL4043093,Eur J Med Chem,2017.0,,CHEMBL4092508,,CHEMBL4092508,,False,http://qudt.org/vocab/unit#Percent,3020066,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
3963,,18211657,[],CHEMBL4045703,Inhibition of IRAK4 conserved Lys2 (DIKSANILLDEAFTAK) in human PBMC at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,,,CHEMBL4043168,Bioorg Med Chem Lett,2017.0,,CHEMBL3971067,,CHEMBL3971067,,False,http://qudt.org/vocab/unit#Percent,3021631,=,1,True,=,,Inhibition,%,,-2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-2.5
3964,,18211663,[],CHEMBL4045702,Inhibition of IRAK4 conserved Lys1 (GYVNNTTVAVKK) in human PBMC at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,,,CHEMBL4043168,Bioorg Med Chem Lett,2017.0,,CHEMBL3971067,,CHEMBL3971067,,False,http://qudt.org/vocab/unit#Percent,3021631,=,1,True,=,,Inhibition,%,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.0
3965,,18211847,[],CHEMBL4045943,Inhibition of IRAK4 conserved Lys1 (GYVNNTTVAVKK) in human PBMC at 0.1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,,,CHEMBL4043168,Bioorg Med Chem Lett,2017.0,,CHEMBL3971067,,CHEMBL3971067,,False,http://qudt.org/vocab/unit#Percent,3021631,=,1,True,=,,Inhibition,%,,10.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,10.2
3966,,18211848,[],CHEMBL4045944,Inhibition of IRAK4 conserved Lys2 (DIKSANILLDEAFTAK) in human PBMC at 0.1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1,,,CHEMBL4043168,Bioorg Med Chem Lett,2017.0,,CHEMBL3971067,,CHEMBL3971067,,False,http://qudt.org/vocab/unit#Percent,3021631,=,1,True,=,,Inhibition,%,,-1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.8
3967,,18220802,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccccc2)cc1NCc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.04', 'le': '0.33', 'lle': '2.20', 'sei': '7.18'}",CHEMBL4072239,,CHEMBL4072239,5.75,False,http://www.openphacts.org/units/Nanomolar,3023420,=,1,True,=,,IC50,nM,,1800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1800.0
3968,,18220803,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccccc2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '16.93', 'le': '0.31', 'lle': '3.20', 'sei': '6.12'}",CHEMBL4099198,,CHEMBL4099198,6.14,False,http://www.openphacts.org/units/Nanomolar,3023421,=,1,True,=,,IC50,nM,,730.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,730.0
3969,,18220804,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccccc2)cc1N[C@H](CO)c1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.44', 'le': '0.32', 'lle': '3.01', 'sei': '6.06'}",CHEMBL4080656,,CHEMBL4080656,6.08,False,http://www.openphacts.org/units/Nanomolar,3023422,=,1,True,=,,IC50,nM,,840.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,840.0
3970,,18220805,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3)cc1NCc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.26', 'le': '0.31', 'lle': '3.41', 'sei': '5.90'}",CHEMBL4098698,,CHEMBL4098698,6.44,False,http://www.openphacts.org/units/Nanomolar,3023423,=,1,True,=,,IC50,nM,,360.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,360.0
3971,,18220806,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)cc1NCc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.88', 'le': '0.32', 'lle': '3.00', 'sei': '5.89'}",CHEMBL4088523,,CHEMBL4088523,6.41,False,http://www.openphacts.org/units/Nanomolar,3023424,=,1,True,=,,IC50,nM,,390.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,390.0
3972,,18220807,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(Nc2cc(NCc3ccccc3)c(C(N)=O)cn2)cc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.51', 'le': '0.32', 'lle': '3.69', 'sei': '5.14'}",CHEMBL4060298,,CHEMBL4060298,6.33,False,http://www.openphacts.org/units/Nanomolar,3023425,=,1,True,=,,IC50,nM,,470.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,470.0
3973,,18220808,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2ccc(Nc3cc(NCc4ccccc4)c(C(N)=O)cn3)cc2)CC1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,,CHEMBL4096246,,CHEMBL4096246,,False,http://www.openphacts.org/units/Nanomolar,3023426,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10000.0
3974,,18220809,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NCc1cc(F)ccc1F,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '16.39', 'le': '0.32', 'lle': '2.32', 'sei': '7.26'}",CHEMBL4068975,,CHEMBL4068975,6.75,False,http://www.openphacts.org/units/Nanomolar,3023427,=,1,True,=,,IC50,nM,,180.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,180.0
3975,,18220810,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.41', 'le': '0.35', 'lle': '4.17', 'sei': '6.82'}",CHEMBL4104005,,CHEMBL4104005,7.72,False,http://www.openphacts.org/units/Nanomolar,3023428,=,1,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
3976,,18220811,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.45', 'le': '0.35', 'lle': '4.19', 'sei': '8.07'}",CHEMBL4079743,,CHEMBL4079743,8.00,False,http://www.openphacts.org/units/Nanomolar,3023429,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3977,,18220812,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '15.06', 'le': '0.29', 'lle': '3.36', 'sei': '6.64'}",CHEMBL4091863,,CHEMBL4091863,7.19,False,http://www.openphacts.org/units/Nanomolar,3023430,=,1,True,=,,IC50,nM,,64.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,64.0
3978,,18220813,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '14.88', 'le': '0.28', 'lle': '3.56', 'sei': '7.13'}",CHEMBL4064106,,CHEMBL4064106,7.30,False,http://www.openphacts.org/units/Nanomolar,3023431,=,1,True,=,,IC50,nM,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,50.0
3979,,18220814,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCC1CC1)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '15.11', 'le': '0.29', 'lle': '2.56', 'sei': '7.21'}",CHEMBL4096937,,CHEMBL4096937,7.16,False,http://www.openphacts.org/units/Nanomolar,3023432,=,1,True,=,,IC50,nM,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,70.0
3980,,18220815,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CC1)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '15.89', 'le': '0.30', 'lle': '2.96', 'sei': '7.36'}",CHEMBL4091402,,CHEMBL4091402,7.30,False,http://www.openphacts.org/units/Nanomolar,3023433,=,1,True,=,,IC50,nM,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,50.0
3981,,18220816,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '10.80', 'le': '0.21', 'lle': '0.69', 'sei': '5.35'}",CHEMBL4089510,,CHEMBL4089510,4.84,False,http://www.openphacts.org/units/Nanomolar,3023434,=,1,True,=,,IC50,nM,,14600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,14600.0
3982,,18220817,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '19.58', 'le': '0.38', 'lle': '3.30', 'sei': '7.77'}",CHEMBL4068348,,CHEMBL4068348,6.14,False,http://www.openphacts.org/units/Nanomolar,3023435,=,1,True,=,,IC50,nM,,730.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,730.0
3983,,18220818,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CCCC1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '21.46', 'le': '0.41', 'lle': '3.74', 'sei': '9.99'}",CHEMBL4081634,,CHEMBL4081634,7.89,False,http://www.openphacts.org/units/Nanomolar,3023436,=,1,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
3984,,18220819,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CCCCC1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '20.18', 'le': '0.39', 'lle': '3.16', 'sei': '9.75'}",CHEMBL4059689,,CHEMBL4059689,7.70,False,http://www.openphacts.org/units/Nanomolar,3023437,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
3985,,18220820,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H]1CCCC[C@H]1O,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.43', 'le': '0.36', 'lle': '3.82', 'sei': '7.39'}",CHEMBL4071076,,CHEMBL4071076,7.33,False,http://www.openphacts.org/units/Nanomolar,3023438,=,1,True,=,,IC50,nM,,47.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,47.0
3986,,18220821,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCCC[C@H]1O,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.32', 'le': '0.34', 'lle': '3.38', 'sei': '6.94'}",CHEMBL4098137,,CHEMBL4098137,6.89,False,http://www.openphacts.org/units/Nanomolar,3023439,=,1,True,=,,IC50,nM,,130.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,130.0
3987,,18220822,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCCC[C@@H]1O,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.83', 'le': '0.35', 'lle': '3.58', 'sei': '7.15'}",CHEMBL4069224,,CHEMBL4069224,7.09,False,http://www.openphacts.org/units/Nanomolar,3023440,=,1,True,=,,IC50,nM,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,82.0
3988,,18220823,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NCCO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '19.71', 'le': '0.39', 'lle': '4.57', 'sei': '6.83'}",CHEMBL4075948,,CHEMBL4075948,6.77,False,http://www.openphacts.org/units/Nanomolar,3023441,=,1,True,=,,IC50,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,170.0
3989,,18220824,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CC[C@H](O)CC1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.61', 'le': '0.36', 'lle': '3.89', 'sei': '7.46'}",CHEMBL4102532,,CHEMBL4102532,7.40,False,http://www.openphacts.org/units/Nanomolar,3023442,=,1,True,=,,IC50,nM,,40.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,40.0
3990,,18220825,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCC[C@H](O)C1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '19.12', 'le': '0.37', 'lle': '4.09', 'sei': '7.67'}",CHEMBL4078264,,CHEMBL4078264,7.60,False,http://www.openphacts.org/units/Nanomolar,3023443,=,1,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
3991,,18220826,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCC[C@@H](O)C1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '20.02', 'le': '0.39', 'lle': '4.45', 'sei': '8.03'}",CHEMBL4094792,,CHEMBL4094792,7.96,False,http://www.openphacts.org/units/Nanomolar,3023444,=,1,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
3992,,18220827,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CC[C@H](NC(C)=O)CC1,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.51', 'le': '0.34', 'lle': '4.03', 'sei': '7.11'}",CHEMBL4067341,,CHEMBL4067341,7.68,False,http://www.openphacts.org/units/Nanomolar,3023445,=,1,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
3993,,18220828,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1c2ccccc2C[C@@H]1O,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '13.21', 'le': '0.25', 'lle': '1.84', 'sei': '5.75'}",CHEMBL4073229,,CHEMBL4073229,5.70,False,http://www.openphacts.org/units/Nanomolar,3023446,=,1,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2000.0
3994,,18220829,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)CC(C)C,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.27', 'le': '0.36', 'lle': '3.69', 'sei': '7.36'}",CHEMBL4093910,,CHEMBL4093910,7.30,False,http://www.openphacts.org/units/Nanomolar,3023447,=,1,True,=,,IC50,nM,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,50.0
3995,,18220830,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.47', 'le': '0.35', 'lle': '5.00', 'sei': '6.95'}",CHEMBL4075955,,CHEMBL4075955,8.30,False,http://www.openphacts.org/units/Nanomolar,3023448,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
3996,,18220831,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.68', 'le': '0.34', 'lle': '4.66', 'sei': '5.77'}",CHEMBL4069401,,CHEMBL4069401,7.70,False,http://www.openphacts.org/units/Nanomolar,3023449,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20.0
3997,,18220832,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.55', 'le': '0.34', 'lle': '6.11', 'sei': '6.12'}",CHEMBL4065667,,CHEMBL4065667,8.30,False,http://www.openphacts.org/units/Nanomolar,3023450,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
3998,,18220833,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3C)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.33', 'le': '0.32', 'lle': '5.79', 'sei': '6.31'}",CHEMBL4075758,,CHEMBL4075758,8.00,False,http://www.openphacts.org/units/Nanomolar,3023451,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
3999,,18220834,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '19.42', 'le': '0.36', 'lle': '5.83', 'sei': '6.21'}",CHEMBL4101382,,CHEMBL4101382,8.40,False,http://www.openphacts.org/units/Nanomolar,3023452,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.0
4000,,18220835,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3c(cnn3C)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.66', 'le': '0.33', 'lle': '5.31', 'sei': '6.34'}",CHEMBL4077863,,CHEMBL4077863,7.89,False,http://www.openphacts.org/units/Nanomolar,3023453,=,1,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
4001,,18220836,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '19.88', 'le': '0.37', 'lle': '5.74', 'sei': '6.37'}",CHEMBL4059465,,CHEMBL4059465,8.30,False,http://www.openphacts.org/units/Nanomolar,3023454,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.0
4002,,18220837,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(F)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '19.49', 'le': '0.36', 'lle': '5.17', 'sei': '7.51'}",CHEMBL4087806,,CHEMBL4087806,8.00,False,http://www.openphacts.org/units/Nanomolar,3023455,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
4003,,18220838,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(OC)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '18.94', 'le': '0.35', 'lle': '5.30', 'sei': '6.91'}",CHEMBL4068127,,CHEMBL4068127,8.00,False,http://www.openphacts.org/units/Nanomolar,3023456,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
4004,,18220839,[],CHEMBL4047622,Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(OC)c(F)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '17.90', 'le': '0.34', 'lle': '5.05', 'sei': '6.81'}",CHEMBL4095514,,CHEMBL4095514,7.89,False,http://www.openphacts.org/units/Nanomolar,3023457,=,1,True,=,,IC50,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,13.0
4005,,18220870,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '14.51', 'le': '0.28', 'lle': '3.22', 'sei': '5.46'}",CHEMBL4075955,,CHEMBL4075955,6.52,True,http://www.openphacts.org/units/Nanomolar,3023448,=,1,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,300.0
4006,,18220871,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '12.84', 'le': '0.24', 'lle': '3.55', 'sei': '4.24'}",CHEMBL4065667,,CHEMBL4065667,5.75,False,http://www.openphacts.org/units/Nanomolar,3023450,=,1,True,=,,IC50,nM,,1800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1800.0
4007,,18220872,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3C)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '13.35', 'le': '0.25', 'lle': '3.95', 'sei': '4.86'}",CHEMBL4075758,,CHEMBL4075758,6.16,False,http://www.openphacts.org/units/Nanomolar,3023451,=,1,True,=,,IC50,nM,,690.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,690.0
4008,,18220873,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '13.40', 'le': '0.25', 'lle': '3.23', 'sei': '4.29'}",CHEMBL4101382,,CHEMBL4101382,5.80,False,http://www.openphacts.org/units/Nanomolar,3023452,=,1,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1600.0
4009,,18220874,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3c(cnn3C)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '11.87', 'le': '0.22', 'lle': '2.72', 'sei': '4.26'}",CHEMBL4077863,,CHEMBL4077863,5.30,False,http://www.openphacts.org/units/Nanomolar,3023453,=,1,True,=,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
4010,,18220875,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '12.90', 'le': '0.24', 'lle': '2.83', 'sei': '4.13'}",CHEMBL4059465,,CHEMBL4059465,5.39,False,http://www.openphacts.org/units/Nanomolar,3023454,=,1,True,=,,IC50,nM,,4100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4100.0
4011,,18220876,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(F)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '14.34', 'le': '0.27', 'lle': '3.06', 'sei': '5.53'}",CHEMBL4087806,,CHEMBL4087806,5.89,False,http://www.openphacts.org/units/Nanomolar,3023455,=,1,True,=,,IC50,nM,,1300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1300.0
4012,,18220877,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(OC)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '13.72', 'le': '0.26', 'lle': '3.10', 'sei': '5.01'}",CHEMBL4068127,,CHEMBL4068127,5.80,False,http://www.openphacts.org/units/Nanomolar,3023456,=,1,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1600.0
4013,,18220878,[],CHEMBL4047625,Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc(OC)c(F)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4043252,Bioorg Med Chem Lett,2017.0,"{'bei': '12.54', 'le': '0.24', 'lle': '2.68', 'sei': '4.77'}",CHEMBL4095514,,CHEMBL4095514,5.52,False,http://www.openphacts.org/units/Nanomolar,3023457,=,1,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3000.0
4014,,18232094,[],CHEMBL4050408,Inhibition of human IRAK4 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O,,,CHEMBL4049403,Bioorg Med Chem,2017.0,,CHEMBL4077554,,CHEMBL4077554,,False,http://qudt.org/vocab/unit#Percent,3025568,=,1,False,=,,Activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,103.0
4015,,18253839,[],CHEMBL4055204,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,,,CHEMBL4052645,Bioorg Med Chem Lett,2017.0,,CHEMBL4096145,,CHEMBL4096145,,False,http://qudt.org/vocab/unit#Percent,3028953,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
4016,,18253840,[],CHEMBL4055204,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,,,CHEMBL4052645,Bioorg Med Chem Lett,2017.0,,CHEMBL4080797,,CHEMBL4080797,,False,http://qudt.org/vocab/unit#Percent,3028982,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
4017,,18265951,[],CHEMBL4057401,Inhibition of IRAK4 (unknown origin) at 0.45 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,,,CHEMBL4052759,Bioorg Med Chem Lett,2017.0,,CHEMBL4095072,,CHEMBL4095072,,True,http://qudt.org/vocab/unit#Percent,3031589,=,1,True,=,,Inhibition,%,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,11.0
4018,,18266167,[],CHEMBL4057617,Inhibition of IRAK4 (unknown origin) at 0.49 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1,,,CHEMBL4052759,Bioorg Med Chem Lett,2017.0,,CHEMBL4088455,,CHEMBL4088455,,False,http://qudt.org/vocab/unit#Percent,3031591,=,1,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.0
4019,,18266216,[],CHEMBL4057666,Inhibition of IRAK4 (unknown origin) at 0.078 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12,,,CHEMBL4052759,Bioorg Med Chem Lett,2017.0,,CHEMBL4066592,,CHEMBL4066592,,False,http://qudt.org/vocab/unit#Percent,3031604,=,1,True,=,,Inhibition,%,,5.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.7
4020,,18274959,[],CHEMBL4118365,Inhibition of IRAK4 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKSANILLDEAFTAK probe by mass-spectrometric analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4118021,Bioorg Med Chem,2017.0,,CHEMBL3883384,,CHEMBL3883384,,False,http://qudt.org/vocab/unit#Percent,3033216,=,1,True,=,,Inhibition,%,,-16.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-16.5
4021,,18274960,[],CHEMBL4118365,Inhibition of IRAK4 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKSANILLDEAFTAK probe by mass-spectrometric analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4118021,Bioorg Med Chem,2017.0,,CHEMBL3884839,,CHEMBL3884839,,False,http://qudt.org/vocab/unit#Percent,3033235,=,1,True,=,,Inhibition,%,,-43.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-43.2
4022,,18274961,[],CHEMBL4118365,Inhibition of IRAK4 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKSANILLDEAFTAK probe by mass-spectrometric analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4118021,Bioorg Med Chem,2017.0,,CHEMBL1077979,,CHEMBL1077979,,False,http://qudt.org/vocab/unit#Percent,3033237,=,1,True,=,,Inhibition,%,,-66.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-66.5
4023,,18282073,[],CHEMBL4120028,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system at 1 uM by FRET relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21,,,CHEMBL4118097,J Med Chem,2017.0,,CHEMBL3719135,,CHEMBL3719135,,False,http://qudt.org/vocab/unit#Percent,3034512,=,1,True,=,,Inhibition,%,,-1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.3
4024,,18282392,[],CHEMBL4120028,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system at 1 uM by FRET relative to control,B,,,BAO_0000201,BAO_0000019,assay format,Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F,,,CHEMBL4118097,J Med Chem,2017.0,,CHEMBL3715238,,CHEMBL3715238,,False,http://qudt.org/vocab/unit#Percent,3034522,=,1,True,=,,Inhibition,%,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,5.3
4025,,18282796,[],CHEMBL4120381,Inhibition of IRAK4 (unknown origin) at 0.45 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,,,CHEMBL4118098,Bioorg Med Chem Lett,2017.0,,CHEMBL4095072,,CHEMBL4095072,,False,http://qudt.org/vocab/unit#Percent,3034528,=,1,True,=,,Inhibition,%,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,11.0
4026,,18282965,[],CHEMBL4120550,Inhibition of IRAK4 (unknown origin) at 0.19 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1,,,CHEMBL4118098,Bioorg Med Chem Lett,2017.0,,CHEMBL4125807,,CHEMBL4125807,,False,http://qudt.org/vocab/unit#Percent,3034534,=,1,True,=,,Inhibition,%,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,4.3
4027,,18283189,[],CHEMBL4120774,Inhibition of IRAK4 (unknown origin) at 0.164 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12,,,CHEMBL4118098,Bioorg Med Chem Lett,2017.0,,CHEMBL4129737,,CHEMBL4129737,,False,http://qudt.org/vocab/unit#Percent,3034544,=,1,True,=,,Inhibition,%,,-7.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-7.7
4028,,18286309,[],CHEMBL4121544,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system at 10 uM in presence of ATP relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4118122,Bioorg Med Chem Lett,2018.0,,CHEMBL4128926,,CHEMBL4128926,,False,http://qudt.org/vocab/unit#Percent,3035290,=,1,True,=,,Inhibition,%,,-15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-15.0
4029,,18300341,[],CHEMBL4124643,Inhibition of full length recombinant human N-terminal His6-tagged IRAK4 expressed in Sf21 insect cells assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018.0,,CHEMBL4126750,,CHEMBL4126750,,False,http://qudt.org/vocab/unit#Percent,3038026,=,1,False,=,,Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,96.0
4030,,18379924,[],CHEMBL4145825,Inhibition of IRAK4 (unknown origin) at 10 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4145442,Eur J Med Chem,2017.0,,CHEMBL4159506,,CHEMBL4159506,,False,http://qudt.org/vocab/unit#Percent,3050754,=,1,True,=,,Inhibition,%,,-47.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-47.31
4031,,18379976,[],CHEMBL4145877,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4145442,Eur J Med Chem,2017.0,"{'bei': '17.59', 'le': '0.32', 'lle': '3.86', 'sei': '11.82'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.21,False,http://www.openphacts.org/units/Nanomolar,3050784,=,1,True,=,,IC50,nM,,6.19,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6.19
4032,,18431063,[],CHEMBL4155744,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system at 1 uM by Z'-Lyte relative to control,B,,,BAO_0000201,BAO_0000019,assay format,O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1,,,CHEMBL4152294,Eur J Med Chem,2018.0,,CHEMBL4160587,,CHEMBL4160587,,False,http://qudt.org/vocab/unit#Percent,3058875,=,1,True,=,,Inhibition,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,84.0
4033,,18440252,[],CHEMBL4157076,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1,,,CHEMBL4152344,Eur J Med Chem,2018.0,,CHEMBL4174988,,CHEMBL4174988,,False,http://qudt.org/vocab/unit#Percent,3060325,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
4034,,18443272,[],CHEMBL4157936,Inhibition of human IRAK4 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O,,,CHEMBL4152360,Bioorg Med Chem,2018.0,,CHEMBL4177303,,CHEMBL4177303,,False,http://qudt.org/vocab/unit#Percent,3060673,=,1,False,=,,Activity,%,,102.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,102.0
4035,,18449856,[],CHEMBL4178094,Inhibition of human IRAK4 (14 to 460 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1,,,CHEMBL4177526,Bioorg Med Chem,2017.0,,CHEMBL4209540,,CHEMBL4209540,,False,http://qudt.org/vocab/unit#Percent,3061808,=,1,False,=,,Activity,%,,110.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,110.0
4036,,18450300,[],CHEMBL4178278,Inhibition of recombinant human full length N-terminal GST-tagged IRAK4 expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1,,,CHEMBL4177534,Bioorg Med Chem Lett,2017.0,,CHEMBL3967108,,CHEMBL3967108,,False,http://qudt.org/vocab/unit#Percent,3061884,=,1,False,=,,Activity,%,,-3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,-3.0
4037,,18450350,[],CHEMBL4178278,Inhibition of recombinant human full length N-terminal GST-tagged IRAK4 expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO,,,CHEMBL4177534,Bioorg Med Chem Lett,2017.0,,CHEMBL3966346,,CHEMBL3966346,,False,http://qudt.org/vocab/unit#Percent,3061886,=,1,False,=,,Activity,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,2.0
4038,,18462173,[],CHEMBL4180860,Inhibition of IRAK4 (unknown origin) assessed as residual activity at 1 uM relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21,,,CHEMBL4177643,Bioorg Med Chem,2017.0,,CHEMBL4203120,,CHEMBL4203120,,False,http://qudt.org/vocab/unit#Percent,3063989,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
4039,,18484208,[],CHEMBL4185855,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,,,CHEMBL4184148,Bioorg Med Chem Lett,2017.0,,CHEMBL3969370,,CHEMBL3969370,,False,http://qudt.org/vocab/unit#Percent,3068012,=,1,False,=,,Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,95.0
4040,,18484692,[],CHEMBL4185855,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000219,cell-based format,CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,,,CHEMBL4184148,Bioorg Med Chem Lett,2017.0,,CHEMBL4206831,,CHEMBL4206831,,False,http://qudt.org/vocab/unit#Percent,3068013,=,1,False,=,,Activity,%,,79.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,79.0
4041,,18507750,[],CHEMBL4191012,Inhibition of recombinant full-length human IRAK4 at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method,B,,,BAO_0000201,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4190187,Bioorg Med Chem Lett,2017.0,,CHEMBL4207014,,CHEMBL4207014,,False,http://qudt.org/vocab/unit#Percent,3072743,=,1,True,=,,Inhibition,%,,-20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-20.0
4042,,18578890,[],CHEMBL4222504,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1,,,CHEMBL4219148,Bioorg Med Chem Lett,2018.0,"{'bei': '13.97', 'le': '0.27', 'lle': '1.92', 'sei': '5.91'}",CHEMBL4225923,,CHEMBL4225923,6.42,False,http://www.openphacts.org/units/Nanomolar,3085066,=,1,True,=,,IC50,nM,,380.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,380.0
4043,,18653585,[],CHEMBL4230111,Inhibition of IRAK4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21,,,CHEMBL4229333,Eur J Med Chem,2018.0,,CHEMBL3736320,,CHEMBL3736320,,False,http://qudt.org/vocab/unit#Percent,3098169,=,1,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.0
4044,,18653586,[],CHEMBL4230111,Inhibition of IRAK4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21,,,CHEMBL4229333,Eur J Med Chem,2018.0,,CHEMBL4247506,,CHEMBL4247506,,False,http://qudt.org/vocab/unit#Percent,3098161,=,1,True,=,,Inhibition,%,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,3.0
4045,,18655480,[],CHEMBL4230755,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1,,,CHEMBL4229344,Eur J Med Chem,2018.0,,CHEMBL4247298,,CHEMBL4247298,,False,http://qudt.org/vocab/unit#Percent,3098356,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
4046,,18665407,[],CHEMBL4233340,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,,,CHEMBL4229420,Bioorg Med Chem Lett,2018.0,,CHEMBL4245507,,CHEMBL4245507,,False,http://www.openphacts.org/units/Nanomolar,3100083,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10000.0
4047,,18665480,[],CHEMBL4233340,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,,,CHEMBL4229420,Bioorg Med Chem Lett,2018.0,,CHEMBL4251324,,CHEMBL4251324,,False,http://www.openphacts.org/units/Nanomolar,3100085,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10000.0
4048,,18674713,[],CHEMBL4235372,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1,,,CHEMBL4229506,Bioorg Med Chem Lett,2018.0,"{'bei': '13.38', 'le': '0.27', 'lle': '2.48', 'sei': '4.90'}",CHEMBL4249925,,CHEMBL4249925,5.72,False,http://www.openphacts.org/units/Nanomolar,3101705,=,1,True,=,,Ki,nM,,1900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1900.0
4049,,18674714,[],CHEMBL4235372,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1,,,CHEMBL4229506,Bioorg Med Chem Lett,2018.0,,CHEMBL4245242,,CHEMBL4245242,,False,http://www.openphacts.org/units/Nanomolar,3101712,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,4000.0
4050,,18674715,[],CHEMBL4235372,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000192,BAO_0000357,single protein format,CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1,,,CHEMBL4229506,Bioorg Med Chem Lett,2018.0,,CHEMBL4248525,,CHEMBL4248525,,False,http://www.openphacts.org/units/Nanomolar,3101714,>,1,True,>,,Ki,nM,,4000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,4000.0
4051,,18702493,[],CHEMBL4255114,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,,,CHEMBL4251655,Eur J Med Chem,2018.0,,CHEMBL4278211,,CHEMBL4278211,,False,http://qudt.org/vocab/unit#Percent,3106010,=,1,True,=,,Inhibition,%,,-9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-9.0
4052,,18702546,[],CHEMBL4255114,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,,,CHEMBL4251655,Eur J Med Chem,2018.0,,CHEMBL4282644,,CHEMBL4282644,,False,http://qudt.org/vocab/unit#Percent,3106015,=,1,True,=,,Inhibition,%,,-1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-1.0
4053,,18702590,[],CHEMBL4255114,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,,,CHEMBL4251655,Eur J Med Chem,2018.0,,CHEMBL4287097,,CHEMBL4287097,,False,http://qudt.org/vocab/unit#Percent,3106016,=,1,True,=,,Inhibition,%,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,3.0
4054,,18702642,[],CHEMBL4255114,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,,,CHEMBL4251655,Eur J Med Chem,2018.0,,CHEMBL4283739,,CHEMBL4283739,,False,http://qudt.org/vocab/unit#Percent,3106018,=,1,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.0
4055,,18702686,[],CHEMBL4255114,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,,,CHEMBL4251655,Eur J Med Chem,2018.0,,CHEMBL4294318,,CHEMBL4294318,,False,http://qudt.org/vocab/unit#Percent,3106019,=,1,True,=,,Inhibition,%,,-2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-2.0
4056,,18702729,[],CHEMBL4255114,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1,,,CHEMBL4251655,Eur J Med Chem,2018.0,,CHEMBL4289040,,CHEMBL4289040,,False,http://qudt.org/vocab/unit#Percent,3106020,=,1,True,=,,Inhibition,%,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,4.0
4057,,18725390,[],CHEMBL4259087,Inhibition of untagged IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N,,,CHEMBL4257503,MedChemComm,2018.0,,CHEMBL4276946,,CHEMBL4276946,,False,http://www.openphacts.org/units/Nanomolar,3110948,>,1,True,>,,IC50,nM,,100000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,100.0
4058,,18751085,[],CHEMBL4263829,Inhibition of IRAK4 (unknown origin) at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1,,,CHEMBL4261595,Bioorg Med Chem Lett,2018.0,,CHEMBL4278763,,CHEMBL4278763,,False,http://qudt.org/vocab/unit#Percent,3115649,=,1,True,=,,Inhibition,%,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,7.0
4059,,18751559,[],CHEMBL4264344,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,,,CHEMBL4261600,Eur J Med Chem,2018.0,,CHEMBL4281048,,CHEMBL4281048,,False,http://qudt.org/vocab/unit#Percent,3115711,=,1,False,=,,Activity,%,,81.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,81.0
4060,,18761505,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '15.92', 'le': '0.30', 'lle': '3.12', 'sei': '6.12'}",CHEMBL4279192,,CHEMBL4279192,6.12,False,http://www.openphacts.org/units/Nanomolar,3117271,=,1,True,=,,IC50,nM,,758.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.758
4061,,18761509,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '21.84', 'le': '0.41', 'lle': '5.40', 'sei': '8.40'}",CHEMBL4279192,,CHEMBL4279192,8.40,False,http://www.openphacts.org/units/Nanomolar,3117271,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.004
4062,,18761523,[],CHEMBL4266576,Inhibition of recombinant human N-terminal His6-tagged full length IRAK4 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,,CHEMBL4279192,,CHEMBL4279192,,False,http://qudt.org/vocab/unit#Percent,3117271,=,1,True,=,,Inhibition,%,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,98.0
4063,,18761591,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '23.88', 'le': '0.45', 'lle': '3.95', 'sei': '10.90'}",CHEMBL4093475,,CHEMBL4093475,6.19,False,http://www.openphacts.org/units/Nanomolar,3117272,=,1,True,=,,IC50,nM,,640.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.64
4064,,18761593,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '23.90', 'le': '0.45', 'lle': '3.96', 'sei': '10.91'}",CHEMBL4093475,,CHEMBL4093475,6.20,False,http://www.openphacts.org/units/Nanomolar,3117272,=,1,True,=,,IC50,nM,,630.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.2
4065,,18761594,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.42', 'le': '0.39', 'lle': '2.39', 'sei': '13.07'}",CHEMBL4097847,,CHEMBL4097847,5.37,False,http://www.openphacts.org/units/Nanomolar,3117273,=,1,True,=,,IC50,nM,,4300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.3
4066,,18761596,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.43', 'le': '0.39', 'lle': '2.39', 'sei': '13.08'}",CHEMBL4097847,,CHEMBL4097847,5.37,False,http://www.openphacts.org/units/Nanomolar,3117273,=,1,True,=,,IC50,nM,,4265.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.37
4067,,18761597,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3cscc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.05', 'le': '0.44', 'lle': '3.11', 'sei': '14.85'}",CHEMBL4294035,,CHEMBL4294035,6.09,False,http://www.openphacts.org/units/Nanomolar,3117274,=,1,True,=,,IC50,nM,,804.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.804
4068,,18761600,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3cscc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.03', 'le': '0.44', 'lle': '3.11', 'sei': '14.84'}",CHEMBL4294035,,CHEMBL4294035,6.09,False,http://www.openphacts.org/units/Nanomolar,3117274,=,1,True,=,,IC50,nM,,812.83,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.09
4069,,18761601,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccsc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.49', 'le': '0.45', 'lle': '3.24', 'sei': '15.14'}",CHEMBL4287208,,CHEMBL4287208,6.21,False,http://www.openphacts.org/units/Nanomolar,3117275,=,1,True,=,,IC50,nM,,609.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.609
4070,,18761603,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccsc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.50', 'le': '0.45', 'lle': '3.24', 'sei': '15.15'}",CHEMBL4287208,,CHEMBL4287208,6.22,False,http://www.openphacts.org/units/Nanomolar,3117275,=,1,True,=,,IC50,nM,,602.56,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.22
4071,,18761604,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccoc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '20.70', 'le': '0.39', 'lle': '2.88', 'sei': '9.95'}",CHEMBL4295137,,CHEMBL4295137,5.39,False,http://www.openphacts.org/units/Nanomolar,3117276,=,1,True,=,,IC50,nM,,4080.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,4.08
4072,,18761606,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccoc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '20.70', 'le': '0.39', 'lle': '2.88', 'sei': '9.95'}",CHEMBL4295137,,CHEMBL4295137,5.39,False,http://www.openphacts.org/units/Nanomolar,3117276,=,1,True,=,,IC50,nM,,4073.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.39
4073,,18761607,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3cc[nH]c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.18', 'le': '0.41', 'lle': '3.51', 'sei': '10.12'}",CHEMBL4283847,,CHEMBL4283847,5.75,False,http://www.openphacts.org/units/Nanomolar,3117277,=,1,True,=,,IC50,nM,,1770.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.77
4074,,18761610,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3cc[nH]c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.17', 'le': '0.41', 'lle': '3.51', 'sei': '10.12'}",CHEMBL4283847,,CHEMBL4283847,5.75,False,http://www.openphacts.org/units/Nanomolar,3117277,=,1,True,=,,IC50,nM,,1778.28,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.75
4075,,18761611,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3cccc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.42', 'le': '0.42', 'lle': '3.81', 'sei': '12.79'}",CHEMBL4291706,,CHEMBL4291706,5.82,False,http://www.openphacts.org/units/Nanomolar,3117278,=,1,True,=,,IC50,nM,,1530.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.53
4076,,18761614,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3cccc23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.44', 'le': '0.42', 'lle': '3.81', 'sei': '12.80'}",CHEMBL4291706,,CHEMBL4291706,5.82,False,http://www.openphacts.org/units/Nanomolar,3117278,=,1,True,=,,IC50,nM,,1513.56,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.82
4077,,18761615,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '30.36', 'le': '0.57', 'lle': '5.75', 'sei': '14.60'}",CHEMBL4063689,,CHEMBL4063689,8.30,False,http://www.openphacts.org/units/Nanomolar,3117279,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.005
4078,,18761619,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '30.51', 'le': '0.57', 'lle': '5.79', 'sei': '14.67'}",CHEMBL4063689,,CHEMBL4063689,8.34,False,http://www.openphacts.org/units/Nanomolar,3117279,=,1,True,=,,IC50,nM,,4.571,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,8.34
4079,,18761620,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '27.54', 'le': '0.52', 'lle': '4.93', 'sei': '14.60'}",CHEMBL4085735,,CHEMBL4085735,8.30,False,http://www.openphacts.org/units/Nanomolar,3117280,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.005
4080,,18761624,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '27.60', 'le': '0.52', 'lle': '4.95', 'sei': '14.64'}",CHEMBL4085735,,CHEMBL4085735,8.32,False,http://www.openphacts.org/units/Nanomolar,3117280,=,1,True,=,,IC50,nM,,4.786,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,8.32
4081,,18761625,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '23.94', 'le': '0.45', 'lle': '5.08', 'sei': '12.44'}",CHEMBL4089379,,CHEMBL4089379,8.22,False,http://www.openphacts.org/units/Nanomolar,3117281,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.006
4082,,18761629,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '23.90', 'le': '0.45', 'lle': '5.07', 'sei': '12.43'}",CHEMBL4089379,,CHEMBL4089379,8.21,False,http://www.openphacts.org/units/Nanomolar,3117281,=,1,True,=,,IC50,nM,,6.166,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,8.21
4083,,18761630,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.43', 'le': '0.42', 'lle': '3.88', 'sei': '13.34'}",CHEMBL4288288,,CHEMBL4288288,6.13,False,http://www.openphacts.org/units/Nanomolar,3117282,=,1,True,=,,IC50,nM,,738.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.738
4084,,18761632,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.42', 'le': '0.42', 'lle': '3.88', 'sei': '13.33'}",CHEMBL4288288,,CHEMBL4288288,6.13,False,http://www.openphacts.org/units/Nanomolar,3117282,=,1,True,=,,IC50,nM,,741.31,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.13
4085,,18761633,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)n1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '23.76', 'le': '0.44', 'lle': '3.86', 'sei': '15.57'}",CHEMBL4276955,,CHEMBL4276955,7.16,False,http://www.openphacts.org/units/Nanomolar,3117283,=,1,True,=,,IC50,nM,,69.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.069
4086,,18761637,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)n1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '23.75', 'le': '0.44', 'lle': '3.86', 'sei': '15.57'}",CHEMBL4276955,,CHEMBL4276955,7.16,False,http://www.openphacts.org/units/Nanomolar,3117283,=,1,True,=,,IC50,nM,,69.18,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.16
4087,,18761638,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccn(C4CCOCC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '18.49', 'le': '0.35', 'lle': '3.28', 'sei': '11.50'}",CHEMBL4288880,,CHEMBL4288880,6.35,False,http://www.openphacts.org/units/Nanomolar,3117284,=,1,True,=,,IC50,nM,,446.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.446
4088,,18761640,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3ccn(C4CCOCC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '18.49', 'le': '0.35', 'lle': '3.28', 'sei': '11.50'}",CHEMBL4288880,,CHEMBL4288880,6.35,False,http://www.openphacts.org/units/Nanomolar,3117284,=,1,True,=,,IC50,nM,,446.68,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.35
4089,,18761641,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '24.24', 'le': '0.45', 'lle': '4.31', 'sei': '14.58'}",CHEMBL4284323,,CHEMBL4284323,6.63,False,http://www.openphacts.org/units/Nanomolar,3117285,=,1,True,=,,IC50,nM,,236.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.236
4090,,18761644,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '24.25', 'le': '0.45', 'lle': '4.31', 'sei': '14.58'}",CHEMBL4284323,,CHEMBL4284323,6.63,False,http://www.openphacts.org/units/Nanomolar,3117285,=,1,True,=,,IC50,nM,,234.42,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.63
4091,,18761645,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '24.47', 'le': '0.46', 'lle': '4.24', 'sei': '16.23'}",CHEMBL4294631,,CHEMBL4294631,7.38,False,http://www.openphacts.org/units/Nanomolar,3117286,=,1,True,=,,IC50,nM,,42.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.042
4092,,18761649,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '24.45', 'le': '0.46', 'lle': '4.23', 'sei': '16.21'}",CHEMBL4294631,,CHEMBL4294631,7.37,False,http://www.openphacts.org/units/Nanomolar,3117286,=,1,True,=,,IC50,nM,,42.66,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.37
4093,,18761650,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc(C4CCOCC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '20.41', 'le': '0.38', 'lle': '4.10', 'sei': '12.82'}",CHEMBL4282412,,CHEMBL4282412,7.01,False,http://www.openphacts.org/units/Nanomolar,3117287,=,1,True,=,,IC50,nM,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.098
4094,,18761654,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc(C4CCOCC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '20.41', 'le': '0.38', 'lle': '4.10', 'sei': '12.82'}",CHEMBL4282412,,CHEMBL4282412,7.01,False,http://www.openphacts.org/units/Nanomolar,3117287,=,1,True,=,,IC50,nM,,97.72,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.01
4095,,18761655,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.76', 'le': '0.31', 'lle': '3.45', 'sei': '6.45'}",CHEMBL4292700,,CHEMBL4292700,6.45,False,http://www.openphacts.org/units/Nanomolar,3117288,=,1,True,=,,IC50,nM,,358.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.358
4096,,18761657,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.66', 'le': '0.24', 'lle': '1.87', 'sei': '4.87'}",CHEMBL4292700,,CHEMBL4292700,4.87,False,http://www.openphacts.org/units/Nanomolar,3117288,=,1,True,=,,IC50,nM,,13600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,13.6
4097,,18761658,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.77', 'le': '0.31', 'lle': '3.45', 'sei': '6.45'}",CHEMBL4292700,,CHEMBL4292700,6.45,False,http://www.openphacts.org/units/Nanomolar,3117288,=,1,True,=,,IC50,nM,,354.81,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.45
4098,,18761659,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.66', 'le': '0.24', 'lle': '1.87', 'sei': '4.87'}",CHEMBL4292700,,CHEMBL4292700,4.87,False,http://www.openphacts.org/units/Nanomolar,3117288,=,1,True,=,,IC50,nM,,13489.63,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,4.87
4099,,18761660,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.11', 'le': '0.36', 'lle': '4.58', 'sei': '8.30'}",CHEMBL4285338,,CHEMBL4285338,7.35,False,http://www.openphacts.org/units/Nanomolar,3117289,=,1,True,=,,IC50,nM,,45.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.045
4100,,18761664,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.85', 'le': '0.32', 'lle': '3.71', 'sei': '7.32'}",CHEMBL4285338,,CHEMBL4285338,6.48,False,http://www.openphacts.org/units/Nanomolar,3117289,=,1,True,=,,IC50,nM,,331.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.331
4101,,18761665,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.11', 'le': '0.36', 'lle': '4.58', 'sei': '8.30'}",CHEMBL4285338,,CHEMBL4285338,7.35,False,http://www.openphacts.org/units/Nanomolar,3117289,=,1,True,=,,IC50,nM,,44.67,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.35
4102,,18761666,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.85', 'le': '0.32', 'lle': '3.71', 'sei': '7.32'}",CHEMBL4285338,,CHEMBL4285338,6.48,False,http://www.openphacts.org/units/Nanomolar,3117289,=,1,True,=,,IC50,nM,,331.13,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.48
4103,,18761667,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,,CHEMBL4293161,,CHEMBL4293161,,False,http://www.openphacts.org/units/Nanomolar,3117290,>,1,True,>,,IC50,nM,,8500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,8.5
4104,,18761669,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '13.29', 'le': '0.25', 'lle': '2.34', 'sei': '5.77'}",CHEMBL4293161,,CHEMBL4293161,5.11,False,http://www.openphacts.org/units/Nanomolar,3117290,=,1,True,=,,IC50,nM,,7762.47,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.11
4105,,18761670,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.01', 'le': '0.30', 'lle': '3.43', 'sei': '7.20'}",CHEMBL4283453,,CHEMBL4283453,6.17,False,http://www.openphacts.org/units/Nanomolar,3117291,=,1,True,=,,IC50,nM,,671.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.671
4106,,18761674,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '14.61', 'le': '0.27', 'lle': '2.89', 'sei': '6.57'}",CHEMBL4283453,,CHEMBL4283453,5.63,False,http://www.openphacts.org/units/Nanomolar,3117291,=,1,True,=,,IC50,nM,,2340.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,2.34
4107,,18761675,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.00', 'le': '0.30', 'lle': '3.43', 'sei': '7.20'}",CHEMBL4283453,,CHEMBL4283453,6.17,False,http://www.openphacts.org/units/Nanomolar,3117291,=,1,True,=,,IC50,nM,,676.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.17
4108,,18761676,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '14.60', 'le': '0.27', 'lle': '2.89', 'sei': '6.57'}",CHEMBL4283453,,CHEMBL4283453,5.63,False,http://www.openphacts.org/units/Nanomolar,3117291,=,1,True,=,,IC50,nM,,2344.23,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.63
4109,,18761677,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.70', 'le': '0.43', 'lle': '4.89', 'sei': '14.25'}",CHEMBL4294023,,CHEMBL4294023,7.80,False,http://www.openphacts.org/units/Nanomolar,3117292,=,1,True,=,,IC50,nM,,16.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.016
4110,,18761681,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.14', 'le': '0.36', 'lle': '3.66', 'sei': '12.02'}",CHEMBL4294023,,CHEMBL4294023,6.57,False,http://www.openphacts.org/units/Nanomolar,3117292,=,1,True,=,,IC50,nM,,267.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.267
4111,,18761682,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '22.74', 'le': '0.43', 'lle': '4.90', 'sei': '14.28'}",CHEMBL4294023,,CHEMBL4294023,7.81,False,http://www.openphacts.org/units/Nanomolar,3117292,=,1,True,=,,IC50,nM,,15.49,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.81
4112,,18761683,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.13', 'le': '0.36', 'lle': '3.66', 'sei': '12.01'}",CHEMBL4294023,,CHEMBL4294023,6.57,False,http://www.openphacts.org/units/Nanomolar,3117292,=,1,True,=,,IC50,nM,,269.15,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.57
4113,,18761684,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '18.30', 'le': '0.34', 'lle': '4.38', 'sei': '11.04'}",CHEMBL4286802,,CHEMBL4286802,7.06,False,http://www.openphacts.org/units/Nanomolar,3117293,=,1,True,=,,IC50,nM,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.088
4114,,18761688,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.71', 'le': '0.31', 'lle': '3.76', 'sei': '10.08'}",CHEMBL4286802,,CHEMBL4286802,6.44,False,http://www.openphacts.org/units/Nanomolar,3117293,=,1,True,=,,IC50,nM,,361.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.361
4115,,18761689,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '18.31', 'le': '0.34', 'lle': '4.38', 'sei': '11.05'}",CHEMBL4286802,,CHEMBL4286802,7.06,False,http://www.openphacts.org/units/Nanomolar,3117293,=,1,True,=,,IC50,nM,,87.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.06
4116,,18761690,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.71', 'le': '0.31', 'lle': '3.76', 'sei': '10.08'}",CHEMBL4286802,,CHEMBL4286802,6.44,False,http://www.openphacts.org/units/Nanomolar,3117293,=,1,True,=,,IC50,nM,,363.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.44
4117,,18761691,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.91', 'le': '0.37', 'lle': '4.92', 'sei': '11.64'}",CHEMBL4278882,,CHEMBL4278882,7.66,False,http://www.openphacts.org/units/Nanomolar,3117294,=,1,True,=,,IC50,nM,,22.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.022
4118,,18761695,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '17.45', 'le': '0.33', 'lle': '3.97', 'sei': '10.20'}",CHEMBL4278882,,CHEMBL4278882,6.71,False,http://www.openphacts.org/units/Nanomolar,3117294,=,1,True,=,,IC50,nM,,195.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.195
4119,Active,18761711,[],CHEMBL4266489,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in NF-kappaB signalling by measuring reduction in IkappaBalpha phosphorylation at 0.12 to 10 uM after 14 hrs by Western blot analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,,CHEMBL4278882,,CHEMBL4278882,,False,,3117294,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4120,Active,18761712,[],CHEMBL4266490,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in NF-kappaB signalling by measuring reduction in IkappaBalpha phosphorylation at 0.12 to 10 uM cotreated with 3 nM of ibrutinib after 14 hrs by Western blot analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,,CHEMBL4278882,,CHEMBL4278882,,False,,3117294,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4121,,18761717,[],CHEMBL4266497,Inhibition of recombinant human N-terminal His6-tagged full length IRAK4 expressed in baculovirus infected Sf21 insect cells in presence of 5000 uM ATP,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.91', 'le': '0.37', 'lle': '4.92', 'sei': '11.64'}",CHEMBL4278882,,CHEMBL4278882,7.66,False,http://www.openphacts.org/units/Nanomolar,3117294,=,1,True,=,,IC50,nM,,22.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.022
4122,,18761794,[],CHEMBL4266576,Inhibition of recombinant human N-terminal His6-tagged full length IRAK4 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,,CHEMBL4278882,,CHEMBL4278882,,False,http://qudt.org/vocab/unit#Percent,3117294,=,1,True,=,,Inhibition,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,97.0
4123,,18761862,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '19.92', 'le': '0.37', 'lle': '4.92', 'sei': '11.65'}",CHEMBL4278882,,CHEMBL4278882,7.66,False,http://www.openphacts.org/units/Nanomolar,3117294,=,1,True,=,,IC50,nM,,21.88,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.66
4124,,18761863,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '17.45', 'le': '0.33', 'lle': '3.97', 'sei': '10.20'}",CHEMBL4278882,,CHEMBL4278882,6.71,False,http://www.openphacts.org/units/Nanomolar,3117294,=,1,True,=,,IC50,nM,,194.98,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.71
4125,,18761864,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.47', 'le': '0.31', 'lle': '4.52', 'sei': '9.37'}",CHEMBL4290222,,CHEMBL4290222,7.03,False,http://www.openphacts.org/units/Nanomolar,3117295,=,1,True,=,,IC50,nM,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.094
4126,,18761868,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '14.95', 'le': '0.28', 'lle': '3.87', 'sei': '8.50'}",CHEMBL4290222,,CHEMBL4290222,6.38,False,http://www.openphacts.org/units/Nanomolar,3117295,=,1,True,=,,IC50,nM,,420.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.42
4127,,18761880,[],CHEMBL4266497,Inhibition of recombinant human N-terminal His6-tagged full length IRAK4 expressed in baculovirus infected Sf21 insect cells in presence of 5000 uM ATP,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.47', 'le': '0.31', 'lle': '4.52', 'sei': '9.37'}",CHEMBL4290222,,CHEMBL4290222,7.03,False,http://www.openphacts.org/units/Nanomolar,3117295,=,1,True,=,,IC50,nM,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.094
4128,,18761957,[],CHEMBL4266576,Inhibition of recombinant human N-terminal His6-tagged full length IRAK4 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,,CHEMBL4290222,,CHEMBL4290222,,False,http://qudt.org/vocab/unit#Percent,3117295,=,1,True,=,,Inhibition,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,95.0
4129,,18762025,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.48', 'le': '0.31', 'lle': '4.52', 'sei': '9.37'}",CHEMBL4290222,,CHEMBL4290222,7.03,False,http://www.openphacts.org/units/Nanomolar,3117295,=,1,True,=,,IC50,nM,,93.33,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.03
4130,,18762026,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '14.96', 'le': '0.28', 'lle': '3.87', 'sei': '8.51'}",CHEMBL4290222,,CHEMBL4290222,6.38,False,http://www.openphacts.org/units/Nanomolar,3117295,=,1,True,=,,IC50,nM,,416.87,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.38
4131,,18762027,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '15.20', 'le': '0.29', 'lle': '4.73', 'sei': '6.53'}",CHEMBL4282348,,CHEMBL4282348,7.11,False,http://www.openphacts.org/units/Nanomolar,3117296,=,1,True,=,,IC50,nM,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.078
4132,,18762031,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.37', 'le': '0.23', 'lle': '3.40', 'sei': '5.31'}",CHEMBL4282348,,CHEMBL4282348,5.78,False,http://www.openphacts.org/units/Nanomolar,3117296,=,1,True,=,,IC50,nM,,1650.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.65
4133,,18762032,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '15.20', 'le': '0.29', 'lle': '4.73', 'sei': '6.53'}",CHEMBL4282348,,CHEMBL4282348,7.11,False,http://www.openphacts.org/units/Nanomolar,3117296,=,1,True,=,,IC50,nM,,77.62,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.11
4134,,18762033,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.36', 'le': '0.23', 'lle': '3.40', 'sei': '5.31'}",CHEMBL4282348,,CHEMBL4282348,5.78,False,http://www.openphacts.org/units/Nanomolar,3117296,=,1,True,=,,IC50,nM,,1659.59,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.78
4135,,18762034,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '17.96', 'le': '0.34', 'lle': '6.08', 'sei': '7.05'}",CHEMBL4293607,,CHEMBL4293607,7.68,False,http://www.openphacts.org/units/Nanomolar,3117297,=,1,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.021
4136,,18762038,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.02', 'le': '0.30', 'lle': '5.25', 'sei': '6.29'}",CHEMBL4293607,,CHEMBL4293607,6.85,False,http://www.openphacts.org/units/Nanomolar,3117297,=,1,True,=,,IC50,nM,,141.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.141
4137,,18762039,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '17.94', 'le': '0.34', 'lle': '6.07', 'sei': '7.05'}",CHEMBL4293607,,CHEMBL4293607,7.67,False,http://www.openphacts.org/units/Nanomolar,3117297,=,1,True,=,,IC50,nM,,21.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.67
4138,,18762040,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.02', 'le': '0.30', 'lle': '5.25', 'sei': '6.29'}",CHEMBL4293607,,CHEMBL4293607,6.85,False,http://www.openphacts.org/units/Nanomolar,3117297,=,1,True,=,,IC50,nM,,141.25,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.85
4139,,18762041,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,,CHEMBL4293993,,CHEMBL4293993,,False,http://www.openphacts.org/units/Nanomolar,3117298,>,1,True,>,,IC50,nM,,10000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,10.0
4140,,18762043,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '18.68', 'le': '0.35', 'lle': '4.52', 'sei': '9.98'}",CHEMBL4288305,,CHEMBL4288305,7.48,False,http://www.openphacts.org/units/Nanomolar,3117299,=,1,True,=,,IC50,nM,,33.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.033
4141,,18762047,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.09', 'le': '0.30', 'lle': '3.48', 'sei': '8.59'}",CHEMBL4288305,,CHEMBL4288305,6.45,False,http://www.openphacts.org/units/Nanomolar,3117299,=,1,True,=,,IC50,nM,,359.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.359
4142,,18762048,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '18.68', 'le': '0.35', 'lle': '4.52', 'sei': '9.97'}",CHEMBL4288305,,CHEMBL4288305,7.48,False,http://www.openphacts.org/units/Nanomolar,3117299,=,1,True,=,,IC50,nM,,33.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.48
4143,,18762049,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '16.08', 'le': '0.30', 'lle': '3.48', 'sei': '8.59'}",CHEMBL4288305,,CHEMBL4288305,6.44,False,http://www.openphacts.org/units/Nanomolar,3117299,=,1,True,=,,IC50,nM,,363.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.44
4144,,18762050,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '17.36', 'le': '0.33', 'lle': '5.88', 'sei': '6.52'}",CHEMBL4280559,,CHEMBL4280559,7.70,False,http://www.openphacts.org/units/Nanomolar,3117300,=,1,True,=,,IC50,nM,,20.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.02
4145,,18762054,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '15.45', 'le': '0.29', 'lle': '5.03', 'sei': '5.80'}",CHEMBL4280559,,CHEMBL4280559,6.85,False,http://www.openphacts.org/units/Nanomolar,3117300,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.14
4146,,18762062,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '17.38', 'le': '0.33', 'lle': '5.89', 'sei': '6.53'}",CHEMBL4280559,,CHEMBL4280559,7.71,False,http://www.openphacts.org/units/Nanomolar,3117300,=,1,True,=,,IC50,nM,,19.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,7.71
4147,,18762063,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '15.47', 'le': '0.29', 'lle': '5.04', 'sei': '5.81'}",CHEMBL4280559,,CHEMBL4280559,6.86,False,http://www.openphacts.org/units/Nanomolar,3117300,=,1,True,=,,IC50,nM,,138.04,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.86
4148,,18762064,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '14.61', 'le': '0.28', 'lle': '4.60', 'sei': '6.42'}",CHEMBL4290202,,CHEMBL4290202,6.68,False,http://www.openphacts.org/units/Nanomolar,3117301,=,1,True,=,,IC50,nM,,207.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.207
4149,,18762068,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.46', 'le': '0.24', 'lle': '3.62', 'sei': '5.48'}",CHEMBL4290202,,CHEMBL4290202,5.70,False,http://www.openphacts.org/units/Nanomolar,3117301,=,1,True,=,,IC50,nM,,1990.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.99
4150,,18762069,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '14.60', 'le': '0.28', 'lle': '4.60', 'sei': '6.42'}",CHEMBL4290202,,CHEMBL4290202,6.68,False,http://www.openphacts.org/units/Nanomolar,3117301,=,1,True,=,,IC50,nM,,208.93,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.68
4151,,18762070,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.46', 'le': '0.24', 'lle': '3.62', 'sei': '5.48'}",CHEMBL4290202,,CHEMBL4290202,5.70,False,http://www.openphacts.org/units/Nanomolar,3117301,=,1,True,=,,IC50,nM,,1995.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.7
4152,,18762071,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.56', 'le': '0.24', 'lle': '3.50', 'sei': '6.22'}",CHEMBL4280028,,CHEMBL4280028,5.92,False,http://www.openphacts.org/units/Nanomolar,3117302,=,1,True,=,,IC50,nM,,1190.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.19
4153,,18762075,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '10.71', 'le': '0.20', 'lle': '2.63', 'sei': '5.30'}",CHEMBL4280028,,CHEMBL4280028,5.05,False,http://www.openphacts.org/units/Nanomolar,3117302,=,1,True,=,,IC50,nM,,8910.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,8.91
4154,,18762076,[],CHEMBL4266468,Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '12.55', 'le': '0.24', 'lle': '3.50', 'sei': '6.21'}",CHEMBL4280028,,CHEMBL4280028,5.92,False,http://www.openphacts.org/units/Nanomolar,3117302,=,1,True,=,,IC50,nM,,1202.26,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.92
4155,,18762077,[],CHEMBL4266473,Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1,,,CHEMBL4265877,Bioorg Med Chem,2018.0,"{'bei': '10.71', 'le': '0.20', 'lle': '2.63', 'sei': '5.30'}",CHEMBL4280028,,CHEMBL4280028,5.05,False,http://www.openphacts.org/units/Nanomolar,3117302,=,1,True,=,,IC50,nM,,8912.51,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,5.05
4156,,18763085,[],CHEMBL4266882,Inhibition of IRAK4 (unknown origin) at 1 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O,,,CHEMBL4265887,Bioorg Med Chem Lett,2018.0,,CHEMBL4290876,,CHEMBL4290876,,False,http://qudt.org/vocab/unit#Percent,3117557,=,1,True,=,,Inhibition,%,,8.14,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,8.14
4157,,18763118,[],CHEMBL4266915,Inhibition of IRAK4 (unknown origin) at 10 uM,B,,,BAO_0000201,BAO_0000357,single protein format,CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O,,,CHEMBL4265887,Bioorg Med Chem Lett,2018.0,,CHEMBL4288081,,CHEMBL4288081,,False,http://qudt.org/vocab/unit#Percent,3117561,=,1,True,=,,Inhibition,%,,15.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,15.96
4158,Not Determined,18764629,[],CHEMBL4267112,Inhibition of human IRAK4 at 100 nM,B,,,BAO_0000376,BAO_0000357,single protein format,CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1,,,CHEMBL4265899,Bioorg Med Chem Lett,2018.0,,CHEMBL4288103,,CHEMBL4288103,,False,,3117834,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4159,,18764630,[],CHEMBL4267112,Inhibition of human IRAK4 at 100 nM,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1,,,CHEMBL4265899,Bioorg Med Chem Lett,2018.0,,CHEMBL4286880,,CHEMBL4286880,,False,http://qudt.org/vocab/unit#Percent,3117840,<,1,True,<,,Inhibition,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,70.0
4160,,18764631,[],CHEMBL4267112,Inhibition of human IRAK4 at 100 nM,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1,,,CHEMBL4265899,Bioorg Med Chem Lett,2018.0,,CHEMBL4286841,,CHEMBL4286841,,False,http://qudt.org/vocab/unit#Percent,3117845,<,1,True,<,,Inhibition,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,70.0
4161,,18782842,[],CHEMBL4270708,Inhibition of IRAK4 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control,B,,,BAO_0001103,BAO_0000357,single protein format,Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1,,,CHEMBL4270481,Eur J Med Chem,2017.0,,CHEMBL4277021,,CHEMBL4277021,,False,http://qudt.org/vocab/unit#Percent,3120985,>,1,False,>,,Activity,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,80.0
4162,,18849493,[],CHEMBL4305559,Inhibition of recombinant N-terminal GST-fusion protein tagged human full length IRAK4 (1 to 460 residues) expressed in baculovirus expression system assessed as decrease in fluorescence labelled IRAK1 phosphorylation at 200 nM by off-chip mobility shift assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(C#N)c3cn[nH]c(=O)c23)c1,,,CHEMBL4304751,ACS Med Chem Lett,2019.0,,CHEMBL4461851,,CHEMBL4461851,,False,http://qudt.org/vocab/unit#Percent,3145974,>,1,True,>,,Inhibition,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,90.0
4163,,18857626,[],CHEMBL4307631,Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CCC(N2C(=O)c3ccc(OCCOCCOCCN4CCN(Cc5ccc6c(c5)nc(NC(=O)c5cccc(C(F)(F)F)c5)n6[C@H]5CC[C@@H](CO)CC5)CC4)cc3C2=O)C(=O)N1,,,CHEMBL4304808,ACS Med Chem Lett,2019.0,,CHEMBL4447648,,CHEMBL4447648,,False,http://www.openphacts.org/units/Nanomolar,3147763,<,1,True,<,,IC50,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.0
4164,,18857627,[],CHEMBL4307631,Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1nc2cc(CN3CCN(CCOCCOCCOCCOc4ccc5c(c4)C(=O)N(C4CCCNC4=O)C5=O)CC3)ccc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc(C(F)(F)F)c1,,,CHEMBL4304808,ACS Med Chem Lett,2019.0,,CHEMBL4560045,,CHEMBL4560045,,False,http://www.openphacts.org/units/Nanomolar,3147764,<,1,True,<,,IC50,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.0
4165,,18857628,[],CHEMBL4307631,Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CCC(N2C(=O)c3ccc(N4CCC(CN5CCN(Cc6ccc7c(c6)nc(NC(=O)c6cccc(C(F)(F)F)c6)n7[C@H]6CC[C@@H](CO)CC6)CC5)CC4)cc3C2=O)C(=O)N1,,,CHEMBL4304808,ACS Med Chem Lett,2019.0,,CHEMBL4472363,,CHEMBL4472363,,False,http://www.openphacts.org/units/Nanomolar,3147765,<,1,True,<,,IC50,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.0
4166,,18857629,[],CHEMBL4307631,Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2nn(C3CCN(CCOCCOc4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1,,,CHEMBL4304808,ACS Med Chem Lett,2019.0,,CHEMBL4441283,,CHEMBL4441283,,False,http://www.openphacts.org/units/Nanomolar,3147766,<,1,True,<,,IC50,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.0
4167,,18857630,[],CHEMBL4307631,Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2nn(C3CCN(CCOCCOc4ccc5c(c4)CN(C4CCC(=O)NC4=O)C5=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1,,,CHEMBL4304808,ACS Med Chem Lett,2019.0,,CHEMBL4592457,,CHEMBL4592457,,False,http://www.openphacts.org/units/Nanomolar,3147767,<,1,True,<,,IC50,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.0
4168,,18857631,[],CHEMBL4307631,Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CCC(N2C(=O)c3ccc(OC4CCC(CN5CCN(Cc6ccc7c(c6)nc(NC(=O)c6cccc(C(F)(F)F)c6)n7[C@H]6CC[C@@H](CO)CC6)CC5)CC4)cc3C2=O)C(=O)N1,,,CHEMBL4304808,ACS Med Chem Lett,2019.0,,CHEMBL4570072,,CHEMBL4570072,,False,http://www.openphacts.org/units/Nanomolar,3147768,<,1,True,<,,IC50,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,30.0
4169,,18858008,[],CHEMBL4307854,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl,,,CHEMBL4304811,ACS Med Chem Lett,2019.0,,CHEMBL4533018,,CHEMBL4594742,,False,http://qudt.org/vocab/unit#Percent,3147806,=,1,False,=,,Activity,%,,74.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,74.0
4170,,18919396,[],CHEMBL4322756,Binding affinity to recombinant full-length human N-terminal his-tagged IRAK4 expressed in baculovirus expression system using IRAK1 peptide as substrate incubated for 1 hr by TR-FRET assay,B,,,BAO_0000034,BAO_0000019,assay format,CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4321812,Bioorg Med Chem Lett,2019.0,"{'bei': '8.47', 'le': None, 'lle': None, 'sei': None}",CHEMBL4465866,,CHEMBL4465866,7.64,False,http://www.openphacts.org/units/Nanomolar,3156325,=,1,True,=,,Kd,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,23.0
4171,,18919584,[],CHEMBL4322756,Binding affinity to recombinant full-length human N-terminal his-tagged IRAK4 expressed in baculovirus expression system using IRAK1 peptide as substrate incubated for 1 hr by TR-FRET assay,B,,,BAO_0000034,BAO_0000019,assay format,CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4321812,Bioorg Med Chem Lett,2019.0,"{'bei': '7.78', 'le': None, 'lle': None, 'sei': None}",CHEMBL4576489,,CHEMBL4576489,7.12,False,http://www.openphacts.org/units/Nanomolar,3156326,=,1,True,=,,Kd,nM,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Kd,nM,UO_0000065,,75.0
4172,,18921626,[],CHEMBL4323537,Inhibition of IRAK4 (unknown origin) at 0.1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL4582624,,CHEMBL4582624,,False,http://qudt.org/vocab/unit#Percent,3156630,=,1,True,=,,Inhibition,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,104.0
4173,,18921631,[],CHEMBL4323532,Inhibition of IRAK4 (unknown origin) at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL4455718,,CHEMBL4455718,,False,http://qudt.org/vocab/unit#Percent,3156622,=,1,True,=,,Inhibition,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,97.0
4174,,18921700,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C5(C#N)CC5)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '13.60', 'le': '0.25', 'lle': '4.05', 'sei': '5.26'}",CHEMBL4581832,,CHEMBL4581832,7.21,False,http://www.openphacts.org/units/Nanomolar,3156633,=,1,True,=,,IC50,nM,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.061
4175,,18921701,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)(C)C#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '10.88', 'le': '0.20', 'lle': '2.39', 'sei': '4.23'}",CHEMBL4438228,,CHEMBL4438228,5.80,False,http://www.openphacts.org/units/Nanomolar,3156632,=,1,True,=,,IC50,nM,,1600.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,1.6
4176,,18921702,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)C#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '13.28', 'le': '0.25', 'lle': '3.65', 'sei': '5.02'}",CHEMBL4548760,,CHEMBL4548760,6.89,False,http://www.openphacts.org/units/Nanomolar,3156631,=,1,True,=,,IC50,nM,,130.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.13
4177,,18921703,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '14.54', 'le': '0.27', 'lle': '4.66', 'sei': '5.35'}",CHEMBL4582624,,CHEMBL4582624,7.34,False,http://www.openphacts.org/units/Nanomolar,3156630,=,1,True,=,,IC50,nM,,46.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.046
4178,,18921704,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '14.29', 'le': '0.27', 'lle': '3.93', 'sei': '6.05'}",CHEMBL4521212,,CHEMBL4521212,6.85,False,http://www.openphacts.org/units/Nanomolar,3156629,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.14
4179,,18921705,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '14.92', 'le': '0.28', 'lle': '4.84', 'sei': '5.34'}",CHEMBL4556866,,CHEMBL4556866,7.32,False,http://www.openphacts.org/units/Nanomolar,3156628,=,1,True,=,,IC50,nM,,48.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.048
4180,,18921706,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '15.80', 'le': '0.30', 'lle': '3.64', 'sei': '7.28'}",CHEMBL4583622,,CHEMBL4583622,6.08,False,http://www.openphacts.org/units/Nanomolar,3156627,=,1,True,=,,IC50,nM,,840.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.84
4181,,18921707,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '17.47', 'le': '0.33', 'lle': '3.65', 'sei': '9.49'}",CHEMBL4471452,,CHEMBL4471452,6.70,False,http://www.openphacts.org/units/Nanomolar,3156626,=,1,True,=,,IC50,nM,,200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.2
4182,,18921708,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '15.25', 'le': '0.28', 'lle': '4.38', 'sei': '6.01'}",CHEMBL4439748,,CHEMBL4439748,7.47,False,http://www.openphacts.org/units/Nanomolar,3156625,=,1,True,=,,IC50,nM,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.034
4183,,18921709,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '13.51', 'le': '0.25', 'lle': '3.53', 'sei': '5.56'}",CHEMBL4539647,,CHEMBL4539647,6.40,False,http://www.openphacts.org/units/Nanomolar,3156624,=,1,True,=,,IC50,nM,,400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.4
4184,,18921710,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(Nc2nc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c3cc(C#N)ccc3n2)cn1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '16.71', 'le': '0.31', 'lle': '4.20', 'sei': '6.96'}",CHEMBL4452521,,CHEMBL4452521,7.23,False,http://www.openphacts.org/units/Nanomolar,3156623,=,1,True,=,,IC50,nM,,59.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.059
4185,,18921711,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '17.23', 'le': '0.32', 'lle': '4.19', 'sei': '7.20'}",CHEMBL4455718,,CHEMBL4455718,6.80,False,http://www.openphacts.org/units/Nanomolar,3156622,=,1,True,=,,IC50,nM,,160.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.16
4186,,18921712,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '16.85', 'le': '0.31', 'lle': '3.99', 'sei': '7.49'}",CHEMBL4528699,,CHEMBL4528699,6.38,False,http://www.openphacts.org/units/Nanomolar,3156621,=,1,True,=,,IC50,nM,,420.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.42
4187,,18921713,[],CHEMBL4323524,Inhibition of IRAK4 (unknown origin) by cell based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '19.57', 'le': '0.36', 'lle': '4.04', 'sei': '8.91'}",CHEMBL4070214,,CHEMBL4070214,6.60,False,http://www.openphacts.org/units/Nanomolar,3156620,=,1,True,=,,IC50,nM,,250.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.25
4188,,18921714,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C5(C#N)CC5)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '14.64', 'le': '0.27', 'lle': '4.61', 'sei': '5.67'}",CHEMBL4581832,,CHEMBL4581832,7.77,False,http://www.openphacts.org/units/Nanomolar,3156633,=,1,True,=,,IC50,nM,,17.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.017
4189,,18921715,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)(C)C#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '13.44', 'le': '0.25', 'lle': '3.75', 'sei': '5.22'}",CHEMBL4438228,,CHEMBL4438228,7.16,False,http://www.openphacts.org/units/Nanomolar,3156632,=,1,True,=,,IC50,nM,,69.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.069
4190,,18921716,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)C#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '15.85', 'le': '0.30', 'lle': '4.98', 'sei': '6.00'}",CHEMBL4548760,,CHEMBL4548760,8.22,False,http://www.openphacts.org/units/Nanomolar,3156631,=,1,True,=,,IC50,nM,,6.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.006
4191,,18921717,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '16.64', 'le': '0.31', 'lle': '5.72', 'sei': '6.12'}",CHEMBL4582624,,CHEMBL4582624,8.40,False,http://www.openphacts.org/units/Nanomolar,3156630,=,1,True,=,,IC50,nM,,4.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.004
4192,,18921718,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '16.78', 'le': '0.31', 'lle': '5.13', 'sei': '7.10'}",CHEMBL4521212,,CHEMBL4521212,8.05,False,http://www.openphacts.org/units/Nanomolar,3156629,=,1,True,=,,IC50,nM,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.009
4193,,18921719,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '16.92', 'le': '0.31', 'lle': '5.82', 'sei': '6.05'}",CHEMBL4556866,,CHEMBL4556866,8.30,False,http://www.openphacts.org/units/Nanomolar,3156628,=,1,True,=,,IC50,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.005
4194,,18921720,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '17.05', 'le': '0.32', 'lle': '4.11', 'sei': '7.85'}",CHEMBL4583622,,CHEMBL4583622,6.55,False,http://www.openphacts.org/units/Nanomolar,3156627,=,1,True,=,,IC50,nM,,279.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.279
4195,,18921721,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '19.35', 'le': '0.36', 'lle': '4.37', 'sei': '10.51'}",CHEMBL4471452,,CHEMBL4471452,7.42,False,http://www.openphacts.org/units/Nanomolar,3156626,=,1,True,=,,IC50,nM,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.038
4196,,18921722,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '18.38', 'le': '0.34', 'lle': '5.91', 'sei': '7.24'}",CHEMBL4439748,,CHEMBL4439748,9.00,False,http://www.openphacts.org/units/Nanomolar,3156625,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.001
4197,,18921723,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '19.00', 'le': '0.35', 'lle': '6.13', 'sei': '7.83'}",CHEMBL4539647,,CHEMBL4539647,9.00,False,http://www.openphacts.org/units/Nanomolar,3156624,=,1,True,=,,IC50,nM,,1.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.001
4198,,18921724,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(Nc2nc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c3cc(C#N)ccc3n2)cn1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '20.11', 'le': '0.37', 'lle': '5.67', 'sei': '8.37'}",CHEMBL4452521,,CHEMBL4452521,8.70,False,http://www.openphacts.org/units/Nanomolar,3156623,=,1,True,=,,IC50,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.002
4199,,18921725,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '18.84', 'le': '0.35', 'lle': '4.82', 'sei': '7.87'}",CHEMBL4455718,,CHEMBL4455718,7.43,False,http://www.openphacts.org/units/Nanomolar,3156622,=,1,True,=,,IC50,nM,,37.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,0.32,0.037
4200,,18921726,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '18.27', 'le': '0.34', 'lle': '4.52', 'sei': '8.12'}",CHEMBL4528699,,CHEMBL4528699,6.91,False,http://www.openphacts.org/units/Nanomolar,3156621,=,1,True,=,,IC50,nM,,122.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.122
4201,,18921727,[],CHEMBL4323523,Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1,,,CHEMBL4321825,J Med Chem,2019.0,"{'bei': '21.74', 'le': '0.40', 'lle': '4.78', 'sei': '9.91'}",CHEMBL4070214,,CHEMBL4070214,7.34,False,http://www.openphacts.org/units/Nanomolar,3156620,=,1,True,=,,IC50,nM,,46.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,0.046
4202,,18921819,[],CHEMBL4323557,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in pIKBalpha levels at 0.3 uM in presence of 3 nM ibrutinib incubated for 14 hrs by Western blotting analysis relative to control,B,,,BAO_0000201,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL4582624,,CHEMBL4582624,,False,http://qudt.org/vocab/unit#Percent,3156630,=,1,True,=,,Inhibition,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,100.0
4203,Active,18921820,[],CHEMBL4323556,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in pIKBalpha levels at 0.12 to 10 uM in presence of 3 nM ibrutinib incubated for 14 hrs by Western blotting analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL4582624,,CHEMBL4582624,,False,,3156630,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4204,Active,18921821,[],CHEMBL4323556,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in pIKBalpha levels at 0.12 to 10 uM in presence of 3 nM ibrutinib incubated for 14 hrs by Western blotting analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL4455718,,CHEMBL4455718,,False,,3156622,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4205,Dose-dependent effect,18921822,[],CHEMBL4323555,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in pIKBalpha levels incubated for 14 hrs by Western blotting analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL1873475,IBRUTINIB,CHEMBL1873475,,False,,3156634,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4206,Dose-dependent effect,18921823,[],CHEMBL4323555,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in pIKBalpha levels incubated for 14 hrs by Western blotting analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL4582624,,CHEMBL4582624,,False,,3156630,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4207,Dose-dependent effect,18921824,[],CHEMBL4323555,Inhibition of IRAK4 in human OCI-LY10 cells assessed as decrease in pIKBalpha levels incubated for 14 hrs by Western blotting analysis,B,,,BAO_0000376,BAO_0000219,cell-based format,COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1,,,CHEMBL4321825,J Med Chem,2019.0,,CHEMBL4455718,,CHEMBL4455718,,False,,3156622,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4208,,18938001,[],CHEMBL4327727,Inhibition of human IRAK4 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],,,CHEMBL4325871,Eur J Med Chem,2019.0,,CHEMBL4438024,,CHEMBL4597936,,False,http://qudt.org/vocab/unit#Percent,3159528,=,1,False,=,,Activity,%,,91.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,92.7,91.5
4209,,18938002,[],CHEMBL4327727,Inhibition of human IRAK4 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],,,CHEMBL4325871,Eur J Med Chem,2019.0,,CHEMBL4446405,,CHEMBL4594846,,False,http://qudt.org/vocab/unit#Percent,3159529,=,1,False,=,,Activity,%,,92.08,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,96.83,92.08
4210,,18938572,[],CHEMBL4328091,Inhibition of human IRAK4 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control,B,,,BAO_0001103,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4325871,Eur J Med Chem,2019.0,,CHEMBL388978,STAUROSPORINE,CHEMBL388978,,False,http://qudt.org/vocab/unit#Percent,3159540,<,1,False,<,,Activity,%,,65.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,65.0
4211,,18938951,[],CHEMBL4328455,Inhibition of human IRAK4 using MBP as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4325871,Eur J Med Chem,2019.0,"{'bei': '17.95', 'le': '0.33', 'lle': '4.03', 'sei': '12.06'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.38,False,http://www.openphacts.org/units/Nanomolar,3159540,=,1,True,=,,IC50,nM,,4.21,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,10'-9M,UO_0000065,,4.21
4212,,18952500,[],CHEMBL4331758,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)[C@@H](O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21,,,CHEMBL4330088,Eur J Med Chem,2019.0,"{'bei': '19.90', 'le': '0.39', 'lle': '6.91', 'sei': '8.02'}",CHEMBL3361255,,CHEMBL3361255,8.89,False,http://www.openphacts.org/units/Nanomolar,3161692,=,1,True,=,,IC50,nM,,1.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.3
4213,,18952501,[],CHEMBL4331758,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21,,,CHEMBL4330088,Eur J Med Chem,2019.0,"{'bei': '19.51', 'le': '0.38', 'lle': '5.50', 'sei': '8.97'}",CHEMBL3361254,,CHEMBL3361254,8.12,False,http://www.openphacts.org/units/Nanomolar,3161691,=,1,True,=,,IC50,nM,,7.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.5
4214,,18952502,[],CHEMBL4331758,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2nn(CC(=O)N3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1,,,CHEMBL4330088,Eur J Med Chem,2019.0,"{'bei': '15.70', 'le': '0.30', 'lle': '4.99', 'sei': '8.08'}",CHEMBL4579427,,CHEMBL4579427,7.48,False,http://www.openphacts.org/units/Nanomolar,3161690,=,1,True,=,,IC50,nM,,33.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,33.0
4215,,18952503,[],CHEMBL4331758,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1,,,CHEMBL4330088,Eur J Med Chem,2019.0,"{'bei': '18.92', 'le': '0.36', 'lle': '4.38', 'sei': '9.68'}",CHEMBL4064608,,CHEMBL4064608,7.29,False,http://www.openphacts.org/units/Nanomolar,3161689,=,1,True,=,,IC50,nM,,51.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,51.0
4216,,18952504,[],CHEMBL4331758,Inhibition of IRAK4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1[C@@H](COc2cccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F,,,CHEMBL4330088,Eur J Med Chem,2019.0,"{'bei': '26.91', 'le': '0.51', 'lle': '7.51', 'sei': '10.70'}",CHEMBL4520946,,CHEMBL4520946,9.70,False,http://www.openphacts.org/units/Nanomolar,3161688,=,1,True,=,,IC50,nM,,0.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.2
4217,,18958920,[],CHEMBL4333442,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N,,,CHEMBL4330132,Bioorg Med Chem Lett,2019.0,,CHEMBL4563315,,CHEMBL4563315,,False,http://qudt.org/vocab/unit#Percent,3162858,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
4218,,19008952,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4466517,,CHEMBL4466517,,False,http://qudt.org/vocab/unit#Percent,3172075,=,1,False,=,,Imax,%,,72.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,72.0
4219,,19008955,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '21.10', 'le': '0.39', 'lle': '5.77', 'sei': '10.25'}",CHEMBL4473269,,CHEMBL4473269,8.30,False,http://www.openphacts.org/units/Nanomolar,3172054,=,1,True,=,,Ki,nM,,5.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,5.3,5.0
4220,,19008956,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.55', 'le': '0.34', 'lle': '4.94', 'sei': '8.47'}",CHEMBL4557715,,CHEMBL4557715,7.52,False,http://www.openphacts.org/units/Nanomolar,3172055,=,1,True,=,,Ki,nM,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,30.0
4221,,19008957,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '20.16', 'le': '0.37', 'lle': '5.78', 'sei': '8.93'}",CHEMBL4439292,,CHEMBL4439292,8.21,False,http://www.openphacts.org/units/Nanomolar,3172056,=,1,True,=,,Ki,nM,,6.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,6.1
4222,,19008958,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '16.68', 'le': '0.31', 'lle': '4.37', 'sei': '7.39'}",CHEMBL4439292,,CHEMBL4439292,6.80,False,http://www.openphacts.org/units/Nanomolar,3172057,=,1,True,=,,Ki,nM,,160.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,160.0
4223,,19008959,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '19.33', 'le': '0.36', 'lle': '6.19', 'sei': '8.24'}",CHEMBL4468790,,CHEMBL4468790,7.58,False,http://www.openphacts.org/units/Nanomolar,3172058,=,1,True,=,,Ki,nM,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,26.0
4224,,19008960,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CN1CCc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '17.46', 'le': '0.32', 'lle': '5.65', 'sei': '7.71'}",CHEMBL4592237,,CHEMBL4592237,7.10,False,http://www.openphacts.org/units/Nanomolar,3172059,=,1,True,=,,Ki,nM,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,80.0
4225,,19008961,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,Cn1ccc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2c1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '16.51', 'le': '0.30', 'lle': '5.01', 'sei': '7.12'}",CHEMBL4518564,,CHEMBL4518564,6.68,False,http://www.openphacts.org/units/Nanomolar,3172060,=,1,True,=,,Ki,nM,,210.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,210.0
4226,,19008962,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '17.79', 'le': '0.35', 'lle': '5.92', 'sei': '7.42'}",CHEMBL4444608,,CHEMBL4444608,7.85,False,http://www.openphacts.org/units/Nanomolar,3172061,=,1,True,=,,Ki,nM,,14.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,14.0
4227,,19008963,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2[S+]1[O-],,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.00', 'le': '0.35', 'lle': '5.40', 'sei': '8.62'}",CHEMBL4464216,,CHEMBL4464216,7.66,False,http://www.openphacts.org/units/Nanomolar,3172062,=,1,True,=,,Ki,nM,,22.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,22.0
4228,,19008964,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2[S+]1[O-],,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '14.83', 'le': '0.29', 'lle': '4.05', 'sei': '7.10'}",CHEMBL4464216,,CHEMBL4464216,6.31,False,http://www.openphacts.org/units/Nanomolar,3172063,=,1,True,=,,Ki,nM,,490.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,490.0
4229,,19008965,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.02', 'le': '0.35', 'lle': '6.77', 'sei': '7.07'}",CHEMBL4537890,,CHEMBL4537890,7.72,False,http://www.openphacts.org/units/Nanomolar,3172064,=,1,True,=,,Ki,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,19.0
4230,,19008966,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2c(cc1N1CCOCC1)C(=O)N(CC1CCOCC1)C2)c1cnn2cccnc12,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '17.69', 'le': '0.33', 'lle': '6.23', 'sei': '8.32'}",CHEMBL4452765,,CHEMBL4452765,8.43,False,http://www.openphacts.org/units/Nanomolar,3172065,=,1,True,=,,Ki,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.7
4231,,19008967,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,COC(C)(C)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.22', 'le': '0.34', 'lle': '6.13', 'sei': '8.61'}",CHEMBL4466981,,CHEMBL4466981,8.72,False,http://www.openphacts.org/units/Nanomolar,3172066,=,1,True,=,,Ki,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.9
4232,,19008968,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.64', 'le': '0.35', 'lle': '6.72', 'sei': '7.71'}",CHEMBL4472406,,CHEMBL4472406,8.66,False,http://www.openphacts.org/units/Nanomolar,3172067,=,1,True,=,,Ki,nM,,2.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,2.2
4233,,19008969,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.35', 'le': '0.35', 'lle': '6.97', 'sei': '7.88'}",CHEMBL4475494,,CHEMBL4475494,8.85,False,http://www.openphacts.org/units/Nanomolar,3172068,=,1,True,=,,Ki,nM,,1.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.4
4234,,19008970,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '15.64', 'le': '0.31', 'lle': '6.68', 'sei': '6.27'}",CHEMBL4536154,,CHEMBL4536154,8.11,False,http://www.openphacts.org/units/Nanomolar,3172069,=,1,True,=,,Ki,nM,,7.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,7.8
4235,,19008971,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(F)F)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '15.74', 'le': '0.30', 'lle': '6.16', 'sei': '8.08'}",CHEMBL4545898,,CHEMBL4545898,8.59,False,http://www.openphacts.org/units/Nanomolar,3172070,=,1,True,=,,Ki,nM,,2.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,2.6
4236,,19008972,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CCC4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '16.28', 'le': '0.31', 'lle': '6.00', 'sei': '8.20'}",CHEMBL4556091,,CHEMBL4556091,8.72,False,http://www.openphacts.org/units/Nanomolar,3172071,=,1,True,=,,Ki,nM,,1.9,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.9
4237,,19008973,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CC(F)(F)C4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '14.82', 'le': '0.28', 'lle': '5.50', 'sei': '7.97'}",CHEMBL4568894,,CHEMBL4568894,8.47,False,http://www.openphacts.org/units/Nanomolar,3172072,=,1,True,=,,Ki,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.4
4238,,19008974,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4COC4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '15.68', 'le': '0.30', 'lle': '6.86', 'sei': '7.30'}",CHEMBL4566431,,CHEMBL4566431,8.43,False,http://www.openphacts.org/units/Nanomolar,3172073,=,1,True,=,,Ki,nM,,3.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.7
4239,,19008975,[],CHEMBL4345130,Inhibition of recombinant full-length N-terminal His6-tagged human IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR peptide as substrate after 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4CC(F)(F)C4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '14.79', 'le': '0.28', 'lle': '5.49', 'sei': '7.95'}",CHEMBL4445098,,CHEMBL4445098,8.46,False,http://www.openphacts.org/units/Nanomolar,3172074,=,1,True,=,,Ki,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.5
4240,,19008976,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '21.46', 'le': '0.40', 'lle': '5.91', 'sei': '10.43'}",CHEMBL4473269,,CHEMBL4473269,8.44,False,http://www.openphacts.org/units/Nanomolar,3172054,=,1,True,=,,IC50,nM,,3.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.6
4241,,19008977,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '24.01', 'le': '0.44', 'lle': '8.02', 'sei': '10.23'}",CHEMBL4468790,,CHEMBL4468790,9.42,False,http://www.openphacts.org/units/Nanomolar,3172058,=,1,True,=,,IC50,nM,,0.38,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.38
4242,,19008978,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '19.00', 'le': '0.37', 'lle': '7.19', 'sei': '7.46'}",CHEMBL4537890,,CHEMBL4537890,8.14,False,http://www.openphacts.org/units/Nanomolar,3172064,=,1,True,=,,IC50,nM,,7.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.2
4243,,19008979,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,O=C(Nc1cc2c(cc1N1CCOCC1)C(=O)N(CC1CCOCC1)C2)c1cnn2cccnc12,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '19.57', 'le': '0.36', 'lle': '7.13', 'sei': '9.21'}",CHEMBL4452765,,CHEMBL4452765,9.33,False,http://www.openphacts.org/units/Nanomolar,3172065,=,1,True,=,,IC50,nM,,0.47,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.47
4244,,19008980,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,COC(C)(C)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '19.84', 'le': '0.37', 'lle': '6.90', 'sei': '9.37'}",CHEMBL4466981,,CHEMBL4466981,9.49,False,http://www.openphacts.org/units/Nanomolar,3172066,=,1,True,=,,IC50,nM,,0.32,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.32
4245,,19008981,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '21.09', 'le': '0.39', 'lle': '7.86', 'sei': '8.72'}",CHEMBL4472406,,CHEMBL4472406,9.80,False,http://www.openphacts.org/units/Nanomolar,3172067,=,1,True,=,,IC50,nM,,0.16,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.16
4246,,19008982,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '20.15', 'le': '0.38', 'lle': '7.84', 'sei': '8.66'}",CHEMBL4475494,,CHEMBL4475494,9.72,False,http://www.openphacts.org/units/Nanomolar,3172068,=,1,True,=,,IC50,nM,,0.19,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.19
4247,,19008983,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '17.20', 'le': '0.34', 'lle': '7.49', 'sei': '6.90'}",CHEMBL4536154,,CHEMBL4536154,8.92,False,http://www.openphacts.org/units/Nanomolar,3172069,=,1,True,=,,IC50,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1.2
4248,,19008984,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(F)F)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.50', 'le': '0.35', 'lle': '7.66', 'sei': '9.49'}",CHEMBL4545898,,CHEMBL4545898,10.09,False,http://www.openphacts.org/units/Nanomolar,3172070,=,1,True,=,,IC50,nM,,0.081,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.081
4249,,19008985,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CCC4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '19.76', 'le': '0.37', 'lle': '7.87', 'sei': '9.96'}",CHEMBL4556091,,CHEMBL4556091,10.59,False,http://www.openphacts.org/units/Nanomolar,3172071,=,1,True,=,,IC50,nM,,0.026,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.026
4250,,19008986,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CC(F)(F)C4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '17.42', 'le': '0.33', 'lle': '6.99', 'sei': '9.37'}",CHEMBL4568894,,CHEMBL4568894,9.96,False,http://www.openphacts.org/units/Nanomolar,3172072,=,1,True,=,,IC50,nM,,0.11,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.11
4251,,19008987,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4COC4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '18.80', 'le': '0.35', 'lle': '8.54', 'sei': '8.75'}",CHEMBL4566431,,CHEMBL4566431,10.11,False,http://www.openphacts.org/units/Nanomolar,3172073,=,1,True,=,,IC50,nM,,0.078,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.078
4252,,19008988,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4CC(F)(F)C4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '17.49', 'le': '0.33', 'lle': '7.03', 'sei': '9.41'}",CHEMBL4445098,,CHEMBL4445098,10.00,False,http://www.openphacts.org/units/Nanomolar,3172074,=,1,True,=,,IC50,nM,,0.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.1
4253,,19009000,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4473269,,CHEMBL4473269,,False,http://qudt.org/vocab/unit#Percent,3172054,=,1,False,=,,Imax,%,,58.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,58.0
4254,,19009001,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4468790,,CHEMBL4468790,,False,http://qudt.org/vocab/unit#Percent,3172058,=,1,False,=,,Imax,%,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,38.0
4255,,19009002,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4537890,,CHEMBL4537890,,False,http://qudt.org/vocab/unit#Percent,3172064,=,1,False,=,,Imax,%,,67.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,67.0
4256,,19009003,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,O=C(Nc1cc2c(cc1N1CCOCC1)C(=O)N(CC1CCOCC1)C2)c1cnn2cccnc12,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4452765,,CHEMBL4452765,,False,http://qudt.org/vocab/unit#Percent,3172065,=,1,False,=,,Imax,%,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,71.0
4257,,19009004,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,COC(C)(C)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4466981,,CHEMBL4466981,,False,http://qudt.org/vocab/unit#Percent,3172066,=,1,False,=,,Imax,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,76.0
4258,,19009005,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4472406,,CHEMBL4472406,,False,http://qudt.org/vocab/unit#Percent,3172067,=,1,False,=,,Imax,%,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,78.0
4259,,19009006,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4475494,,CHEMBL4475494,,False,http://qudt.org/vocab/unit#Percent,3172068,=,1,False,=,,Imax,%,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,82.0
4260,,19009007,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4536154,,CHEMBL4536154,,False,http://qudt.org/vocab/unit#Percent,3172069,=,1,False,=,,Imax,%,,60.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,60.0
4261,,19009008,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(F)F)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4545898,,CHEMBL4545898,,False,http://qudt.org/vocab/unit#Percent,3172070,=,1,False,=,,Imax,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,85.0
4262,,19009009,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CCC4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4556091,,CHEMBL4556091,,False,http://qudt.org/vocab/unit#Percent,3172071,=,1,False,=,,Imax,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,87.0
4263,,19009010,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CC(F)(F)C4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4568894,,CHEMBL4568894,,False,http://qudt.org/vocab/unit#Percent,3172072,=,1,False,=,,Imax,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,75.0
4264,,19009011,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4COC4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4566431,,CHEMBL4566431,,False,http://qudt.org/vocab/unit#Percent,3172073,=,1,False,=,,Imax,%,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,83.0
4265,,19009012,[],CHEMBL4345133,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4CC(F)(F)C4)CC3)cc2C1=O,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4445098,,CHEMBL4445098,,False,http://qudt.org/vocab/unit#Percent,3172074,=,1,False,=,,Imax,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,84.0
4266,,19009066,[],CHEMBL4345131,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '15.48', 'le': '0.29', 'lle': '4.84', 'sei': '6.26'}",CHEMBL4466517,,CHEMBL4466517,6.34,False,http://www.openphacts.org/units/Nanomolar,3172075,=,1,True,=,,IC50,nM,,460.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,460.0
4267,,19009070,[],CHEMBL4345169,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IFN alpha production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,"{'bei': '15.63', 'le': '0.29', 'lle': '4.90', 'sei': '6.32'}",CHEMBL4466517,,CHEMBL4466517,6.40,False,http://www.openphacts.org/units/Nanomolar,3172075,=,1,True,=,,IC50,nM,,400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,400.0
4268,,19009071,[],CHEMBL4345170,Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IFN alpha production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay relative to control,B,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4342485,ACS Med Chem Lett,2020.0,,CHEMBL4466517,,CHEMBL4466517,,False,http://qudt.org/vocab/unit#Percent,3172075,=,1,False,=,,Imax,%,,56.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Imax,%,UO_0000187,,56.0
4269,,19030036,[],CHEMBL4349175,Inhibition of recombinant human His-tagged IRAK4 expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control,B,,,BAO_0001103,BAO_0000019,assay format,C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1,,,CHEMBL4346710,Eur J Med Chem,2019.0,,CHEMBL4443805,,CHEMBL4443805,,False,http://qudt.org/vocab/unit#Percent,3174658,=,1,False,=,,Activity,%,,19.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,19.3
4270,,19032192,[],CHEMBL4349785,Inhibition of recombinant human IRAK4 C-terminal (A104 to S460) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method,B,,,BAO_0000201,BAO_0000219,cell-based format,Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1,,,CHEMBL4346729,Bioorg Med Chem Lett,2019.0,,CHEMBL4555442,,CHEMBL4555442,,False,http://qudt.org/vocab/unit#Percent,3175183,=,1,True,=,,Inhibition,%,,-8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-8.0
4271,Active,19041146,[],CHEMBL4352407,Inhibition of human IRAK4 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP,B,,,BAO_0000376,BAO_0000357,single protein format,CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1,,,CHEMBL4350963,J Med Chem,2019.0,,CHEMBL4521353,,CHEMBL4521353,,False,,3176405,,1,False,,,Inhibition,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,,,,
4272,,19059632,[],CHEMBL4357933,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl,,,CHEMBL4354843,J Med Chem,2020.0,,CHEMBL4515441,,CHEMBL4515441,,False,http://qudt.org/vocab/unit#Percent,3179937,=,1,False,=,,Activity,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,100.0
4273,,19064568,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,NCC1CCN(c2cc3ncccc3cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '21.67', 'le': '0.40', 'lle': '6.00', 'sei': '8.58'}",CHEMBL3950656,,CHEMBL3950656,8.70,False,http://www.openphacts.org/units/Nanomolar,3180766,=,1,True,=,,Ki,nM,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,2.0
4274,,19064569,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2cccnc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '21.79', 'le': '0.40', 'lle': '6.03', 'sei': '9.17'}",CHEMBL4453861,,CHEMBL4453861,8.77,False,http://www.openphacts.org/units/Nanomolar,3180767,=,1,True,=,,Ki,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.7
4275,,19064570,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,COc1cc2ncccc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '22.81', 'le': '0.41', 'lle': '4.74', 'sei': '8.95'}",CHEMBL3952937,,CHEMBL3952937,7.28,False,http://www.openphacts.org/units/Nanomolar,3180768,=,1,True,=,,Ki,nM,,52.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,52.0
4276,,19064571,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2ccc(N3CCOCC3)nc2cc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '14.29', 'le': '0.26', 'lle': '3.18', 'sei': '7.44'}",CHEMBL4460458,,CHEMBL4460458,6.54,False,http://www.openphacts.org/units/Nanomolar,3180772,=,1,True,=,,Ki,nM,,290.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,290.0
4277,,19064572,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CN(C)c1ccc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCCC3)cc2n1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.26', 'le': '0.33', 'lle': '4.00', 'sei': '9.64'}",CHEMBL4551768,,CHEMBL4551768,7.58,False,http://www.openphacts.org/units/Nanomolar,3180773,=,1,True,=,,Ki,nM,,26.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,26.0
4278,,19064573,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2cnc(N3CCOCC3)nc2cc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '14.76', 'le': '0.27', 'lle': '4.02', 'sei': '6.72'}",CHEMBL4544284,,CHEMBL4544284,6.77,False,http://www.openphacts.org/units/Nanomolar,3180774,=,1,True,=,,Ki,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,170.0
4279,,19064574,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2[nH]cnc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.88', 'le': '0.38', 'lle': '6.10', 'sei': '7.33'}",CHEMBL4554579,,CHEMBL4554579,8.17,False,http://www.openphacts.org/units/Nanomolar,3180776,=,1,True,=,,Ki,nM,,6.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,6.7
4280,,19064575,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2[nH]c(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.40', 'le': '0.34', 'lle': '6.87', 'sei': '7.08'}",CHEMBL4460055,,CHEMBL4460055,8.77,False,http://www.openphacts.org/units/Nanomolar,3180777,=,1,True,=,,Ki,nM,,1.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.7
4281,,19064576,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,Cn1c(N2CCOCC2)nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc21,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '17.83', 'le': '0.33', 'lle': '6.83', 'sei': '7.74'}",CHEMBL4483477,,CHEMBL4483477,8.74,False,http://www.openphacts.org/units/Nanomolar,3180778,=,1,True,=,,Ki,nM,,1.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.8
4282,,19064577,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CCn1c(N2CCOCC2)nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc21,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '13.92', 'le': '0.26', 'lle': '4.62', 'sei': '6.21'}",CHEMBL4436128,,CHEMBL4436128,7.02,False,http://www.openphacts.org/units/Nanomolar,3180779,=,1,True,=,,Ki,nM,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,95.0
4283,,19064578,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.68', 'le': '0.35', 'lle': '6.75', 'sei': '7.36'}",CHEMBL4515682,,CHEMBL4515682,8.92,False,http://www.openphacts.org/units/Nanomolar,3180780,=,1,True,=,,Ki,nM,,1.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.2
4284,,19064579,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.84', 'le': '0.36', 'lle': '6.66', 'sei': '8.60'}",CHEMBL4474636,,CHEMBL4474636,9.30,False,http://www.openphacts.org/units/Nanomolar,3180781,=,1,True,=,,Ki,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.5
4285,,19064580,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CN(C)c1nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc2s1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.60', 'le': '0.40', 'lle': '6.43', 'sei': '9.41'}",CHEMBL4464832,,CHEMBL4464832,9.30,False,http://www.openphacts.org/units/Nanomolar,3180782,=,1,True,=,,Ki,nM,,0.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.5
4286,,19064581,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCOCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.54', 'le': '0.38', 'lle': '6.84', 'sei': '9.37'}",CHEMBL4568867,,CHEMBL4568867,9.10,False,http://www.openphacts.org/units/Nanomolar,3180783,=,1,True,=,,Ki,nM,,0.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,0.8
4287,,19064582,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '21.03', 'le': '0.39', 'lle': '5.75', 'sei': '10.22'}",CHEMBL4473269,,CHEMBL4473269,8.28,False,http://www.openphacts.org/units/Nanomolar,3180784,=,1,True,=,,Ki,nM,,5.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,5.3
4288,,19064583,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(CO)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.93', 'le': '0.39', 'lle': '5.92', 'sei': '9.59'}",CHEMBL4467170,,CHEMBL4467170,8.82,False,http://www.openphacts.org/units/Nanomolar,3180745,=,1,True,=,,Ki,nM,,1.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.5
4289,,19064584,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4c(O)ccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4463353,,CHEMBL4463353,,False,http://www.openphacts.org/units/Nanomolar,3180746,>,1,True,>,,Ki,nM,,8400.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,8400.0
4290,,19064585,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(O)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.75', 'le': '0.39', 'lle': '6.25', 'sei': '8.39'}",CHEMBL4466092,,CHEMBL4466092,8.49,False,http://www.openphacts.org/units/Nanomolar,3180747,=,1,True,=,,Ki,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.2
4291,,19064586,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(OC(F)F)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.26', 'le': '0.31', 'lle': '4.34', 'sei': '8.28'}",CHEMBL4474664,,CHEMBL4474664,7.47,False,http://www.openphacts.org/units/Nanomolar,3180748,=,1,True,=,,Ki,nM,,34.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,34.0
4292,,19064587,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C(F)F)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.93', 'le': '0.32', 'lle': '4.04', 'sei': '9.27'}",CHEMBL4462969,,CHEMBL4462969,7.51,False,http://www.openphacts.org/units/Nanomolar,3180749,=,1,True,=,,Ki,nM,,31.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,31.0
4293,,19064588,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C5CC5)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '17.20', 'le': '0.32', 'lle': '4.05', 'sei': '9.21'}",CHEMBL4550566,,CHEMBL4550566,7.46,False,http://www.openphacts.org/units/Nanomolar,3180750,=,1,True,=,,Ki,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,35.0
4294,,19064589,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C#N)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.63', 'le': '0.36', 'lle': '5.81', 'sei': '7.84'}",CHEMBL4456286,,CHEMBL4456286,8.21,False,http://www.openphacts.org/units/Nanomolar,3180751,=,1,True,=,,Ki,nM,,6.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,6.1
4295,,19064590,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C(N)=O)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.53', 'le': '0.38', 'lle': '7.33', 'sei': '7.22'}",CHEMBL4520118,,CHEMBL4520118,8.96,False,http://www.openphacts.org/units/Nanomolar,3180752,=,1,True,=,,Ki,nM,,1.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,1.1
4296,,19064591,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(CO)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.33', 'le': '0.36', 'lle': '6.17', 'sei': '8.09'}",CHEMBL4518559,,CHEMBL4518559,8.19,False,http://www.openphacts.org/units/Nanomolar,3180753,=,1,True,=,,Ki,nM,,6.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,6.5
4297,,19064592,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.99', 'le': '0.39', 'lle': '4.62', 'sei': '11.04'}",CHEMBL4459509,,CHEMBL4459509,7.92,False,http://www.openphacts.org/units/Nanomolar,3180754,=,1,True,=,,Ki,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,12.0
4298,,19064593,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCNCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.09', 'le': '0.37', 'lle': '5.79', 'sei': '9.41'}",CHEMBL4569547,,CHEMBL4569547,7.89,False,http://www.openphacts.org/units/Nanomolar,3180755,=,1,True,=,,Ki,nM,,13.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,13.0
4299,,19064594,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(C(O)C(F)(F)F)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.34', 'le': '0.31', 'lle': '4.17', 'sei': '8.70'}",CHEMBL4452936,,CHEMBL4452936,8.00,False,http://www.openphacts.org/units/Nanomolar,3180756,=,1,True,=,,Ki,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,10.0
4300,,19064595,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(C(N)=O)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.55', 'le': '0.36', 'lle': '6.09', 'sei': '7.40'}",CHEMBL4461516,,CHEMBL4461516,8.49,False,http://www.openphacts.org/units/Nanomolar,3180757,=,1,True,=,,Ki,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.2
4301,,19064596,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCC(O)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.54', 'le': '0.36', 'lle': '5.19', 'sei': '8.95'}",CHEMBL4531013,,CHEMBL4531013,8.24,False,http://www.openphacts.org/units/Nanomolar,3180758,=,1,True,=,,Ki,nM,,5.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,5.8
4302,,19064597,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CCO)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.74', 'le': '0.35', 'lle': '6.37', 'sei': '8.59'}",CHEMBL4584820,,CHEMBL4584820,8.18,False,http://www.openphacts.org/units/Nanomolar,3180759,=,1,True,=,,Ki,nM,,6.6,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,6.6
4303,,19064598,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(N)=O)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.30', 'le': '0.36', 'lle': '7.38', 'sei': '7.35'}",CHEMBL4483551,,CHEMBL4483551,8.68,False,http://www.openphacts.org/units/Nanomolar,3180760,=,1,True,=,,Ki,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,2.1
4304,,19064599,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CNC(=O)CN1CCN(c2cc3c(cc2NC(=O)c2cnn4cccnc24)CC(C)(C)O3)CC1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.24', 'le': '0.34', 'lle': '6.90', 'sei': '8.12'}",CHEMBL4438027,,CHEMBL4438027,8.46,False,http://www.openphacts.org/units/Nanomolar,3180761,=,1,True,=,,Ki,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,3.5
4305,,19064600,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.25', 'le': '0.38', 'lle': '6.79', 'sei': '8.19'}",CHEMBL4466517,,CHEMBL4466517,8.29,False,http://www.openphacts.org/units/Nanomolar,3180762,=,1,True,=,,Ki,nM,,5.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,5.1
4306,,19064601,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,C[C@@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.11', 'le': '0.36', 'lle': '6.32', 'sei': '7.73'}",CHEMBL4439253,,CHEMBL4439253,7.82,False,http://www.openphacts.org/units/Nanomolar,3180763,=,1,True,=,,Ki,nM,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,15.0
4307,,19064602,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CC(C)(O)[C@]1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.60', 'le': '0.35', 'lle': '5.86', 'sei': '8.04'}",CHEMBL4576141,,CHEMBL4576141,8.14,False,http://www.openphacts.org/units/Nanomolar,3180764,=,1,True,=,,Ki,nM,,7.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,7.3
4308,,19064603,[],CHEMBL4359940,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system using H-KKARFSRFAGSSPSQSSMVAR as substrate incubated for 90 mins by fluorescence polarisation assay,B,,,BAO_0000192,BAO_0000019,assay format,CN1CCC2(CC1)Cc1cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc1O2,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.13', 'le': '0.34', 'lle': '5.91', 'sei': '9.65'}",CHEMBL4524886,,CHEMBL4524886,8.13,False,http://www.openphacts.org/units/Nanomolar,3180765,=,1,True,=,,Ki,nM,,7.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,7.4
4309,,19064626,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,NCC1CCN(c2cc3ncccc3cc2NC(=O)c2cnn3cccnc23)CC1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.40', 'le': '0.34', 'lle': '4.69', 'sei': '7.28'}",CHEMBL3950656,,CHEMBL3950656,7.39,False,http://www.openphacts.org/units/Nanomolar,3180766,=,1,True,=,,IC50,nM,,41.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,41.0
4310,,19064627,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2cccnc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.53', 'le': '0.34', 'lle': '4.72', 'sei': '7.80'}",CHEMBL4453861,,CHEMBL4453861,7.46,False,http://www.openphacts.org/units/Nanomolar,3180767,=,1,True,=,,IC50,nM,,35.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,35.0
4311,,19064628,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc2ncccc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '20.14', 'le': '0.37', 'lle': '3.89', 'sei': '7.90'}",CHEMBL3952937,,CHEMBL3952937,6.43,False,http://www.openphacts.org/units/Nanomolar,3180768,=,1,True,=,,IC50,nM,,370.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,370.0
4312,Not Determined,19064629,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc2ccccc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL3979848,,CHEMBL3979848,,False,,3180769,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4313,Not Determined,19064630,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc2cccnc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4567291,,CHEMBL4567291,,False,,3180770,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4314,Not Determined,19064631,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4569648,,CHEMBL4569648,,False,,3180771,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4315,,19064632,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2ccc(N3CCOCC3)nc2cc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '12.86', 'le': '0.24', 'lle': '2.53', 'sei': '6.70'}",CHEMBL4460458,,CHEMBL4460458,5.89,False,http://www.openphacts.org/units/Nanomolar,3180772,=,1,True,=,,IC50,nM,,1300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1300.0
4316,,19064633,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1ccc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCCC3)cc2n1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.87', 'le': '0.31', 'lle': '3.42', 'sei': '8.91'}",CHEMBL4551768,,CHEMBL4551768,7.01,False,http://www.openphacts.org/units/Nanomolar,3180773,=,1,True,=,,IC50,nM,,98.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,98.0
4317,,19064634,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2cnc(N3CCOCC3)nc2cc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '12.04', 'le': '0.22', 'lle': '2.77', 'sei': '5.48'}",CHEMBL4544284,,CHEMBL4544284,5.52,False,http://www.openphacts.org/units/Nanomolar,3180774,=,1,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3000.0
4318,Not Determined,19064635,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc2cc[nH]c2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL3976860,,CHEMBL3976860,,False,,3180775,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4319,,19064636,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2[nH]cnc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.56', 'le': '0.31', 'lle': '4.41', 'sei': '5.82'}",CHEMBL4554579,,CHEMBL4554579,6.48,False,http://www.openphacts.org/units/Nanomolar,3180776,=,1,True,=,,IC50,nM,,330.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,330.0
4320,,19064637,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2[nH]c(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '13.85', 'le': '0.26', 'lle': '4.70', 'sei': '5.33'}",CHEMBL4460055,,CHEMBL4460055,6.60,False,http://www.openphacts.org/units/Nanomolar,3180777,=,1,True,=,,IC50,nM,,250.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,250.0
4321,,19064638,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1c(N2CCOCC2)nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc21,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '14.30', 'le': '0.27', 'lle': '5.10', 'sei': '6.20'}",CHEMBL4483477,,CHEMBL4483477,7.01,False,http://www.openphacts.org/units/Nanomolar,3180778,=,1,True,=,,IC50,nM,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,97.0
4322,,19064639,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CCn1c(N2CCOCC2)nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc21,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '11.97', 'le': '0.22', 'lle': '3.64', 'sei': '5.34'}",CHEMBL4436128,,CHEMBL4436128,6.04,False,http://www.openphacts.org/units/Nanomolar,3180779,=,1,True,=,,IC50,nM,,910.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,910.0
4323,,19064640,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '15.12', 'le': '0.28', 'lle': '5.05', 'sei': '5.96'}",CHEMBL4515682,,CHEMBL4515682,7.22,False,http://www.openphacts.org/units/Nanomolar,3180780,=,1,True,=,,IC50,nM,,60.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,60.0
4324,,19064641,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.40', 'le': '0.32', 'lle': '5.46', 'sei': '7.49'}",CHEMBL4474636,,CHEMBL4474636,8.10,False,http://www.openphacts.org/units/Nanomolar,3180781,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
4325,,19064642,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)c1nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc2s1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.11', 'le': '0.31', 'lle': '4.41', 'sei': '7.36'}",CHEMBL4464832,,CHEMBL4464832,7.28,False,http://www.openphacts.org/units/Nanomolar,3180782,=,1,True,=,,IC50,nM,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,53.0
4326,,19064643,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCOCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '15.29', 'le': '0.29', 'lle': '4.86', 'sei': '7.33'}",CHEMBL4568867,,CHEMBL4568867,7.12,False,http://www.openphacts.org/units/Nanomolar,3180783,=,1,True,=,,IC50,nM,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,76.0
4327,,19064644,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '17.21', 'le': '0.32', 'lle': '4.24', 'sei': '8.36'}",CHEMBL4473269,,CHEMBL4473269,6.77,False,http://www.openphacts.org/units/Nanomolar,3180784,=,1,True,=,,IC50,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,170.0
4328,,19064645,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(CO)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '17.60', 'le': '0.33', 'lle': '4.52', 'sei': '8.07'}",CHEMBL4467170,,CHEMBL4467170,7.42,False,http://www.openphacts.org/units/Nanomolar,3180745,=,1,True,=,,IC50,nM,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,38.0
4329,,19064646,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4c(O)ccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4463353,,CHEMBL4463353,,False,http://www.openphacts.org/units/Nanomolar,3180746,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20000.0
4330,,19064647,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(O)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '15.83', 'le': '0.30', 'lle': '4.24', 'sei': '6.40'}",CHEMBL4466092,,CHEMBL4466092,6.48,False,http://www.openphacts.org/units/Nanomolar,3180747,=,1,True,=,,IC50,nM,,330.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,330.0
4331,,19064648,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(OC(F)F)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4474664,,CHEMBL4474664,,False,http://www.openphacts.org/units/Nanomolar,3180748,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20000.0
4332,,19064649,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C(F)F)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '13.35', 'le': '0.25', 'lle': '2.45', 'sei': '7.31'}",CHEMBL4462969,,CHEMBL4462969,5.92,False,http://www.openphacts.org/units/Nanomolar,3180749,=,1,True,=,,IC50,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1200.0
4333,,19064650,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C5CC5)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4550566,,CHEMBL4550566,,False,http://www.openphacts.org/units/Nanomolar,3180750,>,1,True,>,,IC50,nM,,20000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,20000.0
4334,,19064651,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C#N)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.91', 'le': '0.31', 'lle': '4.68', 'sei': '6.75'}",CHEMBL4456286,,CHEMBL4456286,7.08,False,http://www.openphacts.org/units/Nanomolar,3180751,=,1,True,=,,IC50,nM,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,84.0
4335,,19064652,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(C(N)=O)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.61', 'le': '0.31', 'lle': '5.62', 'sei': '5.84'}",CHEMBL4520118,,CHEMBL4520118,7.25,False,http://www.openphacts.org/units/Nanomolar,3180752,=,1,True,=,,IC50,nM,,56.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,56.0
4336,,19064653,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cc(CO)cnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.96', 'le': '0.32', 'lle': '5.16', 'sei': '7.09'}",CHEMBL4518559,,CHEMBL4518559,7.18,False,http://www.openphacts.org/units/Nanomolar,3180753,=,1,True,=,,IC50,nM,,66.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,66.0
4337,,19064654,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.16', 'le': '0.33', 'lle': '3.55', 'sei': '9.55'}",CHEMBL4459509,,CHEMBL4459509,6.85,False,http://www.openphacts.org/units/Nanomolar,3180754,=,1,True,=,,IC50,nM,,140.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,140.0
4338,,19064655,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCNCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '18.48', 'le': '0.34', 'lle': '5.15', 'sei': '8.65'}",CHEMBL4569547,,CHEMBL4569547,7.25,False,http://www.openphacts.org/units/Nanomolar,3180755,=,1,True,=,,IC50,nM,,56.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,56.0
4339,,19064656,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(C(O)C(F)(F)F)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '14.81', 'le': '0.28', 'lle': '3.42', 'sei': '7.88'}",CHEMBL4452936,,CHEMBL4452936,7.25,False,http://www.openphacts.org/units/Nanomolar,3180756,=,1,True,=,,IC50,nM,,56.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,56.0
4340,,19064657,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(C(N)=O)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.75', 'le': '0.31', 'lle': '4.88', 'sei': '6.33'}",CHEMBL4461516,,CHEMBL4461516,7.28,False,http://www.openphacts.org/units/Nanomolar,3180757,=,1,True,=,,IC50,nM,,53.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,53.0
4341,,19064658,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCC(O)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.34', 'le': '0.30', 'lle': '3.84', 'sei': '7.49'}",CHEMBL4531013,,CHEMBL4531013,6.89,False,http://www.openphacts.org/units/Nanomolar,3180758,=,1,True,=,,IC50,nM,,130.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,130.0
4342,,19064659,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CCO)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.07', 'le': '0.30', 'lle': '5.20', 'sei': '7.36'}",CHEMBL4584820,,CHEMBL4584820,7.01,False,http://www.openphacts.org/units/Nanomolar,3180759,=,1,True,=,,IC50,nM,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,97.0
4343,,19064660,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(N)=O)CC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.91', 'le': '0.31', 'lle': '6.30', 'sei': '6.44'}",CHEMBL4483551,,CHEMBL4483551,7.60,False,http://www.openphacts.org/units/Nanomolar,3180760,=,1,True,=,,IC50,nM,,25.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,25.0
4344,,19064661,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)CN1CCN(c2cc3c(cc2NC(=O)c2cnn4cccnc24)CC(C)(C)O3)CC1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '15.58', 'le': '0.29', 'lle': '5.66', 'sei': '6.94'}",CHEMBL4438027,,CHEMBL4438027,7.22,False,http://www.openphacts.org/units/Nanomolar,3180761,=,1,True,=,,IC50,nM,,60.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,60.0
4345,,19064662,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '16.53', 'le': '0.31', 'lle': '5.27', 'sei': '6.69'}",CHEMBL4466517,,CHEMBL4466517,6.77,False,http://www.openphacts.org/units/Nanomolar,3180762,=,1,True,=,,IC50,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,170.0
4346,,19064663,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '15.77', 'le': '0.29', 'lle': '4.96', 'sei': '6.38'}",CHEMBL4439253,,CHEMBL4439253,6.46,False,http://www.openphacts.org/units/Nanomolar,3180763,=,1,True,=,,IC50,nM,,350.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,350.0
4347,,19064664,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(O)[C@]1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '15.47', 'le': '0.29', 'lle': '4.49', 'sei': '6.69'}",CHEMBL4576141,,CHEMBL4576141,6.77,False,http://www.openphacts.org/units/Nanomolar,3180764,=,1,True,=,,IC50,nM,,170.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,170.0
4348,,19064665,[],CHEMBL4359943,Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1CCC2(CC1)Cc1cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc1O2,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '14.80', 'le': '0.27', 'lle': '4.42', 'sei': '7.88'}",CHEMBL4524886,,CHEMBL4524886,6.64,False,http://www.openphacts.org/units/Nanomolar,3180765,=,1,True,=,,IC50,nM,,230.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,230.0
4349,,19064668,[],CHEMBL4359945,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CN(C)c1nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc2s1,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4464832,,CHEMBL4464832,,False,http://qudt.org/vocab/unit#Percent,3180782,>=,1,True,>=,,Inhibition,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,70.0
4350,,19064669,[],CHEMBL4359945,Inhibition of human recombinant full length His6-tagged IRAK4 expressed in baculovirus expression system at 1 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCOCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4568867,,CHEMBL4568867,,False,http://qudt.org/vocab/unit#Percent,3180783,>=,1,True,>=,,Inhibition,%,,70.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,70.0
4351,,19064776,[],CHEMBL4360009,Inhibition of recombinant IRAK4 (unknown origin) using KKARFSRFAGSSPSQSSMVAR as substrate in presence of [gamma33P]-ATP by liquid scintillation counting method,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc2ccccc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.52', 'le': '0.35', 'lle': '3.07', 'sei': '9.07'}",CHEMBL3979848,,CHEMBL3979848,6.21,False,http://www.openphacts.org/units/Nanomolar,3180769,=,1,True,=,,Ki,nM,,610.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,610.0
4352,,19064777,[],CHEMBL4360009,Inhibition of recombinant IRAK4 (unknown origin) using KKARFSRFAGSSPSQSSMVAR as substrate in presence of [gamma33P]-ATP by liquid scintillation counting method,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc2cccnc2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,,CHEMBL4567291,,CHEMBL4567291,,False,http://www.openphacts.org/units/Nanomolar,3180770,>,1,True,>,,Ki,nM,,30000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,30000.0
4353,,19064778,[],CHEMBL4360009,Inhibition of recombinant IRAK4 (unknown origin) using KKARFSRFAGSSPSQSSMVAR as substrate in presence of [gamma33P]-ATP by liquid scintillation counting method,B,,,BAO_0000192,BAO_0000357,single protein format,O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '21.74', 'le': '0.39', 'lle': '4.58', 'sei': '10.74'}",CHEMBL4569648,,CHEMBL4569648,8.10,False,http://www.openphacts.org/units/Nanomolar,3180771,=,1,True,=,,Ki,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,8.0
4354,,19064779,[],CHEMBL4360009,Inhibition of recombinant IRAK4 (unknown origin) using KKARFSRFAGSSPSQSSMVAR as substrate in presence of [gamma33P]-ATP by liquid scintillation counting method,B,,,BAO_0000192,BAO_0000357,single protein format,COc1cc2cc[nH]c2cc1NC(=O)c1cnn2cccnc12,,,CHEMBL4359811,J Med Chem,2019.0,"{'bei': '19.86', 'le': '0.36', 'lle': '3.63', 'sei': '7.24'}",CHEMBL3976860,,CHEMBL3976860,6.10,False,http://www.openphacts.org/units/Nanomolar,3180775,=,1,True,=,,Ki,nM,,790.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ki,nM,UO_0000065,,790.0
4355,,19071915,[],CHEMBL4361896,Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(Br)c2cc1C(N)=O,,,CHEMBL4359855,ACS Med Chem Lett,2019.0,"{'bei': '22.01', 'le': '0.49', 'lle': '6.92', 'sei': '8.38'}",CHEMBL4536517,,CHEMBL4536517,8.68,False,http://www.openphacts.org/units/Nanomolar,3181937,=,1,True,=,,IC50,nM,,2.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.1
4356,,19071942,[],CHEMBL4361896,Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCOCCOCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)c2cc1C(N)=O,,,CHEMBL4359855,ACS Med Chem Lett,2019.0,"{'bei': '10.12', 'le': '0.19', 'lle': '6.51', 'sei': '3.93'}",CHEMBL4524299,,CHEMBL4524299,9.54,False,http://www.openphacts.org/units/Nanomolar,3181938,=,1,True,=,,IC50,nM,,0.29,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.29
4357,,19071943,[],CHEMBL4361896,Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)c2cc1C(N)=O,,,CHEMBL4359855,ACS Med Chem Lett,2019.0,"{'bei': '10.69', 'le': '0.20', 'lle': '3.51', 'sei': '4.65'}",CHEMBL4448950,,CHEMBL4448950,10.00,False,http://www.openphacts.org/units/Nanomolar,3181939,=,1,True,=,,IC50,nM,,0.099,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.099
4358,Not Determined,19071944,[],CHEMBL4361896,Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCOCCOCCOCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)c2cc1C(N)=O,,,CHEMBL4359855,ACS Med Chem Lett,2019.0,,CHEMBL4462890,,CHEMBL4462890,,False,,3181940,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4359,,19071945,[],CHEMBL4361896,Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCCCCCCCCCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)c2cc1C(N)=O,,,CHEMBL4359855,ACS Med Chem Lett,2019.0,"{'bei': '11.44', 'le': '0.21', 'lle': '4.26', 'sei': '4.38'}",CHEMBL4445579,,CHEMBL4445579,8.60,False,http://www.openphacts.org/units/Nanomolar,3181941,=,1,True,=,,IC50,nM,,2.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.5
4360,,19071946,[],CHEMBL4361896,Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCOCCOCCOCC#Cc2cnc(OC[C@@H]3CCC(=O)N3)c3cc(OC)c(C(N)=O)cc23)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C1CCCCC1,,,CHEMBL4359855,ACS Med Chem Lett,2019.0,"{'bei': '10.71', 'le': '0.20', 'lle': '7.92', 'sei': '4.25'}",CHEMBL4443947,,CHEMBL4443947,10.66,False,http://www.openphacts.org/units/Nanomolar,3181942,=,1,True,=,,IC50,nM,,0.022,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,0.022
4361,,19071947,[],CHEMBL4361896,Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCCCCCCCCCC#Cc2cnc(OC[C@@H]3CCC(=O)N3)c3cc(OC)c(C(N)=O)cc23)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C1CCCCC1,,,CHEMBL4359855,ACS Med Chem Lett,2019.0,"{'bei': '7.76', 'le': '0.15', 'lle': '1.48', 'sei': '3.44'}",CHEMBL4582179,,CHEMBL4582179,7.68,False,http://www.openphacts.org/units/Nanomolar,3181943,=,1,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
4362,,19090197,[],CHEMBL4365771,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1,,,CHEMBL4364269,Eur J Med Chem,2019.0,,CHEMBL4436895,,CHEMBL4436895,,False,http://qudt.org/vocab/unit#Percent,3184800,=,1,False,=,,Activity,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,95.0
4363,,19091964,[],CHEMBL4366438,Inhibition of human IRAK4 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4364276,Eur J Med Chem,2019.0,,CHEMBL4528675,,CHEMBL4528675,,False,http://qudt.org/vocab/unit#Percent,3185010,=,1,True,=,,Inhibition,%,,-17.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-17.2
4364,,19159460,[],CHEMBL4382564,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,,,CHEMBL4382192,Eur J Med Chem,2017.0,,CHEMBL4473365,,CHEMBL4473365,,False,http://qudt.org/vocab/unit#Percent,3197524,=,1,False,=,,Activity,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,96.0
4365,,19181054,[],CHEMBL4387265,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,,,CHEMBL4385643,Bioorg Med Chem Lett,2019.0,,CHEMBL3301610,ABEMACICLIB,CHEMBL3301610,,False,http://qudt.org/vocab/unit#Percent,3201546,=,1,True,=,,Inhibition,%,,9.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,9.0
4366,,19181280,[],CHEMBL4387265,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,,,CHEMBL4385643,Bioorg Med Chem Lett,2019.0,,CHEMBL4545456,,CHEMBL4545456,,False,http://qudt.org/vocab/unit#Percent,3201567,=,1,True,=,,Inhibition,%,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,3.5
4367,,19191547,[],CHEMBL4389283,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1,,,CHEMBL4387741,Bioorg Med Chem,2019.0,,CHEMBL4555459,,CHEMBL4555459,,False,http://qudt.org/vocab/unit#Percent,3203184,=,1,True,=,,Inhibition,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,85.0
4368,,19191946,[],CHEMBL4389760,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control,B,,,BAO_0000201,BAO_0000019,assay format,O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1,,,CHEMBL4387741,Bioorg Med Chem,2019.0,,CHEMBL4564973,,CHEMBL4564973,,False,http://qudt.org/vocab/unit#Percent,3203185,=,1,True,=,,Inhibition,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,91.0
4369,,19200202,[],CHEMBL4391386,Binding affinity to wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,B,,,BAO_0001103,BAO_0000019,assay format,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,,,CHEMBL4390652,Eur J Med Chem,2019.0,,CHEMBL4559936,,CHEMBL4559936,,False,http://qudt.org/vocab/unit#Percent,3204733,=,1,False,=,,Activity,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Activity,%,UO_0000187,,93.0
4370,,19225470,[],CHEMBL4395890,Inhibition of human recombinant IRAK4 at 1 uM using Ulight-FLGFTYVAP as substrate measured after 90 mins in presence of ATP by LANCE assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1,,,CHEMBL4393708,Eur J Med Chem,2019.0,,CHEMBL4536012,,CHEMBL4536012,,False,http://qudt.org/vocab/unit#Percent,3209098,=,1,True,=,,Inhibition,%,,2.96,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.96
4371,,19230934,[],CHEMBL4397174,Inhibition of IRAK4 (unknown origin) at 100 nM by [gamma-33P]ATP-based radiometric or Alphascreen assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1,,,CHEMBL4396868,J Med Chem,2019.0,,CHEMBL4440381,,CHEMBL4440381,,False,http://qudt.org/vocab/unit#Percent,3210186,=,1,True,=,,Inhibition,%,,-7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,-7.0
4372,,19266460,[],CHEMBL4405410,Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control,B,,,BAO_0000201,BAO_0000019,assay format,CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1,,,CHEMBL4402587,J Med Chem,2020.0,,CHEMBL4455923,,CHEMBL4455923,,False,http://qudt.org/vocab/unit#Percent,3217153,<,1,True,<,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
4373,,19412463,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL3353206,,CHEMBL3353206,,False,,3244691,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4374,,19412464,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3cncc(Cl)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4559589,,CHEMBL4559589,,False,,3244685,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4375,,19412465,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccc(C4CC4)nc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4436908,,CHEMBL4436908,,False,,3244684,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4376,,19412466,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC(F)(F)F)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4473472,,CHEMBL4473472,,False,,3244680,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4377,,19412467,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(N)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4447180,,CHEMBL4447180,,False,,3244679,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4378,,19412468,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,CN(C)[C@H]1CN(C(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C[C@@H]1O,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4518357,,CHEMBL4518357,,False,,3244670,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4379,,19412469,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CC(CN)C2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4434908,,CHEMBL4434908,,False,,3244669,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4380,,19412470,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4473656,,CHEMBL4473656,,False,,3244660,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4381,,19412471,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4523017,,CHEMBL4523017,,False,,3244659,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4382,,19412472,[],CHEMBL4427863,Ratio of IC50 for IRAK4 inhibition in human THP1-XBlue cells to IC50 for inhibition of human IRAK4,B,,,BAO_0000179,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4459066,,CHEMBL4459066,,False,,3244655,<=,1,False,<=,,Ratio IC50,,,3.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,Ratio IC50,,,,3.0
4383,,19412500,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '21.09', 'le': '0.39', 'lle': '6.29', 'sei': '5.68'}",CHEMBL3353206,,CHEMBL3353206,6.86,False,http://www.openphacts.org/units/Nanomolar,3244691,=,1,True,=,,IC50,nM,,138.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,138.0
4384,,19412501,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3cncc(Cl)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '18.76', 'le': '0.37', 'lle': '4.81', 'sei': '5.78'}",CHEMBL4559589,,CHEMBL4559589,6.70,False,http://www.openphacts.org/units/Nanomolar,3244685,=,1,True,=,,IC50,nM,,202.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,202.0
4385,,19412502,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccc(C4CC4)nc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '17.97', 'le': '0.33', 'lle': '4.40', 'sei': '5.62'}",CHEMBL4436908,,CHEMBL4436908,6.51,False,http://www.openphacts.org/units/Nanomolar,3244684,=,1,True,=,,IC50,nM,,307.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,307.0
4386,,19412503,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC(F)(F)F)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '15.57', 'le': '0.30', 'lle': '4.33', 'sei': '5.11'}",CHEMBL4473472,,CHEMBL4473472,6.53,False,http://www.openphacts.org/units/Nanomolar,3244680,=,1,True,=,,IC50,nM,,294.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,294.0
4387,,19412504,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(N)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '19.53', 'le': '0.36', 'lle': '5.78', 'sei': '4.64'}",CHEMBL4447180,,CHEMBL4447180,6.59,False,http://www.openphacts.org/units/Nanomolar,3244679,=,1,True,=,,IC50,nM,,259.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,259.0
4388,,19412505,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CN(C(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C[C@@H]1O,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '12.43', 'le': '0.23', 'lle': '4.57', 'sei': '4.88'}",CHEMBL4518357,,CHEMBL4518357,6.27,False,http://www.openphacts.org/units/Nanomolar,3244670,=,1,True,=,,IC50,nM,,533.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,533.0
4389,,19412506,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CC(CN)C2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '13.73', 'le': '0.25', 'lle': '4.34', 'sei': '4.82'}",CHEMBL4434908,,CHEMBL4434908,6.32,False,http://www.openphacts.org/units/Nanomolar,3244669,=,1,True,=,,IC50,nM,,477.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,477.0
4390,,19412507,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '16.31', 'le': '0.30', 'lle': '3.71', 'sei': '5.54'}",CHEMBL4473656,,CHEMBL4473656,6.37,False,http://www.openphacts.org/units/Nanomolar,3244660,=,1,True,=,,IC50,nM,,428.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,428.0
4391,,19412508,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '17.30', 'le': '0.32', 'lle': '4.72', 'sei': '5.30'}",CHEMBL4523017,,CHEMBL4523017,6.77,False,http://www.openphacts.org/units/Nanomolar,3244659,=,1,True,=,,IC50,nM,,169.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,169.0
4392,,19412509,[],CHEMBL4427853,Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '18.47', 'le': '0.35', 'lle': '7.60', 'sei': '5.04'}",CHEMBL4459066,,CHEMBL4459066,6.82,False,http://www.openphacts.org/units/Nanomolar,3244655,=,1,True,=,,IC50,nM,,150.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,150.0
4393,,19412510,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '22.88', 'le': '0.42', 'lle': '6.87', 'sei': '6.17'}",CHEMBL3353206,,CHEMBL3353206,7.44,False,http://www.openphacts.org/units/Nanomolar,3244691,=,1,True,=,,IC50,nM,,36.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,36.0
4394,,19412511,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccsc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '19.54', 'le': '0.38', 'lle': '4.51', 'sei': '6.22'}",CHEMBL4436754,,CHEMBL4436754,6.40,False,http://www.openphacts.org/units/Nanomolar,3244690,=,1,True,=,,IC50,nM,,401.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,401.0
4395,,19412512,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-n3cccc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '19.93', 'le': '0.37', 'lle': '5.23', 'sei': '5.74'}",CHEMBL4518902,,CHEMBL4518902,6.18,False,http://www.openphacts.org/units/Nanomolar,3244689,=,1,True,=,,IC50,nM,,653.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,653.0
4396,,19412513,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccccc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '16.92', 'le': '0.31', 'lle': '3.61', 'sei': '5.28'}",CHEMBL4475493,,CHEMBL4475493,5.44,False,http://www.openphacts.org/units/Nanomolar,3244688,=,1,True,=,,IC50,nM,,3649.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3649.0
4397,,19412514,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccc(N4CCOCC4)nc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '14.62', 'le': '0.27', 'lle': '4.90', 'sei': '4.65'}",CHEMBL4561018,,CHEMBL4561018,5.96,False,http://www.openphacts.org/units/Nanomolar,3244687,=,1,True,=,,IC50,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1100.0
4398,,19412515,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3cnccc3Cl)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '17.28', 'le': '0.34', 'lle': '4.29', 'sei': '5.32'}",CHEMBL4467632,,CHEMBL4467632,6.17,False,http://www.openphacts.org/units/Nanomolar,3244686,=,1,True,=,,IC50,nM,,683.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,683.0
4399,,19412516,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3cncc(Cl)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '19.55', 'le': '0.38', 'lle': '5.09', 'sei': '6.02'}",CHEMBL4559589,,CHEMBL4559589,6.97,False,http://www.openphacts.org/units/Nanomolar,3244685,=,1,True,=,,IC50,nM,,106.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,106.0
4400,,19412517,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccc(C4CC4)nc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '19.09', 'le': '0.35', 'lle': '4.81', 'sei': '5.97'}",CHEMBL4436908,,CHEMBL4436908,6.92,False,http://www.openphacts.org/units/Nanomolar,3244684,=,1,True,=,,IC50,nM,,121.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,121.0
4401,,19412518,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3cccnc3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '20.70', 'le': '0.38', 'lle': '5.44', 'sei': '5.76'}",CHEMBL4534461,,CHEMBL4534461,6.67,False,http://www.openphacts.org/units/Nanomolar,3244683,=,1,True,=,,IC50,nM,,212.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,212.0
4402,,19412519,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CCOCC4)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '14.51', 'le': '0.27', 'lle': '4.25', 'sei': '4.61'}",CHEMBL4536303,,CHEMBL4536303,6.32,False,http://www.openphacts.org/units/Nanomolar,3244682,=,1,True,=,,IC50,nM,,478.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,478.0
4403,,19412520,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COCCNc1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)ccn1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '17.02', 'le': '0.32', 'lle': '5.44', 'sei': '4.91'}",CHEMBL4530226,,CHEMBL4530226,6.73,False,http://www.openphacts.org/units/Nanomolar,3244681,=,1,True,=,,IC50,nM,,187.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,187.0
4404,,19412521,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC(F)(F)F)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '16.44', 'le': '0.31', 'lle': '4.69', 'sei': '5.39'}",CHEMBL4473472,,CHEMBL4473472,6.89,False,http://www.openphacts.org/units/Nanomolar,3244680,=,1,True,=,,IC50,nM,,128.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,128.0
4405,,19412522,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(N)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '20.74', 'le': '0.38', 'lle': '6.19', 'sei': '4.93'}",CHEMBL4447180,,CHEMBL4447180,7.00,False,http://www.openphacts.org/units/Nanomolar,3244679,=,1,True,=,,IC50,nM,,101.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,101.0
4406,,19412523,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(N3CCNCC3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '16.58', 'le': '0.31', 'lle': '5.88', 'sei': '4.62'}",CHEMBL4537124,,CHEMBL4537124,5.46,False,http://www.openphacts.org/units/Nanomolar,3244678,=,1,True,=,,IC50,nM,,3452.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3452.0
4407,,19412524,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCCn2cccn2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '11.48', 'le': '0.21', 'lle': '2.99', 'sei': '4.23'}",CHEMBL4473420,,CHEMBL4473420,5.57,False,http://www.openphacts.org/units/Nanomolar,3244677,=,1,True,=,,IC50,nM,,2677.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2677.0
4408,,19412525,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ncc[nH]2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '12.29', 'le': '0.23', 'lle': '3.19', 'sei': '4.07'}",CHEMBL4570872,,CHEMBL4570872,5.79,False,http://www.openphacts.org/units/Nanomolar,3244676,=,1,True,=,,IC50,nM,,1605.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1605.0
4409,,19412526,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)Nc2cncnc2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '12.35', 'le': '0.23', 'lle': '2.81', 'sei': '4.15'}",CHEMBL4545955,,CHEMBL4545955,5.80,False,http://www.openphacts.org/units/Nanomolar,3244675,=,1,True,=,,IC50,nM,,1582.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1582.0
4410,,19412527,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ccncn2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '11.08', 'le': '0.20', 'lle': '2.69', 'sei': '3.84'}",CHEMBL4472720,,CHEMBL4472720,5.36,False,http://www.openphacts.org/units/Nanomolar,3244674,=,1,True,=,,IC50,nM,,4381.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4381.0
4411,,19412528,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ccncc2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4546753,,CHEMBL4546753,,False,http://www.openphacts.org/units/Nanomolar,3244673,>,1,True,>,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
4412,,19412529,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ccccc2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4559539,,CHEMBL4559539,,False,http://www.openphacts.org/units/Nanomolar,3244672,>,1,True,>,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
4413,,19412530,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CCC(O)C2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4463887,,CHEMBL4463887,,False,http://www.openphacts.org/units/Nanomolar,3244671,>,1,True,>,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
4414,,19412531,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)[C@H]1CN(C(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C[C@@H]1O,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '13.32', 'le': '0.25', 'lle': '5.02', 'sei': '5.23'}",CHEMBL4518357,,CHEMBL4518357,6.72,False,http://www.openphacts.org/units/Nanomolar,3244670,=,1,True,=,,IC50,nM,,190.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,190.0
4415,,19412532,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CC(CN)C2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '14.59', 'le': '0.27', 'lle': '4.74', 'sei': '5.13'}",CHEMBL4434908,,CHEMBL4434908,6.72,False,http://www.openphacts.org/units/Nanomolar,3244669,=,1,True,=,,IC50,nM,,191.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,191.0
4416,,19412533,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCCC(CNC(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '13.10', 'le': '0.24', 'lle': '3.56', 'sei': '5.62'}",CHEMBL4466893,,CHEMBL4466893,6.58,False,http://www.openphacts.org/units/Nanomolar,3244668,=,1,True,=,,IC50,nM,,261.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,261.0
4417,,19412534,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCC(CNC(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '12.56', 'le': '0.23', 'lle': '3.51', 'sei': '5.24'}",CHEMBL4472816,,CHEMBL4472816,6.14,False,http://www.openphacts.org/units/Nanomolar,3244667,=,1,True,=,,IC50,nM,,730.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,730.0
4418,,19412549,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCCCCNC(=O)c1nn(C)cc1NC(=O)c1cccc(-c2ccnc(NCC3CC3)c2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '11.21', 'le': '0.21', 'lle': '2.25', 'sei': '4.83'}",CHEMBL4435482,,CHEMBL4435482,5.66,False,http://www.openphacts.org/units/Nanomolar,3244666,=,1,True,=,,IC50,nM,,2197.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2197.0
4419,,19412550,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCCNC(=O)c1nn(C)cc1NC(=O)c1cccc(-c2ccnc(NCC3CC3)c2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '13.15', 'le': '0.24', 'lle': '3.64', 'sei': '5.35'}",CHEMBL4466563,,CHEMBL4466563,6.27,False,http://www.openphacts.org/units/Nanomolar,3244665,=,1,True,=,,IC50,nM,,542.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,542.0
4420,,19412551,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NC2CCCC2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4452662,,CHEMBL4452662,,False,http://www.openphacts.org/units/Nanomolar,3244664,>,1,True,>,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
4421,,19412552,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)CNC(=O)c1nn(C)cc1NC(=O)c1cccc(-c2ccnc(NCC3CC3)c2)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4463551,,CHEMBL4463551,,False,http://www.openphacts.org/units/Nanomolar,3244663,>,1,True,>,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
4422,,19412553,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c1C(N)=O,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '14.22', 'le': '0.26', 'lle': '3.51', 'sei': '4.35'}",CHEMBL4446042,,CHEMBL4446042,5.57,False,http://www.openphacts.org/units/Nanomolar,3244662,=,1,True,=,,IC50,nM,,2725.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2725.0
4423,,19412554,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2ccnc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '16.68', 'le': '0.31', 'lle': '5.10', 'sei': '4.65'}",CHEMBL4535152,,CHEMBL4535152,6.54,False,http://www.openphacts.org/units/Nanomolar,3244661,=,1,True,=,,IC50,nM,,285.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,285.0
4424,,19412555,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '17.23', 'le': '0.32', 'lle': '4.07', 'sei': '5.85'}",CHEMBL4473656,,CHEMBL4473656,6.73,False,http://www.openphacts.org/units/Nanomolar,3244660,=,1,True,=,,IC50,nM,,187.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,187.0
4425,,19412556,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '18.22', 'le': '0.34', 'lle': '5.08', 'sei': '5.58'}",CHEMBL4523017,,CHEMBL4523017,7.13,False,http://www.openphacts.org/units/Nanomolar,3244659,=,1,True,=,,IC50,nM,,74.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,74.0
4426,,19412557,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2ccnc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '14.92', 'le': '0.27', 'lle': '3.79', 'sei': '4.57'}",CHEMBL4526990,,CHEMBL4526990,5.84,False,http://www.openphacts.org/units/Nanomolar,3244658,=,1,True,=,,IC50,nM,,1449.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1449.0
4427,,19412558,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cc(-c3ccnc(NCC4CC4)c3)ccn2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,,CHEMBL4456105,,CHEMBL4456105,,False,http://www.openphacts.org/units/Nanomolar,3244657,>,1,True,>,,IC50,nM,,5000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5000.0
4428,,19412559,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cncc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '15.22', 'le': '0.28', 'lle': '3.91', 'sei': '4.66'}",CHEMBL4467839,,CHEMBL4467839,5.96,False,http://www.openphacts.org/units/Nanomolar,3244656,=,1,True,=,,IC50,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1100.0
4429,,19412560,[],CHEMBL4427852,Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(N)=O)n1,,,CHEMBL4425185,Bioorg Med Chem Lett,2016.0,"{'bei': '20.09', 'le': '0.38', 'lle': '8.20', 'sei': '5.48'}",CHEMBL4459066,,CHEMBL4459066,7.42,False,http://www.openphacts.org/units/Nanomolar,3244655,=,1,True,=,,IC50,nM,,38.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,38.0
4430,,19474310,[],CHEMBL4479304,Inhibition of human IRAK4,B,,,BAO_0000201,BAO_0000357,single protein format,CCC(=O)Nc1nc(C)c(-c2csc(Nc3cc(OC)ccc3OC)n2)s1,,,CHEMBL4477233,Bioorg Med Chem Lett,2016.0,,CHEMBL4537058,,CHEMBL4537058,,False,http://qudt.org/vocab/unit#Percent,3256412,>,1,True,>,,Inhibition,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,50.0
4431,,19476584,[],CHEMBL4479732,Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,"{'bei': '12.61', 'le': '0.25', 'lle': '1.40', 'sei': '9.31'}",CHEMBL4569508,,CHEMBL4569508,6.68,False,http://www.openphacts.org/units/Nanomolar,3256955,=,1,True,=,,IC50,nM,,210.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,210.0
4432,,19476684,[],CHEMBL4479732,Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,"{'bei': '17.70', 'le': '0.35', 'lle': '4.04', 'sei': '9.33'}",CHEMBL4550702,,CHEMBL4550702,7.19,False,http://www.openphacts.org/units/Nanomolar,3256963,=,1,True,=,,IC50,nM,,64.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,64.0
4433,,19476784,[],CHEMBL4479732,Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,"{'bei': '18.12', 'le': '0.35', 'lle': '4.78', 'sei': '7.41'}",CHEMBL4568087,,CHEMBL4568087,7.64,False,http://www.openphacts.org/units/Nanomolar,3256973,=,1,True,=,,IC50,nM,,23.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,23.0
4434,,19476884,[],CHEMBL4479732,Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12,,,CHEMBL4477252,Bioorg Med Chem Lett,2016.0,"{'bei': '12.97', 'le': '0.27', 'lle': '1.86', 'sei': '6.47'}",CHEMBL4552628,,CHEMBL4552628,5.52,False,http://www.openphacts.org/units/Nanomolar,3256981,=,1,True,=,,IC50,nM,,3000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3000.0
4435,,20599555,[],CHEMBL4603083,Inhibition of human IRAK4 at 1 uM relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,Cn1nc2c3c(cc(-c4ccnc(N)n4)cc31)Oc1ccccc1N2,,,CHEMBL4602607,J Med Chem,2020.0,,CHEMBL4638884,,CHEMBL4638884,,False,http://qudt.org/vocab/unit#Percent,3465071,=,1,True,=,,Inhibition,%,,30.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,30.0
4436,,20600555,[],CHEMBL4603507,Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C,,,CHEMBL4602617,Bioorg Med Chem Lett,2020.0,,CHEMBL4634634,,CHEMBL4634634,,False,http://www.openphacts.org/units/Nanomolar,3465297,>,1,True,>,,IC50,nM,,100000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,uM,UO_0000065,,100.0
4437,,20601675,[],CHEMBL4603807,Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12,,,CHEMBL4602634,Eur J Med Chem,2020.0,,CHEMBL4646281,,CHEMBL4646281,,False,http://qudt.org/vocab/unit#Percent,3465563,=,1,True,=,,Inhibition,%,,2.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,INH,%,UO_0000187,,2.0
4438,,20691673,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '18.53', 'le': '0.36', 'lle': '5.03', 'sei': '6.97'}",CHEMBL4075955,,CHEMBL4075955,8.33,False,http://www.openphacts.org/units/Nanomolar,3485137,=,1,True,=,,IC50,nM,,4.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.7
4439,,20691674,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '18.36', 'le': '0.35', 'lle': '4.15', 'sei': '8.03'}",CHEMBL4079743,,CHEMBL4079743,7.96,False,http://www.openphacts.org/units/Nanomolar,3485138,=,1,True,=,,IC50,nM,,11.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,11.0
4440,,20691675,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '22.49', 'le': '0.44', 'lle': '4.07', 'sei': '9.73'}",CHEMBL4633251,,CHEMBL4633251,7.68,False,http://www.openphacts.org/units/Nanomolar,3485139,=,1,True,=,,IC50,nM,,21.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,21.0
4441,,20691676,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '16.14', 'le': '0.32', 'lle': '4.36', 'sei': '5.93'}",CHEMBL4636136,,CHEMBL4636136,8.24,False,http://www.openphacts.org/units/Nanomolar,3485140,=,1,True,=,,IC50,nM,,5.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.7
4442,,20691677,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '22.01', 'le': '0.43', 'lle': '3.82', 'sei': '9.91'}",CHEMBL4639599,,CHEMBL4639599,7.82,False,http://www.openphacts.org/units/Nanomolar,3485141,=,1,True,=,,IC50,nM,,15.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,15.0
4443,,20691678,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '21.44', 'le': '0.42', 'lle': '3.52', 'sei': '10.03'}",CHEMBL4644871,,CHEMBL4644871,7.92,False,http://www.openphacts.org/units/Nanomolar,3485142,=,1,True,=,,IC50,nM,,12.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12.0
4444,,20691679,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '21.26', 'le': '0.41', 'lle': '3.36', 'sei': '10.33'}",CHEMBL4632511,,CHEMBL4632511,8.15,False,http://www.openphacts.org/units/Nanomolar,3485143,=,1,True,=,,IC50,nM,,7.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,7.0
4445,,20691680,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCCO,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '19.77', 'le': '0.39', 'lle': '4.25', 'sei': '7.68'}",CHEMBL4648225,,CHEMBL4648225,7.62,False,http://www.openphacts.org/units/Nanomolar,3485144,=,1,True,=,,IC50,nM,,24.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,24.0
4446,,20691681,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '20.28', 'le': '0.39', 'lle': '4.24', 'sei': '8.46'}",CHEMBL4649875,,CHEMBL4649875,8.39,False,http://www.openphacts.org/units/Nanomolar,3485145,=,1,True,=,,IC50,nM,,4.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.1
4447,,20691682,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '19.44', 'le': '0.38', 'lle': '4.10', 'sei': '8.07'}",CHEMBL4647567,,CHEMBL4647567,8.00,False,http://www.openphacts.org/units/Nanomolar,3485146,=,1,True,=,,IC50,nM,,10.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,10.0
4448,,20691683,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '19.97', 'le': '0.39', 'lle': '4.53', 'sei': '8.69'}",CHEMBL4643871,,CHEMBL4643871,8.62,False,http://www.openphacts.org/units/Nanomolar,3485147,=,1,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
4449,,20691684,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '20.07', 'le': '0.39', 'lle': '4.77', 'sei': '8.69'}",CHEMBL4642013,,CHEMBL4642013,8.62,False,http://www.openphacts.org/units/Nanomolar,3485148,=,1,True,=,,IC50,nM,,2.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2.4
4450,,20691685,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](C)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '18.06', 'le': '0.35', 'lle': '3.33', 'sei': '7.79'}",CHEMBL4647594,,CHEMBL4647594,7.72,False,http://www.openphacts.org/units/Nanomolar,3485149,=,1,True,=,,IC50,nM,,19.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,19.0
4451,,20691686,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCC(F)(F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '18.61', 'le': '0.37', 'lle': '3.98', 'sei': '8.44'}",CHEMBL4648202,,CHEMBL4648202,8.37,False,http://www.openphacts.org/units/Nanomolar,3485150,=,1,True,=,,IC50,nM,,4.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4.3
4452,,20691687,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '18.70', 'le': '0.37', 'lle': '4.18', 'sei': '8.10'}",CHEMBL4645368,,CHEMBL4645368,8.03,False,http://www.openphacts.org/units/Nanomolar,3485151,=,1,True,=,,IC50,nM,,9.3,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,9.3
4453,,20691688,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(Nc3cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn3)cc2s1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '18.17', 'le': '0.36', 'lle': '3.70', 'sei': '8.16'}",CHEMBL4643371,,CHEMBL4643371,8.10,False,http://www.openphacts.org/units/Nanomolar,3485152,=,1,True,=,,IC50,nM,,8.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.0
4454,,20691689,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '19.55', 'le': '0.38', 'lle': '4.97', 'sei': '7.55'}",CHEMBL4645407,,CHEMBL4645407,8.46,False,http://www.openphacts.org/units/Nanomolar,3485153,=,1,True,=,,IC50,nM,,3.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.5
4455,,20691690,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccc3nonc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '19.35', 'le': '0.37', 'lle': '5.04', 'sei': '6.44'}",CHEMBL4649636,,CHEMBL4649636,8.06,False,http://www.openphacts.org/units/Nanomolar,3485154,=,1,True,=,,IC50,nM,,8.7,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,8.7
4456,,20691691,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccn3nccc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '19.99', 'le': '0.38', 'lle': '5.15', 'sei': '8.00'}",CHEMBL4641886,,CHEMBL4641886,8.28,False,http://www.openphacts.org/units/Nanomolar,3485155,=,1,True,=,,IC50,nM,,5.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,5.2
4457,,20691692,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '20.45', 'le': '0.39', 'lle': '5.96', 'sei': '7.29'}",CHEMBL4641090,,CHEMBL4641090,8.49,False,http://www.openphacts.org/units/Nanomolar,3485156,=,1,True,=,,IC50,nM,,3.2,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.2
4458,,20691693,[],CHEMBL4625630,Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cc(Nc2nc3ccnn3cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '19.54', 'le': '0.37', 'lle': '5.80', 'sei': '7.27'}",CHEMBL4634922,,CHEMBL4634922,8.47,False,http://www.openphacts.org/units/Nanomolar,3485157,=,1,True,=,,IC50,nM,,3.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,3.4
4459,,20691694,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.51', 'le': '0.28', 'lle': '3.22', 'sei': '5.46'}",CHEMBL4075955,,CHEMBL4075955,6.52,False,http://www.openphacts.org/units/Nanomolar,3485137,=,1,True,=,,IC50,nM,,300.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,300.0
4460,,20691695,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '12.77', 'le': '0.24', 'lle': '1.73', 'sei': '5.58'}",CHEMBL4079743,,CHEMBL4079743,5.54,False,http://www.openphacts.org/units/Nanomolar,3485138,=,1,True,=,,IC50,nM,,2900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2900.0
4461,,20691696,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '15.66', 'le': '0.30', 'lle': '1.74', 'sei': '6.77'}",CHEMBL4633251,,CHEMBL4633251,5.35,False,http://www.openphacts.org/units/Nanomolar,3485139,=,1,True,=,,IC50,nM,,4500.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,4500.0
4462,,20691697,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '11.59', 'le': '0.23', 'lle': '2.04', 'sei': '4.26'}",CHEMBL4636136,,CHEMBL4636136,5.92,False,http://www.openphacts.org/units/Nanomolar,3485140,=,1,True,=,,IC50,nM,,1200.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1200.0
4463,Not Determined,20691698,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4639599,,CHEMBL4639599,,False,,3485141,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4464,Not Determined,20691699,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4644871,,CHEMBL4644871,,False,,3485142,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4465,Not Determined,20691700,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4632511,,CHEMBL4632511,,False,,3485143,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4466,,20691701,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCCO,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '13.39', 'le': '0.26', 'lle': '1.79', 'sei': '5.20'}",CHEMBL4648225,,CHEMBL4648225,5.16,False,http://www.openphacts.org/units/Nanomolar,3485144,=,1,True,=,,IC50,nM,,6900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,6900.0
4467,,20691702,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '15.81', 'le': '0.31', 'lle': '2.39', 'sei': '6.59'}",CHEMBL4649875,,CHEMBL4649875,6.54,False,http://www.openphacts.org/units/Nanomolar,3485145,=,1,True,=,,IC50,nM,,290.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,290.0
4468,,20691703,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '15.89', 'le': '0.31', 'lle': '2.64', 'sei': '6.59'}",CHEMBL4647567,,CHEMBL4647567,6.54,False,http://www.openphacts.org/units/Nanomolar,3485146,=,1,True,=,,IC50,nM,,290.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,290.0
4469,,20691704,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.64', 'le': '0.29', 'lle': '2.23', 'sei': '6.37'}",CHEMBL4643871,,CHEMBL4643871,6.32,False,http://www.openphacts.org/units/Nanomolar,3485147,=,1,True,=,,IC50,nM,,480.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,480.0
4470,,20691705,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '15.46', 'le': '0.30', 'lle': '2.79', 'sei': '6.69'}",CHEMBL4642013,,CHEMBL4642013,6.64,False,http://www.openphacts.org/units/Nanomolar,3485148,=,1,True,=,,IC50,nM,,230.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,230.0
4471,,20691706,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](C)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '12.95', 'le': '0.25', 'lle': '1.15', 'sei': '5.58'}",CHEMBL4647594,,CHEMBL4647594,5.54,False,http://www.openphacts.org/units/Nanomolar,3485149,=,1,True,=,,IC50,nM,,2900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2900.0
4472,,20691707,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCC(F)(F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '13.89', 'le': '0.28', 'lle': '1.85', 'sei': '6.30'}",CHEMBL4648202,,CHEMBL4648202,6.24,False,http://www.openphacts.org/units/Nanomolar,3485150,=,1,True,=,,IC50,nM,,570.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,570.0
4473,,20691708,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)[C@@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.29', 'le': '0.28', 'lle': '2.29', 'sei': '6.19'}",CHEMBL4645368,,CHEMBL4645368,6.14,False,http://www.openphacts.org/units/Nanomolar,3485151,=,1,True,=,,IC50,nM,,730.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,730.0
4474,,20691709,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2ccc(Nc3cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn3)cc2s1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '12.95', 'le': '0.25', 'lle': '1.37', 'sei': '5.82'}",CHEMBL4643371,,CHEMBL4643371,5.77,False,http://www.openphacts.org/units/Nanomolar,3485152,=,1,True,=,,IC50,nM,,1700.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1700.0
4475,,20691710,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '15.02', 'le': '0.30', 'lle': '3.00', 'sei': '5.80'}",CHEMBL4645407,,CHEMBL4645407,6.50,False,http://www.openphacts.org/units/Nanomolar,3485153,=,1,True,=,,IC50,nM,,320.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,320.0
4476,,20691711,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccc3nonc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.87', 'le': '0.28', 'lle': '3.17', 'sei': '4.95'}",CHEMBL4649636,,CHEMBL4649636,6.19,False,http://www.openphacts.org/units/Nanomolar,3485154,=,1,True,=,,IC50,nM,,640.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,640.0
4477,,20691712,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccn3nccc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '15.41', 'le': '0.29', 'lle': '3.26', 'sei': '6.17'}",CHEMBL4641886,,CHEMBL4641886,6.39,False,http://www.openphacts.org/units/Nanomolar,3485155,=,1,True,=,,IC50,nM,,410.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,410.0
4478,,20691713,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '16.85', 'le': '0.32', 'lle': '4.47', 'sei': '6.01'}",CHEMBL4641090,,CHEMBL4641090,7.00,False,http://www.openphacts.org/units/Nanomolar,3485156,=,1,True,=,,IC50,nM,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,100.0
4479,,20691714,[],CHEMBL4625631,Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cc(Nc2nc3ccnn3cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.84', 'le': '0.28', 'lle': '3.76', 'sei': '5.52'}",CHEMBL4634922,,CHEMBL4634922,6.43,False,http://www.openphacts.org/units/Nanomolar,3485157,=,1,True,=,,IC50,nM,,370.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,370.0
4480,Not Determined,20691715,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4639599,,CHEMBL4639599,,False,,3485141,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4481,Not Determined,20691716,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4644871,,CHEMBL4644871,,False,,3485142,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4482,Not Determined,20691717,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CCCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4632511,,CHEMBL4632511,,False,,3485143,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4483,Not Determined,20691718,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCCO,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4648225,,CHEMBL4648225,,False,,3485144,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4484,,20691719,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCC(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.41', 'le': '0.28', 'lle': '1.81', 'sei': '6.01'}",CHEMBL4649875,,CHEMBL4649875,5.96,False,http://www.openphacts.org/units/Nanomolar,3485145,=,1,True,=,,IC50,nM,,1100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1100.0
4485,,20691720,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.69', 'le': '0.28', 'lle': '2.15', 'sei': '6.10'}",CHEMBL4647567,,CHEMBL4647567,6.05,False,http://www.openphacts.org/units/Nanomolar,3485146,=,1,True,=,,IC50,nM,,900.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,900.0
4486,,20691721,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '13.21', 'le': '0.26', 'lle': '1.61', 'sei': '5.75'}",CHEMBL4643871,,CHEMBL4643871,5.70,False,http://www.openphacts.org/units/Nanomolar,3485147,=,1,True,=,,IC50,nM,,2000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2000.0
4487,,20691722,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.18', 'le': '0.28', 'lle': '2.24', 'sei': '6.14'}",CHEMBL4642013,,CHEMBL4642013,6.09,False,http://www.openphacts.org/units/Nanomolar,3485148,=,1,True,=,,IC50,nM,,810.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,810.0
4488,Not Determined,20691723,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](C)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4647594,,CHEMBL4647594,,False,,3485149,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4489,,20691724,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCC(F)(F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '12.35', 'le': '0.24', 'lle': '1.16', 'sei': '5.60'}",CHEMBL4648202,,CHEMBL4648202,5.55,False,http://www.openphacts.org/units/Nanomolar,3485150,=,1,True,=,,IC50,nM,,2800.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,2800.0
4490,Not Determined,20691725,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)(O)[C@@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,,CHEMBL4645368,,CHEMBL4645368,,False,,3485151,,1,False,,,IC50,,,,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,,,,
4491,,20691726,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,Cc1nc2ccc(Nc3cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn3)cc2s1,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '11.04', 'le': '0.22', 'lle': '0.52', 'sei': '4.96'}",CHEMBL4643371,,CHEMBL4643371,4.92,False,http://www.openphacts.org/units/Nanomolar,3485152,=,1,True,=,,IC50,nM,,12000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,12000.0
4492,,20691727,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '13.72', 'le': '0.27', 'lle': '2.45', 'sei': '5.30'}",CHEMBL4645407,,CHEMBL4645407,5.94,False,http://www.openphacts.org/units/Nanomolar,3485153,=,1,True,=,,IC50,nM,,1160.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,1160.0
4493,,20691728,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccc3nonc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '16.03', 'le': '0.30', 'lle': '3.66', 'sei': '5.33'}",CHEMBL4649636,,CHEMBL4649636,6.68,False,http://www.openphacts.org/units/Nanomolar,3485154,=,1,True,=,,IC50,nM,,210.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,210.0
4494,,20691729,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccn3nccc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '14.93', 'le': '0.28', 'lle': '3.06', 'sei': '5.97'}",CHEMBL4641886,,CHEMBL4641886,6.19,False,http://www.openphacts.org/units/Nanomolar,3485155,=,1,True,=,,IC50,nM,,650.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,650.0
4495,,20691730,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '15.57', 'le': '0.29', 'lle': '3.94', 'sei': '5.55'}",CHEMBL4641090,,CHEMBL4641090,6.47,False,http://www.openphacts.org/units/Nanomolar,3485156,=,1,True,=,,IC50,nM,,340.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,340.0
4496,,20691731,[],CHEMBL4625632,Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA,B,,,BAO_0000190,BAO_0000221,tissue-based format,CC(C)Nc1cc(Nc2nc3ccnn3cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O,,,CHEMBL4622963,ACS Med Chem Lett,2020.0,"{'bei': '13.93', 'le': '0.27', 'lle': '3.37', 'sei': '5.18'}",CHEMBL4634922,,CHEMBL4634922,6.04,False,http://www.openphacts.org/units/Nanomolar,3485157,=,1,True,=,,IC50,nM,,920.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,IC50,nM,UO_0000065,,920.0
4497,Not Active,20717625,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F,,,CHEMBL4507312,,2021.0,,CHEMBL3589752,IPP/CNRS-A017,CHEMBL3589752,,False,http://qudt.org/vocab/unit#Percent,3359753,,54,False,,,% Control,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,95.0
4498,Not Active,20718187,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O,,,CHEMBL4507305,,2021.0,,CHEMBL4082756,TP-024,CHEMBL4082756,,False,http://qudt.org/vocab/unit#Percent,3359739,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4499,Not Active,20718655,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1,,,CHEMBL4507305,,2021.0,,CHEMBL4100408,TP-024n,CHEMBL4100408,,False,http://qudt.org/vocab/unit#Percent,3359740,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4500,Not Active,20719524,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,,,CHEMBL4507274,,2021.0,,CHEMBL1971943,BAY-549,CHEMBL1971943,,False,http://qudt.org/vocab/unit#Percent,3359677,,54,False,,,% Control,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,85.0
4501,Not Active,20719992,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21,,,CHEMBL4507274,,2021.0,,CHEMBL4546802,BAY-4900,CHEMBL4546802,,False,http://qudt.org/vocab/unit#Percent,3359678,,54,False,,,% Control,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,90.0
4502,Not Active,20721006,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,,,CHEMBL4507261,,2021.0,,CHEMBL332794,A-192621,CHEMBL332794,,False,http://qudt.org/vocab/unit#Percent,3359651,,54,False,,,% Control,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,76.0
4503,Not Active,20721474,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1,,,CHEMBL4507261,,2021.0,,CHEMBL4533479,A-1806262,CHEMBL4533479,,False,http://qudt.org/vocab/unit#Percent,3359652,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4504,Not Active,20722068,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1,,,CHEMBL4507279,,2021.0,,CHEMBL2170610,BI 9627,CHEMBL2170610,,False,http://qudt.org/vocab/unit#Percent,3359687,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4505,Not Active,20722536,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1,,,CHEMBL4507279,,2021.0,,CHEMBL4540759,BI 0054,CHEMBL4540759,,False,http://qudt.org/vocab/unit#Percent,3359688,,54,False,,,% Control,%,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,89.0
4506,Not Active,20723156,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,,,CHEMBL4507277,,2021.0,,CHEMBL3358954,BI 653048,CHEMBL3358954,,False,http://qudt.org/vocab/unit#Percent,3359683,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4507,Not Active,20723624,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1,,,CHEMBL4507277,,2021.0,,CHEMBL4531220,BI 3047,CHEMBL4531220,,False,http://qudt.org/vocab/unit#Percent,3359684,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4508,Not Active,20724190,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,,,CHEMBL4507289,,2021.0,,CHEMBL3609637,GSM1,CHEMBL3609637,,False,http://qudt.org/vocab/unit#Percent,3359707,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4509,Not Active,20724658,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,,,CHEMBL4507289,,2021.0,,CHEMBL4534005,GSM-NC,CHEMBL4534005,,False,http://qudt.org/vocab/unit#Percent,3359708,,54,False,,,% Control,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,95.0
4510,Not Active,20725280,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C,,,CHEMBL4507284,,2021.0,,CHEMBL4588900,BI 1230,CHEMBL4588900,,False,http://qudt.org/vocab/unit#Percent,3359697,,54,False,,,% Control,%,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,71.0
4511,Not Active,20725748,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1,,,CHEMBL4507284,,2021.0,,CHEMBL4516471,BI 1675,CHEMBL4516471,,False,http://qudt.org/vocab/unit#Percent,3359698,,54,False,,,% Control,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,88.0
4512,Not Active,20726321,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1,,,CHEMBL4507318,,2021.0,,CHEMBL4537673,BAY-985,CHEMBL4537673,,False,http://qudt.org/vocab/unit#Percent,3359764,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4513,Slightly Active,20726789,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl,,,CHEMBL4507318,,2021.0,,CHEMBL4538591,BAY-440,CHEMBL4538591,,False,http://qudt.org/vocab/unit#Percent,3359765,,54,False,,,% Control,%,,39.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,39.0
4514,Not Active,20727406,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1,,,CHEMBL4507282,,2021.0,,CHEMBL4530740,BI 1950,CHEMBL4530740,,False,http://qudt.org/vocab/unit#Percent,3359693,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4515,Not Active,20727874,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21,,,CHEMBL4507282,,2021.0,,CHEMBL4577237,BI 9446,CHEMBL4577237,,False,http://qudt.org/vocab/unit#Percent,3359694,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4516,Not Active,20728495,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,,,CHEMBL4507273,,2021.0,,CHEMBL4535474,BAY-293,CHEMBL4535474,,False,http://qudt.org/vocab/unit#Percent,3359675,,54,False,,,% Control,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,76.0
4517,Not Active,20728963,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,,,CHEMBL4507273,,2021.0,,CHEMBL4520788,BAY-294,CHEMBL4520788,,False,http://qudt.org/vocab/unit#Percent,3359676,,54,False,,,% Control,%,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,89.0
4518,Not Active,20729573,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4631193,IRAK4(h) Eurofins Kinase panel,B,,,BAO_0000179,BAO_0000357,single protein format,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,,,CHEMBL4507268,,2021.0,,CHEMBL4445670,BAY-885,CHEMBL4445670,,False,http://qudt.org/vocab/unit#Percent,3359665,,54,False,,,% residual kinase activity,%,,106.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% residual kinase activity,%,UO_0000187,,106.0
4519,Not Active,20730001,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,,,CHEMBL4507268,,2021.0,,CHEMBL4445670,BAY-885,CHEMBL4445670,,False,http://qudt.org/vocab/unit#Percent,3359665,,54,False,,,% Control,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,90.0
4520,Not Active,20730469,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1,,,CHEMBL4507268,,2021.0,,CHEMBL4455582,BAY-693,CHEMBL4455582,,False,http://qudt.org/vocab/unit#Percent,3359666,,54,False,,,% Control,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,90.0
4521,Not Active,20731051,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1,,,CHEMBL4507324,,2021.0,,CHEMBL4591082,SR-302,CHEMBL4591082,,False,http://qudt.org/vocab/unit#Percent,3359776,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4522,Not Active,20731519,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1,,,CHEMBL4507324,,2021.0,,CHEMBL4568183,SR-301,CHEMBL4568183,,False,http://qudt.org/vocab/unit#Percent,3359777,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4523,Not Active,20731991,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12,,,CHEMBL4507303,,2021.0,,CHEMBL3799512,TP-004,CHEMBL3799512,,False,http://qudt.org/vocab/unit#Percent,3359735,,54,False,,,% Control,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,94.0
4524,Not Active,20732587,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,,,CHEMBL4507278,,2021.0,,CHEMBL4456123,BI 639667,CHEMBL4456123,,False,http://qudt.org/vocab/unit#Percent,3359685,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4525,Not Active,20733055,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1,,,CHEMBL4507278,,2021.0,,CHEMBL4539555,BI 9307,CHEMBL4539555,,False,http://qudt.org/vocab/unit#Percent,3359686,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4526,Not Active,20733745,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,,,CHEMBL4507266,,2021.0,,CHEMBL4537788,BAY-784,CHEMBL4537788,,False,http://qudt.org/vocab/unit#Percent,3359661,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4527,Not Active,20734213,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1,,,CHEMBL4507266,,2021.0,,CHEMBL4564312,BAY-786,CHEMBL4564312,,False,http://qudt.org/vocab/unit#Percent,3359662,,54,False,,,% Control,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,90.0
4528,Not Active,20734955,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1,,,CHEMBL4507269,,2021.0,,CHEMBL4630644,BAY-386,CHEMBL4630644,,False,http://qudt.org/vocab/unit#Percent,3359667,,54,False,,,% Control,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,80.0
4529,Not Active,20735423,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1,,,CHEMBL4507269,,2021.0,,CHEMBL4630643,BAY-448,CHEMBL4630643,,False,http://qudt.org/vocab/unit#Percent,3359668,,54,False,,,% Control,%,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,83.0
4530,Not Active,20735990,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4510434,IRAK4 Kinase screen,B,,,BAO_0000201,BAO_0000357,single protein format,C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4507291,,2021.0,,CHEMBL4098877,MLi-2,CHEMBL4098877,,False,http://qudt.org/vocab/unit#Percent,3359711,,54,True,,,Inhibition,%,,-13.86,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Inhibition,%,UO_0000187,,-13.8588
4531,Not Active,20736526,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1,,,CHEMBL4507291,,2021.0,,CHEMBL4098877,MLi-2,CHEMBL4098877,,False,http://qudt.org/vocab/unit#Percent,3359711,,54,False,,,% Control,%,,90.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,90.0
4532,Not Active,20736994,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1,,,CHEMBL4507291,,2021.0,,CHEMBL4560589,MLi-2-NC,CHEMBL4560589,,False,http://qudt.org/vocab/unit#Percent,3359712,,54,False,,,% Control,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,76.0
4533,Not Active,20737629,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O,,,CHEMBL4507264,,2021.0,,CHEMBL4585243,BAY-7598,CHEMBL4585243,,False,http://qudt.org/vocab/unit#Percent,3359657,,54,False,,,% Control,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,76.0
4534,Not Active,20738097,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O,,,CHEMBL4507264,,2021.0,,CHEMBL4539943,BAY-694,CHEMBL4539943,,False,http://qudt.org/vocab/unit#Percent,3359658,,54,False,,,% Control,%,,76.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,76.0
4535,,20738643,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4512543,IRAK4(IRK4LGF1) Takeda global kinase panel,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,,,CHEMBL4507327,,2021.0,,CHEMBL4088216,TP-030-1,CHEMBL4088216,,False,http://www.openphacts.org/units/Nanomolar,3359782,,54,True,,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.0
4536,Not Active,20738929,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4511096,IRAK4 Kinase activity screen,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1,,,CHEMBL4507307,,2021.0,,CHEMBL4531334,T3-CLK,CHEMBL4531334,,False,http://qudt.org/vocab/unit#Percent,3359743,,54,True,,,Inhibition,%,,42.39,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% inhibition,%,UO_0000187,,42.3886
4537,Not Active,20738930,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '0.1', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '0.1'}]",CHEMBL4511096,IRAK4 Kinase activity screen,B,,,BAO_0000201,BAO_0000357,single protein format,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1,,,CHEMBL4507307,,2021.0,,CHEMBL4531334,T3-CLK,CHEMBL4531334,,False,http://qudt.org/vocab/unit#Percent,3359743,,54,True,,,Inhibition,%,,25.34,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% inhibition,%,UO_0000187,,25.341
4538,Not Active,20739254,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4631537,IRAK4(h) Eurofins kinase panel,B,,,BAO_0000179,BAO_0000357,single protein format,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12,,,CHEMBL4507319,,2021.0,,CHEMBL4580220,BAY-3827,CHEMBL4580220,,False,http://qudt.org/vocab/unit#Percent,3359766,,54,False,,,% residual kinase activity,%,,103.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% residual kinase activity,%,UO_0000187,,103.0
4539,Not Active,20739705,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12,,,CHEMBL4507319,,2021.0,,CHEMBL4580220,BAY-3827,CHEMBL4580220,,False,http://qudt.org/vocab/unit#Percent,3359766,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4540,Active,20740173,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1,,,CHEMBL4507319,,2021.0,,CHEMBL4630642,BAY-974,CHEMBL4630642,,False,http://qudt.org/vocab/unit#Percent,3359767,,54,False,,,% Control,%,,7.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,7.5
4541,Not Active,20740865,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '3.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '3.0'}]",CHEMBL4509625,IRAK4 Invitrogen selectivity data (BI),B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,,,CHEMBL4507276,,2021.0,,CHEMBL3417525,BI 665915,CHEMBL3417525,,False,http://qudt.org/vocab/unit#Percent,3359681,,54,False,,,% Ctrl,%,,102.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Ctrl,%,UO_0000187,,102.5
4542,Not Active,20741258,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1,,,CHEMBL4507276,,2021.0,,CHEMBL3417525,BI 665915,CHEMBL3417525,,False,http://qudt.org/vocab/unit#Percent,3359681,,54,False,,,% Control,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,85.0
4543,Not Active,20741726,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1,,,CHEMBL4507276,,2021.0,,CHEMBL4560241,BI 0153,CHEMBL4560241,,False,http://qudt.org/vocab/unit#Percent,3359682,,54,False,,,% Control,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,84.0
4544,Not Active,20742548,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '10.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '10.0'}]",CHEMBL4510065,IRAK4 Invitrogen selectivity data (BI),B,,,BAO_0000179,BAO_0000357,single protein format,CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1,,,CHEMBL4507281,,2021.0,,CHEMBL1939876,BI 4394,CHEMBL1939876,,False,http://qudt.org/vocab/unit#Percent,3359691,,54,False,,,% Ctrl,%,,121.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Ctrl,%,UO_0000187,,121.0
4545,Not Active,20742799,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1,,,CHEMBL4507281,,2021.0,,CHEMBL1939876,BI 4394,CHEMBL1939876,,False,http://qudt.org/vocab/unit#Percent,3359691,,54,False,,,% Control,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,91.0
4546,Not Active,20743267,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1,,,CHEMBL4507281,,2021.0,,CHEMBL1939880,BI 4395,CHEMBL1939880,,False,http://qudt.org/vocab/unit#Percent,3359692,,54,False,,,% Control,%,,71.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,71.0
4547,Not Active,20743841,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1,,,CHEMBL4507300,,2021.0,,CHEMBL3337894,T-26c,CHEMBL3337894,,False,http://qudt.org/vocab/unit#Percent,3359729,,54,False,,,% Control,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,85.0
4548,Not Active,20744492,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCC(=N\O)/C(C)=C/c1ccc(F)cc1,,,CHEMBL4507256,,2021.0,,CHEMBL3697701,A-079,CHEMBL3697701,,False,http://qudt.org/vocab/unit#Percent,3359641,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4549,Not Active,20744960,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1,,,CHEMBL4507256,,2021.0,,CHEMBL3701197,A-226,CHEMBL3701197,,False,http://qudt.org/vocab/unit#Percent,3359642,,54,False,,,% Control,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,95.0
4550,Not Active,20745702,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,,,CHEMBL4507288,,2021.0,,CHEMBL1091513,MRK-560,CHEMBL1091513,,False,http://qudt.org/vocab/unit#Percent,3359705,,54,False,,,% Control,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,97.0
4551,Not Active,20746432,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1,,,CHEMBL4507298,,2021.0,,CHEMBL3286797,PF-04418948,CHEMBL3286797,,False,http://qudt.org/vocab/unit#Percent,3359725,,54,False,,,% Control,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,87.0
4552,Not Active,20747208,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1,,,CHEMBL4507310,,2021.0,,CHEMBL4228713,A-1211212,CHEMBL4228713,,False,http://qudt.org/vocab/unit#Percent,3359749,,54,False,,,% Control,%,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,83.0
4553,Not Active,20747676,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1,,,CHEMBL4507310,,2021.0,,CHEMBL4551344,A-1210227,CHEMBL4551344,,False,http://qudt.org/vocab/unit#Percent,3359750,,54,False,,,% Control,%,,85.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,85.0
4554,Not Active,20748188,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4511815,IRAK4 ProQinase selectivity panel,B,,,BAO_0000179,BAO_0000357,single protein format,O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21,,,CHEMBL4507316,,2021.0,,CHEMBL2152944,Skepinone-L,CHEMBL2152944,,False,http://qudt.org/vocab/unit#Percent,3359761,,54,False,,,% Residual activity with Skepinone-L,%,,104.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Residual activity with Skepinone-L,%,UO_0000187,,104.0
4555,Not Active,20748760,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,,,CHEMBL4507295,,2021.0,,CHEMBL1800285,MSD-M1PAM,CHEMBL1800285,,False,http://qudt.org/vocab/unit#Percent,3359719,,54,False,,,% Control,%,,83.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,83.0
4556,Not Active,20749228,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1,,,CHEMBL4507295,,2021.0,,CHEMBL2204283,MSD-M1PAM-NC,CHEMBL2204283,,False,http://qudt.org/vocab/unit#Percent,3359720,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4557,Not Active,20749952,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1,,,CHEMBL4507311,,2021.0,,CHEMBL3342332,A-1155463,CHEMBL3342332,,False,http://qudt.org/vocab/unit#Percent,3359751,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4558,Not Active,20750510,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,,,CHEMBL4507280,,2021.0,,CHEMBL1834184,BI 99179,CHEMBL1834184,,False,http://qudt.org/vocab/unit#Percent,3359689,,54,False,,,% Control,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,87.0
4559,Not Active,20750978,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1,,,CHEMBL4507280,,2021.0,,CHEMBL1834199,BI 99990,CHEMBL1834199,,False,http://qudt.org/vocab/unit#Percent,3359690,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4560,Not Active,20751545,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12,,,CHEMBL4507287,,2021.0,,CHEMBL204232,NAPHTHYRIDINONE,CHEMBL204232,,False,http://qudt.org/vocab/unit#Percent,3359703,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4561,Not Active,20752013,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O,,,CHEMBL4507287,,2021.0,,CHEMBL4578164,MRL-CB1-NC,CHEMBL4578164,,False,http://qudt.org/vocab/unit#Percent,3359704,,54,False,,,% Control,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,95.0
4562,Not Active,20752671,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,,,CHEMBL4507297,,2021.0,,CHEMBL1651534,PF-04457845,CHEMBL1651534,,False,http://qudt.org/vocab/unit#Percent,3359723,,54,False,,,% Control,%,,97.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,97.0
4563,Not Active,20753139,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(Nc1cccnn1)N1CC(CC=Cc2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1,,,CHEMBL4507297,,2021.0,,CHEMBL4567520,PF-04875474,CHEMBL4567520,,False,http://qudt.org/vocab/unit#Percent,3359724,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4564,Not Active,20754016,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1,,,CHEMBL4507292,,2021.0,,CHEMBL1800685,PPTN,CHEMBL1800685,,False,http://qudt.org/vocab/unit#Percent,3359713,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4565,Not Active,20754484,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12,,,CHEMBL4507292,,2021.0,,CHEMBL4566600,PPTN-NC,CHEMBL4566600,,False,http://qudt.org/vocab/unit#Percent,3359714,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4566,Not Active,20755232,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1,,,CHEMBL4507317,,2021.0,,CHEMBL4458424,BAY-899,CHEMBL4458424,,False,http://qudt.org/vocab/unit#Percent,3359762,,54,False,,,% Control,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,95.0
4567,Not Active,20755700,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1,,,CHEMBL4507317,,2021.0,,CHEMBL4592872,BAY-897,CHEMBL4592872,,False,http://qudt.org/vocab/unit#Percent,3359763,,54,False,,,% Control,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,96.0
4568,Not Active,20756372,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,,,,CHEMBL4507304,,2021.0,,CHEMBL4532510,TP-021,CHEMBL4532510,,False,http://qudt.org/vocab/unit#Percent,3359737,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4569,Not Active,20756840,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1,,,CHEMBL4507304,,2021.0,,CHEMBL4063249,TP-021n,CHEMBL4063249,,False,http://qudt.org/vocab/unit#Percent,3359738,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4570,Not Active,20757477,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,,,CHEMBL4507260,,2021.0,,CHEMBL440687,ABT-724,CHEMBL440687,,False,http://qudt.org/vocab/unit#Percent,3359649,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4571,Not Active,20757945,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1,,,CHEMBL4507260,,2021.0,,CHEMBL4630641,A-769,CHEMBL4630641,,False,http://qudt.org/vocab/unit#Percent,3359650,,54,False,,,% Control,%,,74.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,74.0
4572,Not Active,20758440,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1,,,CHEMBL4507270,,2021.0,,CHEMBL3907057,BAY-826,CHEMBL3907057,,False,http://qudt.org/vocab/unit#Percent,3359669,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4573,Not Active,20758910,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1,,,CHEMBL4507270,,2021.0,,CHEMBL4526351,BAY-309,CHEMBL4526351,,False,http://qudt.org/vocab/unit#Percent,3359670,,54,False,,,% Control,%,,98.4,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,98.4
4574,Not Active,20759542,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,,,CHEMBL4507299,,2021.0,,CHEMBL3137331,DEFACTINIB,CHEMBL3137331,,False,http://qudt.org/vocab/unit#Percent,3359727,,54,False,,,% Control,%,,92.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,92.0
4575,Not Active,20760010,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O,,,CHEMBL4507299,,2021.0,,CHEMBL4518706,PF-00911705,CHEMBL4518706,,False,http://qudt.org/vocab/unit#Percent,3359728,,54,False,,,% Control,%,,50.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,50.0
4576,Not Active,20760648,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4507265,,2021.0,,CHEMBL4521594,BAY-1797,CHEMBL4521594,,False,http://qudt.org/vocab/unit#Percent,3359659,,54,False,,,% Control,%,,91.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,91.0
4577,Not Active,20761116,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4507265,,2021.0,,CHEMBL4516843,BAY-207,CHEMBL4516843,,False,http://qudt.org/vocab/unit#Percent,3359660,,54,False,,,% Control,%,,61.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,61.0
4578,Not Active,20761612,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4508707,IRAK4 (h) Millipore kinase activity assay,B,,,BAO_0000201,BAO_0000357,single protein format,CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1,,,CHEMBL4507263,,2021.0,,CHEMBL4593677,BAY-474,CHEMBL4593677,,False,http://qudt.org/vocab/unit#Percent,3359655,,54,True,,,Inhibition,%,,0.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% inhibition,%,UO_0000187,,0.0
4579,Not Active,20762014,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1,,,CHEMBL4507263,,2021.0,,CHEMBL4522773,BAY-827,CHEMBL4522773,,False,http://qudt.org/vocab/unit#Percent,3359656,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4580,Not Active,20762693,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,,,CHEMBL4507267,,2021.0,,CHEMBL4448899,BAY-876,CHEMBL4448899,,False,http://qudt.org/vocab/unit#Percent,3359663,,54,False,,,% Control,%,,84.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,84.0
4581,Not Active,20763161,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1,,,CHEMBL4507267,,2021.0,,CHEMBL4552180,BAY-588,CHEMBL4552180,,False,http://qudt.org/vocab/unit#Percent,3359664,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4582,Not Active,20763822,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,,,CHEMBL4507257,,2021.0,,CHEMBL4586794,ABT-100,CHEMBL4586794,,False,http://qudt.org/vocab/unit#Percent,3359643,,54,False,,,% Control,%,,75.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,75.0
4583,Not Active,20764295,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1,,,CHEMBL4507257,,2021.0,,CHEMBL4526341,A-108,CHEMBL4526341,,False,http://qudt.org/vocab/unit#Percent,3359644,,54,False,,,% Control,%,,80.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,80.0
4584,,20764843,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4512256,IRAK4(IRK4LGF1) Takeda global kinase panel,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,,,CHEMBL4507326,,2021.0,,CHEMBL4549667,TP-030-2,CHEMBL4549667,,False,http://www.openphacts.org/units/Nanomolar,3359780,,54,True,,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.0
4585,,20765204,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '1.0'}]",CHEMBL4512830,IRAK4(IRK4LGF1) Takeda global kinase panel,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,,,CHEMBL4507327,,2021.0,,CHEMBL4097778,TP-030n,CHEMBL4097778,,False,http://www.openphacts.org/units/Nanomolar,3489319,,54,True,,,IC50,nM,,1000.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,pIC50,,UO_0000065,,6.0
4586,Not Active,20765696,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,,,CHEMBL4507320,,2021.0,,CHEMBL4568735,NVS-MALT1,CHEMBL4568735,,False,http://qudt.org/vocab/unit#Percent,3359768,,54,False,,,% Control,%,,88.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,88.0
4587,Not Active,20766164,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12,,,CHEMBL4507320,,2021.0,,CHEMBL4584981,NVS-MALT1-C,CHEMBL4584981,,False,http://qudt.org/vocab/unit#Percent,3359769,,54,False,,,% Control,%,,89.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,89.0
4588,Not Active,20766830,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,,,CHEMBL4507302,,2021.0,,CHEMBL4455357,TP-020,CHEMBL4455357,,False,http://qudt.org/vocab/unit#Percent,3359733,,54,False,,,% Control,%,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,82.0
4589,Not Active,20767298,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1,,,CHEMBL4507302,,2021.0,,CHEMBL4585920,TP-020n,CHEMBL4585920,,False,http://qudt.org/vocab/unit#Percent,3359734,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4590,Not Active,20767881,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1,,,CHEMBL4507286,,2021.0,,CHEMBL4538174,ERKi,CHEMBL4538174,,False,http://qudt.org/vocab/unit#Percent,3359701,,54,False,,,% Control,%,,76.1,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,76.1
4591,Not Active,20768368,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1,,,CHEMBL4507286,,2021.0,,CHEMBL4557026,ERKi-NC,CHEMBL4557026,,False,http://qudt.org/vocab/unit#Percent,3359702,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4592,Not Active,20769223,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2,,,CHEMBL4507293,,2021.0,,CHEMBL2204538,THPP-1,CHEMBL2204538,,False,http://qudt.org/vocab/unit#Percent,3359715,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4593,Not Active,20769691,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1,,,CHEMBL4507293,,2021.0,,CHEMBL4518342,THPP-1-NC,CHEMBL4518342,,False,http://qudt.org/vocab/unit#Percent,3359716,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4594,Not Active,20770431,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1,,,CHEMBL4507315,,2021.0,,CHEMBL4436748,SR-318,CHEMBL4436748,,False,http://qudt.org/vocab/unit#Percent,3359759,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4595,Not Active,20770899,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1,,,CHEMBL4507315,,2021.0,,CHEMBL4531775,SR-321,CHEMBL4531775,,False,http://qudt.org/vocab/unit#Percent,3359760,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4596,Not Active,20771443,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O,,,CHEMBL4507283,,2021.0,,CHEMBL4516982,BI 1935,CHEMBL4516982,,False,http://qudt.org/vocab/unit#Percent,3359695,,54,False,,,% Control,%,,96.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,96.0
4597,Not Active,20771971,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,,,CHEMBL4507290,,2021.0,,CHEMBL561132,MK-7246,CHEMBL561132,,False,http://qudt.org/vocab/unit#Percent,3359709,,54,False,,,% Control,%,,93.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,93.0
4598,Not Active,20772439,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1,,,CHEMBL4507290,,2021.0,,CHEMBL1643772,CRTH2-negative-control,CHEMBL1643772,,False,http://qudt.org/vocab/unit#Percent,3359710,,54,False,,,% Control,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,95.0
4599,Not Active,20773277,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1,,,CHEMBL4507294,,2021.0,,CHEMBL3582478,MSD-CYP11B2,CHEMBL3582478,,False,http://qudt.org/vocab/unit#Percent,3359717,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4600,Not Active,20773745,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,,,CHEMBL4507294,,2021.0,,CHEMBL3582461,MSD-CYP11B2-Negative-control,CHEMBL3582461,,False,http://qudt.org/vocab/unit#Percent,3359718,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4601,Not Active,20774394,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC,,,CHEMBL4507258,,2021.0,,CHEMBL111612,ABT-546,CHEMBL111612,,False,http://qudt.org/vocab/unit#Percent,3359645,,54,False,,,% Control,%,,67.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,67.5
4602,Not Active,20774869,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC,,,CHEMBL4507258,,2021.0,,CHEMBL4513786,A-545,CHEMBL4513786,,False,http://qudt.org/vocab/unit#Percent,3359646,,54,False,,,% Control,%,,94.5,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,94.5
4603,Not Active,20775451,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=c1nc(-c2ccccn2)sc2ccccc12,,,CHEMBL4507329,,2021.0,,CHEMBL4516611,BTZO-1,CHEMBL4516611,,False,http://qudt.org/vocab/unit#Percent,3359785,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4604,Not Active,20775917,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C1NC(c2ccccn2)Sc2ccccc21,,,CHEMBL4507329,,2021.0,,CHEMBL4561806,BTZO-4,CHEMBL4561806,,False,http://qudt.org/vocab/unit#Percent,3359786,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4605,Not Active,20776493,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,,,CHEMBL4507301,,2021.0,,CHEMBL3799292,(R)-9s,CHEMBL3799292,,False,http://qudt.org/vocab/unit#Percent,3359731,,54,False,,,% Control,%,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,82.0
4606,Not Active,20776961,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N,,,CHEMBL4507301,,2021.0,,CHEMBL3797887,(S)-9s,CHEMBL3797887,,False,http://qudt.org/vocab/unit#Percent,3359732,,54,False,,,% Control,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,87.0
4607,Not Active,20778031,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,,,CHEMBL4507259,,2021.0,,CHEMBL4282264,A-485,CHEMBL4282264,,False,http://qudt.org/vocab/unit#Percent,3359647,,54,False,,,% Control,%,,78.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,78.0
4608,Not Active,20778499,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O,,,CHEMBL4507259,,2021.0,,CHEMBL4536197,A-486,CHEMBL4536197,,False,http://qudt.org/vocab/unit#Percent,3359648,,54,False,,,% Control,%,,94.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,94.0
4609,Not Active,20779078,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1,,,CHEMBL4507272,,2021.0,,CHEMBL3617968,BAY-678,CHEMBL3617968,,False,http://qudt.org/vocab/unit#Percent,3359673,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4610,Not Active,20779801,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,,,CHEMBL4507262,,2021.0,,CHEMBL4093612,A-1596586,CHEMBL4093612,,False,http://qudt.org/vocab/unit#Percent,3359653,,54,False,,,% Control,%,,82.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,82.0
4611,Not Active,20780269,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1,,,CHEMBL4507262,,2021.0,,CHEMBL4066040,A-1596584,CHEMBL4066040,,False,http://qudt.org/vocab/unit#Percent,3359654,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4612,Not Active,20780884,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1,,,CHEMBL4507275,,2021.0,,CHEMBL4165749,BI 2545,CHEMBL4165749,,False,http://qudt.org/vocab/unit#Percent,3359679,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4613,Not Active,20781352,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1,,,CHEMBL4507275,,2021.0,,CHEMBL4552354,BI 3017,CHEMBL4552354,,False,http://qudt.org/vocab/unit#Percent,3359680,,54,False,,,% Control,%,,87.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,87.0
4614,Not Active,20781929,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1,,,CHEMBL4507285,,2021.0,,CHEMBL3685796,MRL-SYKi,CHEMBL3685796,,False,http://qudt.org/vocab/unit#Percent,3359699,,54,False,,,% Control,%,,100.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,100.0
4615,Slightly Active,20782398,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '100.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1,,,CHEMBL4507285,,2021.0,,CHEMBL4530401,MRL-SYKi-NC,CHEMBL4530401,,False,http://qudt.org/vocab/unit#Percent,3359700,,54,False,,,% Control,%,,48.8,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,48.8
4616,Not Active,20782984,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'nM', 'standard_value': '1000.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'nM', 'value': '1000.0'}]",CHEMBL4507537,KinomeScan assay: inhibition of IRAK4,B,,,BAO_0000179,BAO_0000357,single protein format,C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1,,,CHEMBL4507296,,2021.0,,CHEMBL3577885,PF-05105679,CHEMBL3577885,,False,http://qudt.org/vocab/unit#Percent,3359721,,54,False,,,% Control,%,,95.0,CHEMBL3778,Homo sapiens,Interleukin-1 receptor-associated kinase 4,9606,,,% Control,%,UO_0000187,,95.0
